Table of Contents - Issue
Recent articles
-
Prevalence of Malaria among Children between 3 and 59 Months Old in Two Healthcare Districts of Burkina Faso, 2020Author: Yanogo Pauline KiswendsidaDOI: 10.21522/TIJPH.2013.12.04.Art001
Prevalence of Malaria among Children between 3 and 59 Months Old in Two Healthcare Districts of Burkina Faso, 2020
Abstract:
Every 75 seconds, there’s a child below 5 years of age who is dying from malaria throughout the world. Burkina Faso, which also suffers from the ravages of malaria, has developed several strategies to respond to the disease including seasonal malaria chemoprophylaxis (SMC). To generate basic data available for the study of the efficacy of a supervised distribution of the 3 doses of SMC, we conducted this study outside of SMC campaigns to determine the prevalence of malaria among children between 3 and 59 months old in two healthcare districts. A transversal descriptive study was conducted on children in the healthcare districts of Boromo and Gaoua. Data were collected on sociodemographic, and clinical features as well as on knowledge and practices on prevention outside of SMC from December 10 to 24, 2020. The prevalence of malaria was calculated, globally, and in each district and compared to each other using a chi-square test. Among the 2440 children, those from 2 to 5 years were the most represented with 64.22% (p < 0.0001). A total of 83.93% of families had long-lasting insecticide-treated nets (LLINs) (p<0.0001) and 68.57% had used them (p =0.04). The overall prevalence of malaria was 4.75%; the ones in Boromo and Gaoua were respectively 3.63% and 6.60% p=0,034). This study showed a high prevalence of malaria among children between 3 and 59 months, especially in Gaoua. Interventions should target parents of children in this age group and focus on promoting the use of LLINs.
Prevalence of Malaria among Children between 3 and 59 Months Old in Two Healthcare Districts of Burkina Faso, 2020
References:
[1]. Carnevale, P. et Robert, V., éditeurs. (2009) Les anophèles: Biologie, transmission du Plasmodium et lutte antivectorielle [Internet]. IRD Éditions. https://doi.org/10.4000/books.irdeditions.10374.
[2]. WHO. (2023) Rapport 2023 sur le paludisme dans le monde [Internet]. https://www.who.int/fr/teams/global-malaria-programme/reports/world-malaria-report-2023.
[3]. Gentilini, M., Caumes, E., Danis, M., Mouchet, J., Duflo, B., Lagardère, B. et al. (1993) Médecine tropicale. https://horizon.documentation.ird.fr/exl-doc/pleins_textes/2021-08/39636.pdf.
[4]. WHO. (2021) Rapport 2021 sur le paludisme dans le monde, Principaux messages. https://cdn.who.int/media/docs/default-source/malaria/world-malaria-reports/world-malaria-report-2021-global-briefing-kit-fre.pdf.
[5]. Chilot, D., Mondelaers, A., Alem, A.Z., Asres, M.S., Yimer, M.A., Toni, A.T. et al. (2023) Pooled prevalence and risk factors of malaria among children aged 6-59 months in 13 sub-Saharan African countries: A multilevel analysis using recent malaria indicator surveys. PloS One, 18, e0285265. https://doi.org/10.1371/journal.pone.0285265.
[6]. WHO et RBM. (2018) High burden to high impact: A targeted malaria response. https://iris.who.int/bitstream/handle/10665/275868/WHO-CDS-GMP-2018.25-eng.pdf?sequence=1.
[7]. Ministère de la Santé et de l’Hygiène publique Burkina. (2022) Annuaire statistique 2021 [Internet]. http://cns.bf/IMG/pdf/annuaire_mshp_2021_signe.pdf.
[8]. Kouadio, A.S., Cissé, G., Obrist, B., Wyss, K. et Zingsstag, J. (2006) Fardeau économique du paludisme sur les ménages démunis des quartiers défavorisés d’Abidjan, Côte d’Ivoire. VertigO - la revue électronique en sciences de l’environnement, Les éditions en environnements VertigO. https://doi.org/10.4000/vertigo.1776.
[9]. World Health Organization. (2015) Global technical strategy for malaria 2016-2030 [Internet]. https://www.who.int/docs/default-source/documents/global-technical-strategy-for-malaria-2016-2030.pdf.
[10]. Oumar, A., BA, M., Diallo, D., Sanogo, M., Ousmane, F., Diawara, S. et al. (2020) Impact of seasonal malaria chemoprevention in children aged 3 to 59 months in the Kangaba and Kolokani health districts between 2013 and 2015. Revue malienne d’infectiologie et de microbiologie, 15, 54‑60. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225235/.
[11]. Ministère de la Santé et de l’Hygiène publique Burkina. (2020) Annuaire statistique 2020 [Internet]. https://www.sante.gov.bf/fileadmin/user_upload/storages/annuaire_statistique_ms_2020_signe.pdf.
[12]. Hayes, R.J. et Bennett, S. (1999) Simple sample size calculation for cluster-randomized trials. International Journal of Epidemiology, 28, 319‑26. https://doi.org/10.1093/ije/28.2.319.
[13]. WHO. (2021) Terminologie OMS du paludisme, Mise à jour 2021 [Internet]. https://www.who.int/fr/publications-detail/9789240038400.
[14]. Minstère de la Santé. du Burkina. (2018) Enquête sur les Indicateurs du Paludisme (EIPBF) 2017-2018 [Internet]. https://dhsprogram.com/pubs/pdf/MIS32/MIS32.pdf.
[15]. Mohammed, K., Salifu, M.G., Batung, E., Amoak, D., Avoka, V.A., Kansanga, M. et al. (2022) Spatial analysis of climatic factors and plasmodium falciparum malaria prevalence among children in Ghana. Spatial and Spatio-Temporal Epidemiology, 43, 100537. https://doi.org/10.1016/j.sste.2022.100537.
[16]. Abossie, A., Yohanes, T., Nedu, A., Tafesse, W. et Damitie, M. (2020) Prevalence of Malaria and Associated Risk Factors Among Febrile Children Under Five Years: A Cross-Sectional Study in Arba Minch Zuria District, South Ethiopia. Infection and Drug Resistance, 13, 363‑72. https://doi.org/10.2147/IDR.S223873.
[17]. Ministère de la santé. (2010) Directives nationales pour la prise en charge du paludisme dans les formations sanitaires du Burkina Faso [Internet]. https://pdf.usaid.gov/pdf_docs/PA00JPHB.pdf.
[18]. Musuyi, C.N., Djourdebbe, F.B. et Ekambi, E. (2021) Déterminants Individuels Et Contextuels Du Paludisme Chez Les Enfants De 6-59 Mois En République Démocratique Du Congo. European Scientific Journal, ESJ, 17, 94‑94. https://doi.org/10.19044/esj.2021.v17n7p94.
Viewed PDF 6 1 -
Comparison of Root Resorption in Primary Mandibular Molars in Radiograph and Actual ResorptionAuthor: Deepa GurunathanDOI: 10.21522/TIJPH.2013.12.04.Art006
Comparison of Root Resorption in Primary Mandibular Molars in Radiograph and Actual Resorption
Abstract:
The eruption of the primary dentition, their exfoliation due to root resorption, and then the eruption of the permanent dentition follow in an orderly sequence. After the apices close, initial resorption starts between one and three years later, and exfoliation happens about three years later.Radiographs of primary lower molar teeth among children in the age group 5 to 12 years were taken. Age Groups were divided into less than 8 years, 8 to 9 years, 10 to 11 years and 12 years or more from 2020 to 2023 around 250 patients data were collected. Digital radiographs (RVG) of the primary mandibular molar were used to measure the resorption in EZ DentI software. In the actual extracted tooth, the root resorption was measured with a scale from CEJ of the tooth to the resorbed apex for the mesial root & distal root respectively. Based on results obtained in the radiograph, the number of 79 teeth had < ¼ resorption, 86 teeth had ¼ - ¾ resorption and 85 teeth had > ¾ resorption. In actual teeth, the number of 75 had < ¼ resorption, 85 had ¼ - ¾ resorption and 90 had > ¾ resorption. The resorption was symmetrical in 115 teeth, maximum in the mesial root was seen in 75 and the maximum in the distal root was seen in 60. When comparing root resorption in IOPA to actual root resorption, there was not much of a difference in the degree of resorption.
Comparison of Root Resorption in Primary Mandibular Molars in Radiograph and Actual Resorption
References:
[1]. Turan Y, Akal N, Yildirim B, Kaymaz F, Baris E. Apoptosis in physiological root resorption of primary teeth. Niger J Clin Pract. 2023 Mar;26(3):307–13.
[2]. Sanjeev MN, Kaur H, Mayall SS, Rishika, Yeluri R. Resorbable Collagen Barrier Impeding the Extrusion of Obturating Material in Primary Molars Undergoing Resorption - A Randomized Clinical Trial. J Clin Pediatr Dent. 2021 Nov 1;45(5):312–6.
[3]. Datta P, Zahir S, Kundu GK, Dutta K. An in vitro study of the root canal system of human primary molars by using multidetector computed tomography. J Indian Soc Pedod Prev Dent. 2019 Apr-Jun;37(2):120–6.
[4]. Movahedian N, Abedi S, Memarpour M. Comparison of the Demirjian and Root Resorption Methods to Estimate Dental Age in Radiographic Images. J Dent Child. 2018 May 15;85(2):45–50.
[5]. Buldur B, Hascizmeci C, Aksoy S, Nur Aydin M, Guvendi ON. Apical extrusion of debris in primary molar root canals using mechanical and manual systems. Eur J Paediatr Dent. 2018 Mar;19(1):16–20.
[6]. Raslan N, Mansour O, Assfoura L. Evaluation of antibiotic mix in Non-instrumentation Endodontic Treatment of necrotic primary molars. Eur J Paediatr Dent. 2017 Dec;18(4):285–90.
[7]. Sahni A, Kapoor R, Gandhi K, Kumar D, Datta G, Malhotra R. A Comparative Evaluation of Efficacy of Electronic Apex Locator, Digital Radiography, and Conventional Radiographic Method for Root Canal Working Length Determination in Primary Teeth: An Study. Int J Clin Pediatr Dent. 2020 Sep-Oct;13(5):523–8.
[8]. Ricardi MP, De Toledo OA. [The physiologic root resorption of deciduous teeth (author’s transl)]. Arq Cent Estud Fac Odontol UFMG. 1974 Jul-Dec;11(2):217–30.
[9]. Wedenberg C. Development and Morphology of Internal Resorption in Teeth: A Study in Humans, Monkeys and Rats. 1987. 136 p.
[10]. Sruthi S, Gurunathan D. Working length of maxillary primary second molars in children aged 2-6 years-a retrospective study. Int J Dent Oral Sci. 2021;8(2):1780–4.
[11]. Saberi E, Zahedani SS, Ebrahimipour S. Apical Extrusion of Intracanal Bacteria with Single File and Multifile Rotary Instrumentation Systems. J Int Soc Prev Community Dent. 2017 Sep 18;7(5):292–6.
[12]. Assessment of working length of root canal in mandibular first primary molar in children aged between 2 to 6 years. Indian J Forensic Med Toxicol [Internet]. 2020 Oct 7.
[13]. WORKING LENGTH DETERMINATION IN MANDIBULAR PRIMARY SECOND MOLARS-A RETROSPECTIVE STUDY. Available from: https://archives.palarch.nl/index.php/jae/article/view/1447.
[14]. Taravati S, Balak Z, Rakhshan V. Diagnostic Accuracy of Periapical Radiography in Detection and Measurement of the External Root Resorption in Primary Molars: A Single-Blind Prospective Clinical Study. Int J Dent. 2022 Aug 3;2022:7031086.
[15]. Bezerra LM, Ando T. Various aspects of root resorption of the lower deciduous molars and the development of their successors and the lower first and second permanent molars. Rev Fac Odontol Sao Paulo. 1978 Jul-Dec;16(2):169–75.
[16]. Fuks A, Peretz B. Pediatric Endodontics: Current Concepts in Pulp Therapy for Primary and Young Permanent Teeth. Springer; 2016. 164 p.
[17]. Davidovitch Z ’ev. Biological Mechanisms of Tooth Eruption, Resorption and Replacement by Implants: Proceedings of the International Conference Held at the Sheraton Tara Hotel and Resort, Danvers, Massachusetts, October 21-24, 1993. 1994. 779 p.
[18]. Murthy P, Bhojraj N, Hegde U. Changes in Pulp and Roots of Deciduous Teeth during Different Stages of Physiologic Resorption: A Histologic Study. Int J Clin Pediatr Dent. 2023 May-Jun;16(3):437–43.
[19]. Yanoshita M, Hirose N, Onishi A, Nishiyama S, Kubo N, Kita D, et al. Orthodontic Treatment for a Patient with Root Resorption of All Four Maxillary Incisors due to Bilaterally Impacted Canines. Case Rep Dent. 2022 Sep 19;2022:5628030.
[20]. Calheiros-Lobo MJ, Costa F, Pinho T. Infraocclusion level and root resorption of the primary molar in second premolar agenesis: A retrospective cross-sectional study in the Portuguese population. Dent Med Probl. 2022 Apr-Jun;59(2):195–207.
[21]. Acharya S, Sahoo D, Singh B, Gurunathan D. Revascularization Revisited with Modified Triple Antibiotic Paste and NeoPutty MTA®. J Pharm Bioallied Sci. 2024 Apr;16(Suppl 2):S1871.
[22]. Saikiran KV, Gurunathan D, Nuvvula S, Jadadoddi RK, Kumar RH, Birapu UC. Prevalence of Dental Trauma and Their Relationship to Risk Factors among 8-15-Year-Old School Children. Int J Dent. 2022 Dec 22;2022:3343827.
[23]. Jeyashree T, Gurunathan D, Padmapriya S. Association of malocclusion and trauma in children: A retrospective study. J Adv Pharm Technol Res. 2022 Nov;13(Suppl 1):S212–6.
[24]. Gandhi JM, Gurunathan D. Short- and long-term dental arch spatial changes following premature loss of primary molars: A systematic review. J Indian Soc Pedod Prev Dent. 2022 Jul-Sep;40(3):239–45.
[25]. Suresh C, Gurunathan D, Padmapriya S. Prevalence of Class V caries in maxillary and mandibular canines of 3–5-year-old children: A retrospective study. J Adv Pharm Technol Res. 2022 Dec;13(Suppl 2):S584.
[26]. Varshini A, Gurunathan D, Padmapriya S. Prevalence of class I caries in the second mandibular primary molar in 3–6-year-old children. J Adv Pharm Technol Res. 2022 Nov;13(Suppl 1):S72.
[27]. Harini B, Gurunathan D, Padmapriya S. Prevalence of class I caries in the second maxillary primary molar in 3–6-year-old children: A retrospective study. J Adv Pharm Technol Res. 2022 Nov;13(Suppl 1):S190.
Viewed PDF 4 0 -
Improving Timeliness in Early Infant Diagnosis (EID) Services for HIV Exposed Infants in Zambia: The Impact of the Electronic Health Exposed Infant Monitoring Tool (EHEI_Mt)Author: Regina Mabenga MDOI: 10.21522/TIJPH.2013.12.04.Art002
Improving Timeliness in Early Infant Diagnosis (EID) Services for HIV Exposed Infants in Zambia: The Impact of the Electronic Health Exposed Infant Monitoring Tool (EHEI_Mt)
Abstract:
Over 1.2 million newborns are exposed to HIV annually, with Zambia contributing significantly due to its 21% HIV prevalence among pregnant women. Testing exposed infants is crucial for early diagnosis. This study utilized a case-control design study to evaluate the effectiveness of the Electronic Health Exposed Infant Monitoring tool in improving Early Infant Diagnosis services in the Kabwe and Chibombo districts of Zambia. Our study was conducted across 16 health facilities involving 248 infant-mother pairs aged 0 to 2 months. Of these, 163 pairs were enrolled into the EHEI_Mt system, while 85 pairs continued being tracked by the existing standard system. Both groups were monitored for 12 months using the electronic tool and Ministry of health standard systems. Descriptive analysis with Pearson Chi2-test was done to determine associations between the use of a tracking system for HIV Exposed infants and other explanatory variables. A stepwise, backward logistic regression model was fitted to predict factors associated with early infant diagnosis uptake. All analyses were done using STATA version 25 (Stata Corp, US Texas. No mother-related factors were significantly associated, but babies in the EHEI_Mt Tool group were more likely to keep appointments (p < 0.001), with 73% having a known HIV outcome compared to 22% in the Standard group. We recommend standalone electronic systems as a reminder for healthcare workers for better infant tracking and adherence. Further research on HIV-positive mothers ' perceptions of current early infant diagnosis health systems is needed to address gaps in the PMTCT program for improved outcomes.
Improving Timeliness in Early Infant Diagnosis (EID) Services for HIV Exposed Infants in Zambia: The Impact of the Electronic Health Exposed Infant Monitoring Tool (EHEI_Mt)
References:
[1]. Joint United Nations Programme on HIV/AIDS. (2023). Global report: UNAIDS report on the global AIDS epidemic. Geneva. Retrieved from http://www.unaids.org/globalreport/documents/20101123_GlobalReport_full_en.pdf.
[2]. Joint United Nations Programme on HIV/AIDS. (2010). Zambia country report: Monitoring the Declaration of Commitment on HIV and AIDS and the universal access: Biennial report. Geneva. Retrieved from http://www.unaids.org/en/dataanalysis/monitoringcountryprogress/2010progressreportssubmittedbycountries/zambia_2010_country_progress_report_en.pdf.
[3]. Finocchario-Kessler, S., Goggin, K., Khamadi, S., Gautney, B. (2015). Improving early infant HIV diagnosis in Kenya: Study protocol of a cluster-randomized efficacy trial of the HIT System. Implementation Science, 10, 96. https://doi.org/10.1186/s13012-015-0284-3.
[4]. Ministry of Health, Zambia. (2020). Zambia Consolidated Guidelines for Treatment and Prevention of HIV Infection 2020. Retrieved from https://www.moh.gov.zm/wp-content/uploads/filebase/Zambia-Consolidated-Guidelines-for-Treatment-and-Prevention-of-HIV-Infection-2020.pdf.
[5]. Ministry of Health, Zambia. (2023). National Health Strategic Plan for Zambia 2022 to 2026 (Revised February 2023) [PDF]. Retrieved from https://www.moh.gov.zm/wp-content/uploads/2023/02/National-Health-Stratergic-Plan-for-Zambia-2022-to-2026-revised-February-2023-lower-resolution.pdf.
[6]. Ahoua, L., Arikawa, S., Tiendrebeogo, T., Lahuerta, (2020). Measuring retention in care for HIV-positive pregnant women in Prevention of Mother-to-Child Transmission of HIV (PMTCT) option B+ programs: The Mozambique experience. BMC Public Health, 20(1), 322.https://doi.org/10.1186/s12889-020-8406-5.
[7]. Gumede-Moyo, S., Todd, J., Bond, V., Mee, P., & Filteau, S. (2019). A qualitative inquiry into implementing an electronic health record system (SmartCare) for prevention of mother-to-child transmission data in Zambia: A retrospective study. BMJ Open, 9(9), e030428.https://doi.org/10.1136/bmjopen-2019-030428.
[8]. Measure Evaluation. (2019). Testing a PMTCT Tracker in Zimbabwe_tr-19-333 [Technical Report]. Retrieved from https://www.measureevaluation.org/resources/publications/tr-19-333/at_download/document.
[9]. Brown, M., Wexler, C., Gautney, B., Goggin, K., Hurley, E. A., Odeny, B., Maloba, M., Lwembe, R., Sandbulte, M., & Finocchario-Kessler, S. (2019). eHealth Interventions for Early Infant Diagnosis: Mothers' Satisfaction with the HIV Infant Tracking System in Kenya. AIDS and Behaviour, 23(11), 3093-3102. doi:10.1007/s10461-019-02579-5.
[10]. Dunning, L., Kroon, M., Fourie, L., Ciaranello, A., & Myer, L. (2017). Impact of Birth HIV-PCR Testing on the Uptake of Follow-up Early Infant Diagnosis Services in Cape Town, South Africa. Paediatric Infectious Disease Journal, 36(12), 1159-1164.doi: 0.1097/INF.0000000000001677.
[11]. Ankunda, R., Cumber, S. N., Atuhaire, C., Kabanda, T., Nkfusai, C. N., Wirsiy, F. S., & Turyakira, E. (2020). Loss to follow-up and associated maternal factors among HEIs at the Mbarara Regional Referral Hospital, Uganda: A retrospective study. BMC Infectious Diseases, 20(1), 235. doi: 10.1186/s12879-020-04964-1.
[12]. Mute, T., Akondé, A., & Doumbia, A. (2011). The prevention of mother-to-child transmission of HIV-1 in Mali HIV-1-positive pregnant women and loss to follow-up in the Segou region. 6th IAS Conference on HIV Pathogenesis and Treatment Abstract no. MOPE480.
[13]. Nyandiko, W. M., Otieno-Nyunya, B., Musick, B., Bucher-Yiannoutsos, S., Akhaabi, P., Lane, K., Yiannoutsos, C. T., & Wools-Kaloustian, K. (2010). Outcomes of HIV-exposed children in western Kenya: Efficacy of prevention of mother to child transmission in a resource-constrained setting. Journal of Acquired Immune Deficiency Syndromes, 54(1), 42-50. doi: 10.1097/QAI.0b013e3181d8ad51.
[14]. Ebonwu, J., Mumbauer, A., Uys, M., Wainberg, M. L., & Medina-Marino, A. (2018). Determinants of late antenatal care presentation in rural and peri-urban communities in South Africa: A cross-sectional study. PLoS ONE, 13(3), e0191903.
[15]. Tesfaye, G., Loxton, D., Chojenta, C., Semahegn, A., & Smith, R. (2017). Delayed initiation of antenatal care and associated factors in Ethiopia: A systematic review and meta-analysis. Reproductive Health, 14(1), 1–17.
[16]. Nikhare, K., Gawde, N., Kamble, S., et al. (2024). Caregivers’ experiences of accessing HIV Early Infant Diagnosis (EID) services and its barriers and facilitators, India. BMC Health Services Research,24(1), 24. https://doi.org/10.1186/s12913-023-10500-z.
[17]. Kiilu, E. M., Karanja, S., & Kikuvi, G. P. W. (2019). Caregiver factors influencing seeking of Early Infant Diagnosis (EID) of HIV services in selected hospitals in Nairobi County, Kenya: A Qualitative Study. International Journal of Scientific and Research Publications, 9(4). https://doi.org/10.29322/IJSRP.9.04.2019.p8825.
[18]. Adeniyi, V. O., Thomson, E., Goon, D. T., & Ajayi, I. A. (2015). Disclosure, stigma of HIV positive child and access to early infant diagnosis in the rural communities of OR Tambo District, South Africa: A qualitative exploration of maternal perspective. BMC Pediatrics, 15(1), 98. https://doi.org/10.1186/s12887-015-0414-8.
[19]. Kalembo, F. W., Zgambo, M., Mulaga, A. N., Yukai, D., & Ahmed, N. I. (2012). Association between household socioeconomic status and adherence to exclusive breastfeeding among HIV-exposed infants in Malawi. World Journal of AIDS, 2(2), 195-200. https://doi.org/10.4236/wja.2012.22025.
[20]. Kreitchmann, R., Harris, D. R., Kakehasi, F., Haberer, J. E., Cahn, P., Losso, M., ... & Read, J. S. (2012). Loss to follow-up among HEIs in Latin America and the Caribbean: the NISDI Pediatric Study. International Journal of Infectious Diseases, 16(12), e935-e941. https://doi.org/10.1016/j.ijid.2012.07.023.
[21]. Cook, R. E., Ciampa, P. J., Sidat, M., Blevins, M., Burlison, J., Davidson, M. A., ... & Moon, T. D. (2011). Predictors of successful early infant diagnosis of HIV in a rural district hospital in Zambezia, Mozambique. Journal of Acquired Immune Deficiency Syndromes (1999), 56(4), e104-e109. https://doi.org/10.1097/QAI.0b013e3182047c97.
[22]. Bazira, J., Apio, K., Kyambadde, M., Nakawungu, R., Nduhuura, D., Ayebarirwe, M., Orikiriza, P., & Kumbakumba, E. (2022). Good Utilization, Low Completion Rates of Early Infant HIV Diagnostic Services at a District Hospital in Rural, Southwestern Uganda. https ://doi.org/10.21203/rs.3.rs-1342532/v1.
[23]. Odekunle, F. F., Adekunle, R. O., & Shankar, S. (2017). Why sub-Saharan Africa lags in electronic health record adoption and possible strategies to increase its adoption in this region. International Journal of Health Sciences, 11, 59-64.
[24]. Modi, S., Callahan, T., Rodrigues, J., Kajoka, M. D., & Dale, H. M. (2017). Overcoming Health System Challenges for Women and Children Living with HIV Through the Global Plan. Journal of Acquired Immune Deficiency Syndromes, 75(Suppl1)S76-S85. doi:10.1097/QAI.0000000000001336.
[25]. World Health Organization. (2018). Prevention of mother-to-child transmission of HIV: Technical update. Retrieved from https://www.afro.who.int/sites/default/files/2018-06/Prevention%20of%20mother-to-child%20transmission%20-%20Technical%20update.pdf.
[26]. Simbaya, J., Funjika, P., Moonga, A., Mwale, J., & Kankasa, C. (2021). Feasibility of using infant testing during immunization to estimate HIV mother-to-child transmission rates in Zambia. BMC Infectious Diseases, 21(1), 1239. doi: 10.1186/s12879-021-06892-0.
[27]. Dunning, L., Gandhi, A. R., Penazzato, M., Soeteman, D. I., & Revill, P. (2021). Optimizing infant HIV diagnosis with additional screening at immunization clinics in three sub-Saharan African settings: A cost-effectiveness analysis. Journal of the International AIDS.
[28]. Suryavanshi, N., Kadam, A., Gupte, N., et al. (2020). A mobile health-facilitated behavioural intervention for community health workers improves exclusive breastfeeding and early infant HIV diagnosis in India: A cluster randomized trial. Journal of the International AIDS Society, 23(7), e25555. https://doi.org/10.1002/jia2.25555.
[29]. Micek, M. A., Gimbel, S., Baptista, A. J., Karagianis, M., Coutinho, M., & Pfeiffer, J. (2014). Evaluation of routine health assessments and vaccination coverage at the 9-month mark in Mozambique. Journal of Pediatric Health Care, 28(6), 505-512. https://doi.org/10.1016/j.pedhc.2014.02.007.
[30]. Obonyo, B., & Mwachari, C. (2013). The impact of routine health assessments and vaccinations on infant health at 9 months in Kenya. East African Medical Journal, 90(5), 192-198. https://doi.org/10.4314/eamj.v90i5.3.
[31]. Banda, R., Habaalu, L., & Chiyesu, G. (2015). The significance of the 9-month health assessment and vaccination schedule for infant health in Zambia. African Health Sciences, 15(3), 856-862. https://doi.org/10.4314/ahs.v15i3.24.
[32]. Chiyesu, G., Habaalu, L., & Banda, R. (2016). The decline in appointment attendance among HEIs beyond the 9-month mark: Implications for tracking and healthcare delivery in Zambia. BMC Pediatrics, 16(1), 125. https://doi.org/10.1186/s12887-016-0662-8-Z.
[33]. Abimbola, J. M., Makanjuola, A. T., Ganiyu, S. A., et al. (2016). The pattern of utilization of ante-natal and delivery services in a semi-urban community of North-Central Nigeria. African Health Sciences, 16(4), 962–971. doi: 10.4314/ahs.v16i4.12.
Viewed PDF 6 0 -
Determinants of Covid-19 Vaccinations among Slum Dwellers: A Case of Katanga, Kampala, UgandaAuthor: Kasirye Elizabeth OmaginoDOI: 10.21522/TIJPH.2013.12.04.Art003
Determinants of Covid-19 Vaccinations among Slum Dwellers: A Case of Katanga, Kampala, Uganda
Abstract:
Coronavirus Disease of 2019 (COVID-19) is caused by the Severe Acute Respiratory Syndrome coronavirus 2(SARS-COV-2). The SARS-COV-2 is a β-coronavirus , which is non-segmented positive-sense RNA virus. The symptoms of COVID-19 may vary. The study was carried out to; examine the individual determinants and socioeconomic determinants and to describe the Health-system determinants of COVID-19 vaccination among Residents of Katanga Slum. The individual determinants were; age between 26 to 35 years (AOR=4.502, CI=1.706-11.886, P=0.002), sex; being of male gender (AOR=2.267, CI=1.316-5.443, P=0.007), marital status; being single (AOR=0.334, CI=0.136-0.820, P=0.017), Being with primary level of education (AOR=17.707, CI=2.393-130.99, P=0.005), occupation; being a peasant (AOR=4.857, CI=1.232-19.14, p=0.024), religion; being a catholic (COR=0.411, CI=0.200-0.846, P-0.016), utilization of health facility for health care (COR=0.047, CI=0.014-0.162, P=0.000) and having a negative attitude towards COVID 19 vaccination (AOR=42.637, CI=320.65, P=0.000). The socio-economic factors were; income (x2=18.861, p=0.000), cost of transport (x2=19.492, p=0.000), cost of vaccination (x2=124.34, p=0.000) and the type of social class of respondents (x2=23.73, p=0.000). In multivariate analysis; only work effect was a determinant of COVID-19 vaccination (AOR=0.327, CI=0.127-0.847 and p=0.021). The health facility determinants were; sensitization (AOR=1.889, CI=1.040-3.431, P=0.037), availability of health workers at facility (AOR=0.211, CI=0.04-0.006, P=0.012), attitudes of health workers (AOR=79.97, CI=11.49-556.3, P=0.000), and Availability of COVID 19 vaccines at the health facility (AOR=0.054, CI=0.006-0.514, P=0.011). The study recommended Increased and continued sensitization for awareness promotion towards the benefits of uptake of COVID-19 vaccination as well as the associated dangers of non-compliance.
Determinants of Covid-19 Vaccinations among Slum Dwellers: A Case of Katanga, Kampala, Uganda
References:
[1]. Rothan, H.A. and S.N. Byrareddy, The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of Autoimmunity, 2020. 109: p. 102433.
[2]. Cucinotta, D. and M. Vanelli, WHO Declares COVID-19 a Pandemic. Acta Biomed, 2020. 91(1): p. 157-160.
[3]. Guo, Y.-R., et al., The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak–an update on the status. Military Medical Research, 2020. 7: p. 1-10.
[4]. Kaplan, A.K., et al., The willingness to accept the COVID‐19 vaccine and affecting factors among healthcare professionals: A cross‐sectional study in Turkey. International Journal of Clinical Practice, 2021: p. e14226.
[5]. UNICEF and GAVI Uganda receives 864,000 doses of COVID-19 vaccines. 2021.
[6]. Ministry of Health Uganda COVID-19 status. 2021.
[7]. Wang, C., et al., A novel coronavirus outbreak of global health concern. The Lancet, 2020. 395(10223): p. 470-473.
[8]. Gong, F., et al., China’s local governments are combating COVID-19 with unprecedented responses—from a Wenzhou governance perspective. Frontiers of Medicine, 2020: p. 1-5.
[9]. Coe, P.F., L.L. Graper, and C.M. Zangerle, Leading Through the Unknown: A Network Perspective of the COVID-19 Pandemic. Critical Care Nursing Quarterly, 2020. 43(4): p. 451-467.
[10]. Snyder, T.M., et al., Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels. MedRxiv, 2020.
[11]. Wu, S.C., Progress and concept for COVID‐19 vaccine development. Biotechnology Journal, 2020.
[12]. UNICEF Uganda receives the first batch of AstraZeneca COVID-19 vaccines. 2021.
[13]. Sun, S., D. Lin, and D. Operario, Interest in COVID-19 vaccine trials participation among young adults in China: Willingness, reasons for hesitancy, and demographic and psychosocial determinants. Preventive Medicine Reports, 2021. 22: p. 101350.
[14]. Reiter, P.L., M.L. Pennell, and M.L. Katz, Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated? Vaccine, 2020. 38(42): p. 6500-6507.
[15]. Kreps, S., et al., Factors associated with US adults’ likelihood of accepting COVID-19 vaccination. JAMA network open, 2020. 3(10): p. e2025594-e2025594.
[16]. Guidry, J.P., et al., Willingness to get the COVID-19 vaccine with and without emergency use authorization. American Journal of Infection Control, 2021. 49(2): p. 137-142.
[17]. Li, P., et al., Analysis of factors influencing parents’ willingness to accept the quadrivalent influenza vaccine for school-aged children in the Nanhai District, China. Human Vaccines & Immunotherapeutics, 2020. 16(5): p. 1078-1085.
[18]. UNICEF Uganda launches first phase of COVID-19 vaccination exercise. 2021.
[19]. Akinyemi, P.A., et al., Community perception and determinants of willingness to uptake COVID-19 vaccines among residents of Osun State, South-West Nigeria. International Journal of Community Medicine and Public Health, 2021. 8(4): p. 1551.
[20]. Echoru, I., P. Decanar Ajambo, and E. Bukenya, Acceptance and Risk Perception of COVID-19 Vaccine in Uganda: A Cross Sectional Study in Western Uganda. 2020.
[21]. Daama, A., et al., Willingness to receive COVID-19 vaccines, associated factors and reasons for not taking a vaccine: a cross sectional study among persons aged 13–80 years in Wakiso, Central Uganda. BMC Infectious Diseases, 2024. 24(1): p. 391.
[22]. King, P., et al., COVID-19 vaccine uptake and coverage, Uganda, 2021-2022. UNIPH Bulletin, 2023. 8.
[23]. Kasozi, K.I., et al., A Descriptive-Multivariate Analysis of Community Knowledge, Confidence, and Trust in COVID-19 Clinical Trials among Healthcare Workers in Uganda. Vaccines, 2021. 9(3): p. 253.
[24]. Peretti-Watel, P., et al., A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation. The Lancet infectious diseases, 2020. 20(7): p. 769-770.
[25]. Mathpati, M.M., et al., ‘Population Self-Reliance in Health’and COVID 19: the need for a 4th Tier in the Health System. Journal of Ayurveda and Integrative Medicine, 2020.
[26]. Kish, L., Sampling organizations and groups of unequal sizes. American Sociological Review, 1965: p. 564-572.
[27]. Creswell, J.W., Qualitative inquiry and research design: Choosing among five traditions. Qualitative inquiry and research design: Choosing among five traditions. 1998, Thousand Oaks, CA, US: Sage Publications, Inc. xv, 403-xv, 403.
[28]. Kuter, B.J., et al., Perspectives on the receipt of a COVID-19 vaccine: A survey of employees in two large hospitals in Philadelphia. Vaccine, 2021. 39(12): p. 1693-1700.
[29]. Browne, N.T., et al., When pandemics collide: the impact of COVID-19 on childhood obesity. Journal of pediatric nursing, 2021. 56: p. 90.
[30]. Nzaji, M.K., et al., Factors associated with COVID-19 vaccine uptake and hesitancy among healthcare workers in the Democratic Republic of the Congo. PLOS Global Public Health, 2024. 4(2): p. e0002772.
[31]. Qattan, A.M., et al., Acceptability of a COVID-19 vaccine among healthcare workers in the Kingdom of Saudi Arabia. Frontiers in medicine, 2021. 8: p. 644300.
[32]. Dror, A.A., et al., Vaccine hesitancy: the next challenge in the fight against COVID-19. European journal of epidemiology, 2020. 35(8): p. 775-779.
[33]. Echoru, I., et al., Sociodemographic factors associated with acceptance of COVID-19 vaccine and clinical trials in Uganda: a cross-sectional study in western Uganda. BMC public health, 2021. 21(1): p. 1106.
[34]. Paudel, P., Online education: Benefits, challenges and strategies during and after COVID-19 in higher education. International Journal on Studies in Education (IJonSE), 2021. 3(2).
[35]. Ruiz, J.B. and R.A. Bell, Predictors of intention to vaccinate against COVID-19: Results of a nationwide survey. Vaccine, 2021. 39(7): p. 1080-1086.
[36]. Barry, M., M. Al Amri, and Z.A. Memish, COVID-19 in the shadows of MERS-CoV in the Kingdom of Saudi Arabia. Journal of epidemiology and global health, 2020. 10(1): p. 1-3.
[37]. Pradhan, A. and P.-E. Olsson, Sex differences in severity and mortality from COVID-19: are males more vulnerable? Biology of sex Differences, 2020. 11(1): p. 53.
[38]. Kanyike, A.M., et al., Acceptance of the coronavirus disease-2019 vaccine among medical students in Uganda. Tropical Medicine and Health, 2021. 49(1): p. 37.
[39]. Wang, H., et al., The psychological distress and coping styles in the early stages of the 2019 coronavirus disease (COVID-19) epidemic in the general mainland Chinese population: A web-based survey. PloS one, 2020. 15(5): p. e0233410.
[40]. Bitar, A.N., et al., Misinformation, perceptions towards COVID-19 and willingness to be vaccinated: a population-based survey in Yemen. PLoS One, 2021. 16(10): p. e0248325.
[41]. De Figueiredo, A., et al., Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study. The Lancet, 2020. 396(10255): p. 898-908.
[42]. Jegede, A.S., What led to the Nigerian boycott of the polio vaccination campaign? PLoS medicine, 2007. 4(3): p. e73.
[43]. Machida, M., et al., Acceptance of a COVID-19 Vaccine in Japan during the COVID-19 Pandemic. Vaccines, 2021. 9(3): p. 210.
[44]. Jain, J., et al., COVID-19 vaccine hesitancy among medical students in India. Epidemiology & Infection, 2021. 149: p. e132.
[45]. Bongomin, F., et al., COVID-19 vaccine acceptance among high-risk populations in Uganda. Therapeutic Advances in Infectious Disease, 2021. 8: p. 204993612110243.
[46]. Chou, W.-Y.S. and A. Budenz, Considering emotion in COVID-19 vaccine communication: addressing vaccine hesitancy and fostering vaccine confidence. Health communication, 2020. 35(14): p. 1718-1722.
[47]. Samarasekera, U., Feelings towards COVID-19 vaccination in Africa. The Lancet Infectious Diseases, 2021. 21(3): p. 324.
[48]. Campo-Arias, A. and J.C. Pedrozo-Pupo, COVID-19 vaccine distrust in Colombian university students: Frequency and associated variables. Acta Biomed, 2022. 92(6): p. e2021367.
[49]. Ohemeng-Tinyase, N.A., Factors Associated with Hepatitis B Vaccination Among Asian Adults (≥ 18 Years) in the United States. 2020, Walden University.
[50]. Endalew, M., et al., Limited handwashing facility and associated factors in sub-Saharan Africa: pooled prevalence and multilevel analysis of 29 sub-Saharan Africa countries from demographic health survey data. BMC Public Health, 2022. 22(1): p. 1969.
[51]. Schmidt, C.W., Lack of Handwashing Access: A Widespread Deficiency in the Age of COVID-19. Environ Health Perspect, 2020. 128(6): p. 64002.
[52]. Malande, O.O., et al., Barriers to effective uptake and provision of immunization in a rural district in Uganda. PloS one, 2019. 14(2): p. e0212270.
[53]. Azodo, C., et al., Hepatitis-B vaccination status among dental surgeons in benin city, Nigeria. Ann Med Health Sci Res, 2012. 2(1): p. 24-8.
Viewed PDF 5 0 -
Prevalence of Multi-Drug Resistant Bacterial Isolates in Healthcare EnvironmentsAuthor: Pasiyappazham RamasamyDOI: 10.21522/TIJPH.2013.12.04.Art007
Prevalence of Multi-Drug Resistant Bacterial Isolates in Healthcare Environments
Abstract:
To evaluate and measure the frequency of multi-drug resistance bacterial isolates in various healthcare environments. This study employed the disc diffusion susceptibility test to assess the antibiotic resistance of Acinetobacter, E. coli, Klebsiella sp., and Pseudomonas sp. to carbapenem, extended-spectrum β-lactamase (ESBL), and colistin. In the present study, Acinetobacter was generally found resistant to carbapenem at 72% and 71% at 75 µg/ml and minimum for Carbapenem + Colistin at 11% at 150 µg/ml. E. coli counts of the antibiotic-resistant carbapenem samples were 85% and 71% at 150 µg/ml and the lowest in colistin 12% at 225 µg/ml. The Klebsiella isolates obtained were highly sensitive to carbapenem (98%) at 150 µg/ml, followed by 75 µg/ml (96%) and 225 µg/ml (92%). Low colistin resistance was also observed (7%). The evaluation presented in Pseudomonas sp. of the antibiotic-resistant carbapenem samples was high at 47 at 225 µg/ml, and minimum in ESBL + Colistin at 5% at 150 µg/ml. Klebsiella (92%), Acinetobacter (71%), E. coli (64%), and Pseudomonas sp. (47%) were highly sensitive to 75 µg/ml carbapenem. The MICs of carbapenem-resistant Acinetobacter were shown in the 6.45 (OD values) at 75 µg/mL. Carbapenem and ESBL antibiotic-resistant Klebsiella were found at OD values of 9.14, 9.74, 9.61, and 3.45, 3.21 3.67, (OD values) at 75, 150, and 225 µg/mL, respectively, and the highest susceptibility was observed with Carbapenem 9.74 at 150 µg/mL. The ternary colour frequency of the graph indicates that Klebsiella sp. showed good susceptibility to carbapenem, carbapenem + ESBL, carbapenem, and colistin. Carbapenem is a highly effective therapy against infections caused by antibiotic-resistant Klebsiella sp.
Prevalence of Multi-Drug Resistant Bacterial Isolates in Healthcare Environments
References:
[1]. Prestinaci, F., Pezzotti, P., Pantosti, A., 2015, Antimicrobial resistance: a global multifaceted phenomenon. Pathogens and Global Health, 109(7), 309-318.
[2]. Das, B., Sarma, M., Kumar, R., Borah, P., Sinha, S., Gupta, P., Durlabhji, P., 2020, Isolation, identification and antibiotic sensitivity pattern of Escherichia coli isolated from various clinical sample in a tertiary care hospital, Jaipur, Rajasthan, India. International Journal of Research in Medical Sciences, 8(5), 1774-1778.
[3]. Kamala, K., Sivaperumal, P., 2023, Predominance of multi-drug resistant extended spectrum β lactamase producing bacteria from marine fishes. Environmental Pollution, 323, 121314.
[4]. Khan, D., Zeb, M., Khattak, S.K., Shah, A.A., Abdullah, M., Bilal, M., 2023, Molecular characterization and antibiotic susceptibility pattern of bacterial strains isolated from diabetic foot ulcers. Endocrine and Metabolic Science, 12, 100136.
[5]. Jabeen, K., Saleem, S., Jahan, S., Nizamudin, S., Arshad, F., Huma, Z.E., Raza, S.M., Mehmood, M., Roman, M., Haq, F.U., 2023, Molecular characterization of extensively drug-resistant Salmonella enterica Serovar Typhi clinical isolates from Lahore, Pakistan. Infection and Drug Resistance, 2987-3001.
[6]. Sivaperumal, P., Kamala, K., Ganapathy, D.M., Dharani, G., Sundarrajan, S., Ramakrishna, S., 2023, Fabrication of AgNPs mediated fibrous membrane from Rhizophora mucronata mangrove plant extract for biological properties. Journal of Drug Delivery Science and Technology, 86, 104710.
[7]. Chaudhary, L., Pandey, A., Singh, P., Chaturvedi, P., Bisht, A.S., 2023, Bacterial Profile and Antimicrobial Susceptibility Pattern of Gram-Negative Bacteria Isolated from Skin and Soft Tissue Infections in a Tertiary Care Hospital of Western Uttar Pradesh, 14(3), 135.
[8]. Vasoo, S., 2017, Susceptibility testing for the polymyxins: two steps back, three steps forward?. Journal of Clinical Microbiology, 55(9), 2573-2582.
[9]. Pauline, C.R., Akshita, Pavithra, T., Kannan, K., Sivaperumal, P., 2024, Characterization and Biological Activity of Silver Nanoparticles from (Rhizophora mucronata) Mangrove Extract. Nano Life, 2450018.
[10]. Clinical and Laboratory Standards Institute, (CLSI), 2019. Performance Standards for antimicrobial Susceptibility Testing; 28th Informational Supplement; CLSI Document m100-S29. Clinical and Laboratory Standards Institute.
[11]. Khalid, S., Migliaccio, A., Zarrilli, R., Khan, A.U., 2023, Efficacy of Novel Combinations of Antibiotics against Multidrug-Resistant—New Delhi Metallo-Beta-Lactamase-Producing Strains of Enterobacterales. Antibiotics, 12(7), 1134.
[12]. Vasaikar, S., Obi, L., Morobe, I., Bisi-Johnson, M., 2017, Molecular characteristics and antibiotic resistance profiles of Klebsiella isolates in Mthatha, Eastern Cape province, South Africa. International Journal of Microbiology, 2017(1), 8486742.
[13]. Magiorakos, A.P., Srinivasan, A., Carey, R.B., Carmeli, Y., Falagas, M.E., Giske, C.G., Harbarth, S., Hindler, J.F., Kahlmeter, G., Olsson-Liljequist, B., Paterson, D.L., 2012, Multidrug-resistant, extensively drug-resistant and pan drug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clinical Microbiology and Infection, 18(3), 268-281.
[14]. Onanuga, A., Mahindroo, J., Singh, S., Taneja, N., 2019, Phenotypic and molecular characterization of antimicrobial resistant Escherichia coli from urinary tract infections in Port-Harcourt, Nigeria. African Medical Journal, 34(1).
[15]. Rosenthal, V.D., Maki, D.G., Jamulitrat, S., Medeiros, E.A., Todi, S.K., Gomez, D.Y., Leblebicioglu, H., Khader, I.A., Novales, M.G.M., Berba, R., Wong, F.M.R., 2010, International nosocomial infection control consortium (INICC) report, data summary for 2003-2008. American Journal of Infection Control, 38(2), 95-104.
[16]. Suma, P., Swetha, C.S., Sudhanthiramani., Goud, S.S., Annie Supriya., Jagadeesh Babu, A., 2016, A study on the antibiotic resistance patterns of Staphylococcus aureus isolated from market milk in and around Tirupati, Andhra Pradesh. International Journal of Recent Scientific Research, 7(4), 10429-10435.
[17]. Gupta, M., Naik, A.K., Singh, S.K., 2019, Bacteriological profile and antimicrobial resistance patterns of burn wound infections in a tertiary care hospital. Heliyon, 5(12). e02956.
[18]. Lagha, R., Abdallah, F.B., ALKhammash, A.A., Amor, N., Hassan, M.M., Mabrouk, I., Alhomrani, M., Gaber, A., 2021, Molecular characterization of multidrug-resistant Klebsiella pneumoniae clinical isolates recovered from King Abdulaziz Specialist Hospital at Taif City, Saudi Arabia Journal of Infection and Public Health, 14(1), 143-151.
[19]. Apenteng, J.A., Yeboah, E.E.A., Kyere-Davies, G., 2022, Antibiotic susceptibility of bacteria isolates from ward environment of a hospital in Tema, Ghana. African Journal of Microbiology Research, 16(6), 211-216.
[20]. Zhang, Y., Li, D., Yang, Y., Su, J., Xu, X., Wang, M., Chen, Y., Li, Y., 2021, Clinical and molecular characteristics of Chryseobacterium indologenes isolates at a teaching hospital in Shanghai, China. Annals of Translational Medicine, 9(8).
[21]. Zarras, C., Karampatakis, T., Pappa, S., Iosifidis, E., Vagdatli, E., Roilides, E., Papa, A., 2023, Genetic characterization of carbapenem-resistant Klebsiella pneumoniae clinical isolates in a tertiary hospital in Greece, 2018–2022. Antibiotics, 12(6), 976.
[22]. Khalid, S., Migliaccio, A., Zarrilli, R., Khan, A.U., 2023, Efficacy of Novel Combinations of Antibiotics against Multidrug-Resistant—New Delhi Metallo-Beta-Lactamase-Producing Strains of Enterobacterales. Antibiotics, 12(7), 1134.
[23]. Shanahan, P.M., Jesudason, M.V., Thomson, C.J., Amyes, S.G., 1998, Molecular analysis of and identification of antibiotic resistance genes in clinical isolates of Salmonella typhi from India. Journal of Clinical Microbiology, 36(6), 1595-1600.
Viewed PDF 6 0 -
The Effect of Orthodontic Therapy on Periodontal HealthAuthor: Murukesan SDOI: 10.21522/TIJPH.2013.12.04.Art008
The Effect of Orthodontic Therapy on Periodontal Health
Abstract:
Orthodontic therapy plays a pivotal role in correcting malocclusions and enhancing dental aesthetics. However, the impact of orthodontic treatment on periodontal health remains a subject of debate among dental professionals. This review aims to provide a comprehensive overview of the effects of orthodontic therapy on periodontal health, highlighting both positive and negative outcomes. The periodontal changes induced by orthodontic forces, including gingival inflammation, attachment loss, and root resorption, are explored in detail. Additionally, the role of microbial shifts in the oral microbiome during orthodontic treatment and their implications for periodontal health are discussed. Furthermore, the review examines the importance of proper oral hygiene practices and the use of adjunctive therapies in mitigating potential adverse effects on periodontal tissues during orthodontic therapy. The impact of different types of orthodontic appliances, such as removable and fixed appliances, on periodontal health is also evaluated. Finally, the review outlines recommendations for clinicians to optimize periodontal health outcomes in orthodontic patients, emphasizing the importance of multidisciplinary collaboration and personalized treatment approaches. By elucidating the complex interplay between orthodontic therapy and periodontal health, this review aims to provide valuable insights for dental practitioners and researchers, ultimately contributing to improved patient care and outcomes in orthodontics.
The Effect of Orthodontic Therapy on Periodontal Health
References:
[1]. Feu, D., 2020, Orthodontic treatment of periodontal patients: challenges and solutions, from planning to retention. Dental Press Journal of Orthodontics, 25(6), 79-116.
[2]. Ristoska, S., Dzipunova, B., Stefanovska, E., Rendzova, V., Radojkova-Nikolovska, V., Evrosimovska, B., 2019, Orthodontic Treatment of a Periodontally - Affected Adult Patient (Case Report). Open Access Macedonian Journal of Medical Sciences, 7(14), 2343-2349.
[3]. Alfuriji, S., Alhazmi, N., Alhamlan, N., Al-Ehaideb, A., Alruwaithi, M., Alkatheeri, N., Geevarghese, A., 2014, The effect of orthodontic therapy on periodontal health: a review of the literature. International Journal of Dentistry, 2014, 585048.
[4]. Singh, G., Batra, P., 2014, The orthodontic periodontal interface: A narrative review. Journal of the International Clinical Dental Research Organization, 6(2), 77-85.
[5]. Preoteasa, C. T., Ionescu, E., Preoteasa, E., 2012, Risks and complications associated with orthodontic treatment. Orthodontics-basic aspects and clinical considerations, 2012, 403-28.
[6]. Talic, N. F., 2011, Adverse effects of orthodontic treatment: A clinical perspective. The Saudi Dental Journal, 23(2), 55-9.
[7]. Tripuwabhrut, P., Brudvik, P., Fristad, I., Rethnam, S., 2010, Experimental orthodontic tooth movement and extensive root resorption: periodontal and pulpal changes. European Journal of Oral Sciences, 118(6), 596-603.
[8]. Crescini, A., Nieri, M., Buti, J., Baccetti, T., Pini Prato, G. P., 2007, Orthodontic and periodontal outcomes of treated impacted maxillary canines: An appraisal of prognostic factors. The Angle Orthodontist, 77(4), 571-577.
[9]. Gorbunkova, A., Pagni, G., Brizhak, A., Farronato, G., Rasperini, G., 2016, Impact of Orthodontic Treatment on Periodontal Tissues: A Narrative Review of Multidisciplinary Literature. International Journal of Dentistry, 2016, 4723589.
[10]. Li, Y., Jacox, L. A., Little, S. H., Ko, C. C., 2018, Orthodontic tooth movement: The biology and clinical implications. The Kaohsiung Journal of Medical Sciences, 34(4), 207-214.
[11]. Vinod, K., Reddy, Y. G., Reddy, V. P., Nandan, H., Sharma, M., 2012, Orthodontic-periodontics interdisciplinary approach. Journal of Indian Society of Periodontology, 16(1), 11-15.
[12]. Zanatta, F. B., Ardenghi, T. M., Antoniazzi, R. P., Pinto, T. M. P., Rösing, C. K., 2012, Association between gingival bleeding and gingival enlargement and oral health-related quality of life (OHRQoL) of subjects under fixed orthodontic treatment: a cross-sectional study. BMC Oral Health, 12(1), Article 53.
[13]. Cardoso, M. de A., Saraiva, P. P., Maltagliati, L. Á., Rhoden, F. K., Costa, C. C., Normando, D., Capelozza Filho, L., 2015, Alterations in plaque accumulation and gingival inflammation promoted by treatment with self-ligating and conventional orthodontic brackets. Dental Press Journal of Orthodontics, 20(2), 35-41.
[14]. Meeran, N. A., 2013, Iatrogenic possibilities of orthodontic treatment and modalities of prevention. Journal of Orthodontic Science, 2(3), 73-86.
[15]. Wise, G. E., King, G. J., 2008, Mechanisms of tooth eruption and orthodontic tooth movement. Journal of Dental Research, 87(5), 414-434.
[16]. Jeon, H. H., Teixeira, H., Tsai, A., 2021, Mechanistic Insight into Orthodontic Tooth Movement Based on Animal Studies: A Critical Review. Journal of Clinical Medicine, 10(8), Article 1733.
[17]. Li, Y., Zhan, Q., Bao, M., Yi, J., Li, Y., 2021, Biomechanical and biological responses of periodontium in orthodontic tooth movement: up-date in a new decade. International Journal of Oral Science, 13(1), Article 20.
[18]. Antoun, J. S., Mei, L., Gibbs, K., Farella, M., 2017, Effect of orthodontic treatment on the periodontal tissues. Periodontology 2000, 74(1), 140-157.
[19]. Shekar, S., Bhagyalakshmi, A., Chandrashekar, B. R., Avinash, B. S., 2017, Periodontal considerations during orthodontic treatment. Indian Journal of Oral Health and Research, 3(1), 1-7.
[20]. Kanarakis, I., Sandu, D., Solomon, S. M., Pasarin, L., Sufaru, I. G., Martu, M. A., Sioustis, I. A., Kappenberg-Nitescu, D. C., Luchian, I., 2021, Contemporary aspects regarding the etiology of gingival recessions. Romanian Journal of Oral Rehabilitation, 13, 78-86.
[21]. Vu, H. V., Melnick, P. R., 2016, Orthodontic complications and the periodontal aspects related to clinical orthodontics. Avoiding and Treating Dental Complications: Best Practices in Dentistry, 202-236.
[22]. Heboyan, A., Avetisyan, A., Karobari, M. I., Marya, A., Khurshid, Z., Rokaya, D., Zafar, M. S., Fernandes, G. V., 2022, Tooth root resorption: A review. Science Progress, 105(3), 00368504221109217.
[23]. Brezniak, N., Wasserstein, A., 2002, Orthodontically induced inflammatory root resorption. Part II: The clinical aspects. The Angle Orthodontist, 72(2), 180-184.
[24]. Ng, C. L., The extent of orthodontically induced inflammatory root resorption following transverse and vertical jiggling movement with heavy forces for 12 weeks: A micro-CT study (Doctoral dissertation).
[25]. Kim, Y. K., Kwon, E. Y., Cho, Y. J., Lee, J. Y., Kim, S. J., Choi, J., 2014, Changes in the vertical position of interdental papillae and interseptal bone following the approximation of anterior teeth. International Journal of Periodontics & Restorative Dentistry, 34(2), 219-224.
[26]. Yu, J. H., Nguyen, T., Kim, Y. I., Hwang, S., Kim, K. H., Chung, C. J., 2022, Morphologic changes of the incisive canal and its proximity to maxillary incisor roots after anterior tooth movement. American Journal of Orthodontics and Dentofacial Orthopedics, 161(3), 396-403.
[27]. Sebbar, M., Abidine, Z., Laslami, N., Bentahar, Z., 2015, Periodontal health and orthodontics. Emerging Trends in Oral Health Sciences and Dentistry, IntechOpen.
[28]. Krishnan, V., Davidovitch, Z. E., 2006, Cellular, molecular, and tissue-level reactions to orthodontic force. American Journal of Orthodontics and Dentofacial Orthopedics, 129(4), 469-e1.
[29]. Binderman, I., Gadban, N., Yaffe, A., 2021, The effects of mechanical loading on hard and soft tissues and cells. Biological Mechanisms of Tooth Movement, 68-76.
[30]. Wazwaz, F., Investigations Into Orthodontic Tooth Movement Rate (Doctoral dissertation, King's College London).
[31]. Melsen, B., Cattaneo, P. M., Dalstra, M., Kraft, D. C., 2007, The importance of force levels in relation to tooth movement. Seminars in Orthodontics, 13(4), 220-233.
[32]. Hinz, B., 2013, Matrix mechanics and regulation of the fibroblast phenotype. Periodontology 2000, 63(1), 14-28.
[33]. Lekic, P., McCulloch, C. A., 1996, Periodontal ligament cell populations: the central role of fibroblasts in creating a unique tissue. The Anatomical Record, 245(2), 327-341.
[34]. Yamaguchi, M., Garlet, G. P., 2015, The role of inflammation in defining the type and pattern of tissue response in orthodontic tooth movement. Biological Mechanisms of Tooth Movement: Second Edition, 121-137.
[35]. Nugraha, A. P., Khoswanto, C., Kriswandini, I. L., The involvement of damage-associated molecular patterns and resolution-associated molecular patterns in alveolar bone remodeling during orthodontic tooth movement: Narrative review. Teikyo Medical Journal, 45(1), 3799-3808.
[36]. Kishore, S., Barai, V., Siva, S., Venkatesan, K., Orthodontic-Periodontics: An Interdisciplinary Approach [Internet]. https://www.intechopen.com/chapters/77211
[37]. Guo, R., Yu, Q., Lin, Y., Li, J., Huang, Y., Li, W., 2022, Pulp blood flow changes in maxillary and mandibular anterior teeth after orthodontic retraction: a prospective study. BMC Oral Health, 22(1), 508.
[38]. Caviedes-Bucheli, J., Moreno, J. O., Aranguren-Carrero, M., Buitrago-Rojas, S., Lopez-Matheus, R., Martinez-Corredor, G., Díaz-Barrera, L. E., Muñoz-Alvear, H. D., Gomez-Sosa, J. F., Munoz, H. R., 2022, The effect of orthodontic forces on calcitonin gene-related peptide (CGRP) expression in the human periodontal ligament and its relationship with the human dental pulp. Journal of Clinical and Experimental Dentistry, 14(11), e932.
[39]. Meikle, M. C., 2006, The tissue, cellular, and molecular regulation of orthodontic tooth movement: 100 years after Carl Sandstedt. The European Journal of Orthodontics, 28(3), 221-240.
[40]. Denes, B. J., Ait-Lounis, A., Wehrle-Haller, B., Kiliaridis, S., 2020, Core matrisome protein signature during periodontal ligament maturation from pre-occlusal eruption to occlusal function. Frontiers in Physiology, 11, 174.
Viewed PDF 5 0 -
Aloe emodin Inhibits Proliferation and Promotes Apoptosis in Non-Small Cell Lung Carcinoma (NSCLC) Cells by Deactivating PI3K/Akt/mTOR Signaling PathwaysAuthor: R PriyadharshiniDOI: 10.21522/TIJPH.2013.12.04.Art004
Aloe emodin Inhibits Proliferation and Promotes Apoptosis in Non-Small Cell Lung Carcinoma (NSCLC) Cells by Deactivating PI3K/Akt/mTOR Signaling Pathways
Abstract:
Non-small cell lung cancer (NSCLC) accounts for approximately 85% of lung cancer cases and is often detected at advanced stages, limiting treatment options and adversely affecting patient outcomes. Recognized by the WHO as the leading cause of cancer-related deaths, NSCLC necessitates improved diagnostic and therapeutic strategies. Aloe-emodin (AE), a natural compound with known anticancer properties, has demonstrated efficacy in inducing apoptosis and inhibiting cell proliferation in various cancer types. This study investigates AE's potential in treating NSCLC by targeting the PI3K/Akt/mTOR signalling pathway, crucial for cancer cell survival and proliferation. A549 lung cancer cells were treated with varying concentrations of AE, and cell viability was assessed using the MTT assay. Molecular docking studies were conducted to explore AE's interactions with PI3K, Akt1, and mTOR. Gene expression levels of these proteins were analysed using RT-PCR. Results showed a concentration-dependent decrease in NSCLC cell viability, with significant reductions observed at 72 hours. RT-PCR analysis indicated the downregulation of PI3K, Akt1, and mTOR in AE-treated cells. Docking studies revealed strong binding affinities of AE to PI3K, suggesting its inhibitory potential. These findings highlight AE's promise as a therapeutic agent against NSCLC, warranting further investigation into its mechanisms and clinical applicability.
Aloe emodin Inhibits Proliferation and Promotes Apoptosis in Non-Small Cell Lung Carcinoma (NSCLC) Cells by Deactivating PI3K/Akt/mTOR Signaling Pathways
References:
[1]. Araghi M, Mannani R, Heidarnejad maleki A, Hamidi A, Rostami S, Safa SH, et al. 2023, Recent advances in non-small cell lung cancer targeted therapy; an update review. Cancer Cell International, 23(1):1–26, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416536/.
[2]. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F.2021, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 1(3):209-49, https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.21660.
[3]. Jovanoski N, Abogunrin S, Di Maio D, Belleli R, Hudson P, Bhadti S, et al.2023, Systematic Literature Review to Identify Cost and Resource Use Data in Patients with Early-Stage Non-small Cell Lung Cancer (NSCLC). Pharmacoeconomics, 1(11):1437–52, https://pubmed.ncbi.nlm.nih.gov/37389802/.
[4]. Korytowsky B, Radtchenko J, Nwokeji ED, Tuell KW, Kish JK, Feinberg BA.2018,Understanding total cost of care in advanced non-small cell lung cancer pre-and post approval of immuno-oncology therapies. American Journal of Managed Care, 24(20Suppl):S439-47, https://pubmed.ncbi.nlm.nih.gov/30362811/.
[5]. Thimmegowda NR, Park C, Shwetha B, Sakchaisri K, Liu K, Hwang J, et al.2015, Synthesis and antitumor activity of natural compound aloe emodin derivatives. Chemical Biology & Drug Design, 85(5):638–44, https://pubmed.ncbi.nlm.nih.gov/25323822/.
[6]. Jiang D, Ding S, Mao Z, You L, Ruan Y. 2021, Integrated analysis of potential pathways by which aloe-emodin induces the apoptosis of colon cancer cells. Cancer Cell International,21(1):1–12, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077783/.
[7]. Pecere T, Sarinella F, Salata C, Gatto B, Bet A, Dalla Vecchia F, et al. 2003, Involvement of p53 in specific anti-neuroectodermal tumor activity of aloe-emodin. International Journal of Cancer, 106(6):836–47, https://pubmed.ncbi.nlm.nih.gov/12918060/.
[8]. Li SW, Yang TC, Lai CC, Huang SH, Liao JM, Wan L, et al. 2014, Antiviral activity of aloe-emodin against influenza A virus via galectin-3 up-regulation. European Journal of Pharmacology, 738:125–32, https://pubmed.ncbi.nlm.nih.gov/24877694/.
[9]. Li T, Lu Y, Zhang H, Wang L, Beier RC, Jin Y, et al. 2021, Antibacterial Activity and Membrane-Targeting Mechanism of Aloe-Emodin Against Staphylococcus epidermidis. Frontiers in Microbiology, 12:621866, https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2021.621866/full.
[10]. Xiao-li PAN, Xue-bo LI, Bing WU.2021, Study on the Antioxidant Activity of Aloe-Emodin Metal Complex. Journal of Sichuan University (Medical sciences). 52(2):241–7, https://pubmed.ncbi.nlm.nih.gov/33829698/.
[11]. Park MY, Kwon HJ, Sung MK. 2009, Evaluation of aloin and aloe-emodin as anti-inflammatory agents in aloe by using murine macrophages. Bioscience Biotechnology Biochemistry.73(4):828–32, https://pubmed.ncbi.nlm.nih.gov/19352036/.
[12]. Shen F, Ge C, Yuan P.2020, Aloe-emodin induces autophagy and apoptotic cell death in non-small cell lung cancer cells via Akt/mTOR and MAPK signaling. European Journal of Pharmacology. 886:173550, https://pubmed.ncbi.nlm.nih.gov/32926915/.
[13]. Şeker Karatoprak G, Küpeli Akkol E, Yücel Ç, Bahadır Acıkara Ö, Sobarzo-Sánchez E. 2022, Advances in Understanding the Role of Aloe Emodin and Targeted Drug Delivery Systems in Cancer. Oxidative Medicine and Cellular Longetivity. 2022:7928200, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789423/.
[14]. Wang H, Guo M, Wei H, Chen Y. 2023, Targeting p53 pathways: mechanisms, structures, and advances in therapy. Signal Transduction and Targeted Therapy. 8(1):92, https://pubmed.ncbi.nlm.nih.gov/36859359/.
[15]. Peng Y, Wang Y, Zhou C, Mei W, Zeng C. 2022, PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway? Frontiers in Oncology. 12:819128, https://pubmed.ncbi.nlm.nih.gov/35402264/.
[16]. Szwed A, Kim E, Jacinto E. 2021,Regulation and metabolic functions of mTORC1 and mTORC2. Physiological Reviews. 101(3):1371–426, https://pubmed.ncbi.nlm.nih.gov/33599151/.
[17]. Wiese W, Barczuk J, Racinska O, Siwecka N, Rozpedek-Kaminska W, Slupianek A, et al. 2023,PI3K/Akt/mTOR Signaling Pathway in Blood Malignancies—New Therapeutic Possibilities. Cancers. 15(21):5297, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648005/.
[18]. Zhu M, He Q, Wang Y, Duan L, Rong K, Wu Y, et al. 2023, Exploring the mechanism of aloe-emodin in the treatment of liver cancer through network pharmacology and cell experiments. Frontiers in Pharmacology. 14:1238841, https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1238841/full.
[19]. Li T, Shi L, Liu W, Hu X, Hui Y, Di M, et al. 2022, Aloe-Emodin Induces Mitochondrial Dysfunction and Pyroptosis by Activation of the Caspase-9/3/Gasdermin E Axis in HeLa Cells. Frontiers in Pharmacology. 13:854526, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157280/.
[20]. Tseng Hsin Shun TH, Wang YuFen WY, Tzeng YewMin TY, Chen DarRen CD, Liao YaFan LY, et al. 2017, Aloe-emodin enhances tamoxifen cytotoxicity by suppressing Ras/ERK and PI3K/mTOR in breast cancer cells. The American Journal of Chinese Medicine. 45(02):337-50, https://www.worldscientific.com/doi/abs/10.1142/S0192415X17500215.
[21]. Sharma D, Kumar N, Mehrotra T, Pervaiz N, Agrawal L, Tripathi S, et al. 2021, In vitro and in silico molecular docking studies of Rheum emodi-derived diamagnetic SnO2 nanoparticles and their cytotoxic effects against breast cancer. New Journal of Chemistry. 45:1695–711, https://pubs.rsc.org/en/content/articlelanding/2021/nj/d0nj04670a
Viewed PDF 5 0 -
To Assess the Effectiveness of Forward Chaining Technique on Dressing Skills among Mentally Retarded Children at Kiruba Nursing HomeAuthor: T. Mary MinolinDOI: 10.21522/TIJPH.2013.12.04.Art005
To Assess the Effectiveness of Forward Chaining Technique on Dressing Skills among Mentally Retarded Children at Kiruba Nursing Home
Abstract:
Mental retardation a developmental disability marked by lower-than-normal intelligence and limited daily living skills, affects 1-3% of children and is typically present at birth. This study employed a pre-experimental design with a quantitative research approach to assess the impact of forward chaining techniques on dressing skills in mentally retarded children. The sample consisted of 30 children aged 6-12 years from a nursing home in Chennai, selected through purposive sampling. The children were divided into three age groups: 6-8 years (33.3%), 8-10 years (30%), and 10-12 years (36.6%). The sample included 66.6% male and 33.3% female children. A majority (90%) had no family history of retardation. Post-intervention, the children required minimal assistance with eating, bathing, upper body dressing, and toileting, while supervision was needed for grooming and lower body dressing. The forward chaining technique significantly improved dressing skills, enhancing the children's self-esteem and quality of life. The findings of this study reveal promising outcomes, suggesting that forward chaining is an effective method for promoting independence in daily living skills among mentally retarded children.
To Assess the Effectiveness of Forward Chaining Technique on Dressing Skills among Mentally Retarded Children at Kiruba Nursing Home
References:
[1]. Rusli, R., Istiqomah, I., & Safitri, J. 2022, Teknik Perantaian Untuk Keterampilan Berpakaian Pada Anak Tunagrahita Sedang. JIP (Jurnal Intervensi Psikologi), 14(2). https://doi.org/10.20885/intervensipsikologi.vol14.iss2.art6.
[2]. Lee, Supawadee & Muccio, Brianne & Osborne, Nina, 2009, The Effect of Chaining Techniques on Dressing Skills of Children with Moderate Mental Retardation: A Single-Subject Design Study. Journal of Occupational Therapy, Schools, & Early Intervention. 2. 178-192. 10.1080/19411240903392590.
[3]. Wibowo, Sarah & Tedjasaputra, Mayke, 2019, The Effectiveness of Backward Chaining in Improving Buttoning Skills in a Child with Moderate Intellectual Disability and Poor Vision: Single-Case Design. 10.2991/iciap-18.2019.11.
[4]. Muharib, Reem & Alzrayer, Nouf & Wood, Charles & Voggt, Ashley, 2019, Backward chaining and speech-output technologies to enhance functional communication skills of children with autism spectrum disorder and developmental disabilities. Augmentative and Alternative Communication. 35. 1-12. 10.1080/07434618.2019.1704433.
[5]. Sadlier, J., Dixon, R.S., & Moore, D.W., 1992, Use of a changing criterion procedure incorporating backward chaining to teach an autistic youth to tie shoe laces. Australasian Journal of Special Education, 15, 14-16. doi:10.1017/S1030011200022508.
[6]. BATRA, DR & Batra, Vijay., 2005, Effectiveness of forward chaining over Backward chaining technique in children with Mental Retardation. Indian Journal of Occupational Therapy. 38.
[7]. Gaur, Nupur & Dhenwa, Sunita., 2024, Delineating Gender Disparities in Cognitive Abilities and Social Functioning Among Children with Intellectual Disabilities. Educational Administration Theory and Practices. 30. 10.53555/kuey.v30i4.2801.
[8]. McGrath, J. J., Wray, N. R., Pedersen, C. B., Mortensen, P. B., Greve, A. N., & Petersen, L., 2014, The association between family history of mental disorders and general cognitive ability. Translational psychiatry, 4(7), e412. https://doi.org/10.1038/tp.2014.60.
[9]. Kumar, I., Singh, A. R., & Akhtar, S., 2009, Social development of children with mental retardation. Industrial Psychiatry Journal, 18(1), 56–59. https://doi.org/10.4103/0972-6748.57862.
[10]. Sheha, Eman & Abdelhamed Soultan, Asmaa & Malk, Rasha & El-sherbeny, Eman., 2020, Effect of a Planned Health Teaching on Improving Knowledge and Competence of Home Care Practice of Post Stroke Patient Among Caregivers' Achievement. International Journal of Studies in Nursing. 5. 51. 10.20849/ijsn.v5i2.761.
[11]. Muhrodji, P., Wicaksono, H. D. A., Satiti, S., Trisnantoro, L., Setyopranoto, I., & Vidyanti, A. N., 2021, Roles and Problems of Stroke Caregivers: A Qualitative Study in Yogyakarta, Indonesia. F1000Research, 10, 380. https://doi.org/10.12688/f1000research.52135.2.
[12]. Jimenez, D. E., Bartels, S. J., Cardenas, V., Dhaliwal, S. S., & Alegría, M., 2012, Cultural beliefs and mental health treatment preferences of ethnically diverse older adult consumers in primary care. The American journal of geriatric psychiatry: official journal of the American Association for Geriatric Psychiatry, 20(6), 533–542. https://doi.org/10.1097/JGP.0b013e318227f876.
[13]. Udonwa, Rose & Ekaete, & Iyam, Mary & Arikpo, & Chukwudi, Nelson & Ofem, Obono & John, John & Agbu, Michael & Ikong, Michael., 2024, Mentally Retarded Children and Deficits in Daily Living Skills: Case Study of Calabar Municipality Local Government Area, Cross River State, Nigeria. 10.9790/7388-05232126.
[14]. Ugur, H. G., & Erci, B., 2019, The Effect of Home Care for Stroke Patients and Education of Caregivers on the Caregiver Burden and Quality of Life. Acta clinica Croatica, 58(2), 321–332. https://doi.org/10.20471/acc.2019.58.02.16.
[15]. Heward, W. L., & Orlansky, M. D., 2019, Teaching Self-Care Skills to Children with Severe Disabilities. Journal of Applied Behavior Analysis, 23(4), 477-489.
[16]. McConnell, S. R., & Llewellyn, G. C., 2018, Teaching Dressing Skills to Children with Severe Disabilities: Forward Chaining versus Total Task Presentation. Journal of Developmental and Physical Disabilities, 11(2), 129-144.
[17]. Miller, R., & Buehler, K., 2016, Using Forward Chaining to Teach Adaptive Behaviors to Children with Autism. Behavior Modification, 19(3), 377-393.
[18]. Schreibman, L., & Stahmer, A. C., 2002, Effective Behavioral Interventions for Children with Autism." Journal of Autism and Developmental Disorders, 32(4), 289-308.
[19]. Wilder, D. A., & Carr, J. E., 2018, The Use of Forward Chaining to Teach Dressing Skills to Children with Developmental Disabilities. Behavior Modification, 22(3), 278-295.
[20]. Baker, B. L., & Brightman, A., 2016, Training Parents to Use Forward Chaining to Teach Dressing Skills to Their Children with Intellectual Disabilities. Journal of Positive Behavior Interventions, 2(2), 123-134.
[21]. Gagnon, J. C., & O'Connor, J., 2017, Comparative Analysis of Chaining Techniques in Skill Acquisition for Children with Special Needs. Education and Training in Developmental Disabilities, 38(4), 434-447
Viewed PDF 6 0 -
In vitro Anti-inflammatory and Antioxidant Activity of Ormocarpum cochinchinenseAuthor: Dhanraj GanapathyDOI: 10.21522/TIJPH.2013.12.04.Art011
In vitro Anti-inflammatory and Antioxidant Activity of Ormocarpum cochinchinense
Abstract:
Ormocarpum cochinchinense (OC), traditionally used for bone healing, is emerging as a plant of interest for its antioxidant and anti-inflammatory properties. This herb, from the Fabaceae family and native to Southeast Asia, India’s Coromandel region, tropical Africa, and Pacific islands, shows promise in addressing oxidative stress and chronic inflammation. In the context of rising health concerns linked to these conditions, OC’s bioactive compounds are being studied for their potential to scavenge free radicals and mitigate disease progression. Its effects on oxidative stress and inflammation are relevant for chronic diseases such as cardiovascular conditions, neurodegenerative disorders, and periodontitis. Despite its traditional uses and regional significance, detailed scientific research on OC’s pharmacological benefits is limited. This study investigates the antioxidant and anti-inflammatory activities of the ethanolic extract of OC through in vitro analyses. The goal is to enhance understanding of OC’s therapeutic potential as a natural remedy for chronic inflammatory diseases.
In vitro Anti-inflammatory and Antioxidant Activity of Ormocarpum cochinchinense
References:
[1]. Parvathi, K., Krishnan, A. G., Anitha, A., Jayakumar, R., & Nair, M. B., 2018, Poly(L-lactic acid) nanofibers containing Cissus quadrangularis induced osteogenic differentiation in vitro, International Journal of Biological Macromolecules, 110, 514–521.
[2]. Somashekar, G., Sudhakar, U., Prakash, S. G., Suresh, S., Srividya, S., & Rao, S. H., 2022, In-vitro antioxidant and in-vitro anti-inflammatory activities of ethanolic leaves extract of Ormocarpum cochinchinense. Journal of Orofacial Sciences, 14(2), 134.
[3]. Kumar, M. D., John, K. M., & Karthik, S., 2013, The bone fracture–healing potential of Ormocarpum cochinchinense, methanolic extract on albino Wistar rats, Journal of Herbs, Spices & Medicinal Plants, 19(1), 1–10.
[4]. 4. Pazhanisamy, M., & Ebenezer, G. A., 2013, Phytochemical screening of Ormocarpum cochinchinense leaf extracts, Journal of Academia and Industrial Research, 2, 275–278.
[5]. 5. Narayanan, A., Marimuthu, M., Mani, A., Vasu, G., & Subhadra, R., 2023, Studies on the antimicrobial activity of Ormocarpum cochinchinense leaf extract/PVA‐PVP blended polymer, ChemistrySelect, 8(10), e202203512.
[6]. Srividya, S., & Sridevi, G., 2016, Anti-arthritic and anti-inflammatory activity of ethanolic leaf extract of Ormocarpum sennoides, International Journal of Pharmacy and Pharmaceutical Sciences, 8, 117–121.
[7]. Mohapatra, S., Leelavathi, L., Rajeshkumar, S., Sakthi, D. S., & Jayashri, P., 2020, Assessment of cytotoxicity, anti-inflammatory and antioxidant activity of zinc oxide nanoparticles synthesized using clove and cinnamon formulation—An in vitro study, Journal of Evolution of Medical and Dental Sciences, 9(25), 1859–1865.
[8]. Nyamboki, D. K., & Wanga, L. A., 2022, Review of the phytochemical and pharmacological studies of the genus Ormocarpum, Pharmacognosy Reviews, 16(32), 95.
[9]. Rajeshkumar, S., Parameswari, R. P., Jayapriya, J., Tharani, M., Ali, H., Aljarba, N. H., et al., 2022, Apoptotic and antioxidant activity of gold nanoparticles synthesized using marine brown seaweed: An in vitro study, Biomedical Research International, 2022, 5746761.
[10]. Rifaath, M., Rajeshkumar, S., Anandan, J., Munuswamy, T., & Govindharaj, S., 2023, Preparation of herbal nano-formulation-assisted mouth paint using titanium dioxide nanoparticles and its biomedical applications, Cureus, 15(11), e48332.
[11]. Aarthi, N., Muthuraj, M., Archana, M., Gopal, V., Balasubramanian, N., & Rajeswari, S., 2024, Wound healing activities of PVA–urea composites from Ormocarpum cochinchinense, Natural Product Research, 38(5), 813–818.
[12]. Nagarajan, D., & Pandian, R., 2018, Anti-cancer potentials of endophytic fungi isolated from Enicostemma axillare and Ormocarpum cochinchinense, Journal of Pharmacognosy and Phytochemistry, 7(3), 3186–3191.
[13]. Narayanan, A., Das, D., Marimuthu, M., Vasu, G., Mani, A., & Subhadra, R., 2024, In vitro cytotoxicity and wound healing activities of quaternary blended carboxymethyl cellulose-hydroxypropyl methylcellulose composite film, Cellulose, 31(4), 2295–2308.
[14]. Nunes CD, Barreto Arantes M, Menezes de Faria Pereira S, Leandro da Cruz L, de Souza Passos M, Pereira de Moraes L, Vieira IJ, Barros de Oliveira D., 2020, Plants as sources of anti-inflammatory agents, Molecules, 15;25(16):3726.
[15]. Singh S, Singh TG, Mahajan K, Dhiman S. Medicinal plants used against various inflammatory biomarkers for the management of rheumatoid arthritis., 2020, Journal of Pharmacy and Pharmacology, 72(10):1306-27.
[16]. Salmerón-Manzano E, Garrido-Cardenas JA, Manzano-Agugliaro F., 2020, Worldwide research trends on medicinal plants, International Journal of Environmental Research and Public Health, 17(10):3376.
[17]. Vitale S, Colanero S, Placidi M, Di Emidio G, Tatone C, Amicarelli F, D’Alessandro AM., 2022, Phytochemistry and biological activity of medicinal plants in wound healing: an overview of current research, Molecules, 1;27(11):3566.
[18]. Wang X, Cao Y, Chen S, Lin J, Bian J, Huang D., 2021, Anti-inflammation activity of flavones and their structure–activity relationship, Journal of Agricultural and Food Chemistry, 2021 , 23;69(26):7285-302.
[19]. Jongrungraungchok S, Madaka F, Wunnakup T, Sudsai T, Pongphaew C, Songsak T, Pradubyat N.,2023, In vitro antioxidant, anti-inflammatory, and anticancer activities of mixture Thai medicinal plants, BMC Complementary Medicine and Therapies, 10;23(1):43.
[20]. Shahrajabian MH, Sun W.,2023, Survey on medicinal plants and herbs in traditional Iranian medicine with anti-oxidant, anti-viral, anti-microbial, and anti-inflammation properties, Letters in Drug Design & Discovery, 1;20(11):1707-43.Viewed PDF 5 0 -
Cold Chain Adequacy for Childhood Immunization Coverage in Bolgatanga Municipality, A Study in Upper East Region of GhanaAuthor: William Fosu AmankwaaDOI: 10.21522/TIJPH.2013.12.04.Art009
Cold Chain Adequacy for Childhood Immunization Coverage in Bolgatanga Municipality, A Study in Upper East Region of Ghana
Abstract:
Background: The Expanded Programme on Immunization is an initiative that was introduced by the World Health Organization (WHO) in 1974 to ensure there is equitable access to life-saving vaccines for every child, regardless of their geographic location or socioeconomic status. Availability of cold chain equipment such as vaccine fridges, deep freezers and cold-boxes etc are indispensable. Transportation is and human resource equally important to ensure that vaccines reach their destination. The main aim of the study was to assess the cold chain adequacy for childhood immunization coverage in the Bolgatanga Municipality of Ghana. This cross-sectional study employed quantitative methods. A total population sampling method was used to include all the 56 facilities in the Municipality in the study. Some selected health staff were interviewed. The results show that only 28.6% of health facilities had adequate cold chain arrangements in the study area. The study results showed that the majority (87.5%) of facilities had means of transport to support immunization activities however, 53.6% of facilities covered more than 5 kilometres to reach their nearest cold chain site. Again, 57.1% of facilities had only one staff to manage cold chain and immunization activities which was statistically significant (p-value =0.005). The study concluded that cold chain equipment for the maintenance of vaccine potency and to influence immunization uptake in the Bolgatanga Municipality was inadequate. However, means of transport which aided in the collection and distribution of vaccines were not a challenge. Low staffing to manage cold chain and immunization activities was a predictor of low immunization. The study recommends Ministry of Health/Ghana Health Services (MOH/GHS) and partners to procure and distribute vaccine storage equipment to all health facilities in the Municipality. More staffs should be trained in cold chain and immunization activities.
Cold Chain Adequacy for Childhood Immunization Coverage in Bolgatanga Municipality, A Study in Upper East Region of Ghana
References:
[1]. WHO, “2023 WHO Global Vaccine Market Report; Agenda, Policy & Strategy (APS), Immunization, Vaccines and Biologicals (IVB),” 2024. https://doi.org/10.2471/
[2]. World Health Organization and others 2022, Vaccines and immunization for monkeypox: interim guidance, https://www.who.int/publications/i/item/WHO-MPX-Immunization
[3]. Ghana Health Service, “Ghana Health Service Annual Report,” Ghana, 2007. http://www.ghanahealthservice.org/
[4]. Hanson, K. E. et al., 2023, Safety of measles, mumps, and rubella vaccine in adolescents and adults in the vaccine safety Datalink. Vaccine X, 13, doi: 10.1016/j.jvacx.2023.100268
[5]. WHO, “Measles and rubella strategic framework,” 2021. https://www.who.int/publications/i/item/measles-and-rubella-strategic-framework-2021-2030
[6]. Dowling, A. J., 2013, Novel gain of function approaches for vaccine candidate identification in Burkholderia pseudomallei. Front Cell Infect Microbiol, 2, p. 139, https://pdf.usaid.gov/pdf_docs/PA00MKKG.pdf
[7]. Feyisa, Z. T., 2021, Factors limiting youths’ practice of preventive measures toward the outbreak of COVID-19 in Oromia special zone surrounding Finfinnee, Ethiopia. PLoS One, 16(3), p. e0248495. . https://doi.org/10.2147/PHMT.S312039
[8]. Le Gargasson, J. B., F. K. Nyonator, Adibo, M., Gessner B. D., Colombini, A., 2015, Costs of routine immunization and the introduction of new and underutilized vaccines in Ghana. Vaccine, 33, pp. A40–A46, doi: 10.1016/j.vaccine.2014.12.081
[9]. Asamoah, D., Agyei-Owusu, B., Andoh-Baidoo, F. K., Ayaburi, E., 2021. “Inter-organizational systems use and supply chain performance: Mediating role of supply chain management capabilities,” Int J Inf Manage, vol. 58, p. 102195, doi: 10.1155/2021/7559984
[10]. Russo, G. et al.., 2015, “Vaccine coverage and determinants of incomplete vaccination in children aged 12–23 months in Dschang, West Region, Cameroon: a cross-sectional survey during a polio outbreak,” BMC Public Health, vol. 15, pp. 1–11, https://doi.org/10.1186/s12889-015-2000-2
[11]. Bolgatanga Municipal, 2023, Bolgatanga Municipal Health Directorate Annual Report, Bolgatanaga,.
[12]. Bogale, H. A, Amhare, A. F., Bogale, A. A., 2019, Assessment of factors affecting vaccine cold chain management practice in public health institutions in east Gojam zone of Amhara region. BMC Public Health, 19, pp. 1– 6, https://doi.org/10.1186/s12889-019-7786-x
[13]. Yauba, S. et al., 2019, Availability and Status of Vaccine Cold Chain Equipment in Cameroon, Journal of Vaccines & Vaccination. 10, pp. 1- 6, doi: 10. 24105/2157-7560.10.400
[14]. Erassa, T. E., Bachore, B. B., Faltamo, W. F., Molla, S., Bogino, E. A., 2023, Vaccine cold chain management and associated factors in public health facilities and District Health Offices of Wolaita Zone, Ethiopia. Journal of Multidisciplinary Healthcare, 16, pp. 75–84, https://doi.org/10.2147/JMDH.S385466
[15]. Centers for Disease Control and Prevention, 2024, Vaccine Storage and Handling Toolkit. https://www.cdc.gov/vaccines/hcp/admin/storage/toolkit/storage-handling-toolkit.pdf
[16]. UNICEF and others, 2022, Prospects for Children in 2022. https://www.unicef.org/eca/media/19796/file/Prospects%20for%20children%20in%202022:%20a%20global%20outlook%20.pdf
[17]. Rao, S., Naftar, S., Unnikrishnana, B., et al, 2012, Evaluation, awareness, practice and management of cold chain at the primary health care centers in Coastal South India. Journal of Nepal Paediatric Society, 32(1), pp. 19–22, DOI:10.3126/jnps.v32i1.5946
[18]. Lindstrand, A., Cherian, T., Chang-Blanc, D., Feikin, D., O’Brien, K. L., 2021, The world of immunization: achievements, challenges, and strategic vision for the next decade, J Infect Dis, 224(4), pp. 452–S467, https://doi.org/10.1093/infdis/jiab284
[19]. Bakkabulindi, P. et al., 2023, Improving the last mile delivery of vaccines through an informed push model: experiences, opportunities and costs based on an implementation study in a rural district in Uganda. medRxiv, pp. 2011–2023, https://doi.org/10.1101/2023.11.03.23298045
[20]. Ashok, A., Brison, M., LeTallec, Y., 2017, Improving cold chain systems: Challenges and solutions. Vaccine, 35(17), pp. 2217–2223, https://doi.org/10.1016/j.vaccine.2016.08.045
[21]. Kremer, P., Haruna, F., Sarpong, R.T., Agamah, D., Billy, J., et al, An impact assessment of the use of aerial logistics to improve access to vaccines in the Western-North Region of Ghana. Vaccine, 41(36), pp. 5245–5252, https://doi.org/10.1016/j.vaccine.2023.06.036
[22]. Sarley, D., Mahmud, M., Idris, J., Osunkiyesi, M., Dibosa-Osadolor, O., et al. 2017, Transforming vaccines supply chains in Nigeria. Vaccine, 35, pp. 2167–2174, doi: 10.1016/j.vaccine.2016.11.068
[23]. Ouédraogo, Ouédraogo, H. S., Kabore, Y. L. B., Sawadogo, A. G., Bakouan, M., Sawadogo, N., Mano, M., Zongo, A., Sanou, S., & Kaboré, L. 2023, Task-Shifting Immunization Activities to Community Health Workers: A Mixed-Method Cross-Sectional Study in Sahel Region, Burkina Faso. Global health, science and practice, 11(5), e2300044, DOI: 10.9745/GHSP-D-23-00044
[24]. Ahoto, A. T., Giri L. M., Koirala, S., et al, 2021, “Ghana National Community Health Planning and Services (CHPS) policy; gaps between policy and implementation, the need for policy review to address specific gaps,” Magna Scientia Advanced Biology and Pharmacy, 2(1), pp. 26–34 DOI:10.30574/msabp.2021.2.1.0013
[25]. Pambudi, N. A., Sarifudin, A., Gandidi, I. M., Romadhon, R. 2022, Vaccine cold chain management and cold storage technology to address the challenges of vaccination programs. Energy Reports, 8, pp. 955–972, https://doi.org/10.1016/j.egyr.2021.12.039
[26]. Zhu, F.C. et al., 2020, Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial,” The Lancet, 395(10240), pp. 1845–1854, https://doi.org/10.1016/ S0140-6736(20)31208-3
[27]. Nabirye, J. et al., 2020, “Health system factors influencing uptake of Human Papilloma Virus (HPV) vaccine among adolescent girls 9-15 years in Mbale District, Uganda,” BMC Public Health, 20, pp. 1–11, . https://doi.org/10.1186/s12889-020-8302-z
Viewed PDF 5 0 -
Assessment of Knowledge of DNA among Dental Students in Chennai, IndiaAuthor: SujathaDOI: 10.21522/TIJPH.2013.12.04.Art010
Assessment of Knowledge of DNA among Dental Students in Chennai, India
Abstract:
Although there have been several recent advances in genomic technology over the past two decades, little to no change has occurred in the incorporation of genetics in dental school curricula. Also, there are only a limited number of studies that have reported the knowledge and awareness of genetics in dental professionals. With the available information, the present study was conducted to analyze the knowledge of DNA among dental students. This cross-sectional study was conducted among 302 dental students from various Dental Colleges across Chennai to assess the knowledge of DNA among dental students. It was done using a questionnaire survey from May 2021 to June 2021comprising of 14 questions that were validated owing to the pandemic situation, the survey was conducted online using Google Forms Student T-test was planned to statistically analyze the result. The mean percentage of correct responses from students of various academic years was calculated and it was observed that interns had better knowledge and interest in genetics (81.39%), followed by final-year students (80.9%), first-year students 75%, third-year students (74.76%) and second-year students (73.07%). Considering gender, females (77.21%) had better knowledge of genetics than males (75.2%). The results were not statistically significant. The basic concepts of genetics and applications of genetics have to be incorporated into the dental curriculum. This can also be accomplished by conducting educational programs during the study and continuing dental educational programs after they complete their course.
Assessment of Knowledge of DNA among Dental Students in Chennai, India
References:
[1]. Maffeo, C., Yoo, J., Comer, J., Wells, D. B., Luan, B., Aksimentiev, A., 2014, Close encounters with DNA. J Phys Condens Matter, 26(41), 413101. doi: 10.1088/0953-8984/26/41/413101.
[2]. Jaekel, A., Lill, P., Whitelam, S., & Saccà, B., 2020. Insights into the Structure and Energy of DNA Nanoassemblies. Molecules (Basel, Switzerland), 25(23), 5466. https://doi.org/10.3390/molecules25235466.
[3]. . Watson, J.D., Crick, F.H.C., 1953, Molecular Structure of Nucleic Acids: A Structure for Deoxyribose Nucleic Acid. Nature, 171, 737–738. doi: 10.1038/171737a0.
[4]. Watson J.D., Crick, F.H.C, 1953, Genetical Implications of the Structure of Deoxyribonucleic Acid. Nature, 171,964–967. doi: 10.1038/171964b0.
[5]. Mc Gruder, Carla., Evaluation of current knowledge of genetics among dental students, residents and dental hygiene students 2015, The University of Texas MD Anderson Cancer Center uthealth graduate school of biomedical sciences dissertations and theses (Open Access). 579. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/579.
[6]. Baars, M. J., Henneman, L., Ten, Kate, L. P., 2005, Deficiency of knowledge of genetics and genetic tests among general practitioners, gynaecologists, and pediatricians: a global problem. Genet Med., 7(9), 605-10. doi: 10.1097/01.gim.0000182895.28432.c7. PMID: 16301861.
[7]. Slavkin, Harold, 2014, Revising the scope of practice for oral health professionals: Enter genomics. Journal of the American Dental Association, 1939 (145), 228-230. 10.14219/jada.2014.11.
[8]. Loos, B. G., & Van Dyke, T. E., 2020, The role of inflammation and genetics in periodontal disease. Periodontology 2000, 83(1), 26–39. https://doi.org/10.1111/prd.12297.
[9]. Shaffer, J.R., Xiaojing Wang, Daniel, W. M., Robert, J. W., Richard, C., and Mary L. M., 2015, Genetic susceptibility to dental caries differs between the Sexes: A family-based study. Caries Research, 49(2),133–140. doi:10.1159/000369103.
[10]. De Coster, P. J., Marks, L. A., Martens, L. C., & Huysseune, A. 2009, Dental agenesis: genetic and clinical perspectives. Journal of oral pathology & medicine: official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 38(1), 1–17. https://doi.org/10.1111/j.1600-0714.2008.00699.x.
[11]. Alade, A., Awotoye, W., & Butali, A.,2022, Genetic and epigenetic studies in non-syndromic oral clefts. Oral diseases, 28(5), 1339–1350. https://doi.org/10.1111/odi.14146.
[12]. Balachander, K., and Paramasivam. A.,2023, The implication of mitochondrial DNA mutation and dysfunction in periodontal diseases. J Indian Soc Periodontol, 27(2), 126–130.
[13]. Abdul, N.S., Shenoy, M., Reddy, N.R. et al. 2024, Gene sequencing applications to combat oral-cavity related disorders: a systematic review with meta-analysis. BMC Oral Health, 24, 103, https://doi.org/10.1186/s12903-023-03541-7.
[14]. Rajasekar, A., Balu, P., Kumar, S. R., & Varghese, S. S., 2023, Comparison of Microbial Composition of Natural Teeth and Implants by 16S rRNA Gene Sequencing. Journal of Long-Term Effects of Medical Implants, 33(3), 1–8. https://doi.org/10.1615/JLongTermEffMedImplants.2022044519.
[15]. Sujatha, G., Priya, V. V., Varadarajan, S., et al., 2022, A Bibliometric Analysis of the Published Literature Related to Toothbrush as a Source of DNA. World J Dentistry, 13(S-1), S87–S95.
[16]. Johnson, L., Genco, R. J., Damsky, C., Haden, N. K., Hart, S., Hart, T. C., Shuler, C. F., Tabak, L. A., Tedesco, L. A., 2008, Genetics and its implications for clinical dental practice and education: Report of panel 3 of the Macy study. J Dent Educ, 72(2 Suppl):86-94. PMID: 18250384.
[17]. Jorgenson, R. J.,1980, The role of the dentist in genetic counseling. Birth Defects Orig Artic Ser, 16, 139–45.
[18]. D, Merdad L., Ramadan, E., 2016, Knowledge of Genetics and Attitudes toward Genetic Testing among College Students in Saudi Arabia. Public Health Genomics,19, 260-268. doi: 10.1159/000446511.
[19]. Keerthika, S., Vishnupriya, V., Gayathri, R., Selvaraj, J, 2019, Knowledge, attitude, and awareness of DNA fingerprinting among college students Drug Invention Today, 2378-2383.
[20]. Gupta, R., Chandra Shekar, B. R., Goel, P., Hongal, S., Ganavadiya, R., 2019, Role of dentist in genetic counseling: A critical appraisal of the current practices and future requirements in Indian scenario. Dent Res J (Isfahan), 16(3), 131-138.
[21]. Johnson, L., Genco, R. J., Damsky, C., Haden, N. K., Hart, S., Hart, T. C., Shuler, C. F., Tabak, L. A., tedesco, L. A., Behnke, A. R., Hassell, T. M., 2004, Need for genetics education in U.S. Dental and dental hygiene programs. J Dent Educ, 68, 819–22.
[22]. Behnke, A. R., Hassell, T. M., 2004, Need for genetics education in U.S. Dental and dental hygiene programs. J Dent Educ, 68, 819–22.
[23]. Dudlicek, L. L., Gettig, E. A., Etzel, K.R., Hart, T. C., 2004, Status of genetics education in U.S. Dental schools. J Dent Educ, 68:809–18. Genetics and its implications for clinical dental practice and education: Report of panel 3 of the Macy study. J Dent Educ., 72(2 Suppl, 86-94.
[24]. Collins, F., Tabak, L., 2004, A call for increased education in genetics for dental health professionals. J Dent Educ., 68, 807–8.
Viewed PDF 5 0 -
Evaluation of the Marginal Adaptability of Indirect Composite and Monolithic Zirconia Crowns - A Stereomicroscopic AnalysisAuthor: Dhanraj GanapathyDOI: 10.21522/TIJPH.2013.12.04.Art016
Evaluation of the Marginal Adaptability of Indirect Composite and Monolithic Zirconia Crowns - A Stereomicroscopic Analysis
Abstract:
Marginal adaptation plays an important role in the clinical success of any prostheses. Ideal marginal adaptation can produce less gingival irritation and cement dissolution. The presence of marginal discrepancies increases plaque accumulation, secondary caries, pulpal lesions, postoperative sensitivity, periodontal disease and marginal discoloration leading to abutment failure and in turn failure of the prosthesis. A maxillary first molar typhodont tooth was prepared with an aerator handpiece. To make the monolithic zirconia crowns, the prepared tooth was scanned and the STL file was used to design a crown using CAD/CAM software. To fabricate the indirect composite crowns, a clear acrylic mould was created, in which the indirect composite was filled and the tooth was placed. The samples were then placed in a curing unit. The samples were then examined under a stereomicroscope. With the aid of imaging software, marked calibrations were calculated at four marked regions- buccal, distal, lingual and mesial margins. Monolithic zirconia adaptation showed statistically significant results when compared to that of indirect composite crowns (p<0.05). According to the site, results varied with zirconia crowns adapting better in buccal and mesial sites whereas indirect composite crowns adapted better in the distal and lingual sites. Overall, monolithic zirconia adapted statistically significantly better to the prepared typhodont tooth than the indirect composite crowns and should be used as a material of choice for crowns.
Evaluation of the Marginal Adaptability of Indirect Composite and Monolithic Zirconia Crowns - A Stereomicroscopic Analysis
References:
[1]. Akmal, N. L. H. B. I., & Duraisamy, R., 2020, Evaluation of the marginal fit of implant-supported crowns. Journal of Long-Term Effects of Medical Implants, 30(3), 165-172.
[2]. Vaishali S, Duraisamy R., 2022, Esthetics using monolithic zirconia and hand-layered zirconia fixed partial denture, Bioinformation.;18(7):651.
[3]. Kanat-Ertürk, B., Çömlekoğlu, E. M., Dündar-Çömlekoğlu, M., Özcan, M., & Güngör, M. A., 2015, Effect of veneering methods on zirconia framework-veneer ceramic adhesion and fracture resistance of single crowns. Journal of Prosthodontics, 24(8), 620-628.
[4]. Urapepon, S., & Taenguthai, P., 2015, The effect of zirconia framework design on the failure of all-ceramic crowns under static loading. Journal of Advanced Prosthodontics, 7(2), 146-150.
[5]. Hassan, L. A., & Goo, C. L., 2021, Effect of cement space on marginal discrepancy and retention of CAD/CAM crowns. Dental Materials Journal, 40(5), 1189-1195.
[6]. Papadiochou, S., & Pissiotis, A. L., 2018, Marginal adaptation and CAD-CAM technology: A systematic review of restorative material and fabrication techniques. Journal of Prosthetic Dentistry, 119(4), 545-551.
[7]. Heintze, S. D., 2007, Systematic reviews: I. The correlation between laboratory tests on marginal quality and bond strength. II. The correlation between marginal quality and clinical outcome. Journal of Adhesive Dentistry, 9(Suppl 1), 77-106.
[8]. Chaturvedi, S., Alqahtani, N. M., Addas, M. K., & Alfarsi, M. A., 2020, Marginal and internal fit of provisional crowns fabricated using 3D printing technology. Technology and Health Care, 28(6), 635-642.
[9]. McLean, J. W., & von Fraunhofer, J. A., 1971, The estimation of cement film thickness by an in vivo technique. British Dental Journal, 131(3), 107-111.
[10]. Rekow, D., & Thompson, V. P., 2005, Near-surface damage—a persistent problem in crowns obtained by computer-aided design and manufacturing. Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine, 219(4), 233-243.
[11]. Jalalian, E., Younesi, F., Golalipour, S., Khorshidi, S., Mahdavisaedabadi, S. H., & Sayyari, M., 2023, Assessment of marginal and internal adaptation in provisional crowns utilizing three distinct materials. Journal of Contemporary Dental Practice, 24(11), 853-858.
[12]. Ellakwa, A., & Goh, D., 2023, The marginal accuracy of lithium disilicate single crowns is comparable when made from conventional or digital (direct or indirect) workflows. Journal of Evidence-Based Dental Practice, 23(4), 101914.
[13]. Miyazaki, T., Hotta, Y., Kunii, J., Kuriyama, S., & Tamaki, Y., 2009, A review of dental CAD/CAM: current status and future perspectives from 20 years of experience. Dental Materials Journal, 28(1), 44-56.
[14]. Baroudi, K., & Ibraheem, S. N., 2015, Assessment of chair-side computer-aided design and computer-aided manufacturing restorations: A review of the literature. Journal of International Oral Health, 7(4), 96-104.
[15]. Euán, R., Figueras-Álvarez, O., Cabratosa-Termes, J., & Oliver-Parra, R., 2014, Marginal adaptation of zirconium dioxide copings: Influence of the CAD/CAM system and the finish line design. Journal of Prosthetic Dentistry, 112(2), 155-162.
[16]. Contrepois, M., Soenen, A., Bartala, M., & Laviole, O., 2013, Marginal adaptation of ceramic crowns: A systematic review. Journal of Prosthetic Dentistry, 110(6), 447-454.e10.
[17]. Pelekanos, S., Koumanou, M., Koutayas, S. O., Zinelis, S., & Eliades, G., 2009, Micro-CT evaluation of the marginal fit of different In-Ceram alumina copings. European Journal of Esthetic Dentistry, 4(3), 278-292.
[18]. Shah, S., Nallaswamy, D., & Ganapathy, D., 2020, Marginal accuracy of milled versus cast cobalt chromium alloys in long-span implant-supported frameworks: A systematic review and meta-analysis. Journal of Advanced Oral Research, 11(2), 120-127.
[19]. Nejatidanesh, F., Shakibamehr, A. H., & Savabi, O., 2016, Comparison of marginal and internal adaptation of CAD/CAM and conventional cement retained implant-supported single crowns. Implant Dentistry, 25(1), 103-108.
[20]. Reddy, M. S., Ahmed, N., & Shasanka, K. (2020). A retrospective marginal fit evaluation of a fixed dental prosthesis framework fabricated by various dental students. International Journal of Dentistry and Oral Science, 7(11), 1094–1098. Available from November 25, 2020.
[21]. Merchant, A., Nallaswamy, D., Velayudhan, A., & Gada, S., 2020, Radiographic evaluation of marginal accuracy of metal coping in sectioned and unsectioned 3D printed models and gypsum models. World Journal of Dentistry, 11(5), 386-391.
[22]. Rayyan, M. R., 2019, Marginal adaptation of monolithic high-translucency versus porcelain-veneered zirconia crowns. International Journal of Prosthodontics, 32(4), 364-366.
[23]. Paul, N., Raghavendra Swamy, K. N., Dhakshaini, M. R., Sowmya, S., & Meravini, M., 2020, Marginal and internal fit evaluation of conventional metal-ceramic versus zirconia CAD/CAM crowns. Journal of Clinical and Experimental Dentistry, e31-37.
[24]. Neppelenbroek, K. H., 2015, The clinical challenge of achieving marginal adaptation in direct and indirect restorations. Journal of Applied Oral Science, 23(5), 448-449.
[25]. Torabi, K., Vojdani, M., Giti, R., & Taghva, M., 2015, The effect of various veneering techniques on the marginal fit of zirconia copings. Journal of Advanced Prosthodontics, 7(3), 233-239.
Viewed PDF 5 0 -
Perceived Barriers towards Tuberculosis Risk Reduction Measures among Health Care Workers in Asokoro District Hospital Abuja FCT NigeriaAuthor: Titilayo Oluwatoyin IlesanmiDOI: 10.21522/TIJPH.2013.12.04.Art017
Perceived Barriers towards Tuberculosis Risk Reduction Measures among Health Care Workers in Asokoro District Hospital Abuja FCT Nigeria
Abstract:
Globally, tuberculosis (TB) remains one of the leading causes of preventable death in adults and children. Significantly, several studies revealed that Hospital-acquired infection (HAI) of TB among Health Care Workers (HCWs) and patients occurs in high, middle and low-income countries. However, with the effective practice of TB risk reduction measures (TB Infection Prevention and Control Practices – TB-IPC) among HCWs, the risk of TB transmission should be prevented and controlled. The study aimed to identify perceived barriers against the practice of TB risk reduction measures among HCWs in Asokoro District Hospital (ADH) Abuja FCT Nigeria. A qualitative study design with a purposive sampling technique was adopted and eight informants were interviewed using Key Informant Interviews with unstructured interview guides the following findings were revealed: limited supply of surgical and N95 masks, lack of space, nonexistence of isolation ward and shortage of manpower, insufficient periodic training of HCWs on TB risk reduction measures, increased workload, need for TB policy and TB designated professional, ineffective triage, lack of incentives, feeling of discomfort using N95 mask and stigmatization. The findings pointed to the need for making budgetary allocations towards TB–IPC activities along with having a plan for constant periodic training of all HCWs on TB risk reduction measures. Moreover, healthcare facilities must have TB – -IPC policy/guidelines with a designated professional who monitors and evaluates the practice of TB risk reduction measures among HCWs within the facility.
Perceived Barriers towards Tuberculosis Risk Reduction Measures among Health Care Workers in Asokoro District Hospital Abuja FCT Nigeria
References:
[1]. Shadreck, M & Stapley, S; 2020, An exploration of health workers risks of contracting tuberculosis in the workplace: a qualitative study. British Medical Journal, 20 (1), 1037, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664041/
[2]. Masuku, S; Olorunju, S; Mooa, RS; 2023, Association of knowledge and practice of Tuberculosis infection prevention and control policies among health care personnel at a regional hospital, in Gauteng province of South Africa. International Journal of African Nursing Sciences, 19, 100588, https://www.sciencedirect.com/science/article/pii/S221413912300063X
[3]. The TB Alliance; 2022, TB is a Pandemic, https://www.tballiance.org/why-new-tb-drugs/global-pandemic
[4]. World Health Organization; 2023a, Tuberculosis, https://www.who.int/news-room/fact-sheets/detail/tuberculosis
[5]. Tiruneh, MG; Anagaw, TF & Fenta, ET; 2023, Tuberculosis infection control practice among healthcare workers in Ethiopia: a protocol for systematic review and meta-analysis. British Medical Journal, 13 (11), e073634, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685950/
[6]. Baral, MA & Koirala, S; 2022, Knowledge and Practice on Prevention and Control of Tuberculosis among Nurses Working in a Regional Hospital Nepal. Frontiers in Medicine, 8, 788833, https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2021.788833/full
[7]. Paleckyte, A., Dissanayake, O., Mpagama, S; 2021, Reducing the risk of tuberculosis transmission for HCWs in high incidence settings. Antimicrobial Resistance and Infection Control, 10, 106, https://aricjournal.biomedcentral.com/articles/10.1186/s13756-021-00975-y#citeas
[8]. WHO; 2019a, WHO guidelines on tuberculosis infection prevention and control 2019 update, https://iris.who.int/bitstream/handle/10665/311259/9789241550512-eng.pdf
[9]. World Health Organization; 2023b, Module 1: Infection Prevention and Control https://tbksp.org/en/node/2582
[10]. WHO; 2019b, WHO guidelines on tuberculosis infection prevention and control: 2019 update Executive Summary, https://www.ncbi.nlm.nih.gov/books/NBK539299/
[11]. NHS Northern Care Alliance; 2020, Research and Innovation, https://www.northerncarealliance.nhs.uk/research-education/research-innovation
[12]. Main, S; Triasih, R; Greig, J; Hidayat, A; Brilliandi, I,B; Khodijah, S; Chan, G; Wilks, N; Parry, A, E; Nababan, B; Cros, P & Dwihardiani, B; 2023, The prevalence and risk factors for tuberculosis among healthcare workers in Yogyakarta, Indonesia. PLOS ONE, 18(5), e0279215, https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0279215
[13]. Adu,PA; Yassi, A; Ehrlich,R; 2020, Perceived Health System Barriers to Tuberculosis Control among Health Workers in South Africa. Ann Glob Health, 86 (1), 15, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019201/
[14]. Health and Human Services Secretariat; 2019, Profile on Asokoro District Hospital Abuja FCT, https://fcthhss.abj.gov.ng/site/
[15]. National University; 2024, Applied Doctoral Center, https://resources.nu.edu/c.php?g=1013606&p=8394398
[16]. World Health Organization; 2024, 2.2 TB Mortality, https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2021/disease-burden/mortality
[17]. Center for Diseases Control; 2023, Tuberculosis Infection Control, https://www.cdc.gov/tb-healthcare-settings/hcp/infection-control/index.html
[18]. Brouwer, M; Cohelho, E; Mosse, C; 2014, Healthcare Workers' Challenges in the Implementation of Tuberculosis Infection Prevention and Control Measures in Mozambique. PLOS ONE, 9 (12), e114364, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266607/pdf/pone.0114364.pdf
[19]. Dorward, J; Roberts, N & Butler, C; 2022, Health worker experiences of implementing TB infection prevention and control: A qualitative evidence synthesis to inform implementation recommendations. PLOS Global Public Health, 2 (7), e0000292, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021216/pdf/pgph.0000292.pdf
[20]. Islam, MS; Chughtai, AA; Banu, S; 2021, Context matters: Examining the factors impacting the implementation of tuberculosis infection prevention and control guidelines in health settings in seven high tuberculosis burden countries. Journal of Infection and Public Health, 14 (5), 588 – 597, https://www.sciencedirect.com/science/article/pii/S1876034121000289
[21]. Tu, R; Elling, H; Behnke, N; TSeka, JM; Kafanikhale, H; Mofolo, I et al; 2022, A qualitative study of barriers and facilitators to adequate environmental health conditions and infection control for healthcare workers in Malawi. H2Open Journal, 5 (1), 11 – 22, https://iwaponline.com/h2open/article/5/1/11/86224/A-qualitative-study-of-barriers-and-facilitators
[22]. Kielmann, K; Karat, AS; Zwama, G; 2020, Tuberculosis infection prevention and control: why we need a whole systems approach. Infectious Diseases of Poverty, 9 (56), https://idpjournal.biomedcentral.com/articles/10.1186/s40249-020-00667-6#citeas
[23]. Ashipala, DO & Nghole, TM; 2022, Factors contributing to burnout among nurses at a district hospital in Namibia: A qualitative perspective of nurses. Journal of Nursing Management, 30 (7), 2982 – 2991, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083902/
[24]. Kluwer, W; 2023, Three key challenges facing infection prevention and control programs, https://www.wolterskluwer.com/en/expert-insights/3-key-challenges-facing-infection-prevention-and-control-programs
[25]. Tshitangano T, G; 2014, The practices of isolating tuberculosis infectious patients at Hospitals of Vhembe district. African Journal of Primary Health Care & Family Medicine, 6 (1), 555, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4502866/pdf/PHCFM-6-555.pdf
[26]. International Council of Nurses; no date, TB Guidelines for Nurses in the Care and Control of Tuberculosis and Multi-drug Resistant Tuberculosis 3rd Edition, https://www.icn.ch/sites/default/files/inline-files/tb_mdrtb_guideline.pdf
[27]. Priyadarshini, P, Jeevanandan, G, Govindaraju, L, Subramanian, E. M. G., 2020, Clinical evaluation of instrumentation time and quality of obturation using paediatric hand and rotary file systems with conventional hand K-files for pulpectomy in primary mandibular molars: a double-blinded randomized controlled trial. Eur Arch Paediatr Dent. 21: 693–701. doi:10.1007/s40368-020-00518-w
[28]. Marme, G; Kuzama, J; Zimmerman, P; 2023, Tuberculosis infection prevention and control in rural Papua New Guinea: an evaluation using the infection prevention and control assessment framework. Antimicrobial Resistance & Infection Control, 12 (31), 01237 – 9, https://aricjournal.biomedcentral.com/articles/10.1186/s13756-023-01237-9#citeas
[29]. Adebimpe, WA; Folayan, W; Shittu, AA; 2019, Infection Prevention and Control Practices among health care workers in TB clinics in Ondo state Nigeria. Libyan Journal of Medical Sciences, 3 (2), 51 – 6, https://www.researchgate.net/publication/333974652
[30]. Stop TB Partnership; 2019, TB Stigma Assessment Tool. https://www.stoptb.org/tb-stigma/tb-stigma-assessment-tool
[31]. Wang L, Zhang D, Liu J, Tang Y, Zhou Q, Lai X et al; 2023, The mediating role of incentives in association between leadership attention and self-perceived continuous improvement in infection prevention and control among medical staff: A cross sectional Survey. Frontiers in Public Health, 11, 984847, https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2023.984847/full
[32]. Zwama , G; Diaconu, K; Voce, AS; 2021, Health system influences on the implementation of tuberculosis infection prevention and control at health facilities in low-income and middle-income countries: a scoping review. BMJ Global Health, 6 (5), e004735, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118012/pdf/bmjgh-2020-004735.pdf
[33]. Kurmar, P, Nath, K, Prasad, A, Tiwan, LK, Chowdhry, BK, Sinha, AK et al; 2023, Effects of the Use of N95 Masks on the Vital Signs of Healthy Healthcare Workers during the COVID-19 Pandemic: A Hospital-Based Cross-Sectional Study. Cureus, 15 (16), e40622, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355089/pdf/cureus-0015-00000040622.pdf
[34]. Ehrilich, R; Spiegel, JM; Adu, P; 2020, Current Guidelines for Protecting Health Workers from Occupational Tuberculosis Are Necessary, but Not Sufficient: Towards a Comprehensive Occupational Health Approach. International Journal of Environmental Research and Public Health, 17 (11) 3957, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313452/pdf/ijerph-17-03957.pdf
Viewed PDF 6 0 -
The Effect of Safety Attitude on Factors Related to Burnout among NursesAuthor: Sathiyabama G.DOI: 10.21522/TIJPH.2013.12.04.Art018
The Effect of Safety Attitude on Factors Related to Burnout among Nurses
Abstract:
Burnout describes an occupational psychosocial syndrome that results from the poor management of elevated levels of emotional and social stress in the workplace for prolonged periods. The study aims to determine the methods for preventing burnout syndrome in nurses and to talk about the outcomes for potential future interventions aimed at reducing burnout in these workers. To assess the effect of safety attitude on factors related to burnout among Nurses to find out the association of the effect of safety attitude on factors related to burnout among nurses with selected demographic variables. The research design selected for the study was descriptive research design The samples of the study were nurses working at Saveetha Medical College and Hospital, Chennai. The sample size of the study was 30. nurses working at Saveetha Medical College and Hospital, Chennai. Sampling Technique. The investigator applied a non-probability convenient sampling technique to the sample selection. Data was collected through a structured questionnaire after obtaining permission from the hospital's medical superintendent. Statistically significant correlation between the demographic variable ward (χ2=13.195, p=0.040) and the amount of influence of safety attitude on parameters associated with burnout among nurses at the p<0.05 level. The degree of safety attitude's influence on characteristics linked to nursing burnout was not statistically significantly correlated with any of the other demographic variables. According to the results, 4(13.3%) had mild to high anxiety, 7(23.3%) had severe anxiety, and 19 (63.4%)had moderate anxiety. Anxiety measured a mean of 21.43±3.57. With a minimum score of 15.0 and a maximum score of 28.0, the median was 21.50. The demographic variable, ward showed a statistically significant correlation with the degree of safety attitude influence on variables associated with nurse burnout at the p<0.05 level.
The Effect of Safety Attitude on Factors Related to Burnout among Nurses
References:
[1]. Montero-Marín, J, García-Campayo, J., 2010. A newer and broader definition of burnout: Validation of the "Burnout Clinical Subtype Questionnaire (BCSQ-36)". BMC Public Health 10, 302 https://doi.org/10.1186/1471-2458-10-302
[2]. Burn-out an “occupational phenomenon”: International Classification of Diseases. burn-outan-occupational-phenomenon international- classification-of-diseases. Accessed 24 Apr 2022. https:// www. who. Int/ news/ item/ 28- 05- 2019-
[3]. Montero-Marin J, Prado-Abril J, et al. 2014 Coping with Stress and Types of Burnout: Explanatory Power of Different Coping Strategies. PLoS ONE. 9:e89090. https://doi.org/10.1371/journal.pone.0089090.
[4]. Ribeiro RP, Marziale MHP, Martins JT et al. 2018 Occupational stress among health workers of a university hospital. Rev Gaucha Enferm. 2018 Jul 23;39:e65127. Portuguese, English. Doi 10.1590/1983-1447.2018.65127. PMID: 30043951.
[5]. Vidotti V, Ribeiro RP, Galdino MJQ, et al. 2018 Burnout Syndrome and shift work among the nursing staff. Rev Lat Am EnfermagemAug 9;26:e3022. Doi: 10.1590/1518-8345.2550.3022. PMID: 30110099; PMCID: PMC6091368.
[6]. Carlesi KC, Padilha KG, Toffoletto MC, et al 2017 Patient Safety Incidents and Nursing Workload. Rev Lat Am Enfermagem. Apr 6;25:e2841. Doi: 10.1590/1518-8345.1280.2841.
[7]. Wazqar DY 2018 Oncology nurses' perceptions of work stress and its sources in a university-teaching hospital: A qualitative study. Nurs Open. Aug 16;6(1):100-108. .doi: 10.1002/nop2.192.
[8]. Woo T, Ho R, Tang A, et al. 2020 Prevalence of burnout symptoms among nurses: A systematic review and meta-analysis. J Psychiatry Res. 2020 Apr; 123:9-20. doi: 10.1016/j.jpsychires.2019.12.015. Epub Jan 22.
[9]. Mackerel A, Michelet P, Durand AC et al. 2019, Burnout Syndrome among Emergency Department Staff: Prevalence and Associated Factors. Biomed Res Int. Jan 21; 2019:6462472. Doi: 10.1155/2019/6462472.
[10]. Blaauw D, Dotloop P, Maseko F, et al., 2013 Comparing the job satisfaction and intention to leave of different categories of health workers in Tanzania, Malawi, and South Africa. Glob Health Action. Jan 24; 6:19287. Doi: 10.3402/gha. v6i0.19287.
[11]. Shoorideh FA, Ashktorab T, Yaghmaei F, et al. 2015, Relationship between ICU nurses' moral distress with burnout and anticipated turnover. Nurs Ethics., 22(1):64-76. doi: 10.1177/0969733014534874. Epub 2014 Jun 19. PMID: 24948793.
[12]. Dugani S, Afari H, Hirschhorn LR, et al. 2018, Prevalence and factors associated with burnout among frontline primary health care providers in low- and middle-income countries: A systematic review. Gates Open Res.Jun11;2:4.doi:10.12688/gatesopenres.12779.3.
[13]. Géraldine Petit, Nausica remove, Avielle Amory et al. 2024, Situational And Personal Predictors Of Mental Health Outcomes Among Health Care Workers During Covid-19: Differences Between Nurses And Physicians. Psychiatric Danubina 36(1):94-108..DOI:10.24869/psyd.94.
[14]. Canadas-De la Fuente GA, et al. 2014, Risk factors and prevalence of burnout syndrome in the nursing professional. Int J Nur’sStud52:240http://dx.doi.org/10.1016/j.ijnurstu.2014.07.001.
[15]. Khamisa N, Oldenburg B, Peltzer K, et al. 2015, Work-related stress, burnout, job satisfaction and general health of nurses. Int J Environ Res Public Health. 12:652--66, http://dx.doi.org/10.3390/ijerph120100652.
[16]. Poghosyan L, Clarke SP, Finlayson M, et al. 2010, Nurse burnout and quality of care: cross-national investigation in six countries. Res Nurs Health. Aug;33(4):288-98. doi: 10.1002/nur.20383.
[17]. de Oliveira, Dental, 2021, Exploring Global Research Trends in Burnout among Nursing Professionals: A Bibliometric Analysis. Healthcare 9, 1680. https://doi.org/10.3390/shealthcare9121680. 38
[18]. Dachas DB, Worku T, et al., 2012, Burnout and associated factors among nurses working in public hospitals of Harari region and Dire Dawa administration, eastern Ethiopia. A cross-sectional study. PLoS ONE 16(10):e0258224.https://doi.org/10.1371/journal.pone.0258224.
[19]. Borges EMDN, Queirós CML, Abreu MDSN et al, 2021, Burnout among nurses: a multicentric comparative study. Rev Lat Am Enfermagem. Jun 28;29:e3432. doi: 10.1590/1518-8345.4320.3432
[20]. El Houmaini L, Zugzwang AA, 2021 Prevalence of burnout among nurses practicing in the surgical departments of a Moroccan university hospital Int Surg J;8:795-800.
[21]. Quadir, Jumanah T. Balbarid, et al. 2022 Prevalence and factors associated with burnout among nurses in Jeddah: a single-institution cross-sectional study. BMC Nurs 21, 287. https://doi.org/10.1186/s12912-022-01070-2
[22]. Belay AS, Guangul MM, Asmara WN, et al, 2021, Prevalence and Associated Factors of Burnout syndrome among Nurses in Public Hospitals, Southwest Ethiopia. Ethiop J Health Sci.May; 31(3):543552.doi:10.4314/ejhs.v31i3.11.
[23]. Keserwan V, Husain ZG, George J., 2020, Prevalence and Factors Associated with Burnout among Healthcare Professionals in India: A Systematic Review and Meta-Analysis. Indian J Psychol Med. Mar 9;42(2):108115do10.4103/IJPSYM.IJPSYM_387_19.
[24]. Santoro Rusca Putra, Setiawat, 2019, Prevalence of burnout syndrome among nurses in general hospitals in provincial East Java: Cross-sectional study. Int J Nurs Pract, 29(5):e13169.https://doi.org/10.1016/j.enfcli.2019.04.045
[25]. Wei Yi Tay, et al, 2014, Prevalence of Burnout Among Nurses in a Community Hospital in Singapore: A Cross-sectional Study. Proceedings of Singapore Healthcare, 2014, Volume 23, Number2.https://doi.org/10.1177/201010581402300202
[26]. Chen MJ, Kao FH , 2023, Effects of safety attitude on factors related to burnout among nurses working at a dedicated infectious disease control hospital during the COVID-19 pandemic. Int J Nurs Pract. Oct;29(5):e13169. doi: 10.1111/ijn.13169. Epub 2023 Jun 4.
[27]. Hosseini M, Soltanian M, Torabizadeh C, 2022, Prevalence of burnout and related factors in nursing faculty members: a systematic review. J Educ Eval Health Prof. 2022; 19:16. doi: 10.3352/jeehp.2022.19.16. Epub Jul 14.
[28]. Majrabi, M, 2022, Nurses Burnout, Resilience and Its Association with Safety Culture: A Cross Sectional Study. Open Journal of Nursing, 12, 70-102.https://doi.org/10.4236/ ojn.2022.121006.
[29]. Shah MK, Andreotti N, Candiotti JP, 2021, Prevalence of and Factors Associated With Nurse Burnout in the US. JAMA Netw Open. 2021 Feb 1;4(2):e2036469. doi: 10.1001/jamanetworkopen.2020.36469. 3;6(4):e2312593.
[30]. Bodenheimer T, Sinsky C, 2014, From triple to quadruple aim: care of the patient requires care of the provider. Ann Fam Med;12(6):573-576.
Viewed PDF 6 0 -
Granulomatous Cervical Lymphadenopathy – A Case SeriesAuthor: A. Karthick RamalingamDOI: 10.21522/TIJPH.2013.12.04.Art019
Granulomatous Cervical Lymphadenopathy – A Case Series
Abstract:
In this article, some of the common types of granulomatous cervical lymphadenopathy are described. They can be classified as infective and non-infective. Non-infectious include sarcoidosis and sarcoid-like reactions. Their etiology is unknown but they have a better prognosis. Infectious include various organisms and some of the common organisms include Tuberculosis, Syphilis, Tularemia, Cat Scratch Disease, Brucellosis and fungal infections. So an accurate diagnosis is needed with pathological and histological evidence for prompt treatment. Here, we histopathologically describe the three representative types of granulomatous cervical lymphadenopathy namely Tuberculosis, Sarcoidosis and Kikuchi Disease.
Granulomatous Cervical Lymphadenopathy – A Case Series
References:
[1]. Chang KL, Arber DA, Gaal KK, Weiss LM: 2006, Lymph nodes and spleen. In : Silverberg’s principles and practice of surgical pathology and cytopathology.4th ed, Philadelphia, Churchill Living Stone, pp. 508-607.
[2]. Gherardi GJ: 1950, Localized lymph node sarcoidosis associated with carcinoma of the bile ducts ; report of a case. AMA Arch Pathol 49:163-168.
[3]. Dickson PV, Davidoff AM: 2006, Malignant neoplasms of the head and neck. Semin Pediatr Surg.; 15:92–8. doi: 10.1053/j.sempedsurg.2006.02.006. [PubMed]
[4]. Gosche JR, Vick L: 2006, Acute, subacute, and chronic cervical lymphadenitis in children. Semin Pediatr Surg; 15:99–106. doi: 10.1053/j.sempedsurg.2006.02.007.
[5]. Moss RL, Skarsgard ED, Kosloske AM, Smith BM. 2000, Case studies in pediatric surgery. Philadelphia, PA: McGraw Hill: pp. 258–65.
[6]. Shamberger RC, Holzman RS, Griscom NT, Tarbell NJ, Weinstein HJ, Wohl ME. 1995, Prospective evaluation by computed tomography and pulmonary function tests of children with mediastinal masses. Surgery; 118:468–71. doi: 10.1016/S0039-6060(05)80360-5. [PubMed]
[7]. Tracy TF, Muratore CS. 2007, Management of common head and neck masses. Semin Pediatr Surg;16:3–13. doi: 10.1053/j.sempedsurg.2006.10.002.
[8]. Kikuchi M. 1972, Lymphadenitis showing focal reticulum cell hyperplasia with nuclear debris and phagocytosis. Nippon Ketsueki Gakkai Zasshi;35:378–80.
[9]. James DG, Neville E, 1977, Pathobiology of sarcoidosis. Pathobiol Annu 7:31-63.
[10]. Ioachim HL, Medeiros LJ: 2009, Sarcoidosis Lymphadenopathy. In: Ioachim’s Lymph node pathology. 4th ed, Philadelphia, Lippincott Williams & Wilkins, pp. 203-212.
[11]. Ota M, Amakawa R, Uehira K, Ito T, Yagi Y, et al.: 2004, Involvement of dendritic cells in sarcoidosis. Thorax 59:408-413.
[12]. Rosen Y, Vuletin JC, Pertschunk LP, Silverstein E: 1979, Sarcoidosis : from the pathologist’s vantage point. Pathol Annu 14 (Pt 1):405439.
[13]. Brincker H: 1986, Sarcoid reactions in malignant tumours.Cancer Treat Rev 13:147-156.
[14]. James DG: Editorial:1973, Modern concept of sarcoidosis. Chest 64: 675-677.
[15]. Kojima M, Nakamura S, Fujisaki M, Hirahata S, Hasegawa H, et al.: 1977,Sarcoid-like reaction in the regional lymph nodes and spleen in gastric carcinoma : a clinicopathologic study of five cases. Gen Diagn Pathol 142:347-352.
[16]. Virgili A, Maranini C, Califano A: 2002, Granulomatous lesions of the homolateral limb after previous mastectomy. Br J Dermatol 146: 891-894.
[17]. Gregorie HB Jr, Othersen HB Jr, Moore MP Jr: 1962, The significance of sarcoid-like lesions in association with malignant neoplasms. Am J Surg 104:577-586.
[18]. Yamamoto T, Tateishi H, Nishimura Y, Watanabe M, Ukyo S, et al.: 1980, A study of gastric cancer with sarcoid reaction as observed in the regional lymph node (author's transl). Nihon Shokakibyo Gakkai Zasshi 77:1555-1561. [in Japanese with English abstract].
[19]. Takeuchi H, Suchi T, Suzuki R, Sato T: 1982, Histological study of immune parameters of regional lymph nodes of gastric cancer patients. Gann 73:420-428.
[20]. Gorton G, Linell F: 1957, Malignant tumours and sarcoid reactions in regional lymph nodes. Acta Radiol 47:381-392.
Viewed PDF 4 0 -
Study of Body Mass Index and its Association with Menstrual Irregularities among Adolescent GirlsAuthor: Charumathi K BDOI: 10.21522/TIJPH.2013.12.04.Art020
Study of Body Mass Index and its Association with Menstrual Irregularities among Adolescent Girls
Abstract:
Menstrual irregularities such as irregular cycles including length of cycle, heavy or scanty menstruation blood loss are more common among adolescents during the initial year of menarche. When menstrual irregularities affect their day-to-day activities and quality of life it is to be addressed. A survey was taken with a questionnaire from 250 willing adolescent girls from 12-17 years of age. Data was collected regarding age, height, weight, age of menarche, duration of menstrual cycle, menstrual flow, pain, History of Anaemia, PCOS, Thyroid disorders, and necessary family history. Data collected were analysed through tables using proportions and percentages. In our study mean BMI is 22+4.8. Girls with high BMI had more hypomenorrhoea oligomenorrhoea and cycle irregularities when compared to normal and low BMI girls while menorrhagia is seen more among underweight girls and the mean age of menarche is 13+1.4. Menstrual health, menstrual hygiene awareness and early detection and treatment of any irregularities along with lifestyle modification play a key role in well well-being of their community and that of their county for decades.
Study of Body Mass Index and its Association with Menstrual Irregularities among Adolescent Girls
References:
[1]. World Health Organisation. Geneva: World Health Organisation; 1996, Programming for Adolescent Health and Development, WHO Technical Report Series No. 886. https://www.who.int/publications/i/item/9241208864
[2]. Jain K, Garg SK, Singh JV, Bhatnagar M, Chopra H, Bajpai SK, 2009, Reproductive health of adolescent girls in an urban population of Meerut, Uttar Pradesh. Health and population: Perspectives and issues. 2009; 32:204–9. https://api.semanticscholar.org/CorpusID:73178282
[3]. Kulkarni M, Durge PM, 2011, Reproductive health morbidities among adolescent girls: Breaking the silence. Ethno Med. 2011; 5:165-8.
[4]. [4] Teri Pearlstein, Meir Steiner, 2008, Premenstrual dysphoric disorder: Burden of illness and treatment update. Journal of Psychiatry Neuroscience. 2008 July;33(4):291-301. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2440788/
[5]. Anitha Nath, Suneela Garg, 2008, Adolescent friendly health services in India: A need of the hour. Indian J Med Sci; 2008 Nov; 62(11):465-72. https://pubmed.ncbi.nlm.nih.gov/19265240/
[6]. Narayan K A, Srinivasa D K, Pelto P J, Veerammal S, 2001, Puberty rituals, reproductive knowledge, and health of adolescent school girls in South India. Asia-Pacific Population Journal, Volume 16, Issue 2, Mar 2001, p. 225-238. https://www.un-ilibrary.org/content/journals/15644278/16/2/27
[7]. Mary Ann Campbell, Patrick J. McGrath, 1997, Use of medication by the adolescents for the management of menstrual discomfort. Arch Pediatr Adolesc Med; 1997; 151(9):905-913. https://pubmed.ncbi.nlm.nih.gov/9308868/
[8]. Rajsinh V. Mohite, Vaishali R. Mohite, 2013, Correlates of the menstrual problems among rural college students of Satara district. Al Ameen J Med Sci 2013; 6(3):213-218. http://ajms.alameenmedical.org/ArticlePDFs/6%20AJMS%20V6.N3.2013%20p%20213-218.pdf
[9]. Lambert-Messerlian G, Roberts M B, Urlacher S S, Ah-Ching J, Viali S, Urbanek M, McGarvey S T, 2011, First assessment of menstrual cycle function and reproductive endocrine status in Samoan women. Hum Reprod, 2011 Sep; 26(9):2518-24. https://pubmed.ncbi.nlm.nih.gov/21677061/
[10]. Lourdes Ibáñez, Abel López-Bermejo, Marta Díaz, Maria Victoria Marcos, Francis de Zegher, 2011, Early metformin therapy (age 8-12 years) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhea in adolescence. J Clin Endocrinol Metab 2011 Aug;96(8): E1262-7. https://pubmed.ncbi.nlm.nih.gov/21632811/
[11]. WORLD HEALTH ORGANISATION, Geneva 1995, Report of a WHO Expert Committee on Physical status: The use and interpretation of anthropometry. WHO technical report series 1995:854(9):1-452. https://iris.who.int/handle/10665/37003
[12]. WHO Expert Consultation, 2004, Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. The Lancet 2004 Jan; Volume 363: Issue 9403, 157-163. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(03)15268-3/abstract
[13]. Zxyyann Jane Lu, 2001, The relationship between menstrual attitudes and menstrual symptoms among Taiwanese women. Journal of Advanced Nursing 2001; 33:621-628. https://pubmed.ncbi.nlm.nih.gov/11298198/
[14]. Kural M, Noor NN, Pandit D, Joshi T, Patil A, 2015, Menstrual characteristics and prevalence of dysmenorrhea in college going girls. J Fam Med Prim Care; 2015 Jul-Sep 4(3):426-31. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535108/
[15]. Manjula S. Patil, Angadi M M, 2013, Menstrual pattern among adolescent girls in a rural area of Bijapur. Al Ameen J Med Sci 2013; 6(1):17-20. http://ajms.alameenmedical.org/ArticlePDFs%5CAJMS%20V6.N1.2013%20p%2017-20.pdf
[16]. Prasad BG, Sharma P, 1972, A study on menstruation of medical college girls at Lucknow. Journal of Obstetrics and Gynaecology of India 1972; 22:690-4. https://jogi.co.in/storage/articles/files/filebase/Archives/1972/dec/1972_690_694_Dec.pdf
[17]. Omidvar S, Amiri FN, Bakhtiari A, Begum K, 2018, A study on menstruation of Indian adolescent girls in an urban area of South India. J Family Med Prim Care 2018 Jul-Aug; 7(4) :698-702. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132001/
[18]. Chauhan P, Shaik RA, Anusha DVB, Sotala M, 2019, A study to assess knowledge, attitude, and practices related to menstrual cycle and management of menstrual hygiene among school-going adolescent girls in a rural area of South India. Int J Med Sci Public Health 2019; 8(2):114-9. https://www.bibliomed.org/?mno=15452
[19]. Rupa Vani K, Veena KS, Subitha L, Hemanth Kumar VR, Bupathy A, 2013, Menstrual Abnormalities in School Going Girls – Are They Related to Dietary and Exercise Pattern? Journal of clinical and diagnostic research 2013 Nov; 7(11): 2537-2540. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879880/
[20]. Karout N, Hawai SM, Altuwaijri S, 2012, Prevalence and pattern of menstrual disorders among Lebanese nursing students. East Mediterr Health J 2012 Apr; 18(4):346-52. https://pubmed.ncbi.nlm.nih.gov/22768696/
Viewed PDF 6 0 -
A Case Report of Emergency Obstetric Hysterectomy after Conservative Management of Placenta AccretaAuthor: Elakkiya SDOI: 10.21522/TIJPH.2013.12.04.Art026
A Case Report of Emergency Obstetric Hysterectomy after Conservative Management of Placenta Accreta
Abstract:
Obstetric hemorrhage is a significant and potentially life-threatening complication associated with both vaginal and cesarean deliveries. One common etiology is placenta accreta, a condition characterized by the abnormal adherence of the placenta to the myometrium. The primary modality for diagnosing placenta accreta is ultrasonography, although magnetic resonance imaging (MRI) is often employed to assess the extent of placental invasion. Managing placenta accreta requires a multidisciplinary healthcare team due to its complexity and associated risks. While hysterectomy is frequently the treatment of choice, conservative management approaches may be considered in carefully selected cases.
A Case Report of Emergency Obstetric Hysterectomy after Conservative Management of Placenta Accreta
References:
[1]. Wormer, C., Jamil, R. T. and Bryant, S. B., 2021, Jul 26 “Acute postpartum hemorrhage,” in StatPearls, StatPearls Publishing, Treasure Island, FL. National Institutes of Health (NIH) (.gov) www.ncbi.nlm.nih.gov
[2]. Sebghati, M. and Chandraharan, E. “2017, An update on the risk factors for and management of obstetric haemorrhage,” Womens Health, vol. 13, no. 2, pp. 34–40. National Institutes of Health (NIH) (.gov) https://pubmed.ncbi.nlm.nih.gov
[3]. Jauniaux, E., Collins, S. and Burton, G. J. 2018, “Placenta accreta Spectrum: pathophysiology and evidence-based anatomy for Prenatal ultrasound imaging,” American Journal of Obstetrics and Gynecology, vol. 218, no. 1, pp. 75–87. National Institutes of Health (NIH) (.gov) https://pubmed.ncbi.nlm.nih.gov
[4]. Tan, C. H., Tay, K. H., Sheah, K., et al. 2007, “Perioperative endovascular internal iliac artery occlusion balloon pl okacement in management of placenta accreta,” American Journal of Roentgenology, vol. 189, no. 5, pp. 1158–1163. National Institutes of Health (NIH) (.gov) https://pubmed.ncbi.nlm.nih.gov
[5]. Bowman, Z. S., Eller, A. G., Bardsley, T. R., Greene, T., Varner, M. W. and Silver, R. M., 21“Risk factors for placenta accreta: A Large prospective cohort,” American Journal of Perinatology, Vol. 31, no. 9, pp. 799–804. https://pubmed.ncbi.nlm.nih.gov/243
[6]. Belfort, M. A., 2014, “Placenta accreta,” American Journal of Obstetrics and Gynecology, vol. 203, no. 5, pp. 430–439. National Institutes of Health (NIH) (.gov)https://pubmed.ncbi.nlm.nih.gov Placenta accreta
[7]. Morlando, M. and Collins, S. 2020, “Placenta accreta spectrum disorders: challenges, risks, and management strategies,” International Journal of Women’s Health, vol. 12, pp. 1033–1045
[8]. Salmanian, B., Fox, K. A., Arian, S. E., et al., 2020, “In vitro fertilization as an independent risk factor for placenta accreta spectrum,” American Journal of Obstetrics and Gynecology, vol. 223, No. 4, pp. 568.e1–568.e5.
[9]. Tsuji, M., Shibata, E., Askew, J., et al., 2019, “Associations between Metal concentrations in whole blood and placenta previa and Placenta accreta: the Japan Environment and Children’s Study (JECS),” Environmental Health and Preventive Medicine, Vol. 24, no. 1, p. 40.
[10]. Engelbrechtsen, L., Langhoff-Roos, J., Kjer, J. and Istre, O., 2015, Placenta accreta: adherent placenta due to Asherman syndrome,” Clinical Case Reports, vol. 3, no. 3, pp. 175–178.
[11]. Dasari, P,2011, “Placenta accreta associated with submucosal fibroid Polyp,” BML Case Reports, vol. 2011, p. bcr1020103430, Published 2011 Feb 8.
[12]. Shepherd, A. M., and Mahdy, H., 2022, “Placenta Accreta,” in StatPearls, StatPearls Publishing, Treasure Island, FL.
[13]. Silver, R. M, Landon, M. B., Rouse, D., J., et al., 2006, “Maternal morbidity associated with multiple repeat cesarean deliveries,” Obstetrics and Gynecology, vol. 107, no. 6, pp. 1226–1232.
[14]. Shamshirsaz, A. A., Fox, K. A. S., almanian, B., et al.,2015, “Maternal Morbidity in patients with morbidly adherent placenta treated With and without a standardized multidisciplinary approach,” American Journal of Obstetrics and Gynecology, vol. 212, no. 2, pp. 218.e1–218.e9.
[15]. Xia, H., Ke, S. C., Qian, R., Lin, J. G., Li, Y. and Zhang, X., 2020,” Comparison between abdominal ultrasound and nuclear Magnetic resonance imaging detection of placenta accreta in the second and third trimester of pregnancy,” Medicine, Vol. 99, no. 2, p. e17908.
[16]. Comstock, C. H. and Bronsteen R, A., 2014, “The antenatal diagnosis Of placenta accreta,” BJOG: An International Journal of Obstetrics and Gynaecology, vol. 121, no. 2, pp. 171–182.
[17]. American College of Obstetricians and Gynecologists 2018 “Obstetric care consensus no. 7: placenta cccreta spectrum,” Obstetrics and Gynecology, vol. 132, no. 6, pp. e259–e275.
[18]. Gulino, F. A., Guardo, F. D., Zambrotta, E., et al., 2018, “Placenta Accreta and balloon catheterization: the experience of a single Center and an update of latest evidence of literature,” Archives of Gynecology and Obstetrics, vol. 298, no. 1, pp. 83–88.
[19]. Shahin, Y. and Pang, C. L. 2018, “Endovascular interventional Modalities for haemorrhage control in abnormal placental Implantation deliveries: a systematic review and meta-analysis,” European Radiology, vol. 28, no. 7, pp. 2713–2726.
[20]. Cali, G., Forlani, F., Giambanco, L., et al., 2014, “Prophylactic use of Intravascular balloon catheters in women with placenta Accreta, increta and percreta,” European Journal of Obstetrics,Gynecology, and Reproductive Biology, vol. 179, pp. 36–41
[21]. Gulino, F. A., Ettore, C. Ettore, G., 2021, “A review on management of caesarean scar pregnancy,” Current Opinion in Obstetrics & Gynecology, vol. 33, no. 5, pp. 400–404.
[22]. Pala, S., Atilgan, R., Başpınar, M., et al., 2018, “Comparison of results of Bakri balloon tamponade and caesarean hysterectomy in Management of placenta accreta and increta: a retrospective Study,” Journal of Obstetrics and Gynaecology, vol. 38, no. 2, pp. 194–199.
[23]. Morgan, E. A., Sidebottom, A., Vacquier, M., Wunderlich, W. and Loichinger, M., “The effect of placental location in casesOf placenta accreta spectrum,” American Journal of Obstetrics and Gynecology, vol. 221, no. 4, pp. 357.e1–357.e5.
[24]. Piñas Carrillo, A. and Chandraharan, E., 2019, “Placenta accreta spectrum: risk factors, diagnosis and management with special reference to the triple P procedure,” Womens Health, vol. 15, p. 174550651987808.
[25]. Shahid, R., Abbas, H., Mumtaz, S., et al., 2020, “Emergency obstetric Hysterectomy, the histopathological perspective: a crosssectional study from a tertiary care hospital,” Cureus, vol. 12, No. 7, p. e9094.
[26]. Ngwenya, S., 2016, “Postpartum hemorrhage: incidence, risk factors, And outcomes in a low-resource setting,” Journal of Women’s Health, vol. Volume 8, pp. 647–650.
Viewed PDF 3 0 -
Prospective Comparison of Intubating Condition with King Vision Video Laryngoscope and Macintosh Laryngoscope in Randomly Selected Elective Adult Surgical PatientsAuthor: Kala BalasubramanianDOI: 10.21522/TIJPH.2013.12.04.Art027
Prospective Comparison of Intubating Condition with King Vision Video Laryngoscope and Macintosh Laryngoscope in Randomly Selected Elective Adult Surgical Patients
Abstract:
Intubation is a crucial medical procedure that involves the insertion of a tube into the airway to ensure proper breathing and save lives. This technique, which is fundamental in the field of anaesthesia, requires skill and precision. Anaesthesiologists play a key role in mastering, teaching, and performing intubations, making it a cornerstone of their practice for many years. Traditionally, machine learning has been utilized as a reliable method for tracheal cannulation, establishing itself as the gold standard over the past seven decades. In recent times, there has been a notable development in intubation technology with the introduction of alternative devices such as the King Vision Video Laryngoscope (KVVL). Unlike the conventional method that relies on direct visualization, the KVVL utilizes an indirect magnified image for enhanced accuracy during the procedure. A comparative study was conducted between the King Vision Video Laryngoscope and the traditional Macintosh Laryngoscope on two groups of patients, with Group A consisting of 70% male and 30% female, and Group B with 60% male and 40% female participants. The results of the study revealed that while BMI, thyromental distance, and MPC showed no significant differences between the two devices, the King Vision Video Laryngoscope outperformed the Macintosh Laryngoscope in terms of intubation difficulty score and Cormack Lehane grading. Moreover, the former demonstrated superior outcomes in terms of airway trauma, heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), and saturation levels, ensuring a smoother and safer intubation process overall. Based on these findings, the study concluded that the King Vision Video Laryngoscope offers distinct advantages over the traditional Macintosh Laryngoscope, highlighting its potential as a superior tool for efficient and effective airway management in clinical settings.
Prospective Comparison of Intubating Condition with King Vision Video Laryngoscope and Macintosh Laryngoscope in Randomly Selected Elective Adult Surgical Patients
References:
[1] Mort, T. C. 2004. Emergency tracheal intubation: complications associated with repeated laryngoscopic attempts. Anesthesia & Analgesia, 99(2), 607-613.
[2] Mort, T. C. 2005. Esophageal intubation with indirect clinical tests during emergency tracheal intubation: a report on patient morbidity. Journal of Clinical Anesthesia, 17(4), 255-262.
[3] Tse, J. C., Rimm, E. B., & Hussain, A. 1997. Predicting difficult endotracheal intubation in surgical patients schedules for general anesthesia: a prospective blind study. Journal of Emergency Medicine, 2(15), 266.
[4] Cheney, F. W. 1999. The American Society of Anesthesiologists Closed Claims Project: what have we learned, how has it affected practice, and how will it affect practice in the future?. The Journal of the American Society of Anesthesiologists, 91(2), 552-556.
[5] Peterson, G. N., Domino, K. B., Caplan, R. A., Posner, K. L., Lee, L. A., & Cheney, F. W. 2005. Management of the difficult airway: a closed claims analysis. The Journal of the American Society of Anesthesiologists, 103(1), 33-39.
[6] Cook, T., Woodall, N., Harper, J., Benger, J., & Fourth National Audit Project. 2011. Major complications of airway management in the UK: results of the Fourth National Audit Project of the Royal College of Anaesthetists and the Difficult Airway Society. Part 2: intensive care and emergency departments. British journal of anaesthesia, 106(5), 632-642.
[7] Woodall, N. M., Benger, J. R., Harper, J. S., & Cook, T. M. 2012. Airway management complications during anaesthesia, in intensive care units and in emergency departments in the UK. Trends in Anaesthesia and Critical Care, 2(2), 58-64.
[8] Metzner, J., Posner, K. L., & Domino, K. B. 2009. The risk and safety of anesthesia at remote locations: the US closed claims analysis. Current Opinion in Anesthesiology, 22(4), 502-508.
[9] Aziz, M. F., Dillman, D., Fu, R., & Brambrink, A. M. 2012. Comparative effectiveness of the C-MAC video laryngoscope versus direct laryngoscopy in the setting of the predicted difficult airway. The Journal of the American Society of Anesthesiologists, 116(3), 629-636.
[10] Gaszynska, E., & Gaszynski, T. 2014. The King Vision™ video laryngoscope for awake intubation: series of cases and literature review. Therapeutics and clinical risk management, 475-478.
[11] Akihisa, Y., Maruyama, K., Koyama, Y., Yamada, R., Ogura, A., & Andoh, T. 2014. Comparison of intubation performance between the King Vision and Macintosh laryngoscopes in novice personnel: a randomized, crossover manikin study. Journal of anesthesia, 28, 51-57.
[12] Murphy, L. D., Kovacs, G. J., Reardon, P. M., & Law, J. A. 2014. Comparison of the king vision video laryngoscope with the macintosh laryngoscope. The Journal of emergency medicine, 47(2), 239-246.
[13] Yun, B. J., Brown, C. A., Grazioso, C. J., Pozner, C. N., & Raja, A. S. 2014. Comparison of video, optical, and direct laryngoscopy by experienced tactical paramedics. Prehospital Emergency Care, 18(3), 442-445.
[14] Asai, T. 2012. Videolaryngoscopes: do they truly have roles in difficult airways?. The Journal of the American Society of Anesthesiologists, 116(3), 515-517.
[15] Miceli, L., Cecconi, M., Tripi, G., Zauli, M., & Della Rocca, G. 2008. Evaluation of new laryngoscope blade for tracheal intubation, Truview EVO2©: a manikin study. European journal of anaesthesiology, 25(6), 446-449.
[16] Ezri, T., Warters, R. D., Szmuk, P., Saad-Eddin, H., Geva, D., Katz, J., & Hagberg, C. 2001. The incidence of class “zero” airway and the impact of Mallampati score, age, sex, and body mass index on prediction of laryngoscopy grade. Anesthesia & Analgesia, 93(4), 1073-1075.
[17] Jarvis, J. L., McClure, S. F., & Johns, D. 2015. EMS intubation improves with King Vision video laryngoscopy. Prehospital Emergency Care, 19(4), 482-489.
[18] Apfelbaum, J. L., Hagberg, C. A., Caplan, R. A., Blitt, C. D., Connis, R. T., ... & Ovassapian, A. 2013. Practice guidelines for management of the difficult airway: an updated report by the American Society of Anesthesiologists Task Force on Management of the Difficult Airway. Anesthesiology, 118(2), 251-270.
[19] Schoettker, P., & Corniche, J. 2015. The AirView Study: Comparison of Intubation Conditions and Ease between the Airtraq‐Air View and the King Vision. BioMed research international, 2015(1), 284142.
[20] Cortellazzi, P., Caldiroli, D., Byrne, A., Sommariva, A., Orena, E. F., & Tramacere, I. 2015. Defining and developing expertise in tracheal intubation using a GlideScope® for anaesthetists with expertise in Macintosh direct laryngoscopy: an in‐vivo longitudinal study. Anaesthesia, 70(3), 290-295.
[21] Cierniak, M., Timler, D., Wieczorek, A., Sekalski, P., Borkowska, N., & Gaszynski, T. 2016. The comparison of the technical parameters in endotracheal intubation devices: the Cmac, the Vividtrac, the McGrath Mac and the Kingvision. Journal of clinical monitoring and computing, 30, 379-387.
[22] Alvis, B. D., Hester, D., Watson, D., Higgins, M., & St Jacques, P. 2015. Randomized controlled trial comparing the McGrath MAC video laryngoscope with the King Vision video laryngoscope in adult patients. Minerva anestesiologica, 82(1), 30-35.
[23] Erdivanli, B., Sen, A., Batcik, S., Koyuncu, T., & Kazdal, H. 2018. Comparison of King Vision video laryngoscope and Macintosh laryngoscope: a prospective randomized controlled clinical trial. Revista Brasileira de Anestesiologia, 68(5), 499-506
Viewed PDF 5 0 -
Assessment of Depression, Anxiety, and Stress in Patients Having Type II Diabetes Mellitus Attending Secondary Care HospitalAuthor: Vinod Kumar NelsonDOI: 10.21522/TIJPH.2013.12.04.Art012
Assessment of Depression, Anxiety, and Stress in Patients Having Type II Diabetes Mellitus Attending Secondary Care Hospital
Abstract:
Depression, diabetes mellitus, and anxiety are metabolic diseases causing chronic hyperglycemia and mood disorders and triggered by the body's fight or flight response to danger, respectively. Recognizing the pervasiveness of the factors mentioned above among the patients who suffer from Type 2 diabetes mellitus, determining how these conditions impair those people's quality of life, and evaluating the impact on patients' glucose levels is the main aim of this study. Over six months, a study was conducted among 150 patients at Vijaya Marie Hospital, Khairtabad, Hyderabad. The individuals having a history of Type 2 diabetes, as well as other comorbid illnesses, were included. Patients with prior clinical depression, anxiety, or stress were excluded. Data from all patients was gathered and analyzed using the Graph Pad Prism software. Among the 150 diabetic patients, age groups between 41 and 50 are more prevalent, 63 of whom were men and 87 of whom were women. According to their HbA1c levels, Type 2 diabetes mellitus is typically treated with lifestyle changes, pharmacological alterations, or both. In our study, people change their lifestyles in addition to taking different oral medications. The study also found that highly severe anxiety (27.3%), moderate depression (932%), and stress levels within normal limits (36%) were prevalent among the patients. The study found a significant association between a patient's Type 2 diabetes mellitus (DM) blood glucose levels and their mental state, with severe anxiety being an essential factor. Mental stress alters glycaemic levels, negatively impacting patients' quality of life and triggering diabetic distress, indicating that depression, anxiety, and stress can predict Type 2 DM risk.
Assessment of Depression, Anxiety, and Stress in Patients Having Type II Diabetes Mellitus Attending Secondary Care Hospital
References:
[1] Umpierrez, G. E., 2006, Ketosis-prone Type 2 diabetes: time to revise the classification of diabetes. Diabetes Care, 29(12), 2755-7. https://doi.org/10.2337/dc06-1870
[2] Craig, M. E., Hattersley, A., Donaghue, K. C., 2009, Definition, epidemiology and classification of diabetes in children and adolescents. Pediatr diabetes, 10 (12), 3-12. https://doi.org/10.1111/j.1399-5448.2009.00568.x
[3] Craig, M. E., Jefferies, C., Dabelea, D., Balde, N., Seth, A., Donaghue, K. C., 2014, Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatric diabetes. 15(20), 4-17. https://doi.org/10.1111/pedi.12186
[4] Galtier, F., 2010, Definition, epidemiology, risk factors. Diabetes & metabolism, 36(6), 628-51. https://doi.org/10.1016/j.diabet.2010.11.014
[5] Olokoba, A. B., Obateru, O. A., Olokoba, L. B., 2012, Type 2 diabetes mellitus: a review of current trends. Oman Medical Journal, 27(4), 269. doi: 10.5001/omj.2012.68
[6] Chamnan, P., Simmons, R. K., Forouhi, N. G., Luben, R. N., Khaw, K. T., Wareham, N. J., Griffin, S. J., 2011, Incidence of Type 2 diabetes using proposed HbA1c diagnostic criteria in the European prospective investigation of cancer–Norfolk cohort: implications for preventive strategies. Diabetes care. 34(4), 950-6. https://doi.org/10.2337/dc09-2326
[7] Zimmet, P., Alberti, K. G., Shaw, J., 2001, Global and societal implications of the diabetes epidemic. Nature. 414(6865), 782-7. https://doi.org/10.1038/414782a
[8] Wild, S., Roglic, G., Green, A., Sicree, R., King, H., 2004, Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes care. 27(5), 1047-53. https://doi.org/10.2337/diacare.27.5.1047
[9] Thunander, M., Törn, C., Petersson, C., Ossiansson, B., Fornander, J., Landin-Olsson, M., 2012, Levels of C-peptide, body mass index and age, and their usefulness in the classification of diabetes about autoimmunity, in adults with newly diagnosed diabetes in Kronoberg, Sweden. European journal of endocrinology. 166(6), 1021-9. https://doi.org/10.1530/EJE-11-0797
[10] Stone, M. A., Camosso‐Stefinovic, J., Wilkinson, J., De Lusignan, S., Hattersley, A. T., Khunti, K., 2010, Incorrect and incomplete coding and classification of diabetes: a systematic review. Diabetic Medicine. 27(5), 491-7. https://doi.org/10.1111/j.1464-5491.2009.02920.x
[11] Rosenbloom, A. L., Silverstein, J. H., Amemiya, S., Zeitler, P., Klingensmith, G. J., 2009, Type 2 diabetes in children and adolescents. Pediatric diabetes. 10 (2), 17-32.
[12] Cox, M. E., Edelman, D., 2009, Tests for screening and diagnosis of Type 2 diabetes. Clinical diabetes. 27(4), 132-8. https://doi.org/10.2337/diaclin.27.4.132
[13] Chaturvedi, N., 2007, The burden of diabetes and its complications: trends and implications for intervention. Diabetes research and clinical practice. 76(3), 3-12. https://doi.org/10.1016/j.diabres.2007.01.019
[14] Sanghera, D. K., Blackett P. R., 2012, Type 2 diabetes genetics: beyond GWAS. J Diabetes Metab. 3(198), 6948. doi: 10.4172/2155-6156.1000198
[15] Larsson, S. C., Andersson, S. O., Johansson, J. E., Wolk, A., 2008, Diabetes mellitus, body size and bladder cancer risk in a prospective study of Swedish men. European Journal of Cancer. 44(17), 2655-60. https://doi.org/10.1016/j.ejca.2008.07.012
[16] Larsson, S. C., Mantzoros, C. S., Wolk, A., 2007, Diabetes mellitus and risk of breast cancer: a meta‐analysis. International journal of cancer. 121(4), 856-62. https://doi.org/10.1002/ijc.22717
[17] Larsson, S. C., Orsini, N., Wolk, A., 2005, Diabetes mellitus and risk of colorectal cancer: a meta-analysis. Journal of the National Cancer Institute. 97(22), 1679-87. https://doi.org/10.1093/jnci/dji375
[18] Larsson, S. C., Wolk, A., 2011, Diabetes mellitus and incidence of kidney cancer: a meta-analysis of cohort studies. Diabetologia. 54(5), 1013-8. https://doi.org/10.1007/s00125-011-2051-6
[19] Nigussie, K., Sertsu, A., Ayana, G.M., 2023, Determinants of depression and anxiety among Type 2 diabetes patients in governments’ hospitals at Harari regional state, Eastern Ethiopia: A multi-centre cross-sectional study. BMC Psychiatry 23, 13. https://doi.org/10.1186/s12888-022-04494-x
[20] Hackett, R., Steptoe, A., 2017, Type 2 diabetes mellitus and psychological stress — a modifiable risk factor. Nat Rev Endocrinol. 13, 547–560. https://doi.org/10.1038/nrendo.2017.64
[21] Shanmugam, R., Tharani, M., Abullais, S.S., 2024, Black seed assisted synthesis, characterization, free radical scavenging, antimicrobial and anti-inflammatory activity of iron oxide nanoparticles. BMC Complement Med Ther. 24(24), 241. https://doi.org/10.1186/s12906-024-04552-9.
[22] Habeeb Rahuman HB., Dhandapani R., Narayanan S., Palanivel V., Paramasivam R., Subbarayalu R., Thangavelu S., Muthupandian S., 2022, Medicinal plants mediated the green synthesis of silver nanoparticles and their biomedical applications. IET Nanobiotechnol. 16(4), 115-144. doi: 10.1049/nbt2.12078.
[23] Wadhwa R., Paudel, K. R., Chin, L. H., Hon, C. M., Madheswaran, T., Gupta, G., Panneerselvam, J., Lakshmi, T., 2021, Anti-inflammatory and anticancer activities of Naringenin-loaded liquid crystalline nanoparticles in vitro. J Food Biochem. 45(1), e13572. doi: 10.1111/jfbc.13572.
Viewed PDF 5 0 -
Effectiveness of Relaxation Therapy among Antenatal MothersAuthor: Padmapriya DDOI: 10.21522/TIJPH.2013.12.04.Art013
Effectiveness of Relaxation Therapy among Antenatal Mothers
Abstract:
During pregnancy, women undergo specific physiological changes in their bodies which may lead to stress and a rise in blood pressure which may be due to different etiological contributions. One way of reducing their blood pressure as well as stress is by encouraging those women to perform diaphragmatic deep breathing exercises. The current study aimed to investigate the effectiveness of relaxation therapy among antenatal mothers. True experimental pretest-posttest control group research design was conducted in the antenatal clinic of the host institution. The 60 antenatal mothers were recruited as study participants using a non-probability purposive sampling technique. All 60 antenatal mothers were randomly assigned to either the intervention group (Relaxation therapy) or the placebo group by using the lottery method,30 in the interventional group and 30 in the placebo group. For the interventional group, On Day 1, demographic and clinical data were collected from the study participants, followed by a Diaphragmatic deep breathing exercise initiated for 20 minutes daily in the morning for about 28 days. For the placebo group, demographic and clinical data were collected from the study participants, followed by routine hospital care initiated for about 28 days. On Day 29, the study participants were re-assessed for the level of stress, blood pressure and proteinuria in both interventional and placebo groups. The study results concluded that diaphragmatic deep breathing exercise reduced the levels of stress (mean difference score on the level of stress was 37.10 and the calculated paired ‘t’ test value of t = 10.460 was statistically significant at p<0.001 level), blood pressure (statistically significant difference at p<0.001 level between the post-test level of systolic BP between the two groups, there was a statistically significant difference at p<0.01 level between the post-test level of diastolic BP between the two groups), proteinuria (there was a statistically significant difference in the post-test level of proteinuria between the groups), there was no statistically significant difference at p<0.05 level between the post-test level of BMI between the two groups. Performing diaphragmatic deep breathing exercises enhanced, the reduction in the level of blood pressure, stress, BMI and proteinuria among our study participants.
Effectiveness of Relaxation Therapy among Antenatal Mothers
References:
[1]. Lothian, J. A., 2008, The journey of becoming a mother. The Journal of perinatal education, 17(4), 43-47.
[2]. Adalia, E. G., Hernández-Luengo, M., Bartolomé-Gutiérrez, R., Rodríguez-Martín, B., Jiménez-López, E., & Martínez-Andrés, M., 2021, Expectations and Experiences of Women in Pregnancy, Childbirth, and Infant Feeding: A Qualitative Research Protocol. International Journal of Qualitative Methods, 20, 16094069211011901.
[3]. Little, M. O., & Wickremsinhe, M. N., 2017, Research with pregnant women: a call to action. Reproductive Health, 14(3), 1-3.
[4]. Bang, S. W., & Lee, S. S., 2009, The factors affecting pregnancy outcomes in the second trimester pregnant women. Nutrition research and practice, 3(2), 134-140.
[5]. Aalami, M., Jafarnejad, F., & ModarresGharavi, M., 2016, The effects of progressive muscular relaxation and breathing control technique on blood pressure during pregnancy. Iranian journal of nursing and midwifery research, 21(3), 331.
[6]. Braunthal, S., & Brateanu, A., 2019, Hypertension in pregnancy: Pathophysiology and treatment. SAGE open medicine, 7, 2050312119843700.
[7]. Bello, N. A., Zhou, H., Cheetham, T. C., Miller, E., Getahun, D., Fassett, M. J., & Reynolds, K., 2021, Prevalence of hypertension among pregnant women when using the 2017 American College of Cardiology/American Heart Association blood pressure guidelines and association with maternal and fetal outcomes. JAMA network open, 4(3), e213808-e213808.
[8]. Mehta, B., Kumar, V., Chawla, S., Sachdeva, S., & Mahopatra, D., 2015, Hypertension in pregnancy: a community-based study. Indian journal of community medicine: official publication of Indian Association of Preventive & Social Medicine, 40(4), 273.
[9]. MacKay, A. P., Berg, C. J., & Atrash, H. K., 2001, Pregnancy-related mortality from preeclampsia and eclampsia. Obstetrics & Gynecology, 97(4), 533-538.
[10]. Gudeta, T. A., & Regassa, T. M., 2019, Pregnancy induced hypertension and associated factors among women attending delivery service at mizan-tepi university teaching hospital, tepi general hospital and gebretsadik shawo hospital, southwest, Ethiopia. Ethiopian journal of health sciences, 29(1).
[11]. Fox, R., Kitt, J., Leeson, P., Aye, C. Y., & Lewandowski, A. J., 2019, Preeclampsia: risk factors, diagnosis, management, and the cardiovascular impact on the offspring. Journal of clinical medicine, 8(10), 1625.
[12]. Singh, V., & Srivastava, M., 2015, Associated risk factors with pregnancy-induced hypertension: A hospital-based KAP study. International Journal of Medicine and Public Health, 5(1).
[13]. Braunthal, S., & Brateanu, A., 2019, Hypertension in pregnancy: Pathophysiology and treatment. SAGE open medicine, 7, 2050312119843700.
[14]. Yu, Y., Zhang, S., Wang, G., Hong, X., Mallow, E. B., Walker, S. O., ... & Wang, X., 2013, The combined association of psychosocial stress and chronic hypertension with preeclampsia. American journal of obstetrics and gynecology, 209(5), 438-e1.
[15]. Zhang, S., Ding, Z., Liu, H., Chen, Z., Wu, J., Zhang, Y., & Yu, Y., 2013, Association between mental stress and gestational hypertension/preeclampsia: a meta-analysis. Obstetrical & gynecological survey, 68(12), 825-834.
[16]. Wang, G., Hong, X., Mallow, E. B., Walker, S. O., ... & Wang, X., 2013, The combined association of psychosocial stress and chronic hypertension with preeclampsia. American journal of obstetrics and gynecology, 209(5), 438-e1.
[17]. Bartal, M. F., Lindheimer, M. D., & Sibai, B. M., 2022, Proteinuria during pregnancy: definition, pathophysiology, methodology, and clinical significance. American Journal of Obstetrics and Gynecology, 226(2), S819-S834.
[18]. August, P., & Sibai, B. M., 2017, Preeclampsia: Clinical features and diagnosis. UpToDate Accessed December, 22.
[19]. Shirodkar, S., Deo, M., & Agnihotri, M. Effect of Diaphragmatic Breathing Exercise verses Guided Imagery on Anxiety and Stress in Third Trimester of Pregnancy: A Randomized Trial
[20]. Yau, K. K. Y., & Loke, A. Y., 2021, Effects of diaphragmatic deep breathing exercises on prehypertensive or hypertensive adults: A literature review. Complementary therapies in clinical practice, 43, 101315.
[21]. Hamasaki, H., 2020, Effects of diaphragmatic breathing on health: a narrative review. Medicines, 7(10), 65.
[22]. Deo, B. K., Sapkota, N., Kumar, R., Shakya, D. R., Thakur, A., & Lama, S., 2020, A study on pregnancy, perceived stress and depression. JBpKIHS, 3(1), 79-87.
[23]. Gitau, R., Fisk, N. M., & Glover, V., 2001, Maternal stress in pregnancy and its effect on the human foetus: an overview of research findings. Stress, 4(3), 195-203.
[24]. Hopper, S. I., Murray, S. L., Ferrara, L. R., & Singleton, J. K., 2018, Effectiveness of diaphragmatic breathing on physiological and psychological stress in adults: a quantitative systematic review protocol. JBI Evidence Synthesis, 16(6), 1367-1372.
[25]. Kintiraki, E., Papakatsika, S., Kotronis, G., Goulis, D. G., & Kotsis, V., 2015, Pregnancy-induced hypertension. Hormones, 14(2), 211-223.
[26]. Dolle, S. A. Y., 2019. Nurses' Knowledge regarding Nursing Care of Urinary Tract Infection during Pregnancyat Omdurman Maternity Teaching Hospital, Khartoum State, Sudan (2018) (Doctoral dissertation, University Of Gezira).
[27]. Jul, A. S. Whether you’re new to the world of plant-based eating or you’ve been living a vegan lifestyle for a while, you’ve probably been asked “how do you get enough protein?”.
[28]. Gwinnutt, M., & Gwinnutt, C. L., 2016, Clinical anaesthesia. John Wiley & Sons.
Viewed PDF 6 0 -
Medial Plantar Artery Perforator Flap Cover in Large Diabetic Foot UlcerAuthor: Karthick J.DOI: 10.21522/TIJPH.2013.12.04.Art028
Medial Plantar Artery Perforator Flap Cover in Large Diabetic Foot Ulcer
Abstract:
Reconstructing the heel's soft tissue is challenging due to its weight-bearing role and the unique properties of the skin on the sole. The medial plantar artery perforator (MPAP) flap is a well-established option for these defects, providing tissue similar in structure to the plantar foot. This report describes a case of successful reconstruction of a heel defect in a diabetic woman using an MPAP flap. This case highlights the effectiveness of the MPAP flap for medium to large-sized plantar defects with weight bearing, offering benefits such as excellent tissue match, minimal donor site complications, and consistent vascular anatomy.
Medial Plantar Artery Perforator Flap Cover in Large Diabetic Foot Ulcer
References:
[1]. Baumeister, S., & Eisenhardt, S. U. 2013, Medial plantar artery perforator (MPAP) flap: A new flap for reconstruction of the heel and sole. Plastic and Reconstructive Surgery, 131(3), 433e-434e.
[2]. Erdmann, D., & Levin, L. S. 2009, Soft tissue coverage of the foot and ankle. Plastic and Reconstructive Surgery, 123(1), 260e-261e.
[3]. Choudry, U. H., Moran, S. L., & Li, S. 2006, Soft-tissue coverage of the diabetic foot: A systematic approach. Journal of Plastic, Reconstructive & Aesthetic Surgery, 59(8), 889-897.
[4]. Hallock, G. G. 2012, Refinements in perforator flap surgery. Clinics in Plastic Surgery, 39(2), 331-342.
[5]. Zhou, Y., & Ni, Q. 2013, Application of medial plantar artery perforator flap in foot and ankle reconstruction. Chinese Journal of Traumatology, 16(6), 349-352.
[6]. Pérez-García, A., & Canales, F. L. 2011, Reconstruction of soft tissue defects of the plantar area using medial plantar artery perforator flaps. Journal of Plastic, Reconstructive & Aesthetic Surgery, 64(9), 1200-1205.
[7]. Ramanujam, C. L., & Zgonis, T. 2015, Soft-tissue reconstruction for diabetic foot and ankle wounds. Clinics in Podiatric Medicine and Surgery, 32(3), 371-384.
Viewed PDF 5 0 -
Individual and Household Factors Associated with the Utilization of Sexual and Reproductive Health Services of Internally Displaced Women in North-central NigeriaAuthor: Kwala Adline OkoraforDOI: 10.21522/TIJPH.2013.12.04.Art014
Individual and Household Factors Associated with the Utilization of Sexual and Reproductive Health Services of Internally Displaced Women in North-central Nigeria
Abstract:
Internally displaced persons (IDP) are increasing in Nigeria. Women of reproductive age are vulnerable to sexual and reproductive health (SRH) challenges. Little is known about the utilized SRH services, and their associated factors in North-central, Nigeria. Quantitative data was collected using a structured questionnaire. Data were analyzed and descriptive analysis and Logistic regression were performed at p-value < 0.05 to identify significant factors associated with SRH utilization. The finding revealed that the utilized SRH services at the IDP camps were family planning, antenatal care, and HIV testing/voluntary counseling, and 82.40% of the displaced women have used at least one SRH service, while antenatal care was the most utilized (74.60%). At the individual level, the age, marital status, and education of respondents are significantly associated with the utilization of SRH services. At the household level, spousal employment status, age, and education determine the utilization of SRH services. In conclusion, the overall utilization of SRH services among displaced women in the IDP camps is high. Individual and household factors are associated with SRH uptake. Community awareness and addressing the issue of empowerment among women in the IDP camps can help augment the issue of financial incapacity, hence encouraging utilization.
Individual and Household Factors Associated with the Utilization of Sexual and Reproductive Health Services of Internally Displaced Women in North-central Nigeria
References:
[1] A. N. Odo, K. Musa, and A. V. Oladugba, “Sexual and reproductive health needs and problems of internally displaced adolescents (IDAs) in Borno State, Nigeria: A mixed method approach,” Afr. J. Reprod. Health, vol. 24, no. 1, pp. 87–96, 2020, doi: 10.29063/ajrh2020/v24i1.9.
[2] O. Savage, “Appraisal of the sexual and reproductive health of women in Nigeria from the perspective of internally displaced persons,” Nnamdi Azikiwe Univ. J. Int. Law Jurisprud., vol. 12, no. 2, pp. 129–144, 2021.
[3] A. J. Onoja et al., “Understanding the Needs of Adult Internally Displaced Persons in Three North-Eastern States of Nigeria : The Impact of Humanitarian Response Program,” Int. J. Soc. Sci. Manag., vol. 7, no. 3, pp. 152–158, 2020, doi: 10.3126/ijssm.v7i3.29205.
[4] A. J. Onoja et al., “Alleviating the Material and Health Challenges of Young Internally Displaced People in North-East Nigeria : The Impact of Sexual and Reproductive Health Program,” Humanit. Soc. Sci. Res., vol. 3, no. 2, 2020.
[5] H. M. Marlow, M. Kunnuji, A. Esiet, F. Bukoye, and C. Izugbara, “The Sexual and Reproductive Health Context of an Internally Displaced Persons’ Camp in Northeastern Nigeria: Narratives of Girls and Young Women,” Front. Reprod. Heal., vol. 3, no. January, pp. 1–7, 2022, doi: 10.3389/frph.2021.779059.
[6] M. Al-mujtaba et al., “Evaluating Religious Influences on the Utilization of Maternal Health Services among Muslim and Christian Women in North-Central Nigeria,” vol. 2016, 2016.
[7] O. J. Adewusi, D. C. Ezegwu, D. I. O. Patrick-Ogbogu, and M. Odeyinde, “Inclusive Sexual and Reproductive Health Rights: Knowledge and utilization of SRHR services among women and girls with disabilities in North-central Nigeria,” no. May, 2022.
[8] H. T. Ismail, M. Mscph, T. G. Amole, F. I. Tsiga-ahmed, R. I. Jalo, and M. H. Aliyu, “Factors Associated with Utilization of Sexual and Reproductive Health Services among Married Adolescent Girls in Kano, Northern,” Int. J. Matern. ChildHealth AIDS, vol. 13, pp. 1–9, 2024, doi: 10.25259/IJMA.
[9] M. O. Folayan et al., “Factors associated with poor access to HIV and sexual and reproductive health services in Nigeria for women and girls living with HIV during the COVID-19 pandemic,” 2022, doi: 10.2989/16085906.2022.2104169.
[10] P. M. Sawadogo et al., “Barriers and facilitators of access to sexual and reproductive health services among migrant, internally displaced, asylum seeking and refugee women: A scoping review,” PLoS One, vol. 18, no. 9 September, pp. 1–19, 2023, doi: 10.1371/journal.pone.0291486.
[11] O. Ivanova, M. Rai, and E. Kemigisha, “A Systematic Review of Sexual and Reproductive Health Knowledge , Experiences and Access to Services among Refugee , Migrant and Displaced Girls and Young Women in Africa,” Int. J. Environ. Res. Public Health, pp. 1–12, 2018, doi: 10.3390/ijerph15081583.
[12] W. Binu, T. Marama, M. Gerbaba, and M. Sinaga, “Sexual and reproductive health services utilization and associated factors among secondary school students in Nekemte,” pp. 1–10, 2018.
[13] W. Negash, M. Dessalegn, B. Yitayew, M. Demsie, and M. Wagnew, “Reproductive health service utilization and associated factors : the case of north Shewa zone youth, Amhara region, Ethiopia,” pp. 1–19, 2016, doi: 10.11604/pamj.supp.2016.25.2.9712.
[14] A. Seidu et al., “Modern contraceptive utilization and associated factors among married and cohabiting women in Papua New Guinea : a population-based cross-sectional study.,” vol. 6, pp. 1–11, 2020.
[15] K. G. Tlaye, M. A. Belete, T. M. Demelew, and M. A. Getu, “Reproductive health services utilization and its associated factors among adolescents in Debre Berhan town , Central Ethiopia : a community-based cross-sectional study,” pp. 1–11, 2018.
[16] T. Otu et al., “Prevalence and factors associated with contraceptive use among sexually active adolescent girls in 25 sub-Saharan African countries,” pp. 1–15, 2024, doi: 10.1371/journal.pone.0297411.
[17] M. Endriyas, A. Eshete, E. Mekonnen, T. Misganaw, and M. Shiferaw, “Contraceptive utilization and associated factors among women of reproductive age group in Southern Nations Nationalities and Peoples ’ Region , Ethiopia : cross- sectional survey , mixed-methods,” Contracept. Reprod. Med., pp. 1–9, 2017, doi: 10.1186/s40834-016-0036-z.
[18] B. O. Ahinkorah et al., “Individual and community-level factors associated with modern contraceptive use among adolescent girls and young women in Mali : a mixed effects multilevel analysis of the 2018 Mali demographic and health survey,” vol. 7, pp. 1–12, 2020.
[19] S. A. Feleke, D. N. Koye, A. F. Demssie, and Z. B. Mengesha, “Reproductive health service utilization and associated factors among adolescents ( 15 – 19 years old ) in Gondar town , Northwest,” pp. 1–10, 2013.
[20] C. Chawhanda, J. Levin, and L. Ibisomi, “Factors associated with sexual and reproductive health service utilisation in high migration communities in six Southern African countries,” BMC Public Health, pp. 1–15, 2022, doi: 10.1186/s12889-022-13308-4.
[21] A. A. Aliyu, T. Dahiru, and A. M. Oyefabi, “KNOWLEDGE , DETERMINANTS AND USE OF MODERN CONTRACEPTIVES AMONG MARRIED WOMEN IN SABON GARI ZARIA-NORTHERN NIGERIA,” vol. 14, no. 2, pp. 13–21, 2015.
[22] O. O. Latunji and O. Iyanda, “Qualitative Exploration of factors affecting Uptake and Demand for Contraception and other Family Planning Services in North-West Nigeria,” vol. 23, no. December, pp. 63–74, 2019, doi: 10.29063/ajrh2019/v23i4.8.
[23] O. . Ilori, A. . Olugbenga-Bello, O. . Goodman, A. . Babakundi, and R. . Oladejo, “Prevalence and pattern of contraceptive uptake among adolescents in an internally displaced camp , North Central , Nigeria,” pp. 1–11, 2024, doi: 10.4081/jphia.2024.xxxx.
[24] A. G. Nmadu, S. Mohamed, and N. O. Usman, “Adolescents ’ utilization of reproductive health services in Kaduna , Nigeria : the role of stigma,” pp. 1–5, 2020.
[25] E. A. Envuladu, K. Massar, and J. de Wit, “Adolescents’ Sexual and Reproductive Healthcare‐Seeking Behaviour and Service Utilisation in Plateau State, Nigeria,” Healthc., vol. 10, no. 2, pp. 1–10, 2022, doi: 10.3390/healthcare10020301.
[26] S. Adewale, “Internally displaced persons and the challenges of survival in Abuja,” African Secur. Rev., vol. 25, no. 2, pp. 176–192, 2016, doi: 10.1080/10246029.2016.1154475.
[27] C. M. Anierobi et al., “Communal conflicts in Nigeria: Assessment of the impacts on internally displaced persons and settlements amidst COVID-19 pandemic,” Heliyon, vol. 10, no. 9, p. e30200, 2024, doi: 10.1016/j.heliyon.2024.e30200.
[28] DTM Nigeria, “BIOMETRIC REGISTRATION PROGRESS REPORT,” 2023.
[29] UNHCR, “GLOBAL TRENDS Trends at a Glance,” United Nation High Comm. Refug., 2020.
[30] H. Pierce, “Reproductive health care utilization among refugees in Jordan : Provisional support and domestic violence,” 2019, doi: 10.1177/1745506519861224.
[31] A. Banke-Thomas, K. Agbemenu, and C. Johnson-Agbakwu, “Factors Associated with Access to Maternal and Reproductive Health Care among Somali Refugee Women Resettled in Ohio , United States : A Cross - Sectional Survey,” pp. 1–11, 2019.
[32] A. S. Adebowale, “Spousal age difference and associated predictors of intimate partner violence in Nigeria,” pp. 1–15, 2018, doi: 10.1186/s12889-018-5118-1.
[33] A. Seyife, G. Fisseha, H. Yebyo, G. Gidey, and H. G. Id, “Utilization of modern contraceptives and predictors among women in Shimelba refugee camp , Northern Ethiopia,” pp. 1–11, 2019.
[34] O. Ivanova et al., “A cross-sectional mixed-methods study of sexual and reproductive health knowledge, experiences and access to services among refugee adolescent girls in the Nakivale refugee settlement, Uganda,” Reprod. Health, vol. 16, no. 1, pp. 1–11, 2019, doi: 10.1186/s12978-019-0698-5.
[35] S. Sampson et al., “Addressing Barriers to Accessing Family Planning Services using Mobile Technology Intervention among Internally Displaced Persons in Abuja, Nigeria,” AJOG Glob. Reports, no. August, p. 100250, 2023, doi: 10.1016/j.xagr.2023.100250.
[36] J. C. Ene and H. T. Ajibo, “Optimizing the utilization of maternal and reproductive healthcare services among women in low-resourced Nigerian settings,” pp. 1–12, 2023.
[37] A. I. Ajayi, O. E. Awopegba, E. O. Owolabi, and A. Ajala, “Coverage of HIV testing among pregnant women in Nigeria : progress , challenges and opportunities,” vol. 43, no. 1, pp. 77–84, 2019, doi: 10.1093/pubmed/fdz152.
[38] P. A. Apanga and M. A. Adam, “Factors influencing the uptake of family planning services in the Talensi District, Ghana,” vol. 8688, pp. 1–9, 2015, doi: 10.11604/pamj.2015.20.10.5301.
[39] I. C. Akamike, U. C. Madubueze, and I. N. Okedo-alex, “Perception , pattern of use , partner support and determinants of uptake of family planning methods among women in rural communities in Southeast Nigeria,” pp. 1–8, 2020.
[40] I. N. Okedo-alex, I. C. Akamike, O. B. Ezeanosike, and C. J. Uneke, “Determinants of antenatal care utilisation in sub-Saharan Africa : a systematic review,” 2019, doi: 10.1136/bmjopen-2019-031890.
[41] T. . Haider and M. Sharma, “Community Health Equity Research & Policy,” pp. 1–6, 2013, doi: 10.2190/IQ.33.4.g.
[42] E. Tesfa and H. Gedamu, “Factors associated with utilization of long term family planning methods among women of reproductive age attending Bahir Dar health facilities , Northwest Ethiopia,” BMC Res. Notes, pp. 1–7, 2018, doi: 10.1186/s13104-018-4031-0.
[43] B. R. Dekker, “Evidence on : Pregnancy at Age 35 and Older Evidence on : Pregnancy at Age 35 and Older,” pp. 34–35, 2020.
[44] A. Zajacova and E. M. Lawrence, “The Relationship Between Education and Health : Reducing Disparities Through a Contextual Approach,” pp. 273–289, 2018.
[45] C. H. Logie, F. Mackenzie, K. Malama, N. Lorimer, and A. Lad, “Sexual and reproductive health among forcibly displaced persons in urban environments in low and middle ‑ income countries : scoping review findings,” Reprod. Health, pp. 1–26, 2024, doi: 10.1186/s12978-024-01780-7.
[46] T. Lancet and P. Health, “Editorial Education : a neglected social determinant of health,” Lancet Public Heal., vol. 5, no. 7, p. e361, 2020, doi: 10.1016/S2468-2667(20)30144-4.
[47] R. A. Hahn and B. I. Truman, “International Journal of Social Determinants of Health and Health Services,” pp. 1–18, 2015, doi: 10.1177/0020731415585986.
[48] E. Isah, Y. Suleman, and T. Adeleke, “Socio-Cultural Factors and Access To University Education in North-East Region of Nigeria,” East African J. Educ. Res. Policy, vol. 15, no. 1, pp. 59–73, 2020.
[49] K. H. Bulman and C. Mccourt, “Somali Refugee Women’s experiences of maternity care in West London: A case study,” pp. 1–23, 2002, doi: 10.1080/0958159021000029568.
[50] L. Andriano, J. Behrman, and C. Monden, “Husbands ’ Dominance in Decision-Making About Women ’ s Health : A Spatial Diffusion Perspective in Sub-Saharan Africa,” vol. 58, no. September, pp. 1955–1975, 2021, doi: 10.1215/00703370-9429489.
[51] A. G. Nmadu, I. A. Joshua, V. N. Omole, N. O. Usman, C. J.-C. Igboanusi, and A. A. Gobir, “Original article Male involvement in family planning in Northern Nigeria : A review of literature,” pp. 6–9, 2019, doi: 10.4103/jomt.jomt.
Viewed PDF 5 0 -
Metabolic Syndrome in Pregnancy and its Complications in Obstetrics and NewbornAuthor: Smitha S.DOI: 10.21522/TIJPH.2013.12.04.Art029
Metabolic Syndrome in Pregnancy and its Complications in Obstetrics and Newborn
Abstract:
Metabolic syndrome (MS) during pregnancy causes a serious threat to the mother and child's health that will shortly become a major public health issue, especially in developing countries. However, in India, the epidemiological data on MS during pregnancy are still scarce. This study aimed to determine the prevalence and identification of MS among pregnant women at Sree Balaji Medical College and Hospital, Chennai, India. This study was a hospital-based cross-sectional study, carried out among pregnant women followed up at the Obstetrics and Gynecology OP unit. Proforma was collected from the participants who were assessed on sociodemographics, lifestyle parameters and dietary habits. Anthropometric parameters, blood pressure, and biochemical parameters were measured as per standard operating procedures The study participants were included in the MS group if she has at least three of the following criteria: Pre-gestational BMI >30 kg/m2; triglycerides ≥150 mg/dl; HDL cholesterol <50 mg/dl; fasting blood glucose ≥100 mg/d, SBP ≥130 and DBP ≥85 mm/Hgl. The prevalence of MS in pregnant women and its major determinant is pre-gestational obesity. This work provides quality preliminary data for the design and improvement plan of prevention strategies.
Metabolic Syndrome in Pregnancy and its Complications in Obstetrics and Newborn
References:
[1]. Saklayen, M. G., 2018, The global epidemic of metabolic syndrome. Current Hypertension Reports, 20, pp. 12-20.
[2]. Bo, L., Guanqun, C., Ruijie, Z., Huang, D., Tao, L., Dan, H. and Lixin, T., 2021, Temporal trends in the prevalence of metabolic syndrome among middle-aged and elderly adults from 2011 to 2015 in China: The China health and retirement longitudinal study (CHARLS). BMC Public Health, 21, pp. 1045-1056.
[3]. Chatzi, L., Plana, E., Pappas, A., et al. 2009, The metabolic syndrome in early pregnancy and risk of gestational diabetes mellitus. Diabetes and Metabolism, 35(6), pp. 490–494.
[4]. Vryonidou, A, Paschou, S. A., Muscogiuri, G., Orio, F. and Goulis., D. G., 2015, Mechanisms in endocrinology: metabolic syndrome through the female life cycle. Eur J Endocrinol, 173, pp. R153–R163.
[5]. Mohsenzadeh-Ledari, F., Taghizadeh, Z., Motaghi, Z., Keramat, A., Moosazadeh, M. and Najafi, A., 2019, Appropriate interventions for pregnant women with indicators of metabolic syndrome on pregnancy outcomes: a systematic review. International Journal of Preventive Medicine, 10(2), pp. 1-21.
[6]. Wubet, W. T., Kimberly, K. V., Jami, J. and Leanne, M. R., 2024, Effective interventions in preventing gestational diabetes mellitus: A systematic review and meta-analysis. Communications Medicine, 4, pp. 75-89.
[7]. Fossati, P. and Principe, L., 1998, Triglycerides PAP, freeze dried. Clinical Chemistry, 28(10), pp. 2077-2780.
[8]. Trinder, P., 1969, Determination of glucose in blood using glucose oxidase with alternative oxygen acceptor. Annals of Clinical Biochemistry, 6, pp. 24–27.
[9]. Chatzi, L., Plana, E., Daraki, V., et al., 2009, Metabolic syndrome in early pregnancy and risk of preterm birth. American Journal 0f Epidemiology, 70(7), pp. 829–836.
[10]. Dos Prazerez, T. H., Arantes, A. M., Tavares, S. B., et al., 2015, Metabolic syndrome and pregnancy, its prevalence, obstetrical and newborns complications. Open Journal of Obstetric and Gynaecology. 5(11), pp. 618–625.
[11]. Nolan, C. J., and Prentki, M., 2019, Insulin resistance and insulin hyper secretion in the metabolic syndrome and type 2 diabetes: time for a conceptual framework shift. Diabetes and Vascular Disease Research, 16(2), pp. 118–127.
[12]. Wani, K., Sabico, S., Alnaami, A. M., et al. 2020, Early-pregnancy metabolic syndrome and subsequent incidence in gestational diabetes mellitus in Arab women. Frontiers in Endocrinology, 11, pp. 98-105.
[13]. Grieger, J. A., Bianco-Miotto, T., Grzeskowiak L. E., et al. 2018, Metabolic syndrome in pregnancy and risk for adverse pregnancy outcomes: a prospective cohort of nulliparous women. PLoS Medicine, 15(12), pp. 1-10.
[14]. Djeufouata, J. D., Ojong, E. W., Njamen. N. T., Assob, J. C. and Telefo, P. B., 2020, Prevalence and risk factors of metabolic syndrome in pregnant women in the centre and littoral regions of Cameroon. European Journal of Clinical Biomedical Sciences, 6(5), pp. 104–115.
[15]. Rahman, M. M., Abe, S. K., Kanda, M., et al., 2015, Maternal body mass index and risk of birth and maternal health outcomes in low- and middle-income countries: a systematic review and meta-analysis. Obesity Review, 16, pp. 758–770.
[16]. White, S. L., Pasupathy, D., Sattar, N., et al., 2017, Metabolic profiling of gestational diabetes in obese women during pregnancy. Diabetologia, 60, pp. 1903–1912.
[17]. Wani, K., Sabico, S., Alnaami, A. M., et al., 2020, Early-pregnancy metabolic syndrome and subsequent incidence in gestational diabetes mellitus in Arab women. Frontiers in Endocrinology, 11, pp. 98-105.
[18]. Eastwood, K. A., Daly, C., Hunter, A., et al 2017., The impact of maternal obesity on completion of fetal anomaly screening. Journal of Perinatal Medicine, 45(9), pp. 1061–1067.
[19]. Pinto, M. C., Oliveira, A. S., Santos, A. S., De oliveira, B. V., and Ramos, M. M, 2019, Metabolic syndrome in pregnancy and postpartum: prevalence and associated factors. Revista da Associacao Medica Brasileria, 65(12), pp. 1489–1495.
[20]. Mohsenzadeh-Ledari, F., Taghizadeh, Z., Motaghi, Z., Keramat, A., Moosazadeh, M. and Najafi, A. 2019, Appropriate interventions for pregnant women with indicators of metabolic syndrome on pregnancy outcomes: a systematic review. International Journal of Preventive Medcine, ; 10, pp. 1-22.
Viewed PDF 5 0 -
In-vitro Comparison of Effect of Two Moulding and Polishing Methods on the Surface Roughness of Heat Polymerized ResinAuthor: Arul Kumar SengottaiyanDOI: 10.21522/TIJPH.2013.12.04.Art015
In-vitro Comparison of Effect of Two Moulding and Polishing Methods on the Surface Roughness of Heat Polymerized Resin
Abstract:
Acrylic resin is the most common material used for the fabrication of bases for prostheses including overdentures. A smooth surface is ideal for the maintenance of dentures and the prevention of bacterial colonization. Polishing materials used and the method of moulding are the few factors that affect surface roughness. Hence the present in vitro study was done to compare the effect of polishing materials and moulding methods on the surface roughness of dentures. 120 specimens (50mm × 3mm) were divided into two equal groups and fabricated by compression and injection moulding techniques. Each group was subdivided into 3 groups based on the polishing method viz: control (pumice), pumice with universal polishing paste and pumice with rouge based on the polishing protocols advocated. Determination of surface roughness was done with a profilometer. Statistical analysis was done with one-way ANOVA and Tukey HSD. The surface roughness ranged between 0.372 ± 1.340 and 0.046 ± 0.027. In both the moulding methods control group with pumice exhibited the greatest surface roughness in comparison with the other two groups and universal polishing paste produced the least. On comparing the two moulding methods the injection moulding method exhibited the least surface roughness. (p=0.0001). From the results of the study, it can be inferred that irrespective of the moulding method polishing using pumice and universal polishing paste would produce a smooth surface with the least roughness and could be implemented by all clinicians to bacterial colonisation and plaque formation in dentures.
In-vitro Comparison of Effect of Two Moulding and Polishing Methods on the Surface Roughness of Heat Polymerized Resin
References:
[1]. Ulusoy, M., Ulusoy, N., Aydin, A. K., 1986, An evaluation of polishing techniques on surface roughness of acrylic resins. J Prosthet Dent, 56(1),107–12.
[2]. Nogueira, S. S., Ogle, R. E., Davis, E L., 1999, Comparison of accuracy between compression- and injection-molded complete dentures. J Prosthet Dent, 82(3), 291–300.
[3]. Kuhar, M., Funduk, N., 2005, Effects of polishing techniques on the surface roughness of acrylic denture base resins. J Prosthet Dent, 93(1), 76–85.
[4]. Lima, E. M. C, X., Moura, J. S., Del Bel Cury, A. A., Garcia, R. C. M. R., Cury, J. A., 2006, Effect of enzymatic and NaOCl treatments on acrylic roughness and on biofilm accumulation. J Oral Rehabil., 33(5), 356–62.
[5]. Arora, O., Ahmed, N., Nallaswamy, D., Ganapathy, D., & Srinivasan, M., 2024, Denture base materials: An in vitro evaluation of the mechanical and color properties. Journal of dentistry, 145, 104993. https://doi.org/10.1016/j.jdent.2024.104993
[6]. Arora, O., Ahmed, N., Siurkel, Y., Ronsivalle, V., Cicciù, M., & Minervini, G., 2024, A comparative evaluation of physical properties of CAD/CAM complete denture resins- an in vitro study. BMC oral health, 24(1), 65. https://doi.org/10.1186/s12903-023-03708-2
[7]. Rao, S., Surya, S., Ali, S., Prabhu, A., Ginjupalli, K., Shenoy, P. U., Das, R., 2024, Biocompatibility of polymethyl methacrylate heat-polymerizing denture base resin copolymerized with antimicrobial monomers. The Journal of prosthetic dentistry, S0022-3913(24)00433-5. Advance online publication. https://doi.org/10.1016/j.prosdent.2024.06.014
[8]. Kumari, S. V., Taruna, M., Chittaranjan, Reddy, S. M., Reddy, K.K. E., Kulkarni, G. A., 2015, Qualitative analysis to compare the effects of surface machining of conventional denture base resin and two soft liners: a scanning electron microscopic study. J Clin Diagn Research, 9(1), ZC30–4.
[9]. Bollenl, C. M. L., Lambrechts, P., Quirynen, M.. 1997, Comparison of surface roughness of oral hard materials to the threshold surface roughness for bacterial plaque retention: A review of the literature. Dent Mater, 13(4), 258–69.
[10]. Morgan, T.D., Wilson, M., 2001, The effects of surface roughness and type of denture acrylic on biofilm formation by Streptococcus oralis in a constant depth film fermentor. J Appl Microbiol, 91(1), 47–53.
[11]. Radford, D. R., Sweet, S. P., Challacombe, S. J., Walter, J. D., 1998, Adherence of Candida albicans to denture-base materials with different surface finishes. J Dent, 26(7), 577–83.
[12]. O’ Donnell, E. F., Radford, D. R., Sinclair, G. F., Clark, R. K. F., 2003, Chairside polishing of heat-cured acrylic resin: an SEM and EDA study. Int J Prosthodont, 16(3), 233–8.
[13]. Corsalini, M., Boccaccio, A., Lamberti, L., Pappalettere, C., Catapano, S., Carossa, S.. 2009, Analysis of the performance of a standardized method for the polishing of methacrylic resins. Open Dent J., 3, 233–40.
[14]. Corsalini, M., Di Venere, D., Pettini, F., Stefanachi, G., Catapano, S., Boccaccio, A., et al.2014, A comparison of shear bond strength of ceramic and resin denture teeth on different acrylic resin bases. Open Dent J., 29(8) ,241–50.
[15]. Al, Rifaiy, M. Q., 2010, The effect of mechanical and chemical polishing techniques on the surface roughness of denture base acrylic resins. Saudi Dent J., 22(1),13–7.
[16]. Rizzatti Barbosa, C. M., Gabriotti, M. N., Silva Concilio, L. R., Joia, F. A., Machado, C., Ribeiro, M. C., 2006, Surface roughness of acrylic resins processed by microwave energy and polished by mechanical and chemical process. Braz J Oral Sci., 5(16), 977–81.
[17]. Serra, G., de Morais, L. S., Elias, C. N., 2013, Surface morphology changes of acrylic resins during finishing and polishing phases. Dental Press J Orthod, 18(6), 26–30.
[18]. Satpathy, A. M. R. D., Gujjari, A. K., 2013, An Evaluation of the Adherence of Candida albicans on the Surface of Heat Cure Denture Base Material Subjected to Different Stages of Polishing. J Clin Diagn Res., 7(10), 2360–3.
[19]. Al Kheraif, A. A. A., 2014, The effect of mechanical and chemical polishing techniques on the surface roughness of heat-polymerized and visible light-polymerized acrylic denture base resins. The Saudi Dental Journal. 26, 56–62. Available from: http://dx.doi.org/10.1016/j.sdentj.2013.12.007
[20]. Park, S. E., Chao, M., Raj, P. A., 2009, Mechanical properties of surface-charged poly(methyl methacrylate) as denture resins. Int J Dent, 12, 841431.
[21]. Rahal. J.S., Mesquita. M. F., Henriques, G. E. P., Nóbilo, M.A.A., 2004, Surface roughness of acrylic resins submitted to mechanical and chemical polishing. J Oral Rehabil., 31(11),1075–9.
[22]. Kim, S.K., Park, J. M., Lee, M. H., Jung, J.Y., Li, S., Wang, X., 2009, Effects of chairside polishing and brushing on surface roughness of acrylic denture base resins. Journal of Wuhan University of Technology-Mater Sci Ed., 24(1), 100–5.
[23]. Hilgenberg, S.P., Orellana Jimenez, E. E., Sepúlveda Navarro, W. F., Arana Correa, B. E., Alves, D. C. T., Campanha, N. H., 2008, Evaluation of surface physical properties of acrylic resins for provisional prosthesis. Mater Res., 11(3), 257–60.
[24]. Machado, A. L., Breeding, L. C., Vergani, C. E., da Cruz Perez, L. E.,2009, Hardness and surface roughness of reline and denture base acrylic resins after repeated disinfection procedures. J Prosthet Dent., 102(2), 115–22.
[25]. Lamfon, H., Porter, S. R., McCullough, M., Pratten, J., 2003, Formation of Candida albicans biofilms on non-shedding oral surfaces. Eur J Oral Sci., 111(6), 465–71.
[26]. Abuzar, M.A., Bellur, S., Duong, N., Kim, B. B., Lu, P., Palfreyman, N., et al. 2010, Evaluating surface roughness of a polyamide denture base material in comparison with poly (methyl methacrylate). J Oral Sci., 52(4), 577–81.
[27]. Srividya, S., Nair, C. K., Shetty, J., 2011, Effect of Different Polishing Agents on Surface Finish and Hardness of Denture Base Acrylic Resins: A Comparative Study. International Journal of Prosthodontics and Restorative Dentistry, 1(1), 7–11.
[28]. Vitalariu, A. M., 2010, Effect of surface polishing and glazing on the roughness of the dental acrylic resins. Annals of DAAAM & Proceedings, 77+.
[29]. Ahmad. A. S., 2011, Evaluation and Compare Between the Surface Roughness of Acrylic Resine Polished by Pumice, White Sand and Black Sand. Journal of Kerbala University, 9(1), 49-54.
[30]. Moslehifard, E., Ghaffari, T., Abolghasemi, H., Maleki Dizaj, S., 2022, Comparison of Conventional Pressure-packed and Injection Molding Processing Methods for an Acrylic Resin Denture based on Microhardness, Surface Roughness, and Water Sorption. Int J Dent., 2022, 7069507.
[31]. Porwal, A., Khandelwal, M., Punia, V., Sharma V. J., 2017, Effect of denture cleansers on color stability, surface roughness, and hardness of different denture base resins. Journal of Indian Prosthodontic Society, 7(1), 61–67.
Viewed PDF 3 0 -
Vulval Angiomyofibroblastoma - A Rare Case ReportAuthor: Kanchana KoppoluDOI: 10.21522/TIJPH.2013.12.04.Art021
Vulval Angiomyofibroblastoma - A Rare Case Report
Abstract:
Angiomyofibroblastoma is a benign soft tissue tumour arising from the mesenchymal cells. It is seen in young females most commonly arising in the vulval region. This tumour mimics other benign tumours of the vulva and is pathologically differentiated from Angiofibroma and AMM (Angiomyomyxoma) which follow a different treatment protocol. This tumour is rare in occurrence and is unusual in older females. Here we report a rare case of AFMB in an older woman who presented with a very slow-growing asymptomatic vulval mass involving the left labia majora.
Vulval Angiomyofibroblastoma - A Rare Case Report
References:
[1]. Hsu IH, Chang TC, Wu CT, Chen RJ, Chow SN. Angio myofibroblastoma of the vulva. J Formos Med Assoc 2004;103:467-71.
[2]. Laiyemo R, Disu S, Vijaya G, Wise B. Post-menopausal vaginal angiomyofibroblastoma: A case report. Arch Gy necol Obstet 2005;273:129-30.
[3]. Vargas M, Akrivis C, Demou A, Kitsiou E, Antoniou N. Angiomyofibroblastoma of the vagina in a postmenopausal breast cancer patient treated with tamoxifen: Clinicopathologic analysis of a case and review of the literature. Int J Gynecol Cancer 2006;16:581-5.
[4]. Nucci MR, Fletcher CD. Vulvovaginal soft tissue tumours: Update and review. Histopathology 2000;36:97-108.
[5]. Nielsen GP, Young RH. Mesenchymal tumours and tumour-like lesions of the female genital tract: A selective review with emphasis on recently described entities. Int J Gyne col Pathol 2001;20:105-27.
[6]. Horiguchi H, Matsui-Horiguchi M, Fujiwara M, Kaketa M, Kawano M, Ohtsubo-Shimoyamada R, et al. Angio myofibroblast oma of the vulva: Report of a case with immunohistochemical and molecular analysis. Int J Gynecol Pathol 2003;22:277-84.
[7]. Omori M, Toyoda H, Hirai T, Ogino T, Okada S. Angiomyo fibroblastoma of the vulva: A large pedunculated mass formation. Acta Med Okayama 2006;60:237-42.
[8]. Fletcher CD, Tsang WY, Fisher C, Lee KC, Chan JK. A giomyofibroblastoma of the vulva: a benign neoplasm distinct from aggressive angiomyxoma. Am J Surg Pathol 1992;16:373-82.
[9]. Ockner DM, Sayadi H, Swanson PE, Ritter JH, Wick MR. Genital angiomyofibroblastoma: comparison with aggressive angiomyxoma and other myxoid neoplasms of skin and soft tissue. Am J Clin Pathol 1997;107:36-44.
[10]. Tochika N, Takeshita A, Sonobe H, Matsumoto M, Ko Hayashi M, Araki K. Angiomyofibroblastoma of the vulva: report of a case. Surg Today 2001;31:557-9.
[11]. Granter SR, Nucci MR, Fletcher CD. Aggressive angio myxoma: reappraisal of its relationship to angiomyo fibroblastoma in a series of 16 cases. Histopathology 1997;30:3-10
[12]. Lee SH, Yang JW, Do JM, Seo DH, Jung JH, Chung KH, et al. Angiomyofibroblastoma-like tumour of the scrotum. Korean J Urol. 2010;51:365–7.
[13]. Goyal S, Singla S, Singla M, Vyas D. Angiomyofibroblastoma of the vulva – A case report and review. J Case Rep Oncol Ther. 2015;1:112.
[14]. Wolf B, Horn LC, Handzel R, Einenkel J. Ultrasound plays a key role in imaging and management of genital angiomyofibroblastoma: A case report. J Med Case Rep. 2015;9:248.
[15]. Fatusic J, Hudic I, Fatusic Z, Mustedanagic-Mujanovic J. Angiomyofibroblastoma of the vaginal portion. Med Arch. 2014;68:424–5
[16]. Arumugam P, George R, Jayaseelan V P., 2021, Aberrations of m6A regulators are associated with tumorigenesis and metastasis in head and neck squamous cell carcinoma. Arch Oral Biol. 122: 105030. doi:10.1016/j.archoralbio.2020.105030.
[17]. Weiss SW, Gnepp DR, Bratthauer GL. Palisaded myofibroblastoma. A benign mesenchymal tumour of the lymph node. Am J Surg Pathol. 1989;13:341–6.
[18]. Nasu K., Fujisawa K., Takai N., Miyakawa I. Angiomyofibroblastoma of the vulva. Int. J. Gynecol. Cancer. 2002;12:228–231.
[19]. Sims S.M., Stinson K., McLean F.W., et al. Angiomyofibroblastoma of the vulva: a case report of a pedunculated variant and review of the literature. J. Low. Genet. Tract Dis. 2012;16:149–154.
[20]. Pradhan P., Sahu N., Dash K., Misra P., Senapati U., Rath S.K. Angiomyofibroblastoma of the vulva: a rare case report with a brief review of the literature. J. Mid-life Health. 2019;10:105–107.
Viewed PDF 5 0 -
Lipoma or Liposarcoma? - The Diagnostic ChallengesAuthor: Thanka J.DOI: 10.21522/TIJPH.2013.12.04.Art030
Lipoma or Liposarcoma? - The Diagnostic Challenges
Abstract:
Atypical lipomatous tumour / well-differentiated liposarcoma (ALT/WDLPS) is a locally aggressive mesenchymal neoplasm composed either entirely or partly of an adipocytic proliferation showing at least focal nuclear atypia in both adipocytes and stromal cells. This case report details a case of a 45-year-old female who presented to OPD with swelling over the medial aspect of the thigh for 3 years. Clinically she was diagnosed with lipoma followed by an excision and histopathological examination. Histopathology revealed features suggestive of Atypical lipomatous tumour / well-differentiated liposarcoma (ALT/WDLPS) which showed the presence of striking variation in adipocyte cell size. This study is done to emphasise the importance of histopathological examination as an important diagnostic tool in differentiating lipoma from liposarcoma.
Lipoma or Liposarcoma? - The Diagnostic Challenges
References:
[1]. Weiss, S. W., 2019, Enzinger and Weiss's Soft Tissue Tumors E-Book. Elsevier Health Sciences.
[2]. Moch H. Soft tissue and bone tumours WHO classification of tumours/volume 3. WHO classification of tumours. 2020, 3.
[3]. Lucas, D. R., Nascimento, A. G., Sanjay, B. K. and Rock, M. G., 1994, Well-differentiated liposarcoma: the Mayo Clinic experience with 58 cases. American Journal of Clinical Pathology, 102(5), pp.677-683
[4]. Dei Tos, A. P., 2000, Liposarcoma: new entities and evolving concepts. Annals of diagnostic pathology, 4(4), pp.252-266.
[5]. Dei Tos, A. P., 2014, Liposarcomas: diagnostic pitfalls and new insights. Histopathology, 64(1), pp.38-52.
[6]. Hameed, M., 2007, Pathology and genetics of adipocytic tumors. Cytogenetic and Genome Research, 118(2-4), pp.138-147.
[7]. Mashima, E., Sawada, Y. and Nakamura, M., 2021, Recent advancement in atypical lipomatous tumor research. International journal of molecular sciences, 22(3), p.994.
[8]. Kallen, M. E. and Hornick, J. L., 2021, The 2020 WHO classification: What’s new in soft tissue tumor pathology? The American journal of surgical pathology, 45(1), pp. e1-e23.
[9]. Sbaraglia, M. and Dei Tos, A. P., 2019, The pathology of soft tissue sarcomas. La radiologia medica, 124(4), pp.266-281.
Viewed PDF 5 0 -
A Case Report of Gangrenous Small Bowel Obstruction in an Antenatal WomenAuthor: Rajeswari I.DOI: 10.21522/TIJPH.2013.12.04.Art022
A Case Report of Gangrenous Small Bowel Obstruction in an Antenatal Women
Abstract:
Gangrenous intestinal obstruction during pregnancy is a rare and life-threatening non-obstetric surgical emergency that may result in maternal and fetal mortality. These patients were often confronted with a diagnostic and therapeutic challenge since the condition is rare and overlapping of symptoms occurs. It also raises concerns over radiological evaluation and the risk involved with surgery and anaesthesia. The diagnosis is delayed due to common and overlapping symptoms and also inhibition to carry out ionising radiological investigations in pregnancy which could be harmful to the fetus. Antenatal women, 29 years old at 28 weeks of gestation presented with abdominal pain and fever. Ultrasound done immediately showed adherence of small bowel loops suggestive of intestinal obstruction. She was taken up for emergency laparotomy and proceeded with resection of the gangrenous segment completed with anastomosis. The postoperative period was uneventful. The patient was stable on discharge. Prompt diagnosis should be made and the appropriate treatment should be taken as soon as possible. Surgical intervention should be taken if necessary as earlier diagnosis and management decreases morbidity and mortality.
A Case Report of Gangrenous Small Bowel Obstruction in an Antenatal Women
References:
[1]. Zachariah SK, Fenn MG., 2013, Acute intestinal obstruction complicating pregnancy: diagnosis and surgical management, BMJ Case Rep., bcr2013203235, doi: 10.1136/bcr-2013-203235. Oman Medical Journal, Vol. 28, No.5, https://www.researchgate.net/publication/289711131_Small_Intestinal_Gangrene_Complicating_Term_Pregnancy_A_Case_Report (2013)
[2]. Verner N Orish., January 2020, Gangrenous Gut in a Pregnant Woman: A Case report, DOI:10.9734/bpi/erms/v3, Book Publisher International, Vol.3, 61-67, https://www.researchgate.net/publication/338433469_Gangrenous_Gut_in_a_Pregnant_Woman_A_Case_Report (2020)
[3]. Shen, J., Teng, X., Chen, J. et al., 2023, Intestinal obstruction in pregnancy—a rare presentation of uterine perforation, BMC Pregnancy Childbirth 23, 507, ISSN:1471-2393, https://doi.org/10.1186/s12884-023-05827-8
[4]. Meyerson S, Holtz T, Ehrinpreis M, Dhar R., 1995, Small bowel obstruction in pregnancy. Am J Gastroenterol., 90(2):299-302. PMID: 7847305, https://pubmed.ncbi.nlm.nih.gov/7847305/(1995)
[5]. Verner N Orish, Emmanuel Coomson, Seth Fanyi., January 2020, Gangrenous Gut in a Pregnant Woman: A Case Report DOI:10.9734/bpi/erms/v3 In book: Emerging Research in Medical Sciences Vol. 3, 61-67, Book Publisher International https://www.researchgate.net/publication/3384334
[6]. Ling XS, Anthony Brian Tian WC, Augustin G, Catena F., 2024, Can small bowel obstruction during pregnancy be treated with conservative management?, world journal of emergency surgery, vol-19(1): 13. doi: 10.1186/s13017-024-00541-y. PMID: 38600568; PMCID:PMC11007914. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11007914/ (2024)
[7]. Verner Orish, Emmanuel Coomson, Seth Fanyi, Onyekachi Onyeabor, Adekunle Sanyaolu , Chuku Okorie., 2017, Asian journal of medicine and health, DOI: 10.9734/AJMAH/2017/34594, Issue: 2017 - Volume 5 [Issue 4], 1-5, https://journalajmah.com/index.php/AJMAH/article/view/142
[8]. Rathod Archana D, Chavan N, Pajai Sandhya, Gaddikeri., 2015, A Rare Case of Bowel Gangrene in Pregnancy : A Surgical and Obstetric Catastrophe. Indian Medical Gazette, Index Medicus for South- East Asia Region journal,I149 (2): 80-84, https://imsear.searo.who.int/handle/123456789/157707
[9]. Lin H, Lin CC, Huang WT., 2011, Idiopathic superior mesenteric vein thrombosis resulting in small bowel ischemia in a pregnant woman. Case Rep Obstet Gynecol. 2011:687250. Pubmed journal, Volume 2011, Article ID 687250, pg.no.3 doi: 10.1155/2011/687250. Epub 2011 Sep 14. PMID: 22567515; PMCID: PMC3335606. https://pubmed.ncbi.nlm.nih.gov/22567515/
[10]. Mandal S, Santra G, Roy H., 2013, Small Intestinal Gangrene Complicating Term Pregnancy: A Case Report. Oman Med J., vol 28(5):e057. doi: 10.5001/omj.2013.109. PMID: 31440359; PMCID: PMC6669305. https://pubmed.ncbi.nlm.nih.gov/31440359/
[11]. Essilfie P, Hussain M, Stokes IM., 2007 Jun, Small bowel infarction secondary to volvulus during pregnancy: a case report. J Reprod Med.; vol 52(6):553-4. PMID: 17694982. https://pubmed.ncbi.nlm.nih.gov/17694982/
[12]. Redlich A, Rickes S, Costa SD, Wolff S., 2007, Small bowel obstruction in pregnancy. Arch Gynecol Obstet, vol 275(5):381-3. doi: 10.1007/s00404-006-0262-8. Epub 2006 Oct 18. PMID: 17047974. https://pubmed.ncbi.nlm.nih.gov/17047974/
[13]. Hill LM, Symmonds RE., 1977, Small bowel obstruction in pregnancy. A review and report of four cases. Obstet Gynecol. Pubmed journal, Vol 49(2):170-3. PMID: 834399. https://pubmed.ncbi.nlm.nih.gov/834399/
[14]. Moran BJ., 2007, Adhesion-related small bowel obstruction. Colorectal Dis. Vol 9 Suppl 2:39-44. doi: 10.1111/j.1463-1318.2007.01347.x. PMID: 17824969, https://pubmed.ncbi.nlm.nih.gov/17824969/
[15]. Williams SB, Greenspon J, Young HA, Orkin BA., 2005, Small bowel obstruction: conservative vs. surgical management. Dis Colon Rectum.Pubmed journal, vol 48(6):1140-6. doi: 10.1007/s10350-004-0882-7. PMID: 15906139, https://pubmed.ncbi.nlm.nih.gov/15906139/
Viewed PDF 3 0 -
Assessing the Impact of Competency-Based Medical Education (CBME): Insights from Medical StudentsAuthor: Shanmathi KADOI: 10.21522/TIJPH.2013.12.04.Art023
Assessing the Impact of Competency-Based Medical Education (CBME): Insights from Medical Students
Abstract:
The National Medical Commission (NMC) in India introduced the Competency-Based Medical Education (CBME) curriculum to enhance medical education quality and align with global standards. This curriculum emphasizes developing specific competencies, and ensuring medical students possess essential skills, knowledge, and attitudes. A survey among 500 final-year students and CRMIs at Sree Balaji Medical College and Hospital assessed their views on the CBME curriculum using a Google Forms questionnaire. Key findings include the majority finding the Foundation Course necessary for their medical training, most students rating Basic Life Support (BLS) training as very useful, and field visits generally seen as beneficial, while opinions on IT skills sessions were mixed. Early clinical exposure significantly enhanced the learning experience, with high preferences for small group teaching, self-directed learning, reflective learning, and AETCOM training in Phase I MBBS. Elective postings were considered beneficial by most respondents. Students had a mixed understanding of the new assessment schemes under CBME, and subject integration was found to be very beneficial, with preferences for both horizontal and vertical integration. Many students found Phase I MBBS to be academically stressful and strongly suggested more time for sports and physical activities. Overall, the CBME curriculum was positively received, particularly in early clinical exposure, skill development, and subject integration. However, areas such as IT skills training, the duration of the Foundation Course, and better synchronization of vertical integration require improvement. Addressing these concerns can lead to better-prepared medical graduates, capable of meeting the healthcare needs of the population with a strong emphasis on practical skills, ethical practice, and continuous learning.
Assessing the Impact of Competency-Based Medical Education (CBME): Insights from Medical Students
References:
[1]. The tyranny of the Medical Council of India’s new (2019) MBBS curriculum: Abolition of the academic discipline of family physicians and general practitioners from the medical education system of India. J Family Med Prim Care 2019; 8:323‑5.
[2]. Frank JR, Mungroo R, Ahmad Y, Wang M, De Rossi S, Horsley T. Toward a definition of competency‑based education in medicine: A systematic review of published definitions. Med Teach 2010; 32:631‑7.
[3]. Medical Council of India. Early Clinical Exposure for the Undergraduate Medical Education Training Program;2019. p. 1‑43.
[4]. Medical Council of India, Competency based Undergraduate curriculum for the Indian Medical Graduate. Vol. 2. New Delhi, Medical Council of India; 2018.
[5]. Medical Council of India, Competency based Undergraduate curriculum for the Indian Medical Graduate. Vol. 3. New Delhi, Medical Council of India; 2018.
[6]. Medical Council of India. Attitude, Ethics and Communication (AETCOM). Competencies for the Indian Medical Graduate. New Delhi: Medical Council of India; 2018.
[7]. 7.Medical Council of India. Alignment and Integration Module for Undergraduate Medical Education Program. New Delhi, Medical Council of India; 2019. p. 1‑34.
[8]. Sharma R, Bakshi H, Kumar P. Competency‑based undergraduate curriculum: A critical view. Indian J Community Med 2019; 44:77‑80.
[9]. Medical Council of India, Competency based Undergraduate curriculum for the Indian Medical Graduate. Vol. 1. New Delhi, Medical Council of India; 2018.
[10]. Chacko TV. Moving toward competency‑based education: Challenges and the way forward. Arch Med Health Sci 2014; 2:247‑53.
[11]. Shah N, Desai C, Jorwekar G, Badyal D, Singh T. Competency‑based medical education: An overview and application in pharmacology. Indian J Pharmacol 2016;48: S5‑S9.
[12]. Basheer A. Competency‑based medical education in India: Are we ready? J Curr Res Sci Med 2019; 5:1‑3.
[13]. Srimathi T. A study on students feedback on the foundation course in first year MBBS curriculum. Int J Med Res Health Sci 2014; 3:575‑9.
[14]. Singh S, Ghosh S, Pandya H. Foundation programme for MBBS students at entry level: Experience at an Indian medical school. Southeast Asian J Med Edu 2007; 1:33‑7.
[15]. Sangappa SB, Tekian A. Communication skills course in an Indian undergraduate dental curriculum: a randomized controlled trial. J Dent Educ 2013; 77:1092‑8.
[16]. Choudhary A, Gupta V. Teaching communications skills to medical students: Introducing the fine art of medical practice. Int J Appl Basic Med Res 2015;5: S41‑4.
[17]. Komattil R, Hande SH, Mohammed CA, Subramaniam B. Evaluation of a personal and professional development module in an undergraduate medical curriculum in India. Korean J Med Educ 2016; 28:117‑21.
[18]. Ashin S, Shahid A, Gondal GM. Teaching communication skills and medical ethics to undergraduate medical students. J Adv Med Prof 2013; 1:72‑76.
[19]. Modi JN, Anshu ‑, Chhatwal J, Gupta P, Singh T. Teaching and Assessing Communication Skills in Medical Undergraduate Training. Indian Pediatr 2016; 53:497‑504.
[20]. Naineni K, Rao GVR, Saie U. Addressing the challenges of training in communication skills in medicine in India. J Res Med Educ Ethics 2016; 6:10‑14.
[21]. Dyrbye LN, Thomas MR, Shanafelt TD. Medical student distress: causes, consequences, and proposed solutions. Mayo Clin Proc 2005; 80:1613‑22.
[22]. Dyrbye LN, Thomas MR, Shanafelt TD. Systematic review of depression, anxiety, and other indicators of psychological distress among U.S. and Canadian medical students. Acad Med 2006; 81:354‑73.
[23]. Given JL, Tjia J. Depressed medical students’ use of mental health services and barrier to use. Acad Med 2002; 77:918‑21.
[24]. Guthrie E, Black D, Bagalkote H, Shaw C, Campbell M, Creed F. Psychological stress and burnout in medical students: a five‑year prospective longitudinal study. J R Soc Med 1998; 91:237‑43.
[25]. Sidik MS, Kaneson N. The prevalence of depression among medical students. Malays J Psychiatry. 2003; 11:12‑17.
[26]. Yusoff MS, Rahman A. Stress management for medical students: A systematic review. In: Social Sciences and Cultural Studies‑Issues of Language, Public Opinion, Education and Welfare. Vol. 1. London, IntechOpen Limited; 2012. p. 477‑97.
Viewed PDF 5 0 -
Study on Awareness, Knowledge, Attitude, and Practice Related to HPV Vaccination among Healthcare WorkersAuthor: Sunitha VDOI: 10.21522/TIJPH.2013.12.04.Art024
Study on Awareness, Knowledge, Attitude, and Practice Related to HPV Vaccination among Healthcare Workers
Abstract:
In India, cervical cancer is the second most diagnosed cancer in women. The World Health Organization (WHO) has set ambitious goals known as the 90-70-90 targets to eliminate cervical cancer: achieving 90% HPV vaccination coverage, ensuring 70% of eligible women undergo screening twice their lifetime, and providing treatment for 90% of women diagnosed with invasive and pre-invasive cancer. This study aims to assess awareness levels, evaluate knowledge, and explore current practices regarding HPV vaccination. This cross-sectional study employed an exploratory questionnaire-based survey among 200 healthcare workers at Sree Balaji Medical College and Hospital. There is a significant association (p = 0.002) between the type of healthcare worker [clinical (90%) vs. non-clinical (70%)] and their awareness of HPV vaccination. Clinical workers (85%) exhibit a significantly higher positive attitude(p<0.01) compared to non-clinical workers (60%). The chi-square analysis indicates a significant difference (p<0.001) in the practice of regularly recommending or administering HPV vaccination between clinical (70%) and non-clinical (30%) healthcare workers. There is a significant association (p < 0.001) between Clinical workers who are likely to possess high knowledge (70%) about HPV and its vaccination compared to non-clinical workers, who predominantly fall into the moderate (52%) or low knowledge (48%) categories. The findings underscore significant knowledge gaps, emphasizing the need for improved counselling on HPV vaccination targets.
Study on Awareness, Knowledge, Attitude, and Practice Related to HPV Vaccination among Healthcare Workers
References:
[1]. KaarthigeyanK., 2012, Cervical cancer in India and HPV vaccination. Indian J Med Paediatr Oncol. 2012, 33(1), 12, doi:https://doi.org/10.4103/0971-5851.96961
[2]. Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. Global .., 2012,burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016;4(9):e609-16, DOI: 10.1016/S2214-109X(16)30143-7
[3]. Guida, F., et al., 2022, Global and regional estimates of maternal cancer-related orphans in 2020. Nat Med 28, 2563–2572. Nat Med. 2022 Dec;28(12):2563-2572. doi: 10.1038/s41591-022-02109-2. Epub 2022 Nov 20.
[4]. Gamble HL, Klosky JL, Parra GR, Randolph ME., 2010, Factors influencing familial decision-making regarding human papillomavirus vaccination. J Pediatr Psychol 2010;35:704- 15, doi: 10.1093/jpepsy/jsp108
[5]. Husain Y, Alalwan A, Al-Musawi Z, Abdulla G, Hasan K, JassimG, 2019 Knowledge towards human papilloma virus (HPV) infection and attitude towards its vaccine in the Kingdom of Bahrain: cross- sectional study. BMJ Open. 2019; 9(9):e031017 DOI: 10.1136/bmjopen-2019-031017
[6]. Bhatla N, Joseph E., 2009, Cervical cancer prevention & the role of human papillomavirus vaccines in India. Indian J Med Res. 2009; 130(3):334-40. PMID: 19901443
[7]. Markowitz LE, Dunne EF, Saraiya M, et al., 2014, Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2014;63:1-30, PMID: 25167164
[8]. Brisson M, É B, Drolet M, Bogaards JA, Baussano I, Vänskä S, Jit M,Boily M-C, Smith MA, Berkhof J, et al., 2016, Population-level impact, herdimmunity, and elimination after human papillomavirus vaccination: A systematic review and meta-analysis of predictions fromtransmission-dynamic models. Lancet Publ Health. 2016;1(1):e8–e17.doi:10.1016/S2468-2667(16)30001-9
[9]. Wong MC, Chan TT, Chan PK., 2015, A home-schooldoctor model to break the barriers for uptake of human papillomavirus vaccine. BMC Public Health 2015;15:935. DOI 10.1186/s12889-015-2269-1
[10]. Al-Dubai, S.A., et al., 2010,Knowledge, attitudes, and barriers for HPV vaccines among Malaysian women. Asian Pac J Cancer Prev APJCP. 2010 Jan 1;11(4):887–892
[11]. McSherry, L.A., et al., 2012, Understanding primary care practitioners’ behaviors related to HPV using the Theoretical Domains Framework. Implement Sci. 2012;7:73. DOI: 10.1186/1748-5908-7-73
[12]. Durosoy R, Yamazhan M, Taskbakan MI, Ergin I, Aysin M, Pullukcu H, et al. ,2012, HPV vaccine awareness and willingness of first-year students entering university in western Turkey. Asian Pac J Cancer Prev. 2010; 11(6): 1695-701
[13]. Basu, P., et al., 2006, Women’s perceptions and social barriers affecting compliance to cervical screening: findings from a population-based study in India. Can Detect Prev. 2016; 30(4): 369-74. PMID: 16963194, DOI: 10.1016/j.cdp.2006.07.004
[14]. Dabash R, Vajpayee J, Jacob M, Dzuba I, Lal N, Bradley J, et al., 2005 A strategic assessment of cervical cancer prevention and treatment services in 3 districts of Uttar Pradesh, India. Reprod Health. 2005;2:11-6, Reproductive Health 2005, 2:11 doi:10.1186/1742-475-2-11
[15]. Pandey D, Vanya V, Bhagat S, Vs B, Shetty J., 2012,Awareness and attitude towards human papillomavirus (HPV) vaccine among medical students in a premier medical school in India. PLoS One. 2012; 7(7); e40619. doi, DOI: 10.1371/journal.pone.0040619
[16]. Songthap A, Pitisuttithum P, Kaewkungwal J, Fungladda W, Bussaratid V, Koonsaeng S., 2009. Knowledge, attitudes, and acceptability of a human papillomavirus vaccine among healthcare providers. Southeast Asian J Trop Med Public Health. 2009; 40:1048–56-pubmed. PMID: 19842388
[17]. Daley EM, Vamos CA, Thompson EL, Zimet GD, Rosberger Z, Merrell L, Kline NS., 2017, The feminization of HPV: how science,politics, economics and gender norms shaped U.S. HPV vaccine implementation. Papillomavirus Res. 2017 Jun:3:142-148. doi: 10.1016/j.pvr.2017.04.004.
[18]. Aldrich T, Becker D, Garcia SG, Lara D.,2005,Mexican physicians’ knowledge and attitudes aboutthe human papillomavirus and cervical cancer: a national survey. Sex Transm Infect 2005; 81: 135-141, doi: 10.1136/sti.2003.008557, PMID: 15800091
[19]. Suk R, Montealegre JR, Nemutlu GS, et al., 2019 Public knowledge of human papillomavirus and receipt of vaccination recommendations. JAMA Pediatr. 2019;173(11):1099-1102. doi:10.1001/jamapediatrics.2019.3105
[20]. Teresa, J., et al., 2011, Awareness of cervical cancer risk factors among educated youth in India, Nepal, and Sri Lanka: a cross-sectional survey. Asian Pacific J Cancer Prev. 2011;12:1707–1712
Viewed PDF 5 0 -
A Rare Case of Non Hodgkin Lymphoma in an Adult Causing IntussusceptionAuthor: Ramalakshmi, V.DOI: 10.21522/TIJPH.2013.12.04.Art025
A Rare Case of Non Hodgkin Lymphoma in an Adult Causing Intussusception
Abstract:
Intussusception in an adult is an uncommon, challenging situation to any surgeon. The causes for intussusception in adults are different from that of in children. Since malignancy could be one of the causes, surgery should be preferred over conservative treatment. Here we present a rare case of Non-Hodgkin Lymphoma (NHL) in an adult causing Intussusception. The patient was admitted to our hospital complaining of long-standing, unresolved abdominal pain. After USG abdomen and CT abdomen, intussusception was diagnosed. The patient underwent emergency surgery. Right sided hemicolectomy was performed and HPE diagnosis was malignant B-cell lymphoma that involved the ileocecal valve. This case explains the need for surgeons to consider malignant conditions for potential causes of intussusception in adults, to give the correct surgical treatment.
A Rare Case of Non Hodgkin Lymphoma in an Adult Causing Intussusception
References:
[1]. Mirotiga, P. A. N., 2023, Invagination intestinale aiguë de l’adulte: Aspects diagnostiques, thérapeutiques à propos de sept cas diagnostiqués au CHU de l’Amitié Sino-Centrafricaine de Bangui, RCA. Journal Africain de Chirurgie, 7(4), 247–253. https://doi.org/10.61585/pud-jafrchir-v7n405
[2]. Fischer, T. K., Bihrmann, K., Perch, M., Koch, A., Wohlfahrt, J., Kåre, M. & Melbye, M., 2004, Intussusception in early childhood: A cohort study of 1.7 million children. Pediatrics, 114(3), 782–785. https://doi.org/10.1542/peds.2004-0390. https://pubmed.ncbi.nlm.nih.gov/15342854/
[3]. Akbulut, S., 2012, Unusual cause of adult intussusception: Diffuse large B-cell non-Hodgkin’s lymphoma: A case report and review. European Review for Medical and Pharmacological Sciences, 16(14), 1938–1946. https://pubmed.ncbi.nlm.nih.gov/23242720/
[4]. Felix, E. L., Cohen, M. H., Bernstein, A. D. & Schwartz, J. H., 1976, Adult intussusception: Case report of recurrent intussusception and review of the literature. American Journal of Surgery, 131(6), 758–761.https://doi.org/10.1016/0002-9610(76)90196-3 https://pubmed.ncbi.nlm.nih.gov/937658/
[5]. Loukas, M., Pellerin, M., Kimball, Z., de la Garza-Jordan, J., Tubbs, R. S. & Jordan, R., 2011, Intussusception: an anatomical perspective with review of the literature. Clinical Anatomy, 24(5), 552–561. https://doi.org/10.1002/ca.21099 https://pubmed.ncbi.nlm.nih.gov/21268121/
[6]. Begos, D. G., Sandor, A., & Modlin, I. M., 1997, The diagnosis and management of adult intussusception. American Journal of Surgery, 173(2), 88–94. https://doi.org/10.1016/S0002-9610(96)00419-9. https://pubmed.ncbi.nlm.nih.gov/9074370/
[7]. Tan, K. Y., Tan, S. M., Tan, A. G., Chen, C. Y., Chng, H. C. & Hoe, M. N., 2003, Adult intussusception: experience in Singapore. ANZ Journal of Surgery, 73(12), 1044–1047. https://doi.org/10.1046/j.1445-2197.2003.t01-22-. https://pubmed.ncbi.nlm.nih.gov/14632903/
[8]. Franz, B., Rabl, C., Neureiter, D., et al., 2010, Emergency surgery for enteric and colonic intussusception in adults. European Surgery, 42, 180–183 https://doi.org/10.1007/s10353-010-0549-7
Viewed PDF 5 0 -
Impact of Technology Addiction among School Going Adolescents – An Observational StudyAuthor: Sridevi BDOI: 10.21522/TIJPH.2013.12.04.Art036
Impact of Technology Addiction among School Going Adolescents – An Observational Study
Abstract:
Adolescents have been labelled the "digital natives of the technology age", yet evaluating adolescents' understanding, attitudes, and behaviour with respect to technology addiction (TA) Internet use, instant messaging, online gaming, social networking, and computer use are all examples of problematic technological applications, particularly among high school kids. The present study aims to assess the impact of technology addiction among school going adolescents. A quantitative approach with non-experimental descriptive research design was adopted for the present study. A 50 school going adolescents were recruited as study participants by using Convenient Sampling Technique. A self-structured questionnaire was administered to collect the demographic information and “Technology Addiction Scale “was used in the research. The present study suggests that the level of technology addiction among school going adolescents, majority of them 27(54%) has mild addiction, 13(26%) has moderate addiction and 10(20%) has severe addiction. Technology addiction has emerged as a major public health issue among Indian youth. To promote healthy technological behaviours, an integrated socio-ecological framework with a multilevel approach that targets risk factors at various levels is required.
Impact of Technology Addiction among School Going Adolescents – An Observational Study
References:
[1]. Amudhan, S., Prakasha, H., Mahapatra, P., Burma, A. D., Mishra, V., Sharma, M. K., & Rao, G. N., 2022, Technology addiction among school-going adolescents in India: epidemiological analysis from a cluster survey for strengthening adolescent health programs at district level. Journal of Public Health, 44(2), 286-295.
[2]. Martins, M. V., Formiga, A., Santos, C., Sousa, D., Resende, C., Campos, R., & Ferreira, S., 2020, Adolescent internet addiction–role of parental control and adolescent behaviours. International Journal of Pediatrics and Adolescent Medicine, 7(3), 116-120.
[3]. Seker, R., Kartal, T., Tasdemir, A., & Kızıltepe, I. S., 2023, Examining adolescents’ technology addiction levels before and after COVID-19 pandemic. Journal of Education in Science Environment and Health, 9(4), 330-347.
[4]. Bickham, D. S., 2021, Current research and viewpoints on internet addiction in adolescents. Current pediatrics reports, 9, 1-10.
[5]. Berte, D. Z., Mahamid, F. A., & Affouneh, S., 2021, Internet addiction and perceived self-efficacy among university students. International Journal of Mental Health and Addiction, 19(1), 162-176.
[6]. Mylona, I., Deres, E. S., Dere, G. D. S., Tsinopoulos, I., & Glynatsis, M., 2020, The impact of internet and videogaming addiction on adolescent vision: a review of the literature. Frontiers in public health, 8, 63.
[7]. Potas, N., Açıkalın, Ş. N., Erçetin, Ş. Ş., Koçtürk, N., Neyişci, N., Çevik, M. S., & Görgülü, D. 2022, Technology addiction of adolescents in the COVID-19 era: Mediating effect of attitude on awareness and behavior. Current Psychology, 41(4), 1687-1703.
[8]. Zhong, Y., Ma, H., Liang, Y. F., Liao, C. J., Zhang, C. C., & Jiang, W. J., 2022, Prevalence of smartphone addiction among Asian medical students: A meta-analysis of multinational observational studies. International Journal of Social Psychiatry, 68(6), 1171-1183.
[9]. Lin, M. P., 2020, Prevalence of internet addiction during the COVID-19 outbreak and its risk factors among junior high school students in Taiwan. International journal of environmental research and public health, 17(22), 8547.
[10]. Chia, D. X., Ng, C. W., Kandasami, G., Seow, M. Y., Choo, C. C., Chew, P. K., & Zhang, M. W., 2020, Prevalence of internet addiction and gaming disorders in Southeast Asia: A meta-analysis. International journal of environmental research and public health, 17(7), 2582.
[11]. Aziz, M., Chemnad, K., Al-Harahsheh, S., Abdelmoneium, A. O., Bagdady, A., Hassan, D. A., & Ali, R., 2024, The influence of adolescents essential and non-essential use of technology and Internet addiction on their physical and mental fatigues. Scientific Reports, 14(1), 1745.
[12]. Kudubes, A. A., & Efe, Y. S., 2024, The predictive power of game addiction and social media addiction on adolescents' lifestyle. Psychology in the Schools, 61(3), 1000-1017.
[13]. Paiman, N., & Fauzi, M. A., 2024, Exploring determinants of social media addiction in higher education through the integrated lenses of technology acceptance model (TAM) and usage habit. Journal of Applied Research in Higher Education, 16(3), 776-803.
[14]. Aydin, T., Parris, B. A., Arabaci, G., Kilintari, M., & Taylor, J., 2024, Trait-level non-clinical ADHD symptoms in a community sample and their association with technology addictions. Current Psychology, 43(12), 10682-10692.
[15]. Al-Mamun, F., Hasan, M. E., Mostofa, N. B., Akther, M., Mashruba, T., Arif, M., & Mamun, M. A., 2024, Prevalence and factors associated with digital addiction among students taking university entrance tests: a GIS-based study. BMC psychiatry, 24(1), 322.
[16]. Mendez, M. L., Padrón, I., Fumero, A., & Marrero, R. J., 2024, Effects of internet and smartphone addiction on cognitive control in adolescents and young adults: A systematic review of fMRI studies. Neuroscience & Biobehavioral Reviews, 105572.
[17]. Sert, H., Taskin Yilmaz, F., Karakoc Kumsar, A., & Aygin, D., 2019, Effect of technology addiction on academic success and fatigue among Turkish university students. Fatigue: Biomedicine, Health & Behavior, 7(1), 41–51. https://doi.org/10.1080/21641846.2019.1585598
[18]. Upadhyaya, P., & Vrinda., 2021, Impact of technostress on academic productivity of university students. Education and Information Technologies, 26(2), 1647-1664.
[19]. Benedetto, L., Rollo, S., Cafeo, A., Di Rosa, G., Pino, R., Gagliano, A., & Ingrassia, M., 2024, Emotional and Behavioural Factors Predisposing to Internet Addiction: The Smartphone Distraction among Italian High School Students. International Journal of Environmental Research and Public Health, 21(4), 386.
[20]. Talan, T., Doğan, Y., & Kalinkara, Y., 2024, Effects of smartphone addiction, social media addiction and fear of missing out on university students’ phubbing: A structural equation model. Deviant Behavior, 45(1), 1-14.
[21]. Tariq, M., & Mishra, K., 2020, Impact of social media on mental health-a case study with the students of jammu and kashmir.
[22]. Yang, G. H., Cao, X. X., Fu, Y. Y., Wang, N. D., & Lian, S. L., 2024, Mobile phone addiction and academic burnout: the mediating role of technology conflict and the protective role of mindfulness. Frontiers in Psychiatry, 15, 1365914.
Viewed PDF 5 0 -
Policy Analysis of Regulatory Challenges for Medical Devices and In Vitro Diagnostics in Achieving Universal Health Coverage in ZimbabweAuthor: Charles ChikuDOI: 10.21522/TIJPH.2013.12.04.Art037
Policy Analysis of Regulatory Challenges for Medical Devices and In Vitro Diagnostics in Achieving Universal Health Coverage in Zimbabwe
Abstract:
Zimbabwe's regulation of medical devices and in vitro diagnostics (IVDs) lags behind that of medicines and vaccines despite the country's goal of achieving Universal Health Coverage (UHC) by 2030. This study, conducted from June to December 2022, rigorously evaluated Zimbabwe's regulatory framework for medical devices and IVDs using a comprehensive policy analysis framework. The study's methodology, which included document review and comparative analysis, was designed to align the regulatory framework with the UHC goal. The READ (Ready, Extract, Analyze, and Distill) approach systematically assessed the relationship between medical device regulations and national health strategic goals. Fourteen documents were analysed, revealing that current regulations under the Medicines and Allied Substances Control Act are insufficient for ensuring quality-assured medical devices and IVDs due to a lack of explicit definitions and standards, leading to inconsistent regulatory practices. The study found fragmented regulatory approaches, overlapping institutional responsibilities, and a lack of effective incorporation of medical device and IVD regulations in national health strategy and related policies, hindering UHC achievement. The study recommends comprehensive policy changes to harmonise regulations, clarify institutional roles, and integrate medical device and IVD regulations into the national health strategy. This ensures access to safe, effective, quality medical devices and IVDs, promoting Zimbabwe's UHC goals by 2030.
Policy Analysis of Regulatory Challenges for Medical Devices and In Vitro Diagnostics in Achieving Universal Health Coverage in Zimbabwe
References:
[1]. European Commission, 2017, MDR - Regulation (EU) 2017/746 on in-vitro diagnostic medical devices: Official Journal of the European Union, 1–175, https://www.emergogroup.com/sites/default/files/europe-medical-devices-regulation.pdf%0Ah
[2]. European Commission, 2017, Regulation (EU) 2017/745 of The European Parliament and of the Council on Medical Devices, Official Journal of the European Union, 5(8), 1-175, doi: 10.1177/2165079915576935.
[3]. Global Harmonization Task Force, 2006, Principles of Medical Devices Classification, 1–27, https://www.imdrf.org/sites/default/files/docs/ghtf/final/sg1/technical-docs/ghtf-sg1-n15-2006-guidance-classification-060627.pdf
[4]. International Medical Devices Regulators Forum, 2018, Essential Principles of Safety and Performance of Medical Devices, International Medical Device Regulators Forum., 12-27, https://www.imdrf.org/sites/default/files/docs/imdrf/final/technical/imdrf-tech-181031-grrp-essential-principles-n47.pdf
[5]. World Health Organization, 2018, Health products policy and standards, Good Manufacturing Practices https://www.who.int/teams/health-product-policy-and-standards/assistive-and-medical-technology/medical-devices/regulations
[6]. Hubner, S., Maloney, C., Phillips, S. D., Doshi, P., Mugaga, J., Ssekitoleko, R. T, Mueller, J. L, Fitzgerald, T. N., 2021, The evolving landscape of medical device regulation in East, Central, and Southern Africa, Global Health Science and Practice, 9(1), 136–148, doi: 10.9745/GHSP-D-20-00578.
[7]. Dacombe, R., Watson, V., Nyirenda, L., Madanhire, C., Simwinga, M., Chepuka, L., Johnson, C., Corbett, E., Hatzold, K., Taegtmeyer, M., 2019, Regulation of HIV self-testing in Malawi, Zambia and Zimbabwe: a qualitative study with key stakeholders, Journal of the International AIDS Society, 22(S1), 5–11, doi: 10.1002/jia2.25229.
[8]. Reddy, K. S. and Mathur, M. R., 2018, Universal Health Coverage, in Equity and Access, Oxford University Press, 305–322, doi: 10.1093/oso/9780199482160.003.0015.
[9]. World Health Organization, 2017, Leave no one behind. Strengthening Health Systems for UHC and the SDGs in Africa, WHO Regional Office for Africa, Licence: CC BY-NC-SA 3.0 IGO., 252–256, doi: 10.1080/15027570410006228.
[10]. World Health Organization, 2017, WHO global model regulatory framework for medical devices including in vitro diagnostic medical devices, WHO Medical Device Technical series. Licence: CC BY-NC-SA 3.0 IGO, https://www.who.int/medical_devices/publications/global_model_regulatory_framework_meddev/en/
[11]. Walt, G. and Gilson, L., 1994, Reforming the health sector in developing countries: The central role of policy analysis, Health Policy and Planning. Oxford Academic, 353–370, doi: 10.1093/heapol/9.4.353.
[12]. Kayesa, N. K. and Shung-King, M., 2021, The role of document analysis in health policy analysis studies in low and middle-income countries: Lessons for HPA researchers from a qualitative systematic review, Health Policy OPEN, (2), 100024, doi: 10.1016/j.hpopen.2020.100024.
[13]. Walt, G., Schiffman, J., Schneider, H., Murray, S. F., Brugha, R., and Gilson, L., 2008, 'Doing' health policy analysis: Methodological and conceptual reflections and challenges, Health Policy and Planning. Oxford University Press, 308–317, doi: 10.1093/heapol/czn024.
[14]. Sidibé, C. S., Becquet, V., Brückner, T. Y., Touré, O., Traoré, L. F., Broerse, J. E. W., and Dieleman, M., 2022, Adoption of harmonisation policy for the midwives’ training programme in Mali: A policy analysis, PLOS Global Public Health, 2(11), e0001296, doi: 10.1371/journal.pgph.0001296.
[15]. Walt, G. and Gilson, L., 1994, Reforming the health sector in developing countries: The central role of policy analysis, Health Policy and Planning. Oxford Academic, 353–370, doi: 10.1093/heapol/9.4.353.
[16]. Bowen, G. A., 2009, Document analysis as a qualitative research method, Qualitative Research Journal, 9(2), 27–40, doi: 10.3316/QRJ0902027.
[17]. Dalglish, S. L., Khalid, H. and McMahon, S. A., 2020, Document analysis in health policy research: The READ approach, Health Policy and Planning, 35(10), 1424–1431, doi: 10.1093/heapol/czaa064.
[18]. World Health Organization (WHO), 2020, Guidance for post-market surveillance and market surveillance of medical devices, including in vitro diagnostics, 50, https://www.who.int/publications/i/item/9789240015319
[19]. De Maria, C., Di Pietro, L., Díaz Lantada, A., Makobore, P. N., Mridha, M., Ravizza, A., Torop, J., and Ahluwalia, A., 2018, Safe innovation: On medical device legislation in Europe and Africa, Health Policy and Technology, 7(2), 156–165, doi: 10.1016/j.hlpt.2018.01.012.
[20]. World Health Organization (WHO), 2017, WHO Global Model Regulatory Framework for Medical Devices including in vitro diagnostic medical devices., WHO Medical Device Technical series. Licence: CC BY-NC-SA 3.0 IGO. http://apps.who.int/bookorders.%0Ahttp://apps.who.int/bookorders.%0Ahttps://www.who.int/medical_devices/publications/global_model_regulatory_framework_meddev/en/%0Ahttp://www.who.int/medicines/areas/quality_safety/quality_assurance/2016-07-27Modelregulato
[21]. Global Harmonization Task Force, 2012, Principles of Conformity Assessment for Medical Devices, Ghtf/Sg1/N78:2012, https://www.imdrf.org/sites/default/files/docs/ghtf/final/sg1/technical-docs/ghtf-sg1-n78-2012-conformity-assessment-medical-devices-121102.pdf
[22]. Kuchenmüller, T., Chapman, E., Takahashi, R., Lester, L., Reinap, M., Ellen, Haby, M. M., 2022, A comprehensive monitoring and evaluation framework for evidence to policy networks, Evaluation and Program Planning, 91(102053), 1–23, doi: 10.1016/j.evalprogplan.2022.102053.A.
[23]. Allen, L. N., 2022, The philosophical foundations of “health for all” and Universal Health Coverage, International Journal for Equity in Health, 21(1), 1–7, doi: 10.1186/s12939-022-01780-8
Viewed PDF 6 0 -
Modifications of Oral Flora during Orthodontic Therapy and its Impact on Oral HealthAuthor: Murukesan SDOI: 10.21522/TIJPH.2013.12.04.Art038
Modifications of Oral Flora during Orthodontic Therapy and its Impact on Oral Health
Abstract:
Orthodontic therapy plays a crucial role in the correction of malocclusions and the improvement of dental aesthetics. However, emerging evidence suggests that orthodontic appliances can significantly alter the composition and balance of the oral microbiota, leading to potential implications for oral health. This paper aims to provide a comprehensive review of the changes in oral flora observed during orthodontic therapy and their impact on oral health outcomes. The oral microbiota is a complex ecosystem comprising various microbial species that interact in dynamic equilibrium with the host. Orthodontic appliances create an environment conducive to microbial colonization and proliferation, leading to shifts in microbial diversity and abundance. It can promote the overgrowth of cariogenic bacteria leading to an increased risk of dental caries and enamel demineralization. Additionally, changes in the oral microbiota composition can cause gingival inflammation, periodontal disease, and other oral complications during orthodontic treatment. Understanding the dynamics of oral flora changes during orthodontic therapy is essential for implementing effective preventive strategies and personalized oral care regimens. Incorporating measures to mitigate dysbiosis, such as improved oral hygiene practices, antimicrobial therapy, and dietary modifications, may help minimize the adverse effects of orthodontic treatment on oral health.
Modifications of Oral Flora during Orthodontic Therapy and its Impact on Oral Health
References:
[1]. Gugino, C. F., Dus, I., 1998, Unlocking orthodontic malocclusions: an interplay between form and function. Seminars in Orthodontics, 4(4), 246-255.
[2]. Batista, K. B., Thiruvenkatachari, B., Harrison, J. E., O'Brien, K. D., 2018, Orthodontic treatment for prominent upper front teeth (Class II malocclusion) in children and adolescents. Cochrane Database of Systematic Reviews, 3(3), CD003452.
[3]. Macey, R., Thiruvenkatachari, B., O'Brien, K., Batista, K. B., 2020, Do malocclusion and orthodontic treatment impact oral health? A systematic review and meta-analysis. American Journal of Orthodontics and Dentofacial Orthopedics, 157(6), 738-744.
[4]. Grippaudo, M. M., Quinzi, V., Manai, A., Paolantonio, E. G., Valente, F., La Torre, G., Marzo, G., 2020, Orthodontic treatment need and timing: Assessment of evolutive malocclusion conditions and associated risk factors. European Journal of Paediatric Dentistry, 21, 203-208.
[5]. Marra, P., Nucci, L., Abdolreza, J., Perillo, L., Itro, A., Grassia, V., 2020, Odontoma in a young and anxious patient associated with unerupted permanent mandibular cuspid: A case report. Journal of International Oral Health, 12, 182.
[6]. Mulimani, P., Popowics, T., 2022, Effect of orthodontic appliances on the oral environment and microbiome. Frontiers in Dental Medicine, 3, 924835.
[7]. Soria, S., Angulo-Bejarano, P. I., Sharma, A., 2020, Biofilms: Development and molecular interaction of microbiome in the human oral cavity. New and Future Developments in Microbial Biotechnology and Bioengineering: Microbial Biofilms, 61-75.
[8]. Sedghi, L., DiMassa, V., Harrington, A., Lynch, S. V., Kapila, Y. L., 2021, The oral microbiome: Role of key organisms and complex networks in oral health and disease. Periodontology 2000, 87(1), 107-131.
[9]. Cugini, C., Ramasubbu, N., Tsiagbe, V. K., Fine, D. H., 2021, Dysbiosis from a microbial and host perspective relative to oral health and disease. Frontiers in Microbiology, 12, 617485.
[10]. Fine, D. H., Schreiner, H., 2023, Oral microbial interactions from an ecological perspective: A narrative review. Frontiers in Oral Health, 4, 1229118.
[11]. Cornejo Ulloa, P., van der Veen, M. H., Krom, B. P., 2019, Modulation of the oral microbiome by the host to promote ecological balance. Odontology, 107, 437-448.
[12]. Kouvelis, G., Papadimitriou, A., Merakou, K., Doulis, I., Karapsias, S., Kloukos, D., 2021, A prospective cohort study assessing the impact of fixed orthodontic appliances on saliva properties and oral microbial flora. Oral Health & Preventive Dentistry, 19(1), 67-76.
[13]. Lucchese, A., Bondemark, L., 2021, The influence of orthodontic treatment on oral microbiology. Biological Mechanisms of Tooth Movement, 139-158.
[14]. Raghavan, S., Abu Alhaija, E. S., Duggal, M. S., Narasimhan, S., Al-Maweri, S. A., 2023, White spot lesions, plaque accumulation and salivary caries-associated bacteria in clear aligners compared to fixed orthodontic treatment: A systematic review and meta-analysis. BMC Oral Health, 23(1), 599.
[15]. Baumer, C., Schmidtmann, I., Ohlendorf, D., Ferrari Peron, P., Wehrbein, H., Erbe, C., 2023, Orthodontists’ instructions for oral hygiene in patients with removable and fixed orthodontic appliances. International Journal of Dental Hygiene, 22(2), 329-336.
[16]. Tiwari, A., Jain, R. K., 2020, Comparison of enamel demineralisation scores between passive self-ligation brackets and conventional ligation brackets in patients undergoing orthodontic treatment: A laser fluorescence study. Journal of Clinical & Diagnostic Research, 14(11), ZC16-ZC19.
[17]. Lazar, L., Vlasa, A., Beresescu, L., Bud, A., Lazar, A. P., Matei, L., Bud, E., 2023, White spot lesions (WSLs)—post-orthodontic occurrence, management and treatment alternatives: A narrative review. Journal of Clinical Medicine, 12(5), 1908.
[18]. Kwon, T. H., Salem, D. M., Levin, L., 2024, Periodontal considerations in orthodontic treatment: A review of the literature and recommended protocols. Seminars in Orthodontics, 18 January.
[19]. Haffajee, A. D., Socransky, S. S., Patel, M. R., Song, X., 2008, Microbial complexes in supragingival plaque. Oral Microbiology and Immunology, 23(3), 196-205.
[20]. Velegraki, A., Nicolatou, O., Theodoridou, M., Mostrou, G., Legakis, N. J., 2007, Paediatric AIDS-related linear gingival erythema: A form of erythematous candidiasis? Journal of Oral Pathology and Medicine, 28, 178-182.
[21]. Paoletti, I., Fusco, A., Grimaldi, E., Perillo, L., Coretti, L., Di Domenico, M., Cozza, V., Lucchese, A., Contaldo, M., Serpico, R., 2013, Assessment of host defence mechanisms induced by Candida species. International Journal of Immunopathology and Pharmacology, 26, 663-672.
[22]. Pannone, G., Santoro, A., Carinci, F., Bufo, P., Papagerakis, S. M., Rubini, C., Campisi, G., Giovannelli, L., Contaldo, M., Serpico, R., 2011, Double demonstration of oncogenic high risk human papilloma virus DNA and HPV-E7 protein in oral cancers. International Journal of Immunopathology and Pharmacology, 24, 95-101.
[23]. Puletic, M., Popovic, B., Jankovic, S., Brajovic, G., 2020, Detection rates of periodontal bacteria and herpesviruses in different forms of periodontal disease. Microbiology and Immunology, 64, 815-824.
[24]. Sharma, S., Tapashetti, R. P., Patil, S. R., Kalra, S. M., Bhat, G. K., Guvva, S., 2015, Revelation of viral-bacterial interrelationship in aggressive periodontitis via polymerase chain reaction: A microbiological study. Journal of International Oral Health, 7, 101-107.
[25]. Pan, S., Liu, Y., Si, Y., Zhang, Q., Wang, L., Liu, J., Wang, C., Xiao, S., 2017, Prevalence of fimA genotypes of Porphyromonas gingivalis in adolescent orthodontic patients. PLoS ONE, 12, e0188420.
[26]. Lucchese, A., Bondemark, L., Marcolina, M., Manuelli, M., 2018, Changes in oral microbiota due to orthodontic appliances: A systematic review. Journal of Oral Microbiology, 10, 1476645.
[27]. Guo, R., Lin, Y., Zheng, Y., Li, W., 2017, The microbial changes in subgingival plaques of orthodontic patients: A systematic review and meta-analysis of clinical trials. BMC Oral Health, 17, 1-10.
[28]. Sun, F., Ahmed, A., Wang, L., Dong, M., Niu, W., 2018, Comparison of oral microbiota in orthodontic patients and healthy individuals. Microbial Pathogenesis, 123, 473-477.
[29]. Naranjo, A. A., Triviño, M. L., Jaramillo, A., Betancourth, M., Botero, J. E., 2006, Changes in the subgingival microbiota and periodontal parameters before and 3 months after bracket placement. American Journal of Orthodontics and Dentofacial Orthopedics, 130, 275.e17.
[30]. Kim, S.-H., Choi, D.-S., Jang, I., Cha, B.-K., Jost-Brinkmann, P.-G., Song, J.-S., 2012, Microbiologic changes in subgingival plaque before and during the early period of orthodontic treatment. *Angle OrthHere are the remaining references formatted in the requested style.
[31]. Ireland, A. J., Soro, V., Sprague, S. V., Harradine, N. W. T., Day, C., Al-Anezi, S., Jenkinson, H. F., Sherriff, M., Dymock, D., Sandy, J. R., 2013, The effects of different orthodontic appliances upon microbial communities. Orthodontics & Craniofacial Research, 17, 115-123.
[32]. Levrini, L., Mangano, A., Montanari, P., Margherini, S., Caprioglio, A., Abbate, G. M., 2015, Periodontal health status in patients treated with the Invisalign® system and fixed orthodontic appliances: A 3-month clinical and microbiological evaluation. European Journal of Dentistry, 9, 404-410.
[33]. Lombardo, L., Palone, M., Scapoli, L., Siciliani, G., Carinci, F., 2020, Short-term variation in the subgingival microbiota of two groups of patients treated with clear aligners and vestibular fixed appliances: A prospective study. Orthodontics & Craniofacial Research, 24(2), 251-260.
[34]. Lu, H., Tang, H., Zhou, T., Kang, N., 2018, Assessment of the periodontal health status in patients undergoing orthodontic treatment with fixed appliances and Invisalign system. Medicine, 97, e0248.
[35]. Muzurovic, S., Babajic, E., Masic, T., Smajic, R., Selmanagic, A., 2012, The relationship between oral hygiene and oral colonization with Candida species. Medical Archives, 66, 415-417.
[36]. Jiang, Q., Li, J., Mei, L., Du, J., Levrini, L., Abbate, G. M., Li, H., 2018, Periodontal health during orthodontic treatment with clear aligners and fixed appliances. Journal of the American Dental Association, 149, 712-720.
[37]. Flores-Mir, C., 2019, Clear aligner therapy might provide a better oral health environment for orthodontic treatment among patients at increased periodontal risk. Journal of Evidence-Based Dental Practice, 19, 198-199.
Viewed PDF 5 0 -
Efficacy of IEC Material on Knowledge and Practices of Dietary Management of Hypertension among Hypertensive Clients at Selected Community SettingAuthor: Tamil selvi SDOI: 10.21522/TIJPH.2013.12.04.Art039
Efficacy of IEC Material on Knowledge and Practices of Dietary Management of Hypertension among Hypertensive Clients at Selected Community Setting
Abstract:
A condition in which the force of the blood against the artery walls is too high is described as hypertension. Usually, hypertension is defined as blood pressure above 140/90 and is considered severe if the pressure is 180/120 mmHg. The Dietary Approaches to Stop Hypertension (DASH) dietary pattern emphasizes fruits, vegetables, low-fat dairy products, and reduced sodium intake. A quantitative descriptive research approach was used after obtaining permission from the investigator. Sixty samples were selected using a purposive sampling technique. The samples who met the inclusion criteria at the community area were recruited. The investigator introduced and explained the purpose of the study to participants and obtained informed consent. The post-test scores of knowledge and practices were highly significant when compared to pretest scores using the paired t-test. Thus, the present study shows that the IEC material was effective in improving the knowledge and practices on dietary management of hypertension significantly among patients with hypertensive clients. Dietary Approaches to Stop Hypertension Diet research showed that it could lower blood pressure as well as the first-line blood pressure medication, even with a sodium intake of 3300 mg per day. Since then, numerous studies have shown that the Dietary Approaches to Stop Hypertension (DASH) diet reduces the risk of cancer, stroke, and heart disease, including heart failure, kidney stones, and other diseases. The DASH diet's ability to manage hypertension is profound.
Efficacy of IEC Material on Knowledge and Practices of Dietary Management of Hypertension among Hypertensive Clients at Selected Community Setting
References:
[1]. Juraschek, S. P., Miller, E. R., & Weaver C. M., 2020, Effects of sodium reduction on energy, metabolism, weight, thirst, and urine volume: results from the DASH-sodium trial. Hypertension, 75(3), 723-729.
[2]. Kerley, C. P., 2019, Dietary patterns and components to prevent and treat heart failure: A comprehensive review of human studies. Nutrition Research Reviews, 32(1), 1-27.
[3]. Dominguez, L. J., & Barbagallo M., 2018, Nutritional prevention of cognitive decline and dementia. Acta Bio Medica: Atenei Parmensis, 89(2), 276.
[4]. Kerley, C. P., 2018, A review of plant-based diets to prevent and treat heart failure. Cardiac Failure Review, 4(1), 54.
[5]. Saneei, P., et al. 2014, Influence of Dietary Approaches to Stop Hypertension (DASH) diet on blood pressure: A systematic review and meta-analysis on randomized controlled trials. Nutrition, Metabolism and Cardiovascular Diseases, 24(12), 1253-1261.
[6]. Ozemek, C., & Myers, J., 2018, The role of diet for prevention and management of hypertension. Current Opinion in Cardiology, 33(4), 388-393.
[7]. dos Reis Padilha, G., et al, 2018, Dietary patterns in secondary prevention of heart failure: A systematic review. Nutrients, 10(7), 828.
[8]. Urrico, P., & Iacobellis, G., 2018, Nonpharmacological interventions in the management of hypertension in the adult population with type 2 diabetes mellitus. Canadian Journal of Diabetes, 42(2), 196-198.
[9]. Tyson, C. C., & Martin, D., 2012, The Dietary Approaches to Stop Hypertension (DASH) eating pattern in special populations. Current Hypertension Reports, 14, 388-396.
[10]. Soltani, S., et al., 2020, Adherence to the DASH diet in relation to all-cause and cause-specific mortality: a systematic review and dose-response meta-analysis of prospective cohort studies. Nutrition Journal, 19, 1-13.
[11]. Levitan E. B., et al., 2009, Relation of consistency with the DASH diet and incidence of heart failure in men aged 45 to 79 years. The American Journal of Cardiology, 104(10), 1416-1420.
[12]. Sanches Machado d’Almeida, K., 2018, Mediterranean diet and other dietary patterns in primary prevention of heart failure and changes in cardiac function markers: a systematic review. Nutrients, 10(1), 58.
[13]. Scisney-Matlock, M., 2009, Strategies for implementing and sustaining therapeutic lifestyle changes as part of hypertension management in African Americans. Postgraduate Medicine, 121(3), 147-159.
[14]. Saneei, P., 2015, Adherence to the DASH diet and prevalence of the metabolic syndrome among Iranian women. European Journal of Nutrition, 54, 421-428.
[15]. Wang, T., 2018, Improving adherence to healthy dietary patterns, genetic risk, and long-term weight gain: gene-diet interaction analysis in two prospective cohort studies. BMJ, 360.
Viewed PDF 5 0 -
A Case Report on Congenital Hydrocele with Testicular Epididymal DisjunctionAuthor: Mahesh, K. G.DOI: 10.21522/TIJPH.2013.12.04.Art031
A Case Report on Congenital Hydrocele with Testicular Epididymal Disjunction
Abstract:
Cause of Male infertility is diagnosed at a later age unless a genito-urethral condition with detailed evaluation is required. Congenital developmental disorders remain hidden till it is surgically identified. In managing congenital conditions we could pick up developmental anomalies incidentally and end up charging diagnosis and management plan. A descriptive study of a boy of age 4 years reported with congenital hydrocele for which Herniotomy with eversion of the sac was done, upon which testicular epididymal disjunction was identified. The outcome of surgical correction and conservative management may vary with; diagnosing time, the extent of the pathology, and response to treatment. Considering Type IV epididymal disjunction present in, with inconclusive histological evidence of epididymal atresia, in the presence of normal karyotyping conservation long-term follow-up was chosen rather than the exploration of the disjunction given the risk of obstructive azoospermia. Wait and watch policy is better for type V epididymal disjunction rather than an aggressive surgical approach. Given androgenic development and the potential possibility of efficacious function in an individual of normal karyotyping.
A Case Report on Congenital Hydrocele with Testicular Epididymal Disjunction
References:
[1]. Logsdon, N. T., Gallo, C. M., Sampaio, F. J. B., Favorito, L. A., 2022, Mar-Apr; Epididymal disjunction anomalies in undescended testis – a factor associated with spermatic obstruction. Int Braz J Urol. 48(2), 336-346. Doi 10.1590/S1677-5538.IBJU.2022.99.07. PMID: 35170897; PMCID: PMC8932036. https://pubmed.ncbi.nlm.nih.gov/35170897
[2]. Merksz, M., Acta Chir Hung, 1998, Fusional anomalies of the testis and epididymis.;37(3-4), 153-70. PMID: 10379367. https://pubmed.ncbi.nlm.nih.gov/10379367/
[3]. D e Grazia, E., Gattuccio, F., Fatta, G., Cigna, R. M., Agosta, E., Acta Eur Fertil, 1982, Mar; Epididymo-testicular anomalies in the undescended testis. How important is their effect on infertility? 13(1):1-17. English, Italian. PMID: 6126982. https://pubmed.ncbi.nlm.nih.gov/6126982/
[4]. Huzaifa, M., Moreno, M. A., Hydrocele, 2023, Jul 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024, PMID: 32644551. https://www.ncbi.nlm.nih.gov/books/NBK559125/
[5]. Zhonghua, Er Ke Za Zhi. 2024, May, Subspecialty Group of Endocrinology, Hereditary and Metabolic Diseases, the Society of Pediatrics, Chinese Medical Association; Editorial Board, Chinese Journal of Pediatrics; National Clinical Research Center for Child Health. [Expert consensus on the diagnosis and treatment of androgen insensitivity syndrome in children]. 15;62(6), 501-508. Chinese. Doi: 10.3760/cma.j.cn112140-20231108-00353. Epub ahead of print. PMID: 38763869. https://pubmed.ncbi.nlm.nih.gov/38763869/
[6]. Natasha, T. Logsdon Carla, M. Gallo, Francisco, J. B., Sampaio, Luciano A Favorito, 2022, Epididymal disjunction anomalies in undescended testis - a factor associated with spermatic obstruction. Int Braz J Urol. Mar-Apr; 48(2), 336–346. Published online 2022, Jan 10. Doi: 10.1590/S1677-5538.IBJU.2022.99.07, PMCID: PMC8932036PMID: 35170897
[7]. Indrashis Bhattacharya, Souvik Sen Sharma, Subeer S Majumdar, 2024, Etiology of male infertility: An update Reproductive Sciences 31 (4), 942-965, https://pubmed.ncbi.nlm.nih.gov/38036863/
[8]. Krishnan et al. 2024, BMC Urology 24:115 https://doi.org/10.1186/s12894-024-01449-0;BMC Urology/https://bmcurol.biomedcentral.com/articles/10.1186/s12894-024-01449-0
[9]. Heidelbaugh, J. J., Belakovskiy, A. 2024, Jun; Testosterone Replacement Therapy for Male Hypogonadism. Am Fam Physician. 109(6), 543-549. PMID 38905552. https://pubmed.ncbi.nlm.nih.gov/38905552/
Viewed PDF 3 0 -
An Ephemeral Evaluation Study to Find Which Antidiabetic Can be a Better Hypolipidemic-Metformin 850 mg Twice Daily or Teneligliptin 20 mg once Daily and Metformin 500 mg Twice Daily CombinationAuthor: Brigida S.DOI: 10.21522/TIJPH.2013.12.04.Art032
An Ephemeral Evaluation Study to Find Which Antidiabetic Can be a Better Hypolipidemic-Metformin 850 mg Twice Daily or Teneligliptin 20 mg once Daily and Metformin 500 mg Twice Daily Combination
Abstract:
Background: The global scenario of Diabetes Mellitus is worsening every day irrespective of so many positive moves to mitigate it by WHO guided Health awareness programs and treatment protocols. Even now health professionals are engaged in managing its complications rather than treatment as such. A major portion of sufferers of this deadly disease need attention to reduce the sequelae of insulin insensitivity or insulin resistance like dysfunction in lipid, carbohydrate, and protein metabolism. To achieve the same, it is unavoidable to increase the pill count. Most of the drugs can’t be boxed into fixed-dose combinations. Choosing a drug with a pleiotropic effect for a disease is the need of the hour. Both study drugs are known for their pleiotropic effects. The study drug used is metformin higher dose of 850 mg twice daily against teneligliptin (DPP4 Inhibitor) 20 mg once daily with metformin 500mg twice daily combination. This study was conducted to find which antidiabetic can better act as hypolipidemic as well. Method: The study tenure was from May 2020 – October 2020, a total of 6 months. Overall, one hundred and sixty patients were assessed; among them hundred members were selected and ninety-one completed the study. The members were included as per the inclusion criteria. Research significance: This study aims to explore the synergistic effects of combining Teneligliptin 20 mg once daily with Metformin 500 mg twice daily on lipid profile improvement in patients with Type 2 Diabetes Mellitus (T2DM). While Metformin is a well-established first-line treatment, its efficacy at higher doses may come with increased side effects. By integrating Teneligliptin, a DPP-4 inhibitor, with Metformin at a moderate dose, we hypothesize that this combination will not only provide effective glycemic control but also offer superior lipid profile management. The findings could suggest a more effective and safer therapeutic strategy, reducing the need for higher Metformin doses and minimizing associated risks. Therefore, the combination of Teneligliptin with Metformin is a promising therapeutic approach for T2DM management.
An Ephemeral Evaluation Study to Find Which Antidiabetic Can be a Better Hypolipidemic-Metformin 850 mg Twice Daily or Teneligliptin 20 mg once Daily and Metformin 500 mg Twice Daily Combination
References:
[1]. Saeedi, P., Peterson, I., Salpea, P., et al. 2019, Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045, Results from the International Diabetes Federation Diabetes Atlas. Diabetes Research and Clinical Practice, 157, 107843. https://doi.org/10.1016/j.diabres.2019.107843
[2]. Leon, B. M., & Maddox, T. M. 2015, Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations, and future research. World Journal of Diabetes, 6(13), 1246–1258. https://doi.org/10.4239/wjd.v6.i13.1246
[3]. Polonsky, W. H., & Henry, R. R. 2016, Poor medication adherence in type 2 diabetes: Recognizing the scope of the problem and its key contributors. Patient Preference and Adherence, 10, 1299–1307. https://doi.org/10.2147/PPA.S106821
[4]. Ranjbar, T., Nekooeian, A. A., Tanideh, N., et al. 2020, A comparison of the effects of Stevia extract and metformin on metabolic syndrome indices in rats fed with a high-fat, high-sucrose diet. Journal of Food Biochemistry, 44(8), e13242. https://doi.org/10.1111/jfbc.13242
[5]. Agarwal, P., Jindal, C., & Sapakal, V. 2018, Efficacy and safety of teneligliptin in Indian patients with inadequately controlled type 2 diabetes mellitus: A randomized, double-blind study. Indian Journal of Endocrinology and Metabolism, 22(1), 41-46. https://doi.org/10.4103/ijem.IJEM_147_17
[6]. Ji, L., Ma, J., Lu, W., Liu, J., Zeng, J. E., Yang, J., Li, W., Zhang, X., Xiao, X., Takayanagi, G., & Wang, Y. 2021, Phase III, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of teneligliptin monotherapy in Chinese patients with type 2 diabetes mellitus inadequately controlled with diet and exercise. Journal of Diabetes Investigation, 12(4), 537-545. https://doi.org/10.1111/jdi.13418
[7]. Panchal, J. S., & Panchal, M. R. 2018, Effect of teneligliptin and metformin on glycemic control and weight in patients with type 2 diabetes: A retrospective study. Journal of Clinical and Diagnostic Research, 12(1), OC07-OC10. https://doi.org/10.7860/JCDR/2018/28002.11043
[8]. Pryor, R., & Cabreiro, F. 2015, Repurposing metformin: An old drug with new tricks in its binding pockets. Biochemical Journal, 471(3), 307–322. https://doi.org/10.1042/BJ20150618
[9]. Nauck, M. A., & Meier, J. J. 2018, Incretin hormones: Their role in health and disease. Diabetes, Obesity and Metabolism, 20(S1), 5-21. https://doi.org/10.1111/dom.13129
[10]. Holst, J. J., & Gromada, J. 2004, Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans. American Journal of Physiology-Endocrinology and Metabolism, 287(2), E199-E206. https://doi.org/10.1152/ajpendo.00002.2004
[11]. Drucker, D. J. 2006, The biology of incretin hormones. Cell Metabolism, 3(3), 153-165. https://doi.org/10.1016/j.cmet.2006.01.004
[12]. Deacon, C. F. 2004, Therapeutic strategies based on glucagon-like peptide 1. Diabetes, 53(1), 2181-2189. https://doi.org/10.2337/diabetes.53.9.2181
[13]. Flint, A., Raben, A., Astrup, A., & Holst, J. J. 1998, Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. Journal of Clinical Investigation, 101(3), 515-520. https://doi.org/10.1172/JCI990
[14]. Yip, R. G., & Wolfe, M. M. 2000, GIP biology and fat metabolism. Life Sciences, 66(2), 91-103. https://doi.org/10.1016/S0024-3205(99)00543-2
[15]. Meier, J. J., & Nauck, M. A. 2010, GIP as a potential therapeutic agent? Hormone and Metabolic Research, 42(10), 791-795. https://doi.org/10.1055/s-0030-1262893
[16]. Drucker, D. J., & Nauck, M. A. 2006, The incretin system: Glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. The Lancet, 368(9548), 1696-1705. https://doi.org/10.1016/S0140-6736(06)69705-5
[17]. Bailey, C. J., & Turner, R. C. 1996, Metformin. New England Journal of Medicine, 334(9), 574-579. https://doi.org/10.1056/NEJM199602293340906
[18]. Wulffelé, M. G., Kooy, A., de Zeeuw, D., Stehouwer, C. D. A., & Gansevoort, R. T. 2004, The effect of metformin on blood pressure, plasma cholesterol, and triglycerides in type 2 diabetes mellitus: A systematic review. Journal of Clinical Pharmacology, 57(6), 859-866. https://doi.org/10.1046/j.1365-2125.2004.02078.x
[19]. Goda, M., & Kadowaki, T. 2013, Teneligliptin for the treatment of type 2 diabetes. Clinical Pharmacokinetics, 52(9), 741-754. https://doi.org/10.1007/s40262-013-0073-9
[20]. Morishita, R., & Nakagami, H. 2015, Teneligliptin: Expectations for its pleiotropic action. Expert Opinion on Pharmacotherapy, 16(3), 417-426. https://doi.org/10.1517/14656566.2015.995617
[21]. Mulvihill, E. E., & Drucker, D. J. 2014, Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors. Endocrine Reviews, 35(6), 992-1019. https://doi.org/10.1210/er.2014-1035
[22]. Ahren, B. 2011, DPP-4 inhibition and the path to clinical proof. Frontiers in Endocrinology, 2, 22. https://doi.org/10.3389/fendo.2011.00022
[23]. Lin, S. H., Cheng, P. C., Te Tu, S., et al. 2018, Effect of metformin monotherapy on serum lipid profile in statin-naïve individuals with newly diagnosed type 2 diabetes mellitus: A cohort study. PeerJ, 6, e4578. https://doi.org/10.7717/peerj.4578
[24]. He, L. 2020, Metformin and systemic metabolism. Trends in Pharmacological Sciences, 41(11), 868–881. https://doi.org/10.1016/j.tips.2020.09.008
[25]. Gillani, S. W., Ghayedi, N., Roosta, P., et al. 2021, Effect of metformin on lipid profiles of type 2 diabetes mellitus: A meta-analysis of randomized controlled trials. Journal of Pharmacy and Bioallied Sciences, 13(1), 76–82. https://doi.org/10.4103/jpbs.JPBS_113_20
[26]. Tarry-Adkins, J. L., Grant, I. D., Ozanne, S. E., et al. 2021, Efficacy and side effect profile of different formulations of metformin: A systematic review and meta-analysis. Diabetes Therapy, 12(7), 1901–1914. https://doi.org/10.1007/s13300-021-01122-3
[27]. Fisman, E. Z., & Tenenbaum, A. 2015, Antidiabetic treatment with gliptins: Focus on cardiovascular effects and outcomes. Cardiovascular Diabetology, 14(1), 129. https://doi.org/10.1186/s12933-015-0273-5
[28]. Batta Raghuveer, & Nama, N. 2020, Efficacy of teneligliptin with metformin in Type 2 diabetes mellitus patients. National Journal of Physiology, Pharmacy and Pharmacology, 10(8), 1–4. https://doi.org/10.5455/njppp.2020.10.042302020080520
[29]. Ferreira, M. A., Gomes, A. P., de Moraes, A. P., et al. 2017, Green tea extract outperforms metformin in lipid profile and glycaemic control in overweight women: A double-blind, placebo-controlled, randomized trial. Clinical Nutrition ESPEN, 22, 1–6. https://doi.org/10.1016/j.clnesp.2017.10.008
[30]. Morishita, R., & Nakagami, H. 2015, Teneligliptin: Expectations for its pleiotropic action. Expert Opinion on Pharmacotherapy, 16(3), 417–426. https://doi.org/10.1517/14656566.2015.1008527
Viewed PDF 5 0 -
Evaluation of Pterygoid Hamulus Dimensions in Completely Edentulous Patients Using Cone Beam Computed TomographyAuthor: Dhanraj GanapathyDOI: 10.21522/TIJPH.2013.12.04.Art033
Evaluation of Pterygoid Hamulus Dimensions in Completely Edentulous Patients Using Cone Beam Computed Tomography
Abstract:
The inferior border of the medial pterygoid plate extends to form the pterygoid hamulus (PH). The PH's length and location are crucial for these functions. The PH’s morphology helps in interpreting the imaging and also provides information regarding anatomical determinants to limit the posterolateral borders of maxillary complete dentures. This can also aid in gender identification in forensic situations. This study analyzed 80 CBCT scans from 40 male and 40 female patients (ages 25–67, median 38). Significant differences were found in pterygoid hamulus length between sexes: males had longer hamuli on both the right (8.840±0.299 mm vs. 7.940±0.349 mm, P=0.000) and left sides (7.899±0.419 mm vs. 7.277±0.271 mm, P=0.002). However, no significant differences in hamulus width were observed between males and females. These findings suggest length variations could be useful in clinical and anthropological contexts. Dimensions of pterygoid hamulus in completely edentulous patients will aid the clinician in precisely recording the posterolateral borders of maxillary dentures; this can also aid in gender determination in fragmented skulls in forensic applications.
Evaluation of Pterygoid Hamulus Dimensions in Completely Edentulous Patients Using Cone Beam Computed Tomography
References:
[1]. Putz, R., & Kroyer, A., 1999, Functional morphology of the pterygoid hamulus. Annals of Anatomy, 181(1), 85–88.
[2]. Orhan, K., Sakul, B. U., Oz, U., & Bilecenoglu, B., 2011, Evaluation of the pterygoid hamulus morphology using cone beam computed tomography. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, 112(2), e48–55.
[3]. Motiwala, I. A., & Bathina, T., 2022, A radiographic study on pterygoid implants with hamulus as a landmark for engaging the pterygoid plate - A retrospective study. Annals of Maxillofacial Surgery, 12(2), 190.
[4]. Ahmed Khan, H. L., Murthykumar, K., Sekaran, S., & Ganapathy, D., 2023, Digital panoramic radiographs for age prediction utilizing the Tooth Coronal Index of first mandibular bicuspids among the south Indian population. Cureus, 15(9), e45870.
[5]. Devi, V. A., Sivakumar, N., & Ganapathy, D., 2021, Location of greater palatine foramen in dry human skulls. International Journal of Dentistry and Oral Science, 8(1), 1419–1421.
[6]. Kumar, A. S., Ganapathy, D., & Duraisamy, R., 2022, Awareness on mastoid implants among dental students. Journal of Pharmacy & Negative Results, 13(10), 461–466.
[7]. Kende, P., Aggarwal, N., Meshram, V., Landge, J., Nimma, V., Mathai, P., 2019, The pterygoid hamulus syndrome–An important differential in orofacial pain. Contemporary Clinical Dentistry, 1;10(3), 571-6.
[8]. Oz, U., Orhan, K., Aksoy, S., Ciftci, F., Özdoğanoğlu, T., & Rasmussen, F., 2016, Association between pterygoid hamulus length and apnea hypopnea index in patients with obstructive sleep apnea: A combined three-dimensional cone beam computed tomography and polysomnographic study. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, 121(3), 330–339.
[9]. Bindhoo, Y. A., Thirumurthy, V. R., Jacob, S. J., Anjanakurien, F. N. U., & Limson, K. S., 2011, Posterior palatal seal: A literature review. International Journal of Prosthodontics and Restorative Dentistry, 1(2), 108–114.
[10]. Silverman, S. I., 1971, Dimensions and displacement patterns of the posterior palatal seal. Journal of Prosthetic Dentistry, 25(5), 470–488.
[11]. Winland, R. D., & Young, J. M., 1973, Maxillary complete denture posterior palatal seal: Variations in size, shape, and location. Journal of Prosthetic Dentistry, 29(3), 256–261.
[12]. Mehra, A., Karjodkar, F. R., Sansare, K., Kapoor, R., Tambawala, S., & Saxena, V. S., 2021, Assessment of the dimensions of the pterygoid hamulus for establishing age- and sex-specific reference standards using cone-beam computed tomography. Imaging Science in Dentistry, 51(1), 49–54.
[13]. Romoozi, E., Razavi, S. H., Barouti, P., & Rahimi, M., 2018, Investigating the morphologic indices of the hamulus pterygoid process using the CBCT technique. Journal of Research in Medical and Dental Science, 6(2), 240–244.
[14]. Kachhara, S., Nallaswamy, D., Ganapathy, D., & Ariga, P., 2021, Comparison of the CBCT, CT, 3D printing, and CAD-CAM milling options for the most accurate root form duplication required for the root analogue implant (RAI) protocol. Journal of the Indian Academy of Oral Medicine and Radiology, 33(2), 141–145.
[15]. Prakash, M. S., Ganapathy, D. M., & Nesappan, T., 2019, Assessment of labial alveolar bone thickness in maxillary central incisor and canine in Indian population using cone-beam computed tomography. Drug Invention Today, 11(3).
[16]. Mahipathy, S. R., Jesudasan, J. S., V. S. A. C., Durairaj, A. R., & Ananthappan, M., 2023, Misplaced pterygoid implant removed following surgical exploration. Journal of Evolution of Medical and Dental Sciences, 12(24), 205–207.
[17]. Shivanni, S. S., & Babu, K. Y., 2016, An anatomical study of occurrence of pterygospinous bar in Indian skulls. Research Journal of Pharmacy and Technology, 9(8), 1166–1168.
[18]. Navaneethan, A., & Varghese, R., 2021, Comparison between antegonial notch depth, symphysis morphology, and ramus morphology among different growth patterns in skeletal Class I and Class II subjects. International Journal of Dentistry and Oral Science, 8(1), 1510–1517.
[19]. Chithralekha, B., Duraisamy, R., Ganapathy, D. M., Maiti, S., 2022, Awareness on Pterygoid Implant Among Dental Undergraduates. Journal for Educators, Teachers and Trainers, 13(6). 423-430. DOI: [10.47750/jett.2022.13.06.040]
[20]. Orhan, K., Sakul, B. U. Oz. U., Bilecenoglu, B.,2011, Evaluation of the pterygoid hamulus morphology using cone beam computed tomography. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 1;112(2), e48-55
Viewed PDF 5 0 -
Unveiling the Therapeutic Potential: Antidiabetic Activity of Nelumbo nuciferaAuthor: Soujania Singh. GDOI: 10.21522/TIJPH.2013.12.04.Art034
Unveiling the Therapeutic Potential: Antidiabetic Activity of Nelumbo nucifera
Abstract:
The escalating prevalence of diabetes mellitus on a global scale has spurred an urgent need for innovative and effective therapeutic interventions, Nelumbo nucifera, commonly known as the sacred lotus, has been revered for centuries in various cultures for its symbolic significance and aesthetic appeal. Beyond its cultural importance, various parts of the Nelumbo nucifera plant, including its seeds, leaves, and rhizomes, are rich repositories of bioactive compounds. These compounds, ranging from alkaloids and flavonoids to polysaccharides, exhibit diverse pharmacological activities and its been a subject of interest for researchers due to their rich phytochemical composition. Among its various bioactive properties, the alpha-glucosidase and amylase inhibition capabilities stand out for their potential in managing diabetes mellitus. These enzymes play crucial roles in carbohydrate metabolism, and their inhibition can effectively control postprandial hyperglycemia, a critical aspect of diabetes management This study is done using different concentrations of samples and standard drugs showing amylase and alpha-glucosidase inhibition properties and analysed and calculated using percentage inhibition formula and it showed the percentage of alpha amylase inhibition by standard concentration 400ug is 53.3 % and sample 500ug is 50%, The percentage inhibition of concentration alpha glucosidase inhibition for standard concentration 400ug is 72.2% and sample 500ug is 71.4%. The study concluded that Nelumbo nucifera possesses both alpha-glucosidase and amylase inhibition properties and is a good natural source of remedy for diabetes, that can be combined with other drugs.
Unveiling the Therapeutic Potential: Antidiabetic Activity of Nelumbo nucifera
References:
[1]. Kim, M. K., Lee, J. M., Kim, N. Y., Shin, J. H., & Lee, M. Y. 2016, Antidiabetic effect of Nelumbo nucifera leaf ethanol extract in high-fat diet/streptozotocin-induced diabetic rats. Journal of Ethnopharmacology, 178, 217-224. https://doi.org/10.1016/j.jep.2015.12.038
[2]. Wang, Q., Ge, X., Tian, X., Zhang, Y., Zhang, J., & Zhang, P. 2017, Flavonoids from lotus (Nelumbo nucifera) seed embryo and their antioxidant and alpha-glucosidase inhibitory activities. Journal of Agricultural and Food Chemistry, 65(43), 9489-9495. https://doi.org/10.1021/acs.jafc.7b04508
[3]. Davis, R. J., & Jones, R. E. 2018, Antioxidant and antidiabetic properties of Nelumbo nucifera extracts. Phytotherapy Research, 32(9), 1770-1777. https://doi.org/10.1002/ptr.6068
[4]. Gao, J., Xu, P., Wang, Y., Wang, Y., & Hochstetter, D. 2020, Combined effects of three polyphenols from Nelumbo nucifera on inhibition of alpha-glucosidase: Enzyme kinetics and interaction mechanism. International Journal of Biological Macromolecules, 165(Pt B), 3096-3104. https://doi.org/10.1016/j.ijbiomac.2020.09.183
[5]. Miller, M. L., & Thompson, L. A. 2020, Comparative study of Nelumbo nucifera and other natural extracts for managing type 2 diabetes. Journal of Natural Products, 83(1), 112-119. https://doi.org/10.1021/acs.jnatprod.9b00872
[6]. Yeo, J., & Kang, Y. J. 2016, The anti-diabetic effects of Nelumbo nucifera leaves in vitro and in vivo. Food and Chemical Toxicology, 91, 38-45. https://doi.org/10.1016/j.fct.2016.02.008
[7]. Wu, T., Qi, X., Liu, Y., Guo, J., Zhu, R., Chen, W., … & Liu, Y. 2019, Dietary supplementation with Nelumbo nucifera Gaertn. leaves alleviates insulin resistance and hepatic steatosis in high-fat diet-induced obese mice. Nutrition & Metabolism, 16, 85. https://doi.org/10.1186/s12986-019-0415-8
[8]. Gupta, M., & Kaur, G. 2019, Application of lotus (Nelumbo nucifera) in antidiabetic and anticancer therapy: Current perspectives and future prospects. Journal of Food Biochemistry, 43(10). https://doi.org/10.1111/jfbc.12841
[9]. Jung, H. A., Hwang, G. S., Yu, H., Kim, Y. M., & Kim, J. 2017, Evaluation of antidiabetic therapeutic potential of flavonoids from the leaves of Nelumbo nucifera. Molecules, 22(10), 1885. https://doi.org/10.3390/molecules22101885
[10]. Zhang, L., Tu, Z., Yuan, T., Wang, H., & Tan, T. 2017, Inhibitory effects of flavonoids-rich extracts from the lotus (Nelumbo nucifera Gaertn.) leaf on alpha-glucosidase in diabetic rats. Journal of Functional Foods, 29, 267-275. https://doi.org/10.1016/j.jff.2016.12.014
[11]. Chen, H., Zhou, Y., Shao, H., & Ma, Q. 2015, Evaluation of the antidiabetic potential of Nelumbo nucifera seeds in streptozotocin-induced diabetic rats. Journal of Ethnopharmacology, 174, 326-334. https://doi.org/10.1016/j.jep.2015.07.034
[12]. Jiang, Y., Wang, X., Xie, Z., Huang, Y., & Zhu, S. 2016, Antidiabetic effects of Nelumbo nucifera leaves ethanol extract in high fat diet/streptozotocin-induced diabetic rats. Journal of Ethnopharmacology, 181, 50-58. https://doi.org/10.1016/j.jep.2016.01.046
[13]. Cao, J., Zhang, Z., Huang, Y., & Chen, Y. 2020, Mechanistic insights into the synergistic inhibition of alpha-glucosidase by flavonoid compounds from Nelumbo nucifera Gaertn. leaves. Food Chemistry, 325, 126848. https://doi.org/10.1016/j.foodchem.2020.126848
[14]. Peng, C. H., Liu, L. K., Chuang, C. M., Chyau, C. C., Huang, C. N., & Wang, C. J. 2013, Effect of ethanolic extract of Nelumbo nucifera on high fat diet-induced metabolic disorders in C57BL/6 mice. Journal of Agricultural and Food Chemistry, 61(33), 8027-8033. https://doi.org/10.1021/jf401546h
[15]. Smith, J. E., & Williams, L. A. 2017, Effects of Nelumbo nucifera on insulin resistance and glucose metabolism in animal models. Nutrition Research, 37(5), 354-363. https://doi.org/10.1016/j.nutres.2017.02.005
[16]. Kim, A. R., Kim, J. H., Lee, H. M., Choi, Y. H., & Kim, Y. O. 2014, Antidiabetic effects of the leaf and root extracts of Nelumbo nucifera on insulin-stimulated glucose uptake in skeletal muscle cells. Bioscience, Biotechnology, and Biochemistry, 78(10), 1665-1669. https://doi.org/10.1080/09168451.2014.931505
[17]. Jung, H. A., Kim, J. E., Chung, H. Y., & Choi, J. S. 2003, Antioxidant principles of Nelumbo nucifera stamens. Archives of Pharmacal Research, 26(4), 279-285. https://doi.org/10.1007/BF02980358
[18]. Li, M., Yu, Q., Shen, W., Liu, Z., & Hu, X. 2016, Anti-diabetic, and anti-obesity effects of resveratrol on high-fat diet-induced diabetic mice. International Journal of Molecular Sciences, 17(7), 1115. https://doi.org/10.3390/ijms17071115
[19]. Lee, J. H., Lee, S. H., Kang, H. G., & Lee, S. H. 2014, Protective effect of Nelumbo nucifera leaves on high-fat diet-induced obesity in mice. Journal of Medicinal Food, 17(4), 382-389. https://doi.org/10.1089/jmf.2013.0086
[20]. Kunanusorn, P., Panthong, A., Pittayanurak. P., Wanauppathamkul, S., Nathasaen, N., Reutrakul, V., Acute and subchronic oral toxicity studies of Nelumbo nucifera stamens extract in rats. J Ethnopharmacology. 2011, Apr 12; 134(3), 789-95. doi: 10.1016/j.jep.2011.01.031.
[21]. Johnson, K., & Chen, T. 2015, The antidiabetic effects of Nelumbo nucifera leaf extract: A systematic review. Journal of Alternative and Complementary Medicine, 21(4), 222-229. https://doi.org/10.1089/acm.2014.0291
[22]. Choi, Y. J., Kim, J. Y., Lee, J. K., & Kim, H. K. 2018, Nelumbo nucifera leaf extract enhances insulin sensitivity and improves glucose metabolism in type 2 diabetic mice. Phytomedicine, 50, 142-148. https://doi.org/10.1016/j.phymed.2018.10.016
[23]. Harris, R., & Cooper, R. 2018, Nelumbo nucifera and its potential therapeutic effects in diabetes management: Insights from recent studies. Journal of Diabetes Research, 2018, 8314237. https://doi.org/10.1155/2018/8314237
Viewed PDF 5 0 -
Perceptions and Reasons for Dissatisfaction with PMTCT Services among Women Living with HIV during the PMTCT Scale-up in Akwa-Ibom, NigeriaAuthor: Dolapo T. OgundehinDOI: 10.21522/TIJPH.2013.12.04.Art035
Perceptions and Reasons for Dissatisfaction with PMTCT Services among Women Living with HIV during the PMTCT Scale-up in Akwa-Ibom, Nigeria
Abstract:
This study assessed perceptions and satisfaction with PMTCT services, and reasons for dissatisfaction among women living with HIV who received PMTCT services in Akwa Ibom State, Nigeria. Data for this cross-sectional study was collected using a validated questionnaire from women living with HIV who were at least two months post-partum between January – March 2023 and had received PMTCT services during the PMTCT scale-up period (January 2022 – December 2022) across 13 health facilities in Akwa Ibom, Nigeria. Client perception and satisfaction were assessed based on the Mosadeghrad framework for quality of care. Women with satisfaction scores ≥ the cut-off were classified as “satisfied,” otherwise “not satisfied”. Logistic regression analysis determined differences in satisfaction, at p-value ≤0.05. A total of 631 women living with HIV participated: 435 (69%) were 25-34 years old, 524 (83%) were married, 59% resided in rural areas and 414 (66%) received their first antenatal care at a health facility. Participants had the lowest perception regarding their ability to access PMTCT services at any day and time, with only 74% responding affirmatively. Conversely, 99% of participants responded that their care providers listened to their concerns and provided adequate information in a friendly manner. Overall, 71.5% (450/629) of participants were satisfied with the PMTCT services. The main reasons for dissatisfaction were the proximity of services, staff attitude and professionalism and providers' knowledge and skills. By addressing these, the PMTCT program can meet the needs of women living with HIV, ultimately contributing to better health outcomes and a reduction in mother-to-child transmission rates.
Perceptions and Reasons for Dissatisfaction with PMTCT Services among Women Living with HIV during the PMTCT Scale-up in Akwa-Ibom, Nigeria
References:
[1]. Joint United Nations Programme on HIV/AIDS. 2024, Transforming Vision into Reality: The 2024, Global Alliance Progress Report on Ending AIDS in Children by 2030, Geneva: Licence: CC BY-NC-SA 3.0 IGO. Retrieved from https://www.childrenandaids.org/sites/default/files/2024-07/transforming-vision-into-reality_en.pdf
[2]. Joint United Nations Programme on HIV/AIDS. July 2024, Fast-Track Commitments to End AIDS by 2030. Retrieved from https://www.unaids.org/sites/default/files/media_asset/fast-track-commitments_en.pdf.
[3]. Joint United Nations Programme on HIV/AIDS. (2024). Global and regional trends. Retrieved from https://data.unicef.org/topic/hivaids/global-regional-trends/.
[4]. Federal Ministry of Health Nigeria. 2020, National Guidelines for HIV Prevention, Treatment and Care. Retrieved from https://nascp.gov.ng/resources/get_resource_doc/31.
[5]. Mathewson, T. 2023, March 17. Maternal mortality remains a major challenge in Sub-Saharan Africa. Vox. Retrieved from https://www.vox.com/future-perfect/2023/3/17/23641598/maternal-mortality-pregnancy-sub-saharan-africa-who-cdc-report-womens-health.
[6]. Joint United Nations Programme on HIV/AIDS. 2019, Data 2019, Retrieved from https://www.unaids.org/sites/default/files/media_asset/2019-UNAIDS-data_en.pdf.
[7]. Joint United Nations Programme on HIV/AIDS. 2020, Country Report. Retrieved from https://www.unaids.org/sites/default/files/media_asset/2020_aids-data-book_en.pdf
[8]. Oyefabi, A., Ameh, N., & Aliyu, A. 2018, Awareness and Utilization: Prevention of Mother-to-Child Transmission (PMTCT) Services among Primigravid Women attending Primary Health Care Facilities in Zaria, North-Western Nigeria. West African Journal of Medicine, 35(3), 144–152. Retrieved from https://pubmed.ncbi.nlm.nih.gov/30387085/
[9]. Ntoimo, L. F. C., Okonofua, F. E., Ekwo, C., Solanke, T. O., Igboin, B., Imongan, W., & Yaya, S. 2022, Why women utilize traditional rather than skilled birth attendants for maternity care in rural Nigeria: Implications for policies and programs. Midwifery, 104, 103158. Retrieved from https://doi.org/10.1016/j.midw.2021.103158
[10]. Teasdale, C. A., Geller, A., Shongwe, S., Mafukidze, A., Choy, M., Magaula, B., Yuengling, K., King, K., De Gusmao, E. P., Ryan, C., Ao, T., Callahan, T., Modi, S., & Abrams, E. J. 2021, Patient feedback surveys among pregnant women in Eswatini to improve antenatal care retention. PloS One, 16(3), e0248685. Retrieved from https://doi.org/10.1371/journal.pone.0248685
[11]. UNICEF. 2022, Progress in reducing new HIV infections among children has stagnated in recent years. Retrieved from https://data.unicef.org/topic/hivaids/emtct/.
[12]. Sasse, S. A., Harrington, B. J., DiPrete, B. L., Chagomerana, M. B., Klyn, L. L., Wallie, S. D., & S4 Study. 2022, Factors associated with a history of treatment interruption among pregnant women living with HIV in Malawi: A cross-sectional study. PloS One, 17(4), e0267085. Retrieved from https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0267085
[13]. Mpinganjira, S., Tchereni, T., Gunda, A., & Mwapasa, V. 2020, Factors associated with loss-to-follow-up of HIV-positive mothers and their infants enrolled in HIV care clinic: a qualitative study. BMC Public Health, 20, 1-10. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060526/
[14]. Leon, C., Koosed, T., Philibert, B., Raposo, C., & Benzaken, A. S. 2019, HIV/AIDS health services in Manaus, Brazil: patient perception of quality and its influence on adherence to antiretroviral treatment. BMC health services research, 19(1), 344. https://doi.org/10.1186/s12913-019-4062-9
[15]. Yakasai, H. B., & Yakasai, B. A. 2022, Socio-ecological predictors of HIV testing in women of childbearing age in Nigeria. The Pan African Medical Journal, 41, 162. https://doi.org/10.11604/pamj.2022.41.162.30345
[16]. PEPFAR. April 28, 2022, Nigeria Country Operational Plan (COP) 2022, Strategic Direction Summary. Retrieved from https://www.state.gov/wp-content/uploads/2022/09/Nigeria-COP22-SDS.pdf.
[17]. National AIDS/STI Control Programme (NASCP). 2024, Sustaining HIV Program and Epidemic Control in Nigeria through Equitable Service Delivery, AIDS 2024 Presentation; Future directions: Achieving UNAIDS 95-95-95 targets for adults and children in PEPFAR-supported high-burden HIV countries. Retrieved from National AIDS and STDs Control Programme (nascp.gov.ng)
[18]. Xuan, X., Li, Z., Chen, X., Cao, Y., & Feng, Z. 2021, Study of the Physical Environment of Waiting Areas and Its Effects on Patient Satisfaction, Experience, Perceived Waiting Time, and Behavior in China. HERD: Health Environments Research & Design Journal, 14(3), 108-123. Retrieved from https://doi.org/10.1177/1937586721989058.
[19]. Abayneh, K., Mengistie, B., Oljira, L., & Tiruye, G. 2020, Clients' Satisfaction with Services for Prevention of Mother-to-Child Transmission of HIV in Public Health Facilities in Diredawa City, Eastern Ethiopia. HIV/AIDS (Auckland, N.Z.), 12, 611–620. Retrieved from https://doi.org/10.2147/HIV.S264854
[20]. George, L. U., Oku, A. O., Asibong, I. U., Ibitham, D. A., & Idem, N. I. 2022, Client satisfaction with antenatal care among clinic attendees in a tertiary health institution in Calabar, Cross River State, Nigeria. African Journal of Reproductive Health, 26(8), 20–29. Retrieved from https://doi.org/10.29063/ajrh2022/v26i8.3
[21]. Collins E. M., Ehigha J. E., and Maryjane I. O. 2020, “Women’s Perception and Satisfaction With the Quality of Antenatal Care Services in Mission Hospitals in Benin City, Nigeria”. Pyramid Journal of Medicine 3 (1), Retrieved from https://africa.pagepress.net/pjm/article/view/82
[22]. Population.City 2021, Retrieved from http://population.city/nigeria/adm/akwa-ibom/
[23]. Federal Ministry of Health, Nigeria 2019, Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS) 2018, Technical Report. Abuja, Nigeria. Retrieved from https://www.naiis.ng/resource/factsheet/NAIIS%20PA%20NATIONAL%20FACTSHEET%20FINAL.pdf
[24]. Akwa Ibom State Ministry of Health, FHI 360 and UNAIDS. 2013, Operational Plan for the Elimination of Mother-to-Child Transmission of HIV, Nigeria: Akwa Ibom State Ministry of Health FHI 360 and UNAIDS. Retrieved from https://www.fhi360.org/wp-content/uploads/drupal/documents/Akwa%20State%20Op%20Plan.pdf
[25]. Federal Ministry of Health. Second National Strategic Health Development Plan (NSHDP II) 2018-2022, Ensuring healthy lives, promoting the health of all Nigerians. 2018, Retrieved from https://extranet.who.int/countryplanningcycles/planning-cycle-files/second-national-strategic-health-development-plan-2018-2022
[26]. Nwanja, E., Akpan, U., Toyo, O., Nwaokoro, P., Badru, T., Gana, B., Nwanja, I., Ayabi, O., Ayeni, B., Xavier, E., Idemudia, A., Sanwo, O., Khamofu, H., & Bateganya, M. 2023, Improving access to HIV testing for pregnant women in community birth centres in Nigeria: an evaluation of the Prevention of Mother-to-Child Transmission program. Therapeutic advances in infectious disease, 10, 20499361231172088. Retrieved from https://pubmed.ncbi.nlm.nih.gov/37152184/
[27]. Mosadeghrad, A. 2012, A Conceptual Framework for Quality of Care. Materia socio-medica. 24. 251-61. 10.5455/msm.2012.24.251-261. Retrieved from https://pubmed.ncbi.nlm.nih.gov/23922534/
[28]. Merga, H., Woldemichael, K., Dube, L. 2016, Utilization of prevention of mother-to-child transmission of HIV services and associated factors among antenatal care attending mothers in Sebeta Town, Central Ethiopia. Adv Public Health; 2016:1–10. doi: 10.1155/2016/6250898. Retrieved from https://pubmed.ncbi.nlm.nih.gov/30428835/
[29]. Bayou, N. and Tsehay, Y. 2015, Quality of PMTCT Services in Gebretsadiq Shawo Memorial Hospital, Kafa Zone, South West Ethiopia: A Descriptive Study. Open Access Library Journal, 2, 1-12. doi: 10.4236/oalib.1101499. Retrieved from https://www.researchgate.net/publication/276440992_Quality_of_PMTCT_Services_in_Gebretsadiq_Shawo_Memorial_Hospital_Kafa_Zone_South_West_Ethiopia_A_Descriptive_Study
[30]. Naburi, H., Mujinja, P., Kilewo, C., Bärnighausen, T., Orsini, N., Manji, K., Biberfeld, G., Sando, D., Geldsetzer, P., Chalamila, G., & Ekström, A. M. 2016, Predictors of Patient Dissatisfaction with Services for Prevention of Mother-To-Child Transmission of HIV in Dar es Salaam, Tanzania. PloS One, 11(10), e0165121. Retrieved from https://doi.org/10.1371/journal.pone.0165121.
[31]. Idiong, H. M., Ekanem, A. M., Nwanja, E., Idiong, P. E., & Udofia, E. A. 2023, Awareness and Knowledge of HIV in the Workplace Policy Among Employees, Employers, and Decision-makers in Akwa Ibom State, Nigeria. Texila International Journal of Public Health, 12(1).
[32]. Oke, O.O., Akinboro, A.O., Olanrewaju, F.O., Oke, O.A., Omololu, A.S. Assessment of HIV-related stigma and determinants among people living with HIV/AIDS in Abeokuta, Nigeria: A cross-sectional study. SAGE Open Medicine. 2019,7. doi:10.1177/2050312119869109. Retrieved from https://pubmed.ncbi.nlm.nih.gov/31448118/
[33]. Akafa, T. A., & Iseko, K. I. 2024, Factors Determining Satisfaction with Service Delivery at Family Medicine Clinics of a Tertiary Hospital in North Central Nigeria. Nigerian medical journal: Journal of the Nigeria Medical Association, 65(2), 132–141. Retrieved from https://doi.org/10.60787/nmj-v65i2-393
[34]. Olamuyiwa, T. E., & Adeniji, F. O. 2021, Patient's Satisfaction With Quality of Care at a National Health Insurance Clinic at a Tertiary Center, South-South Nigeria. Journal of patient experience, 8, 2374373520981471. Retrieved from https://doi.org/10.1177/2374373520981471
[35]. Ajah, L. O., Onu, F. A., Ogbuinya, O. C., Ajah, M. I., Ozumba, B. C., Agbata, A. T., Onoh, R. C., & Ekwedigwe, K. C. 2019, Choice of birth place among antenatal clinic attendees in rural mission hospitals in Ebonyi State, South-East Nigeria. PloS one, 14(11), e0211306. Retrieved from https://doi.org/10.1371/journal.pone.0211306
[36]. Manzoor, F., Wei, L., Hussain, A., Asif, M., & Shah, S. I. A. 2019, Patient Satisfaction with Health Care Services; An Application of Physician's Behavior as a Moderator. International journal of environmental research and public health, 16(18), 3318. Retrieved from https://doi.org/10.3390/ijerph16183318
[37]. Bako, I. A., Sasetu, S. I., Joshua, A. I., & Rimamnunra, G. N. 2022, Are clients satisfied with communication with health workers? A study among pregnant women attending primary health care centers in Nasarawa State, Nigeria. African journal of reproductive health, 26(6), 55–63. Retrieved from https://doi.org/10.29063/ajrh2022/v26i6.7
[38]. Balogun, S. A., Ubom, A. E., Adesunkanmi, A. O., Ugowe, O. J., Idowu, A. O., Mogaji, I. K., Nwigwe, N. C., Kolawole, O. J., Nwebo, E. E., Sanusi, A. A., Odedeyi, A. A., Ogunrinde, O. V., Adedayo, O. O., Ndegbu, C. U., Ojo, A. S., Anele, C. O., Ogunjide, O. E., Olasehinde, O., Awowole, I. O., Ijarotimi, O. A., … Komolafe, E. O. 2022, Nigerian resident doctors' work schedule: A national study. Nigerian journal of clinical practice, 25(4), 548–556. Retrieved from https://doi.org/10.4103/njcp.njcp_1901_21
[39]. Oladimeji, A., Adetunji L., Franklin E., Leslie O. 2016, Health Workforce for 2016-2030, Will Nigeria have enough? International Journal of Innovative Research & Growth. 4. 9-16. Retrieved from https://www.researchgate.net/publication/295902930_Health_Workforce_for_2016-2030_Will_Nigeria_have_enough
[40]. Mehmet, K., Serdar, D., Feyza, İ. and Ali, K. 2024, "The Effects of Workload Excess on Quality of Work Life in Third-Level Healthcare Workers: A Structural Equation Modeling Perspective" Healthcare 12, no. 6: 651. Retrieved from https://doi.org/10.3390/healthcare12060651
Viewed PDF 5 0 -
Study to Assess the Effect of Isometric Exercise on Body Mass Index and Perceived Stress among Adolescent GirlsAuthor: Ajith MDOI: 10.21522/TIJPH.2013.12.04.Art041
Study to Assess the Effect of Isometric Exercise on Body Mass Index and Perceived Stress among Adolescent Girls
Abstract:
Obesity is a serious public health concern in the Middle East and around the world, and in most Asian nations; its incidence is fast increasing. This paper reviews research on activity level differences in thin and obese persons, and basic research on energy balance, or intake/expenditure relationships. The study evaluates the impact of isometric exercise on adolescent girls on BMI and stress. Then convenience techniques were used to study the effects of isometric walking and jogging exercises for weight and fat loss. The selective effects of exercise for thin and heavy individuals, and the parametric effects of increased frequency or expenditure on weight loss. The anthropometric evaluation The World Health Organization stress scale was used to measure stress and determine the test's level of stress. The results showed that among the demographic variables of adolescent girls, age, gender, type of family, diet pattern, level of education, number of siblings, living area and usage of substances had a statistically significant association with the patient's level of BMI and stress at the p0.05 level. The study found that isometric exercises can promote relaxation and enhance mental focus, and their regular practice was linked to a meaningful reduction in perceived stress. It is advised that more studies be conducted to examine the long-term impacts of aerobic exercise on body mass index and stress levels, as well as to investigate how they might be integrated with other exercise forms for optimal health outcomes.
Study to Assess the Effect of Isometric Exercise on Body Mass Index and Perceived Stress among Adolescent Girls
References:
[1]. Mahmoud, W. S., Elnaggar, R. K., & Ahmed, A. S., 2017. Influence of isometric exercise training on quadriceps muscle architecture and strength in obese subjects with knee osteoarthritis. Int. J. Med. Res. Health Sci, 6, 1-9.
[2]. Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Mullany, E. C., & Gakidou, E., 2014, Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: A systematic analysis for the Global Burden of Disease Study 2013. The lancet.
[3]. Manson, J. E., Colditz, G. A., Stampfer, M. J., Willett, W. C., Rosner, B., Monson, R. R., & Hennekens, C. H., 1990. A prospective study of obesity and risk of coronary heart disease in women. New England Journal of Medicine, 322, 13, 882-889.
[4]. Armstrong, A., Jungbluth Rodriguez, K., Sabag, A., Mavros, Y., Parker, H. M., Keating, S. E., & Johnson, N. A., 2022, Effect of aerobic exercise on waist circumference in adults with overweight or obesity: A systematic review and meta‐analysis, Obesity Reviews, 23,8, e13446.
[5]. Epstein, L. H., & Wing, R. R. 1980, Aerobic exercise and weight. Addictive Behaviors, 5, 371-388.
[6]. Puterman, E., Prather, A. A., Epel, E. S., Loharuka, S., Adler, N. E., Laraia, B., & Tomiyama, A. J., 2016, Exercise mitigates cumulative associations between stress and BMI in girls age 10 to 19. Health Psychology, 35, 191.
[7]. Eddolls, W. T., McNarry, M. A., Lester, L., Winn, C. O., Stratton, G., & Mackintosh, K. A., 2018, The association between physical activity, fitness and body mass index on mental well-being and quality of life in adolescents. Quality of Life Research, 27, 2313-2320.
[8]. Uchôa, F. N., Lustosa, R. P., Andrade, J. C., da Costa Daniele, T., Deana, N. F., Aranha, Á. M., & Alves, N., 2019. Impact of physical activity on the Body Mass Index and self-esteem of adolescents, Motricidade, 15, 68-74.
[9]. Rabiei, L., Babaei Heydarabadi, A., Tavassoli, E., Abbasi, M., Khayeri, F., & Masoudi, R., 2018. Evaluation of the effect of physical activity programs on self-esteem and Body Mass Index of overweight adolescent girls, based on Health Belief Model with school-centered approach. Int J Pediatr, 6, 7103-16.
[10]. Rabiei, L., Babaei Heydarabadi, A., Tavassoli, E., Abbasi, M., Khayeri, F., & Masoudi, R., 2018. Evaluation of the effect of physical activity programs on self-esteem and Body Mass Index of overweight adolescent girls, based on Health Belief Model with school-centered approach. Int J Pediatr, 6, 7103-16.
[11]. Kangeswari, P., Murali, K., & Arulappan, J., 2021, Effectiveness of isometric exercise and counseling on level of pain among patients with knee osteoarthritis. SAGE Open Nursing, 7, 2377960821993515.
[12]. Seema, S., Rohilla, K. K., Kalyani, V. C., & Babbar, P. 2021., Prevalence and contributing factors for adolescent obesity in present era: Cross-sectional Study. Journal of Family Medicine and Primary Care, 10, 1890-1894.
[13]. Johnson, V. R., Cao, M., Czepiel, K. S., Mushannen, T., Nolen, L., & Stanford, F. C. 2020, Strategies in the management of adolescent obesity. Current Pediatrics Reports, 8, 56-65.
[14]. Pandurangi, R., Mummadi, M. K., Challa, S., Reddy, N. S., Kaliaperumal, V., Khadar Babu, C., & Hemalatha, R. 2022, Burden and predictors of malnutrition among Indian adolescents 10–19 years: Insights from Comprehensive National Nutrition Survey Data. Frontiers in Public Health, 10, 877073.
[15]. Singh, M., Rajoura, O. P., & Honnakamble, R. A., 2019, Menstrual patterns and problems in association with body mass index among adolescent school girls. Journal of Family Medicine and Primary Care 8, 2855-2858.
[16]. Bellizzi, S., Pichierri, G., Napodano, C. M. P., Salaris, P., Fiamma, M., Fozza, C., & Cegolon, L., 2021, Iron deficiency anaemia and low BMI among adolescent girls in India: The transition from 2005 to 2015. Public Health Nutrition, 24, 1577-1582.
[17]. Jha, R. K., Yadav, A. K., Shrestha, S., Shrestha, P. R., Shrestha, S., Jha, M., & Nepal, O. 2021, Study of body mass index among medical students of a medical college in Nepal: a descriptive cross-sectional study. JNMA: Journal of the Nepal Medical Association, 59, 280.
[18]. Baetge, C., Earnest, C. P., Lockard, B., Coletta, A. M., Galvan, E., Rasmussen, C., & Kreider, R. B., 2017, Efficacy of a randomized trial examining commercial weight loss programs and exercise on metabolic syndrome in overweight and obese women. Applied Physiology, Nutrition, and Metabolism, 42, 216-227.
[19]. Flegal, K. M., Kit, B. K., & Graubard, B. I., 2014, Body mass index categories in observational studies of weight and risk of death. American Journal of Epidemiology, 180, 288-296.
[20]. Edwards, C. H., Aas, E., & Kinge, J. M. 2019, Body mass index and lifetime healthcare utilization. BMC Health Services Research, 19, 1-10.
[21]. Fang, H., Berg, E., Cheng, X., & Shen, W 2018, How to best assess abdominal obesity. Current Opinion in Clinical Nutrition & Metabolic Care, 21, 360-36.
[22]. Haraguchi, N., Koyama, T., Kuriyama, N., Ozaki, E., Matsui, D., Watanabe, I., & Watanabe, Y., 2019, Assessment of anthropometric indices other than BMI to evaluate arterial stiffness. Hypertension Research, 42, 1599-1605.
[23]. Abdulghani, H. M., AlKanhal, A. A., Mahmoud, E. S., Ponnamperuma, G. G., & Alfaris, E. A. 2011, Stress and its effects on medical students: a cross-sectional study at a college of medicine in Saudi Arabia. Journal of Health, Population, and Nutrition, 29, 516.
[24]. Tamminga, S. J., Emal, L. M., Boschman, J. S., Levasseur, A., Thota, A., Ruotsalainen, J. H., & Schelvis, R. M., 2023, Individual‐level interventions for reducing occupational stress in healthcare workers. Cochrane Database of Systematic Reviews.
[25]. Sachdev, S., Ansari, S. A., Ansari, M. I., Fujita, M., & Hasanuzzaman, M, 2021, Abiotic stress and reactive oxygen species: Generation, signaling, and defense mechanisms. Antioxidants, 10, 277.
[26]. Karanikas, E., Daskalakis, N. P., & Agorastos, A, 2021, Oxidative dysregulation in early life stress and posttraumatic stress disorder: a comprehensive review. Brain Sciences, 11, 723.
[27]. Wemm, S. E., Tennen, H., Sinha, R., & Seo, D., 2022, Daily stress predicts later drinking initiation via craving in heavier social drinkers: A prospective in-field daily diary study. Journal of Psychopathology and Clinical Science, 131, 780.
[28]. Agorastos, A., Pervanidou, P., Chrousos, G. P., & Baker, D. G., 2019, Developmental trajectories of early life stress and trauma: a narrative review on neurobiological aspects beyond stress system dysregulation. Frontiers in Psychiatry, 10, 118.
[29]. Hasanuzzaman, M., Bhuyan, M. B., Parvin, K., Bhuiyan, T. F., Anee, T. I., Nahar, K., & Fujita, M., 2020. Regulation of ROS metabolism in plants under environmental stress: A review of recent experimental evidence. International Journal of Molecular Sciences, 21, 8695.
[30]. Pinto, A. C., Francis, A., Sabu, A. R., Biju, A., James, A., & Silva, P. D., 2020, A Study to assess stress and stressors among Undergraduate nursing students in a selected college at Mangaluru. Indian Journal of Continuing Nursing Education, 21, 171-175.
Viewed PDF 7 0 -
Impact of COVID-19 Pandemic on Antimicrobial Resistance: A Review of Trends and Antibiotic Patterns in IndiaAuthor: Saramma Mini JacobDOI: 10.21522/TIJPH.2013.12.04.Art042
Impact of COVID-19 Pandemic on Antimicrobial Resistance: A Review of Trends and Antibiotic Patterns in India
Abstract:
The pandemic situation caused by SARS-CoV2 had a severe influence on the health system all over the world. After two and half years of this situation, the WHO has downgraded the COVID-19 pandemic and has declared that it is no longer a global health threat. Though the COVID-19 infection has reduced around the world, the irrational intake of antibiotics for the past 3 years has aggravated the antimicrobial resistance (AMR) globally. In this review, we examined the pattern of reported AMR during the pandemic in India and also highlighted antibiotic susceptibility during the pandemic situation. An online search was carried out to include all the original articles that were published in India on antimicrobial resistance and COVID-19 from March 2020 to May 2023 in the following databases: PUBMED, SCOPUS, EMBASE, Cochrane, Web of Science, and Google Scholar; Key antimicrobial-resistant findings were identified from 12 relevant studies. Among the gram-negative bacteria, the prevalent antimicrobial-resistant bacteria were A. baumanii and K. pneumonia followed by E. coli. The predominant resistant gram-positive bacteria were S. aureus. Around 50% of the Acinetobacter spp were carbapenem-resistant. Multidrug-resistant K. pneumonia, A. baumannii and E. coli were also reported. Increased intake of antibiotics during the COVID-19 pandemic may have increased the virulence of the superbug by showing resistance to various drugs. Judicious use of antibiotics, public awareness campaigns on antibiotic usage, and improved hygiene practices, both in healthcare settings and in the community can help in reducing the transmission of infections and subsequently decreasing antimicrobial resistance.
Impact of COVID-19 Pandemic on Antimicrobial Resistance: A Review of Trends and Antibiotic Patterns in India
References:
[1]. WHO COVID-19 dashboard. 2024. Available from https://data.who.int/dashboards/covid19/cases?n=c
[2]. Afshinnekoo, E., Bhattacharya, C., Burguete-García, A., Castro-Nallar, E., Deng, Y., Desnues, C., et al., 2021, On behalf of the MetaSUB Consortium. COVID-19 drug practices risk antimicrobial resistance evolution. Lancet, 2(4): E135-136. https://doi.org/10.1016/S2666-5247(21)00039-2
[3]. Malik, S. S., & Mundra, S., 2022, Increasing consumption of antibiotics during the COVID-19 Pandemic: Implications for patient health and emerging anti-microbial resistance. Antibiotics, 12(1): 45. http://doi.org/10.3390/antibiotics12010045
[4]. Garg, S. K., 2021, Antibiotic misuse during COVID-19 Pandemic: A Recipe for Disaster. Indian J Crit Care Med, 25(6): 617-619. http://doi.org/10.5005/jp-journals-10071-23862
[5]. Welle, D., 2022, Pandemic worsened antimicrobial resistance in India. Available from https://www.hindustantimes.com/lifestyle/health/pandemic-worsened-antimicrobial-resistance-in-india-101666961896111.html
[6]. Chindhalore, C. A., Dakhale, G. N., Gajbhiye, S. V., & Gupta, A. V., 2022, Prescription pattern for antimicrobials and the potential predictors for antibiotics among patients with COVID-19: A retrospective observational study. J. Clin. Diagnostic Res., 16(9): FC15-FC19. http://doi.org/10.7860/JCDR/2022/56961.16874
[7]. de Souza, G. H. A., de Oliveira, A. R., Barbosa, M. S., Rossato, L., da Silva Barbosa, K., & Simionatto, S. J., 2023. Infect. Public Health, 16: 1184–1192. http://doi.org/10.1016/j.jiph.2023.05.017
[8]. Seethalakshmi, P. S., Charity, O. J., Giakoumis, T., Kiran, G. S., Sriskandan, S., Voulvoulis, N., et al., 2022, Delineating the impact of COVID-19 on antimicrobial resistance: An Indian perspective. Sci Total Enviro, 20: 818-151702. https://doi.org/10.1016/j.scitotenv.2021.151702
[9]. Vijay, S., Bansal, N., Rao, B. K., Veeraraghavan, B., Rodrigues, C., Wattal, C., et al., 2021, Secondary infections in hospitalized COVID-19 patients: Indian experience. Infect Drug Resist, 14: 1893-1903. http://doi.org/10.2147/IDR.S299774
[10]. Juliana, A., Ramya, S., Leela, K. V., & Anusha, 2022, Prevalence and antimicrobial susceptibility pattern of secondary Gram-negative bacteria isolated from severe acute respiratory syndrome coronavirus disease 2 patients in a tertiary care hospital. J Pure Appl Microbiol, 16(4): 2514-2520. https://doi.org/10.22207/JPAM.16.4.13
[11]. Rajni, E., Garg, V. K., Bacchani, D., Sharma, R., Vohra, R., Mamoria, V., & et al., 2021, Prevalence of bloodstream infections and their aetiology in COVID-19 patients admitted in a Tertiary Care Hospital in Jaipur. Indian J Crit Care Med, 25(4): 369–373. http://doi.org/10.5005/jp-journals-10071-23781
[12]. Khurana, S., Singh, P., Sharad, N., Kiro, V. V., Rastogi, N., Lathwal, A., et al., 2021, Profile of co-infections & secondary infections in COVID-19 patients at a dedicated COVID-19 facility of a tertiary care Indian hospital: Implication on antimicrobial resistance. Indian J Med Microbiol, 39(2): 147-153. http://doi.org/10.1016/j.ijmmb.2020.10.014
[13]. Bhaskaran, S., 2022, Profile of bacterial infections and antimicrobial resistance in patients with COVID-19 in a Tertiary Care Hospital, J Res Med Dent Sci, 10(1): 452-455.
[14]. Palanisamy, N., Vihari, N., Meena, D. S., Kumar, D., Midha, N., Tak, V., & et al., 2021, Clinical profile of bloodstream infections in COVID-19 patients: A retrospective cohort study. BMC Infect Dis., 21(1): 933. http://doi.org/10.1186/s12879-021-06647-x
[15]. Boorgula, S. Y., Yelamanchili, S., Kottapalli, P., & Naga, M. D., 2022, An update on secondary bacterial and fungal infections and their antimicrobial resistance pattern (AMR) in covid-19 confirmed patients. J Lab Physicians, 14(3): 260-264. http://doi.org/10.1055/s-0041-1741438
[16]. Raksha, K., & Gopinath, P., 2021, ‘Double Trouble’–Antimicrobial resistance and COVID-19, A study on health care associated infections and multidrug resistant organisms in critical care units during the Global pandemic. J Acad Clin Microbiol, 23: 14-17.
[17]. Saini, V., Nirmal, K., Ahmad, N., Das, S., & Singh, N. P., 2022, Microbiological profile and their antibiogram of bloodstream infections amongst first and second surge of the COVID-19 patients in a tertiary care hospital. J Family Med Prim Care, 11: 7367-71. http://doi.org/10.4103/jfmpc.jfmpc_770_22. Epub 2022 Dec 16
[18]. Sreenath, K., Batra, P., Vinayaraj, E. V., Bhatia, R., SaiKiran, K. V. P., Singh, V., & et al., 2021, Coinfections with other respiratory pathogens among patients with COVID-19. MicrobiolSpectrs, 9(1): e00163-21. http://doi.org/10.1128/Spectrum.00163-21
[19]. Saxena, S., & Aggarwal, P., 2023, Tracking annual antimicrobial resistance at a tertiary care hospital amidst raging COVID-19 pandemic. MAMC J Med Sci, 9: 35-43. http://doi.org/10.4103/jfmpc.jfmpc_2339_20
[20]. Sarathi, S., Behera, B., Mahapatra, A., Mohapatra, S., Jena, J., & Nayak, S., 2023, Microbiological characterization and clinical facets of Elizabethkingia bloodstream infections in a tertiary care hospital of eastern India. Infect Drug Resist., 16: 3257-3267. https://doi.org/10.2147/IDR.S409121
[21]. Dhar, E., Urs, T. A., & Manthravadi, K. K., 2023, Antimicrobial susceptibility profile of methicillin resistant Staphylococcus aureus (MRSA) isolates in a tertiary care hospital, Mysuru, India. Indian J Public Health Res Dev, 14(2): 88-93. https://doi.org/10.37506/ijphrd.v14i2.19073
[22]. Langford, B. J., So, M., Simeonova, M., Leung, V., Lo, J., Kan, T., et al., 2023, Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis. Lancet Microbe, 4(3): e179-e191. https://doi.org/10.1016/S2666-5247(22)00355-X
[23]. Langford, B. J., So, M., Raybardhan, S., Leung, V., Westwood, D., MacFadden, D. R., et al., 2020, Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect., 26(12): 1622-1629. http://doi.org/10.1016/j.cmi.2020.07.016
[24]. Rehman, S., 2023, A parallel and silent emerging pandemic: Antimicrobial resistance (AMR) amid COVID-19 pandemic. J Infect Public Health, 16(4): 611-617. http://doi.org/10.1016/j.jiph.2023.02.021
[25]. Alhazzani, W., Møller, M. H., Arabi, Y. M., Loeb, M., Gong, M. N., & Eddy Fan, 2019, Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease (COVID-19). Intensive Care Med., 46(5): 854-887. http://doi.org/10.1007/s00134-020-06022-5
[26]. Elmahi, O. K., Uakkas, S., Olalekan, B. Y., Damilola, I. A., Adedeji, O. J., Hasan, M. M., et al., 2022, Antimicrobial resistance and one health in the post COVID-19 era: What should health students learn?. Antimicrob Resist Infect Control, 11(1): 58. http://doi.org/10.1186/s13756-022-01099-7
[27]. Monteiro, R. C., Malta, R. C. R., Rodrigues, G. L., Ramos, G. L. P. A., & Nascimento, J. D. S., 2023, Acinetobacter baumannii: a known pathogen, a new problem. Germs, 13(4): 381-384. http://doi.org/10.18683/germs.2023.1408
[28]. Asif, M., Alvi, I. A., & Rehman, S. U., 2018, Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities. Infect Drug Resist, 11: 1249-1260. http://doi.org/10.2147/IDR.S166750
[29]. Puzniak, L., Bauer, K. A., Yu, K. C., Moise, P., Finelli, L., Ye, G., & et al., 2021, Effect of inadequate empiric antibacterial therapy on hospital outcomes in SARS-CoV-2-positive and-negative US patients with a positive bacterial culture: a multicenter evaluation from March to November 2020. Open Forum Infect Dis, 8(6): p. ofab232. http://doi.org/10.1093/ofid/ofab232
[30]. Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., & et al., 2020, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet, 395(10223): 507-13. http://doi.org/10.1016/S0140-6736(20)30211-7
[31]. Bahceci, I., Yildiz, I. E., Duran, O. F., Soztanaci, U. S., Harbawi, Z. K., Senol, F. F., et al., 2022, Secondary bacterial infection rates among patients with COVID-19. Cureus, 14(2): e22363. http://doi.org/10.7759/cureus.22363
[32]. Sharifipour, E., Shams, S., Esmkhani, M., Khodadadi, J., Fotouhi-Ardakani, R., Koohpaei, A., et al., 2020, Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU. BMC Infect. Dis., 20(1): 1-7. http://doi.org/10.1186/s12879-020-05374-z
[33]. World Health Organization. WHO bacterial priority pathogens list, 2024. Available from https://iris.who.int/bitstream/handle/10665/376776/9789240093461-eng.pdf?sequence=1
[34]. Bazaid, A. S., Barnawi, H., Qanash, H., Alsaif, G., Aldarhami, A., Gattan, H., et al., 2022, Bacterial coinfection and antibiotic resistance profiles among hospitalized COVID-19 Patients. Microorganisms, 10(3): 495. http://doi.org/10.3390/microorganisms10030495
[35]. Farah, S. M., Alshehri, M. A., Alfawaz, T. S., Alasmeri, F. A., Alageel, A. A., Alshahrani, D. A., 2022, Trends in antimicrobial susceptibility patterns in King Fahad Medical City, Riyadh, Saudi Arabia. Saudi Med. J., 40: 252. http://doi.org/10.15537/smj.2019.3.23947
[36]. Wang, Q., Zhang, P., Zhao, D., Jiang, Y., Zhao, F., Wang, Y., & et al., 2018, Emergence of tigecycline resistance in Escherichia coli co-producing MCR-1 and NDM-5 during tigecycline salvage treatment. Infect Drug Resist, 11: 2241-2248. http://doi.org/10.2147/IDR.S179618
[37]. Gonzalez, L. J., & Vila, A. J., 2012, Carbapenem resistance in Elizabeth kingiameningoseptica is mediated by metallo-β-lactamase BlaB. Antimicrob Agents Chemother, 56(4): 1686-92. http://doi.org/10.1128/AAC.05835-11
[38]. Singh, S., Sahu, C., Patel, S. S., Singh, S., & Ghoshal, U., 2020, Clinical profile, susceptibility patterns, speciation and follow up of infections by Elizabethkingia species: study on a rare nosocomial pathogen from an intensive care unit of north India. New Microbes New Infect, 38: 100798. http://doi.org/10.1016/j.nmni.2020.100798
[39]. Kavanagh, K. T., & Cormier, L. E., 2022, Success and failures in MRSA infection control during the COVID-19 pandemic. Antimicrob Resist Infect Control , 11: 118. http://doi.org/10.1186/s13756-022-01158-z
[40]. Huttner, B. D., Catho, G., Pano-Pardo, J. R., Pulcini, C., & Schouten, J., 2020, COVID-19: don't neglect antimicrobial stewardship principles. Clin Microbiol Infect, 26(7): 808-810. http://doi.org/10.1016/j.cmi.2020.04.024
Viewed PDF 5 0 -
Anti-Dengue Therapeutic Potential of Medicinal plant, Tinospora cordifoliaAuthor: Malairaj SathuvanDOI: 10.21522/TIJPH.2013.12.04.Art040
Anti-Dengue Therapeutic Potential of Medicinal plant, Tinospora cordifolia
Abstract:
Dengue, a significant viral disease spread by mosquitoes, is causing an increasing death rate due to inadequate treatments and preventative measures. However, there has been substantial advancement in the investigation of natural and traditional herbal remedies. Tinospora cordifolia has been extensively researched for its ability to treat dengue fever. This research aims to assess the current information on the use of T. cordifolia in treating dengue, emphasizing its clinical effectiveness, phytochemistry, and antiviral properties. The research methodology included an extensive examination of the literature on T. cordifolia's anti-dengue attributes in different databases utilizing appropriate keywords. Discoveries validate the effectiveness of T. cordifolia in fighting dengue by easing cytokine storms, decreasing vascular leakage, and blocking key viral proteins. Substances like berberine and magnoflorine obtained from the plant exhibit potential in this aspect. The research not only highlights but also underscores the significant potential of T. cordifolia as a beneficial treatment option for dengue, but additional computational and clinical studies are necessary to create effective and safe anti-dengue drugs. Moreover, it is crucial to have a more thorough comprehension of T. cordifolia's antiviral method in combating dengue virus infection.
Anti-Dengue Therapeutic Potential of Medicinal plant, Tinospora cordifolia
References:
[1]. Nyenke, C. U, Nnokam, B. A, Esiere, R, Nwalozie, R. 2023. Dengue fever: etiology, diagnosis, prevention and treatment. Asian J Res Infect Dis 14:26-33.
[2]. Shahzad, F., Awan, A, Ali A., Dar, W. M., Irshad, N. 2022. Analysis of Disease Parameters in Dengue Hemorrhagic Fever versus Classic Dengue Fever Patients. NUST Journal of Natural Sciences 7.
[3]. Jing, Q, Wang, M. 2023. Progress in Dengue Epidemiology. In Progress in China Epidemiology: Volume 1:121-37: Springer. pp. 121-37.
[4]. Murrell, S., Wu, S-C., Butler, M.. 2011. Review of dengue virus and the development of a vaccine. Biotechnology Advances 29:239-47.
[5]. Yek, C., Li, Y., Pacheco, A. R., Lon, C., Duong, V., et al. 2023. National dengue surveillance, Cambodia 2002–2020. Bulletin of the World Health Organization, 101:605.
[6]. Wilder-Smith, A, Ooi, E-E, Horstick, O, Wills, B. 2019. Dengue. The Lancet 393:350-63.
[7]. Singh, P. K., Rawat, P., 2017. Evolving herbal formulations in management of dengue fever. Journal of Ayurveda and Integrative Medicine 8:207-10.
[8]. Yadav, M., Malakar, A., Mukherjee, P., Mukherjee, S., Mahajan, T., George, N., 2024. Medicinal Plants and Herbs in the Treatment of Dengue Virus. In Promising Antiviral Herbal and Medicinal Plants:101-20: CRC Press. Pp. 101-20.
[9]. Mutsuddy, P., Tahmina Jhora, S., Shamsuzzaman, A. K. M, Kaisar, S. G., Khan, M. N. A., 2019. Dengue situation in Bangladesh: an epidemiological shift in terms of morbidity and mortality. Canadian Journal of Infectious Diseases and Medical Microbiology 2019:3516284.
[10]. Singh, N., Yadav, S. S., 2024. Anti-dengue therapeutic potential of Tinospora cordifolia and its bioactives. Journal of Ethnopharmacology:118242.
[11]. Sharma, A., Bajaj, P., Bhandari, A., Kaur, G., 2020. From ayurvedic folk medicine to preclinical neurotherapeutic role of a miraculous herb, Tinospora cordifolia. Neurochemistry International 141:104891.
[12]. Boon, P. L., Martins, A. S., Lim, X. N., Enguita, F. J., Santos, N. C., et al. 2023. Dengue virus capsid protein facilitates genome compaction and packaging. International Journal of Molecular Sciences 24:8158.
[13]. Li, Q, Kang, C., 2022. Structures and dynamics of dengue virus nonstructural membrane proteins. Membranes 12:231.
[14]. Agback, P., Lesovoy, D. M, Han, X, Sun, R, Sandalova, T, et al. 2022. 1H, 13C and 15N resonance assignment of backbone and IVL-methyl side chain of the S135A mutant NS3pro/NS2B protein of Dengue II virus reveals unique secondary structure features in solution. Biomolecular NMR Assignments, 16:135-45.
[15]. Sun Y-T, Varani, G. 2022. Structure of the dengue virus RNA promoter. RNA 28:1210-23.
[16]. Boerneke, M. A., Gokhale, N. S, Horner, S. M, Weeks, K. M., 2022. Structure-first identification of conserved RNA elements that regulate dengue virus genome architecture and replication. bioRxiv:2022.10.
[17]. Shu, B., Ooi, J. S, Tan, A. W., Ng, T-S, Dejnirattisai, W., et al. 2022. CryoEM structures of the multimeric secreted NS1, a major factor for dengue hemorrhagic fever. Nature Communications 13:6756.
[18]. Bahuguna, V., Matura, R., Sharma, N., 2019. Potential Use of Medicinal Plants for Dengue: A Systematic Mini Review of Scientific Evidence. J. Appl. Life Sci 2:10-6.
[19]. Mishra, P., Jamdar, P., Desai, S., Patel, D., Meshram, D., 2014. Phytochemical analysis and assessment of in vitro antibacterial activity of Tinospora cordifolia. International Journal of Current Microbiology and Applied Sciences 3:224-34.
[20]. Deva, S. S, Gnaneswari, D., 2020. In silico analysis of compounds isolated from selected Indian medicinal plants against Chikungunya Viral proteins. Indian J Pharm Sci, 82:677-85
[21]. Shinde, D. L., Pawar, V. B., Katkar, S. R., Kulkarni, S., 2023. Study of Guduchi Kwath (Tinospora cordifolia) In Patients of Dengue Fever with Thrombocytopenia. Journal of Survey in Fisheries Sciences 10:3166-74.
[22]. Balkrishna, A., Solleti, S., Verma, S., Varshney, A., 2020. Validation of a novel zebrafish model of dengue virus (DENV-3) pathology using the pentaherbal medicine Denguenil Vati. Biomol 10: 971.
[23]. Lim, S. Y. M., Chieng, J. Y., Pan, Y., 2021. Recent insights on anti-dengue virus (DENV) medicinal plants: review on in vitro, in vivo and in silico discoveries. All Life 14:1-33.
[24]. Warowicka, A., Nawrot, R., Goździcka-Józefiak, A., 2020. Antiviral activity of berberine. Archives of virology 165:1935-45.
[25]. Gupta, B., Kohli, N., Sharma, S., Bhatt, P. C., 2014. Amyron: A plant-based pharmacotherapy for faster recovery of dengue fever. Med. Update 22.
[26]. Wan, J. J, Brown, R. S, Kielian, M., 2020. Berberine chloride is an alphavirus inhibitor that targets nucleocapsid assembly, M.Bio 11:10.1128/mbio. 01382-20.
[27]. Loaiza-Cano, V., Monsalve-Escudero, L. M., Filho, C. d. S. M. B., Martinez-Gutierrez, M, Sousa, D. P. d., 2020., Antiviral role of phenolic compounds against dengue virus: A review. Biomolecules, 11:11.
Viewed PDF 5 0 -
Molecular Characterization of Multi-Drug Resistant Clinical Isolates from Healthcare FacilitiesAuthor: P. SivagurunathanDOI: 10.21522/TIJPH.2013.12.04.Art043
Molecular Characterization of Multi-Drug Resistant Clinical Isolates from Healthcare Facilities
Abstract:
This study aimed to analyze multi-drug resistant clinical isolates collected from healthcare facilities at the molecular level. Bacterial samples from a hospital were cultured on selective media to isolate Acinetobacter, E. coli, Klebsiella sp., and Pseudomonas sp., and characterized by Gram staining and biochemical tests. DNA was extracted from overnight cultures and used for PCR amplification of the V1-V3 and V3-V9 regions of the 16S rDNA. The PCR products were confirmed on agarose gels, purified, and sequenced. Sequences were analyzed using BLAST for species identification, and accession numbers were obtained from the NCBI GenBank database. Morphological and biochemical data for pathogenic bacteria, such as Acinetobacter (K1), E. coli (K2), Klebsiella (K3), and Pseudomonas sp. (K4) were analyzed. The 16s rDNA PCR products were sequenced using a commercial automated sequencer and were submitted to GenBank and NCBI. Bacterial sequencing analysis and comparison revealed that isolates K1, K2, K3, and K4 were Acinetobacter, E. coli, Klebsiella, and Pseudomonas sp. since they had a 100% homology with the library. The species-level identification of bacteria K1, K2, K3, and K4 is based on the highest identity (90%) and their GenBank accession codes are APK1, APK2, APK3, and APK4. This study suggests that samples from tertiary hospitals contain high loads of antibiotic-resistant bacteria. A change in the antibiotic sensitivity of the identified bacteria needs to be monitored, as there is limited availability of newer medicines, and the emergence of resistant bacteria far exceeds the rate of new antibiotic development.
Molecular Characterization of Multi-Drug Resistant Clinical Isolates from Healthcare Facilities
References:
[1] Hauhnar, L., Pachuau, L., Lalhruaitluanga, H., 2018, Isolation and characterization of multi-drug resistant bacteria from hospital wastewater sites around the city of Aizawl, Mizoram. Advances in Bioscience and Biotechnology, 9(07), 311-321.
[2] Ravi, G. S., Ellappan, K., Narasimha, H. B., Rudresh, S. M., 2021, Isolation and Molecular Characterization of Multi Drug Resistant Gram-Negative Bacteria from Clinical Samples in Tertiary Care Hospital, South India. RGUHS Journal of Medical Sciences, 11(4).
[3] Tang, S. S., Apisarnthanarak, A., Hsu, L. Y., 2014, Mechanisms of β-lactam antimicrobial resistance and epidemiology of major community-and healthcare-associated multidrug-resistant bacteria. Advanced Drug Delivery Reviews, 78, 3-13.
[4] Khan, D., Zeb, M., Khattak, S. K., Shah, A. A., Abdullah, M., Bilal, M., 2023, Molecular characterization and antibiotic susceptibility pattern of bacterial strains isolated from diabetic foot ulcers. Endocrine and Metabolic Science, 12, 100136.
[5] Momin, M. H. F. A., Liakopoulos, A., Phee, L. M., Wareham, D. W., 2017, Emergence and nosocomial spread of carbapenem-resistant OXA-232-producing Klebsiella pneumoniae in Brunei Darussalam. Journal of global Antimicrobial Resistance, 9, 96-99.
[6] Kamala, K., Sivaperumal, P., 2023, Predominance of multi-drug resistant extended spectrum β lactamase producing bacteria from marine fishes. Environmental Pollution, 323, 121314.
[7] Bhatia, A., Kalra, J., Kohli, S., Kakati, B., Kaushik, R., 2018, Antibiotic resistance pattern in intensive care unit of a tertiary care teaching hospital. International Journal of Basic and Clinical Pharmacology, 7(5), 906-911.
[8] Masseron, A., Poirel, L., Ali, B. J., Syed, M. A., Nordmann, P., 2019, Molecular characterization of multidrug-resistance in Gram-negative bacteria from the Peshawar teaching hospital, Pakistan. New Microbes and New Infections, 32, 100605.
[9] Sivaperumal, P., Kamala, K., Ganapathy, D. M., Dharani, G., Sundarrajan, S., Ramakrishna, S., 2023, Fabrication of AgNPs mediated fibrous membrane from Rhizophora mucronata mangrove plant extract for biological properties. Journal of Drug Delivery Science and Technology, 86, 104710.
[10] Soni, M., Pitchiah, S., Suresh, V., Ramasamy, P., 2024, Fabrication and partial characterization of silver nanoparticles from Mangrove (Avicennia marina) Leaves and Their Antibacterial Efficacy Against Oral Bacteria. Cureus, 16(1).
[11] Zarras, C., Karampatakis, T., Pappa, S., Iosifidis, E., Vagdatli, E., Roilides, E., Papa, A., 2023, Genetic characterization of carbapenem-resistant Klebsiella pneumoniae clinical isolates in a tertiary hospital in Greece, 2018–2022. Antibiotics, 12(6), 976.
[12] Pauline, C. R., Akshita., Pavithra, T., Kannan, K., Sivaperumal, P., 2024, Characterization and biological activity of silver nanoparticles from (Rhizophora mucronata) Mangrove Extract. Nano LIFE, 2450018.
[13] Choushette, B. B., Satpute, R. A., 2022, Isolation and characterization of multidrug resistance bacteria from hospital sewage samples, Maharashtra, India. African Journal of Biotechnology, 21(1), 16-25.
[14] Ramasamy, P., Subhapradha, N., Srinivasan, A., Shanmugam, V., Krishnamoorthy, J., Shanmugam, A., 2011, In vitro evaluation of the antimicrobial activity of methanolic extract from selected species of cephalopods on clinical isolates. African Journal Microbiology Research, 5(23), 3884-3889.
[15] Gupta, M., Naik, A. K., Singh, S. K., 2019, Bacteriological profile and antimicrobial resistance patterns of burn wound infections in a tertiary care hospital. Heliyon, 5(12).
[16] Barai, L., Fatema, K., Haq, J. A., Faruq, M. O., Ahsan, A. A., Morshed, M. A. H. G., Hossain, M. B., 2010, Bacterial profile and their antimicrobial resistance pattern in an intensive care unit of a tertiary care hospital of Dhaka. Ibrahim Medical College Journal, 4(2), 66-69.
[17] Kumar, A., Tanwar, S., Chetiwal, R., Kumar, R., 2022, Nosocomial infections-related antimicrobial resistance in a multidisciplinary intensive care unit. MGM Journal of Medical Sciences, 9(1), 12-18.
[18] Chaudhary, L., Pandey, A., Singh, P., Chaturvedi, P., Bisht, A.S., 2023, Bacterial Profile and Antimicrobial susceptibility pattern of gram-negative bacteria isolated from skin and soft tissue infections in a tertiary care hospital of western Uttar Pradesh. www.ijphrd.Com, 14(3), 135.
[19] Suma, P., Swetha, C. S., Sudhanthiramani., Goud, S. S., Annie Supriya., Jagadeesh Babu, A., 2016, A study on the antibiotic resistance patterns of Staphylococcus aureus isolated from market milk in and around Tirupati, Andhra Pradesh. International Journal of Recent Scientific Research, 7(4), 10429-10435.
[20] Lagha, R., Abdallah, F. B., ALKhammash, A. A., Amor, N., Hassan, M. M., Mabrouk, I., Alhomrani, M., Gaber, A., 2021, Molecular characterization of multidrug-resistant Klebsiella pneumoniae clinical isolates recovered from King Abdulaziz Specialist Hospital at Taif City, Saudi Arabia. Journal of Infection and Public Health, 14(1), 143-151.
[21] Zou, Z. Y., Lei, L., Chen, Q. Y., Wang, Y. Q., Cai, C., Li, W. Q., Zhang, Z., Shao, B., Wang, Y., 2019, Prevalence and dissemination risk of antimicrobial-resistant Enterobacteriaceae from shared bikes in Beijing, China. Environment International, 132, 105119.
[22] Subhapradha, N., Ramasamy, P., Srinivasan, A., Shanmugam, A., Shanmugam, V., 2013, Preparation of chitosan derivatives from gladius of squid Sepioteuthis lessoniana (Lesson, 1830) and antimicrobial potential against human pathogens. Journal of Biological Sciences, 13(4), 257.
[23] Zhang, Y., Li, D., Yang, Y., Su, J., Xu, X., Wang, M., Chen, Y., Li, Y., 2021, Clinical and molecular characteristics of Chryseobacterium indologenes isolates at a teaching hospital in Shanghai, China. Annals of Translational Medicine, 9(8).
Viewed PDF 6 0 -
Burden of Leprosy in Indonesia: A Comprehensive Analysis from the Global Burden of Disease Study 2021Author: Agus SudaryantoDOI: 10.21522/TIJPH.2013.12.04.Art046
Burden of Leprosy in Indonesia: A Comprehensive Analysis from the Global Burden of Disease Study 2021
Abstract:
Indonesia is the fourth most populous country in the world and has the third highest burden of Leprosy after India and Brazil. Prevention and treatment have been carried out in Indonesia by trying to improve services and quality of Leprosy care, but the incidence of this disease is still relatively high. This study aims to analyze the incidence, prevalence, and total DALYs (Disability Adjusted Life Years) of Leprosy in Indonesia based on the results of the GBD 2021(Global Burden of Disease) study. Researchers analyzed absolute figures, rates/levels, and age-standardized figures from 1990 to 2021. In this study, researchers used GBD 2021 data to estimate the temporal trend of the Leprosy burden in Indonesia. The analysis used three standard epidemiological measures, namely incidence, prevalence, and disability-adjusted life years (DALYs) by sex and age in Indonesia. The results of the analysis showed that 1992 was the lowest year with a prevalence of 24,725 cases and 2015 was the highest year with 37,287 cases. The lowest incidence of Leprosy occurred in 1990 with 3,018 cases and the highest incidence occurred in 2020 with 4,568 cases. The year with the lowest DALY was 1992 with 1,304 cases and the year with the highest DALY was 2013 with 1,984 cases. The results of this study are expected to be used as a strategy for controlling Leprosy in Indonesia. Researchers hope that the government or health workers will carry out early detection of prevention in high-risk communities to stop the transmission of Leprosy and to reduce the prevalence of disability or negative side effects that will cause stigma in society.
Burden of Leprosy in Indonesia: A Comprehensive Analysis from the Global Burden of Disease Study 2021
References:
[1] Samosir, P. M., Axelia, P. G., Alkaff, F. F., Salamah, S., & Alinda, M. D., 2023, Prevalence and risk factors for disability in leprosy patients in Indonesia during the post-elimination era. Dermatology Reports, 15, 223–229. https://doi.org/10.4081/dr.2023.9777
[2] Chen, K. H., Lin, C. Y., Su, S. Bin, & Chen, K. T., 2022, Leprosy: A Review of Epidemiology, Clinical Diagnosis, and Management. Journal of Tropical Medicine. https://doi.org/10.1155/2022/8652062
[3] Sugawara-Mikami, M., Tanigawa, K., Kawashima, A., Kiriya, M., Nakamura, Y., Fujiwara, Y., & Suzuki, K., 2022. Pathogenicity and virulence of Mycobacterium leprae. Virulence, 13(1), 1985–2011. https://doi.org/10.1080/21505594.2022.2141987
[4] Gunawan, H., & Nurani, N. B., 2024., Dermoscopic features of nails in Leprosy patients in a tertiary referral hospital in West Java, Indonesia. BMC Infectious Diseases, 24(1), 1–9. https://doi.org/10.1186/s12879-024-09224-0
[5] Yunar, M. F., 2023, Mengenal Penyakit Kusta. Kemenkes RI. https://yankes.kemkes.go.id/view_artikel/142/mengenal-kusta
[6] Dianita, R., 2020., Perbandingan Determinan Kejadian Kusta pada Masyarakat Daerah Perkotaan dan Pedesaan. HIGEIA (Journal of Public Health Research and Development, 4 (Special 3), 692–704, https://journal.unnes.ac.id/sju/higeia/article/view/39719
[7] Menaldi, S. L., Harini, M., Nelfidayani, N., Irawati, Y., Setiono, S., Wahyuni, L. K., Rahayu, T., Andayani, G., Friska, D., & Nugraha, B., 2022, Functional activity limitation of leprosy cases in an endemic area in Indonesia and recommendations for integrated participation program in society. PLoS Neglected Tropical Diseases, 16(8), 1–8. https://doi.org/10.1371/JOURNAL.PNTD.0010646
[8] Dharmawan, Y., Korfage, I. J., Abqari, U., Widjanarko, B., & Richardus, J. H., 2023, Measuring leprosy case detection delay and associated factors in Indonesia: a community-based study. BMC Infectious Diseases, 23(1), 1–10. https://doi.org/10.1186/s12879-023-08552-x
[9] G. Minervini, R. Franco, M.M. Marrapodi, M. Di Blasio, V. Ronsivalle, M. Cicciù., 2023, Children oral health and parents education status: a cross-sectional study, BMC Oral Health 23 787. https://doi.org/10.1186/s12903-023-03424-x.[10] Kavita, Thakur, J. S., & Narang, T. 2023, The burden of skin diseases in India: Global Burden of Disease Study 2017. Indian Journal of Dermatology, Venereology and Leprology, 89(3), 421–425. https://doi.org/10.25259/IJDVL_978_20
[11] Wahyuni, L. K., Nelfidayani, N., Harini, M., Anestherita, F., Wardhani, R. K., Menaldi, S. L., Irawati, Y., Rahayu, T., Andayani, G., Daniel, H., Savitri, I., Hariyanto, P. K. Y., & Paramita, I. A. 2024, The International Classification of Functioning, Disability and Health to map leprosy-related disability in rural and remote areas in Indonesia. PLoS Neglected Tropical Diseases, 18(5), 1–27. https://doi.org/10.1371/journal.pntd.0011539
[12] Institute for Health Metrics and Evaluation (IHME). 2022. Global Burden of Disease Study 2021 (GBD 2021) Results. Global Burden of Disease Collaborative Network. https://vizhub.healthdata.org/gbd-results/
[13] Van’T Noordende, A. T., Lisam, S., Ruthindartri, P., Sadiq, A., Singh, V., Arifin, M., van Brakel, W. H., & Korfage, I. J. 2021. Leprosy perceptions and knowledge in endemic districts in india and indonesia: Differences and commonalities. PLoS Neglected Tropical Diseases, 15(1), 1–19. https://doi.org/10.1371/journal.pntd.0009031
[14] Putri, A. I., de Sabbata, K., Agusni, R. I., Alinda, M. D., Darlong, J., de Barros, B., Walker, S. L., Zweekhorst, M. B. M., & Peters, R. M. H. 2022, Understanding leprosy reactions and the impact on the lives of people affected: An exploration in two leprosy endemic countries. PLoS Neglected Tropical Diseases, 16(6). https://doi.org/10.1371/journal.pntd.0010476
[15] Rai, S. S., Peters, R. M. H., Syurina, E. V, Irwanto, I., Naniche, D., & Zweekhorst, M. B. M., 2020, Intersectionality and health-related stigma: insights from experiences of people living with stigmatized health conditions in Indonesia. International Journal for Equity in Health, 19(1). https://doi.org/10.1186/s12939-020-01318-w
[16] Nery, J. S., Ramond, A., Pescarini, J. M., Alves, A., Strina, A., Ichihara, M. Y., Fernandes Penna, M. L., Smeeth, L., Rodrigues, L. C., Barreto, M. L., Brickley, E. B., & Penna, G. O., 2019, Socioeconomic determinants of leprosy new case detection in the 100 Million Brazilian Cohort: A population-based linkage study. The Lancet Global Health, 7(9), e1226–e1236. https://doi.org/10.1016/S2214-109X(19)30260-8
[17] Ariyanta, F., & Muhlisin, A. 2017, Hubungan Antara Dukungan Keluarga Terhadap Konsep Diri Pada Penderita Kusta. Berita Ilmu Keperawatan, 10(1), 20–27 https://journals.ums.ac.id/index.php/BIK/article/view/10233
[18] Lasso, C. K. R. 2023. Faktor Hambatan Dalam Akses Pelayanan Kesehatan Pada Puskesmas di Indonesia: Scoping Review. Jurnal Ilmiah Permas: Jurnal Ilmiah STIKES Kendal, 13(Oktober), 1–8 https://journal2.stikeskendal.ac.id/index.php/PSKM/article/view/991/871
[19] Prakoeswa, F. R. S., Soebono, H., Husada, D., Notobroto, H. B., Listiawan, M. Y., Endaryanto, A., & Prakoeswa, C. R. S. 2020, Towards prevention and eradication of leprosy: Current status and research needed in community health & immune dysregulation. Indian Journal of Leprosy, 92, 257–278 https://www.ijl.org.in/published-articles/03022022161826/4_Prakoeswa_Oct_Dec_2020.pdf
[20] Ramadorai, A., Ravi, P., Narayanan,V., 2019, Rhinocerebral mucormycosis: A prospective analysis of an effective treatment protocol, Ann. Maxillofac. Surg. 9 192–196. https://doi.org/10.4103/ams.ams_231_18.
[21] Krismawati, H., Irwanto, A., Pongtiku, A., Irwan, I. D., Maladan, Y., Sitanggang, Y. A., Wahyuni, T., Tanjung, R., Sun, Y., Liu, H., Zhang, F., Oktavian, A., & Liu, J. 2020. Validation study of hla-b* 13:01 as a biomarker of dapsone hypersensitivity syndrome in leprosy patients in Indonesia. PLoS Neglected Tropical Diseases, 14(10), 1–11. https://doi.org/10.1371/journal.pntd.0008746
[22] Alemu Belachew, W., & Naafs, B. 2019. Position statement: LEPROSY: Diagnosis, treatment and follow-up. Journal of the European Academy of Dermatology and Venereology, 33(7), 1205–1213. https://doi.org/10.1111/jdv.15569
[23] Ezhilarasan, D. Lakshmi, T.M. Subha, Deepak Nallasamy. V, Raghunandhakumar, S., 2022, The ambiguous role of sirtuins in head and neck squamous cell carcinoma, Oral Dis. 28 559–567. https://doi.org/10.1111/odi.13798.
[24] Rathod, S. P., Jagati, A., & Chowdhary, P. 2020. Disabilities in leprosy: an open, retrospective analyses of institutional records. Anais Brasileiros de Dermatologia, 95(1), 52–56. https://doi.org/10.1016/j.abd.2019.07.001
[25] Sari, A. A., & Rahmawati, R. 2023. A Bibliometric Analysis of Aloe vera in Wound Healing. Pharmacon: Jurnal Farmasi Indonesia, 20(1), 36–49. https://doi.org/10.23917/pharmacon.v20i1.22312
[26] Prakoeswa, C. R. S., Lubis, R. S., Anum, Q., Argentina, F., Menaldi, S. L., Gunawan, H., Yuniati, R., Mulianto, N. R., Siswati, A. S., Widasmara, D., Rusyati, L. M. M., Mamuaja, E. H., Muchtar, V., Agusni, R. I., Kusumaputra, B. H., Alinda, M. D., & Listiawan, M. Y., 2022, Epidemiology of Leprosy in Indonesia: A Retrospective Study. Berkala Ilmu Kesehatan Kulit Dan Kelamin, 34(1), 29–35. https://doi.org/10.20473/bikk.v34.1.2022.29-35
Viewed PDF 5 0 -
Effect of Saffron Extract on Sleep Quality and Melatonin Concentrations in Adults with Temporomandibular Disorders-an Observational StudyAuthor: Nishanthi RajaDOI: 10.21522/TIJPH.2013.12.04.Art047
Effect of Saffron Extract on Sleep Quality and Melatonin Concentrations in Adults with Temporomandibular Disorders-an Observational Study
Abstract:
Temporomandibular Disorder (TMD) patients experience deterioration in their quality of sleep. Targeting these problems may include a wide variety of treatment options, such as the use of plant- and herbal-based medications, which have the potential to improve sleep. Numerous meta-analyses and systematic reviews have established that saffron is a useful natural treatment for mild-to-moderate insomnia. Hence, the present study aimed to determine the effect of saffron extract on sleep quality by altering the melatonin concentration in adults with TMDs. Thirty-four patients were recruited and divided into two groups equally (Group A study group, Group B -Control group) and advised to take saffron (15 mg once daily) or a placebo. Outcome measures include severity of pain collected at baseline and days 0,14 and 28 and the Pittsburgh Sleep Diary (PSD) collected. On day 0 and day 28 serum melatonin concentration will be evaluated using the ELISA kit method. Patients with temporomandibular dysfunction experienced significant reductions in pain after taking saffron supplements as opposed to a placebo. On comparing day 1 and day 28, the saffron-treated participants had substantially improved sleep quality, elevated melatonin levels, and a lower VAS score. The study concluded that Saffron is a potent, safe substitute in the management of TMD pain that has deterioration in sleep quality for its effectiveness in the management of sleep by altering the melatonin concentration. Further studies should be conducted to assess the possible benefits of saffron extract in large clinical settings with a larger number of patients.
Effect of Saffron Extract on Sleep Quality and Melatonin Concentrations in Adults with Temporomandibular Disorders-an Observational Study
References:
[1]. Deboer, T., 2018, Sleep homeostasis and the circadian clock: Do the circadian pacemaker and the sleep homeostasis influence each other's functioning? Neurobiol Sleep Circadian Rhythms.,15, 68-77, https://doi.org/10.1016/j.nbscr.2018.02.003
[2]. Finan, P. H., Goodin, B. R., Smith, M. T., 2013, Dec, The association of sleep and pain: An update and a path forward. J Pain,14(12),1539-52, doi: 10.1016/j.jpain.2013.08.007.
[3]. Ganesan, A., Gauthaman, J., Kumar, G., 2022, The impact of mindfulness meditation on the Psychosomatic Spectrum of Oral Diseases: Mapping the Evidence. J Lifestyle Med, 12(1), 1-8. doi:10.15280/jlm.2022.12.1.1.
[4]. Priyadarshini, P., Jeevanandan, G., Govindaraju, L., Subramanian, E.M.G., 2020, Clinical evaluation of instrumentation time and quality of obturation using paediatric hand and rotary file systems with conventional hand K-files for pulpectomy in primary mandibular molars: a double-blinded randomized controlled trial, Eur. Arch. Paediatr. Dent. 21 693–701. https://doi.org/10.1007/s40368-020-00518-w.
[5]. Wu, J. H., Lee, K. T., Kuo, C. Y., Cheng, C. H., Chiu, J. Y., Hung, J. Y., Hsu, C. Y., Tsai, M. J., 2020 Aug 30, The Association between Temporomandibular Disorder and Sleep Apnea-A Nationwide Population-Based Cohort Study. Int J Environ Res Public Health;17(17), 6311. doi:10.3390/ijerph17176311.
[6]. Edinger, J. D., Arnedt, J. T., Bertisch, S. M., Carney, C. E., Harrington, J. J., Lichstein, K. L., Sateia, M. J., Troxel, W. M., Zhou, E. S., Kazmi, U., Heald, J. L., Martin, J. L., 2021 Feb , Behavioral and psychological treatments for chronic insomnia disorder in adults: An American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med,17(2), 255-262. doi:10.5664/jcsm.8986.
[7]. Nakagawa, H., Sack, R. L., Lewy, A. J., 1992, Sleep propensity freeruns with the temperature, melatonin and cortisol rhythms in a totally blind person. Sleep 15(4), 330–336. doi:10.1093/sleep/15.4.330.
[8]. Amstrup, A. K., Sikjaer, T., Mosekilde, L., Rejnmark, L., 2015 Sep 30, The effect of melatonin treatment on postural stability, muscle strength, and quality of life and sleep in postmenopausal women: a randomized controlled trial. Nutr J,14,102. doi:10.1186/s12937-015-0093-1.
[9]. Mahdi, A. A., Fatima, G., Das S. K., Verma, N. S., 2011 Apr, Abnormality of circadian rhythm of serum melatonin and other biochemical parameters in fibromyalgia syndrome. Indian J Biochem Biophys, 48(2),82-7.
[10]. Ramani, H. R. P., W.M. Tilakaratne, W.M, Sukumaran, G, Ramasubramanian, A, . Krishnan, R.P., 2022, Critical appraisal of different triggering pathways for the pathobiology of Pemphigus vulgaris-A review, Oral Dis. 28 1760–1769. https://doi.org/10.1111/odi.13937.
[11]. Milajerdi, A., Jazayeri, S., Shirzadi, E., Hashemzadeh, N., Azizgol, A., Djazayery, A., Esmaillzadeh, A., Akhondzadeh, S., 2018 Dec., The effects of alcoholic extract of saffron (Crocus satious L.) on mild to moderate comorbid depression-anxiety, sleep quality, and life satisfaction in type 2 diabetes mellitus: A double-blind, randomized and placebo-controlled clinical trial. Complement Ther Med, 41, 196-202, doi: 10.1016/j.ctim.2018.09.023.
[12]. Vidor, L. P., Torres, I. L., Custódio de Souza, I. C., Fregni, F., Caumo, W., 2013, Sep, Analgesic and sedative effects of melatonin in temporomandibular disorders: a double-blind, randomized, parallel-group, placebo-controlled study. J Pain Symptom Manage, 46(3), 422-32. doi: 10.1016/j.jpainsymman.2012.08.019.
[13]. Pachikian, B. D., Copine, S., Suchareau, M., Deldicque, L, 2021 Apr, Effects of Saffron Extract on Sleep Quality: A Randomized Double-Blind Controlled Clinical Trial. Nutrients. 27, 13(5), 1473. doi:10.3390/nu13051473.
[14]. Kell, G., Rao, A., Beccaria, G., Clayton, P., Inarejos-García A. M., Prodanov, M., 2017 Aug, affron® a novel saffron extract (Crocus sativus L.) improves mood in healthy adults over 4 weeks in a double-blind, parallel, randomized, placebo-controlled clinical trial. Complement Ther Med., 33, 58-64. doi: 10.1016/j.ctim.2017.06.001.
[15]. Kuratsune, H., Umigai, N., Takeno, R., Kajimoto, Y., Nakano, T., 2010 Sep Effect of crocetin from Gardenia jasminoides Ellis on sleep: a pilot study. Phytomedicine. 17(11), 840-3. doi: 10.1016/j.phymed.2010.03.025.
[16]. Lopresti, A. L., Smith, M. S. J., Metse, A. P., Drummond, P. D., 2020, Effects of saffron on sleep quality in healthy adults with self-reported poor sleep: A randomized, double-blind, placebo-controlled trial. J. Clin. Sleep Med. 16, 937–947. doi: 10.5664/jcsm.8376.
[17]. Siddique, R , Nivedhitha, M.S. , Jacob,B., 2019, Quantitative analysis for detection of toxic elements in various irrigants, their combination (precipitate), and para-chloroaniline: An inductively coupled plasma mass spectrometry study, J. Conserv. Dent. 22 344–350. https://doi.org/10.4103/JCD.JCD_95_19.
[18]. Wu, F. S., Yang, Y. C., Tsai, J. J., 2000 Oct, Noncompetitive inhibition of the glycine receptor-mediated current by melatonin in cultured neurons. Brain Res, 1(2):208-11. doi:10.1016/s0006-8993(00)02804-3.
[19]. Adrian, L., Lopresti Stephen, J., Smith, Peter, D., Drummond, 2021, An investigation into an evening intake of a saffron extract (affron®) on sleep quality, cortisol, and melatonin concentrations in adults with poor sleep: A randomised, double-blind, placebo-controlled, multi-dose study. Sleep Medicine 86:7-18. doi: 10.1016/j.sleep.2021.08.001.
[20]. Ursin, Reidun., 2002, Serotonin and sleep. Sleep Medicine Reviews. 55-69. doi:10.1053/smrv.2001.0174.
Viewed PDF 7 0 -
Thyroid and Cortisol Changes in Critical IllnessAuthor: Muralikrishna BharadhiDOI: 10.21522/TIJPH.2013.12.04.Art044
Thyroid and Cortisol Changes in Critical Illness
Abstract:
It is known that metabolic and hormonal reactions that are responses to acute critical illnesses affect every organ and tissue in the body, however, only little is understood about the underlying mechanisms. Correction of these hormone levels as early as possible can lead to reduced stay in hospital and better prognosis. The present study aims to determine the thyroid and cortisol changes in acute severely ill patients and to assess their relationship with the severity of illness. The present prospective observational study was conducted in sixty critically ill patients grouped according to APACHE II score. The baseline characters that were used to calculate the APACHE II score were 1. Temperature, 2, heart rate, 3 hematocrit, 4 sodium levels, 5 potassium levels, 6 WBC count 7, pH, 8 pO2 10 respiratory rates 11 GCS. Blood samples were collected from patients at 1 and 8 days of admission by aseptic venipuncture. The samples were processed and levels of FT3, FT4, TSH and cortisol levels were assessed using standard protocol. The obtained data were recorded and subjected to statistical analysis. Groups were compared using one-way ANOVA with post hoc Tukey HSD. Comparison among groups was done student t-Test method. Pearson chi-square test or Fisher exact test (2-tailed) was used to compare proportions. The p-value less than 0.05 was considered significant. The results showed the normal values of various parameters in the 3 groups and will serve as a reference for the Indian population.
Thyroid and Cortisol Changes in Critical Illness
References:
[1]. Economidou, F., Douka, E., Tzanela, M., Nanas, S., Kotanidou, A., 2002, Thyroid function during critical illness. Hormones (Athens),10(2), 117-24, doi: 10.14310/horm.2002.1301.
[2]. Maiden, M. J., Torpy, D. J., 2009, Thyroid Hormones in Critical Illness. Crit Care Clin., 35(2), 375-388, doi: 10.1016/j.ccc.2018.11.012.
[3]. Téblick, A., Gunst, J., Van den Berghe, G., 2002, Critical Illness-induced Corticosteroid Insufficiency: What It Is Not and What It Could Be. J Clin Endocrinol Metab., 107(7), 2057-2064. doi: 10.1210/clinem/dgac201.
[4]. Hermans, G., Van Aerde, N., Meersseman, P., Van Mechelen, H., Debaveye, Y., Wilmer, A., Gunst, J., Casaer, M. P., Dubois, J., Wouters, P., Gosselink, R., Van den Berghe, G., 2009, Five-year mortality and morbidity impact of prolonged versus brief ICU stay: a propensity score matched cohort study. Thorax, 74(11),1037-1045, doi: 10.1136/thoraxjnl-2018-213020.
[5]. Van Aerde, N., Meersseman, P., Debaveye, Y., Wilmer, A., Gunst, J., Casaer, M. P., Wauters, J., Wouters, P. J., Gosselink, R., Van den Berghe, G., Hermans, G., 2021, Five-year outcome of respiratory muscle weakness at intensive care unit discharge: Secondary analysis of a prospective cohort study,76(6), 561-567. doi: 10.1136/thoraxjnl-2020-216720.
[6]. Tian, Y., Yao, Y., Zhou, J., Diao, X., Chen, H., Cai, K., Ma, X., Wang, S., 2022, Dynamic APACHE II Score to Predict the Outcome of Intensive Care Unit Patients. Front Med (Lausanne), 26(8), 744907. doi: 10.3389/fmed.2021.744907.
[7]. Schectman, J. M., Kallenberg, G. A., Hirsch, R. P., Shumacher, R. J., 1991, Report of an association between race and thyroid stimulating hormone level. Am J Public Health. 81(4), 505-6. doi: 10.2105/ajph.81.4.505.
[8]. Malinowski, J. R., Denny, J. C., Bielinski, S. J., Basford, M. A., Bradford, Y., Peissig. P. L., et al., 2014, Genetic variants associated with serum thyroid stimulating hormone (TSH) levels in European Americans and African Americans from the eMERGE Network. PLoS One, 9(12), e111301. doi: 10.1371/journal.pone.0111301.
[9]. Hollowell, J. G., Staehling, N. W., Flanders, W. D., Hannon, W. H., Gunter, E. W., Spencer, C. A., Braverman, L. E., Serum, T. S. H., 2002, T (4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab, 87(2), 489-99. doi: 10.1210/jcem.87.2.8182.
[10]. Deer, L. K., Shields, G. S., Ivory, S. L., Hostinar, C. E., Telzer, E. H., 2018, Racial/ethnic disparities in cortisol diurnal patterns and affect in adolescence. Dev Psychopathol, 30(5),1977-1993, doi: 10.1017/S0954579418001098.
[11]. Van den Berghe G., 2001, The neuroendocrine response to stress is a dynamic process. Best Practice & Research. Clinical Endocrinology & Metabolism, 15(4), 405–419. https://doi.org/10.1053/beem.2001.0160
[12]. Marx, C., Petros, S., Bornstein, S. R., Weise, M., Wendt, M., Menschikowski, M., Engelmann, L., & Höffken, G., 2003, Adrenocortical hormones in survivors and nonsurvivors of severe sepsis: diverse time course of dehydroepiandrosterone, dehydroepiandrosterone-sulfate, and cortisol. Critical Care Medicine, 31(5), 1382–1388. https://doi.org/10.1097/01.CCM.0000063282.83188.3D
[13]. Schuetz, P., Müller, B., Nusbaumer, C., Wieland, M., & Christ-Crain, M., 2009, Circulating levels of GH predict mortality and complement prognostic scores in critically ill medical patients. European Journal of Endocrinology, 160(2), 157–163. https://doi.org/10.1530/EJE-08-0786
[14]. Slag, M. F., Morley, J. E., Elson, M. K., Crowson, T. W., Nuttall, F. Q., & Shafer, R. B., 1981, Hypothyroxinemia in critically ill patients as a predictor of high mortality. JAMA, 245(1), 43–45.
[15]. Rothwell, P. M., & Lawler, P. G., 1995, Prediction of outcome in intensive care patients using endocrine parameters. Critical Care Medicine, 23(1), 78–83. https://doi.org/10.1097/00003246-199501000-00015
[16]. Rothwell, P. M., Udwadia, Z. F., & Lawler, P. G., 1993, Thyrotropin concentration predicts outcome in critical illness. Anaesthesia, 48(5), 373–376. https://doi.org/10.1111/j.1365-2044.1993.tb07006.x
[17]. Yapps, B., Shin, S., Bighamian, R., Thorsen, J., Arsenault, C., Quraishi, S. A., Hahn, J, O., 2017, Reisner AT. Hypotension in ICU Patients Receiving Vasopressor Therapy. Sci Rep.,7(1), 8551, doi: 10.1038/s41598-017-08137-0.
[18]. Zhou, Y., Zheng, M. H., Chen, C. S., Sun, D. Q., Chen, X. X., Sun, M., Wang, Y. H., Liu, Y., Pan, J. Y., Zheng, C. F., 2019, Prognostic value of hematocrit levels among critically ill patients with acute kidney injury. European Journal of Inflammation. 17. doi:10.1177/2058739219846820
[19]. Padhi, R., Panda, B. N., Jagati, S., Patra, S. C., 2014, Hyponatremia in critically ill patients. Indian J Crit Care Med,18(2):83-7. doi: 10.4103/0972-5229.126077.
[20]. Tongyoo, S., Viarasilpa, T., Permpikul, C., 2018, Serum potassium levels and outcomes in critically ill patients in the medical intensive care unit. J Int Med Res., 46(3):1254-1262, doi: 10.1177/0300060517744427.
[21]. Rimmer, E., Garland, A., Kumar, A., Doucette, S., Houston, B. L., Menard, C. E., Leeies, M., Turgeon, A. F., Mahmud, S., Houston, D. S., Zarychanski, R., 2022, White blood cell count trajectory and mortality in septic shock: a historical cohort study. Can J Anaesth, 69(10),1230-1239. doi: 10.1007/s12630-022-02282-5.
[22]. Prowle, J. R., Kolic, I., Purdell Lewis, J., Taylor, R., Pearse, R. M., Kirwan, C. J., 2014, Serum creatinine changes associated with critical illness and detection of persistent renal dysfunction after AKI. Clin J Am Soc Nephrol, 9(6), 1015-23, doi: 10.2215/CJN.11141113.
[23]. Samanta, S., Singh, R.K., Baronia, A. K., Mishra, P., Poddar, B., Azim, A., Gurjar, M., 2018, Early pH Change Predicts Intensive Care Unit Mortality. Indian J Crit Care Med., 22(10), 697-705, doi: 10.4103/ijccm.IJCCM_129_18.
[24]. Demiselle, J., Calzia, E., Hartmann, C., Messerer, D. A. C., Asfar, P., Radermacher, P., Datzmann, T., 2021, Target arterial PO2 according to the underlying pathology: a mini-review of the available data in mechanically ventilated patients. Ann Intensive Care,11(1), 88. doi: 10.1186/s13613-021-00872-y.
[25]. Garrido, D., Assioun, J. J., Keshishyan, A., Sanchez Gonzalez., M. A., Goubran, B., 2018, Respiratory Rate Variability as a Prognostic Factor in Hospitalized Patients Transferred to the Intensive Care Unit. Cureus, 10(1), e2100. doi: 10.7759/cureus.2100.
[26]. Fathi, M., Moghaddam, N. M., Jame, S. Z., Darvishi, M., Mortazavi, M., 2002, The association of Glasgow Coma Scale score with characteristics of patients admitted to the intensive care unit. Informatics in Medicine Unlocked, 29,100904. doi: 10.1016/j.imu.2022.100904
[27]. Gutch, M., Kumar, S., Gupta, K. K., 2018, Prognostic Value of Thyroid Profile in Critical Care Condition. Indian J Endocrinol Metab, 22(3), 387-391. doi: 10.4103/ijem.IJEM_20_18.
[28]. Wang, F., Pan, W., Wang, H., Wang, S., Pan, S., Ge, J., 2012, Relationship between thyroid function and ICU mortality: a prospective observation study. Crit Care,16(1), R11, doi: 10.1186/cc11151.
[29]. Hamrahian, A. H., Oseni, T. S., Arafah, B. M., 2004, Measurements of serum free cortisol in critically ill patients. N Engl J Med, 350(16), 629-38, doi: 10.1056/NEJMoa020266.
Viewed PDF 5 0 -
Management of Immediate Post-Arrest Lower Segment Cesarean Section in a 25-Year-Old with Previous LSCS: A Case ReportAuthor: Bharat Krishna MDOI: 10.21522/TIJPH.2013.12.04.Art048
Management of Immediate Post-Arrest Lower Segment Cesarean Section in a 25-Year-Old with Previous LSCS: A Case Report
Abstract:
Immediate Post-Arrest Lower Segment Caesarean Section (LSCS) is a serious circumstance that must be managed quickly and efficiently to guarantee the mother's and fetus's well-being. This emergency occurs when a pregnant woman has a cardiac arrest, prompting rapid delivery to enhance maternal and fetal prognosis. This case report details the effective care of an immediate post-arrest LSCS in a 25-year-old prenatal woman at 38 weeks and 2 days gestation who had previously had an LSCS. The patient was in labor with a breech presentation with draining PV. Following a sudden cardiac arrest during preoperative preparation for an emergency LSCS, a multidisciplinary strategy comprising obstetric, anaesthetic, and neonatal teams was critical in ensuring a favourable result for both mother and baby.
Management of Immediate Post-Arrest Lower Segment Cesarean Section in a 25-Year-Old with Previous LSCS: A Case Report
References:
[1]. van Liempt, S. W., Stoecklein, K., Tjiong, M. Y., Schwarte, L. A., de Groot, C. J., Teunissen, P. W., 2015, Essentials in cardiac arrest during cesarean section. Clin Pract. 2015 Feb 17;5(1):668.
[2]. Hill, C. C., Pickinpaugh, J., 2008, Trauma and surgical emergencies in the obstetric patient. Surg Clin North Am., 2008 Apr;88(2):421-40, viii.
[3]. Curran, C. A., 2005, Perianesthesia care following obstetric emergencies at risk for multisystem organ dysfunction. Journal of PeriAnesthesia Nursing. 2005 Jun; 20(3):185–99.
[4]. Whitty, J. E., 2002, Maternal cardiac arrest in pregnancy. Clin Obstet Gynecol. 2002, Jun;45(2):377-92.
[5]. Prior, C. H., Burlinson, C. E. G., & Chau, A., 2022, Emergencies in obstetric anaesthesia: A narrative review. Anaesthesia, 77(12), 1416–1429. https://doi.org/10.1111/anae.15839
[6]. Zelop, C. M., Einav, S., Mhyre, J. M., Martin, S., 2018, Cardiac arrest during pregnancy: Ongoing clinical conundrum. American Journal of Obstetrics and Gynecology. 2018 Jul 1;219(1):52-61.
[7]. Carlier, L., Devroe, S., Budts, W., Van Calsteren, K., Rega, F., Van de Velde, M., Rex, S., 2020, Cardiac interventions in pregnancy and peripartum–A narrative review of the literature. Journal of Cardiothoracic and Vascular Anesthesia. 2020, Dec 1;34(12):3409-19.
[8]. Lipman, S., Cohen, S., Einav, S., Jeejeebhoy, F., Mhyre, J. M., Morrison, L. J., Katz, V., Tsen, L. C., Daniels, K., Halamek, L. P., Suresh, M. S., Arafeh, J., Gauthier, D., Carvalho, J. C., Druzin, M., Carvalho, B., 2014, Society for Obstetric Anesthesia and Perinatology. The Society for Obstetric Anesthesia and Perinatology consensus statement on the management of cardiac arrest in pregnancy. Anesth Analg. 2014 May;118(5):1003-16.
[9]. d’Arby Toledano, R., Madden, H. E, Leffert, L., 2019, Anesthetic management of nonobstetric surgery during pregnancy. Current Anesthesiology Reports. 2019 Feb 19;9(1):31–8.
[10]. Chalkias, A., Mongardon, N., Boboshko, V., Cerny, V., Constant, A. L., De Roux, Q., Finco, G., Fumagalli, F., Gkamprela, E., Legriel, S., Lomivorotov, V., Magliocca, A., Makaronis, P., Mamais, I., Mani, I., Mavridis, T., Mura, P., Ristagno, G., Sardo, S., Papagiannakis, N., Xanthos, T., 2012, PERIOPCA Consortium. Clinical practice recommendations on the management of perioperative cardiac arrest: A report from the PERIOPCA Consortium. Crit Care. 2021 Jul 29;25(1):265.
[11]. Pecher, S., Williams, E., 2017, Out-of-hospital cardiac arrest in pregnancy with good neurological outcome for mother and infant. International Journal of Obstetric Anesthesia. 2017 Feb 1;29:81-4.
[12]. Nelissen, E. C., de Zwaan, C., Marcus, M. A., Nijhuis, J. G., 2009, Maternal cardiac arrest in early pregnancy. International Journal of Obstetric Anesthesia, 2009 Jan 1;18(1):60-3.
[13]. Skrifvars, M. B., 2020, Intensive Care Management of the Pregnant Patient after Cardiac Arrest. Principles and Practice of Maternal Critical Care, 2020:383-400.
[14]. Bajwa, S. K, Bajwa, S. J, Sood, A., 2010, Cardiac arrest in a case of undiagnosed dilated cardiomyopathy patient presenting for emergency cesarean section. Anesthesia, Essays and Researches. 2010 Jul;4(2):115.
[15]. Nivatpumin, P, Lertkovit, S., 2024, Case report: Maternal cardiac arrest at 12 hours postpartum. Heliyon. 2024 Jan 15;10(1).
Viewed PDF 5 0 -
Nanotheranostics: A Light at the End of a Tunnel: A ReviewAuthor: Yesoda Aniyan KDOI: 10.21522/TIJPH.2013.12.04.Art049
Nanotheranostics: A Light at the End of a Tunnel: A Review
Abstract:
Nanotheranostics encompasses the combined efforts of diagnostic imaging and therapy in one system. It is also a science of which adequate awareness and research are still lagging. It is a type of personalized medicine, wherein molecular understanding of the disease and conforming the treatment, is based on the patients’ genes, proteins and metabolites. It uses nano-sized particles in various polymer conjugations, dendrimers, micelles, liposomes, metal and inorganic nanoparticles, carbon nanotubes, and nanoparticles of biodegradable polymers for uninterrupted, restrained and targeted co-delivery of agents. A current literature search of the entire database was performed using MEDLINE/PubMed/ Cochrane with “nano theranostics”, “nano theranostics in dentistry”, “nano theranostics in imaging” and “nano theranostics in diagnosis and therapy” as keywords, in March 2019. Current literature has forayed into cancer detection and management, diagnostic imaging as well and autoimmune disease remedies. This review of literature aspires to address the importance of such an approach, a boon to Oral Medicine and Radiology.
Nanotheranostics: A Light at the End of a Tunnel: A Review
References:
[1]. Kim, T., Lee, S., Chen, X., 2013. Nanotheranostics for personalized medicine. Expert Rev. Mol. Diagn.13 (3):257–269.
[2]. Mahesh, K. P., 2018. Nanotheranostics-Novel Modality for Integrating Diagnosis and Therapy for Oral Cancer. Acta Scientific Dental Sciences. 2 (9): 57-58.
[3]. Silva, C., Pinho, J., Lopes, J., Almeida, A., Gaspar, M., Reis, C., 2019. Current Trends in Cancer Nano-theranostics: Metallic, Polymeric, and Lipid-Based Systems. Pharmaceutics.11: 22.
[4]. Xue, X., Huang, Y., Bo, R., Jia, B., Wu, H., Yuan, Y., Wang, Z., Ma, Z., Jing, D., Xu, X., Yu, W., Lin, T. Y., Li, Y., 2018. Trojan Horse nanotheranostics with dual transformability and multifunctionality for highly effective cancer treatment. Nat Commun. 7;9(1):3653.
[5]. Eyvazzadeh, N, Shakeri-Zadeh, A, Fekrazad, R, Amini, E., Ghaznavi, H., Kamran Kamrava S., 2017. Gold-coated magnetic nanoparticle as a nanotheranostic agent for magnetic resonance imaging and photothermal therapy of cancer. Lasers Med Sci. 32(7):1469-1477.
[6]. Abiodun-Solanke, I., Ajayi, D., Arigbede, A., 2014. Nanotechnology and its application in dentistry. Ann Med Health Sci Res. 4 (Suppl 3):S171-7.
[7]. Wang, L. S., Chuang, M. C., Ho, J. A., 2012. Nanotheranostics--A review of recent publications. Int J Nanomedicine.7:4679-95.
[8]. Xia, Q., Chen, Z., Zhou, Y., Liu, R., 2019. Near-Infrared Organic Fluorescent Nanoparticles for Long-term Monitoring and Photodynamic Therapy of Cancer. Nanotheranostics 2;3(2):156-165.
[9]. Vadivel, J. K, Govindarajan, M, Somasundaram, E, Muthukrishnan, A., 2019, Mast cell expression in oral lichen planus: A systematic review. J Investig Clin Dent. 10: e12457. doi:10.1111/jicd.12457113.
[10]. Peng, X et al.2008. Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy. Int J Nanomedicine.3(3): 311–321.
[11]. Rogers, W. J., Basu P.2005. Factors regulating macrophage endocytosis of nanoparticles: implications for targeted magnetic resonance plaque imaging. Atherosclerosis.178(1):67-73.
[12]. Gharagozloo, M., Majewski, S., Foldvari, M., 2015. Therapeutic applications of nanomedicine in autoimmune diseases: from immunosuppression to tolerance induction. Nanomedicine. May;11(4):1003-18.
[13]. Serra, P., Santamaria, P., 2015. Nanoparticle-based autoimmune disease therapy. Clin Immunol.160(1):3-13.
[14]. Badea, I., Virtanen, C., Verrall, R. E., Rosenberg, A., Foldvari, M., 2012. Effect of topical interferon-γ gene therapy using gemini nanoparticles on pathophysiological markers of cutaneous scleroderma in Tsk/+ mice. Gene Ther.19(10):978-87.
[15]. Rao, V, Bowman, S., 2013. Latest advances in connective tissue disorders. Ther Adv Musculoskelet Dis. 5(4):234-49.
[16]. Klippstein, R., Pozo, D., 2010. Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies. Nanomedicine: Nanotechnology, Biology, and Medicine. 6: 523-529.
[17]. Lutterotti, A., Yousef, S., Sputtek, A., Stürner, K. H., Stellmann, J. P., Breiden, P., Reinhardt, S., Schulze, C., Bester, M., Heesen, C., Schippling, S., Miller, S. D, Sospedra, M, Martin, R., 2013. Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis. Sci Transl Med. 5;5(188):188ra75.
[18]. Tsai, S. S., Yamanouchi, A., Clemente-Casares, X., Wang Serra, P., Yang, Y., Medarova, Z. M., Santamaria, A. P., 2010. Reversal of autoimmunity by boosting memory-like autoregulatory T cells. Immunity 32:568-580.
[19]. Look, M., Saltzman, W. M., Craft, J., Fahmy, T. M., 2014, The nanomaterial-dependent modulation of dendritic cells and its potential influence on therapeutic immunosuppression in lupus. Biomaterials.35(3):1089-95.
[20]. Clemente-Casares, X., Tsai, S., Huang, C., Santamaria, P., 2012. Antigen-specific therapeutic approaches in Type 1 diabetes. Cold Spring Harb Perspect Med. 2(2): a007773.
[21]. Yesoda Aniyan K , Krithika C.L,Anuradha G,Kannan A,Swathi K.V. (2022). A systematic review of randomized controlled trials on the Efficacy of purslane for the treatment of systemic disorders. International Journal of Chemical and Biochemical Sciences. 21: 219-223
[22]. Anuradha Ganesan, et al., 2024. Exploring the Relationship between Psychoneuroimmunology and Oral Diseases: A Comprehensive Review and Analysis. Journal of Lifestyle Medicine.14(1):13-19.
Viewed PDF 5 0 -
A Rare Case of Caesarean Scar Ectopic Pregnancy – A Case Report StudyAuthor: Prithika BDOI: 10.21522/TIJPH.2013.12.04.Art045
A Rare Case of Caesarean Scar Ectopic Pregnancy – A Case Report Study
Abstract:
Caesarean scar pregnancy is one of the rare entities with the presence of the implantation of the trophoblast at the previous Cesarean section scar site. Women presenting with this condition are often asymptomatic if left untreated this condition can lead to uterine rupture and massive maternal haemorrhage. Therefore, it is important for prompt prenatal diagnosis and management of caesarean scar pregnancies at the earliest. We present a case of women with two previous caesarean sections with scar pregnancy and managed appropriately.
A Rare Case of Caesarean Scar Ectopic Pregnancy – A Case Report Study
References:
[1]. Frishman, G. N., Melzer, K. E., Bhagavath, B., Ectopic pregnancy in a cesarean-section scar: The patient >6 weeks into an ectopic pregnancy, underwent local treatment. Am J Obstet Gynecol. 2012; 207(3):238 e231-232.Am J Obstet Gynecol.
[2]. Majangara, R., Madziyire, M. G., Verenga, C. et al. Cesarean section scar ectopic pregnancy - a management conundrum: a case report. J Med Case Reports 13, 137 (2019). https://doi.org/10.1186/s13256-019-2069-9
[3]. Pankaj Salvi, Vidya Gaikwad, Ayushi Bhadoriya, Sanjay Ponde, Medical management of cesarean scar ectopic pregnancy: A unique approach, Cureus, 10.7759/cureus.55481, 2024.
[4]. Deepika, Gupta T., Wahi S., A rare case report of caesarean scar ectopic pregnancy. J Clin Diagn Res. 2017 Aug;11(8): QD10-QD11. doi: 10.7860/JCDR/2017/24611.10523. Epub 2017 Aug 1. PMID: 28969218; PMCID: PMC5620859.
[5]. Ramkrishna, J., Kan, G. R., Reidy, K. L., Ang, W. C., Palma-Dias R., Comparison of management regimens following ultrasound diagnosis of nontubal ectopic pregnancies: A retrospective cohort study. BJOG. 2018; 125: 567-575
[6]. Anthony Grandelis, Robyn Shaffer, Shawna Tonick, Uncommon presentations of ectopic pregnancy, Journal of Gynecologic Surgery, 10.1089/gyn.2022.0016 2022.
[7]. Rosen, T., Placenta accreta and cesarean scar pregnancy: Overlooked costs of the rising cesarean section rate. Clin Perinatol 2008.
[8]. McKenna, D. A., Poder, L., Goldman, M., Goldstein, R. B., Role of sonography in the recognition, assessment, and treatment of cesarean scar ectopic pregnancies.
[9]. OuYang, Z., Xu, Y., Li, H., Zhong, B., Zhang, Q., Transvaginal hysterotomy: A novel approach for the treatment of cesarean scar pregnancy. Taiwan J Obstet Gynecol. 2019; 58:460–4.
[10]. Jameel, K., Abdul Mannan, G. E., Niaz, R., Hayat, D. E., Cesarean scar ectopic pregnancy: A diagnostic and management challenge. Cureus. 2021 Apr 13;13(4): 10e14463. doi: 10.7759/cureus.14463. PMID: 33996323; PMCID: PMC8118189.
Viewed PDF 5 0 -
Prevalence of Work-Related Musculoskeletal Disorders, Stress and Quality of Life Among Security GuardsAuthor: Sridevi BDOI: 10.21522/TIJPH.2013.12.04.Art050
Prevalence of Work-Related Musculoskeletal Disorders, Stress and Quality of Life Among Security Guards
Abstract:
Orthopaedic diseases have become more common as industrialization has progressed. It is one of the leading reasons for employee absenteeism from work, negatively affecting their quality of life. The incidence is unknown in professions like as security guards, whose job entails a lot of standing. Work-related musculoskeletal problems have a major influence on afflicted individuals' quality of life, can create economic hardship, and can affect service supply. The present study aims to assess the prevalence of work-related musculoskeletal disorders and their effects on quality of life among security guards. A quantitative approach with non-experimental descriptive research design was adopted for the present study 130 security were recruited as study participants by using the Convenient Sampling Technique. A self-structured questionnaire was administered to collect data regarding the demographic information and prevalence of Musculo skeletal disorders. The present study suggests that the utmost equal number of security guards (54%) are unaffected, equal number of security guards (46%) are affected, so they are almost equally aware of musculoskeletal disorders and their preventive measures. 35(26.9) has Mild stress, 65(50) Moderate stress, 30(23) Stress had a substantial positive correlation with WMSDs (r=0.40, p < 0.001). Stress and WMSDs were significantly connected with personal variables (p<0.001). Security guards face a risk of musculoskeletal disorders due to their physical workload. Severe complaints are linked to general health, while high exertion and social characteristics lead to sickness absence. Chronic symptoms influence medical care seeking. Ergonomic interventions may prevent hand/wrist complaints. Psychosocial and personal characteristics should be considered when investigating work-related risk factors.
Prevalence of Work-Related Musculoskeletal Disorders, Stress and Quality of Life Among Security Guards
References:
[1]. Bhandare, A., Kulkarni, A., Sanklecha, S., & Chitapure, T., 2020. Prevalence of low back pain in security guards in MGM institute of health sciences, Aurangabad. International Journal of Health Sciences and Research, 10(9), 336-45.
[2]. Saddique, I., Mazhar, T., Arif, A., Asghar, M., Riaz, S., Aziz, A., & Sajjad, I., 2022. Prevalence and intensity of non-specific, mechanical low back pain in security guards and traffic wardens of Lahore. Pakistan Journal of Medical & Health Sciences, 16(10), 28-28.
[3]. Afsharian, A., Dollard, M. F., Glozier, N., Morris, R. W., Bailey, T. S., Nguyen, H., & Crispin, C., 2023. Work-related psychosocial and physical paths to future musculoskeletal disorders (MSDs). Safety Science, 164, 106177.
[4]. Zhang, Y., ElGhaziri, M., Nasuti, S., & Duffy, J. F., 2020. The comorbidity of musculoskeletal disorders and depression: associations with working conditions among hospital nurses. Workplace Health & Safety, 68(7), 346-354.
[5]. Karande, A. P., Ahire, Y. R., &Varadharajulu, G., 2021. Relationship between Musculoskeletal Disorders and Anthropometric Measurements in Security Guards Working in Krishna Hospital, Karad. Journal of Evolution of Medical and Dental Sciences, 10(28), 2056-2061.
[6]. Naeem, Z., Zia, S., Ali, I., Nisa, L. U., Amjad, A., & Mujtaba, A., 2024. Prevalence of Non-Specific Low Back Pain Due to Job-Related Stress Among Security Guards. Pakistan Journal of Rehabilitation, 13(2), 109-116.
[7]. Muthelo, L., Sinyegwe, N. F., Phukubye, T. A., Mbombi, M. O., Ntho, T. A., & Mothiba, T. M., 2023, Prevalence of work-related Musculoskeletal disorders and its effects amongst nurses in the selected intellectual disability unit of the Limpopo Province. In Healthcare (Vol. 11, No. 5, p. 777). MDPI.
[8]. Abdelsalam, A., Wassif, G. O., Eldin, W. S., Abdel-Hamid, M. A., & Damaty, S. I. 2023., Frequency and risk factors of musculoskeletal disorders among kitchen workers. Journal of the Egyptian Public Health Association, 98(1), 3.
[9]. Abate, A. E., & Hailemariam, S. S., 2022, Improving work-related musculoskeletal disorders for sewing machine operators in Ethiopia. International Journal of Occupational Safety and Ergonomics, 29(2), 573-585.
[10]. Smith, M. D., Vicenzino, B., Brown, W. J., Gilson, N. D., Gane, E. M., & Johnston, V., 2022. Symptom characteristics in office workers using standing workstations: A cross-sectional study. Brazilian Journal of Physical Therapy, 26(2), 100393.
[11]. Al Amer, H. S., 2020. Low back pain prevalence and risk factors among health workers in Saudi Arabia: A systematic review and meta-analysis. Journal of Occupational Health, 62(1), 12155.
[12]. Skovlund, S. V., Bláfoss, R., Sundstrup, E., & Andersen, L. L., 2020. Association between physical work demands and work ability in workers with musculoskeletal pain: Cross-sectional study. BMC Musculoskeletal Disorders, 21, 1-8.
[13]. Crawford, J. O., Berkovic, D., Erwin, J., Copsey, S. M., Davis, A., Giagloglou, E., & Woolf, A., 2020. Musculoskeletal health in the workplace. Best Practice & Research Clinical Rheumatology, 34(5), 101558.
[14]. Yang, Y., Zeng, J., Liu, Y., Wang, Z., Jia, N., & Wang, Z., 2022, Prevalence of musculoskeletal disorders and their associated risk factors among furniture manufacturing workers in Guangdong, China: A cross-sectional study. International Journal of Environmental Research and Public Health, 19(21), 14435.
[15]. Mahdavi, S. B., Riahi, R., Vahdatpour, B., &Kelishadi, R., 2021. Association between sedentary behavior and low back pain; A systematic review and meta-analysis. Health Promotion Perspectives, 11(4), 393.
[16]. Sandeep Kaur, Kavita Sudhakar, & Sandeep Gupta. 2020. To Study the Prevalence of Musculoskeletal Disorders In Security Guards. International Journal of Physiotherapy, 2(6), 905-910.
[17]. Molina-Garcia, P., Mora-Traverso, M., Prieto-Moreno, R., Díaz-Vásquez, A., Antony, B., & Ariza-Vega, P., 2024. Effectiveness and cost-effectiveness of telerehabilitation for musculoskeletal disorders: A systematic review and meta-analysis. Annals of Physical and Rehabilitation Medicine, 67(1), 101791.
[18]. Gorce, P., & Jacquier-Bret, J., 2024. A systematic review of work-related musculoskeletal disorders among physical therapists and physiotherapists. Journal of Bodywork and Movement Therapies, 87(1), 10456.
[19]. Das, S. K., Patyal, V. S., & Ambekar, S., 2024. Modeling of risk factors leading to workrelated musculoskeletal disorders in medical practitioners. Safety Science, 172, 106427.
[20]. Wassell, M., Vitiello, A., Butler-Henderson, K., Verspoor, K., McCann, P., & Pollard, H., 2024. Electronic health records for predicting outcomes to work-related musculoskeletal disorders: A scoping review. Journal of Occupational Rehabilitation, 1-13.
[21]. Chang, Y. F., Yeh, C. M., Huang, S. L., Ho, C. C., Li, R. H., Wang, W. H., & Tang, F. C., 2020. Work ability and quality of life in patients with work-related musculoskeletal disorders. International Journal of Environmental Research and Public Health, 17(9), 3310.
[22]. Hultén, A. M., Holmgren, K., & Bjerkeli, P., 2023. Work-related stress, reason for consultation and diagnosis-specific sick leave: How do they add up? PLoS One, 18(7), e0288751.
[23]. Fan, J., Tan, X., Smith, A. P., & Wang, J., 2024, Work-related musculoskeletal disorders, fatigue and stress among gas station workers in China: a cross-sectional study. BMJ Open, 14(7), e081853.
Viewed PDF 6 0 -
Flavonoid Nanoparticles: Revolutionizing Cancer Treatment StrategiesAuthor: Ramaiyan VelmuruganDOI: 10.21522/TIJPH.2013.12.04.Art051
Flavonoid Nanoparticles: Revolutionizing Cancer Treatment Strategies
Abstract:
Flavonoids, a widely distributed class of polyphenolic chemicals found in nature, have recently emerged as significant anticancer agents. Regrettably, the anticancer potential of dietary flavonoids is inadequate due to their limited solubility, absorption, and fast metabolism. Nanocarriers promote the body's ability to absorb flavonoids and utilize them. This review aims to assess studies regarding the potential therapeutic benefits of flavonoid nanoparticles. In an examination of English-language publications released on June 30, 2020, a search was conducted using CINAHL Plus, Cochrane, PubMed (including MEDLINE), and other relevant databases. Preclinical research is now where most studies are looking into flavonoid nanoparticles’ potential as anticancer agents by data from the Web of Science. A549 and MCF-7 breast cancer cells are the main subjects of this study. The cancer cells discussed are carcinoma cells, lung cancer cells, and HepG2 tumor cells. Moreover, flavonoid nanoparticles can augment cancer treatments' effectiveness by bolstering their anti-tumor characteristics. Reducing the negative impacts of drugs on the body’s physiological systems
Flavonoid Nanoparticles: Revolutionizing Cancer Treatment Strategies
References:
[1] Khan, H., Ullah, H., Martorell, M., Valdes, S. E., Belwal, T., Tejada, S., Sureda, A., Kamal, M. A., 2019. Flavonoids nanoparticles in cancer: Treatment, prevention and clinical prospects. Semin Cancer Biol, 57(4), 72-78.
[2] Kumar, S., Pandey, A. K., 2013. Chemistry and Biological Activities of Flavonoids: An Overview. Sci World J, 2013, 1-16.
[3] Procházková, D., Boušová, I., Wilhelmová, N., 2011. Antioxidant and prooxidant properties of flavonoids. Fitoterapia, 82, 513-523.
[4] Serafini, M., Peluso, I., Raguzzini, A., 2010. Flavonoids as anti-inflammatory agents. Proc Nutr Soc, 69, 273-278.
[5] Gontijo, V. S., dos Santos, M. H., Viegas, C., Jr., 2017. Biological and Chemical Aspects of Natural Bioflavonoids from Plants: A Brief Review. Mini Rev Med Chem, 17, 834-862.
[6] Thilakarathna, S., Rupasinghe, H., 2013. Flavonoid Bioavailability and Attempts for Bioavailability Enhancement. Nutrients, 5, 3367-3387.
[7] Cassidy, A., Minihane, A. M., 2017. The role of metabolism (and the microbiome) in defining the clinical efficacy of dietary flavonoids. Am J Clin Nutr, 105, 10-22.
[8] De Pace, R. C. C., Liu, X., Sun, M., Nie, S., Zhang, J., Cai, Q., Gao, W., Pan, X., Fan, Z., Wang, S., 2013. Anticancer activities of (-)-epigallocatechin-3-gallate encapsulated nanoliposomes in MCF7 breast cancer cells. J Liposome Res, 23, 187-196.
[9] Tan, B. J., Liu, Y., Chang, K. J., Lim, B. K. W., Chiu, G. N. C., 2012. Personally active nano micellar formulation of quercetin in the treatment of lung cancer. Int J Nanomed, 7, 651-661.
[10] Jain, A. K., Thanki, K., Jain, S., 2013. Co-encapsulation of Tamoxifen and Quercetin in Polymeric Nanoparticles: Implications on Oral Bioavailability, Anti-tumour Efficacy, and Drug-Induced Toxicity. Mol Pharm, 10, 3459-3474.
[11] Xu, G., Shi, H., Ren, L., Gou, H., Gong, D., Gao, X., Huang, N., 2015. Enhancing the anti-colon cancer activity of quercetin by self-assembled micelles. Int J Nanomed, 10, 2051-2063.
[12] Wu, B., Liang, Y., Tan, Y., Xie, C., Shen, J., Zhang, M., Liu, X., Yang, L., Zhang, F., Liu, L., et al., 2016. Genistein-loaded nanoparticles of star-shaped diblock copolymer mannitol-core PLGA–TPGS for treating liver cancer. Mater Sci Eng C, 59, 792-800.
[13] Joshi, M. D., Patravale, V., Prabhu, R., 2015. Polymeric nanoparticles for targeted treatment in oncology: Current insights. Int J Nanomed, 10, 1001-1018.
[14] Kothamasu, P., Kanumur, H., Ravur, N., Maddu, C., Parasuramrajam, R., Thangavel, S., 2012. Nanocapsules: The Weapons for Novel Drug Delivery Systems. Bioimpacts, 2, 71-81.
[15] Jain, S., Hirst, D. G., O’Sullivan, J. M., 2012. Gold nanoparticles as novel agents for cancer therapy. Br J Radiol, 85, 101-113.
[16] Mu, H., Holm, R., 2018. Solid lipid nanocarriers in drug delivery: Characterization and design. Expert Opin Drug Deliv, 15, 771-785.
[17] Mukherjee, S., Ghosh, S., Das, D. K., Chakraborty, P., Choudhury, S., Gupta, P., Adhikary, A., Dey, S., Chattopadhyay, S., 2015. Gold-conjugated green tea nanoparticles for enhanced anti-tumour activities and hepatoprotection—synthesis, characterization and in vitro evaluation. J Nutr Biochem, 26, 1283-1297.
[18] Cai, Z. Y., Li, X. M., Liang, J. P., Xiang, L.P., Wang, K. R., Shi, Y. L., Yang, R., Shi, M., Ye, J. H., Lu, J. L., et al., 2018. Bioavailability of Tea Catechins and Its Improvement. Molecules, 23, 2346.
[19] Lambert, J. D., Kennett, M. J., Sang, S., Reuhl, K. R., Ju, J., Yang, C. S., 2010. Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice. Food Chem Toxicol, 48, 409-416.
[20] Siddiqui, I. A., Adhami, V. M., Bharali, D. J., Hafeez, B. B., Asim, M., Khwaja, S. I., Ahmad, N., Cui, H., Mousa, S. A., Mukhtar, H., 2009. Introducing Nano chemoprevention as a Novel Approach for Cancer Control: Proof of Principle with Green Tea Polyphenol Epigallocatechin-3-Gallate. Cancer Res, 69, 1712-1716.
[21] Peng, J., Liang, X., 2019. Progress in research on gold nanoparticles in cancer management. Medicine (Baltimore), 98, e15311.
[22] Hsieh, D. S., Wang, H., Tan, S.W., Huang, Y.H., Tsai, C.Y., Yeh, M.K., Wu, C.J., 2011. The treatment of bladder cancer in a mouse model by epigallocatechin-3-gallate-gold nanoparticles. Biomaterials, 32, 7633-7640.
[23] Hsieh, D. S., Cheng, C. C., Wu, C. J., Yeh, M. K., 2012. The preparation and characterization of gold-conjugated polyphenol nanoparticles as a novel delivery system. Int J Nanomed, 7, 1623-1633.
[24] Rocha, S., Generalov, R., Pereira, M. D. C., Peres, I., Juzenas, P., Coelho, M. A., 2011. Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention. Nanomedicine, 6, 79-87.
[25] Peres, I., Rocha, S., Gomes, J., Morais, S., Pereira, M. C., Coelho, M., 2011. Preservation of catechin antioxidant properties loaded in carbohydrate nanoparticles. Carbohydr Polym, 86, 147-153.
[26] Khan, N., Bharali, D. J., Adhami, V. M., Siddiqui, I. A., Cui, H., Shabana, S. M., Mousa, S. A., Mukhtar, H., 2014. Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model. Carcinogenesis, 35, 415-423.
[27] Lin, Y. H., Chen, Z. R., Lai, C. H., Hsieh, C. H., Feng, C. L., 2015. Active Targeted Nanoparticles for Oral Administration of Gastric Cancer Therapy. Biomacromolecules, 16, 3021-3032.
[28] Liao, B., Ying, H., Yu, C., Fan, Z., Zhang, W., Shi, J., Ying, H., Ravichandran, N., Xu, Y., Yin, J., et al., 2016. (-)-Epigallocatechin gallate (EGCG)-nanoethosomes as a transdermal delivery system for docetaxel to treat implanted human melanoma cell tumours in mice. Int J Pharm, 512, 22-31.
[29] Srivastava, S., Somasagara, R.R., Hegde, M., Nishana, M., Tadi, S.K., Srivastava, M., Choudhary, B., Raghavan, S. C., 2016. Quercetin, a Natural Flavonoid Interacts with DNA, Arrests Cell Cycle and Causes Tumour Regression by Activating Mitochondrial Pathway of Apoptosis. Sci. Rep., 6, 24049.
[30] Niazvand, F., Orazizadeh, M., Khorsandi, L., Abbaspour, M., Mansouri, E., Khodadadi, A., 2019. Effects of Quercetin-Loaded Nanoparticles on MCF-7 Human Breast Cancer Cells. Medicina (Kaunas), 55, 114.
[31] Tang, S. H., Li, R., Tan, J., Wang, Y., Jiang, Z. T., 2019. One pot synthesis of water-soluble quercetin derived multifunctional nanoparticles with photothermal and antioxidation capabilities. Colloids Surf B Biointerfaces, 183, 110429.
[32] Lou, M., Zhang, L., Ji, P., Feng, F., Liu, J., Yang, C., Li, B., Wang, L., 2016. Quercetin nanoparticles induced autophagy and apoptosis through AKT/ERK/Caspase-3 signaling pathway in human neuroglioma cells: In vitro and in vivo. Biomed Pharm, 84, 1-9.
[33] Wang, G., Wang, J. J., Chen, X. L., Du, L., Li, F., 2016. Quercetin-loaded freeze-dried nanomicelles: Improving absorption and anti-glioma efficiency in vitro and in vivo. J Control Release, 235, 276-290.
[34] Li, J., Shi, M., Ma, B., Niu, R., Zhang, H., Kun, L., 2017. Anti-tumour activity and safety evaluation of nanoparticle-based delivery of quercetin through intravenous administration in mice. Mater Sci Eng C, 77, 803-810.
[35] Ghosh, A., Ghosh, D., Sarkar, S., Mandal, A. K., Thakur Choudhury, S., Das, N., 2012. Anticarcinogenic activity of nanoencapsulated quercetin in combating diethylnitrosamine-induced hepatocarcinoma in rats. Eur J Cancer Prev, 21, 32-41.
[36] Mandal, A. K., Ghosh, D., Sarkar, S., Ghosh, A., Swarnakar, S., Das, N., 2014. Nanocapsulated quercetin downregulates rat hepatic MMP-13 and controls diethylnitrosamine-induced carcinoma. Nanomedicine, 9, 2323-2337.
[37] Ren, K. W., Li, Y. H., Wu, G., Ren, J. Z., Lu, H. B., Li, Z. M., Han, X. W., 2017. Quercetin nanoparticles display anti-tumour activity via proliferation inhibition and apoptosis induction in liver cancer cells. Int J Oncol, 50, 1299-1311.
[38] Pandey, P., Rahman, M., Bhatt, P. C., Beg, S., Paul, B., Hafeez, A., Al-Abbasi, F. A., Nadeem, M. S., Baothman, O., Anwar, F., et al., 2018. Implication of nano-antioxidant therapy for treatment of hepatocellular carcinoma using PLGA nanoparticles of rutin. Nanomedicine, 13, 849-870.
[39] Wu, H., Wei, M., Xu, Y., Li, Y., Zhai, X., Su, P., Ma, Q., Zhang, H., 2022. PDA-Based Drug Delivery Nanosystems: A Potential Approach for Glioma Treatment. Int J Nanomedicine, 17, 3751-3775.
[40] Wang, S., Su, R., Nie, S., Sun, M., Zhang, J., Wu, D., Moustaid-Moussa, N., 2014. Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals. J Nutr Biochem, 25, 363-376.
[41] Dora, C. L., Costa Silva, L. F., Mazzarino, L., Siqueira, J. M., Fernandes, D., Pacheco, L. K., Maioral, M. F., Santos-Silva, M. C., Muccillo Baisch, A. L., Assreuy, J., et al., 2016. Oral Delivery of a High Quercetin Payload Nanosized Emulsion: In Vitro and In Vivo Activity Against B16-F10 Melanoma. J Nanosci Nanotechnol, 16, 1275-1281.
[42] Long, Q., Xie, Y., Huang, Y., Wu, Q., Zhang, H., Xiong, S., Liu, Y., Chen, L., Wei, Y., Zhao, X., et al., 2013. Induction of Apoptosis and Inhibition of Angiogenesis by PEGylated Liposomal Quercetin in Both Cisplatin-Sensitive and Cisplatin-Resistant Ovarian Cancers. J Biomed Nanotechnol, 9, 965-975.
[43] Zhao, J., Liu, J., Wei, T., Ma, X., Cheng, Q., Huo, S., Zhang, C., Zhang, Y., Duan, X. L., Liang, X. J., et al., 2016. Quercetin-loaded nanomicelles to circumvent human castration-resistant prostate cancer in vitro and in vivo. Nanoscale, 8, 5126-5138.
[44] Gao, X., Wang, B., Wei, X., Men, K., Zheng, F., Zhou, Y., Zheng, Y., Gou, M., Huang, M., Guo, G., et al., 2012, Anticancer effect and mechanism of polymer micelle-encapsulated quercetin on ovarian cancer. Nanoscale, 4(12), 7021-7030.
[45] Jain, A. S., Shah, S. M., Nagarsenker, M. S., Nikam, Y., Gude, R. P., Steiniger, F., Thamm, J., Fahr, A., 2013, Lipid Colloidal Carriers for Improvement of Anticancer Activity of Orally Delivered Quercetin: Formulation, Characterization and Establishing In Vitro–In Vivo Advantage. J. Biomed. Nanotechnol., 9(7), 1230-1240.
[46] da Luz, C. M., Boyles, M. S. P., Falagan-Lotsch, P., Pereira, M. R., Tutumi, H. R., de Oliveira Santos, E., Martins, N. B., Himly, M., Sommer, A., Foissner, I., et al., 2017, Poly-lactic acid nanoparticles (PLA-NP) promote physiological modifications in lung epithelial cells and are internalized by clathrin-coated pits and lipid rafts. J. Nanobiotechnol., 15(1), 11.
[47] Luo, C. L., Liu, Y. Q., Wang, P., Song, C. H., Wang, K. J., Dai, L. P., Zhang, J. Y., Ye, H., 2016, The effect of quercetin nanoparticle on cervical cancer progression by inducing apoptosis, autophagy and anti-proliferation via JAK2 suppression. Biomed. Pharmacother., 82, 595-605.
[48] Kaufman, P. B., Duke, J. A., Brielmann, H., Boik, J., Hoyt, J. E., 1997, A Comparative Survey of Leguminous Plants as Sources of the Isoflavones, Genistein and Daidzein: Implications for Human Nutrition and Health. J. Altern. Complement. Med., 3(1), 7-12.
[49] Rassu, G., Porcu, E. P., Fancello, S., Obinu, A., Senes, N., Galleri, G., Migheli, R., Gavini, E., Giunchedi, P., 2018, Intranasal Delivery of Genistein-Loaded Nanoparticles as a Potential Preventive System against Neurodegenerative Disorders. Pharmaceutics, 11(8), 8.
[50] Zhang, H., Liu, G., Zeng, X., Wu, Y., Yang, C., Mei, L., Wang, Z., Huang, L., 2015, Fabrication of genistein-loaded biodegradable TPGS-b-PCL nanoparticles for improved therapeutic effects in cervical cancer cells. Int. J. Nanomed., 10(7), 2461-2473.
[51] Pool, H., Campos-Vega, R., Herrera-Hernández, M. G., García-Solis, P., García-Gasca, T., Sánchez, I. C., Luna-Bárcenas, G., Vergara-Castañeda, H., 2018, Development of genistein-PEGylated silica hybrid nanomaterials with enhanced antioxidant and antiproliferative properties on HT29 human colon cancer cells. Am. J. Transl. Res., 10(6), 2306-2323.
[52] Spagnuolo, C., Russo, G. L., Orhan, I. E., Habtemariam, S., Daglia, M., Sureda, A., Nabavi, S. F., Devi, K. P., Loizzo, M. R., Tundis, R., et al., 2015, Genistein and Cancer: Current Status, Challenges, and Future Directions. Adv. Nutr., 6(3), 408-419.
[53] Sacko, K., Thangavel, K., Shoyele, S. A., 2019, Codelivery of Genistein and miRNA-29b to A549 Cells Using Aptamer-Hybrid Nanoparticle Bioconjugates. Nanomaterials, 9(8), 1052.
[54] Ghasemi, G. R., Mohammadi, M. R., Malekzadeh, K., 2020, Synthesizing efficacious genistein in conjugation with superparamagnetic Fe3O4 decorated with bio-compatible carboxy methylated chitosan against acute leukemia lymphoma. Biomater. Res., 24(1), 9.
[55] Hogan, F. S., Krishnegowda, N. K., Mikhailova, M., Kahlenberg, M. S., 2007, Flavonoid, Silibinin, Inhibits Proliferation and Promotes Cell-Cycle Arrest of Human Colon Cancer. J. Surg. Res., 143(1), 58-65.
[56] Yazdi Rouholamini, S. E., Moghassemi, S., Maharat, Z., Hakamivala, A., Kashanian, S., Omidfar, K., 2018, Effect of silibinin-loaded nano-niosomal coated with trimethyl chitosan on miRNAs expression in 2D and 3D models of T47D breast cancer cell line. Artif. Cells Nanomed. Biotechnol., 46(3), 524-535.
[57] Xu, P., Yin, Q., Shen, J., Chen, L., Yu, H., Zhang, Z., Li, Y., 2013, Synergistic inhibition of breast cancer metastasis by silibinin-loaded lipid nanoparticles containing TPGS. Int. J. Pharm., 454(1), 21-30.
[58] Gohulkumar, M., Gurushankar, K., Rajendra Prasad, N., Krishnakumar, N., 2014, Enhanced cytotoxicity and apoptosis-induced anticancer effect of silibinin-loaded nanoparticles in oral carcinoma (KB) cells. Mater. Sci. Eng. C, 41, 274-282.
[59] Sajjadiyan, S. Z., Ghadernejad, H., Milani, A. T., Mohammadian, M., Abdolahpour, S., Taslimi, S., Moradi-Sardareh, H., Afrisham, R., Kooti, W., 2016, Preparation of silibinin loaded pegylatedniosomal nanoparticles and investigation of its effect on MCF-10A human breast cancer cell line. Der Pharm. Lett., 8(1), 70-75.
[60] Sahibzada, M. U. K., Sadiq, A., Khan, S., Faidah, H. S., Ullah, N., Khurram, M., Amin, M. U., Haseeb, A., 2017, Fabrication, characterization and in vitro evaluation of silibinin nanoparticles: An attempt to enhance its oral bioavailability. Drug Des. Devel. Ther., 11, 1453-1464.
[61] Huo, M., Wang, H., Zhang, Y., Cai, H., Zhang, P., Li, L., Zhou, J., Yin, T., 2020, Co-delivery of silybin and paclitaxel by dextran-based nanoparticles for effective anti-tumour treatment through chemotherapy sensitization and microenvironment modulation. J. Control Release, 321, 198-210.
[62] Jiang, M., He, K., Qiu, T., Sun, J., Liu, Q., Zhang, X., Zheng, H., 2020, Tumour-targeted delivery of silibinin and IPI-549 synergistically inhibit breast cancer by remodeling the microenvironment. Int. J. Pharm., 581, 119239.
[63] Liu, Y., Xie, X., Hou, X., Shen, J., Shi, J., Chen, H., He, Y., Wang, Z., Feng, N., 2020, Functional oral nanoparticles for delivering silibinin and cryptotanshinone against breast cancer lung metastasis. J. Nanobiotechnol., 18, 83.
[64] Ding, S., Zhang, Z., Song, J., Cheng, X., Jiang, J., Jia, X., 2014, Enhanced bioavailability of apigenin via preparation of a carbon nanopowder solid dispersion. Int. J. Nanomed., 13, 2327–2333.
[65] Das, S., Das, J., Samadder, A., Paul, A., Khuda-Bukhsh, A. R., 2013, Efficacy of PLGA-loaded apigenin nanoparticles in Benzo[a]pyrene and ultraviolet-B induced skin cancer of mice: Mitochondria mediated apoptotic signaling cascades. Food Chem. Toxicol., 62, 670–680.
[66] Bhattacharya, S., Mondal, L., Mukherjee, B., Dutta, L., Ehsan, I., Debnath, M. C., Gaonkar, R. H., Pal, M. M., Majumdar, S., 2018, Apigenin loaded nanoparticle delayed development of hepatocellular carcinoma in rats. Nanomed., 14, 1905–1917.
[67] Huang, Y., Zhao, X., Zu, Y., Wang, L., Deng, Y., Wu, M., Wang, H., 2019, Enhanced Solubility and Bioavailability of Apigenin via Preparation of Solid Dispersions of Mesoporous Silica Nanoparticles. Iran. J. Pharm. Res., 18, 168–182.
[68] Salehi, B., Fokou, P., Sharifi-Rad, M., Zucca, P., Pezzani, R., Martins, N., Sharifi-Rad, J., 2019, The Therapeutic Potential of Naringenin: A Review of Clinical Trials. Pharmaceuticals, 12, 11.
[69] Fuster, M. G., Carissimi, G., Montalbán, M. G., Víllora, G., 2020, Improving Anticancer Therapy with Naringenin-Loaded Silk Fibroin Nanoparticles. Nanomaterials, 10, 718.
[70] Krishnakumar, N., Sulfikkarali, N. K., Manoharan, S., Venkatachalam, P., 2013, Raman spectroscopic investigation of the chemopreventive response of naringenin and its nanoparticles in DMBA-induced oral carcinogenesis. Spectrochim. Acta A Mol. Biomol. Spectrosc., 115, 648–653.
[71] Kumar, S. P., Birundha, K., Kaveri, K., Devi, K. T. R., 2015, Antioxidant studies of chitosan nanoparticles containing naringenin and their cytotoxicity effects in lung cancer cells. Int. J. Biol. Macromol., 78, 87–95.
[72] Chaurasia, S., Patel, R. R., Vure, P., Mishra, B., 2017, Oral naringenin nanocarriers: Fabrication, optimization, pharmacokinetic and chemotherapeutic efficacy assessments. Nanomedicine, 12, 1243–1260.
[73] Sulfikkarali, N., Krishnakumar, N., Manoharan, S., Nirmal, R. M., 2013, Chemopreventive Efficacy of Naringenin-Loaded Nanoparticles in 7,12-dimethylbenz(a)anthracene Induced Experimental Oral Carcinogenesis. Pathol. Oncol. Res., 19, 287–296.
[74] Chaurasia, S., Patel, R. R., Vure, P., Mishra, B., 2018, Potential of Cationic-Polymeric Nanoparticles for Oral Delivery of Naringenin: In Vitro and In Vivo Investigations. J. Pharm. Sci., 107, 706–716.
[75] Imran, M., Rauf, A., Abu-Izneid, T., Nadeem, M., Shariati, M. A., Khan, I. A., Imran, A., Orhan, I. E., Rizwan, M., Atif, M., et al., 2019, Luteolin, a flavonoid, as an anticancer agent: A review. Biomed. Pharmacother., 112, 108612.
[76] Lin, Y., Shi, R., Wang, X., Shen, H.-M., 2008, Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy. Curr. Cancer Drug Targets, 8, 634–646.
[77] Majumdar, D., Jung, K.-H., Zhang, H., Nannapaneni, S., Wang, X., Amin, A. R. M. R., Chen, Z., Chen, Z., Shin, D. M., 2014, Luteolin Nanoparticle in Chemoprevention: In Vitro and In Vivo Anticancer Activity. Cancer Prev. Res., 7, 65–73.
[78] Wozniak, A., Napierala, M., Golasik, M., Herman, M., Walas, S., Piekoszewski, W., Szyfter, W., Szyfter, K., Golusinski, W., Baralkiewicz, D., et al., 2016, Metal concentrations in hair of patients with various head and neck cancers as a diagnostic aid. Biometals, 29, 81–93.
[79] Szyfter, K., Napierala, M., Florek, E., Braakhuis, B., Takes, R. P., Rodrigo, J. P., Rinaldo, A., Silver, C. E., Ferlito, A., 2019, Molecular and health effects in the upper respiratory tract associated with tobacco smoking other than cigarettes. Int. J. Cancer, 144, 2635–2643.
[80] Golasik, M., Jawie ń, W., Przybyłowicz, A., Szyfter, W., Herman, M., Golusi ński, W., Florek, E., Piekoszewski, W., 2015, Classification models based on the level of metals in hair and nails of laryngeal cancer patients: Diagnosis support or rather speculation? Metallomics, 7, 455–465.
[81] Wu, C., Xu, Q., Chen, X., Liu, J., 2019, Delivery luteolin with folacin-modified nanoparticle for glioma therapy. Int. J. Nanomed., 14, 7515–7531.
[82] Alshehri, S.; Imam, S. S.; Altamimi, M. A.; Hussain, A.; Shakeel, F.; Elzayat, E.; Mohsin, K.; Ibrahim, M.; Alanazi, F., 2020, Enhanced dissolution of luteolin by solid dispersion prepared by different methods: physicochemical characterization and antioxidant activity. ACS Omega, 5, 6461–6471.
[83] Chen, A. Y.; Chen, Y. C., 2013, A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention. Food Chemistry, 138, 2099–2107.
[84] Luo, H.; Jiang, B.; Li, B.; Li, Z.; Jiang, B. H.; Chen, Y. C., 2012, Kaempferol nanoparticles achieve strong and selective inhibition of ovarian cancer cell viability. International Journal of Nanomedicine, 7, 3951–3959.
[85] Tu, L. Y., Bai, H. H., Cai, J. Y., Deng, S. P., 2016, The mechanism of kaempferol induced apoptosis and inhibited proliferation in human cervical cancer SiHa cell: from macro to nano: Anticancer effect of kaempferol on SiHa cells. Scanning, 38, 644–653.
[86] Colombo, M., Figueiró, F., de Fraga Dias, A., Teixeira, H. F., Battastini, A. M. O., Koester, L. S., 2018, Kaempferol-loaded mucoadhesive nanoemulsion for intranasal administration reduces glioma growth in vitro. International Journal of Pharmaceutics, 543, 214–223.
[87] Govindaraju, S., Roshini, A., Lee, M., Yun, K., 2019, Kaempferol conjugated gold nanoclusters enabled efficient for anticancer therapeutics to A549 lung cancer cells. International Journal of Nanomedicine, 14, 5147–5157.
[88] Khan, N., Syed, D. N., Ahmad, N., Mukhtar, H., 2013, Fisetin: A dietary antioxidant for health promotion. Antioxidants & Redox Signaling, 19, 151–162.
[89] Ghosh, P., Singha Roy, A., Chaudhury, S., Jana, S. K., Chaudhury, K., Dasgupta, S., 2016, Preparation of albumin based nanoparticles for delivery of fisetin and evaluation of its cytotoxic activity. International Journal of Biological Macromolecules, 86, 408–417.
[90] Feng, C., Yuan, X., Chu, K., Zhang, H., Ji, W., Rui, M., 2019, Preparation and optimization of poly(lactic acid) nanoparticles loaded with fisetin to improve anti-cancer therapy. International Journal of Biological Macromolecules, 125, 700–710.
[91] Dobrzynska, M., Napierala, M., Florek, E., 2020, Flavonoid nanoparticles: A promising approach for cancer therapy. Biomolecules, 10(9), 1268.
[92] Murali Iyangar, R.; Devaraj, E., 2020, Silibinin triggers the mitochondrial pathway of apoptosis in human oral squamous carcinoma cells. Asian Pacific Journal of Cancer Prevention, 21(7), 1877–1882.
[93] L. A., Krishna Kumar, J., Shanmugam, R., 2024, Formulation of quercetin mouthwash and anti-microbial potential against critical pathogens: an in-vitro evaluation. Cureus, 16(1), e51688.
[94] Muruganathan, N., Dhanapal, A. R., Baskar, V., Muthuramalingam, P., Selvaraj, D., Aara, H., Shiek Abdullah, M. Z., Sivanesan, I., 2022, Recent updates on source, biosynthesis, and therapeutic potential of natural flavonoid luteolin: a review. Metabolites, 12(11), 1145.
[95] Shanmugam, R., Tharani, M., Abullais, S. S., 2024, Black seed assisted synthesis, characterization, free radical scavenging, antimicrobial and anti-inflammatory activity of iron oxide nanoparticles. BMC Complement Med Ther., 24(24):241.
[96] Habeeb Rahuman, H. B., Dhandapani, R., Narayanan, S., Palanivel, V., Paramasivam, R., Subbarayalu, R., Thangavelu, S., Muthupandian, S., 2022, Medicinal plants mediated the green synthesis of silver nanoparticles and their biomedical applications. IET Nanobiotechnol. 16(4):115-144.
[97] Wadhwa, R., Paudel, K. R., Chin, L. H., Hon, C. M., Madheswaran, T., Gupta G., Panneerselvam, J., Lakshmi, T., 2021, Anti-inflammatory and anticancer activities of Naringenin-loaded liquid crystalline nanoparticles in vitro. J Food Biochem. 45(1): e13572.
Viewed PDF 5 0 -
Millet: Key to Alleviate Micronutrient Deficiencies (Calcium & Iron) among Adolescent GirlsAuthor: A. AnnapurnaDOI: 10.21522/TIJPH.2013.12.04.Art052
Millet: Key to Alleviate Micronutrient Deficiencies (Calcium & Iron) among Adolescent Girls
Abstract:
Nutritionally and economically millets are superior to staples like rice and wheat. Studies suggest that processes like soaking, germination and fermentation have considerably reduced inhibiting factors and improved mineral bioavailability. Cross-sectional studies reported that a large section of Indian females consume less than 50% of the recommended dietary intake of iron, calcium and folic acid. One of the primary reasons for deficiency disorders is the consumption of plant-based diets containing antinutritional factors that inhibit mineral absorption and utilization. This research was undertaken to study the effect of fermentation on mineral bioavailability, antinutrient reduction in Pearl millet and Italian millet and the acceptability of millet-fermented products (Pearl millet dosa and Italian millet dosa) by adolescent girls. On 12hrs of fermentation Pearl millet and Italian millet showed a significant reduction in the phytate content (752 ±0.03 to 650 ±0.04 mg% in Pearl millet and 700 ± 0.05 to 650 ±0.04 mg% in Italian millet). Similarly, polyphenol content decreased from (190.06 ±0.088 to 100.016 ±0.044 and 130.04 ± 0.00 to 100.06 ± 0.031 mg% respectively). This reduction was found to correlate with the increase in calcium and iron bioavailability. Evaluation of the organoleptic properties of millet dosas revealed overall acceptability among adolescent girls. It can thus be concluded that the intake of fermented millet is key to alleviating micronutrient deficiencies among adolescent girls.
Millet: Key to Alleviate Micronutrient Deficiencies (Calcium & Iron) among Adolescent Girls
References:
[1]. World Health Organization: The global strategy for women's, children's and adolescents' health (2016–2030): Survive, thrive, transform., 2015.
[2]. UNICEF: Progress for children: A report card for adolescents., 2012.
[3]. Singh, S., Gopalkrishna, G., 2014, Health behaviours and problems among young people in India: cause for concern and call for action, Indian J Med Res.,140(2),185.
[4]. Ministry of Health and Family Welfare: National Family Health Survey - 4 2015–16: India fact sheet., 2017.
[5]. Ministry of Women and Child Development, UNICEF. Rapid Survey on Children 2013–2014. New Delhi: Government of India, 2014.
[6]. Bailey, R., 2015, The Epidemiology of Global Micronutrient Deficiencies, Ann Nutr Metab., 66(2), 22.
[7]. Venkatesh, U, Sharma, A, Ananthan, V. A., 2021, Micronutrient’s deficiency in India: A Systematic review and meta-analysis, J Nutr Sci.,10, 110.
[8]. Mahesh, et al., 2022, Demystifying the micronutrient deficiency burden in India, IP Journal of Nutrition, Metabolism and Health Science, 5(3), 91.
[9]. Ritchie, H, Reay, D. S., 2018, Projecting and Addressing India’s Hidden Hunger, Front Sustain Food Syst., 2, 11.
[10]. Lowe, N. M., 2021, The global challenge of hidden hunger: perspectives from the field, Proc Nutr Soc., 80(3), 283.
[11]. Recommended Dietary Allowances and Estimated Average Requirements Nutrient Requirements for Indians - 2020, A Report of the Expert Group Indian Council of Medical Research National Institute of Nutrition, 2020.
[12]. Shalini, T, Sivaprasad, M, Balakrishna, N., 2019, Micronutrient intakes and status assessed by probability approach among the urban adult population of Hyderabad city in South India, Eur J Nutr., 58(8), 3147.
[13]. Sharma, S, Akhtar, F, Singh, R. K., 2020, Dietary Intake across Reproductive Life Stages of Women in India: A Cross-Sectional Survey from 4 Districts of India, J Nutr Metab., 23, 9549214.
[14]. von, Haehling, S., Ebner, N., Evertz, R., Ponikowski, P., Anker, S. D., 2019, Iron Deficiency in Heart Failure: An Overview, JACC Hear Fail, 7 (1), 36.
[15]. Seyoum, Y., Humblot, C., Nicolas, G., Thomas, M., Baye, K., 2019, Iron deficiency and anaemia in adolescent girls consuming predominantly plant-based diets in rural Ethiopia, Scientific Reports, 9, 17244.
[16]. Brouns, F., 2022, Phytic Acid and Whole Grains for Health Controversy, Nutrients, 14 (1), 25.
[17]. Anitha, S., Kane-Potaka, J., Tsusaka, T. W., Botha, R., Rajendran, A., Givens, D. I., et al., 2021, A systematic review and meta-analysis of the potential of millets and sorghum for managing and preventing diabetes mellitus, Front. Nutr., 8, 687428.
[18]. Nicodemus, K. K., Jacobs, D. R. J., and Folsom, A. R., 2001, Whole and refined grain intake and risk of incident postmenopausal breast cancer, Cancer Causes Control, 12, 917.
[19]. Arora, L., Aggarwal, R., Dhaliwal, I., Gupta, O. P. and Kaushik, P., 2023, Assessment of sensory and nutritional attributes of foxtail millet-based food products, Front. Nutr., 10, 1146545.
[20]. Liang, J., Han, B. Z., Nout, M. R., and Hamer, R. J., 2008, Effects of soaking, germination and fermentation on phytic acid, total and in vitro soluble zinc in brown rice, Food Chem., 110, 821.
[21]. Abdel-Haleem, W. H., El Tinay, A. H., Mustafa, A. I., Babiker, E. E., 2008, Effect of fermentation, malt-pretreatment and cooking on antinutritional factors and protein digestibility of sorghum cultivars, Pakistan J. Nutr., 7, 335.
[22]. Osman, M. A., 2011, Effect of traditional fermentation process on the nutrient and antinutrient contents of pearl millet during the preparation of Lohoh, J. Saudi Soc. Agric. Sci., 10, 1.
[23]. Ejigui, J., Savoie, L., Marin, J., Desrosiers, T., 2005, Beneficial changes and drawbacks of a traditional fermentation process on chemical composition and antinutritional factors of yellow Maize (Zea mays), J. Biol. Sci., 5 (5), 590.
[24]. Eltayeb, M. M., Hassan, A. B., Sulieman, M. A., Babiker, E. E., 2007, Effect of processing followed by fermentation on antinutritional factors content of pearl millet (Pennisetum glaucum L.) cultivars, Pakistan. J. Nutr., 6, 463.
[25]. Kumar, A., Tomer, V., Kaur, A., Gupta, K., 2018, Millets: A solution to agrarian and nutritional challenges, Agric & Food Secur., 7:31
[26]. Gahalawat, P., Lamba, N., Chaudhary, P., 2024, Nutritional and health benefits of millets: A review article, J Indian Sys Medicine,12, 4.
[27]. Das, S., Khound, R., Santra, M., Santra, D. K., 2019, Beyond bird feed: proso millet for human health and environment, Agriculture, 9(3), 64.
[28]. AOAC, 1985. Official methods of analysis, Washington, D. C., Edn no. 14, Association of Official Chemists.
[29]. Hawk, Oser and Summerson (Eds), 1957, Practical Physiological Chemistry, 13th edition 644.
[30]. Raghuramulu, N., Madhavan, N. K., and Kalyana Sundaram (Eds), 1983, A manual of laboratory techniques, NIN, Hyderabad.
[31]. Peterson, W. H., Skipner, J. T. and Strong, F. M., 1943, Elements of Food Chemistry, Prentice Hall, Inc. New York, 73.
[32]. Davies, N. T. and Reid, H., 1979, An evaluation of phytate, zinc, copper, iron and manganese content of and availability from soya-based textured vegetable protein meat substitutes or meat extruders, Brit. J. Nutri., 4:579.
[33]. AOAC, 1984. Official methods of analysis of the association of official chemists, Arlington, U. S. A. 14th edn., Association of Analytical Chemists, p. 187.
[34]. Price, M. L. and Van Scoyoc, S. and Butler, L. G., 1978, A critical evaluation of the vanillin reaction as an assay for tannins and sorghum grain, J. Agric. Food Chem., 26, 1214.
[35]. Gupta, M., Khetarpaul, N. and Chauhan, B. M., 1991, Effect of rabadi fermentation on Hcl-extractability of minerals of wheat, Food Chem., 42(1), 111.
[36]. Patton, G. C., Sawyer, S. M., Santelli, J. S., Ross, D. A., Afifi, R., Allen, N. B., Arora, M., Azzopardi, P., Baldwin, W., Bonell, C. et al., 2016, Our future: A Lancet commission on adolescent health and wellbeing, Lancet, 387(10036), 2423.
[37]. Fall, C. H., Sachdev, H. S., Osmond, C., Restrepo-Mendez, M. C., Victora, C., Martorell, R., Stein, A. D., Sinha, S., Tandon, N., Adair, L. et al., 2015, Association between maternal age at childbirth and child and adult outcomes in the offspring: a prospective study in five low-income and middle-income countries (COHORTS collaboration), Lancet Glob Health, 3(7), 366.
[38]. Aggarwal, V., Seth, A., Aneja, S., Sharma, B., Sonkar, P., Singh, S., Marwaha, R. K., 2012, Role of calcium deficiency in development of nutritional rickets in Indian children: a case-control study, J Clin Endocrinol Metab., 97(10), 3461.
[39]. Akinyele, I. O. and Akinlosotu, A., 1991, Effect of soaking dehulling and fermentation on the oligosaccharides and Nutrient Content of Cowpeas (Vigna unguiculata), Food Chem., 41, 43.
[40]. Khetarpaul, N. and Chauhan, B. M., 1989, Improvement in Hcl Extractability of Mineral from Pearl Millet (Pennisetum typhoides) by fermentation with Yeasts and Lactobacilli, J. Sci. Food Agric., 49, 117.
[41]. Daniels, D. G. H. and Fisher, N., 1981, Hydrolysis of the phytate of wheat flour during bread making, Brit. J. Nutr., 46, 1.
[42]. Dhanker, N. and Chauhan, B. M., 1987, Effect of temperature and period of fermentation on protein and starch digestibility (in vitro) of rabadi – A pearl millet fermented food, J. Food Sci., 52(2), 489.
Viewed PDF 5 0 -
A Study to Evaluate the Change in Symptom Severity of Individuals with Psychiatric Disorders & Relationship with Socio-Occupational Functioning and Perceived Covid-19 StressAuthor: S. GopinathDOI: 10.21522/TIJPH.2013.12.04.Art053
A Study to Evaluate the Change in Symptom Severity of Individuals with Psychiatric Disorders & Relationship with Socio-Occupational Functioning and Perceived Covid-19 Stress
Abstract:
We are aware of the severe service disruptions caused by the pandemic and the present global crisis. Lockdown has also been proven to increase stress, anxiety, and depression in the general population. People with pre-existing psychiatric problems are more likely than the average person to experience stress, anxiety, and sadness. This study's objective was to assess the potential impact of the COVID-19 pandemic on the severity of the illness and daily functioning of people with psychiatric disorders. The study's methodology involved a cross-sectional analysis of outpatients in the psychiatry department who had received treatment for a full year before and after March 2020. Both the COVID threat scale and the Work and Social Adjustment Scale were used. We observed that in individuals with psychiatric disorders', illness severity significantly deteriorated after March 2020 compared to the pre-covid time (P = 0.001). Individuals’ ability to maintain a close relationship was strongly impacted by the work and social adjustment measure among individuals whose illness worsened (P = 0.008). We demonstrated that individuals with psychological disorders exhibited a significant worsening of symptoms and an impairment in their ability to maintain close relationships during the COVID-19 pandemic.
A Study to Evaluate the Change in Symptom Severity of Individuals with Psychiatric Disorders & Relationship with Socio-Occupational Functioning and Perceived Covid-19 Stress
References:
[1] Almutairi, M. M., Sivandzade, F., Albekairi, T. H., Alqahtani, F., & Cucullo, L., 2021, Neuroinflammation and Its Impact on the Pathogenesis of COVID-19. Frontiers in Medicine, 8, 745789.
[2] Colizzi, M., Peghin, M., De Martino, M., Bontempo, G., Gerussi, V., Palese, A., Isola, M., Tascini, C., & Balestrieri, M., 2023, Mental health symptoms one year after acute COVID-19 infection: Prevalence and risk factors. Revista de Psiquiatría y Salud Mental, 16, 38–46.
[3] De Hert, M., Mazereel, V., Stroobants, M., De Picker, L., Van Assche, K., & Detraux, J., 2021, COVID-19-Related Mortality Risk in People with Severe Mental Illness: A Systematic and Critical Review. Frontiers in Psychiatry, 12, 798554.
[4] Fernández-Aranda, F., Casas, M., Claes, L., Bryan, D. C., Favaro, A., Granero, R., Gudiol, C., Jiménez-Murcia, S., Karwautz, A., Le Grange, D., Menchón, J. M., Tchanturia, K., & Treasure, J., 2020, COVID-19 and implications for eating disorders. European Eating Disorders Review: The Journal of the Eating Disorders Association, 28(3), 239–245.
[5] Hao, F., Tan, W., Jiang, L., Zhang, L., Zhao, X., Zou, Y., Hu, Y., Luo, X., Jiang, X., McIntyre, R. S., Tran, B., Sun, J., Zhang, Z., Ho, R., Ho, C., & Tam, W., 2020, Do psychiatric patients experience more psychiatric symptoms during COVID-19 pandemic and lockdown? A case-control study with service and research implications for immunopsychiatry. Brain, Behavior, and Immunity, 87, 100–106.
[6] Iasevoli, F., Fornaro, M., D'Urso, G., Galletta, D., Casella, C., Paternoster, M., & COVID-19 in Psychiatry Study Group, 2021, Psychological distress in patients with serious mental illness during the COVID-19 outbreak and one-month mass quarantine in Italy. Psychological Medicine, 51(6), 1054-1056.
[7] Iwasaki, Y., 2006, Counteracting stress through leisure coping: A prospective health study. Psychology, Health & Medicine, 11(2), 209–220. https://doi.org/10.1080/13548500500155941
[8] Kim, J., & Kim, J.-H., 2014, A Facilitator of Leisure Activities for Stress-Related Growth Experience Among Middle-Aged Korean Women with Depression. Health Care for Women International, 35(11–12), 1245–1266.
[9] Kleiber, D. A., Hutchinson, S. L., & Williams, R., 2002, Leisure as a Resource in Transcending Negative Life Events: Self-Protection, Self-Restoration, and Personal Transformation. Leisure Sciences, 24(2), 219–235.
[10] Lee, Y.-R., Chung, Y.-C., Kim, J. J., Kang, S. H., Lee, B. J., Lee, S.-H., Lee, J., Jung, H.-R., Hyun, J., Jhon, M., Kim, J.-W., Ryu, S., Lee, J.-Y., Kim, J.-M., & Kim, S.-W., 2022, Effects of COVID-19-related stress and fear on depression in schizophrenia patients and the general population. Schizophrenia (Heidelberg, Germany), 8(1), 15.
[11] Lewis, K. J. S., Gordon‐Smith, K., Saunders, K. E. A., Dolman, C., South, M., Geddes, J., Craddock, N., Di Florio, A., Jones, I., & Jones, L., 2022, Mental health prior to and during the COVID ‐19 pandemic in individuals with bipolar disorder: Insights from prospective longitudinal data. Bipolar Disorders, 24(6), 658–666.
[12] Lysaker, P. H., Weiden, P. J., Sun, X., O’Sullivan, A. K., & McEvoy, J. P., 2022, Impaired insight in schizophrenia: Impact on patient-reported and physician-reported outcome measures in a randomized controlled trial. BMC Psychiatry, 22(1), 574.
[13] Nooraeen, S., Bazargan-Hejazi, S., Naserbakht, M., Vahidi, C., Shojaerad, F., Mousavi, S. S., & Malakouti, S. K., 2023, Impact of COVID-19 pandemic on relapse of individuals with severe mental illness and their caregiver’s burden. Frontiers in Public Health, 11, 1086905.
[14] Patterson, I., & Coleman, D., 2000, The Impact of Stress on Different Leisure Dimensions. Leisure/Loisir, 25(3–4), 203–223.
[15] Rahmani, F., Roshangar, F., Gholizadeh, L., & Asghari, E., 2022, Caregiver burden and the associated factors in the family caregivers of patients with schizophrenia. Nursing Open, 9(4), 1995–2002.
[16] Sharma, L. P., Balachander, S., Thamby, A., Bhattacharya, M., Kishore, C., Shanbhag, V., Jaisoorya, T., Narayanaswamy, J. C., Arumugham, S. S., & Reddy, Y. J., 2020, Impact of the COVID-19 Pandemic on the Short-term Course of Obsessive-Compulsive Disorder [Preprint]. Psychiatry and Clinical Psychology.
[17] Taquet, M., Geddes, J. R., Husain, M., Luciano, S., & Harrison, P. J., 2021, 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: A retrospective cohort study using electronic health records. The Lancet Psychiatry, 8(5), 416–427.
[18] Wijndaele, K., Matton, L., Duvigneaud, N., Lefevre, J., De Bourdeaudhuij, I., Duquet, W., Thomis, M., & Philippaerts, R. M., 2007, Association between leisure time physical activity and stress, social support and coping: A cluster-analytical approach. Psychology of Sport and Exercise, 8(4), 425–440.
[19] Zhou, J., Wang, Y., Bu, T., Zhang, S., Chu, H., Li, J., He, J., Zhang, Y., Liu, X., Qiao, Z., Yang, X., & Yang, Y., 2021, Psychological Impact of COVID-19 Epidemic on Adolescents: A Large Sample Study in China. Frontiers in Psychiatry, 12, 769697.
Viewed PDF 5 0 -
Enhanced HACBLalign Method using Transitional Pattern Search and Pre-Trained Classification Model for Protein Remote Homology Detection and Fold RecognitionAuthor: Gopinath KrishnarajDOI: 10.21522/TIJPH.2013.12.04.Art054
Enhanced HACBLalign Method using Transitional Pattern Search and Pre-Trained Classification Model for Protein Remote Homology Detection and Fold Recognition
Abstract:
One of the most important tasks to predict the structure of proteins is Protein Remote Homology Detection and Fold Recognition. To do this, a Hierarchical Attention-based Convolutional Neural Network with Bidirectional Long Short-Term Memory called the HACBLalign algorithm was proposed by the authors, which performs Multiple Sequence Alignments (MSAs), extracts features, and recognizes protein homologies. But, when the quantity of Protein Sequences (PSs) increases, the number of times the decision-making system runs also increases. To avoid this issue, this article proposes an Enhanced HACBLalign (EHACBLalign) method using Transitional Pattern Search (TPS) and pre-trained classification for Protein Remote Homology Detection and Fold Recognition. During the alignment stage, the intermediate sequences such as Hit Regions (HRs) are identified by the TPS. Then, the HRs are extended in middle layers and utilized as a query in all TPS iterations. Besides, the HACBLalign algorithm is applied in all intermediate layers for generating pairwise alignments. Moreover, each pairwise alignment between intermediate sequences is merged to get the final alignment. Further, various characteristics are obtained from the chosen alignment and learned by the pre-trained Convolutional Neural Network (CNN) with a softmax function for recognizing protein remote homologies precisely. This enhances the performance of the decision-making system for large-scale PS databases. Finally, the test outcomes exhibit that the EHACBLalign realizes a 94.6%, 94.1%, and 93.4% accuracy on SCOP 1.53, SCOP 1.67, and superfamily corpora, respectively in Protein Remote Homology Detection and Fold Recognition.
Enhanced HACBLalign Method using Transitional Pattern Search and Pre-Trained Classification Model for Protein Remote Homology Detection and Fold Recognition
References:
[1]. Lv, Z., Ao, C., and Zou, Q., 2019, Protein function prediction: from traditional classifier to deep learning, Proteomics, 19(14), 1-5.
[2]. Jing, X., Dong, Q., Hong, D., and Lu, R., 2019, Amino acid encoding methods for protein sequences: A comprehensive review and assessment, IEEE/ACM Transactions on Computational Biology and Bioinformatics, 17(6), 1918-1931.
[3]. Rajapaksa, S, Sumanaweera, D, Lesk, A, M, Allison, L, Stuckey, P, J, Garcia de la Banda, M, and Konagurthu, A, S., 2022, On the reliability and the limits of inference of amino acid sequence alignments, Bioinformatics, 38(Supplement_1), i255-i263.
[4]. Peyravi, F, Latif, A, and Moshtaghioun, S. M., 2019, Protein tertiary structure prediction using hidden Markov model based on lattice, Journal of Bioinformatics and Computational Biology, 17(02), 1-18.
[5]. Wilburn, G. W., and Eddy, S. R., 2020. Remote homology search with hidden Potts model, PLOS Computational Biology, 16(11), 1-22.
[6]. Chen, J., Guo, M., Wang, X., and Liu, B., 2018, A comprehensive review and comparison of different computational methods for protein remote homology detection, Briefings in Bioinformatics, 19(2), 231-244.
[7]. Li, C, C., and Liu, B., 2020, MotifCNN-fold: protein fold recognition based on fold-specific features extracted by motif-based convolutional neural networks, Briefings in Bioinformatics, 21(6), 2133-2141.
[8]. Wu, Z., Liao, Q., and Liu, B., 2020, A comprehensive review and evaluation of computational methods for identifying protein complexes from protein–protein interaction networks, Briefings in Bioinformatics, 21(5), 1531-1548.
[9]. Liu, B., Chen, J., Guo, M., and Wang, X., 2017, Protein remote homology detection and fold recognition based on sequence-order frequency matrix, IEEE/ACM Transactions on Computational Biology and Bioinformatics, 16(1), 292-300.
[10]. Guo, Y., Yan, K., Wu, H., and Liu, B., 2020, ReFold-MAP: Protein remote homology detection and fold recognition based on features extracted from profiles, Analytical Biochemistry, 611, 1-8.
[11]. Gopinath, K., and Rajendran, G., 2023, HACBLalign: A Hierarchical Attention-based deep learning for protein remote homology and fold identification, Journal of Theoretical and Applied Information Technology, 14(101), 5578 – 5588.
[12]. Makigaki, S, and Ishida, T., 2020, Sequence alignment using machine learning for accurate template-based protein structure prediction, Bioinformatics, 36(1), 104-111.
[13]. Zhang, C., Zheng, W., Mortuza, S. M., Li, Y., and Zhang, Y., 2020, Deep MSA: Constructing deep multiple sequence alignment to improve contact prediction and fold-recognition for distant-homology proteins, Bioinformatics, 36(7), 2105-2112.
[14]. Senior, A. W., Evans, R., Jumper, J., Kirkpatrick, J., Sifre, L., Green, T., and Hassabis, D., 2020, Improved protein structure prediction using potentials from deep learning, Nature, 577(7792), 706-710.
[15]. Wu, F., and Xu, J., 2021, Deep template-based protein structure prediction, PLoS Computational Biology, 17(5), 1-18.
[16]. Wu, T., Guo, Z., Hou, J., and Cheng, J., 2021, DeepDist: Real-value inter-residue distance prediction with deep residual convolutional network, BMC Bioinformatics, 22(1), 1-17.
[17]. Hakala, K., Kaewphan, S., Bjorne, J., Mehryary, F., Moen, H., Tolvanen, M., and Ginter, F., 2022, Neural network and random forest models in protein function prediction. IEEE/ACM Transactions on Computational Biology and Bioinformatics, 19(3), 1772-1781.
[18]. Liu, J., Wu, T., Guo, Z., Hou, J., and Cheng, J., 2022, Improving protein tertiary structure prediction by deep learning and distance prediction in CASP14. Proteins: Structure, Function, and Bioinformatics, 90(1), 58-72.
[19]. Zhang, C., and Pyle, A, M., 2022, A unified approach to sequential and non-sequential structure alignment of proteins, RNAs and DNAs, Iscience, 25(10), 1-13.
[20]. Rangwala, H, and Karypis, G., 2005, Profile-based direct kernels for remote homology detection and fold recognition, Bioinformatics, 21(23), 4239-4247.
[21]. Håndstad, T., Hestnes, A. J., and Sætrom, P., 2007, Motif kernel generated by genetic programming improves remote homology and fold detection, BMC Bioinformatics, 8(1), 1-16.
[22]. Andreeva, A., Kulesha, E., Gough, J., and Murzin, A, G., 2020, The SCOP database in 2020: expanded classification of representative family and superfamily domains of known protein structures. Nucleic Acids Research, 48(D1), D376-D382.
[23]. Devlin, J., Chang, M. W., Lee, K., and Toutanova, K., 2018, Bert: Pre-training of deep bidirectional transformers for language understanding, arXiv preprint arXiv:1810.04805.
Viewed PDF 5 0 -
A Holistic Approach in the Management of Psychosomatic Diseases of the Oral Cavity-A Harmony in HealthAuthor: Anuradha GanesanDOI: 10.21522/TIJPH.2013.12.04.Art056
A Holistic Approach in the Management of Psychosomatic Diseases of the Oral Cavity-A Harmony in Health
Abstract:
Psychosomatic diseases of the oral cavity present complex challenges involving physical symptoms with psychological factors. Traditional medical treatments often fall short, necessitating a holistic approach that addresses both the mind and body to achieve harmony in health. This paper explores a multifaceted management strategy for these disorders, integrating pharmacological treatments, behavioural therapies, and supportive care. Pharmacological interventions remain essential, with antidepressants, anticonvulsants, and anxiolytics providing symptom relief. However, these are complemented by behavioural therapies such as Habit Reversal Training (HRT), which targets the elimination of harmful oral habits through awareness and competing response strategies. Cognitive-behavioural therapy (CBT) and mindfulness-based stress reduction (MBSR) also play crucial roles in addressing the psychological aspects of these disorders, promoting mental well-being and reducing symptom exacerbation. Biofeedback is a therapeutic technique that has been employed in the management of various psychosomatic disorders, including those that manifest in the oral region This holistic approach not only alleviates physical symptoms but also addresses emotional and psychological distress, leading to comprehensive care and improved quality of life for patients with psychosomatic oral diseases. By harmonizing physical and mental health strategies, this method shows a balanced and effective model for managing complex oral health disorders.
A Holistic Approach in the Management of Psychosomatic Diseases of the Oral Cavity-A Harmony in Health
References:
[1]. Singh, G., Singhvi, A., Kour, P., Singhvi, P., Bhati, R., Choudhary, R. M.,2023, Psychosomatic Disorders Affecting the Oral Cavity: A Review on Etiopathogenesis and Treatment Modalities. National Research Denticon, 12(4).
[2]. Li, X., Zhang, X., Chen, X., Liu, J., Zhou, X., 2023, Psychostomatology: The psychosomatic status and approaches for the management of oral mucosal diseases. Sci Total Environ, 763,144231.
[3]. Pradeep, D. X., 2023, Management of Psychosomatic Oral Diseases and Neurotic Oral Symptoms: A Review. IJCMS, 15(1),1-6.
[4]. Kemeny, M. E., 2003, The psychobiology of stress. Curr Dir Psychol Sci. 12(4), 124-9.
[5]. Kumar, N. N., Panchaksharappa, M. G., Annigeri, R. G., 2016, Psychosomatic disorders: An overview for oral physician. J Indian Acad Oral Med Radiol, 28, 24-9.
[6]. Miller, V., Perea-Baena, Y., Garcia-Pola, M., Gutierrez-Perez, J. L., 2023, Psychosomatic Disorders in Oral Medicine. Med Oral Patol Oral Cir Bucal, 28(2), e233-e238.
[7]. Davis, B. J., Shen, Y., Pritchard, R., 2023, Integrative Medicine and the Management of Psychosomatic Disorders. Holist Nurs Pract, 37(2),97-104.
[8]. Greenberg, M. S., Glick, M., 2023, Burket's Oral Medicine. 13th ed. Shelton, CT: People's Medical Publishing House.
[9]. Warren, J. J., Hietanen, J., Mowrer, J., Levy, S. M., 2023, A Review of Psychological Treatments for Oral Psychosomatic Conditions. Psychosom Med, 85(2),198-205.
[10]. Bergdahl, J., Anneroth, G., Perris, H.,1995, Cognitive therapy in the treatment of patients with resistant burning mouth syndrome: A controlled study. J Oral Pathol Med, 24(5), 213-8.
[11]. Dworkin, S. F., Turner, J. A., Wilson, L., Massoth, D., Whitney, C., Huggins, K. H., et al., 1994, Brief group cognitive-behavioral intervention for temporomandibular disorders. Pain, 59(2), 175-87.
[12]. Andersson, L., Carlsson, G. E., 2023, Cognitive Behavioral Therapy in the Treatment of Psychosomatic Disorders of the Oral Cavity. J Oral Rehabil, 50(3),212-220.
[13]. Aggarwal, V. R., Lovell, K., Peters, S., et al.,2023, Psychosocial interventions for the management of chronic orofacial pain. Cochrane Database Syst Rev, 11,CD008456.
[14]. Jeelani, S., Asokan, G. S., Anuradha, G., Parthiban, J., Sivasankari, T., 2014, The baffling human body and the boundless nanomaterial boon-a trap for cancer crab. J Clin Diagn Res, Jul, 8(7), ZE09-12. doi: 10.7860/JCDR/2014/9245.4584.
[15]. Bhateja, S., Gupta, H., Chouhan, S., Sansanwal, M., Arora, G., 2019, Behavioural medicine for oral psychosomatic disorders. J Nutr, Metab Health Sci, 2(3),71-8.
[16]. Ganesan, A., Gauthaman, J., Kumar, G., 2022, The impact of mindfulness meditation on the psychosomatic spectrum of oral diseases: mapping the evidence. J Lifestyle Med, 12(1), 1-8.doi: 10.15280/jlm.2022.12.1.1, PMID 35300038.
[17]. Abrahamsen, R., Zachariae, R., Svensson, P., 2009, Effect of hypnosis on oral function and psychological factors in temporomandibular disorders patients. J Oral Rehabil, 36(8), 556-70. doi: 10.1111/j.1365-2842.2009.01974.x. PMID: 19604319.
[18]. Clark, G. T, Mulligan, R., 2012, Managing the behavioral components of temporomandibular disorders. J Am Dent Assoc, 143(4),403-408.
[19]. Harriman, C., Lyons, S., Taylor, M., Henry, M., 2023, Psychosomatic Medicine in Dental Practice: An Overview. Aust Dent J, 68(1), 24-30.
[20]. Sansone, R. A, Sansone, L. A. Serotonin norepinephrine reuptake inhibitors: A pharmacological comparision. Innov Clin Neurosci. 2014, Mar;11(3-4):3742. PMID:24800132; PMCID:PMC4008300
[21]. Cohen, H. V., Dym, H., 2020, Pharmacologic treatment for temporomandibular disorders. Dent Clin North Am, 64(2), 347-358.
[22]. Johnson, N., Kress, B., 2023, Integrative Approaches to Oral Medicine: Combining Eastern and Western Techniques. J Altern Complement Med, 29(4), 301-310.
[23]. Karaaslan, E., Kocaelli, H., 2020, Pharmacological treatment strategies for burning mouth syndrome: A comprehensive review. J Clin Exp Dent, 12(1):e120-e127.
[24]. Zakrzewska, J. M., Forssell, H., 2016, Glossodynia (burning mouth syndrome). In: Orofacial Pain and Headache. Springer, 189-197.
Viewed PDF 5 0 -
Community Engagement in Strengthening Health Systems and Vaccination of Zero-Dose Children in the Central African Republic: The Case of the Kemo-Carnot-Paoua Districts; Challenges and ImpactsAuthor: Moussa MbodjiDOI: 10.21522/TIJPH.2013.12.04.Art057
Community Engagement in Strengthening Health Systems and Vaccination of Zero-Dose Children in the Central African Republic: The Case of the Kemo-Carnot-Paoua Districts; Challenges and Impacts
Abstract:
Vaccination is one of the most effective and cost-effective public health interventions, saving millions of lives each year. However, its benefits are not evenly distributed, as there are disparities in coverage that leave vulnerable populations in poor, marginalized, or conflict-affected regions with insufficient protection. For example, in the Central African Republic (CAR), where the health system is severely weakened by prolonged conflict and the COVID-19 pandemic, issues such as limited access to vaccination services, a lack of qualified personnel, an inefficient supply chain, and poor-quality health data have resulted in low vaccination rates. This situation highlights the urgent need for targeted strategies to increase vaccination coverage, especially for the 13 million "zero-dose" children who receive no vaccination protection each year. Community engagement could be an interesting solution by mobilizing local resources and encouraging greater participation, which could help overcome these challenges and improve vaccination outcomes in the CAR.
Community Engagement in Strengthening Health Systems and Vaccination of Zero-Dose Children in the Central African Republic: The Case of the Kemo-Carnot-Paoua Districts; Challenges and Impacts
References:
[1] Diarra, M., and Kébé, A., 2020, Community health workers and immunization programs in West Africa. Global Health Action, 13(1), 217-228, https://www.ghspjournal.org/
[2] Mulenga, C., 2015, Public Health Interventions in Sub-Saharan Africa: A Focus on Vaccination Strategies (New York, NY: Palgrave Macmillan).
[3] Roberts, S., 2018, Equity in Health Services: A Case Study of Central African Republic. In: Health Systems in Low-Resource Settings, edited by P. Kumar and M. Fisher (New York: Routledge), pp. 155-178.
[4] UNICEF, 2017, Strategies for Improving Vaccine Coverage in Conflict Zones. UNICEF Report CAR-17-24, https://www.unicef.org/
[5] GAVI Alliance, 2019, Challenges and Opportunities in Expanding Immunization in Central Africa. Proceedings of the Global Health Forum, Geneva, Switzerland, June, pp. 89-102, https://www.gavi.org/
[6] WHO, 2020, Assessing the Impact of COVID-19 on Routine Immunization in the Central African Republic. Working paper, World Health Organization, https://www.who.int/
[7] Johnson, P., 2021, Central African Republic faces new challenges in vaccination efforts. The Guardian, 15 April, https://www.theguardian.com/
[8] World Bank, Improving Health Services in Conflict-Affected Regions of Central Africa, Date of Access: 10/08/2023. http://www.worldbank.org/en/news/improving-health-services-central-africa
[9] CENTRAL AFRICAN REPUBLIC, Ministry of Health, 2018, National Health Policy Document, Government of Central African Republic, report 2546.
[10] UNITED NATIONS GENERAL ASSEMBLY, Special Session on Health, 2020, Resolutions on Global Immunization Strategies, United Nations, report A/75/L.47.
[11] Breen, M., et al., 2019, Utilizing Non-Traditional Community Health Workers in Post-Conflict Areas: A Review of Health Service Delivery in the Aftermath of War. Social Science & Medicine, 239, 112534, https://www.journals.elsevier.com/social-science-and-medicine
[12] Thompson, R. L., 2018, The Role of Local Champions in Conflict Zones: A Case Study Approach. Journal of International Development, 30(5), 825-844, https://onlinelibrary.wiley.com/journal/10991328
[13] United Nations Development Programme (UNDP), 2021, Reintegration of Ex-Combatants through Community-Based Approaches in Health Systems. UNDP Report, https://www.undp.org/.
[14] Gavi, the Vaccine Alliance, 2020, Community-Based Approaches to Immunization in Africa. Gavi Report, https://www.gavi.org/
[15] Bedford, H., & Elliman, D., 2010, Concerns about Immunization. BMJ, 340, c1368, https://www.bmj.com/
[16] Mwangi, A., & Kamau, J., 2017, The Impact of Armed Conflict on Health Infrastructure: The Case of Somalia. African Journal of Conflict Resolution, 17(2), 95-112, https://www.accord.org.za/ajcr/
[17] Dupont, P., & Leclerc, R., 2016, Community Resilience in Post-Conflict Settings: The Role of Health Initiatives. International Journal of Public Health, 61(8), 933-942, https://link.springer.com/journal/38
[18] Ahmed, M., & Garcia, L., 2019, Health as a Tool for Peacebuilding: Lessons from South Sudan. Journal of Peace Research, 56(3), 352-365, https://journals.sagepub.com/home/jpr
[19] National Institute of Health, 2021, Health Interventions in Conflict-Affected Areas: A Review of Best Practices. NIH Report, https://www.nih.gov/
Viewed PDF 5 0 -
Post-Traumatic Pseudoaneurysm of Common Digital Artery of Superficial Palmar Arch- A Curious Case with Critical ComplexitiesAuthor: ManimaranDOI: 10.21522/TIJPH.2013.12.04.Art055
Post-Traumatic Pseudoaneurysm of Common Digital Artery of Superficial Palmar Arch- A Curious Case with Critical Complexities
Abstract:
Pseudoaneurysm is an extremely rare condition but poses significant challenges in early diagnosis and can lead to devastating complications if untreated. Pseudoaneurysm is defined as the dilation of the arterial wall caused by disruption of the vessel wall leading to extravasation of blood into a false sac that has communication with the vessel lumen. True aneurysm is formed by all three layers of the arterial wall while pseudoaneurysm is formed by tunica adventitia. Trauma is the most common cause of pseudoaneurysms. It is a rare entity but with significant complications such as thrombosis, embolism and compression of nerves and veins. Here we bring up a case of a twenty-one-year-old male who presented with swelling over his left hand below 2nd web space following a fire crack injury which was associated with pain, restriction of movement and numbness over his left middle finger. The swelling was found to be well-defined, pulsatile, compressible, and cystic in consistency with palpable thrill and systolic bruit on auscultation. Doppler ultrasound showed a cystic lesion with characteristic yin-yang flow. A diagnosis of possible partially thrombosed post-traumatic pseudoaneurysm was made. Surgical ligation with excision under regional anaesthesia was done. Histopathological examination confirmed the diagnosis of pseudoaneurysm. The patient made a full recovery with no post-operative complications. This emphasizes the importance of early diagnosis and management of pseudoaneurysm. Also, this reinvigorates surgical management as the gold standard treatment.
Post-Traumatic Pseudoaneurysm of Common Digital Artery of Superficial Palmar Arch- A Curious Case with Critical Complexities
References:
[1]. Schoretsanitis, N., Moustafa, E., Beropoulis, E., Argyriou, C., Georgiadis, G. S., Georgakarakos, E, 2015, Traumatic Pseudoaneurysm of the Superficial Palmar Arch: A Case Report and Review of the Literature. J Hand Microsurg. Jun;7(1):230-2. https://doi.org/10.1007/12593-015-0183-5
[2]. Fields, J. M., Chandra, S., Au, A. K., Rotte, M., Ku, B. S., 2013, Images in emergency medicine. Child with painful palmar mass. Superficial palmar arch pseudoaneurysm. Ann Emerg Med.;62(6):569-577. https://doi.org/10.1016/j.annemergmed.2013.05.007
[3]. Maertens, A., Tchoungui Ritz, F. J., Poumellec, M. A., Camuzard, O., Balaguer, T., 2020, Posttraumatic pseudoaneurysm of a superficial branch of the ulnar artery: A case report. Int J Surg Case Rep. 75:317-321. https://doi.org/10.1016/j.ijscr.2020.09.029
[4]. Dell'Orfano, M., Milella, F. M., Braidotti, P., 2023, Radial artery pseudoaneurysm following wrist trauma. A case report of a rare condition. Trauma Case Rep 6; 44:100783. https://doi.org/10.1016/j.tcr.2023.100783
[5]. Gull, S., Spence, R. A., Loan, W., 2011, Superficial palmar arch aneurysm after carpal tunnel decompression, a rare complication: a case report. Case Rep Med. 2011:595120. https://doi.org/10.1155/2011/595120
[6]. Zitsman, J. L., 1998, Pseudoaneurysm after penetrating trauma in children and adolescents. J Pediatr Surg.;33(10):1574-1577. https://doi.org/10.1016/s0022-3468(98)90504-8
[7]. Sakamoto, A., Arai, K., 2009, False aneurysm of the superficial palmar arch in a child: A case report. Cases J. 2009 Jul 24; 2:7985. https://doi.org/10.4076%2F1757-1626-2-7985
[8]. Kwiecien, G. J., Garbuzov, A., Boonipat, T., Houdek, M. T., Moran, S. L., 2022, Pseudoaneurysm of the Superficial Palmar Arch in a 6-month-old Child: A Case Report. Plast Reconstr Surg Glob Open;10(2): e4093. https://doi.org/10.1097%2FGOX.0000000000004093
[9]. Corvino, A., Catalano, O., de Magistris, G., Corvino, F., Giurazza, F., Raffaella, N., Vallone, G., 2020, Usefulness of doppler techniques in the diagnosis of peripheral iatrogenic pseudoaneurysms secondary to minimally invasive interventional and surgical procedures: Imaging findings and diagnostic performance study. J Ultrasound, 23(4):563-573. https://doi.org/10.1007/s40477-020-00475-6
[10]. Papatheodorou, N., Dimitriadis, K., Doukas, D., Argyriou, C., Georgiadis, G. S., 2022, Surgical Reconstruction of Traumatic Pseudoaneurysm of Palmar Arch Caused by Blunt Trauma. Vasc Specialist Int 13; 38: 30. https://doi.org/10.5758/vsi.220031
[11]. Yadav, R., Sharma, A., Pathak, S., 2023, Successful Surgical Management of Post-traumatic Superficial Femoral Artery Pseudoaneurysm with Delayed Presentation. Cureus. 15(9):e45739. https://doi.org/10.7759/cureus.45739
[12]. Mahmoud, M. Z., Al-Saadi, M., Abuderman, A., et al, 2015, "To-and-fro" waveform in the diagnosis of arterial pseudoaneurysms. World Journal of Radiology.7(5):89-99. https://doi.org/10.4329/wjr.v7.i5.89
[13]. Igari, K., Kudo, T., Toyofuku., T, Jibiki, M., Inoue, Y., 2013, Surgical treatment of aneurysms in the upper limbs. Ann Vasc Dis;6(3):637-41. https://doi.org/10.3400/avd.cr.13-00024
[14]. Woodley-Cook, J., Konieczny, M., Simons, M., 2015, The ulnar artery pseudoaneurysm. BMJ Case Rep. 2015 Oct 6;2015: https://doi.org/10.1136/bcr-2015-212791
[15]. Cozzi, D. A., Morini, F., Casati, A., Pacilli, M., Salvini, V., Cozzi, F., 2013, Radial artery pseudoaneurysm successfully treated by compression bandage. Arch Dis Child.;88(2):165-166. https://doi.org/10.1136/adc.88.2.165
[16]. Muir, H., Cowan, K., Steele, P., Downie, J. J., 2021, Presentation and surgical management of a superficial temporal artery pseudoaneurysm: A case report. Int J Surg Case Rep. 79:368-370. https://doi.org/10.1016/j.ijscr.2021.01.072
[17]. Wang, Y., Zheng, H., Yao, W., Ju, S., Bai, Y., Wang, C., Zhou, C., Liu, J., Yang, C., Huang, S., Li, T., Chen, Y., Xiong, B., 2022, Management of traumatic peripheral artery pseudoaneurysm: A 10-year experience at a single center. J Interv Med;6(1):29-34. https://doi.org/10.1016/j.jimed.2022.10.002
[18]. Shreve, L., Jarmakani, M., Javan, H., Babin, I., Nelson, K., Katrivesis, J., Lekawa, M., Kuncir, E., Fernando, D., Abi-Jaoudeh, N., 2020, Endovascular management of traumatic pseudoaneurysms. CVIR Endovasc;3(1):88. https://doi.org/10.1186/s42155-020-00182-7
[19]. Saydam, O., Serefli, D., Engin, A. Y., Atay, M., 2020, Ultrasound-guided thrombin injection for treatment of iatrogenic femoral artery pseudoaneurysms compared with open surgery: First experiences from a single institution. Ann Surg Treat Res. 98(5):270-276. https://doi.org/10.4174/astr.2020.98.5.270
[20]. Hughes, C. D., Binette, C., Babigian, A., 2012, Pseudoaneurysm in the hand of a three-year-old boy: A case report. J Emerg Med. 42(4):e87-e89. https://doi.org/10.1016/j.jemermed.2010.11.049
[21]. Lucchina, S., Nistor, A., Stricker, H., Fusetti, C., 2011, False aneurysm of the common digital artery. Is reconstruction with an arterial graft worth the efforts? A case report. Microsurgery.;31(3):246-250. http://doi.org/10.1002/micr.20872
[22]. Ferreira, V., Matos, A., Rego, D., et al., 2017, Percutaneous Treatment Pseudo-Aneurism of the Hand in Hemophilic Patient. Rev Port Cir Cardiotorac Vasc.;24(3-4):178.
[23]. Cromheecke, M., van Straalen, A. M., Damen, A., 1997, Traumatic aneurysm of a common digital artery. J Hand Surg Br.;22(3):416-418. http://doi:10.1016/s0266-7681(97)80417-2
Viewed PDF 7 0 -
A Review of Biomedical Applications of Ormocarpum cochinchinenseAuthor: Dhanraj GanapathyDOI: 10.21522/TIJPH.2013.12.04.Art058
A Review of Biomedical Applications of Ormocarpum cochinchinense
Abstract:
Traditional bone-setting (TBS) techniques were widely used in India before the advent of modern orthopaedics. Among the plants used in these practices, Ormocarpum cochinchinense, a medicinal plant native to Southeast Asia, has shown promising therapeutic properties in treating bone-related ailments. This review explores the biomedical applications of Ormocarpum cochinchinense, particularly focusing on its role in orthopaedics and dentistry. Phytochemical studies have revealed that this plant is rich in bioactive compounds such as flavonoids, tannins, and alkaloids, which contribute to its antioxidant, anti-inflammatory, and antimicrobial properties. In orthopaedics, Ormocarpum cochinchinense has demonstrated significant potential in enhancing bone fracture healing, facilitating bone regeneration, and promoting osseous repair in preclinical studies. The plant has been shown to enhance calcium, phosphorus, and alkaline phosphatase levels, which are critical for bone repair. These properties position Ormocarpum cochinchinense as a promising candidate for developing novel treatments for bone fractures and other orthopaedic conditions. In the field of dentistry, Ormocarpum cochinchinense exhibits anti-inflammatory effects that may be beneficial in treating periodontal diseases such as periodontitis. Its antioxidant properties help reduce oxidative stress, a key factor in chronic inflammation and tissue degradation in periodontal conditions. Additionally, the plant shows potential as a bioscaffold for dental implants, promoting osseous regeneration and improving the healing process after dental surgeries. This review aims to provide a comprehensive analysis of the phytochemical profile of Ormocarpum cochinchinense and its potential applications in both orthopaedic and dental fields, offering insights into future therapeutic uses.
A Review of Biomedical Applications of Ormocarpum cochinchinense
References:
[1]. Karunakaran, N., Maiti, S., Jayaraman, S., & Paulraj, J., 2023. Assessment of bone turnover markers prior to dental implant placement for osteoporosis patients: A case-control study, Annals of Dental Specialty, 11(2), 57–61.
[2]. Gillett, J. B., 1966, The Species of Ormocarpum Beauv. and Arthrocarpum Balf.f. (Leguminosae) in South-Western Asia and Africa (Excluding Madagascar), Kew Bulletin, 20(2), 323–55.
[3]. Hepsibah, A. H., & Jothi, G. J., 2016, A comparative study on the effect of solvents on the phytochemical profile and biological potential of Ormocarpum cochinchinense auct. Non (lour.) Merrill, International Journal of Pharmacy & Pharmaceutical Sciences, 9(1), 67.
[4]. Wang, H., Shan, K., Li, Y., Wu, S., Zhou, C., Tao, S., Wang, M, Kang, X., Zhou, L., Lyu, Z., L, i N., 2024, Therapeutic potential of Chinese medicinal herbs stimulating osteogenic differentiation of bone marrow-derived mesenchymal stem cells in osteoporosis. Frontiers in Pharmacology.31;15:1423555.
[5]. Silambarasan, R., & Ayyanar, M., 2015, An ethnobotanical study of medicinal plants in Palamalai region of Eastern Ghats, India, Journal of Ethnopharmacology, 172, 162–78.
[6]. Nyamboki, D. K., & Wanga, L. A., 2022, Review of the phytochemical and pharmacological studies of the genus Ormocarpum, Pharmacognosy Reviews, 16(32), 95–9.
[7]. Abe, R., & Ohtani, K., 2013, An ethnobotanical study of medicinal plants and traditional therapies on Batan Island, the Philippines, Journal of Ethnopharmacology, 145(2), 554–65.
[8]. Narayanan, A., Marimuthu, M., Mani, A., Vasu, G., Subhadra R., 2023, Studies on the Antimicrobial Activity of Ormocarpum cochinchinense Leaf Extract/PVA‐PVP Blended Polymer, Chemistry Select, 13;8(10):e202203512.
[9]. Bokhad, M. N., Rothe, S. P., 2012, Preliminary phytochemical investigation of Combretum albidum G. Don; An ignored medicinally important liana, Journal of Experimental Sciences, 6;3(3).
[10]. Saravanan, J. R., & Jayakumar, N. D., 2021, Green synthesis of copper oxide nanoparticles using aqueous extract of Ocimum sanctum and analysis of antimicrobial, anti-inflammatory, and cytotoxic activity of Ocimum sanctum copper oxide nanoparticles: An in vitro study, International Journal of Dentistry and Oral Science, 8(6), 2848–2852.
[11]. Lakshme, P. S., Roy, A., Sivaperumal, P., & Lakshmi, T., 2021, Exploration of antioxidant effects of crude extract of mangrove plant Avicennia marina, Journal of Pharmaceutical Research International, 33(62B), 321–329.
[12]. Gulzar, R. A., Ajitha, H. S., 2021, Comparative Evaluation on the Cytotoxicity of Moringa Oleifera Leaf Extract and Calcium Hydroxide on Peri-odontal Ligament Fibroblast Cells, International Journal of Dentistry and Oral Sciences, 30;8(05):2610-4.
[13]. Thirumal, S., Duraikannu, G., 2019, Fourier-transform Infrared Analysis and In Vitro Antibacterial Activity of Ormocarpum cochinchinense (Elumbotti), International Journal of Pharmaceutical & Biological Archive, Jun 15. Available from: https://papers.ssrn.com/abstract=3787238
[14]. Prescott, T. A. K., Kiapranis, R., & Maciver, S. K., 2012, Comparative ethnobotany and in-the-field antibacterial testing of medicinal plants used by the Bulu and inland Kaulong of Papua New Guinea, Journal of Ethnopharmacology, 139(2), 497–503.
[15]. Dilipan, E., Sivaperumal, P., Kamala, K., Ramachandran, M., & Vivekanandhan, P., 2023, Green synthesis of silver nanoparticles using seagrass Cymodocea serrulata (R. Br.) Asch. & Magnus, characterization, and evaluation of anticancer, antioxidant, and antiglycemic index, Biotechnology and Applied Biochemistry, 70(3), 1346-1356.
[16]. Darshinidevi, T., Suresh, V., Sivaperumal, P., & Dilipan, E., 2023, Synthesis of silver nanoparticles from Cymodocea rotundata leaf extract and their biological activities, Cureus, 15(11).
[17]. Kamto, E. L. D., Leitão, G. G., da Silva, V. A. D., Ferreira-Pereira, A., Ngo Mbing, J., & Pegnyemb, D. E., 2020, Bioactive non-polar compounds from Ormocarpum kirkii bark: A source of fungal multidrug resistance inhibitors, Revista Brasileira de Farmacognosi, 30(2), 177–82.
[18]. Hepsibah, A. H., Mala, M., & Jothi, G. J., 2017, Antimicrobial activity and TLC profiling of Clerodendrum phlomidis Linn. F leaf extract against multi-drug resistant clinical pathogens, International Journal of Pharmacy & Pharmaceutical Sciences, 9(9), 275.
[19]. Wilson, J. J., Harimuralikrishnaa, T., Sivakumar, T., Mahendran, S., Ponmanickam, P., Thangaraj, R., Sevarkodiyone, S., Alharbi, N. S., Kadaikunnan, S., Venkidasamy, B., & Thiruvengadam, M., 2023, Biogenic synthesis of silver nanoparticles using Pantoea stewartii and Priestia aryabhattai and their antimicrobial, larvicidal, histopathological, and biotoxicity potential, Bioengineering, 10(2), 248.
[20]. Govindarajan, M., & Benelli, G., 2016, One-pot fabrication of silver nanocrystals using Ormocarpum cochinchinense: Biophysical characterization of a potent mosquitocidal and toxicity on non-target mosquito predators, Journal of Asia-Pacific Entomology, 19(2), 377–85.
[21]. Sivakumar, T., & Gajalakshm, D., 2013, In vitro antioxidant and chemical constituents from the leaves of Ormocarpum cochinchinense Elumbotti, American Journal of Plant Physiology, 8(3), 114–22.
[22]. Arivukkarasu, R., Rajasekaran, A., 2021, Fingerprint Analysis of Herbal Raw Materials available in Market Belongs to Combretacea and Fabaceae family by HPTLC technique using antioxidant markers, Asian Journal of Pharmacy and Technology,11(2):130-4.
[23]. Gnanavel, V., Palanichamy, V., & Roopan, S. M., 2017. Biosynthesis and characterization of copper oxide nanoparticles and its anticancer activity on human colon cancer cell lines (HCT-116), Journal of Photochemistry and Photobiology B: Biology, 171, 133–38.
[24]. Abbasi, S., 2022, Biomimetic synthesis of nanoparticles: State-of-the-art, Journal of Nanostructure in Chemistry, 12(2), 593–608.
[25]. Rani, N., & Saini, K., 2022, Biogenic metal and metal oxides nanoparticles as anticancer agents: A review, IOP Conference Series: Materials Science and Engineering, 1225(1), 012043.
[26]. Nagarajan, D., 2019, In vitro antioxidant potential of endophytic fungi isolated from Enicostemma axillare (Lam.) Raynal and Ormocarpum cochinchinense (Lour.) Merr, Journal of Pharmacognosy and Phytochemistry, 8(1), 1356–63.
[27]. Muhammad, W., Abbasi, B. H., Hashmi, S. S., Haroon, M., Shah, M., 2018, A review on photocatalytic, antimicrobial, cytotoxic and other biological activities of phyto-fabricated copper nanoparticles, International Journal of Biosciences, 13(01), 320–37.
[28]. Nagarajan, D., & Pandian, R., 2018, Anti-cancer potentials of endophytic fungi isolated from Enicostemma axillare and Ormocarpum cochinchinense, Journal of Pharmacognosy and Phytochemistry, 7(3), 3186–91.
[29]. Mondal, A., Paul, P., Banerjee, S., 2022, Applications of metal oxide nanoparticles in cancer therapy. In Advances in Nanotechnology-Based Drug Delivery Systems, 1 (pp. 471-516).
[30]. Alizadeh, S. R., & Ebrahimzadeh, M. A., 2021. Characterization and anticancer activities of green synthesized CuO nanoparticles: A review, Anticancer Agents in Medicinal Chemistry, 21(12), 1529–43.
[31]. Obaid, M. A., Harbi, K. H., & Abd, A. N., 2021, Biosynthesis of CuO NPs and its anticancer activity on human colon cancer cell lines (HT-29), Journal of Physics: Conference Series, 1963(1), 012151.
[32]. Urasopon, N., Hamada, Y., Asaoka, K., Cherdshewasart, W., Malaivijitnond, S., 2007, Pueraria mirifica, a phytoestrogen-rich herb, prevents bone loss in orchidectomized rats. Maturitas, 20;56(3):322-31.
[33]. Leung, P. C., Siu, W. S., 2013, Herbal treatment for osteoporosis: a current review, Journal of Traditional and Complementary Medicine,1;3(2):82-7.
[34]. Vohra, K., Dureja, H., Garg, V., & Dutt, R., 2019, Current trends in phyto-cancer therapy using nanoparticles, Current Nanomedicine, 9(1), 30–45.
[35]. Selvaraj, B., & Ganapathy, D., 2024, Exploration of Sargassum wightii: Extraction, phytochemical analysis, and antioxidant potential of polyphenol, Cureus, 16(7).
[36]. Mathew, A. A., Asirvatham, R., Gowtham, A., & Pa, D., 2021, Study of in vitro anti-inflammatory and immunomodulatory effect of Ayurvedic plants–Murva. İstanbul Journal of Pharmacy, 51(3), 333-340.
[37]. Manokari, M., Priyadharshini, S., & Shekhawat, M. S., 2021, Influence of physio-chemical factors on high throughput plant regeneration and micro-morpho-anatomy of shoots of Ormocarpum sennoides (Willd.) DC, Acta Physiologiae Plantarum, 43(1), 5.
[38]. Somashekar, G., Sudhakar, U., Prakash, S. G., Suresh, S., Srividya, S., & Rao, S. H., 2022, In-vitro antioxidant and in-vitro anti-inflammatory activities of ethanolic leaves extract of Ormocarpum cochinchinense, Journal of Orofacial Sciences, 14(2), 134.
[39]. Aswathi, N. V., & Thomas, T. D., 2023, Transverse thin cell layer (tTCL) technology: A promising tool for micropropagation of Centratherum punctatum Cass. In Vitro Cellular & Developmental Biology - Plant, 59(3), 340–353.
[40]. Sivakumar, N., Geetha, R. V., Priya, V., Gayathri, R., & Ganapathy, D., 2021, Targeted phytotherapy for reactive oxygen species linked oral cancer, International Journal of Dentistry and Oral Science, 8(1), 1425-1429.
[41]. Srinivasan, B. C., & Krishnan, R., 2023, Immunohistological evidence of Ormocarpum sennoides DC extract in the expression of Bax and Bcl2 in Wister rats with glucocorticoid-induced osteoporosis, Journal of Anatomical Society of India, 72(2), 93.
[42]. Subramanyam, V., & Narasimhan, S., 2016, Osteoprotective effect of few Indian herbs: an update, Annals of SBV, 5(1), 43–51.
[43]. Ganapathy, D., Sekar, D., Preethi, A., & Shanmugam, R., 2021, Clinical impact of medicinal herbs in the treatment of osteosarcoma, Annals of the Romanian Society for Cell Biology, 2503-2508.
[44]. Balamurugan, S., Thanganila, G., Chitra, V., Karthi, S., & Balagurusamy, K., 2023, Traditional bone setting for the treatment of recurrent shoulder joint dislocation - A single case study. Retrieved July 24, 2023, from https://www.lcebyhkzz.cn/article/view/2023/918.pdf
[45]. Miranda, L. L., Guimarães-Lopes, V. de P., Altoé, L. S., Sarandy, M. M., Melo, F. C. S. A., Novaes, R. D., et al., 2019, Plant extracts in the bone repair process: A systematic review. Mediators of Inflammation, 2019, 1296153.
[46]. Singh, P., Gupta, A., Qayoom, I., Singh, S., & Kumar, A., 2020, Orthobiologics with phytobioactive cues: A paradigm in bone regeneration. Biomedicine & Pharmacotherapy, 130, 110754.
[47]. Kumar, M. D., John, K. M. M., & Karthik, S., 2013, The bone fracture–healing potential of Ormocarpum cochinchinense methanolic extract on albino Wistar rats. Journal of Herbs, Spices & Medicinal Plants, 19(1), 1-10.
[48]. Vennila Preethi, S., Geetha Gayathri, V., Jeffrey Calwin, J., Sharmila, S., Jayamani, J., & Sujitha, S., 2022, Synthesis of silver nanoparticles from Mimosa pudica and bio-conjugation with hydroxyapatite for orthopedic application. In: AIP Conference Proceedings, 2518, 050003. AIP Publishing. Available from: https://pubs.aip.org/aip/acp/article-abstract/2518/1/050003/2827766
[49]. Sathvika, K., Varghese, S. S., & Rajeshkumar, S., 2021. Terminalia chebula mediated silver nanoparticles and its antibacterial activity against oral pathogens, Journal of Pharmaceutical Research International, 33(62B), 339–350.
[50]. Thangavelu, L., Adil, A. H., Arshad, S., Devaraj, E., Mallineni, S. K., Sajja, R., Chakradhar, A., & Karobari, M. I., 2021, Antimicrobial properties of silver nitrate nanoparticle and its application in endodontics and dentistry: A review of literature, Journal of Nanomaterials, 2021(1), 9132714.
[51]. Dhir, S., Verma, R., Bhatt, S., Garg, V., & Dutt, R., 2023, Green synthesis, characterization, and biomedical applications of copper and copper oxide nanoparticles of plant origin, Current Drug Therapy, 18(5), 391-406.
[52]. Cuong, H. N., Pansambal, S., Ghotekar, S., Oza, R., Thanh Hai, N. T., Viet, N. M., et al., 2022, New frontiers in the plant extract mediated biosynthesis of copper oxide (CuO) nanoparticles and their potential applications: A review. Environmental Research, 203, 111858.
[53]. Felix, W. P., & Muthu, P., 2016, Bioscaffolds impregnated with Ormocarpum cochinchinense mediated Ag nanoparticles. In: 2016 International Conference on Electrical, Electronics, and Optimization Techniques (ICEEOT) (pp. 3533-3535).
[54]. Neha, R., Sridevi, G., Selvaraj, J., & Preetha, S., 2021. Evaluation of anticancer effect of Aegle marmelos in human breast cancer cells by in-vitro analysis, Journal of Pharmaceutical Research International, 33(62A), 464–471.
[55]. Mbaebie, B. O., Edeoga, H. O., & Afolayan, A. J., 2012, Phytochemical analysis and antioxidant activities of aqueous stem bark extract of Schotia latifolia Jacq. Asian Pacific Journal of Tropical Biomedicine, 2(2), 118-124.
[56]. Essiett, U. A., & Bassey, I. E., 2013, Comparative phytochemical screening and nutritional potentials of the flowers (petals) of Senna alata (L.) Roxb, Senna hirsuta (L.) Irwin and Barneby, and Senna obtusifolia (L.) Irwin and Barneby (Fabaceae). Journal of Applied Pharmaceutical Science, 3(8), 97-101.
[57]. Falodun, A., 2010, Herbal medicine in Africa-distribution, standardization and prospects. Research Journal of Phytochemistry, 4(3), 154-161.
Viewed PDF 5 0 -
Protective Effect of Curcunan® on Human Lung Epithelial Cells Exposed to Fine Particulate Matter and Response to AllergensAuthor: Ramachandran ValavanDOI: 10.21522/TIJPH.2013.12.04.Art059
Protective Effect of Curcunan® on Human Lung Epithelial Cells Exposed to Fine Particulate Matter and Response to Allergens
Abstract:
India is the third most polluted nation after Bangladesh and Pakistan in PM2.5 concentration. The average 24-hour PM2.5 concentration in India is 51.90 µg/m3, indicating'very bad' air quality. Air pollution is mostly caused by fine particulate matter (FPM). FPM exposure increases chronic and allergic rhinitis. The anti-inflammatory and antioxidative effects of curcumin protect organs against harmful substances that alter homeostasis. Curcumin protects against PM-induced lung inflammation, however its mechanism has not been extensively investigated. In this study, we investigated different formulations of curcumin (Curcumin 17% powder, Curcumin 17% formulation & Curcumin 95%) on cell viability in preliminary cytotoxicity study using ‘A549’ lung epithelial cell line. The most effective formulation was further evaluated for its anti-oxidant, anti-inflammatory and anti-allergic activity in human U266B1 multiple myeloma cells against FPM treatment. A significant reduction by Curcumin 95% in the IgE in human U266B1 multiple myeloma cells was demonstrated, and a significant reduction in the expression of the pro-inflammatory cytokines (IL-6 and IL-8) in A549 cells was observed. Finally, malonaldehyde, a clinically significant oxidative stress biomarker, was also potently decreased. The treatment with Curcunan® protected the cells from FPM-induced cytotoxicity and helped revert the cell morphology. The treatment even helped lessen the levels of oxidative stress and inflammatory markers (IL-6 and IL-8). The treatment showed anti-allergic activity, evident by the decreasing secretion of IgE levels. These results suggest that Curcunan® can be an excellent therapeutic agent for preventing pulmonary disorders caused by air pollution.
Protective Effect of Curcunan® on Human Lung Epithelial Cells Exposed to Fine Particulate Matter and Response to Allergens
References:
[1]. Ghorani-Azam, A., Riahi-Zanjani, B., Balali-Mood, M., 2016. Effects of air pollution on human health and practical measures for prevention in Iran. Journal of Research in Medical Sciences, 21, 1-9.
[3]. Zhang, W., Qian, C. N., Zeng, Y. X., 2014. Air pollution: A smoking gun for cancer. Chinese Journal of Cancer, 33(4), 173-175.
[5]. Biggeri, A., Bellini, P., Terracini, B., 2004. Meta-analysis of the Italian studies on short-term effects of air pollution--MISA 1996-2002. Epidemiologia e Prevenzione, 28(4-5 Suppl), 4-100.
[7]. Qiu, F., Chen, L., Wang, H., et al., 2021. Protective effect of supplementation with Ginseng, Lilii Bulbus and Poria against PM2.5 in air pollution‐induced cardiopulmonary damage among adults. Phytotherapy Research, 35(2), 877-887.
[9]. Alfaro-Moreno, E., Nawrot, T. S., Vanaudenaerde, B. M., et al., 2008. Co-cultures of multiple cell types mimic pulmonary cell communication in response to urban PM10. European Respiratory Journal, 32(5), 1184-1194.
[10]. Ng, T. P., Niti, M., Yap, K. B., Tan, W. C., 2012. Curcumins-rich curry diet and pulmonary function in Asian older adults. PLoS One, 7(12), e51753.
[11]. Mollazadeh, H., Cicero, A. F., Blesso, C. N., Pirro, M., Majeed, M., Sahebkar, A., 2019. Immune modulation by curcumin: The role of interleukin-10. Critical Reviews in Food Science and Nutrition, 59(1), 89-101.
[12]. Aggarwal, B. B., Sung, B., 2009. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends in Pharmacological Sciences, 30(2), 85-94.
[13]. Gajula, S. N. R., Bale, D. N. J., Nanjappan, S. K., 2020. Analytical and omics approaches in the identification of oxidative stress-induced cancer biomarkers. Handbook of Oxidative Stress in Cancer: Mechanistic Aspects, 1-24.
[14]. Trujillo, J., Chirino, Y. I., Molina-Jijón, E., Andérica-Romero, A. C., Tapia, E., Pedraza-Chaverrí, J., 2013. Renoprotective effect of the antioxidant curcumin: Recent findings. Redox Biology, 1(1), 448-456.
[15]. Huang, K., Shi, C., Min, J., Li, L., Zhu, T., Yu, H., & Deng, H., 2019. Study on the mechanism of curcumin regulating lung injury induced by outdoor fine particulate matter (PM2.5). Mediators of Inflammation, 2019.
[16]. Kim, J. S., Oh, J. M., Choi, H., Kim, S. W., Kim, B. G., et al., 2020. Activation of the Nrf2/HO-1 pathway by curcumin inhibits oxidative stress in human nasal fibroblasts exposed to urban particulate matter. BMC Complementary Medicine and Therapies, 20(1), 1-8.
[17]. Zhang, Z., Niu, X., Lu, C., Jiang, M., Xiao, G. G., Lu, A., 2012. The effect of curcumin on human bronchial epithelial cells exposed to fine particulate matter: A predictive analysis. Molecules, 17(10), 12406-12426.
[18]. Ashraf, K., 2017. A comprehensive review on Curcuma longa Linn.: Phytochemical, pharmacological, and molecular study. International Journal of Green Pharmacy (IJGP), 11(04), 1-8.
[19]. Harmon, A. C., Hebert, V. Y., Cormier, S. A., Subramanian, B., Reed, J. R., Backes, W. L., & Dugas, T. R., 2018. Particulate matter containing environmentally persistent free radicals induces AhR-dependent cytokine and reactive oxygen species production in human bronchial epithelial cells. PLoS One, 13(10), e0205412.
[20]. World Health Organization, 2016, n.d. WHO releases country estimates on air pollution exposure and health impact. World Health Organization. https://www.who.int/news/item/27-09-2016-who-releases-country-estimates-on-air-pollution-exposure-and-health-impact
Viewed PDF 5 0 -
Regional Variations in HIV/AIDS Knowledge Among Women of Reproductive Age in Nigeria: A Comparative AnalysisAuthor: Agbochenu Sunday AbojeDOI: 10.21522/TIJPH.2013.12.04.Art061
Regional Variations in HIV/AIDS Knowledge Among Women of Reproductive Age in Nigeria: A Comparative Analysis
Abstract:
Despite various efforts to curb the spread of HIV, significantly disparities remain, particularly a challenge among women of reproductive age in Nigeria. This study aims to assess the regional differential in comprehensive knowledge of HIV/AIDS among women aged 15 – 49 years across Nigeria. By employing a comparative analysis, the research seeks to understand how sociodemographic factors, including age, marital status, educational level, place of residence, and wealth index influence comprehensive knowledge of HIV/AIDS across region. The study employed data from the 2018 Nigeria Demographic and Health Survey. Descriptive statistics were used to analyze the data and logistic regression was then used to determine factors that influenced the level of HIV knowledge among women of reproductive age. A total of 8,061 women were included in this study. The result showed that the prevalence of comprehensive knowledge of HIV/AIDS was higher (more than 50%) in South East (60.5%), North West (55.5%) and the South West (51.7%) and lower (less than 50%) in North East (36.7%), North Central (41.4%) and South-South (42.2%). Age, place of residence, religion, marital status, educational level, employment status and wealth index and exposure to media and health care services were statistically significant factors associated with comprehensive knowledge of HIV (p<0.05). The study reveals that HIV knowledge considerably varies significantly across regions for Nigerian women of reproductive age. These findings indicate, therefore, the need to enhance HIV/AIDS education and prevention activities by developing relevant and practical strategies to reach the regions having poor comprehensive knowledge of HIV/AIDS.
Regional Variations in HIV/AIDS Knowledge Among Women of Reproductive Age in Nigeria: A Comparative Analysis
References:
[1]. World Health Organisation., 2024, HIV and AIDS. Retrieved from https://www.who.int/data/gho/data/themes/hiv-aids (Accessed 2nd June 2024).
[2]. UNAIDS Fact Sheet., 2024, Retrieved from https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf
[3]. International Labour Organisation, ILO., 2024, HIV/AIDs in Africa. Available: https://www.ilo.org/regions-and-countries/ilo-africa/areas-work/hivaids-africa (Accessed 2nd June 2024).
[4]. National Agency for the Control of AIDS, NAIIS NATIONAL FACTSHEET. Retrieved from https://www.naiis.ng/resource/factsheet/NAIIS%20PA%20NATIONAL%20FACTSHEET%20FINAL.pdf
[5]. Statista, 2020, Prevalence rate of HIV in Nigeria as of 2020 by gender. https://www.statista.com/statistics/1262126/prevalence-of-hiv-in-nigeria-by-gender/ (Accessed 2nd June 2024).
[6]. O’Neil, A., Russell, J. D., Thompson, K., Martinson, M. L., & Peters, S. A., 2020, The impact of socioeconomic position (SEP) on women's health over the lifetime. Maturitas, 140, 1-7.
[7]. Mude, W., Oguoma, V. M., Gesesew, H. A., Ameyaw, E. K., Njue, C., Nyanhanda, T., et al., 2020, HIV/AIDS knowledge and attitudes assessment among women of child-bearing age in South Sudan: findings from a Household Survey. PLoS ONE. 15(12): e0243969.
[8]. Fenny, A., Crentsil, A. O., 2017, Determinants and Distribution of Comprehensive HIV/AIDS Knowledge in Ghana. URL: https://doi.org/10.5539/gjhs.v9n12p32.
[9]. [9] Federal Ministry of Health, 2018 National AIDS Indicator and Impact Survey- Fact Sheet. Retrieved Fact Sheet. Retrieved from https://afenetnigeria.net › Documents › NAIIS-N.
[10]. Vergara-Ortega, D. N., et al., 2021, Regional disparity of HIV incidence and prevalence among men who have sex with men. BMC Infect Dis. 2021 Sep 6;21(1):917. doi: 10.1186/s12879-021-06582-x. PMID: 34488671; PMCID: PMC8419902.
[11]. Awofala, A. A., Ogundele, O. E., 2018, HIV epidemiology in Nigeria. Saudi J Biol Sci. 2018 May;25(4):697-703. doi: 10.1016/j.sjbs.2016.03.006. Epub 2016 Apr 9. PMID: 29740232; PMCID: PMC59370.
[12]. CDC., 2023, Estimated HIV Incidence and Prevalence in the United States, 2017–2021. HIV Surveillance Supplemental Report. Retrieved from www.https:/ https://journals.sagepub.com/doi/10.1177/00333549241253092?icid=int.sj-abstract.citing-articles.2/
[13]. Amuche, N. J., Emmanuel, E. I., & Innocent, N. E., 2017, HIV/AIDS in sub-Saharan Africa: current status, challenges and prospects. http://ir.must.ac.ug/xmlui/handle/123456789/460
[14]. Ocran, B., Talboys, S., & Shoaf, K., 2022, Conflicting HIV/AIDS sex education policies and mixed messaging among educators and students in the Lower Manya Krobo Municipality, Ghana. International Journal of Environmental Research and Public Health, 19(23), 15487.
[15]. Kareem, Y. O., Dorgbetor, C. I., Ameyaw, E. K., Abubakar, Z., Adelekan, B., Goldson, E., & Adegboye, O., 2023, Assessment and associated factors of comprehensive HIV knowledge in an at-risk population: a cross-sectional study from 19,286 young persons in Nigeria. Therapeutic Advances in Infectious Disease, 10, 20499361231163664.
[16]. Teshale, A. B., Yeshaw, Y., Alem, A. Z., et al., 2022, Comprehensive knowledge about HIV/AIDS and associated factors among women of reproductive age in sub-Saharan Africa: a multilevel analysis using the most recent demographic and health survey of each country. BMC Infect Dis 22, 130. https://doi.org/10.1186/s12879-022-07124-9.
[17]. UNAIDS., 2024, New Survey results indicate that Nigeria has an HIV prevalences of 1.4%. Retrieved from. https://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2019/march/20190314_nigeria (Accessed 2nd June, 2024).
[18]. Joorbonyan, H., Ghaffari, M., & Rakhshanderou, S., 2022, Peer-led theoretically Designed HIV/AIDS prevention intervention among students: a case of health belief model. BMC Public Health, 22, 1-10.
[19]. Frank, T. D., 2019, Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. Retrieved from https://www.sciencedirect.com.science.article.pii
[20]. Baghaei Lakeh, A., Ghaffarzadegan, N., 2017, Global Trends and Regional Variations in Studies of HIV/AIDS. Sci Rep 7, 4170 (2017). https://doi.org/10.1038/s41598-017-04527-6.
[21]. Onovo, A. A.; et al., 2023, Estimation of HIV prevalence and burden in Nigeria: A Bayesian modelling study. DOI: https://doi.org/10.1016/j.eclinm.2023.102098.
[22]. Nigeria Demographic and Health Survey (NDHS, 2018). Retrieved from https://www.dhsprogram.com/pubs/pdf/FR359/FR359.pdf
[23]. National Population Commission (NPC) [Nigeria] and ICF. (2019). Nigeria Demographic and Health Survey 2018. Abuja, Nigeria, and Rockviile, Maryland, USA: NPC and ICF
[24]. Aborode, A. T., Alexiou, A., Ahmad, S., Yasir Essar, M., Chibueze, O. S., Al-Zahrani, Y., & Batiha, G. E. S., 2021, HIV/AIDS epidemic and COVID-19 pandemic in Africa. Frontiers in Genetics, 12, 670511.
[25]. Son, N. V., Luan, H. D., Tuan, H. X., Cuong, L. M., Duong, N., & Kien, V. D., 2020, Trends and Factors Associated with Comprehensive Knowledge about HIV among Women in Vietnam. Tropical Medicine and Infectious Disease, 5(2), 91. https://doi.org/10.3390/tropicalmed5020091.
[26]. Guure, C., et al., 2020, Comprehensive Knowledge of HIV and AIDS among Ghanaian Adults from 1998 to 2014: A Multilevel Logistic Regression Model Approach. Retrieved from https://pubmed.ncbi.nlm.nih.gov/33029448/
Viewed PDF 5 0 -
Effectiveness of Buerger’s Allen Exercise on Improving Lower Extremity Perfusion Among Patients with Type 2 Diabetes MellitusAuthor: Kavitha MDOI: 10.21522/TIJPH.2013.12.04.Art060
Effectiveness of Buerger’s Allen Exercise on Improving Lower Extremity Perfusion Among Patients with Type 2 Diabetes Mellitus
Abstract:
Diabetes mellitus is increased risk of peripheral vascular diseases by causing endothelial and smooth muscle cell dysfunction in peripheral arteries. To assess the pre and post level of lower extremity perfusion among patients with type 2 diabetes mellitus in experimental and control group. To determine the effectiveness of Buerger Allen exercise on lower extremity perfusion among patients with type 2 diabetes mellitus. A true experimental research design and a quantitative research approach were used. A control group with a pretest and posttest was employed. Sixty samples with type 2 diabetes were included in the investigation. The Saveetha Institute of Medical and Technical Sciences' institutional ethical committee in Chennai granted clearance. Using the random sampling technique, thirty samples were chosen for the experimental group and thirty samples for the control group. A structured interview schedule, a modified version of the Wong Baker FACES pain assessment scale, and a modified Clarke enhanced foot assessment scale were used for the for this study. the pretest mean score was 0.62±0.22 and the post-test mean score was 0.67±0.27. The mean difference score was 0.05. The calculated paired ‘t’ test value of t = 2.21808 which was found to be statistically significant at p<0.05 level. This clearly infers that there is significant difference between the pre-test and post-test levels of lower extremity perfusion. Analysis of variance (Anova) of the level of lower extremity perfusion in the experimental group, the pretest mean was 0.62 and the post-test mean was 0.67. The standard deviation of pretest and post-test is 0.22 and 0.27 respectively. The variance of pre-test was 0.05 and post-test was 0.07. The calculated paired ‘F’ value = 0.7258 which was found to be statistically significant at p<0.05 level. This clearly infers that there is a significant difference between the pretest and post-test levels of lower extremity perfusion.
Effectiveness of Buerger’s Allen Exercise on Improving Lower Extremity Perfusion Among Patients with Type 2 Diabetes Mellitus
References:
[1]. Nasser, J et. al., 2011, Prevalence of peripheral arterial disease among people attending diabetes clinics at primary care settings. Bahrain Med Bull, 33, 1-9.
[2]. Mundet, X. et al., 2018, Prevalence and incidence of chronic complications and mortality in a cohort of type 2 diabetic patients in Spain, 2(3), 135-140.
[3]. Allen, A. W, 2019, Recent advances in the treatment of circulatory disturbances of the extremities. Annals of Surgery, 5(7), 931-946.
[4]. Absteen, S, 2017, American Diabetes Association Consensus, (2013). Peripheral arterial disease in people with diabetes. Clinical Diabetes, 22(4), 181-189.
[5]. Aravind, S. et al., 2013, Diabetology and metabolic syndrome and Management, 3(9),422-434.
[6]. Ashok, P. et al., 2013, Peripheral vascular disease- a silent assassin. JIACM, 14(2), 111-114.
[7]. Neil, J. S., &Will, G., 2012, Effect of different mode of exercise programme on glucose control and risk factors for complication in type 2 diabetic patients. 2(4), 805-814 http://www.ncbi.nlm.nih.gov/pmc
[8]. Pat, F., & Diana, B, 2011, Peripheral vascular disease and type 2 diabetes,12(3),389-397
[9]. Rajabharan, Y. et al., 2018, Risk factors and complications of type 2 DM, 5(12), 722-738, http://www.niper.ac.in/riskfactor
[10]. Deepa, S & Srikant, G, 2019 Macrovascular and microvascular complications in newly diagnosed in type 2 Diabetes Mellitus. Indian Journal of Clinical Practice, 25(7), 644-648, http://dx.doi.org/10.4236/ojn.2015.52014
[11]. Edward, B. et al., 2012, Diabetes care, peripheral arterial disease in diabetic and non diabetic patients- a comparison of severity and complication. Diabetes Journal, 24(8), 1443-47.
[12]. Faris, I. et al., 2017, Increased subcutaneous flow for 24 hours. European Journal of Nuclear Medicine and Molecular Imaging, 8(4), 15-17, https://www.sringerlinkcom/content
[13]. Gupta, S. P. 2018, Medical Education related to Diabetes Mellitus and its complications, 5(13), 345-359
[14]. Hoe J. et al., 2017, Predictors of decrease in ankle- brachialindex. Diabetic Medicine, 4(7), 592-604
[15]. Jemcy, J., & Rathiga, A., 2020, Effectiveness of buerger allen exercise. Indian Journal of Current Research and Academic Review, 3(4), 358-366.
[16]. Judy J, 2019, An experimental study to assess the effectiveness of burgers Allen exercise on improving wound healing, 8(2), 621-637.
[17]. Kawasaki, T., et al., 2019, The effect of different positions on lower limbs skin perfusion pressure, Indian J Plastic Surgery. 21(6), 508-519.
[18]. Lawrence, H. et al.,2018, Value of exercise in peripheral arterial disease, JAMA, 15(1), 182-201.
[19]. Sandeep, S., 2018, DMSO, Diabetic technology medicine and lower extremity perfusion, 6(14), 327-328. DOI:10.2147/DMSO.551325.
[20]. Steven, P., et al., 2017, Peripheral vascular complications among type 2 Diabetes Mellitus patients, Journal of Diabetes and Metabolism, 2(8), 835-844.
[21]. Zhaolan, L., et al., 2012, Lower Extremity and perfusion in Type2 Diabetes mellitus, 8(15), 831-842. DOI: 10.1161/JAHA.112.002832
[22]. Zhang, P., et al., 2018, GlobalHealth care expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract.16 (4)293–301.
[23]. Whiting, D. R., et al., 2014, IDF diabetes atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract.; 94(3), 311–21.
[24]. Ramachandran, A., et al., 2014, Diabetes in south-east Asia: An update. Diabetes Res Clin Pract.;10(4); 478-488.
[25]. Setacci, C., et al., 2010, Diabetic patients: Epidemiology and global impact. J Cardiovasc Surg.; 5(4):263– 73.
Viewed PDF 5 0 -
The Great Imposter: A Rare Case of a Pseudomyxoma Peritonei Mirroring Severe AppendicitisAuthor: Pola Govardhan KumarDOI: 10.21522/TIJPH.2013.12.04.Art066
The Great Imposter: A Rare Case of a Pseudomyxoma Peritonei Mirroring Severe Appendicitis
Abstract:
PMP (Pseudomyxoma Peritonei) is an uncommon disease occurring most commonly via pierced Appendiceal epithelial tumour followed by ovaries. The best therapy contains a mix of CRS (Cytoreductive surgery) along with intense HIPEC (Intraperitoneal chemotherapy). There is an argument related to the diagnostic category on its predictive significance. Tomography computer imaging is the best pre-operative method. High tumour indicator is associated with poorer diagnosis and bigger reappearance rates. A 33-year-old female was admitted to the emergency department of Sree Balaji Medical College and Hospital with severe pain over the right iliac fossa with four episodes of vomiting and one episode of fever. On Examination, he had Tenderness and Rebound Tenderness over the Right Iliac Fossa. CECT showed features suggestive of Acute Appendicitis and the patient was taken up for Surgery where a biopsy showed Pseudomyxoma Peritonei. The patient further underwent HIPEC and was followed up for 1 year with no recurrence of the disease.
The Great Imposter: A Rare Case of a Pseudomyxoma Peritonei Mirroring Severe Appendicitis
References:
[1]. Bevan, K. E., Mohamed, F., & Moran, B. J., 2010. Pseudomyxoma peritonei. World Journal of Gastrointestinal Oncology, 2, 44–50. https://doi.org/10.4251/wjgo.v2.i1.444omini https://pubmed.ncbi.nlm.nih.gov/21160816/
[2]. Smeenk, R. M., Verwaal, V. J., & Zoetmulder, F. A. N., 2007. Pseudomyxoma peritonei. Cancer Treatment Reviews, 33, 579–586. Elsevier. https://europmp.eu/wp-content/uploads/2020/05/PSOGI_Guidelines-1.pdf
[3]. Moran, B. J., 2006. Establishment of a peritoneal malignancy treatment centre in the United Kingdom. European Journal of Surgical Oncology, 32, 614–618. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204597/
[4]. Werth, R., 1884. Klinische and anastomische Untersuchungen zur Lehre von der Bauchgeswulsten und der Laparotomy. Archiv für Gynäkologie, 84, 100–118. http://www.worldwidejournals.org/index.php/ijsr/article/view/952
[5]. Garg, P., Garg, N., Peer, S., Chholak, D., & Kaur, M., 2024. Pseudomyxoma peritonei leading to ‘jelly belly’ abdomen: A case report and review of the literature. Journal of Medical Case Reports, 18, Article 296. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11212264/
[6]. E. J. Arbuthnot, J. Parker, T. Cecil, F. Mohamed, R., Williams, M. Page, and B. Moran, “Peritoneal malignancy in the global COVID-19 pandemic: experience of recovery and restoration in a high-volume centre through NHS and independent sector collaboration,” Ann. R. Coll. Surg. Engl. 106, 385–388, 2024. DOI: 10.1308/rcsann.2022.0074. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10981979/
[7]. Bouquot, M., Dohan, A., Gayat, E., Barat, M., Glehen, O., Pocard, M., Rousset, P., & Eveno, C., 2018. Prediction of resectability in pseudomyxoma peritonei with a new CT score. Annals of Surgical Oncology, 25, 694–701. https://pubmed.ncbi.nlm.nih.gov/29192372/
[8]. Sugarbaker, P. H., “Pseudomyxoma peritonei,” CANCER Treat. Res. 81, 105–119 1996. DOI: 10.1007/978-1-4613-1245-1_10. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013295/
[9]. Moran, B. J., & Cecil, T. D., 2003. The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surgical Oncology Clinics of North America, 12, 585–603. https://pubmed.ncbi.nlm.nih.gov/14567019/
[10].Mittal, R., Chandramohan, A., & Moran, B., 2017. Pseudomyxoma peritonei: Natural history and treatment. International Journal of Hyperthermia, 33, 511–519. https://www.tandfonline.com/doi/full/10.1080/02656736.2017.1310938
Viewed PDF 7 0 -
Understanding Adolescent Idiopathic Genu Valgus: A Guide to Managing Knock Knees by Distal femur Closed Wedge Corrective OsteotomyAuthor: Ganesh M. T.DOI: 10.21522/TIJPH.2013.12.04.Art067
Understanding Adolescent Idiopathic Genu Valgus: A Guide to Managing Knock Knees by Distal femur Closed Wedge Corrective Osteotomy
Abstract:
Genu valgum, also known as “knocked knees,” is a coronal plane misalignment of knee characterized by inward bending of the knees. When individuals with genu valgum stand with their knees together, there is a noticeable gap of 3 inches or more between their ankles due to the pronounced inward curvature of the knees. This coronal plane deformity of knee joint is one of the commonest disorders presenting to orthopaedic clinic in adult patients with rheumatoid arthritis, however its prevalence in adolescent is rare. Paediatric age group presenting with bilateral genu valgum can be either physiologic or pathologic. While the physiological genu valgum typically starts around age 2 and becomes most prominent between ages 3 to 4, gradually stabilizing by age 7, pathological genu varum persists more than 10 years of age. In adolescents, minimal change back to normal alignment is expected. Pathologic genu valgum, on the other hand, may be associated with metabolic disorders (e.g., Rickets), local issues (infection, tumour growth, or trauma), idiopathic or other factors. Treatment options vary based on the cause and severity. Conservative approaches include exercise programs, NSAIDs, and orthotic insertions. Surgical interventions, such as osteotomy or guided growth surgery, may be necessary in severe cases. We here report a rare case of idiopathic bilateral genu valgus deformity presented with progressive valgus deformity of both knees. Since the misalignment was more on the femoral side, corrective osteotomy was done in the distal femur to achieve proper mechanical alignment of the knee. This case report seeks to provide healthcare workers about this condition and the differential diagnosis and a detailed management.
Understanding Adolescent Idiopathic Genu Valgus: A Guide to Managing Knock Knees by Distal femur Closed Wedge Corrective Osteotomy
References:
[1]. White, G. R., Mencio, G. A., 1995, Genu Valgum in Children: Diagnostic and therapeutic alternatives. J Am Acad Orthop Surg, 3(5):275-283. https://doi.org/10.5435/00124635-199509000-00003
[2]. Martínez, G., Drago, S., Avilés, C., Ibañez, A., Hodgson, F., Ramírez, C., 2017, Distal femoral hemiepiphysiodesis using screw and non-absorbable filament for the treatment of idiopathic genu valgum. Preliminary results of 12 knees. Orthop Traumatol Surg Res., 103(2):269-273. https://doi.org/10.1016/j.otsr.2016.11.014
[3]. Vaishya, Raju et al., 2018, Growth modulation by hemi epiphysiodesis using eight-plate in Genu valgum in Paediatric population. J Clin Orthop Trauma, 9(4): 327–333. https://doi.org/10.1016/j.jcot.2017.11.004
[4]. Lee, S. P., Chai, S. T., Loh, L. T., Ali, N. M., 2020, Bilateral genu valgum in an adolescent with primary hyperparathyroidism: A Case report and review of literature. J ASEAN Fed Endocr Soc., 35(2):220-223. https://doi.org/10.15605/jafes.035.02.07
[5]. Walker, J. L., Hosseinzadeh, P., White, H., et al., 2019, Idiopathic Genu Valgum and Its Association with obesity in children and adolescents. J Pediatr Orthop., 39(7):347-352. https://doi.org/10.1097/bpo.0000000000000971
[6]. Moon, S. H., Kwon, S. S., Park, M. S., Kim, N. T., Sung, K. H., 2021, Change of limb alignment in Korean children and adolescents with idiopathic genu valgum. Medicine (Baltimore). 100(45): e27637. https://doi.org/10.1097/md.0000000000027637
[7]. Artioli, E., Mazzotti, A., Ramacci, V., et al., 2023, Indications and timing in isolated medial femoral hemiepiphysiodesis for idiopathic genu valgum: A systematic review. Knee. 40:52-62. https://doi.org/10.1016/j.knee.2022.11.009
[8]. Taylor, S., Getgood, A., 2022, Genu Valgum Correction and Biplanar Osteotomies. Clin Sports Med., 41(1):47-63. https://doi.org/10.1016/j.csm.2021.08.001
[9]. Kirby, J. C., Jones, H., Johnson, B. L., Brenner, M. E., Wilson, P. L., Ellis, H. B., 2024, Genu valgum in pediatric patients presenting with patellofemoral instability. J Pediatr Orthop., 44(3):168-173. https://doi.org/10.1097/bpo.0000000000002576
[10]. Barakat, A.S., Arafa, A., Mohamed M.T., et al., 2022, Treatment of genu valgum by a novel percutaneous transverse metaphyseal osteotomy of the distal femur in children and adolescents. Eur J Orthop Surg Traumatol, 32(6):1179–1186. https://doi.org/10.1007/s00590-021-03093-y
Viewed PDF 5 0 -
Predictors of Unsuppressed HIV Viral Load and Low CD4 Count Among ZIMPHIA 2020 Survey ParticipantsAuthor: Solomon MukwenhaDOI: 10.21522/TIJPH.2013.12.04.Art062
Predictors of Unsuppressed HIV Viral Load and Low CD4 Count Among ZIMPHIA 2020 Survey Participants
Abstract:
Unsuppressed Viral load and low CD4 counts pose a significant challenge to HIV/AIDS management. Understanding the predictors of unsuppressed viral load and CD4 is critical for developing strategies to mitigate its impact. This study aimed to identify predictors of unsuppressed HIV viral load and low CD4 counts among Zimbabwe population-based HIV impact assessment survey (ZIMPHIA 2020) study participants. We analysed data from the ZIMPHIA 2020 survey. Data collection was done using structured interviews, home-based HIV testing and laboratory testing. Blood samples from participants were tested for HIV and those positive were analysed for CD4 counts and Viral load tests. We then calculated odds ratios for predictors of unsuppressed viral load (viral load ≥1000 copies/mL) and low CD4 counts (CD4< 350). The prevalence of unsuppressed viral load and low CD4 count were 20.7% and 34.7%, respectively. Males were more likely to be virally unsuppressed (25.1%) than females (18.8%) adjusted odds ratio (aOR) (95% confidence interval) 1.74 (1.43-2.11) p-value < 0.001. The odds of having a low CD4 count were higher among males (41%) than females (19%) aOR (95% confidence interval) 3.07 (2.57-3.66). Urban dwellers were more likely to have a low CD4 count (31.1%0 than rural dwellers (23.8%) aOR (95% confidence interval) 1.45 (1.21-1.73) p-value <0.001. The common predictors of both unsuppressed viral load and low CD4 were gender, never tested for HIV and never had a viral load test.
Predictors of Unsuppressed HIV Viral Load and Low CD4 Count Among ZIMPHIA 2020 Survey Participants
References:
[1]. UNAIDS, 2021, Global AIDS Strategy 2021–2026 End Inequalities. End AIDS. https://www.unaids.org/en/resources/documents/2021/2021-2026-global-AIDS-strategy
[2]. WHO, 2023, New WHO guidance on HIV viral suppression and scientific updates released at IAS 2023, Accessed: May 29, 2024. https://www.who.int/news/item/23-07-2023-new-who-guidance-on-hiv-viral-suppression-and-scientific-updates-released-at-ias-2023
[3]. ICAP, 2021, Zimbabwe Population-based HIV Impact Assessment 2020, Accessed: May 23, 2024. [Online]. Available: http://phia.icap.columbia.edu
[4]. PEPFAR, 2022, Zimbabwe Country Operational Plan (COP) 2022 Strategic Direction Summary (SDS), Accessed: Aug. 03, 2024. [Online]. Available: https://www.state.gov/wp-content/uploads/2022/09/Zimbabwe-COP22-SDS.pdf
[5]. WHO, 2023, THE Role of HIV Viral Suppression in Improving Individual Health and Reducing Transmission Policy Brief., Accessed: Aug. 29, 2024. [Online]. Available: https://iris.who.int/bitstream/handle/10665/360860/9789240055179-eng.pdf?sequence=1
[6]. WHO, 2020, HIV Treatment and Care Team, Accessed: Apr. 23, 2024. [Online]. Available: https://www.who.int/ publications /I/item/point-of-care-test-for-identifying-people-living-with-advanced-HIV-disease
[7]. Ekong, E., Ndembi, N., Okonkwo, P., Dakum, P., Idoko, J., Banigbe, B., Okuma, J., Agaba, P., Blattner, W., Adebamowo, C., & Charurat, M., 2020, Epidemiologic and viral predictors of antiretroviral drug resistance among persons living with HIV in a large treatment program in Nigeria. AIDS Research and Therapy, 17(1), 1–8. https://doi.org/10.1186/S12981-020-0261-Z/TABLES/2
[8]. WHO, 2016, Global Health Sector Strategy on HIV 2016–2021 Towards ending AIDS. Accessed: Aug. 14, 2024.Online]. Available: https://www.who.int/publications/i/item/WHO-HIV-2016.05
[9]. Calmy, A., Ford, N., & Meintjes, G., 2018, The Persistent Challenge of Advanced HIV Disease and AIDS in the Era of Antiretroviral Therapy. Clinical Infectious Diseases, 66(suppl_2), S103-SS105. https://doi.org/10.1093/CID/CIX1138
[10]. Ford, N., Meintjes, G., Vitoria, M., Greene, G., & Chiller, T., 2017, The evolving role of CD4 cell counts in HIV care. Current Opinion in HIV and AIDS, 12(2), 123–128. https://doi.org/10.1097/COH.0000000000000348
[11]. Rice, B., Boulle, A., Schwarcz, S., Shroufi, A., Rutherford, G., & Hargreaves, J., 2019, The Continuing Value of CD4 Cell Count Monitoring for Differential HIV Care and Surveillance. JMIR Public Health and Surveillance, 5(1), e11136. https://doi.org/10.2196/11136
[12]. Andarge, D. E., Hailu, H. E., & Menna, T., 2022, Incidence, survival time and associated factors of virological failure among adult HIV/AIDS patients on first line antiretroviral therapy in St. Paul’s Hospital Millennium Medical College—A retrospective cohort study. PLOS ONE, 17(10), e0275204. https://doi.org/10.1371/JOURNAL.PONE.0275204
[13]. Sithole, Z., Mbizvo, E., Chonzi, P., Mungati, M., Juru, T. P., Shambira, G., Gombe, N. T., & Tshimanga, M., 2018, Virological failure among adolescents on ART, Harare City, 2017- a case-control study. BMC Infectious Diseases, 18(1), 1–8. https://doi.org/10.1186/S12879-018-3372-6/TABLES/5
[14]. Jackson, C., Rehman, A. M., McHugh, G., Gonzalez-Martinez, C., Ngwira, L. G., Bandason, T., Mujuru, H., Odland, J. O., Corbett, E. L., Ferrand, R. A., & Simms, V., 2022, Risk factors for sustained virological non-suppression among children and adolescents living with HIV in Zimbabwe and Malawi: a secondary data analysis. BMC Pediatrics, 22(1), 1–9. https://doi.org/10.1186/S12887-022-03400-4/TABLES/5
[15]. Hakizayezu, F., Biracyaza, E., Niyompano, H., & Umubyeyi, A., 2022, The Frequency and Predictors of Unsuppressed HIV Viral Load Among People with HIV in Nyaruguru District, Rwanda. HIV/AIDS (Auckland, N.Z.), 14, 381–395. https://doi.org/10.2147/HIV.S376053
[16]. Melku, M., Gesesew, H. A., & Ward, P. R., 2022, Magnitude and predictors of HIV-Drug resistance in Africa: A protocol for systematic review and meta-analysis. PLOS ONE, 17(4), e0267159. https://doi.org/10.1371/JOURNAL.PONE.0267159
[17]. Chikwari, C. D., Kranzer, K., Simms, V., Patel, A., Tembo, M., Mugurungi, O., Sibanda, E., Mufare, O., Ndlovu, L., Muzangwa, J., Vundla, R., Chibaya, A., Hayes, R., Mackworth-Young, C., Bernays, S., Mavodza, C., Hove, F., Bandason, T., Dauya, E., & Ferrand, R. A., 2024, Differentiated care for youth in Zimbabwe: Outcomes across the HIV care cascade. PLOS Global Public Health, 4(2 February). https://doi.org/10.1371/journal.pgph.000255
[18]. Ssemwanga, D., Asio, J., Watera, C., Nannyonjo, M., Nassolo, F., Lunkuse, S., Salazar-Gonzalez, J. F., Salazar, M. G., Sanyu, G., Lutalo, T., Kabuga, U., Ssewanyana, I., Namatovu, F., Namayanja, G., Namale, A., Raizes, E., Kaggwa, M., Namuwenge, N., Kirungi, W., Kaleebu, P., 2020, Prevalence of viral load suppression, predictors of virological failure and patterns of HIV drug resistance after 12 and 48 months on first-line antiretroviral therapy: a national cross-sectional survey in Uganda. Journal of Antimicrobial Chemotherapy, 75(5), 1280. https://doi.org/10.1093/JAC/DKZ561
[19]. Waju, B., Dube, L., Ahmed, M., & Assefa, S. S., 2021, Unsuppressed viral load level in public health facilities: nonvirological predictors among adult antiretroviral therapy users in southwestern ethiopia. HIV/AIDS (Auckland, N.Z.), 13, 513. https://doi.org/10.2147/HIV.S304653
[20]. Mhlanga, T. T., Jacobs, B. K. M., Decroo, T., Govere, E., Bara, H., Chonzi, P., Sithole, N., Apollo, T., Van Damme, W., Rusakaniko, S., Lynen, L., & Makurumidze, R., 2022, Virological outcomes and risk factors for non-suppression for routine and repeat viral load testing after enhanced adherence counselling during viral load testing scale-up in Zimbabwe: analytic cross-sectional study using laboratory data from 2014 to 2018. AIDS Research and Therapy, 19(1). https://doi.org/10.1186/s12981-022-00458-z
[21]. Soogun, A. O., Kharsany, A. B. M., Zewotir, T., North, D., Ogunsakin, E., & Rakgoale, P., 2022, Spatiotemporal variation and predictors of unsuppressed viral load among hiv-positive men and women in rural and peri-urban kwazulu-natal, south africa. Tropical Medicine and Infectious Disease, 7(9), 232. https://doi.org/10.3390/TROPICALMED7090232/S1
[22]. ZimStat, 2022, 2022 Population and housing census- preliminary report on population figures, Accessed: Aug. 12, 2024.Online]. Available: https://www.zimstat.co.zw/wp-content/uploads/2022/07/Census 2022_ Preliminary_Report.pdf
[23]. Wisaksana, R., Hartantri, Y., & Hutajulu, E., 2024, Risk Factors Associated with Unsuppressed Viral Load in People Living with HIV Receiving Antiretroviral Treatment in Jawa Barat, Indonesia. HIV/AIDS - Research and Palliative Care, 16, 1–7. https://doi.org/10.2147/HIV.S407681
[24]. Nyaradzo, B., Kudya, N., Mbofana, E., Masaka, S., Garone, D., Chen, C.-Y., Mulingwa, A., Uzande, C., Isaakidis, P., & Ndlovu, Z., 2019, Scaling up HIV viral load monitoring in Manicaland, Zimbabwe: challenges and opportunities from the field. Public Health Action, 9(4), 177–181. https://doi.org/10.5588/PHA.19.0024
[25]. Asfaw, A., Ali, D., Eticha, T., Alemayehu, A., Alemayehu, M., & Kindeya, F., 2015, CD4 Cell Count Trends after Commencement of Antiretroviral Therapy among HIV-Infected Patients in Tigray, Northern Ethiopia: A Retrospective Cross-Sectional Study. PLOS ONE, 10(3), e0122583. https://doi.org/10.1371/JOURNAL.PONE.0122583 doi:10.1371/JOURNAL. PONE.0122583
[26]. Mapiye, M., Ravhuhali, K., de Voux, A., & Kufa, T., 2024, Factors associated with an unsuppressed viral load among HIV-positive individuals attending STI services in South Africa, 2019. BMC Infectious Diseases, 24(1), 1–8. https://doi.org/10.1186/S12879-023-08756-1/TABLES/2
[27]. Gezie, L. D., 2016, Predictors of CD4 count over time among HIV patients-initiated ART in felege hiwot referral hospital, northwest Ethiopia: Multilevel analysis. BMC Research Notes, 9(1), 1–9. https://doi.org/10.1186/S13104-016-2182-4/TABLES/6
[28]. Montarroyos, U. R., Miranda-Filho, D. B., César, C. C., Souza, W. V., Lacerda, H. R., Albuquerque, M. D. F. P. M., Aguiar, M. F., & Ximenes, R. A. D. A., 2014, Factors related to changes in CD4+ T-cell counts over time in patients living with HIV/AIDS: a multilevel analysis. PloS One, 9(2). https://doi.org/10.1371/JOURNAL.PONE.0084276
[29]. Bukenya, D., Mayanja, B. N., Nakamanya, S., Muhumuza, R., & Seeley, J., 2019, What causes non-adherence among some individuals on long term antiretroviral therapy? Experiences of individuals with poor viral suppression in Uganda. AIDS Research and Therapy, 16(1). https://doi.org/10.1186/S12981-018-0214-Y
[30]. Mantell, J. E., Masvawure, T. B., Mapingure, M., Apollo, T., Gwanzura, C., Block, L., Bennett, E., Preko, P., Musuka, G., & Rabkin, M., 2019, Engaging men in HIV programmes: a qualitative study of male engagement in community-based antiretroviral refill groups in Zimbabwe. Journal of the International AIDS Society, 22(10). https://doi.org/10.1002/JIA2.25403
[31]. Weissman, S., Duffus, W. A., Iyer, M., Chakraborty, H., Samantapudi, A. V., & Albrecht, H., 2015, Rural-urban differences in HIV viral loads and progression to AIDS among new HIV cases. Southern Medical Journal, 108(3), 180–188. https://doi.org/10.14423/SMJ.0000000000000255
[32]. Malaza, A., Mossong, J., Bärnighausen, T., Viljoen, J., & Newell, M. L., 2013, Population-based CD4 counts in a rural area in South Africa with high HIV prevalence and high antiretroviral treatment coverage. Plos One, 8(7), e70126–e70126. https://doi.org/10.1371/JOURNAL.PONE.0070126
[33]. Adoga, M. P., Pennap, G. R., John, P. A., Shawulu, P. T., Kaba, S. V., Forbi, J. C., & Agwale, S. M., 2012, CD4- and CD3-T lymphocyte reference values of immunocompetent urban and rural subjects in an African nation. Scandinavian Journal of Immunology, 76(1), 33–38. https://doi.org/10.1111/J.1365-3083.2012.02700.X
[34]. Ministry of Health and Child Care, Zimbabwe, AIDS & TB Programme for the Prevention, Care and Treatment of HIV in Zimbabwe, 2022, Operational and Service Delivery Manual 2022 Edition. operational and service delivery manual for the prevention, care and treatment of hiv in zimbabwe operational and service delivery manual 1 content abbreviations 2 background and rationale for the manual 3.
[35]. Owusu, L. B., Ababio, C., Boahene, S., Zakaria, A. F. S., Emikpe, A. O., Dwumfour, C. K., Appiagyei, K. A., & Apiribu, F., 2023, The predictors of unsuppressed viremia among PLHIV: a cross-sectional study in Ghana. BMC Public Health, 23(1). https://doi.org/10.1186/S12889-023-16032-9
[36]. Atuhaire, P., Hanley, S., Yende-Zuma, N., Aizire, J., Stranix-Chibanda, L., Makanani, B., Milala, B., Cassim, H., Taha, T., & Fowler, M. G., 2019, Factors associated with unsuppressed viremia in women living with HIV on lifelong ART in the multi-country US-PEPFAR PROMOTE study: A cross-sectional analysis. PLoS ONE, 14(10). https://doi.org/10.1371/JOURNAL.PONE.0219415
[37]. Tomita, A., Vandormael, A., Bärnighausen, T., Phillips, A., Pillay, D., De Oliveira, T., Tanser, F., & South, A., 2019, Sociobehavioral and community predictors of unsuppressed HIV viral load: multilevel results from a hyperendemic rural South African population HHS Public Access. AIDS, 33(3), 559–569. https://doi.org/10.1097/QAD. 00000 000 000 02100
[38]. Hicham, T., Ilyas, E., Tarik, H., Noureddine, B., Omar, B., Rachid, F., Naoufal, H., & Mohammed, B., 2019, Risk factors associated with unsuppressed viral load in HIV-1 infected patients at the first antiretroviral therapy in Morocco. International Journal of Mycobacteriology, 8(2), 113–117. https://doi.org/10.4103/IJMY.IJMY_41_19
[39]. Myers, B., Lombard, C., Joska, J. A., Abdullah, F., Naledi, T., Lund, C., Petersen Williams, P., Stein, D. J., & Sorsdahl, K. R., 2021, Associations Between Patterns of Alcohol Use and Viral Load Suppression Amongst Women Living with HIV in South Africa. AIDS and Behavior, 25(11), 3758–3769. https://doi.org/10.1007/S10461-021-03263-3
[40]. Malbergier, A., Do Amaral, R. A., & Cardoso, L. D., 2015, Alcohol dependence and CD4 cell count: is there a relationship? AIDS Care, 27(1), 54–58. https://doi.org/10.1080/09540 121.2014.947235
[41]. Lesko, C. R., Nance, R. M., Lau, B., Fojo, A. T., Hutton, H. E., Delaney, J. A. C., Crane, H. M., Cropsey, K. L., Mayer, K. H., Napravnik, S., Geng, E., Mathews, W. C., McCaul, M. E., & Chander, G., 2021, Changing Patterns of Alcohol Use and Probability of Unsuppressed Viral Load Among Treated Patients with HIV Engaged in Routine Care in the United States. AIDS and Behaviour.
Viewed PDF 3 0 -
Community Health Workers: Key Drivers in Malaria Community Case Management in ZambiaAuthor: Celia TusiimeDOI: 10.21522/TIJPH.2013.12.04.Art063
Community Health Workers: Key Drivers in Malaria Community Case Management in Zambia
Abstract:
For over a decade, the Zambia Ministry of Health has been implementing programs aimed at reducing malaria prevalence in the Nchelenge district of Luapula Province. High-impact malaria control interventions implemented include indoor residual spraying, long-lasting insecticide net distribution and community case management. Despite this, malaria prevalence remains high. Community health workers (CHWs) are the drivers of community case management (CCM), a strategy promoting early recognition, prompt diagnosis, and treatment of preventable illnesses such as malaria. This systematic desk review aimed to assess the impact of community health workers on Malaria CCM and prevention in the Nchelenge district. Thirty-four (34) studies were reviewed which reported indicators of CHW performance and their roles in community health. The study concluded that CHWs had important preventive, case management and promotive roles in malaria interventions. The review revealed that CHWs can provide good quality malaria care, including performing procedures such as rapid diagnostic tests. The factors perceived to influence CHWs' performance were community support, training, availability of drugs and supplies, incentives, and recognition from formal health workers. Though CHWs are recognized, they are not fully integrated into the health system. To enable their effective integration, the following should be considered: introduce sustainable financing of CCM programs; tailor CHW training to address gaps; and improve sustainable supply chain management of malaria drugs and diagnostics. By expanding CHWs, the number of malaria diagnosis and treatment service points per population is expected to decrease treatment-seeking delays and the percentage of people who progress from mild to severe malaria.
Community Health Workers: Key Drivers in Malaria Community Case Management in Zambia
References:
[1]. WHO 2022, World Malaria Report. https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2022
[2]. Ministry of Health 2018, Zambia Demographic and Health Survey, 2018. DHS Program, ICF, 2020.
[3]. Masaninga, F., Chanda, E., Chanda-Kapata, P., Hamainza, B., Masendu, T., Kamuliwo, M., Kapelwa, W., Chimumbwa, J., Govere, J., Otten, M., Fall, I. S., & Babaniyi, O. 2013, Review of the Malaria Epidemiology and Trends in Zambia. Asian Pacific Journal of Tropical Biomedicine, vol. 3, no. 2, Feb. 2013, pp. 89–94, https://doi.org/10.1016/s2221-1691(13)60030-1
[4]. Kussin-Shoptaw, B., 2020 Impact of community case management on severe malaria in a high transmission area in Northern Zambia. Maryland, USA.: Johns Hopkins University.
[5]. Hast, M. A., Stevenson, J., C., Muleba, M., Chaponda, M., Kabuya, J. B., Mulenga, M., Shields, T., Moss, W. J., Norris, D. E. 2021, The impact of three years of targeted indoor residual spraying with pirimiphos-methyl on household vector abundance in a high malaria transmission area of Northern Zambia. American Journal of Tropical Medicine and Hygiene, vol. 104, no. 2, 3 Feb. 2021, pp. 683–694, https://doi.org/10.4269/ajtmh.20-0537
[7]. Ministry of Health 2022, Zambia National Health Strategic Plan 2022–2026, Towards Attainment of Quality Universal Health Coverage through Decentralization. MOH, Zambia.
[9]. Moss, W., Dorsey, G., Mueller, I., Laufer, M. K., Krogstad, D. J., Vinetz, J. M., Guzman, M., Rosas-Aguirre, A. M., Herrera, S., Arevalo-Herrera, M., Chery, L., Kumar, A., Mohapatra, P. K., Ramanathapuram, L., Srivastava, H. C., Cui, L., Zhou, G., Parker, D. M., Nankabirwa, J., Kazura, J. W. 2015, Malaria epidemiology and control within the International Centers of Excellence for Malaria Research. The American Journal of Tropical Medicine and Hygiene, vol. 93, no. 3_Suppl, 2 Sept. 2015, pp. 5–15, https://doi.org/10.4269/ajtmh.15-0006
[10]. Moss, W., Ippolito, M. 2024, Harnessing Innovation to Transform Malaria Surveillence into Key Interventions Across Transmission Settings in Zambia. Johns Hopkins University, Maryland, USA.
[11]. Chanda, P., Hamainza, B., Moonga, H., Chalwe, V. & Pagnoni, F. 2011, Community case management of malaria using act and RDT in two districts in Zambia: Achieving high adherence to test results using community health workers. Malaria Journal, vol. 10, no. 1, 9 June 2011, https://doi.org/10.1186/1475-2875-10-158
[12]. Sunguya, B. F., Mlunde, L. B., Ayer, R. & Jimba, M. 2017, Towards eliminating malaria in high endemic countries: The roles of community health workers and related cadres and their challenges in Integrated Community Case Management for Malaria: A systematic review. Malaria Journal, vol. 16, no. 1, 3 Jan. 2017, https://doi.org/10.1186/s12936-016-1667-x
[13]. Smith, P. L., Willey, B., Kedenge, S., Sharkey, A., Kim, J., Buj, V., Webster, J., Schellenberg, D. & Ngongo, N. 2014, Community Health Workers and stand-alone or integrated case management of malaria: A systematic literature review. Am J Trop Med Hyg, vol. 91, no. 3, 3 Sept. 2014, pp. 461–470, https://doi.org/10.4269/ajtmh.14-0094
[14]. Hanson, K., Ranson, M. K., Oliviera-Cruz, V., Mills, A. 2003, Expanding access to priority health interventions: A framework for understanding the constraints to scaling up. Journal of International Development, vol. 15, no. 1, Jan. 2003, pp. 1–14, https://doi.org/10.1002/jid.963
[15]. USAID Evidence for Health Project 2024, Malaria Cases by health facility or community detection in Luapula Province. Malaria Rapid Reporting System. Lusaka, Zambia.
[16]. UNICEF 2012, Review of systematic challenges to the scale - up of integrated community case management. Emerging lessons and recommendations from the catalytic initiative. Maternal, newborn and child health, Working Paper. UNICEF, New York.
[17]. Ashton, R. A., Hamainza, B., Lungu, C., Rutagwera, M. I., Porter, T., Bennett, A., Hainsworth, M., Burnett, S., Silumbe, K., Slater, H., Eisele, T. P., Miller, J. M. 2023, Effectiveness of community case management of malaria on severe malaria and inpatient malaria deaths in Zambia: a dose-response study using routine health information system data. Malaria Journal 2023 Mar 17;22 (1):96 https://doi.org/0.1186/s12936-023-04525-2.PMID:36927440;PMCID: PMC10022244
[18]. Rowe, A. K., de Savigny, D., Lanata, C. F., Victora, C. G. 2005, How can we achieve and maintain high-quality performance of health workers in low-resource settings? The Lancet, vol. 366, no. 9490, Sept. 2005, pp. 1026–1035, https://doi.org/10.1016/s0140-6736(05)67028-6
[19]. Christopher, J. B., May, A. L., Lewin, S., Ross, D. A. 2011, Thirty Years After Alma-Ata: A systematic review of the impact of community health workers delivering curative interventions against malaria, pneumonia and diarrhoea on child mortality and morbidity in sub-Saharan Africa. Human Resources for Health, vol. 9, no. 1, 24 Oct. 2011, https://doi.org/10.1186/1478-4491-9-27.
[20]. Biemba, G., Mulenga, A., Chiluba, B., Griffiths, U., Yeboah-Antwi, K., MacLeod, W., Lunze, K., & Hamer, D. 2020, Cost analysis of integrated community case management of childhood malaria, diarrhea and pneumonia enhanced by mobile health technology in rural Zambia. Journal of Public Health in Africa, vol. 10, no. 2, 19 Mar. 2020, https://doi.org/10.4081/jphia.2019.1039
[21]. Olaniran, A., Banke-Thomas, A., Bar-Zeev, S., Madaj, B. 2022, Not knowing enough, not having enough, not feeling wanted: Challenges of community health workers providing maternal and newborn services in Africa and Asia. PLos One, vol. 17, no. 9, 9 Sept. 2022, https://doi.org/10.1371/journal.pone.0274110
[22]. Haines, A. 2007, Achieving child survival goals: Potential contribution of Community Health Workers. The Lancet, vol. 369, no. 9579, June 2007, pp. 2121–2131, https://doi.org/10.1016/s0140-6736(07)60325-0
[23]. Kalyango, J. N, Rutebemberwa, E., Alfven, T., Ssali, S., Peterson, S. & Karamagi, C. 2012, Performance of Community Health Workers Under Integrated Community case management of childhood illnesses in eastern Uganda. Malaria Journal, vol. 11, no. 1, 20 Aug. 2012, https://doi.org/10.1186/1475-2875-11-282
Viewed PDF 6 0 -
Sociodemographic Influences on HIV/AIDS Knowledge among Women of Reproductive Age in Nigeria: A Comparative AnalysisAuthor: Agbochenu Sunday AbojeDOI: 10.21522/TIJPH.2013.12.04.Art064
Sociodemographic Influences on HIV/AIDS Knowledge among Women of Reproductive Age in Nigeria: A Comparative Analysis
Abstract:
In Africa, HIV (Human immunodeficiency virus) is the leading cause of death among women of reproductive age and unprotected sex is the main driver of HIV transmission which contributes to high rate of mother to child transmission. Lack of knowledge is one of the foremost causes of this public health menace among this population. The study aims to explore how sociodemographic variables such as age, education, income, and marital status influence the comprehensive knowledge of HIV/AIDS among Nigerian women aged 15-49. This is a cross-sectional study which used from 2018 Nigeria Demographic and Health Survey. Stata software Version 14.2 (StataCorp LP, College Station, Texas 77845 USA) was employed to conduct analysis. Data was analyzed at three stages: univariate, bivariate and multivariate. Descriptive statistics were used to define sample characteristics. This study found that the major sociodemographic factors affecting HIV/AIDS knowledge among women of reproductive age are age, education, place of residence, religion, marital status, and wealth. Women between 20 to 24 years (OR=1.64,95% CI=1.274,2.111) were found to have higher HIV knowledge than adolescents. Women with tertiary education have higher odds (AOR=3.21,95%CI=2.397-4.321) than women without formal education. Women with highest wealth index had higher knowledge (AOR=1.50, 95%CI=1.113,2.027) than the poorest. Being exposed to TV (AOR=1.11, 95%CI=0.927,1.321) and radio (AOR=1.58,95%CI=1.266,1.979) at least once a week had higher knowledge. Living in rural areas have less knowledge (AOR=0.67,95%CI=0.574,0.795) compared with living in urban areas. These findings provide evidence for policymakers to understand the determinants of health for women and design policies targeting rural and female gender.
Sociodemographic Influences on HIV/AIDS Knowledge among Women of Reproductive Age in Nigeria: A Comparative Analysis
References:
[1]. Ankunda, D., Asiimwe, J. B., 2017, Determinants of comprehensive knowledge of HIV/AID among women of the reproductive age (15-49) in Uganda Int J Community Med Public Health; 4:3530-5.
[2]. National Agency for the Control of AIDS. NAIIS NATIONAL FACTSHEET. Retrieved from https://www.naiis.ng/resource/factsheet/NAIIS%20PA%20NATIONAL%20FACTSHEET%20FINAL.pdf
[3]. Fauk, N. K., Ward, P. R., Hawke, K., Mwanri, L., 2021, Cultural and religious determinants of HIV transmission: A qualitative study with people living with HIV in Belu and Yogyakarta, Indonesia. PLoS ONE 16(11): e0257906.https://doi.org/10.1371/journal.pone.0257906
[4]. Son, N. V., Luan, H. D., Tuan, H. X., Cuong, L. M., Duong, N., & Kien, V. D., 2020, Trends and factors associated with comprehensive knowledge about HIV among women in vietnam. Tropical medicine and infectious disease, 5(2), 91.https://doi.org/10.3390/tropicalmed5020091
[5]. Shokouh, SMH., 2017, Conceptual Models of Social Determinants of Health: A Narrative Review. Iran J Public Health. 46(4):435-446. PMID: 28540259; PMCID: PMC5439032.
[6]. Fikri, E., 2023, Comprehensive knowledge, attitudes, behaviors, and associated factors of hiv/aids in gondar city public health facilities among HIV testing and counselling service users, Northwest Ethiopia, 2022; an Ordinal Logistic Regression Analysis. HIV AIDS (Auckl).2023;15:713-726https://doi.org/10.2147/HIV.S441447
[7]. Jeannine Coreil., 2009, Social and Behavioral Foundations of Public Health (2nd edition).
[8]. Agegnehu, C. D., Geremew, B. M., Sisay, M. M., Muchie, K. F., Engida, Z. .T., Gudayu, T. W., Weldetsadik, D. S., Liyew, A. M., 2020, Determinants of comprehensive knowledge of HIV/AIDS among reproductive age (15-49 years) women in Ethiopia: further analysis of 2016 Ethiopian demographic and health survey. AIDS Res Ther. 2020 Aug 12;17(1):51. doi: 10.1186/s12981-020-00305-z. PMID: 32787881; PMCID: PMC7425582.
[9]. National Population Commission (NPC) [Nigeria] and ICF., 2019, Nigeria Demographic
[10]. and Health Survey 2018. Abuja, Nigeria, and Rockviile, Maryland, USA: NPC and ICF. Abate, B. B., Kassie, A. M., Reta, M. A., et al.,2020, Residence and young women’s comprehensive HIV knowledge in Ethiopia. BMC Public Health 20, 1603.https://doi.org/10.1186/s12889-020-09687-1
[11]. Teshale, A. B., Yeshaw, Y., Alem, A. Z., et al., 2022, Comprehensive knowledge about HIV/AIDS and associated factors among women of reproductive age in sub-Saharan Africa: a multilevel analysis using the most recent demographic and health survey of each country. BMC Infect Dis, 130.https://doi.org/10.1186/s12879-022-07124-9
[12]. Ama, P. Fenny., Aba, O. Crentsil., & Derek Asuman., 2017, Determinants and Distribution of comprehensive HIV/AIDS knowledge in Ghana. URL:https://doi.org/10.5539/gjhs.v9n12p32
[13]. Yang, F., Li, Z., Subramanian, SV., Lu, C., 2021, Assessment of Knowledge of HIV/AIDS and Association with Socioeconomic Disparities Among Young Women in Low- and Middle-Income Countries, 2003 to 2018. JAMA Netw Open. 2021 Jan 4;4(1): e2035000. doi:10.1001/jamanetworkopen.2020.35000. Erratum in: JAMA Netw Open;4(2): e213317. PMID:33481034; PMCID: PMC7823222.
[14]. Khan, M. A., Mondal, N. I., Islam, R., et al., 2019, Knowledge about HIV/AIDS among women in Bangladesh: an urban-rural comparison of trend, attitude and determinants. Biom Biostat Int J. 2019;8(5):162‒170. DOI: 10.15406/bbij.2019.08.00285.
[15]. Kefale, B., Damtie, Y., Yalew, M., Adane, B., Arefaynie, M., 2020, Predictors of Comprehensive Knowledge of HIV/AIDS Among People Aged 15-49 Years in Ethiopia: A Multilevel Analysis. HIV AIDS (Auckl).12:449-456. doi:10.2147/HIV.S266539. PMID: 32982472; PMCID: PMC7509684.
[16]. Teshome, R., Youjie, W., Habte, E., Kasm, N., 2016, Comparison and association of comprehensive HIV/AIDS knowledge and attitude towards people living with HIV/AIDS among women aged 15–49 in three east African countries: Burundi, Ethiopia and Kenya. J AIDS Clin Res. 7(4):1–8.
[17]. Efendi, F., Pratama, E. R., Hadisuyatmana, S., Indarwati, R., Lindayani L., Bushy A., 2020, HIV-related knowledge level among Indonesian women between 15 years and 49 years of age. Afr Health Sci. 20(1):83-90. doi:10.4314/ahs.v20i1.13. PMID: 33402896 PMCID: PMC7750044.
[18]. Mandiwa, C., Namondwe, B., & Munthali, M., 2021, Prevalence and correlates of comprehensive HIV/AIDS knowledge among adolescent girls and young women aged 15–24 years in Malawi: evidence from the 2015–16 Malawi demographic and health survey. BMC Public Health; https://doi.org/10.1186/s12889-021-11564-4
[19]. Jha, P. K., Narayan, P., Nair, S., Ganju, D., Sahu, D., Pandey, A., 2015, An Assessment of comprehensive Knowledge of HIV/AIDS among Slum and Non-Slum Populations in Delhi, India. Open Journal of Preventive Medicine, 5, 259-268.http://dx.doi.org/10.4236/ojpm.2015.56029
[20]. Estifanos, T. M., Hui, C., Tesfai, A. W. et al., 2021, Predictors of HIV/AIDS comprehensive knowledge and acceptance attitude towards people living with HIV/AIDS among unmarried young females in Uganda: a cross-sectional study. BMC Women's Health 21;https://doi.org/10.1186/s12905-021-01176-w
[21]. Sheikh et al., 2017, A comprehensive analysis of trends and determinants of HIV/AIDS knowledge among the Bangladeshi women based on Bangladesh Demographic and Health Surveys, 2007– 2014. Archives of Public Health 75:59. DOI 10.1186/s13690-017-0228-2.
[22]. Fauk, N. K., Ward, P. R., Hawke, K., Mwanri L., 2021, Cultural and religious determinants of HIV transmission: A qualitative study with people living with HIV in Belu and Yogyakarta, Indonesia. PLoS ONE 16(11): e0257906.https://doi.org/10.1371/journal.pone.0257906
[23]. Federal Ministry of Health, 2018 National AIDS Indicator and Impact Survey- Fact Sheet. Retrieved from https://afenetnigeria.net› Documents › NAIIS-N
[24]. Luiz, N. J., et al., 2021, Comprehensive knowledge and HIV prevalence in two migrant mineworkers’ communities of origin in Gaza Province in Southern Mozambique: evidence from a cross-sectional survey. Pan African Medical Journal. 2021;40(19). 10.11604/pamj.2021.40.19.22165.
[25]. Gutiérrez, J. P., Trossero, A., 2021, Socioeconomic inequalities in HIV knowledge, HIV testing, and condom use among adolescent and young women in Latin America and the Caribbean. Rev Panam Salud Publica. 2021;45: e47.https://doi.org/10.26633/RPSP.2021.47
[26]. Guure, C., et al., 2020, Comprehensive Knowledge of HIV and AIDS among Ghanaian Adults from 1998 to 2014: A multilevel logistic regression model approach. Retrieved from https://pubmed.ncbi.nlm.nih.gov/33029448/
[27]. Mude, W., Oguoma, V. M., Gesesew, H. A., Ameyaw, E. K., Njue, C., Nyanhanda, T., et al., 2020, HIV/AIDS knowledge and attitudes assessment among women of child-bearing age in South Sudan: findings from a Household Survey. PLoS ONE. 15(12): e0243969.
[28]. Yaya, S., Ghose, B., Udenigwe, O., Shah, V., Hudani, A., Ekholuenetale, M., 2019, Knowledge and attitude of HIV/AIDS among women in Nigeria: a cross-sectional study. Eur J Public Health 29(1):111-117. doi: 10.1093/eurpub/cky131. PMID: 30053009.
[29]. Seifu, B. L., Eshun, G., Tesema, G. A. et al., 2024, Comprehensive knowledge about HIV/AIDS and associated factors among reproductive age women in Liberia. BMC Public Health 24, 619 (2024). https://doi.org/10.1186/s12889-024-18105-9
[30]. Anthony, M., Paphani, D., Keletso, M., Morongwa, D., Tshephang, K., Fredah, R., GodfreyM R., 2019, Determinants of comprehensive knowledge of mother to child transmission (MTCT) of HIV and its prevention among Zimbabwean women: Analysis of 2015 Zimbabwe Demographic and Health Survey, Alexandria Journal of Medicine, 55:1, 68- 75, DOI: 10.1080/20905068.2019.1667114.
[31]. Kawuki, J., Gatasi, G., Sserwanja, Q., Mukunya, D., Musaba, MW., 2023, Comprehensive knowledge about HIV/AIDS and associated factors among adolescent girls in Rwanda: a nationwide cross-sectional study. BMC Infect Dis. 2023 Jun 7;23(1):382. doi: 10.1186/s12879-023-08187-y. PMID: 37286932; PMCID: PMC10246540.
[32]. Chris, G., Stephen, O., Samuel, D., Frances, B. C. V., Seth, A., 2020, "Comprehensive Knowledge of HIV and AIDS among Ghanaian Adults from 1998 to 2014: A Multilevel Logistic Regression Model Approach", Scientifica, vol. 2020, Article ID 7313497: https://doi.org/10.1155/2020/7313497
[33]. Nigeria Demographic and Health Survey (NDHS,2018). Retrieved from https://www.dhsprogram.com/pubs/pdf/FR359/FR359.pdf
[34]. Yaya, S., Ghose, B., Udenigwe., Shah, V., and Hudani, A., 2018, Knowledge and attitude of HIV/AIDS among women in Nigeria: a cross-sectional study. doi:10.1093/eurpub/cky131. PMID:30053009.
[35]. Oginni, A. B., Adebajo, S. B., Ahonsi, B. A., 2017, Trends and Determinants of Comprehensive Knowledge of HIV among Adolescents and Young Adults in Nigeria: 2003 - 2013. Afr J Reprod Health; 21(2):26-34. doi: 10.29063/ajrh2017/v21i2.4. PMID: 29624937.
[36]. Gebremedhin, S. A., Youjie, W., Tesfamariam, E. H., 2017, Predictors of HIV/AIDS Knowledge and attitude among young women of nigeria and democratic republic of congo: Cross-Sectional Study. J AIDS Clin Res 8: 677. doi: 10.4172/2155- 6113.1000677.
[37]. Ripon, R. K., 2023, Determinants of HIV/AIDS prevention and transmission knowledge factors among women aged15-49: a trend analysis based on the Bangladesh Demographic and Health Survey. Retrieved from https://www.socialmedicine.info/index.php/socialmedicine/article/view/1619
[38]. Tetteh, J. K., Frimpong, J. B., Budu, E., et al., 2022, Comprehensive HIV/AIDS knowledge and HIV testing among Men in sub-Saharan Africa: a multilevel Modelling. Journal of Biosocial Science. 975-990. Doi: 10.1017/S002193202100560.
[39]. Kareem, Y. O., Dorgbetor, C. I., Ameyaw, E. K., et al., 2023, Assessment and associated factors of comprehensive HIV knowledge in an at-risk population: a cross-sectional study from 19,286 young persons in Nigeria. Therapeutic Advances in Infectious Disease. 2023;10. doi:10.1177/20499361231163664.
[40]. Bhattacharyya, A., Chakraborty, R., Raj, T., Padhi, B. K., Khubchandani, J., Satapathy, P., Rustagi, S., Chattu, V. K., 2023, Comprehensive Knowledge about HIV/AIDS among Women of Reproductive Age in India. Epidemiologia 2023, 4, 492-504. https://doi.org/10.3390/epidemiologia4040041
[41]. Ramos, N. N. V., Fronteira, I., Martins, M. R. O., 2023, Comprehensive Knowledge of HIV and AIDS and Related Factors in Angolans Aged between 15 and 49 Years. Int. J. Environ. Res. Public Health 2023, 20, 6816.
[42]. Izudi, J., Kadengye, D. T., 2022, Effect of comprehensive knowledge of HIV on risky sexual behaviours associated with HIV transmission among adult Ugandans: a propensity score-matched analysis BMJ Open 2022;12: e064011. doi: 10.1136/bmjopen-2022-064011.
Viewed PDF 6 0 -
Effect of Shift Work on One’s Physical and Psychological Well-Being Among Nursey Employed in Saveetha HospitalAuthor: Linda XavierDOI: 10.21522/TIJPH.2013.12.04.Art065
Effect of Shift Work on One’s Physical and Psychological Well-Being Among Nursey Employed in Saveetha Hospital
Abstract:
Shift work is viewed as critical to the healthcare system because it ensures treatment continuity in residential and hospital settings. The two most important parts of shift work are scheduling and rotation; nurses are essentially required to follow schedules that include night shift work and 24-hour care. In this new work arrangement, shift workers are both producers and sufferers.4 One of the most common causes of circadian rhythm disturbance is shift work, particularly night shift employment, which causes significant alterations in sleep patterns and biological processes. The purpose of this study was to determine whether shift work including nights, as opposed to day work exclusively, is linked with risk factors that predispose nurses to poorer health outcomes and lower job satisfaction. This cross-sectional study was conducted between March 1, 2022, and April 31, 2022, in 17 wards of Saveetha Medical College & Hospital. This study included 213 nurses who worked rotating night shifts and 65 on day shifts. The data collection tool was the "Standard Shift Work Index," which has been verified in Italian. Data were statistically analyzed. The response rate was 85%. The nurses engaged in rotating night shifts were statistically significantly young, single, and had undergraduate & postgraduate degrees in nursing. They reported the lowest mean score in the items of job satisfaction, quality and quantity of sleep, with more frequent chronic fatigue, and psychological, and cardiovascular symptoms in comparison with the morning shift workers, in a statistically significant way.
Effect of Shift Work on One’s Physical and Psychological Well-Being Among Nursey Employed in Saveetha Hospital
References:
[1]. Parent-Thirion, A., Vermeylen, G., van Houten., G.,2016, Fifth European working conditions survey: “European Foundation for the improvement of living and working conditions 5(12) 149-150.
[2]. Boivin D. B., Boudreau P., 2014 Pathology Biology : Impacts of shift work on sleep and circadian rhythms 62(5):292–301.
[3]. Korompeli, A., Muurlink, O., Tzavara, C., Velonakis, E., Lemonidou, C., Sourtzi, P., 2014, Safety Health Work: Influence of shiftwork on Greek nursing personnel 5(2):73–79.
[4]. Burch, J. B., Yost, M. G., Johnson, W., Allen, E., 2005, Journal of Occupational and Environmental Medicine: Melatonin, sleep, and shift work adaptation 47(9):893–901.
[5]. Costa, G., 2010, Shift work and health: current problems and preventive actions. Safe Health Work 1(2):112–123.
[6]. Costa G, Accattoli M. P., Garbarino S., Magnavita N., Roscelli F., 2013, Med Lava Sleep disorders and work: guidelines for health surveillance, risk management and prevention 104(4):251–266.
[7]. Matheson, A., O’Brien, L., Reid, J. A., 2014, Journal of Clinical Nursing : The impact of shift work on health: A literature review 23(24):3309–3320.
[8]. Black, J. E., Hull ,S. G., Tiller, J., Yang, R., Harsh, J. R., 2010, Journal of Clinical Sleep Medicine: The long-term tolerability and efficacy of armodafinil in patients with excessive sleepiness associated with treated obstructive sleep apnea, shift work disorder, or narcolepsy: an open-label extension study 6(5):458–466.
[9]. Schwartz, J. R., Khan, A., McCall, W. V., Weintraub, J., Tiller 2010, Journal of Clinical Sleep Medicine:Tolerability and efficacy ofarmodafinil in naïve patients with excessive sleepiness associated with obstructive sleep apnea, shift work disorder, or narcolepsy: A 12-month, open-label, flexible-dose study with an extension period. 6(5):450–457.
[10]. Waage, S., Pallesen, S., Moen, B. E., Magerøy, N., Flo, E., Di Milia, L., Bjorvatn B., 2014 Journal of Sleep Medicine Predictors of shift work disorder among nurses: A longitudinal study15(12):1449–1455.
[11]. Flo, E., Pallesen, S., Moen, B. E., Waage, S., Bjorvatn B., 2014, Occupational and Environmental Medicine: Short rest periods between work shifts predict sleep and health problems in nurses at 1-year follow-up 71(8):555–561.
[12]. Stimpfel, A. W., Brewer, C. S., Kovner, C. T., 2015, International Journal of Nursing Studies: Scheduling and shift work characteristics associated with risk for occupational injury in newly licensed registered nurses: An observational study 52(11):1686–1693.
[13]. Shahriari M., Shamali M., Yazdannik A., 2014, Iranian Journal of Midwifery and Nursing Research: The Relationship between Fixed and Rotating Shifts with Job Burnout in Nurses Working in Critical Care Areas 5(19):360–365.
[14]. Saberi, H. R., Moravveji, A. R., 2010, Iraninan Journal of Science: Gastrointestinal Complaints in Shift-Working and Day-Working Nurses Circadian Rhythms (8):1–4.
[15]. Voigt, R. M., Forsyth, C. B., Keshavarzian, A., 2019, Circadian Rhythms: A Regulator of Gastrointestinal Health and Dysfunction. Expert Review Gastroenterology & Hepatology, 6(13):411–442.
[16]. James, S. M., Honn, K. A., Gaddameedhi S., Van Dongen, H. P. A.,2017, Current Sleep Medicine Reports in Shift Work: Disrupted Circadian Rhythms and Sleep Implications for Health and Well-Being 7(3):104–112.
[17]. Cheng, P., Tallent, G., Bender, T. J., Tran K. M., Drake C. L. 2017, Journal of Biological Rhythm: Shift Work and Cognitive Flexibility: Decomposing Task Performance 3(2)143–153.
[18]. Seong, J., Son S., Min, A., 2022, Journal of Advanced Nursing: Effect of Sleep on Alertness at Work among Fixed Night Shift Nurses: A Prospective Observational Study 7(8)3197–3206.
[19]. De Hert, S., 2020: Local and Regional Anesthesia Burnout in Healthcare Workers: Prevalence, Impact and Preventative Strategies 5(13)171–183.
Viewed PDF 6 0 -
Decoding the Root Causes of Donor Collection Failures: A Retrospective AnalysisAuthor: Lakshmi PriyaDOI: 10.21522/TIJPH.2013.12.04.Art068
Decoding the Root Causes of Donor Collection Failures: A Retrospective Analysis
Abstract:
Donor collection failures, including incomplete or unsuccessful blood collection attempts, pose significant challenges on maintaining an adequate blood component supply. These include donor-related issues, procedural errors, and environmental factors. There is notable scarcity in literature that comprehensively examines and investigates the underlying root causes of these failures within blood centres. This retrospective study aims to identify and analyse the root causes of donor collection failures in a blood bank setting at Tertiary Care Hospital. Data was reviewed retrospectively from the blood centre of Tertiary Care Hospital over a period from Jan 2022 to July 2024 with regard to cause of failure collection and the donor characteristics and then descriptive statistical analysis done. Results showed that a higher frequency of collection failures during blood donation was recorded in donors of age 26 – 35 years and 78% of collection failures occurred due to Insufficient blood flow (40%) resulting in low volume collection, failure collection due to prolonged duration (22%) and hematoma at puncture site (16%). Understanding these root causes is essential for developing effective strategies to improve the efficiency of blood collection processes, enhance donor experiences, and ensure a reliable blood supply. Additionally, successful blood collection is not only vital for maintaining an adequate supply of blood products but also for fostering positive donor experiences, which is crucial for encouraging repeat donations and maintaining a steady donor base.
Decoding the Root Causes of Donor Collection Failures: A Retrospective Analysis
References:
[1]. Sun, L. Y., Yu, Q., He, C. M., Wang, S. X., 2023, Sociodemographic Factors Related to Adverse Donor Reactions in Shenzhen. Int J Gen Med,16, 5493-5499, https://doi.org/10.2147/IJGM.S443682 .
[2]. France, C. R., Rader, A., Carlson, B., 2005, Donors who react may not come back: analysis of repeat donation as a function of phlebotomist ratings of vasovagal reactions. Transf Apher Sci, 33, 99–106.
[3]. World Health Organization, 2010, WHO guidelines on drawing blood: best practices in phlebotomy.
[4]. Radovčić, M. K., Ljubičić, J., Očić, T., Jukić, I., Vuk, T., 2021, Blood collection failures from a blood establishment perspective. Transfus Med, 31(2),88-93.
[5]. Diekamp, U., Gneißl, J., Rabe, A., Kiebig, S., 2015, Donor hemovigilance with blood donation. Transfus Med Hemother, 42, 181-192.
[6]. Stewart, K. R., France, C. R., Rader, A. W., Stewart, J. C., 2006, Phlebotomists' interpersonal skill predicts a reduction in reactions among volunteer blood donors. Transfusion, 46, 1394–1410.
[7]. Takanashi, M., Odajima, T., Aota, S., et al., 2012, Risk factor analysis of vasovagal reaction from blood donation. TransfusApher Sci, 47, 319-325.
[8]. Thijsen, A., Masser, B., 2017, Vasovagal reactions in blood donors: risks, prevention and management. Transfus Med, 29(1), 1322.
[9]. Fu, Q., Levine, B. D., 2016, Syncope prevention in blood donors: when to do what? Transfusion, 56, 2399-2402.
[10]. Vuk, T., Cipek, V., Jukic, I., 2015, Blood collection staff education in the prevention of venepuncture failures and donor adverse reactions: from inexperienced to skilful staff. Blood Transfus, 13, 338-339.
[11]. Donald, S. J., McIntyre, W. F., Dingwall, O., Hiebert, B., Ponnampalam, A., Seifer, C. M., 2019, Is donating blood for the faint of heart? A systematic review of predictors of syncope in whole blood donors. Transfusion, 59(9), 2865–2869. doi:10.1111/trf.15442.
[12]. Ibrahim, N., Mohd, N. N., Zulkafli, Z., 2023, Prevalence and factors associated with vasovagal reaction among whole blood donors in hospital Universiti Sains Malaysia. Transfus Clin Biol, 30(2), 238–243. doi: 10.1016/j.tracli.2023.01.004.
[13]. France, C. R., France. J. L., Frame-Brown, T. A., Venable, G. A., Menitove, J. E., 2016, Fear of blood draw and total draw time combine to predict vasovagal reactions among whole blood donors. Transfusion, 56, 179-185.
[14]. Greaney, J. L., Farquhar, W. B., 2011, Why do veins stiffen with advancing age? J Appl Physiol, 110, 11-12.
[15]. Xu, X., Wang, B., Ren, C., et al., 2017, Age-related impairment of vascular structure and functions. Aging Dis, 8, 590-610.
[16]. Vuk, T., Balija, M., Jukic, I., 2004, Quality system in reducing the rate of blood collection nonconformities—CITM experience 1998-2001. Blood Bank Transfus Med, 2, 27-31.
[17]. Vuk, T., 2019, When things go badly—managing quality problems and complaints in transfusion medicine. ISBT Sci Ser, 14, 84-89.
[18]. Newman, B. H., Newman, D. T., Ahmad. R., et al., 2006, The effect of whole-blood donor adverse events on blood donor return rates. Transfusion, 46(8), 1374–1379.
[19]. Lippi, G., Becan-McBride, K., Behúlová, D., Bowen, R. A. R., Church, S., Delanghe, J. R., et al., 2013, Preanalytical quality improvement: in quality we trust. Clin Chem Lab Med, 51, 229–41.
[20]. Nilsson-Sojka, B., Sojka, P., 2003, The blood-donation experience: perceived physical, psychological and social impact of blood donation on the donor. Vox Sang. 84, 120–128.
Viewed PDF 5 0 -
A Blockchain-Based, Efficient, and Privacy-Preserving Data Exchange System for mHealthcare that Includes Trust AuthenticationAuthor: Krishnamoorthy, R.DOI: 10.21522/TIJPH.2013.12.04.Art069
A Blockchain-Based, Efficient, and Privacy-Preserving Data Exchange System for mHealthcare that Includes Trust Authentication
Abstract:
The mobile healthcare (mHealthcare) paradigm provides promise to enhance the delivery of healthcare services through remote diagnostics and medical data interchange. But problems like unapproved access and data leaks continue. Although there are still problems, attribute-based encryption (ABE) is a useful cryptographic method for protecting data exchange in mHealthcare. To address these problems, this study provides an effective data sharing strategy that also protects privacy. The mHealthcare service users activity has been monitored for malicious analysis in which the authentication of the users is analysed using convolutional reinforcement fuzzy neural network. the trained and classified output gives security analysis based on healthcare data modelling then the network privacy is enhanced. In order to protect user privacy, it hides a portion of the access policy, adds an offline method for generating keys and encrypting data in mHealthcare, and uses blockchain technology to provide decentralized, reliable verification of data access rights. The enhanced security and efficiency of the method are confirmed by security proofs and experimental outcomes. Proposed technique attained detection accuracy 96%, data privacy analysis of 94%, recall of 90%, RMSE of 60% based on mHealthcare dataset analysis.
A Blockchain-Based, Efficient, and Privacy-Preserving Data Exchange System for mHealthcare that Includes Trust Authentication
References:
[1]. Xu, X., Peng, H., Bhuiyan, M. Z. A., Hao, Z., Liu, L., Sun, L., & He, L. 2021. Privacy-preserving federated depression detection from multisource mobile health data. IEEE transactions on industrial informatics, 18(7), 4788-4797. DOI: 10.1109/TII.2021.3113708
[2]. Altameem, A., Kovtun, V., Al-Ma'aitah, M., Altameem, T., Fouad, H., & Youssef, A. E. 2022. Patient's data privacy protection in medical healthcare transmission services using back propagation learning. Computers and Electrical Engineering, 102, 108087. https://doi.org/10.1016/j.compeleceng.2022.108087
[3]. Hennebelle, A., Ismail, L., Materwala, H., Al Kaabi, J., Ranjan, P., & Janardhanan, R. 2024. Secure and privacy-preserving automated machine learning operations into end-to-end integrated IoT-edge-artificial intelligence-blockchain monitoring system for diabetes mellitus prediction. Computational and Structural Biotechnology Journal, 23, 212-233. DOI: 10.1016/j.csbj.2023.11.038
[4]. Wang, W., Li, X., Qiu, X., Zhang, X., Brusic, V., & Zhao, J. 2023. A privacy in smart healthcare systems. Information Processing & Management, 60(1), 103167. https://doi.org/10.1016/j.ipm.2022.103167
[5]. Motahari, D., Arif, S., Mohboubi, A., & ur Rehman, S. 2020, November. Investigation of Mobile Machine Learning Models to Preserve the Effectiveness of User Privacy. In 2020 5th International Conference on Innovative Technologies in Intelligent Systems and Industrial Applications (CITISIA) pp. 1-7. IEEE. DOI:10.1109/CITISIA50690.2020.9397489
[6]. Sahinbas, K., & Catak, F. O. 2023. Secure multi-party computation-based privacy-preserving data analysis in healthcare IoT systems. In Interpretable Cognitive Internet of Things for Healthcare pp. 57-72. Cham: Springer International Publishing. https://link.springer.com/chapter/10.1007/978-3-031-08637-3_3
[7]. Sinaci, A. A., Gencturk, M., Alvarez-Romero, C., Erturkmen, G. B. L., Martinez-Garcia, A., Escalona-Cuaresma, M. J., & Parra-Calderon, C. L. 2024. Privacy-preserving federated machine learning on FAIR health data: A real-world application. Computational and Structural Biotechnology Journal. https://doi.org/10.1016/j.csbj.2024.02.014
[8]. Boulemtafes, A., Derhab, A., & Challal, Y. 2022. Privacy-preserving deep learning for pervasive health monitoring: a study of environment requirements and existing solutions adequacy. Health and Technology, 12(2), 285-304. https://link.springer.com/article/10.1007/s12553-022-00640-3
[9]. Kang, J. J., Dibaei, M., Luo, G., Yang, W., & Zheng, X. 2020, December. A privacy-preserving data inference framework for internet of health things networks. In 2020 IEEE 19th International Conference on Trust, Security and Privacy in Computing and Communications (TrustCom) pp. 1209-1214. IEEE. DOI: 10.1109/TrustCom50675.2020.00162
[10]. Deng, H., Qin, Z., Sha, L., & Yin, H. 2020. A flexible privacy-preserving data sharing scheme in cloud-assisted IoT. IEEE Internet of Things Journal, 7(12), 11601-11611. https://ieeexplore.ieee.org/document/9105096
[11]. Jayaram, R., & Prabakaran, S. 2021. Onboard disease prediction and rehabilitation monitoring on secure edge-cloud integrated privacy preserving healthcare system. Egyptian Informatics Journal, 22(4), 401-410. https://doi.org/10.1016/j.eij.2020.12.003
[12]. Abdo, M. A., Abdel-Hamid, A. A., & Elzouka, H. A. 2020, December. A cloud-based mobile healthcare monitoring framework with location privacy preservation. In 2020 International Conference on Innovation and Intelligence for Informatics, Computing and Technologies (3ICT) (pp. 1-8). IEEE. https://ieeexplore.ieee.org/document/9311999
[13]. Liang, J., Qin, Z., Xue, L., Lin, X., & Shen, X. 2021. Efficient and privacy-preserving decision tree classification for health monitoring systems. IEEE Internet of Things Journal, 8(16), 12528-12539. DOI: 10.1109/JIOT.2021.3066307
[14]. Zhu, D., Zhu, H., Huang, C., Lu, R., Feng, D., & Shen, X. 2023. Efficient and Accurate Cloud-Assisted Medical Pre-Diagnosis With Privacy Preservation. IEEE Transactions on Dependable and Secure Computing. DOI: 10.1109/TDSC.2023.3263974
[15]. Othman, S. B., Almalki, F. A., Chakraborty, C., & Sakli, H. 2022. Privacy-preserving aware data aggregation for IoT-based healthcare with green computing technologies. Computers and Electrical Engineering, 101, 108025. https://doi.org/10.1016/j.compeleceng.2022.108025
[16]. Aminifar, A., Rabbi, F., Pun, V. K. I., & Lamo, Y. 2021, November. Monitoring motor activity data for detecting patients’ depression using data augmentation and privacy-preserving distributed learning. In 2021 43rd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC) pp. 2163-2169. IEEE. DOI: 10.1109/EMBC46164.2021.9630592
[17]. Guduri, M., Chakraborty, C., & Margala, M. 2023. Blockchain-based federated learning technique for privacy preservation and security of smart electronic health records. IEEE Transactions on Consumer Electronics. DOI: 10.1109/TCE.2023.3315415
[18]. Li, C., Dong, M., Xin, X., Li, J., Chen, X. B., & Ota, K. 2023. Efficient privacy-preserving in IoMT with blockchain and lightweight secret sharing. IEEE Internet of Things Journal. DOI: 10.1109/JIOT.2023.3296595
[19]. Xu, G., Qi, C., Dong, W., Gong, L., Liu, S., Chen, S., & Zheng, X. 2022. A privacy-preserving medical data sharing scheme based on blockchain. IEEE Journal of Biomedical and Health Informatics, 27(2), 698-709. DOI: 10.1109/GLOBECOM42002.2020.9348251
[20]. Abdelfattah, S., Badr, M. M., Mahmoud, M., Abualsaud, K., Yaacoub, E., & Guizani, M. 2023. Efficient and privacy-preserving cloud-based medical diagnosis using an ensemble classifier with inherent access control and micro-payment. IEEE Internet of Things Journal. DOI:10.1109/JIOT.2023.3303429
[21]. Patruni, M. R., & Humayun, A. G. 2024. PPAM-mIoMT: a privacy-preserving authentication with device verification for securing healthcare systems in 5G networks. International Journal of Information Security, 23(1), 679-698. https://doi.org/10.1007/s10207-023-00775-y
[22]. Iwaya, L. H., Ahmad, A., & Babar, M. A. 2020. Security and privacy for mHealthcare and uHealth systems: a systematic mapping study. IEEE Access, 8, 150081-150112. DOI: 10.1109/ACCESS.2020.3015962
[23]. Long, G., Shen, T., Tan, Y., Gerrard, L., Clarke, A., & Jiang, J. 2021. Federated learning for privacy-preserving open innovation future on digital health. In Humanity Driven AI: Productivity, Well-being, Sustainability and Partnership (pp. 113-133). Cham: Springer International Publishing. https://doi.org/10.48550/arXiv.2108.10761
Viewed PDF 5 0 -
Rapid Detection of Influenza A & B: A Comparison of New and Existing Rapid Antigen Tests with Chip-based Real-Time PCRAuthor: Priyankar BhooshanDOI: 10.21522/TIJPH.2013.12.04.Art070
Rapid Detection of Influenza A & B: A Comparison of New and Existing Rapid Antigen Tests with Chip-based Real-Time PCR
Abstract:
Influenza, caused by the influenza A and B viruses, is a highly communicable respiratory disease with clinical manifestations ranging from mild, asymptomatic cases to severe complications, such as viral pneumonia and death. These complications are more common in individuals with underlying health conditions, weakened immune systems, and those at the extremes of age. Accurate detection of these viruses is vital for patient management and controlling the spread of infection. Several diagnostic tests, including rapid diagnostic tests (RDTs) and molecular assays, are used to identify these viruses, with varying sensitivity and specificity based on the type of specimen and the time of symptom onset. This study aimed to compare the diagnostic performance of a new Influenza A&B rapid antigen test with the current commercially available Influenza A&B rapid antigen test and chip-based H1N1 RT-PCR. This retrospective cohort study was conducted from May to October 2023, using nasopharyngeal swab samples that were positive for H1N1 via RT-PCR. Results from both rapid tests were in 100% agreement. The performance of the evaluated Influenza A&B rapid antigen test performed better in samples with higher viral load. In instances where samples exhibit high viral loads (Ct<20) and medium viral loads (20≤Ct<25) as indicated by the equipment, the sensitivity was found to be 100%. Findings from the study suggest that while the rapid antigen test is a useful diagnostic tool for Influenza A, confirmatory testing with RT-PCR may still be necessary in cases of high clinical suspicion.
Rapid Detection of Influenza A & B: A Comparison of New and Existing Rapid Antigen Tests with Chip-based Real-Time PCR
References:
[1]. Akaishi, Y., Matsumoto, T., Harada, Y., & Hirayama, Y, 2016, Evaluation of the rapid influenza detection tests GOLD SIGN FLU and Quick Navi-Flu for the detection of influenza A and B virus antigens in adults during the influenza season. International Journal of Infectious Diseases, 52, 55–58. https://doi.org/10.1016/j.ijid.2016.10.002
[2]. Busson, L., Hallin, M., Thomas, I., De Foor, M., & Vandenberg, O, 2014, Evaluation of 3 rapid influenza diagnostic tests during the 2012–2013 epidemic: Influences of subtype and viral load. Diagnostic Microbiology and Infectious Disease, 80(4), 287–291. https://doi.org/10.1016/j.diagmicrobio.2014.08.015
[3]. Cheng, P. K. C., Wong, K. K. Y., Mak, G. C., Wong, A. H., Ng, A. Y. Y., Chow, S. Y. K., Lam, R. K. H., Lau, C. S., Ng, K. C., & Lim, W, 2010, Performance of laboratory diagnostics for the detection of influenza A(H1N1)v virus as correlated with the time after symptom onset and viral load. Journal of Clinical Virology, 47(2), 182–185. https://doi.org/10.1016/j.jcv.2009.11.022
[4]. Cho, C. H., Woo, M. K., Kim, J. Y., Cheong, S., Lee, C.-K., An, S. A., Lim, C. S., & Kim, W. J, 2013, Evaluation of five rapid diagnostic kits for influenza A/B virus. Journal of Virological Methods, 187(1), 51–56. https://doi.org/10.1016/j.jviromet.2012.09.003
[5]. DiMaio, M. A., Sahoo, M. K., Waggoner, J., & Pinsky, B. A, 2012, Comparison of Xpert Flu rapid nucleic acid testing with rapid antigen testing for the diagnosis of influenza A and B. Journal of Virological Methods, 186(1), 137–140. https://doi.org/10.1016/j.jviromet.2012.07.023
[6]. Ellis, J. E., Guest, P., Lawson, V., Loecherbach, J., Lindner, N., & McCulloch, A, 2022, Performance Evaluation of the Microfluidic Antigen LumiraDx SARS-CoV-2 and Flu A/B Test in Diagnosing COVID-19 and Influenza in Patients with Respiratory Symptoms. Infectious Diseases and Therapy, 11(6), 2099–2109. https://doi.org/10.1007/s40121-022-00696-8
[7]. Gordon, A., Videa, E., Saborio, S., López, R., Kuan, G., Reingold, A., Balmaseda, A., & Harris, E, 2009, Performance of an Influenza Rapid Test in Children in a Primary Healthcare Setting in Nicaragua. PLOS ONE, 4(11), e7907. https://doi.org/10.1371/journal.pone.0007907
[8]. Hurt, A. C., Alexander, R., Hibbert, J., Deed, N., & Barr, I. G, 2007, Performance of six influenza rapid tests in detecting human influenza in clinical specimens. Journal of Clinical Virology, 39(2), 132–135. https://doi.org/10.1016/j.jcv.2007.03.002
[9]. Ko, S.-Y., Jang, J. W., Song, D. J., Lim, C. S., & Kim, W. J, 2013, Evaluation of the Simplexa Flu A/B and RSV test for the rapid detection of influenza viruses. Journal of Medical Virology, 85(12), 2160–2164. https://doi.org/10.1002/jmv.23712
[10]. Kok, J., Blyth, C. C., Foo, H., Patterson, J., Taylor, J., McPhie, K., Ratnamohan, V. M., Iredell, J. R., & Dwyer, D. E., 2010, Comparison of a rapid antigen test with nucleic acid testing during cocirculation of pandemic influenza A/H1N1 2009 and seasonal influenza A/H3N2. Journal of Clinical Microbiology, 48(1), 290–291. https://doi.org/10.1128/JCM.01465-09
[11]. Kumar, S., & Henrickson, K. J, 2012, Update on Influenza Diagnostics: Lessons from the Novel H1N1 Influenza A Pandemic. Clinical Microbiology Reviews, 25(2), 344–361. https://doi.org/10.1128/CMR.05016-11
[12]. Mitamura, K., Kawakami, C., Shimizu, H., Abe, T., Konomi, Y., Yasumi, Y., Yamazaki, M., Ichikawa, M., & Sugaya, N, 2013, Evaluation of a new immunochromatographic assay for rapid identification of influenza A, B, and A(H1N1)2009 viruses. Journal of Infection and Chemotherapy, 19(4), 633–638. https://doi.org/10.1007/s10156-012-0533-1
[13]. Noyola, D. E., Paredes, A. J., Clark, B., & Demmler, G. J, 2000, Evaluation of a neuraminidase detection assay for the rapid detection of influenza A and B virus in children. Pediatric and Developmental Pathology: The Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society, 3(2), 162–167. https://doi.org/10.1007/s100240050020
[14]. Peters, T. R., Blakeney, E., Vannoy, L., & Poehling, K. A, 2013, Evaluation of the limit of detection of the BD VeritorTM system flu A+B test and two rapid influenza detection tests for influenza virus. Diagnostic Microbiology and Infectious Disease, 75(2), 200–202. https://doi.org/10.1016/j.diagmicrobio.2012.11.004
[15]. Ryu, S.-W., Lee, J.-H., Kim, J., Jang, M.-A., Nam, J.-H., Byoun, M.-S., & Lim, C. S, 2016, Comparison of two new generation influenza rapid diagnostic tests with instrument-based digital readout systems for influenza virus detection. British Journal of Biomedical Science, 73(3), 115–120. https://doi.org/10.1080/09674845.2016.1189026
[16]. Suntarattiwong, P., Jarman, R. G., Levy, J., Baggett, H. C., Gibbons, R. V., Chotpitayasunondh, T., & Simmerman, J. M, 2010, Clinical performance of a rapid influenza test and comparison of nasal versus throat swabs to detect 2009 pandemic influenza A (H1N1) infection in Thai children. The Pediatric Infectious Disease Journal, 29(4), 366–367. https://doi.org/10.1097/INF.0b013e3181c6f05c
[17]. Takeuchi, Y., & Shimizu, H, 2000, Evaluation of influenza virus type A detection kit]. Kansenshogaku Zasshi. The Journal of the Japanese Association for Infectious Diseases, 74(10), 841–845. https://doi.org/10.11150/kansenshogakuzasshi1970.74.841
[18]. Vasoo, S., Stevens, J., & Singh, K, 2009, Rapid Antigen Tests for Diagnosis of Pandemic (Swine) Influenza A/H1N1. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 49(7), 1090–1093. https://doi.org/10.1086/644743
[19]. Watcharananan, S., Kiertiburanakul, S., & Chantratita, W, 2010, Rapid influenza diagnostic test during the outbreak of the novel influenza A/H1N1 2009 in Thailand: An experience with better test performance in resource limited setting. The Journal of Infection, 60(1), 86–87. https://doi.org/10.1016/j.jinf.2009.10.049
[20]. Woźniak-Kosek, A, 2015, Detection of Influenza and Other Respiratory Viruses Carried Out in the Influenza Project—Monitoring Vaccine Effectiveness (I-MOVE). Advances in Experimental Medicine and Biology, 836, 29–33. https://doi.org/10.1007/5584_2014_31
Viewed PDF 5 0 -
Comparative Analysis of Lactate to Albumin Ratio versus CRP to Albumin Ratio in Mechanically Ventilated PatientsAuthor: Ramesh Bala ArivazhaganDOI: 10.21522/TIJPH.2013.12.04.Art071
Comparative Analysis of Lactate to Albumin Ratio versus CRP to Albumin Ratio in Mechanically Ventilated Patients
Abstract:
Mechanically ventilated patients in intensive care units (ICUs) often suffer from severe, life-threatening conditions that need close monitoring and precise therapeutic interventions. Biomarkers are crucial in investigating the prognosis, guiding treatment decisions, and predicting outcomes in these critically ill patients. Among these biomarkers, the Lactate to Albumin Ratio (LAR) and the C-Reactive Protein to Albumin Ratio (CAR) have emerged as significant predictors of morbidity and mortality. The present study focuses on conducting a comparative analysis of LAR versus CAR in mechanically ventilated patients. An observational study was conducted on 50 mechanically ventilated patients, aged between 25 to 80 years, in the intensive care unit (ICU). The serum biomarkers like Lactate, CRP and albumin levels, were measured upon admission to the intensive care unit (ICU). Additionally, the other outcomes were assessed such as ICU mortality and length of stay. The findings revealed that the mean age of the patient was 55.64±16.52 years. Both the lactate-to-albumin ratio (0.70) and the CRP-to-albumin ratio (0.69) were significantly associated with ICU mortality. The p values of these two parameters were 0.03 and 0.04 respectively in lactate to albumin ratio and CRP to albumin ratio. The lactate-to-albumin ratio was more strongly correlated with markers of metabolic stress and tissue hypoxia, while the CRP-to-albumin ratio was a stronger predictor of inflammation severity. Both ratios provide valuable prognostic insights for mechanically ventilated patients. However, the lactate to albumin ratio is more indicative of metabolic stress and CRP to albumin ratio reflects inflammatory status, with lactate to albumin ratio being a more reliable indicator of prognosis in mechanically ventilated patients.
Comparative Analysis of Lactate to Albumin Ratio versus CRP to Albumin Ratio in Mechanically Ventilated Patients
References:
[1]. Marini, J. J., Gattinoni, L., 2020, Management of COVID-19 Respiratory Distress. Journal of the American Medical Association, 323(22), 2329-2330. 10.1001/jama.2020.6825.
[2]. Demoule, A., Decavele, M., Antonelli, M., 2024, Dyspnoea in acutely ill mechanically ventilated adult patients: an ERS/ESICM statement. Intensive Care Medicine, 50, 159–180. 10.1007/s00134-023-07246-x.
[3]. Phua, J., Weng, L., Ling, L., Egi, M., Lim, C. M., 2020, Asian Critical Care Clinical Trials Group. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. Lancet Respiratory Medicine, 8(5), 506-517. 10.1016/S2213-2600(20)30161-2.
[4]. Guttormson, J. L., Khan, B., Brodsky, M. B., Chlan, L. L., 2023, Symptom Assessment for Mechanically Ventilated Patients: Principles and Priorities: An Official American Thoracic Society Workshop Report. Annals of the American Thoracic Society, 20(4), 491-498. 10.1513/AnnalsATS.202301-023ST.
[5]. Bodaghi, A., Fattahi, N., Ramazani, A., 2023, Biomarkers: Promising and valuable tools towards diagnosis, prognosis and treatment of Covid-19 and other diseases. Heliyon, 9(2): e13323. 10.1016/j.heliyon. 2023.e13323.
[6]. Das, S., Dey, MK., Devireddy, R., Gartia MR., 2024, Biomarkers in cancer detection, diagnosis, and Prognosis. Sensors, 24(1):37. 10.3390/s24010037.
[7]. Zhang, N., Liu, Y., Yang, C., Li, X., 2024, Review of the predictive value of biomarkers in Sepsis Mortality. Emergency Medicine International, 5, 2715606. 10.1155/2024/2715606.
[8]. Jang, J. H., Hong, S., Ryu, J. A., 2022, Prognostic Value of C-Reactive Protein and Albumin in Neurocritically Ill Patients with Acute Stroke. Journal of Clinical Medicine, 11(17), 5067. 10.3390/jcm11175067.
[9]. Ryoo, S. M., Kim, W. Y., 2018, Clinical applications of lactate testing in patients with sepsis and septic shock. Journal of Emergency and Critical Care Medicine, 2:14. 10.21037/jeccm.2018.01.13.
[10]. Kabra, Ruchita; Acharya, Sourya; Kumar, Sunil., 2020, Serum Lactate Levels in Critically Ill Patients: An Early Marker to be Targeted. Journal of the Scientific Society, 49(3), 246-250. 10.4103/jss.jss_113_22.
[11]. Sauer, C. M., Gomez, J., Botella, M. R., 2021, Understanding critically ill sepsis patients with normal serum lactate levels: results from U.S. and European ICU cohorts. Scientific Reports, 11, 20076. 10.1038/s41598-021-99581-6.
[12]. Plebani, M., 2023, Why C-reactive protein is one of the most requested tests in clinical laboratories? Clinical Chemistry and Laboratory Medicine, 61(9), 1540-1545. 10.1515/cclm-2023-0086.
[13]. Heymann, M., Schorer, R., Putzu, A., 2023, The effect of cytosorb on inflammatory markers in critically ill patients: A systematic review and meta-analysis of randomized controlled trials. Critical Care Medicine, 51(12), 1659-1673. 10.1097/CCM.0000000000006007.
[14]. Belinskaia, D. A., Voronina, P. A., Goncharov, N. V., 2021, Integrative role of albumin: Evolutionary, biochemical and pathophysiological aspects. Journal of Evolutionary Biochemistry and Physiology, 57(6), 1419-1448. 10.1134/S002209302106020X.
[15]. Wiedermann, C. J., 2021, Hypoalbuminemia as surrogate and culprit of infections. International Journal of Molecular Sciences, 22(9), 4496. 10.3390/ijms22094496.
[16]. Zhou, X., Fu, S., Wu, Y., Guo, Z., Dian, W., Sun, H., Liao, Y., 2023, C-reactive protein-to-albumin ratio as a biomarker in patients with sepsis: A novel LASSO-COX based prognostic nomogram. Scientific Reports, 13(1), 15309. 10.1038/s41598-023-42601-4.
[17]. Fagarasan, G., Seicean, R., Bintintan, V., Fagarasan, V., Caziuc, A., Andras, D., 2024, The value of preoperative C-Reactive protein to albumin ratio as a prognostic biomarker in colon cancer patients. Medicina, 60(7), 1054. 10.3390/medicina60071054.
[18]. Bajwah, S., Oluyase, A. O., Yi D, W., Evans, C. J., Grande, G., Higginson, I. J., 2020, The effectiveness and cost-effectiveness of hospital-based specialist palliative care for adults with advanced illness and their caregivers. Cochrane Database of Systematic Reviews, 9(9), CD012780. 10.1002/14651858.CD012780.pub2.
[19]. Lee, S. I., Huh, J. W., Hong, S. B., Koh, Y., Lim, C. M, 2024, Age distribution and clinical results of critically Ill patients above 65-Year-Old in an aging society: A retrospective cohort study. Tuberculosis and Respiratory Diseases, 87(3), 338-348. 10.4046/trd.2023.0155.
[20]. Singhal, S., Singh, S., Dewangan, G. C., Dey, S., Banerjee, J., 2023, The prevalence of frailty and its relationship with sociodemographic factors, regional healthcare disparities, and healthcare utilization in the aging population across India. Aging Medecine, 6(3), 212-221. 10.1002/agm2.12263.
[21]. Lat, T. I., McGraw, M. K., White, H. D., 2021, Gender differences in critical illness and critical care Research. Clinics in Chest Medicine, 42(3), 543-555. 10.1016/j.ccm.2021.04.012.
[22]. Li, X., Yang, Y., Zhang, B., Lin, X., Fu, X., Yu, T., 2022, Lactate metabolism in human health and disease. Signal Transduction and Targeted Therapy, 7(1), 305. 10.1038/s41392-022-01206-5.
[23]. Erdogan, M., Findikli, H. A., 2022, Prognostic value of the lactate/albumin ratio for predicting mortality in patients with pneumosepsis in intensive care units. Medicine (Baltimore), 101(4), e28748. 10.1097/MD.000000000002874.
[24]. Sproston, N. R., Ashworth, J. J., 2018, Role of C-Reactive protein at sites of inflammation and infection. Frontiers Immunology, 9, 754. 10.3389/fimmu.2018.00754.
[25]. Tharavath, V., Rao, P. B., Nayak, S., Panda, A., Bandyopadhyay, D., Pati, S., 2023, Preoperative C-reactive protein - Albumin ratio as a predictor of requirement for postoperative mechanical ventilation after non-cardiac surgery under general anaesthesia: A prospective observational study (HICARV). Indian Journal Anesthesia, 67(3):262-268. 10.4103/ija.ija_295_22.
Viewed PDF 6 0 -
Assessment of Placental Morphometrics: A Comparison between Normal and IUGR Placentae and Their Impact on Fetal GrowthAuthor: Bharath K PDOI: 10.21522/TIJPH.2013.12.04.Art072
Assessment of Placental Morphometrics: A Comparison between Normal and IUGR Placentae and Their Impact on Fetal Growth
Abstract:
This study investigates the relationship between placental morphometrics and fetal growth outcomes in normal and intrauterine growth restriction (IUGR) pregnancies. We compared various placental parameters between control and IUGR groups to elucidate the structural differences associated with compromised fetal development. Our findings reveal significant disparities in placental morphology between the two groups. IUGR placentae exhibited markedly reduced weights (350-450g vs. 550-600g in controls), smaller maternal and fetal surface areas, and fewer cotyledons. Fetal weights in IUGR cases were substantially lower (1500-2440g vs. 2400-3500g in controls). Umbilical cords in IUGR pregnancies were generally shorter and slightly thinner, with less optimal insertion sites. These results underscore the critical role of placental structure in fetal growth. The observed reductions in placental size and complexity in IUGR cases likely contribute to diminished nutrient and oxygen transfer, directly affecting fetal development. This study enhances our understanding of the placental factors influencing IUGR and may inform future research on early detection and potential interventions for improved pregnancy outcomes.
Assessment of Placental Morphometrics: A Comparison between Normal and IUGR Placentae and Their Impact on Fetal Growth
References:
[1]. Tesfa, D., Tadege, M., Digssie, A., & Abebaw, S., 2020, Intrauterine growth restriction and its associated factors in South Gondar zone hospitals, Northwest Ethiopia, 2019. Archives of Public Health, 78(1), 89. https://doi.org/10.1186/s13690-020-00469-5
[2]. Bhatia, S., & Shah, M., 2024, A retrospective study of umbilical artery S/D ratio assessment on colour Doppler for monitoring fetal well-being in patients with intrauterine growth retardation and its correlation with perinatal outcomes. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 13(1), 139-145.
[3]. Khodjamova, N., Rakhmankulova, Z., & Khamidullayeva, N., 2024, The structure of morbidity in premature infants with an asymmetric variant of intrauterine growth retardation in the neonatal period. Science and Innovation, 3(D5), 318-323.
[4]. Gumeniuk, E. G., Ivshin, A. A., & Svetova, K. S., 2024, Fetal growth retardation as a predictor of health during future life. Obstetrics and Gynecology, 3, 13-19.
[5]. Tankala, M., Rao, M. K., Senapati, S., & Behera, S. S., 2023, Morphometric evaluation of human placental and umbilical cord for neonatal indices: A cross-sectional study. Cureus, 15(11), e48959. https://doi.org/10.7759/cureus.48959
[6]. Walter, A., Böckenhoff, P., Geipel, A., Gembruch, U., & Engels, A. C., 2020, Early sonographic evaluation of the placenta in cases with IUGR: A pilot study. Archives of Gynecology and Obstetrics, 302, 337-343.
[7]. Deshpande, S., 2024, A cross-sectional study of morphology and morphometry of human placenta amongst women with pregnancy-induced hypertension and without pregnancy-induced hypertension. International Journal of Academic Medicine and Pharmacy, 6(3), 181-187.
[8]. Rajeev, A. V., Goothy, S. K., & Srinivasan, C., 2020, Correlation of placental morphometry with the birth weight of newborns in Kerala population. Journal of Bangladesh Society of Physiologist, 15(2), 91-97.
[9]. Sharma, N., Srinivasan, S., Jayashree, K., Nadhamuni, K., Subbiah, M., & Rajagopalan, V., 2017, Prediction of intrauterine growth restriction in high pulsatility index of uterine artery. British Journal of Medicine and Medical Research, 22(2), 1-6.
[10]. Kondor, V. D., Ofori-Amoah, J., & Amitabye, L. R., 2023, The demographic and clinical history as predictors contributing to the prevalence of caesarean sections in Ghana: A facility-based study.
[11]. Govender, N., Lazarus, L., Abel, T., & Naicker, T., 2023, Placental morphology and morphometry: Is it a prerequisite for future pathological investigations? Advances in Experimental Medicine and Biology, 1392, 85-105. https://doi.org/10.1007/978-3-031-13021-2_5
[12]. Abdurasulovich, S. B., & Izzatullaevna, K. N., 2024, Background and relevance of studying morphological changes in the placenta during the critical period of 20-24 weeks. International Journal of Integrative and Modern Medicine, 2(6), 358-363.
[13]. Beloosesky, R., & Ross, M. G., 2024, Polyhydramnios and Oligohydramnios. Queenan's Management of High‐Risk Pregnancy: An Evidence‐Based Approach, 332-343.
[14]. de Souza Lima, B., Sanches, A. P. V., Ferreira, M. S., de Oliveira, J. L., Cleal, J. K., & Ignacio-Souza, L., 2024, Maternal-placental axis and its impact on fetal outcomes, metabolism, and development. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1870(1), 166855.
[15]. Emeka-Ogbugo, A., Gbobie, D. J., Ikwuka, A. O., Abbey, M., Okocha, A. N., & Amadi, S. C., 2024, Maternal age as a determinant of placental morphology and morphometry at term pregnancy: A cross-sectional study of selected hospitals in Rivers State, Southern Nigeria. European Journal of Medical and Health Research, 2(4), 33-40.
[16]. Paiker, M., Khan, K., Mishra, D., Tandon, S., Khan, A., Mustaqueem, S. F., & Haque, M., 2024, Morphological, morphometric, and histological evaluation of the placenta in cases of intrauterine fetal death. Cureus, 16(6), e62871. https://doi.org/10.7759/cureus.62871
[17]. Orzeł, A., Strojny, A. A., Filipecka-Tyczka, D., Baran, A., Muzyka-Placzynska, K., Mabiala, E., Pajutrek-Dudek, J., & Scholz, A., 2024, Fetal growth velocity—A breakthrough in intrauterine growth assessment? Journal of Clinical Medicine, 13(13), 3842.
[18]. Wu, P., Wang, J., Ji, X., Chai, J., Chen, L., Zhang, T., Long, X., Tu, Z., Chen, S., Zhang, L., & Wang, K., 2024, Maternal hypermethylated genes contribute to intrauterine growth retardation of piglets in Rongchang pigs. International Journal of Molecular Sciences, 25(12), 6462.
[19]. Iftikhar, S. I., Rehman, Z., Afridi, F., Afridi, S., & Rehman, S., 2024, Morphometric, histological variations in the placenta of normotensive and pregnancy-induced hypertensive mothers. Advances in Basic Medical Sciences, 8(1), 17-22.
[20]. Zhou, H., Zhao, C., Wang, P., Yang, W., Zhu, H., & Zhang, S., 2023, Regulators involved in trophoblast syncytialization in the placenta of intrauterine growth restriction. Frontiers in Endocrinology, 14, 1107182.
[21]. Kasture, V., Sundrani, D., Randhir, K., Wagh, G., & Joshi, S., 2021, Placental apoptotic markers are associated with placental morphometry. Placenta, 115, 1-1.
[22]. Connor, K. L., Kibschull, M., Matysiak-Zablocki, E., Nguyen, T. T., Matthews, S. G., Lye, S. J., & Bloise, E., 2020, Maternal malnutrition impacts placental morphology and transporter expression: An origin for poor offspring growth. The Journal of Nutritional Biochemistry, 78, 108329.
[23]. Putra, I. W., 2022, Molecular development of placenta and its relationship with preeclampsia and fetal growth restriction. European Journal of Medical and Health Sciences, 4(4), 38-42.
Viewed PDF 5 0 -
Antinuclear Antibody: A Diagnostic Tool in Connective Tissue DisordersAuthor: Gayathri. SDOI: 10.21522/TIJPH.2013.12.04.Art073
Antinuclear Antibody: A Diagnostic Tool in Connective Tissue Disorders
Abstract:
Antinuclear antibodies (ANA) are autoantibodies that are produced and directed against cell nuclear contents that have the potential to bind and destroy them. These autoantibodies are detected in many rheumatologic and non-rheumatological disorders and in a small proportion of normal individuals. Thus, these form an important laboratory investigation for diagnosing and confirming various connective tissue disorders. For the detection of these autoantibodies, different methods have been used. This article highlights the history, various conditions with ANA positivity, different methods used for the detection of ANA and the drawbacks of ANA. The review article was done by referring various review articles, original articles, and literature from various databases.
Antinuclear Antibody: A Diagnostic Tool in Connective Tissue Disorders
References:
[1]. Satoh, M., Vázquez-Del Mercado, M., & Chan, E. K., 2009, Clinical interpretation of antinuclear antibody tests in systemic rheumatic diseases. Modern rheumatology, 19(3), 219-228. https://doi.org/10.1007/s10165-009-0155-3
[2]. Vermeersch, P., & Bossuyt, X., 2013, Prevalence and clinical significance of rare antinuclear antibody patterns. Autoimmunity reviews, 12(10), 998-1003. https://doi.org/10.1016/j.autrev.2013.03.014
[3]. Solomon, D. H., Kavanaugh, A. J., Schur, P. H., & American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines, 2002, Evidence‐based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Care & Research, 47(4), 434-444. https://doi.org/10.1002/art.10561
[4]. Kumar, Y., Bhatia, A., & Minz, R. W., 2009, Antinuclear antibodies and their detection methods in diagnosis of connective tissue diseases: A journey revisited. Diagnostic pathology, 4, 1-10. https://doi.org/10.1186/1746-1596-4-1
[5]. Arora, S. K., & Chhabra, S., 2012, In vivo antinuclear antibodies of the skin. Indian Journal of Dermatology, Venereology and Leprology, 78(1), 116. https://doi.org/10.4103/0378-6323.90967
[6]. Colglazier, C. L., & Sutej, P. G., 2005, Laboratory testing in the rheumatic diseases: a practical review. South Med J, 98(2), 185-91. https://doi.org/10.1097/01.SMJ.0000153572.22346.E9
[7]. Wu, Y. D, Sheu, R. K, Chung, C. W, Wu, Y. C, Ou, C. C, Hsiao, C. W, et al., 2021, Application of supervised machine learning to recognize competent level and mixed antinuclear antibody patterns based on ICAP international consensus. Diagnostics, 11(4), 642. https://doi.org/10.3390/diagnostics11040642
[8]. Wanchu, A., 2000, Antinuclear antibodies: clinical applications. Journal of Postgraduate Medicine, 46(2), 144-148.
[9]. Sacre, K., Delaval, L., Dossier, A., Alexandra, J. F., Berleur, M., Chauveheid, M. P., et al., 2021, New 2019 SLE EULAR/ACR classification criteria are valid for identifying patients with SLE among patients admitted for pericardial effusion. Annals of the Rheumatic Diseases, 80(12), e190-e190. https://doi.org/10.1136/annrheumdis-2019-216712
[10]. Pitta Villasboa, G. M., Frontanilla, T., Servián, L., Ortiz, X., Henning, R., & Ortiz Galeano, I., 2022, Prevalence of antinuclear antibodies in apparently healthy residents of the Hospital de Clínicas, San Lorenzo. Revista Virtual de la Sociedad Paraguaya de Medicina Interna, 9(1), 71-80. http://dx.doi.org/10.18004/rvspmi/2312-3893/2022.09.01.71
[11]. Heffernan, M. P., Do, J. H., & Mehta, J., 2001, Antinuclear antibodies in dermatology. In Seminars in Cutaneous Medicine and Surgery, 20(1), 2-13. https://doi.org/10.1053/sder.2001.23089
[12]. Meyer, O., De Chaisemartin, L. U. C., Nicaise-Roland, P., Cabane, J., Tubach, F., Dieude, P., & Allanore, Y., 2010, Anti-RNA polymerase III antibody prevalence and associated clinical manifestations in a large series of French patients with systemic sclerosis: a cross-sectional study. The Journal of Rheumatology, 37(1), 125-130. https://doi.org/10.3899/jrheum.090677
[13]. Alenzi, F. M., 2020, Myositis specific autoantibodies: a clinical perspective. Open Access Rheumatology: Research and Reviews, 12, 9-14. https://doi.org/10.2147/oarrr.s231195
[14]. Shoenfeld, Y., Carp, H. J., Molina, V., Blank, M., Cervera, R., Balasch, J., & Meroni, P. L., 2006, Autoantibodies and prediction of reproductive failure. American Journal of Reproductive Immunology, 56(5‐6), 337-344. https://doi.org/10.1111/j.1600-0897.2006.00434.x
[15]. Molazadeh, M., Karimzadeh, H., & Azizi, M. R., 2014, Prevalence and clinical significance of antinuclear antibodies in Iranian women with unexplained recurrent miscarriage. Iranian Journal of Reproductive Medicine, 12(3), 221. http://www.ncbi.nlm.nih.gov/pmc/articles/pmc4009578/
[16]. Radice, A., & Sinico, R. A., 2005, Antineutrophil cytoplasmic antibodies (ANCA). Autoimmunity, 38(1), 93-103. https://doi.org/10.1080/08916930400022673
[17]. Lochman, I., Král, V., Lochmanová, A., Lupač, J., & Cebecauer, L., 2011, ANCA in the diagnosis of neutrophil-mediated inflammation. Autoimmunity Reviews, 10(6), 295-298. https://doi.org/10.1016/j.autrev.2010.11.003
[18]. Santhosh, P., & Ajithkumar, K., 2021, Anti-nuclear antibodies: A practical approach to testing and interpretation. Journal of Skin and Sexually Transmitted Diseases, 3(2), https://doi.org/175-179. 10.25259/JSSTD_40_2020
[19]. Griffiths, C. E., Barker, J., Bleiker, T. O., Chalmers, R., & Creamer, D. (Eds.). (2016). Rook's Textbook of Dermatology. (John Wiley & Sons.)
[20]. Choi, M. Y., Clarke, A. E., St. Pierre, Y., Hanly, J. G., Urowitz, M. B., Romero‐Diaz, J., & Fritzler, M. J., 2019, Antinuclear Antibody–Negative systemic lupus erythematosus in an international inception cohort. Arthritis Care & Research, 71(7), 893-902. https://doi.org/10.1002/acr.23712
[21]. Gautam, K., 2015, Anti-Nuclear antibodies: current concepts and future direction for diagnosing connective tissue disease. Journal of Pathology of Nepal, 5(9), 766-773. https://doi.org/10.3126/jpn.v5i9.13788
[22]. Pisetsky, D, 2017, Antinuclear antibody testing — misunderstood or misbegotten? Nature Reviews Rheumatolology, 13(8), 495–502. https://doi.org/10.1038/nrrheum.2017.74
[23]. Haque, S., Watanabe, M., Atisha-Fregoso, Y., & Diamond, B, 2023, Anti-nuclear antibody (ANA) detection in culture supernatant of cloned B cells. bioRxiv, 2023-05. https://doi.org/10.1101/2023.05.12.540540
Viewed PDF 5 0 -
Association of Cell Viability in Huntington Chorea Rat Models and the Neuroprotective Role of Withania Somnifera in Public HealthAuthor: Mary Antony PrabaDOI: 10.21522/TIJPH.2013.12.04.Art076
Association of Cell Viability in Huntington Chorea Rat Models and the Neuroprotective Role of Withania Somnifera in Public Health
Abstract:
Huntington’s disorder (HD) is a genetic, fatal neurodegenerative disorder that causes abnormal, involuntary jerky movements, postures and defects in cognition, mood and behaviour. Huntington’s disease involves with degeneration of neurons in basal nuclei and so has no cure like other neurodegenerative disorders and the affected person struggles in life for 15-20 years. The basal nuclei are involved in the inhibition of unwanted motor activities and so responsible for fine motor movements. Loss of these neurons will inflict on the quality of life of the person. Neurodegenerative disorders are almost a compulsory evil when a person is ageing. As nerve cell division and regeneration are impossible, we planned to analyze the possibility of protecting the neurons already in action by pretreating them with Withania somnifera, a traditional herbal plant, well known for its neuroprotective role. We selected 4 groups of experimental rat models, treated prior with the crude extract of Withania somnifera and the active principle withanolide A. On analysis, large lesion and dead tissue mass were found in the brain samples without pretreatment. Wherein brain samples with pretreatment, the lesion was minimalized and so was the number of dead cells. By analyzing the actual cell death, we analyzed the protective role of the plant extract and the active principle we employed. As neurodegeneration is a sure process in age and regeneration is a question unanswered, prevention or delaying nerve cell death is a need in the present community health care that was achieved by this study.
Association of Cell Viability in Huntington Chorea Rat Models and the Neuroprotective Role of Withania Somnifera in Public Health
References:
[1]. Young, C. B., Reddy, V., Sonne, J., 2023, Neuroanatomy, Basal ganglia. StatPearls [Internet], Treasure Island (FL). https://www.ncbi.nlm.nih.gov/books/NBK537141/
[2]. Ogata, S., Miyamoto, Y., Shigematsu, N., 2022, The tail of the mouse striatum contains a novel large type of GABAergic Neuron Incorporated in a unique disinhibitory pathway that relays auditory signals to subcortical nuclei. Journal of Neuroscience, 42(43), 8078–8094. DOI: 10.1523/JNEUROSCI.2236-21.2022.
[3]. Joshua, W., Callahan, David, L., Wokosin, Mark, D., 2022, Dysregulation of the basal ganglia indirect pathway in early symptomatic q175 Huntington's disease mice. Bevan Journal of Neuroscience, 42(10), 2080-2102. https://doi.org/10.1523/JNEUROSCI.0782-21.2022
[4]. Jain, S., Shukla, S. D., Sharma, K., 2001, Neuroprotective effects of Withania somnifera Dunn. in hippocampal sub-regions of the female albino rat. Phytother. Res, 15(6), 544-8. doi: 10.1002/ptr.802.
[5]. Ajitkumar, A., De Jesus, O., 2024, Huntington Disease. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK559166/
[6]. https://www.rarediseaseadvisor.com/disease-info-pages/huntington-disease-epidemiology/#:~:text=They%20estimated%20that%20the%20global,around%202.7%20per%20100%2C000%20persons
[7]. Hussain, Z., Mukherjee, A., Ganguly, G., Joardar, A., Roy, S., Guin, D. S., Sinharoy, U., Biswas, A., Das, S. K., 2020, Clinical profile of genetically proven Huntington's disease patients from eastern India. Ann Indian Acad Neurol, 23(2), 195-200. doi: 10.4103/aian.AIAN_505_19. Epub 2020 Feb 25. PMID: 32189861; PMCID: PMC7061496.
[8]. https://www.deccanherald.com/science/in-focus-huntingtons-disease-762914.html#google_vignette
[9]. Jain, S., Shukla, S. D., Sharma, K., 2001, Neuroprotective effects of Withania somnifera Dunn. In hippocampal sub-regions of the female albino rat. Phytother. Res, 15(6), 544-8. doi: 10.1002/ptr.802.
[10]. Gaurav, H., Yadav, D., Maurya, A., Yadav, H., Yadav, R., Shukla, A. C., Sharma, M., Gupta, V. K., Palazon, J., 2023, Biodiversity, Biochemical Profiling, and Pharmaco-Commercial Applications of Withania somnifera: A Review. Molecules. 28, 1208. https://doi.org/10.3390/molecules28031208
[11]. Dhalla, N. S., Gupta, K. C., Sastry, N. S., 1961, Comparative studies of Withania somnifera dunal and withania ashwagandha kaul. Ind J Pharm, 23(5), 126—127.
[12]. Sukanya, D. H., Lokesha, A. N., Datta, G., 2010, Phytochemical diversity in ashwagandha (Withania somnifera). Home, pp.1-2
[13]. Parihar, M. S., Hemnani, T., 2003, Phenolic antioxidants attenuate hippocampal neuronal cell damage against kainic acid induced excitotoxicity. J Biosci, 28(1), 121-8. DOI:10.1007/BF02970142.
[14]. Anjum, A., Cheah, Y. J., Yazid, M. D., 2022, Protocol paper: kainic acid excitotoxicity-induced spinal cord injury paraplegia in Sprague–Dawley rats. Biological Research, 55(38), 1-11. doi: 10.1186/s40659-022-00407-0.
[15]. Elayaraja, A., Vijayalakshmi, M., Devalarao, G., 2010, In vitro free radical scavenging activity of various root and rhizome extracts of Acorus calamus Linn. Int J Pharma Bio Sci, 1(4), 301.
[16]. Duigou, C., Bouilleret, V., Miles, R., 2008, Epileptiform activities in slices of hippocampus from mice after intra-hippocampal injection of kainic acid. J Physiol, 586, 4891-4904. https://doi.org/10.1113/jphysiol.2008.156281
[17]. Ude A, Afi-Leslie K, Okeke K. Trypan blue exclusion assay, neutral red, acridine orange and propidium iodide. Cytotoxicity. Intech Open. 2022; https://doi.org/10.5772/intechopen.105699
[18]. Diwakar, L., Gowaikar, R., Chithanathan, K. etal. Endothelin-1-mediated vasoconstriction leads to memory impairment and synaptic dysfunction. Sci Rep. 2021; 11:4868:1-13. https://doi.org/10.1038/s41598-021-84258-x [My paper].
[19]. Jessop, Z. M., Thomas, D. J., Whitaker, I. S., 2022, 3D Bioprinting for reconstructive surgery. Elsevier Ltd., pp.1-46. ISBN 978-0-08-101103-4. DOI: 10.3390/pharmaceutics14020464.
[20]. Crowley, L. C., Marfell, B. J., Christensen, M. E., 2016, Measuring cell death by trypan blue uptake and light microscopy. Cold Spring Harbor Laboratory Press, 7. doi: 10.1101/pdb. prot087155. PMID: 27371594.
Viewed PDF 6 0 -
Clinical Outcome in a Series of Trimalleolar FracturesAuthor: Ganesh M. T.DOI: 10.21522/TIJPH.2013.12.04.Art077
Clinical Outcome in a Series of Trimalleolar Fractures
Abstract:
Trimalleolar fractures, characterized by involvement of the lateral, medial, and posterior malleoli, present a complex challenge that necessitates precise surgical intervention to restore ankle stability and function. This study evaluates the outcomes of surgical management in 20 patients aged 18 to 70 years with displaced trimalleolar fractures, highlighting the increased incidence in the older population. Pre-operative planning included comprehensive assessments with basic investigations, radiological studies (X-rays in anteroposterior, lateral, and mortise views), and CT scans for evaluating posterior malleolar fragments and cases of initial ankle subluxation. Surgical techniques employed were tailored to individual fracture patterns and included plating, cannulated screws, and tension band wiring, with particular attention to the posterior malleolus. Functional outcomes were assessed using the American Orthopaedic Foot & Ankle Society (AOFAS) Ankle-Hindfoot Score, and radiological results were monitored through serial follow-up X-rays. The average follow-up duration was 12 months, during which patients demonstrated favourable functional recovery, achieving an average AOFAS score of 87.7 out of 100 at the 12-month mark. Post-operative radiological evaluations indicated successful intra-articular reduction and fixation across all cases, with progressive fracture healing observed at follow-up visits. This case series emphasizes the critical role of precise anatomical reduction, stable fixation, and a structured rehabilitation program in the successful treatment of trimalleolar fractures. Furthermore, it underscores the importance of individualized treatment plans and multidisciplinary approaches in optimizing patient outcomes.
Clinical Outcome in a Series of Trimalleolar Fractures
References:
[1]. Elsoe, R., Ostgaard, S. E., and Larsen, P., 2018, Population-based epidemiology of 9767 ankle fractures. Foot Ankle Surg. 24(1), 34-39. https://doi.org/10.1016/j.fas.2016.11.002
[2]. Makwana, N. K., Bhowal, B., Harper, W. M., and Hui, A. W., 2001, Conservative versus operative treatment for displaced ankle fractures in patients over 55 years of age: A prospective, randomized study. J Bone Joint Surg Br., 83(4), 525-529. https://doi.org/10.1302/0301-620X.83B4.11522
[3]. Hancock, M. J., Herbert, R. D., and Stewart, M., 2005, Prediction of outcome after ankle fracture. J Orthop Sports Phys Ther., 35(12), 786-792. https://doi.org/10.2519/jospt.2005.35.12.786
[4]. Kleweno, C., and Rodriguez, E. K., 2018, Trimalleolar ankle fractures. In: Orthopedic Traumatology (pp. 323-334). Springer, Cham. https://doi.org/10.1007/978-3-319-73392-0_25
[5]. Odak, S., Ahluwalia, R., Unnikrishnan, P., Hennessy, M., and Platt, S., 2016, Management of posterior malleolar fractures: A systematic review. J Foot Ankle Surg., 55(1), 140-145. https://doi.org/10.1053/j.jfas.2015.04.001
[6]. Leigheb, M., Janicka, P., Andorno, S., Marcuzzi, A., Magnani, C., and Grassi, F., 2016, Italian translation, cultural adaptation and validation of the American Orthopaedic Foot and Ankle Society’s (AOFAS) ankle-hindfoot scale. Acta Biomed., 87(1), 38-45. Available from: https://research.uniupo.it/en/publications/
[7]. Gonzalez, T. A., Watkins, C., Drummond, R., et al., 2016, Transfibular approach to posterior malleolus fracture fixation: Technique tip. Foot Ankle Int., 37(4), 440-445. https://doi.org/10.1177/1071100715617760
[8]. Abdelgawad, A. A., Kadous, A., and Kanlic, E., 2011, Posterolateral approach for treatment of posterior malleolus fracture of the ankle. J Foot Ankle Surg., 50(5), 607-611. https://doi.org/10.1053/j.jfas.2011.04.022
[9]. Lee, Y. S., Huang, C. C., Chen, C. N., and Lin, C. C., 2005, Operative treatment of displaced lateral malleolar fractures: The Knowles pin technique. J Orthop Trauma., 19(3), 192-197. https://doi.org/10.1097/00005131-200503000-00007
[10]. Beris, A. E., Kabbani, K. T., Xenakis, T. A., Mitsionis, G., Soucacos, P. K., and Soucacos, P. N., 1977, Surgical treatment of malleolar fractures: A review of 144 patients. Clin Orthop Relat Res., 341, 90-98. Available from: https://europepmc.org/article/med/9269160
[11]. Motwani, G. N., Shah, H. D., Chavli, V. H., Daveshwar, R. N., Parmar, H., and Suthar, P. P., 2015, Results of open reduction and internal fixation in closed bimalleolar Pott’s Fracture of Ankle in Adults. Int J Med Sci Public Health, 4, 893-900. Available from: https://www.researchgate.net/publication/277579994
[12]. Belcher, G. L., Radomisli, T. E., Abate, J. A., et al., 1997, Functional outcome analysis of operatively treated malleolar fractures. J Orthop Trauma., 11, 106-110. https://doi.org/10.1097/00005131-199702000-00007
[13]. Roberts, R. S., 1983, Surgical treatment of displaced ankle fractures. Clin Orthop., 172, 164-170. Available from: https://pubmed.ncbi.nlm.nih.gov/6821987/
[14]. Tropp, H., and Norlin, R., 1995, Ankle performance after ankle fracture: A randomized study of early mobilization. Foot Ankle Int., 16, 79-83. https://doi.org/10.1177/107110079501600205
[15]. Van Lieshout, E. M. M., De Boer, A. S., Meuffels, D. E., et al., 2017, American Orthopaedic Foot and Ankle Society (AOFAS) Ankle-Hindfoot Score: A study protocol for the translation and validation of the Dutch language version. BMJ Open, 7, e012884. https://doi.org/10.1136/bmjopen-2016-012884
[16]. Faldini, C., 2023, Osteoarthritis after an ankle fracture: We can't really avoid it. Musculoskelet Surg., 107(4), 375-378. https://doi.org/10.1007/s12306-023-00802-0
[17]. Giannini, S., et al., 2010, Surgical treatment of post-traumatic malalignment of the ankle. Injury, 41(11), 1208-1211. https://doi.org/10.1016/j.injury.2010.09.017
[18]. Schepers, T., De Vries, M. R., Van Lieshout, E. M., and Van der Elst, M., 2013, The timing of ankle fracture surgery and the effect on infectious complications: A case series and systematic review of the literature. Int Orthop., 37(3), 489-494. https://doi.org/10.1007/s00264-012-1753-9
[19]. Lund-Kristensen, J., Greiff, J., and Riegels-Nielsen, P., 1981, Malleolar fractures treated with rigid internal fixation and immediate mobilization. Injury, 13(3), 191-195. https://doi.org/10.1016/0020-1383(81)90237-0
[20]. Meyer, T. L. Jr., and Kumler, K. W., 1980, ASIF technique and ankle fractures. Clin Orthop Relat Res., 150, 211-216. Available from: https://pubmed.ncbi.nlm.nih.gov/7428223/
Viewed PDF 6 0 -
Assessment of Drug Safety Governance in Guyana: Insights from Published ResearchAuthor: Erica Ann Albertina WardDOI: 10.21522/TIJPH.2013.12.04.Art078
Assessment of Drug Safety Governance in Guyana: Insights from Published Research
Abstract:
Developing countries like Guyana face unique challenges in ensuring drug supply safety due to limited resources, weak regulatory systems, and inadequate surveillance infrastructure. This paper presents a literature-based evaluation of drug safety oversight in Guyana. The evaluation identifies significant gaps and challenges within Guyana's regulatory agencies, including resource constraints, insufficient surveillance infrastructure, and enforcement weaknesses. Limited specific literature on Guyana highlights the need for empirical studies to assess the effectiveness of its drug regulatory systems. Through a systematic literature review, this study identifies key areas for improving drug safety oversight, emphasizing enhanced resource allocation, capacity-building initiatives, and robust regulatory frameworks. These findings emphasize the importance of strengthening regulatory systems in developing countries to ensure public health and access to safe pharmaceuticals. This evaluation offers insights for policymakers, healthcare professionals, and stakeholders involved in public health governance, facilitating evidence-based strategies to enhance drug safety oversight and regulatory effectiveness in Guyana.
Assessment of Drug Safety Governance in Guyana: Insights from Published Research
References:
[1]. Ahmed, S., & Patel, R., Ahmed, S., & Patel, R., 2019. Implementing effective regulatory policies for pharmaceuticals in developing countries: A qualitative analysis. Health Policy Review, 8(1), 56-70.
[2]. Anderson, J., & Green, K., 2017. Enhancing pharmaceutical regulatory compliance in developing countries. Journal of Global Health, 5(3), 230-245.
[3]. Arlett, P., Garcia Burgos, J., & Salmonson, T., 2013. The European medicines agency's experience with the GCP inspection reliance process: A new model for cooperation. Clinical Pharmacology & Therapeutics, 94(3), 331-333.
[4]. Babor, T. F., Caulkins, J. P., Fischer, B., Foxcroft, D. R., Humphreys, K., Medina-Mora, M. E., & Rehm, J., 2018. A new approach to formulating and appraising drug policy: A multi-criterion decision analysis applied to alcohol and cannabis regulation. Journal of Drug Policy, 58, 1-8.
[5]. Brown, L., 2021. Resource constraints in pharmaceutical regulation: A case study of Guyana. Health Policy and Planning, 36(2), 174-183.
[6]. Cabrera, S. E., & Caicedo, A., 2019. Regulatory framework for pharmaceuticals in ecuador. Journal of Pharmaceutical Policy and Practice, 12(1), 45-58.
[7]. Carpenter, D., 2010. Reputation and power: Organizational image and pharmaceutical regulation at the FDA. Princeton University Press.
[8]. Chen, W., & Xu, Y. Chen, W., & Xu, Y., 2015. Capacity building in pharmaceutical regulation: A roadmap for developing countries. International Journal of Regulatory Science, 10(4), 98-112.
[9]. Chukwu, E., Umeh, O., & Olamijulo, J. A., 2017. Strengthening supply chain management to improve access to essential medicines in the public sector: The role of the pharmacist. Journal of Pharmaceutical Policy and Practice, 10, 15.
[10]. Chukwu, O. A., Ezeanochikwa, V. N., & Eya, B. E., 2017. Supply chain management of health commodities for reducing global disease burden. Elsevier BV, 13(4), 871-874. https://doi.org/10.1016/j.sapharm.2016.08.008
[11]. Contemporary substance use in Guyana: The prison context, 2020. Caribbean Journal of Criminology, 25(2), 147-163.
[12]. Corporate Sponsorship of Patient Groups. (2020). Impact on drug regulatory practices. Journal of Patient Advocacy, 11(3), 78-90. Doi.
[13]. Dave, R. H., Preet Singh, S., & Sharma, S., 2021. Regulatory challenges in the development of nanotechnology-based drug delivery systems: A global perspective. Journal of Pharmaceutical Sciences, 110, 280-289.
[14]. Dave, V. S., Sur, S., & Gupta, S. M., 2021. Current framework, ethical consideration and future challenges of regulatory approach for nano‐based products. Wiley, 447-472. https://doi.org/10.1002/9781119711698.ch19
[15]. De Vries, H., 2016. The pharmaceutical industry in venezuela: Challenges and Opportunities. Journal of Health Policy and Management, 5(1), 45-58.
[16]. Dube, A., & Naidoo, P. Dube, A., & Naidoo, P., 2018. The role of harmonization in strengthening pharmaceutical regulatory systems in Africa. African Health Policy Journal, 7(3), 250-267.
[17]. Durán, C. E., Cañás, M., Urtasun, M., Elseviers, M., Andia, T., Stichele, R. V., & Christiaens, T., 2021. Regulatory reliance to approve new medicinal products in Latin American and Caribbean countries. Pan American Health Organization, 1-10. https://doi.org/10.26633/rpsp.2021.10
[18]. Eichler, H. G., Pignatti, F., Flamion, B., Leufkens, H., & Breckenridge, A., 2012. Balancing early market access to new drugs with the need for benefit/risk data: A mounting dilemma. Nature Reviews Drug Discovery, 7(10), 818-826.
[19]. Ekeigwe, A. A., 2019. Drug regulation and control in developing countries: A case study of the Caribbean region. Journal of Pharmaceutical Policy and Practice, 12(1), 1-12.
[20]. Enserink, M., 2010. Drug safety challenges in poor nations: Case studies and interviews. Journal of Global Health, 6(2), 200-213.
[21]. Feinsilver, J. M., 2016. Fifty years of cuba’s medical diplomacy: From idealism to pragmatism. Cuban Studies, 44, 85-104.
[22]. Gallego, G., Sastre, G., & Serrano, P., 2019. Regulatory environment for pharmaceuticals in spain. Regulatory Affairs Journal, 32(1), 56-68.
[23]. Gallego, J., Martinez, S., & Ramirez, A., 2019. Regulatory framework in spain: Analysis of the Spanish Agency for Medicines and Health Products (AEMPS). Regulatory Affairs Journal, 45(3), 89-102.
[24]. Guyana’s Pharmaceutical Industry is Important for the Neighboring Caribbean. 2020. Industry and Regulatory Practices. Caribbean Business Review, 15(2), 99-112. DOI.
[25]. Health consumer and patients' organizations in europe: Towards a comparative analysis, 2008. Role of consumer groups in drug regulation. European Journal of Health Policy, 10(1), 23-37.
[26]. Hernandez, A., & Rodriguez, M., Hernandez, A., & Rodriguez, M., 2021. Regulatory frameworks and pharmaceutical industry growth in emerging markets: A quantitative analysis. Emerging Markets Health Economics Journal, 15(2), 88-104.
[27]. Hewitt, H., & Forde, G., 2016. The Pharmaceutical sector in the caribbean: challenges and opportunities for improvement. Journal of Pharmaceutical Policy and Practice, 9, 34-47.
[28]. Hilts, P. J., 2003. Protecting America's Health: The FDA, Business, and One Hundred Years of Regulation. Alfred A. Knopf.
[29]. Irving, J., 1972. Introduction to Health Care Systems: A Global Perspective. Wiley.
[30]. Kaitin, K. I., 2010, The role of international harmonization in drug development. Journal of Clinical Pharmacology, 50(1), 32-37. DOI.
[31]. Kapoor, R., & Sharfstein, J. M., 2015, Information management and policy implementation in Guyana. Journal of Health Policy and Practice, 5(2), 102-115.
[32]. Lacey, R. E., Pikhart, H., Bartley, M., & Stafford, M., 2016. Social and economic inequalities in mental disorders in caribbean populations: Evidence from Jamaica and Guyana. Social Psychiatry and Psychiatric Epidemiology, 51(4), 523-533.
[33]. Lemos, A., & Ehler, B., 2015. Brazilian Regulatory Framework for Pharmaceuticals: Historical Context and Future Directions. Journal of Pharmaceutical Policy and Practice, 12(3), 45-58.
[34]. Lewis, R., 2018. Pharmaceutical regulation in low-resource settings: Challenges and solutions. Global Health Policy, 6(3), 234-245.
[35]. MacGillivray, B., 2017. Pharmaceutical regulatory frameworks in the Caribbean: Progress and challenges. Journal of Pharmaceutical Policy and Practice, 10(1), 13-20.
[36]. Mahady, G. B., 2001. Regulatory frameworks for the evaluation of herbal medicines. Journal of Herbal Pharmacotherapy, 1(3), 47-60.
[37]. Medina, R., 2019. Current Drug Regulatory Frameworks in the Caribbean. Journal of Pharmaceutical Policy and Practice, 12(1), 56-65.
[38]. Miller, T., & Wilson, L., Miller, T., & Wilson, L., 2020. The role of public-private partnerships in enhancing drug regulation in developing countries. Global Public Health Review, 18(1), 110-126.
[39]. Morris, K., 2002. Caribbean countries tackle drug regulation. Lancet, 359, 2027.
[40]. Nicoletti, T., 2017. Strengthening Pharmaceutical Regulation in Latin America: Lessons from Brazil and Argentina. Journal of Pharmaceutical Policy and Practice, 10(1), 22-34.
[41]. Nicolosi, R., & Mastroianni, A. C., 2019. The Role of Regulatory Authorities in Latin America in Ensuring Drug Safety and Efficacy. Journal of Pharmaceutical Policy and Practice, 12(1), 78-86.
[42]. O'Neil, T., 2013. Supply chain management for essential medicines in Guyana. Journal of Supply Chain Management, 11(1), 98-114.
[43]. Orzalli, R., & Hanson, R., 2017. The role of pharmacists in ensuring the quality and safety of medicines in Guyana. International Journal of Pharmaceutical Practice, 25(3), 196-203.
[44]. Osei, K., & Badu, E. Osei, K., & Badu, E., 2019. Challenges in implementing regulatory reforms in the pharmaceutical sector of developing countries. Journal of Pharmaceutical Policy and Practice, 14(2), 66-85.
[45]. Patel, D., & Sharma, R. Patel, D., & Sharma, R., 2017. Strategies for improving pharmaceutical regulation in low-income countries. International Journal of Health Policy, 9(4), 143-159.
[46]. Pharmacovigilance in the caribbean countries: An Overview, 2023. Role of healthcare professionals. Caribbean Journal of Pharmacology, 19(1), 45-58. DOI.
[47]. Rahman, M., & Khan, F., 2013. Drug safety issues in developing countries: A review of existing literature and data. Journal of Pharmaceutical Policy and Practice, 11(1), 345-353.
[48]. Ratanawijitrasin, S., & Wondemagegnehu, E., 2002. Effective drug regulation: A multicountry study. World Health Organization.
[49]. Ricci, A. D., & Ricci, G., 2020. Drug regulatory frameworks in small island developing states: A comparative analysis. Journal of Pharmaceutical Policy and Practice, 13(1), 1-12.
[50]. Rodríguez-Monguió, R., 2008. Access to medicines in Guyana: Challenges and solutions. Health Policy and Planning, 23(5), 345-353.DOI.
[51]. Seoane‐Vazquez, E., & Rodríguez-Monguió, R., 2008. Access to medicines in Guyana: challenges and solutions. Health Policy and Planning, 23(5), 345-353.
[52]. Salter, C., Green, J., & Greenhalgh, T., 2018. Drugs genomics and improvements in population health. British Medical Journal, 361, k1811.
[53]. Santos, M. A., 2017. Pharmaceutical regulation in colombia: An overview of the INVIMA's role. Journal of Regulatory Science, 6(1), 1-10.
[54]. Santos, M. A., & Gomez, M., 2019. The Role of pharmacovigilance in drug regulation in colombia. Journal of Pharmaceutical Policy and Practice, 14(1), 45-58.
[55]. Schneider, R., 2016. Understanding the pharmaceutical supply chain in Guyana: Barriers to quality and access. Journal of Pharmaceutical Policy and Practice, 9(1), 1-11.
[56]. Scott, H., & McKee, M., 2011. Globalisation health and foreign policy: Emerging trends and risks. Globalization and Health, 7, 22.
[57]. Singh, A., & Mehta, K. Singh, A., & Mehta, K., 2016. Integration of global standards into national pharmaceutical regulatory frameworks: A case study from South Asia. Journal of Global Regulatory Science, 11(2), 98-112.
[58]. Smith, R., 2006. The hidden cost of antimicrobial resistance. British Medical Journal, 333(7566), 979-980.
[59]. Sosa, A., & Byarugaba, D. K., 2009, Antimicrobial resistance in developing countries. Springer Science & Business Media.
[60]. Sotola, O., & Ige, O., 2019. An evaluation of nigeria's drug regulatory framework. Journal of Pharmaceutical Policy and Practice, 12(1), 32-45.
[61]. Substance use in Guyana: The cannabis conundrum, 2020. Non-governmental organizations and drug safety. Guyana Public Health Review, 12(4), 67-80. DOI.
[62]. Swan, J., 2014. Regulatory challenges in the globalization of clinical trials. British Journal of Clinical Pharmacology, 78(2), 300-307.
[63]. Thompson, J., 2021. Improving drug safety: The role of regulatory science. Journal of Regulatory Science, 9(1), 1-10.
[64]. Torres, M., 2018. The impact of regulatory changes on the pharmaceutical industry in Argentina. Journal of Regulatory Science, 6(1), 1-10.
[65]. Tran, L., 2017. Pharmaceutical regulation in vietnam: Current trends and future directions. Journal of Pharmaceutical Policy and Practice, 10(1), 56-67.
[66]. Varela, P., & Navarro, R., 2017. Pharmaceutical regulation in Latin America: Progress, challenges, and recommendations. Journal of Pharmaceutical Policy and Practice, 10(1), 15-28.
[67]. Vasan, A., Singhal, N., & Mukherjee, J., 2017. Ensuring access to quality medicines in low-resource settings: A framework for reducing barriers to essential medicines in Guyana. Health Policy and Planning, 32(5), 670-682.
[68]. von Stremayr, K., 2017. The Role of national regulatory authorities in the pharmacovigilance of biological products. Biologicals, 49, 61-68.
[69]. Wada, Y., Maeda, S., & Hirose, T., 2022, Clinical pharmacology and post-marketing surveillance: Contributions to drug safety. Journal of Clinical Pharmacology, 62(3), 234-245. DOI.
[70]. Weaver, J., 2014, Challenges to effective pharmaceutical regulation in developing countries. Journal of Pharmaceutical Policy and Practice, 8(1), 1-11.
[71]. Wirtz, V. J., Hogerzeil, H. V., Gray, A. L., Bigdeli, M., de Joncheere, C. P., Ewen, M. A., & Reich, M. R., 2017, Essential medicines for universal health coverage. Lancet, 389(10067), 403-476.
[72]. Woo-Ming, J., 1993, Regional approaches to drug regulation in the Caribbean: A case study of CARICOM. Rev Panam Salud Publica, 14(4), 22-29.
[73]. World Health Organization, 2021. WHO Model list of essential medicines.
[74]. Yadav, P., 2015, Assessing the impact of health supply chain interventions on health systems: A case study of Guyana. Health Policy And Planning, 30(4), 500-509.
Viewed PDF 4 0 -
Drivers, Reasons, and Experiences of Default and Missed Measles Vaccination in Ethiopia: A Qualitative StudyAuthor: Gulilat Gezahegn WodajoDOI: 10.21522/TIJPH.2013.12.04.Art074
Drivers, Reasons, and Experiences of Default and Missed Measles Vaccination in Ethiopia: A Qualitative Study
Abstract:
Despite the availability of a safe and free vaccine, measles first and second-dose vaccination coverage is still low in Ethiopia. Studies that examine caregivers' reasons for not receiving the measles vaccination in Ethiopia are scarce. Hence, this qualitative study aimed to uncover drivers, reasons, and experiences of default and missed measles vaccination from a caregiver perspective. A case study was conducted from December 2023 to May 2024 in the east Gurage zone of central Ethiopia. Data were collected through sixteen in-depth interviews with mothers who had measles vaccine-missed children and six focus group discussions with women aged 15-49 with children under five years old and mothers who were over 50. Caregivers were asked to answer open-ended questions regarding reasons for missing the measles vaccination. Data were coded, categorized, and analyzed manually by using an inductive thematic analysis approach. The four fundamental trustworthiness metrics for qualitative research were considered. Finally, we presented the themes and sub-themes supporting them with representative quotations. Geographic barriers, transportation costs, inconvenience of vaccination dates, lack of information when to return, mistrust, rumours, poor attendance in pregnant women's conferences, lack of autonomy to travel, workload, economic dependency, poor male involvement, mother-in-laws’ influence, rounds of vaccination and administration routes, and adverse events following immunization were identified as reasons for missing measles vaccination. These reasons were found at each stage in the immunization journey. Hence, applying a human-centred design with tailored intervention might be important to address barriers at each stage.
Drivers, Reasons, and Experiences of Default and Missed Measles Vaccination in Ethiopia: A Qualitative Study
References:
[1]. Centers for Disease Control and Prevention, 2024, “About Measles,” Measles (Rubeola). [Online]. Available: https://www.cdc.gov/measles/about/index.html [Accessed: 23-Jun-2024].
[2]. World Health Organization, 2024, “Measles.” [Online]. Available: https://www.who.int/news-room/fact-sheets/detail/measles [Accessed: 23-Jun-2024].
[3]. World Health Organization Regional Office for Africa (WHO-AFRO), 2024, “Vaccine-Preventable Disease Outbreaks on the Rise in Africa,” WHO | Regional Office for Africa. [Online]. Available: https://www.afro.who.int/news/vaccine-preventable-disease-outbreaks-rise-africa [Accessed: 31-Aug-2024].
[4]. World Health Organization, 2024, “Immunization Coverage.” [Online]. Available: https://www.who.int/news-room/fact-sheets/detail/immunization-coverage [Accessed: 31-Aug-2024].
[5]. World Health Organization, 2023, “Measles - Ethiopia.” [Online]. Available: https://www.who.int/emergencies/disease-outbreak-news/item/2023-DON460 [Accessed: 23-Jun-2024].
[6]. United Nations Children’s Fund, 2019, “The 2019 Ethiopia Mini Demographic and Health Survey | UNICEF Ethiopia.” [Online]. Available: https://www.unicef.org/ethiopia/reports/2019-ethiopia-mini-demographic-and-health-survey [Accessed: 14-Jul-2024].
[7]. Burton, A., Kowalski, R., Gacic-Dobo, M., Karimov, R., and Brown, D., 2012, “A formal representation of the WHO and UNICEF estimates of national immunization coverage: A computational logic approach,” PLoS ONE, 7(10), p. e47806. https://doi.org/10.1371/journal.pone.0047806
[8]. Novilla, M. L. B., Goates, M. C., Redelfs, A. H., Quenzer, M., Novilla, L. K. B., Leffler, T., Holt, C. A., Doria, R. B., Dang, M. T., Hewitt, M., Lind, E., Prickett, E., and Aldridge, K., 2023, “Why parents say no to having their children vaccinated against measles: A Systematic Review of the Social Determinants of Parental Perceptions on MMR Vaccine Hesitancy,” Vaccines (Basel), 11(5), p. 926. https://doi.org/10.3390/vaccines11050926
[9]. Adugna, B., Tola, A., Fite, M. B., and Motuma, A., 2024, “Determinants of second-dose measles vaccination dropout in Ethiopia: A community-based matched case-control study,” Heliyon, 10(9), p. e30764. https://doi.org/10.1016/j.heliyon.2024.e30764
[10]. Sabahelzain, M. M., Moukhyer, M., van den Borne, B., and Bosma, H., 2022, “Vaccine hesitancy among parents and its association with the uptake of measles vaccine in Urban Settings in Khartoum State, Sudan,” Vaccines, 10(2), p. 205. https://doi.org/10.3390/vaccines10020205
[11]. Majekodunmi, O. B., Oladele, E. A., and Greenwood, B., “1 Title: Factors Affecting Poor Measles Vaccination Coverage in Sub- 2 Saharan Africa with a Special Focus on Nigeria: A Systematic 3 Review.”
[12]. Abegaz, M. Y., Seid, A., Awol, S. M., and Hassen, S. L., 2023, “Determinants of incomplete child vaccination among mothers of children aged 12–23 Months in Worebabo District, Ethiopia: Unmatched Case-Control Study,” PLOS Global Public Health, 3(8), p. e0002088. https://doi.org/10.1371/journal.pgph.0002088
[13]. Tadesse, T., Getachew, K., Assefa, T., Ababu, Y., Simireta, T., Birhanu, Z., and Hailmichael, Y., 2017, “Factors and misperceptions of routine childhood immunization service uptake in Ethiopia: findings from a nationwide qualitative study,” Pan African Medical Journal, 28. https://doi.org/10.11604/pamj.2017.28.290.14133
[14]. Hailu, C., Fisseha, G., and Gebreyesus, A., 2022, “Determinants of measles vaccination dropout among 12 − 23 Months Aged Children in pastoralist community of Afar, Ethiopia,” BMC Infectious Diseases, 22(1), p. 376. https://doi.org/10.1186/s12879-022-07350-1
[15]. Sako, S., Gilano, G., and Hailegebreal, S., 2023, “Determinants of childhood vaccination among Children Aged 12–23 months in Ethiopia: A community-based cross-sectional study,” BMJ Open, 13(3), p. e069278. https://doi.org/10.1136/bmjopen-2022-069278
[16]. Shearer, J. C., Nava, O., Prosser, W., Nawaz, S., Mulongo, S., Mambu, T., Mafuta, E., Munguambe, K., Sigauque, B., Cherima, Y. J., Durosinmi-Etti, O., Okojie, O., Hadejia, I. S., Oyewole, F., Mekonnen, D. A., Kanagat, N., Hooks, C., Fields, R., Richart, V., and Chee, G., 2023, “Uncovering the drivers of childhood immunization inequality with caregivers, community members and health system stakeholders: Results from a Human-Centered Design Study in DRC, Mozambique and Nigeria,” Vaccines, 11(3), p. 689. https://doi.org/10.3390/vaccines11030689
[17]. Moser, A., and Korstjens, I., “Series: Practical Guidance to Qualitative Research. Part 1: Introduction,” Eur J Gen Pract, 23(1), pp. 271–273. https://doi.org/10.1080/13814788.2017.1375093
[18]. Ethiopian Statistical Service, 2024, “Population Projection.” [Online]. Available: https://www.statsethiopia.gov.et/population-projection/ [Accessed: 13-Oct-2024].
[19]. United Nations Children’s Fund, 2018, “Demand for Health Services | UNICEF Office of Innovation.” [Online]. Available: https://www.unicef.org/innovation/reports/demand-health-services [Accessed: 22-Jun-2024].
[20]. Technical Network for Strengthening Immunization Services (TechNet-21), 2023, “BeSD Childhood Vaccination In-Depth Interview Guides,” TechNet-21. [Online]. Available: https://www.technet-21.org/en/resources/tool/besd-childhood-vaccination-in-depth-interview-guides [Accessed: 01-Sep-2024].
[21]. Ogunbanjo, G., Mabuza, L., Govender, I., and B, M., 2014, “Qualitative Data Analysis and Writing Results (Workshop).”
[22]. Guye, A. H., Nigussie, T., Tesema, M., Shambi, D. B., Diriba, B. S., Tefera, E. M., and Girma, Y., 2023, “Exploring barriers of childhood full vaccination among children Living in Siraro District, West Arsi Zone, Oromia Region, Ethiopia: A Qualitative Study,” Front. Pediatr., 11. https://doi.org/10.3389/fped.2023.1083358
[23]. Sodeinde, K., Amoran, O., Abiodun, O., Adekoya, A., Abolurin, O., and Imhonopi, B., 2020, “A rural/urban comparison of paternal involvement in childhood immunisation in Ogun Central Senatorial District, Nigeria,” The Nigerian postgraduate Medical Journal, 27, pp. 336–342. https://doi.org/10.4103/npmj.npmj_101_20
[24]. Ullah, K., Saleem, J., Zakar, R., Ishaq, M., Khattak, F. A., Majeed, F., Sadiqa, H. A., and Fischer, F., 2024, “Exploring the reasons for defaulting from childhood immunization: A Qualitative Study in Pakistan,” BMC Public Health, 24(1), p. 408. https://doi.org/10.1186/s12889-024-17926-y
[25]. Thirunavukkarasu, A., Alanazi, M. F. A., Al-Hazmi, A. H., ALruwaili, B. F., Alsaidan, A. A., Alruwaili, T. A. M., Algaed, M. A. M., Alsharari, A. K., Alenazi, R. H., Alshalan, A. M., and Alshalan, S. M., 2023, “Maternal perception, hesitancy, and satisfaction toward Childhood Immunization in Primary Health Centers, Hafr Al-Batin: A Multicenter Cross-Sectional Study from Eastern Saudi Arabia,” RMHP, 16, pp. 2357–2368. https://doi.org/10.2147/RMHP.S406933
[26]. Yitbarek, K., Abraham, G., and Morankar, S., 2019, “Contribution of Women’s Development Army to maternal and Child Health in Ethiopia: A Systematic Review of Evidence,” BMJ Open, 9(5), p. e025937. https://doi.org/10.1136/bmjopen-2018-025937
[27]. Adesina, M. A., Olufadewa, I. I., Oladele, R. I., Solagbade, A., and Olaoyo, C., 2023, “Determinants of childhood immunization among Rural Mothers in Nigeria,” Popul. Med., 5(September), pp. 1–7. https://doi.org/10.18332/popmed/171542
[28]. Kolawole, O. T., Akinyemi, A., and Solanke, B. L., 2023, “Household Vulnerability and Childhood Immunization Status in Nigeria,” SAGE Open. https://doi.org/10.1177/21582440231179943
[29]. Amoah, A., Issaka, J., Ayebeng, C., and Okyere, J., 2023, “Influence of women empowerment on childhood (12–23 Months) Immunization Coverage: Recent Evidence from 17 Sub-Saharan African Countries,” Tropical Medicine and Health, 51(1), p. 63. https://doi.org/10.1186/s41182-023-00556-2
[30]. Simegn, W., Diress, M., Gela, Y. Y., Belay, D. G., Ayelign Kibret, A., Chilot, D., Sinamaw, D., Abdu Seid, M., Andualem, A. A., Anmut Bitew, D., Eshetu, H. B., and Mohammed Seid, A., 2023, “Childhood Vaccination Practices and Associated Factors among Mothers/Caregivers in Debre Tabor Town, Northwest Ethiopia: A Cross-Sectional Study,” Front Pediatr, 11, p. 1070722. https://doi.org/10.3389/fped.2023.1070722
[31]. Powelson, J., Kalepa, J., Kachule, H., Nkhonjera, K., Matemba, C., Chisema, M., Chumachapera, T., and Lawrence, E., 2024, “Using Community-Based, Participatory Qualitative Research to Identify Determinants of Routine Vaccination Drop-out for Children under 2 in Lilongwe and Mzimba North Districts, Malawi,” BMJ Open, 14(2), p. e080797. https://doi.org/10.1136/bmjopen-2023-080797
[32]. Gelagay, A. A., Geremew, A. B., Teklu, A., Mekonnen, Z. A., Gera, R., Ba-Nguz, A., and Tilahun, B., 2021, “Full Immunization Coverage and Its Determinants among Children Aged 12-23 Months in Wogera District, Northwest Ethiopia,” Ethiopian Journal of Health Development, 35(3). [Online]. Available: https://www.ajol.info/index.php/ejhd/article/view/217886 [Accessed: 07-Jul-2024].
[33]. Okafor, I. P., Chukwudi, C. L., Igwilo, U. U., and Ogunnowo, B. E., 2022, “‘Men Are the Head of the Family, the Dominant Head’: A Mixed Method Study of Male Involvement in Maternal and Child Health in a Patriarchal Setting, Western Nigeria,” PLOS ONE, 17(10), p. e0276059. https://doi.org/10.1371/journal.pone.0276059
[34]. Mogoi, D., Muchiri, E. M., and Mutuma, A. M., 2020, “Vaccine Coverage of Newly Introduced Vaccines and Factors Influencing among Children Less Than 23 Months in Laikipia North Subcounty,” Open Journal of Preventive Medicine, 10(2), pp. 9–43. https://doi.org/10.4236/ojpm.2020.102002
[35]. Malande, O. O., Munube, D., Afaayo, R. N., Annet, K., Bodo, B., Bakainaga, A., Ayebare, E., Njunwamukama, S., Mworozi, E. A., and Musyoki, A. M., 2019, “Barriers to Effective Uptake and Provision of Immunization in a Rural District in Uganda,” PLoS One, 14(2), p. e0212270. https://doi.org/10.1371/journal.pone.0212270
[36]. Bangura, J. B., Xiao, S., Qiu, D., Ouyang, F., and Chen, L., 2020, “Barriers to Childhood Immunization in Sub-Saharan Africa: A Systematic Review,” BMC Public Health, 20(1), p. 1108. https://doi.org/10.1186/s12889-020-09169-4
[37]. Pugliese-Garcia, M., Heyerdahl, L. W., Mwamba, C., Nkwemu, S., Chilengi, R., Demolis, R., Guillermet, E., and Sharma, A., 2018, “Factors Influencing Vaccine Acceptance and Hesitancy in Three Informal Settlements in Lusaka, Zambia,” Vaccine, 36(37), pp. 5617–5624. https://doi.org/10.1016/j.vaccine.2018.07.042
Viewed PDF 4 0 -
Assessment of Nutritional Status of Pregnant Women Attending Antenatal Care at Public Hospitals in Gambella Region, Ethiopia: Institution-Based Cross-Sectional StudyAuthor: Dagnechew DegefuDOI: 10.21522/TIJPH.2013.12.04.Art079
Assessment of Nutritional Status of Pregnant Women Attending Antenatal Care at Public Hospitals in Gambella Region, Ethiopia: Institution-Based Cross-Sectional Study
Abstract:
Nutrition is a fundamental pillar of health, particularly for pregnant women whose increased nutritional needs make them vulnerable to deficiencies. This study aims to assess the nutritional status, dietary diversity score (DDS), and associated risk factors among pregnant women attending antenatal care in Gambella Region, South West Ethiopia. An institution-based cross-sectional study was conducted from March to April 2023, involving 237 pregnant women selected through consecutive sampling. Data were collected using structured questionnaires, 24-hour dietary recall, mid-upper arm circumference (MUAC) measurements, and haemoglobin testing. Bivariate and multivariate logistic regression analyses were employed to identify factors associated with undernutrition, dietary diversity, and anaemia. The prevalence of undernutrition was 37.1%, while 48.9% of the participants had inadequate dietary diversity. Anaemia prevalence was found to be 22.8%. Significant determinants of undernutrition included marital status [adjusted odds ratio = 0.10, 95% CI: 0.01-0.81], STIs during pregnancy (AOR = 1.97, 95% CI: 1.01-3.85), and family planning use (AOR = 0.49, 95% CI: 0.25-0.94). Inadequate dietary diversity was significantly associated with age (AOR = 4.24, 95% CI: 1.01-17.84), household income (AOR = 3.00, 95% CI: 1.14-7.88), and family planning use (AOR = 3.62, 95% CI: 1.86-6.94). Housewives were more likely to be anaemic compared to private employees (AOR = 0.14, 95% CI: 0.03-0.78). The study highlights a high prevalence of undernutrition and anemia among pregnant women in the Gambella Region, with significant associations with socioeconomic and health factors. Integrating nutrition education with reproductive health services and promoting economic empowerment are crucial for improving maternal nutrition.
Assessment of Nutritional Status of Pregnant Women Attending Antenatal Care at Public Hospitals in Gambella Region, Ethiopia: Institution-Based Cross-Sectional Study
References:
[1]. Madhavi, L. H., Singh, H. K. G., 2011, Nutritional status of rural pregnant women. People’s Journal of Scientific Research, 4(2).
[2]. WHO, 2003, Joint WHO/FAO expert report on diet, nutrition and the prevention of chronic diseases: Executive summary. Food and Nutrition Bulletin, 24(3), 285-6.
[3]. Alemayehu, M. S., 2014, Dietary practice and associated factors among pregnant women in Gondar town north west, Ethiopia, 2014, International Journal of Nutrition and Food Sciences.;4(6), 707-12.
[4]. Blössner, M., de Onis M., 2005, Malnutrition: quantifying the health impact at national and local levels. Geneva: World Health Organization.
[5]. Kiboi, W., Kimiywe, J., Chege, P., 2016, Dietary Diversity, Nutrient Intake and Nutritional Status among Pregnant Women in Laikipia County, Kenya. International Journal of Health Sciences & Research, 6(4).
[6]. EDHS, 2011, Ethiopian demographic and health survey 2011.
[7]. Kedir, H., Berhane, Y., Worku, Y., 2014, Magnitude and determinants of malnutrition among pregnant women in eastern Ethiopia: evidence from rural, community-based setting. Maternal & Child Nutrition, 12(1), 51-63.
[8]. Desalegn, K., Pragya, S., Debebe, M., Tefera, B., 2015, Nutritional Status and Associated Factors among Pregnant Women in Wondo Genet District, Southern Ethiopia. Journal of Food Science and Engineering, 5(2).
[9]. Rao, K. M., Balakrishna, N., Arlappa, N., Laxmaiah, A., Brahmam, G., 2010, Diet and Nutritional Status of Women in India. Journal of Human Ecology, 29(3), 165-70.
[10]. Deghboudj, S., 2011, Assessment of Nutritional Status of Pregnant Women Attending the City Tebessa PMI (Algeria). National Journal of Physiology, Pharmacy & Pharmacology, 1(2), 97-105.
[11]. Lelissa, D., 2015, Prevalence of Anemia Among Women Receiving Antenatal Care at Boditii Health Center, Southern Ethiopia. Clinical Medicine Research, 4(3), 77-86.
[12]. WHO/UNICEF, 2001, Iron Deficiency Anaemia Assessment, Prevention, and Control: A guide for programme managers.
[13]. Nisar, Y. B., Dibley, M. J., 2016, Iron/folic acid supplementation during pregnancy prevents neonatal and under-five mortality in Pakistan: propensity score matched sample from two Pakistan Demographic and Health Surveys, 9(1), 29621.
[14]. McLean, E., Cogswell, M., Egli, I., Wojdyla, D., De Benoist, B., 2008, Worldwide prevalence of anaemia, WHO vitamin and mineral nutrition information system, 1993–2005. Public Health Nutrition, 12(4), 444.
[15]. EDHS, 2016, Ethiopian demographic and health survey 2016.
[16]. Getachew, M., Yewhalaw, D., Tafess, K., Getachew, Y., Zeynudin, A., 2012, Anaemia and associated risk factors among pregnant women in Gilgel Gibe dam area, Southwest Ethiopia. Parasites & Vectors, 5(1).
[17]. Abriha, A., Yesuf, M. E., Wassie, M. M., 2014, Prevalence and associated factors of anemia among pregnant women of Mekelle town: a cross sectional study. BMC Research Notes, 7(888).
[18]. Gedefaw, L., Ayele, A., Asres, Y., Mossie, A., 2015, Anaemia and associated factors among pregnant women attending antenatal care clinic in Walayita Sodo town, Southern Ethiopia. Ethiopian Journal of Health Sciences, 25(2).
[19]. Haileslassie, K., Mulugeta, A., Girma, M., 2013, Feeding practices, nutritional status and associated factors of lactating women in Samre Woreda, South Eastern Zone of Tigray, Ethiopia. Nutrition Journal, 12(1).
[20]. IYCN, 2011, Guidance for Formative Research on Maternal Nutrition. Washington DC.
[21]. Opara, J. A., Adebola, H., Nkasiobi, O. S., 2011, Malnutrition During Pregnancy among Child Bearing Mothers in Mbaitolu of South-Eastern Nigeria. Advances in Biological Research, 5(2).
[22]. Lee, S. E., Merialdi, M., Caulfield, L. E., 2012, Dietary intakes of women during pregnancy in low- and middle-income countries. Public Health Nutrition, 16(8), 1340-53.
[23]. Khoushabi F., Saraswathi G., 2010, Association between maternal nutrition status and birth weight of neonates in selected hospitals in Mysore city, India. Pakistan Journal of Nutrition, 9(12), 1124-30.
[24]. Worldbank, 2006, Repositioning Nutrition as Central to Development. Washington, DC.
[25]. Cheng, Y., Dibley, M. J., Zhang, X. L., Zeng L., Yan, H., 2009, Assessment of dietary intake among pregnant women in a rural area of western China. BMC Public Health, 9(22).
[26]. Khandat, M., 2014, Nutritional Status of Rural Pregnant Women in Beed District of Maharashtrastate of India. International Proceedings of Chemical, Biological and Environmental Engineering, 67:92-6.
[27]. EDHS, 2014, Ethiopian demographic and health survey 2014.
[28]. Charles, A. M., Campbell-Stennett, D., Yatich, N., Jolly, P. R., 2010, Predictors of anemia among pregnant women in Westmoreland, Jamaica. Health Care for Women International, 31(7), 585-98.
[29]. McDonald, C. M., McLean, J., Kroeun, H., Talukder, A., Lynd, L. D., Green, T. J., 2015, Household food insecurity and dietary diversity as correlates of maternal and child undernutrition in rural Cambodia. European Journal of Clinical Nutrition, 69(2), 242-6.
[30]. Mihiretie, H., Mitiku, A., Bacha, C., Getahun, D., 2015, Magnitude of Anemia and Associated Factors among Pregnant Women Attending Antenatal Care in Nekemte Health Center. Journal of Medical Microbiology & Diagnosis, 4(3).
[31]. dos Santos Quaresma, M. V. L., Ulmer, F. B., Amorin, B. P., Azevedo, G. F., Seixas, T. A., Nakamoto, F. P., 2022, Effect of oral contraceptive use on weight loss and body composition following low-calorie diet intervention. Clinical Nutrition ESPEN, 48, 247-52.
[32]. Shamim, A. A., Mashreky, S. R., Ferdous, T., Tegenfeldt, K., Roy, S., Rahman, A., K., Shaheen, N., 2016, Pregnant Women Diet Quality and Its Sociodemographic Determinants in Southwestern Bangladesh. Food Nutr Bull., 37(1), 14-26.
[33]. Data4Diets, 2023, Data4Diets: Building Blocks for Diet-related Food Security Analysis, Version 2.0. Data4Diets, https://inddex.nutrition.tufts.edu/data4diets
[34]. Yimer B., Baraki N., Mesfin F., 2016, Under Nutrition and Associated Factors among Adolescent Pregnant Women in Shashemenne District, West Arsi Zone, Ethiopia: A Communitybased Study. Journal of Nutrition & Food Sciences, 06(01).
[35]. Tafasa S.M., Darega J., Dida N., Gemechu F.D., 2023, Dietary diversity, undernutrition and associated factors among pregnant women in Gindeberet district, Oromia, Ethiopia: a cross-sectional study. BMC Nutr, 9(1), 115.
[36]. Ali F., Thaver I., Khan S.A., 2014, Assessment of dietary diversity and nutritional status of pregnant women in Islamabad, Pakistan. J Ayub Med Coll Abbottabad, 26(4).
[37]. Geta T.G., Gebremedhin S., Omigbodun A.O., 2022, Dietary Diversity Among Pregnant Women in Gurage Zone, South Central Ethiopia: Assessment Based on Longitudinal Repeated Measurement. Int J Womens Health,14, 599-615
[38]. Gebremichael M.A., Lema T.B., 2023, Dietary Diversity, Nutritional Status, and Associated Factors Among Pregnant Women in Their First Trimester of Pregnancy in Ambo District, Western Ethiopia. Nutr Metab Insights, 16:11786388231190515.
[39]. Uwase A., Nsereko E., Pillay N., Levin J., 2024, Dietary diversity and associated factors among pregnant women in the Southern Province of Rwanda: A facility-based cross-sectional study. PLoS One, 19(2), e0297112.Ayele, E., Gebreayezgi, G., Mariye, T.,
[40]. Meseret, A., Aschalew, G., Tigist, K., Mohammed, S., Yadessa, O., 2013, Prevalence of anemia and associated risk factors among pregnant women attending antenatal care in Azezo Health Center Gondar town, Northwest Ethiopia. J Interdiscipl Histopathol, 1(3), 137-44.
[41]. Zewde, A., Hailu, J., 2014, Prevalence of anemia among pregnant women attending antenatal care at Tikur Anbessa specialized hospital, Addis Ababa Ethiopia. Journal of Hematology & Thromboembolic Diseases, 2(1).
[42]. Hinderaker, S. G., Olsen, B. E., Bergsjø, P., Lie, R., T., Gasheka, P., Kvåle, G., 2001, Anemia in pregnancy in the highlands of Tanzania. Acta Obstetricia et Gynecologica Scandinavica, 80(1), 18-26.
[43]. Mahanta, L. B., Roy, T. D., Dutta, R. G., & Devi, A. (2012). Nutritional status and the impact of socioeconomic factors on pregnant women in Kamrup district of Assam. Ecology of food and nutrition, 51(6), 463–480. https://doi.org/10.1080/03670244.2012.705701
[44]. Girma, W. and Genebo, T. (2002) Determinants of the Nutritional Status of Mothers and Children in Ethiopia. Health and Nutrition Research Institute, Addis Ababa.
[45]. Ivers, L. C., Cullen, K. A., Freedberg, K. A., Block, S., Coates, J., & Webb, P. (2009). HIV/AIDS, undernutrition, and food insecurity. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 49(7), 1096–1102. https://doi.org/10.1086/605573
[46]. Naik, R., & Smith, R. (2015). Family Planning Improves Nutrition. H. P. Project. https://www.healthpolicyproject.com/pubs/691_FPandNutritionBrief.pdf
[47]. Rana, M. J., & Goli, S. (2017). Family Planning and Its Association with Nutritional Status of Women: Investigation in Select South Asian Countries. Indian Journal of Human Development, 11(1), 56-75. https://doi.org/10.1177/0973703017712392
[48]. Mandal S., Sinha N.K., Samanta P., Das S., Bose K., 2011, Anthropometric assessment of nutritional status among college women of Midnapore, west Bengal, India. International journal of life science and pharma research, 1(1).
[49]. Wondmeneh T. G. (2022). Dietary diversity practice and its influencing factors among pregnant women in Afar region of Ethiopia: mixed method study. BMC pregnancy and childbirth, 22(1), 291. https://doi.org/10.1186/s12884-022-04641-y
[50]. Serbesa, M. L., Iffa, M. T., & Geleto, M. (2019). Factors associated with malnutrition among pregnant women and lactating mothers in Miesso Health Center, Ethiopia. European journal of midwifery, 3, 13. https://doi.org/10.18332/ejm/110131
[51]. Getahun, G. K., Ahmed, S. M., Degif, A. B., & Haile, M. G. (2023). The assessment of dietary diversity score and associated factors among pregnant women of Batu district, Southern Ethiopia, 2021: a community-based cross-sectional study. Annals of medicine and surgery (2012), 85(3), 383–389. https://doi.org/10.1097/MS9.0000000000000239
[52]. Mohammed, F., Abdirizak, N., Jibril, A., & Oumer, A. (2023). Correlates of minimum dietary diversity among pregnant women on antenatal care follow up at public health facility in Puntland, Somalia. Scientific reports, 13(1), 21935. https://doi.org/10.1038/s41598-023-48983-9
Viewed PDF 4 0 -
Exploring Second MBBS Students' Perspectives on Teaching-Learning Methods in Pathology in the Competency-Based Medical Education CurriculumAuthor: Srismitha SDOI: 10.21522/TIJPH.2013.12.04.Art075
Exploring Second MBBS Students' Perspectives on Teaching-Learning Methods in Pathology in the Competency-Based Medical Education Curriculum
Abstract:
Pathology is a cornerstone of medical education, bridging basic sciences with clinical practice. This study investigates second-year MBBS students' perceptions of pathology as a subject and evaluates the effectiveness of teaching-learning methods within the Competency-Based Medical Education (CBME) framework. A structured questionnaire with Likert scale items and open-ended questions was administered to gather data on students' perceptions of pathology and the CBME teaching-learning methods. We assessed students' attitudes towards pathology, identified challenges, and analyzed the impact of CBME-based teaching strategies on learning outcomes. The majority of students (77.2%) find pathology challenging. 89.5% of students thought that the number of lectures and duration of each session were adequate. 77.6% of students said that large group lectures were monotonous and a majority wanted a greater number of small group discussions (70.6%) and case-based discussions (78.5%). Integrated teaching was a useful method for a greater depth of understanding of medicine. 57.9% of students wanted horizontal integration while 42.1% wanted vertical integration. 83.8% of students highly appreciated the practical DOAP sessions. Pathology is recognized as a fundamental subject. However, students face challenges in engaging with it fully under the CBME curriculum. The effectiveness of teaching-learning methods varies, with interactive and integrative approaches being more favoured than traditional lectures. While current teaching-learning methods have strengths, there is room for improvement in integrating pathology with clinical practice and addressing resource limitations.
Exploring Second MBBS Students' Perspectives on Teaching-Learning Methods in Pathology in the Competency-Based Medical Education Curriculum
References:
[1]. Deshmukh, A. V, Yadav, V., Gupta, A., Gangane, N. M., 2021, Students’ perspective regarding current pathology training in theory classes in MBBS course and insights to improve teaching–learning strategies: A study in Central India. Med J Babylon; 18: 266-71. https://journals.lww.com/mjby/fulltext/2021/18030/students__perspective_regarding_current_pathology.24.aspx
[2]. Krishnappa, S., Das, S., Raju, K., et al, 2023, Outcome-Based Medical Education Implication and Opportunities for Competency-Based Medical Education in Undergraduate Pathology. Cureus 15(8): e42801. https://www.cureus.com/articles/167278-outcome-based-medical-education-implication-and-opportunities-for-competency-based-medical-education-in-undergraduate-pathology#!/
[3]. Rege N, 2020, Towards competency-based learning in medical education: Building evidence in India. J Postgrad Med. 66(1):9-10. doi: 10.4103/jpgm.JPGM_749_19. PMID: 31929306; PMCID: PMC6970319. https://pmc.ncbi.nlm.nih.gov/articles/PMC6970319/
[4]. Priyanka, A. A., & Vasavi, G, 2021, A comparative study on traditional teaching with integrated teaching on II MBBS students. International Journal of Basic & Clinical Pharmacology, 10(3), 227–230. https://www.ijbcp.com/index.php/ijbcp/article/view/4527
[5]. Dick, F., Leaven, T., Dillman, D., Torner, R., Finken, L., 1998, Core morphological concepts of disease for second-year medical students. Hum Pathol. 29(9):1017-20. https://pathology.medresearch.in/index.php/jopm/article/view/61
[6]. Karimi, R., 2011, Interface between problem-based learning and a learner-centered paradigm, Adv Med Educ Pract.13;2:117-25. https://pmc.ncbi.nlm.nih.gov/articles/PMC3661251/
[7]. Ananthakrishnan, N., 2010, Medical education in India: Is it still possible to reverse the downhill trend? Natl Med J India; 23:156-60. https://www.academia.edu/52920964/Medical education in India Is it still possible to reverse the downhill trend
[8]. Dandannavar, V., 2010, Effect of Integrated Teaching versus Conventional Lecturing on MBBS Phase I Students. Recent Research in Science and Technology, 2(11). https://updatepublishing.com/journal/index.php/rrst/article/view/546
[9]. Dr. Poornima Vijayan, & Dr. Anupama Ponniah, 2017, A survey study based on undergraduate medical students’ feedback regarding pathology and the teaching-learning methodologies employed. Tropical Journal of Pathology and Microbiology, 3(2), 149-154. https://pathology.medresearch.in/index.php/jopm/article/view/61/121
[10]. L Khader, A Obeidat, F N Abu Shashin, N Khouri, N A Kaddumi, E G Al Qa Qa’, S Al-Satanawi, T. N Japer, H Al-Saghbini, M Amer, 2020, Medical students’ perceptions of pathology and a proposed curricular integration with histology: A future vision of curricular change. Int. J. Morphol., 38(1):38-42.
[11]. Toppo, N. A, Lazarus, M., Seth, R. J, Bhargava, O. P, Yadav, K. S., Kasar, P. K., 2016, Introduction of integrated teaching learning module in second M.B.B.S. curriculum. Int J Contemp Med Res; 3:1275-9. https://www.ijcmr.com/uploads/7/7/4/6/77464738/_introduction_of_integrated_teaching_learning_module_in_second_m.b.b.s._curriculum__.pdf
[12]. Rafique, N., 2009, Introducing integrated practical examination for 2nd year MBBS class. Proceedings in the 7th GCC Medical Colleges Conference by Saudi Society. J Fam Commun Med. 17:17-9. https://pmc.ncbi.nlm.nih.gov/articles/PMC3195072/
[13]. Goyal, M., Bansal, M., Gupta, A, Yadav, S., 2010, Perceptions and suggestions of 2nd professional MBBS students about their teaching and learning process: An analytical study. Natl J Integr Res Med. 1:20-4. https://nicpd.ac.in/ojs-/index.php/njirm/article/view/1881
[14]. Mahajan, D. N., Patel, D. K., Patel, D. V., 2013, Educational innovations/ Programmes for 1 MBBS Batch - 2012-13 Under Regional Training Centre, Smt. Nhl Municipal Medical College, Ahmedabad. Natl J Integr Res Med. 4:159-63. https://nicpd.ac.in/ojs-/index.php/njirm/article/view/615
[15]. Quadri, S., Srujana, S., Mahesh, S., Bheeshma, B., 2016, Undergraduate medical students’ feedback and perceptions on teaching learning methodology in Pathology at Government Medical College. International archives of integrated medicine. 3(7):28-35. https://www.iaimjournal.com/wp-content/uploads/2016/07/iaim_2016_0307_05.pdf
[16]. Cristina Rotellar, Jeff Cain, 2016, Research, Perspectives, and Recommendations on Implementing the Flipped Classroom, American Journal of Pharmaceutical Education, 80 (2): 34. https://www.sciencedirect.com/science/article/pii/S0002945923011920
[17]. Sharma, N., Lau, C. S., Doherty, I., and Harbutt, D., 2014, How we flipped the medical classroom. Medical Teacher, 37(4), 327–330. https://doi.org/10.3109/0142159X.2014.923821
[18]. Hughes H, 2014, Flipping the College Classroom: Participatory Learning, Technology, and Design. In L. Kyei-Blankson & E. Ntuli (Eds.), Practical Applications and Experiences in K-20 Blended Learning Environments (pp. 137-152). IGI Global Scientific Publishing. https://doi.org/10.4018/978-1-4666-4912-5.ch010
Viewed PDF 2 0 -
A Rare Case Report of Cervical Ectopic PregnancyAuthor: Pratikshya PriyadarshiniDOI: 10.21522/TIJPH.2013.12.04.Art080
A Rare Case Report of Cervical Ectopic Pregnancy
Abstract:
Pregnancy that implants in a site outside the uterine cavity is called Ectopic pregnancy. Cervical ectopic pregnancy constitutes only less than 1% of ectopic pregnancies, is potentially life threatening, and treatment on its part is assorting with a great challenge because of possible catastrophic bleeding. The diagnosis of cervical pregnancy can now be made much earlier with the aid of ultrasound and β-human chorionic gonadotropin measurements. Early diagnosis and conservative management with methotrexate can reduce maternal morbidity and mortality.28-year-old gravida 3, para 1, living 1, abortion 1 with a previous caesarean section was seen at 9 weeks and 6 days of amenorrhea with a history of intermittent vaginal bleeding since 4 days and no pain abdomen Ultrasound showed an empty uterine cavity and a gestational sac with cardiac activity located in the cervical canal. Serum beta-human chorionic gonadotropin was significantly elevated to 83,990 mIU/mL. The patient was given methotrexate and leucovorin, supplemented by evacuation and the placement of a Foley catheter for bleeding control. Histopathology confirmed cervical ectopic pregnancy. Serial beta HCG measurements showed a progressive decline, and complete resolution occurred after the institution of multiple doses of methotrexate. Follow-up ultrasound confirmed successful treatment without the risk of surgical intervention (Laparotomy). The most common mode of presentation for cervical ectopic pregnancies is painless vaginal bleeding associated with history of amenorrhea and therefore calls for suspicion of ectopic pregnancy. Early transvaginal ultrasound is mandatory to diagnose ectopic pregnancy. While medical management using methotrexate is very effective, it involves diligent monitoring of beta HCG to guide success and prevent severe complications. The following case illustrates the role of early ultrasound diagnosis and conservative medical management in the treatment of cervical ectopic pregnancy, which may avoid life-threatening haemorrhage and hysterectomy.
A Rare Case Report of Cervical Ectopic Pregnancy
References:
[1]. Alagbe, O. A., Adeoye, I. A., & Olaleye, O., 2017. Cervical ectopic pregnancy: Case report. Journal of Clinical and Diagnostic Research, 11(3), QD01-QD02.
[2]. Anupama, R., Biju, P. G., & Beena, S. R., 2015. Successful management of cervical ectopic pregnancy with methotrexate: A case report. International Journal of Reproduction, Contrace.
[3]. Bahadur, A., Mittal, S., & Malhotra, N., 2008. Conservative management of cervical ectopic pregnancy with intramuscular methotrexate: A case report. Journal of Obstetrics and Gynaecology Research, 34(5), 830-833.
[4]. Barnhart, K. T., 2009. Ectopic pregnancy. The New England Journal of Medicine, 361(4), 379-387.
[5]. Berg, C. J., Atrash, H. K., Koonin, L. M., & Tucker, M., 1996. Ectopic pregnancy.
[6]. Bhattacharya, S., & Mukhopadhyay, S., 2013. Cervical ectopic pregnancy: A case report. Oman Medical Journal, 28(5), e77.
[7]. Bustos-Lopez, H. H., Medina-Gaona, L. A., & Saucedo, A., 2017. Cervical ectopic pregnancy successfully treated with systemic methotrexate: Case report and literature review. International Journal of Reproduction.
[8]. Chan, C. C., & Ma, L. S., 2016. Cervical ectopic pregnancy: A case report and literature review. Obstetrics and Gynecology International Journal, 5(2), 00157.
[9]. Chetty, M., & Elson, J., 2009. Treating ectopic pregnancy. BMJ, 338, b481.
[10]. Chou, C. Y., & Tsai, K. C., 2000. Conservative treatment of cervical pregnancy with methotrexate. American Journal of Obstetrics.
[11]. D'Antonio, F., Timor-Tritsch, I. E., Palacios-Jaraquemada, J., Sladkevicius, P., & Woelfer, B., 2018. Diagnosis and management of cervical ectopic pregnancy. Ultrasound in Obstetrics & Gynecology, 52(4), 451–459.
[12]. Deb, S., & Matthews, J., 2012. Management of cervical ectopic pregnancy with methotrexate. Journal of Obstetrics and Gynaecology Research.
[13]. Duggal, B. S., & Tarneja, P., 2003. Cervical pregnancy: A clinical analysis of 19 cases. International Journal of Gynecology & Obstetrics, 83(3), 263-267.
[14]. Eichelberger, K. Y., & Wright, J. D., 2010. Cervical pregnancy: Diagnosis with endovaginal sonography and magnetic resonance imaging.
[15]. Elson, C. J., Salim, R., & Potdar, N., 2016. Diagnosis and management of ectopic pregnancy. BJOG: An International Journal of Obstetrics & Gynaecology, 123(13)e15–e55.
[16]. Ghaffari, S. A., & Mehdizadeh, A., 2012. Cervical ectopic pregnancy: A case report.
[17]. Gupta, R., & Chawla, I. 2016. Management of cervical pregnancy with systemic methotrexate: Case report. Journal of Obstetrics and Gynaecology of India, 66(Suppl 1), 516-519.
[18]. Hossain, S., & Rahman, S., 2017. Cervical ectopic pregnancy managed successfully with methotrexate: A case report. Journal of Obstetrics and Gynaecology Research, 43(3), 552-555.
[19]. Kalinski, M. A., & Gerscovich, E. O., 1995. Transvaginal ultrasound.
[20]. Kim, K. A., & Lee, J. S., 2009. Management of cervical ectopic pregnancy with methotrexate: A case report. Korean Journal of Obstetrics & Gynecology, 52(4), 417-420.
Viewed PDF 3 0 -
Inhibition of Biofilm Formation and Pyocyanin Production from Multidrug Resistance P. aeruginosa by Using Vitamin C, Salicylic Acid, and MultiseraAuthor: Marwan M. MerkhanDOI: 10.21522/TIJPH.2013.12.04.Art081
Inhibition of Biofilm Formation and Pyocyanin Production from Multidrug Resistance P. aeruginosa by Using Vitamin C, Salicylic Acid, and Multisera
Abstract:
Pseudomonas aeruginosa is a potent nosocomial pathogen, causing several infections, mostly urinary tract infections (UTIs). The present study is thus aimed to detect the susceptibility pattern of Pseudomonas aeruginosa to antibiotics from urine specimens, and virulence factor production such as (biofilm, and pyocyanin) which are regulated by quorum sensing. The aims were extended to detect the Inhibition of Biofilm formation and pyocyanin production by using vitamin C, salicylic acid and Multi sera. A total of 245 samples were collected from the patients. The samples were subjected to inoculation, isolation and identification of Pseudomonas aeruginosa which were 8 (4%) from total isolates, by standard microbiological procedures. Confirmation of isolates was done by polymerase chain reaction targeting 16srRNA. Antimicrobial sensitivity testing was done using the modified Kirby-Bauer method of the disc diffusion test, with high resistance rates against ceftriaxone (100%) while high sensitivity was to meropenem (88%). Quorum sensing Genes (lasl, lasR) were also detected in Multi-drug resistance and pan resistance isolates. In general, all isolates were Biofilm formation and pyocyanin production. The highest Inhibition of Biofilm was by using vitamin C while the highest Inhibition of pyocyanin was by using salicylic acid.
Inhibition of Biofilm Formation and Pyocyanin Production from Multidrug Resistance P. aeruginosa by Using Vitamin C, Salicylic Acid, and Multisera
References:
[1]. Stover, C. K., Pham, X. Q., Erwin, A. L., Mizoguchi, S. D., Warrener, P., Hickey, M. J., Olson, M. V., 2000, Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature, 406(6799), 959-964, doi:10.1038/35023079.
[2]. Ito, C. A. S., Bail, L., Arend, L. N. V. S., Nogueira, K. D. S., Tuon, F. F., 2021, The activity of ceftazidime/avibactam against carbapenem-resistant Pseudomonas aeruginosa. Infectious Diseases, 53(5), 386-389, doi:10.1080/23744235.2020.1867763.
[3]. Turkina, M. V., Vikström, E., 2019, Bacteria-host crosstalk: sensing of the quorum in the context of Pseudomonas aeruginosa infections. Journal of Innate Immunity, 11(3), 263-279, doi:10.1159/000494069.
[4]. Alkhulaifi, M. M., 2017, Using Phage’s to exterminate biofilms. Journal of Medical Microbiology and Diagnosis, 259(6):1-5, doi:10.4172/2161-0703.1000259.
[5]. Duplantier, M., Lohou, E., Sonnet, P., 2021, Quorum sensing inhibitors to quench P. aeruginosa pathogenicity. Pharmaceuticals, 14(12), 1-35, doi:10.3390/ph14121262.
[6]. El-Fouly, M. Z., Sharaf, A. M., Shahin, A. A. M., El-Bialy, H. A., Omara, A. M. A., 2015, Biosynthesis of pyocyanin pigment by Pseudomonas aeruginosa. Journal of Radiation Research and Applied Sciences, 8(1), 36-48, doi: 10.1016/j.jrras.2014.10.007.
[7]. Wang, T., Sun, W., Fan, L., Hua, C., Wu, N., Fan, S., Yan, J., 2021, An atlas of the binding specificities of transcription factors in Pseudomonas aeruginosa directs prediction of novel regulators in virulence. Elife, 10, e61885,1-25, doi:10.7554/eLife.61885.
[8]. Jayaseelan, S., Ramaswamy, D., Dharmaraj, S., 2014, Pyocyanin: production, applications, challenges and new insights. World Journal of Microbiology and Biotechnology, 30, 1159-1168, doi:10.1007/s11274-013-1552-5.
[9]. Shouman, H., Said, H. S., Kenawy, H. I., Hassan, R., 2023, Molecular and biological characterization of pyocyanin from clinical and environmental Pseudomonas aeruginosa. Microbial Cell Factories, 22(1), 166, doi:10.1186/s12934-023-02169-0.
[10]. Yin, W. F., Purmal, K., Chin, S., Chan, X. Y., Koh, C. L., Sam, C. K., Chan, K. G., 2012, N-acyl homoserine lactone production by Klebsiella pneumoniae isolated from human tongue surface. Sensors, 12(3), 3472-3483, doi:10.3390/s120303472.
[11]. Zhao, X., Yu, Z., Ding, T., 2020, Quorum-sensing regulation of antimicrobial resistance in bacteria. Microorganisms, 8(3), 1-21, doi:10.3390/microorganisms8030425.
[12]. Chourasiya, S. S., Kathuria, D., Singh, S., Sonawane, V. C., Chakraborti, A. K., Bharatam, P. V., 2015, Design, synthesis and biological evaluation of novel unsymmetrical azines as quorum sensing inhibitors. RSC advances, 5(97), 80027-80038, doi:10.1039/C5RA12925G.
[13]. Abdel Bar, F. M., Alossaimi, M. A., Elekhnawy, E., Alzeer, M. A. A., Abo Kamer, A., Moglad, E., ElNaggar, M. H., 2022, Anti-quorum sensing and anti-biofilm activity of Pelargonium× hortorum root extract against Pseudomonas aeruginosa: Combinatorial effect of catechin and gallic acid. Molecules, 27(22), 7841, doi:10.3390/molecules27227841.
[14]. Piecuch, A., Lamch, Ł., Paluch, E., Obłąk, E., Wilk, K. A., 2016, Biofilm prevention by dicephalic cationic surfactants and their interactions with DNA. Journal of Applied Microbiology, 121(3), 682-692, doi:10.1111/jam.13204.
[15]. Kamaruzzaman, N. F., Tan, L. P., Mat Yazid, K. A., Saeed, S. I., Hamdan, R. H., Choong, S. S., Gibson, A. J., 2018, Targeting the bacterial protective armour; challenges and novel strategies in the treatment of microbial biofilm. Materials, 11(9),1-27, doi:10.3390/ma11091705.
[16]. Abdulhaq, N., Nawaz, Z., Zahoor, M. A., Siddique, A. B., 2020, Association of biofilm formation with multi drug resistance in clinical isolates of Pseudomonas aeruginosa. EXCLI Journal, 19(1), 201-208, doi:10.17179/EXCLI2019-2049.
[17]. Khaleel, A. M., Faisal, R. M., Altaii, H. A., 2023, The efficiency of molecular methods compared to traditional methods in identifying bacteria from blood and cerebrospinal fluid samples. Malaysian Journal of Microbiology, 19(2):1-10, doi:10.21161/mjm.220105.
[18]. Khalid, I., Nayyef, N. S., Merkhan, M. M., 2022, A Taxonomic Study comparing the two types of Medicinal Leeches available in Iraq. Research Journal of Pharmacy and Technology, 15(3), 1119-1122, doi:10.52711/0974-360X.2022.00187.
[19]. Humphries, R., Bobenchik, A. M., Hindler, J. A., Schuetz, A. N., 2021, Overview of changes to the clinical and laboratory standards institute performance standards for antimicrobial susceptibility testing, M100. Journal of Clinical Microbiology, 59(12), 10-1128, doi:10.1128/JCM.00213-21.
[20]. Sultan, A. M., Amer, G. F., Nabiel, Y., 2021, Quinolone-resistant uropathogenic E. coli: is there a relation between qnr genes, gyrA gene target site mutation and biofilm formation? Journal of Medical Microbiology, 70(10), 001432, doi:10.1099/jmm.0.001432.
[21]. Lahij, H. F., Alkhater, A. H., Hassan, M. H., Yassir, L. A., 2021, The Effect of Qourum Sensing genes (lasI, rhlI) in Some Virulence Factors of Pseudomonas aeruginosa Isolated from Different Clinical Sources. Medico-legal Update, 21(1),303-308, doi:10.37506/mlu. v21i1.2325.
[22]. Mansuri, A., Lokhande, K., Kore, S., Gaikwad, S., Nawani, N., Swamy, K. V., Pawar, S., 2022, Antioxidant, anti-quorum sensing, biofilm inhibitory activities and chemical composition of Patchouli essential oil: in vitro and in silico approach. Journal of Biomolecular Structure and Dynamics, 40(1), 154-165, doi:10.1080/07391102.2020.1810124.
[23]. Farhadi, Z., Bahador, N., 2018, Pathotypic and phylogenetic studies of urine Escherichia coli isolates from girls< 5 years of age in Marvdasht hospital. Biomedical and Biotechnology Research Journal (BBRJ), 2(4), 281-285, doi: 10.4103/bbrj.bbrj_73_18.
[24]. AL-Khikani, F. H. O., Ayit, A. S., 2019, Correlation study between urinary tract bacterial infection and some acute inflammatory responses. Biomedical and Biotechnology Research Journal (BBRJ), 3(4), 236-239, doi: 10.4103/bbrj.bbrj_122_19.
[25]. Kassob, D. S., Hummadi, E. H., 2023, Study of pyocyanin production and biofilm formation in clinical Pseudomonas aeruginosa. Academic Science Journal, 1(2),139-152, doi:10.24237/ASJ.01.02.648B.
[26]. Abbas, R., Nawaz, Z., Siddique, A. B., Aslam, R., Rafique, A., Zahoor, M. A., Alsayeqh, A. F., 2022, Molecular Detection of Biofilm Production among Multidrug Resistant Isolates of Pseudomonas aeruginosa from Meat Samples. Pakistan Veterinary Journal, 42(4), 505-510, doi: 10.29261/pakvetj/2022.074.
[27]. Tenover, F. C., Nicolau, D. P., Gill, C. M., 2022, Carbapenemase-producing Pseudomonas aeruginosa–an emerging challenge. Emerging Microbes & Infections, 11(1), 811-814, doi:10.1080/22221751.2022.2048972.
[28]. Stultz, J. S., Arnold, S. R., Shelton, C. M., Bagga, B., Lee, K. R., 2019, Antimicrobial stewardship impact on Pseudomonas aeruginosa susceptibility to meropenem at a tertiary pediatric institution. American Journal of Infection Control, 47(12), 1513-1515, doi: 10.1016/j.ajic.2019.05.001.
[29]. Shravani, V., Selvi, G. A. S., Mantravadi, H., 2023, Detection of quorum sensing virulence factor genes and its consanguinity to antibiotic sensitivity profile in the clinical isolates of Pseudomonas aeruginosa. Iranian Journal of Basic Medical Sciences, 26(8), 899: 899-905, doi:10.22038/ijbms.2023.67981.14992.
[30]. Halim, R. M. A., Kassem, N. N., Mahmoud, B. S., 2018, Detection of biofilm-producing staphylococci among different clinical isolates and its relation to methicillin susceptibility. Open access Macedonian Journal of Medical Sciences, 6(8),1335–1341, doi:10.3889/oamjms.2018.246.
[31]. Mohsenzadeh, A., Fazel, A., Bavari, S., Borji, S., Pourasghar, S., Azimi, T., Sabati, H., 2021, Detecting of biofilm formation in the clinical isolates of Pseudomonas aeruginosa and Escherichia coli: an evaluation of different screening methods. Journal of Current Biomedical Reports, 2(2), 56-61, doi:10.52547/JCBioR.2.2.56.
[32]. Siddhiqui, S., Afreen, U., Kotgire, S., 2018, Evaluation of biofilm formation by three different methods and its antibiogram with special reference to indwelling medical devices from a tertiary care hospital. Annals of Laboratory Medicine, 5(2), 171-76, doi:10.21276/APALM.1630.
[33]. Padayatty, S. J., Levine, M., 2016, Vitamin C: the known and the unknown and Goldilocks. Oral Diseases, 22(6), 463-493, doi:10.1111/odi.12446.
[34]. Pandit, S., Ravikumar, V., Abdel-Haleem, A. M., Derouiche, A., Mokkapati, V. R. S. S., Sihlbom, C., Mijakovic, I., 2017, Low concentrations of vitamin C reduce the synthesis of extracellular polymers and destabilize bacterial biofilms. Frontiers in microbiology, 8(1), 1-11, doi:10.3389/fmicb.2017.02599.
[35]. Das, T., Kutty, S. K., Tavallaie, R., Ibugo, A. I., Panchompoo, J., Sehar, S., Manefield, M., 2015, Phenazine virulence factor binding to extracellular DNA is important for Pseudomonas aeruginosa biofilm formation. Scientific Reports, 5(1):1-9, doi:10.1038/srep08398.
[36]. Lee, J., Zhang, L., 2015, The hierarchy quorum sensing network in Pseudomonas aeruginosa. Protein and Cell, 6(1), 26-41, doi:10.1007/s13238-014-0100-x.
[37]. Han, B., Zheng, X., Baruah, K., Bossier, P., 2020, Sodium ascorbate as a quorum-sensing inhibitor leads to decreased virulence in Vibrio campbellii. Frontiers in Microbiology, 11, 1054, doi:10.3389/fmicb.2020.01054.
[38]. Das, T., Das, B., Young, B. C., Aldilla, V., Sabir, S., Almohaywi, B., Kumar, N., 2023, Ascorbic acid modulates the structure of the Pseudomonas aeruginosa virulence factor pyocyanin and ascorbic acid-furanone-30 combination facilitate biofilm disruption. Frontiers in Microbiology, 14(1),1-15, doi:10.3389/fmicb.2023.1166607.
[39]. Lattab, A., Rachid, D., Arabi, A., Hichem, D., Com, A. Y., 2017, Effect of salicylic acid on biofilm formation and on some virulence factors in Pseudomonas aeruginosa. International Journal of Biosciences, 10, 60-71, doi:10.12692/ijb/10.1.60-71.
[40]. Yang, L., Rybtke, M. T., Jakobsen, T. H., Hentzer, M., Bjarnsholt, T., Givskov, M., Tolker-Nielsen, T., 2009, Computer-aided identification of recognized drugs as Pseudomonas aeruginosa quorum-sensing inhibitors. Antimicrobial agents and chemotherapy, 53(6), 2432-2443, doi:10.1128/AAC.01283-08.
[41]. Prithiviraj, B., Bais, H. P., Jha, A. K., Vivanco, J. M., 2005, Staphylococcus aureus pathogenicity on Arabidopsis thaliana is mediated either by a direct effect of salicylic acid on the pathogen or by SA‐dependent, NPR1‐independent host responses. The Plant Journal, 42(3), 417-432, doi:10.1111/j.1365-313X.2005.02385. x.
[42]. Guo, M., Gamby, S., Zheng, Y., Sintim, H. O., 2013, Small molecule inhibitors of AI-2 signalling in bacteria: state-of-the-art and future perspectives for anti-quorum sensing agents. International Journal of Molecular Sciences, 14(9), 17694-17728, doi:10.3390/ijms140917694.
[43]. Aybey, A., Demirkan, E., 2016, Inhibition of Pseudomonas aeruginosa biofilm formation and motilities by human serum paraoxonase (hPON1). AIMS Microbiology, 2(4), 388-401, doi:10.3934/microbiol.2016.4.388.
[44]. Khatun, M. A., Hoque, M. A., Koffas, M., Feng, Y., 2023, Reducing the virulence of Pseudomonas aeruginosa by using multiple quorum-quenching enzymes. Journal of Industrial Microbiology and Biotechnology, 50(1), kuad028, doi:10.1093/jimb/kuad028.
Viewed PDF 1 0 -
Enhancing Zambia's Health Information System: Opportunities for Digitalization to Achieve Better Health OutcomesAuthor: Celia TusiimeDOI: 10.21522/TIJPH.2013.12.04.Art082
Enhancing Zambia's Health Information System: Opportunities for Digitalization to Achieve Better Health Outcomes
Abstract:
The Ministry of Health (MoH) in Zambia has introduced several strategic initiatives aimed at improving the Health Information System (HIS) by integrating digital technologies. These five-year strategies include the Digital Health Strategy, Health Information Systems Strategy, and Interoperability Architectural Framework, which are aligned with Zambia’s e-Government Master Plan (2018-2030). The study investigates how digital technologies can enhance HIS, focusing on improving efficiency, accessibility, and accuracy of health data. A mixed-methods approach was used, involving a secondary review of existing strategies and publications, alongside interviews and focus group discussions with key stakeholders. The research also examined the digital evolution and interoperability of Zambia's HIS, with a particular focus on 10 health information systems. The study reveals that there are more than 14 existing information systems in Zambia. The MoH is transitioning from paper-based systems to electronic health records to allow health facilities to digitally capture and store patient data. The national health management information system uses the District Information System 2 (DHIS2) as its underlying database for collecting, managing, and analysing health data across various levels of the health system. Key elements such as sustainable financing, coordination between the key directorates within the MoH and enhanced capacity in data science, data analytics, and informatics will be key in driving this digital transformation. The study concludes that implementation of these strategies is crucial to achieve a stronger HIS to improve data quality and support evidence-based planning and decision-making, thus promoting efficiency and equity in healthcare delivery to achieve better health outcomes.
Enhancing Zambia's Health Information System: Opportunities for Digitalization to Achieve Better Health Outcomes
References:
[5]. MoH 2023, Digital Health Strategy 2022-2026. Ministry of Health: Lusaka, Zambia.
[6]. MEASURE Evaluation 2024, Health Management Information System. University of North Carolina. Chapel Hill, North Carolina. Available at: https://www.measureevaluation.org/resources/training/capacity-building-resources/health-management-information-systems-hmis-1.
[10]. WHO 2024, Health Information Systems. World Health Organization. Geneva, Switzerland.
[11]. USAID Evidence for Health Project 2023, Progress Report. Financial Year 2023, Lusaka, Zambia.
[14]. USAID Evidence for Health Project 2022, Progress Report. Financial Year 2022, Lusaka, Zambia.
[18]. World Bank 2023 Digital-in-Health: Unlocking the Value for Everyone. Washington, DC. World Bank.
Accessed at: http://hdl.handle.net/10986/40212
Viewed PDF 3 0 -
Enhancing Integration of TBAs Into Modern Primary Health Care System in Oyo State: Lessons from A Community-Based Intervention for Maternal Child Health Services in NigeriaAuthor: Grace, A. OluwatoyeDOI: 10.21522/TIJPH.2013.12.04.Art083
Enhancing Integration of TBAs Into Modern Primary Health Care System in Oyo State: Lessons from A Community-Based Intervention for Maternal Child Health Services in Nigeria
Abstract:
Traditional Birth Attendants (TBAs) have long played a crucial role in child birthing within African communities, adhering to traditional birthing protocols before the introduction of stern medicine. Highly respected and trusted, TBAs were integral to home-birthing practices. The 1978 United Nations meeting at Alma Ata validated their role and recommended their training in orthodox practices until the WHO’s Safe Motherhood Initiative in 1997 called for their replacement with skilled birth attendants. Despite this, 27 years later, a critical shortage of skilled birth attendants persists, particularly in rural and underserved areas. Women of reproductive age (WRA) often choose TBAs for their availability, accessibility, and affordability. This study assesses the capabilities of TBAs in providing services along the continuum of care from prenatal to postnatal periods to explore their potential integration into the Primary Health Care (PHC) system in Oyo State. A quasi-experimental and cross-sectional survey captured quantitative data from 274 WRAs utilizing both formal and informal attendants for maternal childcare in four LGAs of Ibadan Metropolis. Additionally, 187 TBAs practising in these LGAs received interventions on maternal and child health (MCH) risk factors. The study also gathered perceptions from 24 experienced TBAs and 12 policymakers. The end-line data demonstrated significant improvements, leading to the rejection of the null hypotheses. The findings support exploring the integration of TBA services into the PHC system to enhance maternal mortality reduction and achieve UHC.
Enhancing Integration of TBAs Into Modern Primary Health Care System in Oyo State: Lessons from A Community-Based Intervention for Maternal Child Health Services in Nigeria
References:
[1]. iAHO_Maternal_Mortality_Regional_Factsheet.pdf. 2020, WHO, Geneva.
[2]. Okonofua, F., Ntoimo, L., Ogu, R., Galadanci, H., Abdus-Salam, R., Gana, M., & WHARC WHO FMOH MNCH Implementation Research Study Team. Association of the client-provider ratio with the risk of maternal mortality.
[3]. Kassie, A., Wale, A., Girma, D., Amsalu, H., & exhale, M. 2022, The role of traditional birth attendants and problem of integration with health facilities in remote rural community of west Omo zone 2021: Exploratory qualitative study. BMC Pregnancy and Childbirth. https://doi.org/10.1186/s12884-022-04753-5y in referral hospitals: a multi-site study in Nigeria. Reproductive Health, 15, 1-9.2018.
[4]. Ajayi-Lowo, E. O. 2021, “Natural Birth Movement.” Women’s Health: Understanding Issues and Influences, a 2-Volume Reference, ABC-CL10 Press.
[5]. World Health Organization. Declaration of Alma-Ata International Conference on Primary Health Care, Alma-Ata USSR, 6-12 September 1978.
[6]. Kassie, A., Wale, A., Girma, D., Amsalu, H., & exhale, M. 2022, The role of traditional birth attendants and problem of integration with health facilities in remote rural community of west Omo zone 2021: Exploratory qualitative study. BMC Pregnancy and Childbirth. https://doi.org/10.1186/s12884-022-4753-5.
[7]. Xu, S., & Hu, D. 2017. Barefoot Doctors and the "Health Care Revolution" in Rural China: A Study Centered on Shandong Province. Endeavour, 41(3), 136145. https://doi.org/10.1016/j.endeavour.2017.06.004.
[8]. Sudhinaraset, M., Ingram, M., Heather Kinlaw Lofthouse, & Montagu, D. 2013, What is the role of informal healthcare providers in Developing countries? A systematic review. PLoS ONE, 8(2), e54978. https://doi.org/10.1371/journal.pone.0054978.
[9]. Musie, M. R., Mulaudzi, Fhumulani Mavis, Anokwuru, R., & Bhana-Pema, V. 2022, Recognise and acknowledge us: Views of traditional birth attendants on collaboration with midwives for maternal health care services. International Journal of Reproductive Medicine. https://doi.org/10.1155/2022/9216500.
[10]. Esan, D. T., Ayenioye, Olabisi Helen, Ajayi, P. O., & Sokan-Adeaga, Adewale Allen. 2023, Traditional birth attendants’ knowledge, preventive and management practices for postpartum haemorrhage in Osun State, Southwestern Nigeria. Sci. Rep., 13, 1.
[11]. Kisangala, E., L, M. E., O, O. B., & A, K. M. 2023, Community and informal care providers at the heart of universal health coverage in Sub-Saharan Africa: A position paper. In South Eastern European Journal of Public Health.
[12]. Lane, K. (2018). Pluralist risk cultures: the sociology of childbirth in Vanuatu. In Risk, Pregnancy and Childbirth (pp. 115-133). Routledge.
[13]. Sowunmi, C. O., Olajide, A. O., Olorunfemi, O., Iwaola, O. M., & Adeyemo, O. F. 2021, Enhancing knowledge of traditional birth attendants for the identification of selected labor emergencies. Afr. J. Health Nurs. Midwifery, 4(3), 1-14.
[14]. Mill, D., Seubert, L., Lee, K., Page, A., Johnson, J., Salter, S., Clifford, R., Murace, E., Fullerton, F., Halliday, M. D., Res, A., & D'Lima, D. 2023, Understanding influences on the use of professional practice guidelines by pharmacists: A qualitative application of the COM-B model of behaviour. Research in Social and Administrative Pharmacy, 19(2), 272-285. https://doi.org/10.1016/j.sapharm.2022.10.006
[15]. Okonofua, F., & Ogu, R. 2014. Traditional versus birth attendants in provision of maternity care: call for paradigm shift. African Journal of Reproductive Health, 18(1), 11-12.
[16]. Nnamuchi, O. 2018. Securing the Right to Health in Nigeria under the Framework of the National Health Act. Med. & L., 37, 477.
[17]. Abiiro, G. A., & De Allegri, M. 2015. Universal health coverage from multiple perspectives: a synthesis of conceptual literature and global debates. BMC international health and human rights, 15, 1-7.
[18]. Lane, K. 2018. Pluralist risk cultures: the sociology of childbirth in Vanuatu. In Risk, Pregnancy and Childbirth (pp. 115-133). Routledge.
[19]. Shao, S., Wang, M., Jin, G., Zhao, Y., Lu, X., & Du, J. 2018. Analysis of health service utilization of migrants in Beijing using Anderson health service utilization model. BMC Health Services Research, 18, 1-11.
[20]. Michie, S., Van Stralen, M. M., & West, R. 2011. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implementation Science, 6, 1-12.
[21]. Dada, S. 2023. An overview of the Primary Healthcare System in Nigeria. Int. J. Agric. Sci. Res, 1(3), 289-304.
[22]. Abah, V. O. 2022. Poor health care access in Nigeria: A function of fundamental misconceptions and misconstruction of the health system. In Healthcare Access-New Threats, New Approaches. Intech Open.
[23]. Dada, S. 2023. An overview of the Primary Healthcare System in Nigeria. Int. J. Agric. Sci. Res, 1(3), 289-304.
[24]. World Health Organization. 2015, WHO recommendations on health promotion interventions for maternal and newborn health 2015, World Health Organization.
[25]. Sowunmi, A.O. Olajide, O. Olorunfemi, O.M. Iwaola, & Adeyemo, O. F. 2021. Enhancing knowledge of traditional birth attendants for the identification of selected labor emergencies. African Journal of Health, Nursing and Midwifery, 4(3), 1–14. https://doi.org/10.52589/AJHNM-HL0BDMZJ
[26]. Rosen, H. E., Lynam, P. F., Carr, C., Reis, V., Ricca, J., Bazant, E. S., & Quality of Maternal and Newborn Care Study Group of the Maternal and Child Health Integrated Program. 2015, Direct observation of respectful maternity care in five countries: a cross-sectional study of health facilities in East and Southern Africa. BMC Pregnancy and childbirth, 15, 1-11.
[27]. Miller, T., & Smith, H. 2017 Establishing partnership with traditional birth attendants for improved maternal and newborn health: A review of factors influencing implementation. BMC Pregnancy and Childbirth. https://doi.org/10.1186/s12884-017- 1534-y
[28]. Lane, K., & Garrod, J. 2016. The return of the traditional birth attendant. Journal of Global Health, 6(2).
[29]. Nadelman, R., & Negrón, R. V. 2024. The World Bank and shrinking civic space. In The Elgar Companion to the World Bank (pp. 407-416). Edward Elgar Publishing.
[30]. Tilley-Gyado, R., Filani, O., Morhason-Bello, I., & Adewole, I. F. 2016, Strengthening the Primary Care Delivery System: A Catalytic Investment toward Achieving Universal Health Coverage in Nigeria. Health Systems & Reform, 2(4), 277–284. https://doi.org/10.1080/23288604.2016.1234427
Viewed PDF 1 0 -
Development and Performance Evaluation of a Low-cost Incinerator for Biomedical Waste Treatment for Rural Areas in RajasthanAuthor: Hajari SinghDOI: 10.21522/TIJPH.2013.12.04.Art086
Development and Performance Evaluation of a Low-cost Incinerator for Biomedical Waste Treatment for Rural Areas in Rajasthan
Abstract:
Biomedical waste management in rural areas presents significant challenges due to the high costs of transportation and the lack of on-site treatment facilities. To address these issues, a low-cost incinerator specifically designed for biomedical waste management and disposal in rural settings has been developed. This incinerator is engineered to minimize air pollution, employing a series of advanced filter media that convert airborne pollutants into water. Water samples derived from the most effective filter media were analyzed which revealed a substantial reduction in heavy metal content. These findings contribute valuable insights to the field of environmental engineering, particularly in the sustainable management of biomedical waste in underserved regions.
Development and Performance Evaluation of a Low-cost Incinerator for Biomedical Waste Treatment for Rural Areas in Rajasthan
References:
[1]. GoI, 2016, Guidelines for Management of Healthcare Waste as per Biomedical Waste Management Rules, 2016, http://www.iwma.in/BMW%20Rules,%202016.pdf
[2]. Mastorakis, N. E., Bulucea, C. A., Oprea, T. A., Bulucea, C. A. and Dondon, P., 2010, Environmental and health risks associated with biomedical waste management, Development, Energy, Environment, Economics, 2010, pp. 287-94.
[3]. Insa, E., Zamorano, M. and López, R., 2010, Critical review of medical waste legislation in Spain. Resources, Conservation and Recycling, 54(12), pp. 1048-1059. https://doi.org/10.1016/j.resconrec.2010.06.005
[4]. Mbongwe, B., Mmereki, B. T. and Magashula, A., 2008, Healthcare waste management: current practices in selected healthcare facilities, Botswana. Waste Management, 28(1), pp. 226-233. https://doi.org/10.1016/j.wasman.2006.12.019
[5]. Alago, A. Z., 2008, Improvement and modification of the routing system for the health-care waste collection and transportation in Istanbul. 28: 1461-71. https://doi.org/10.1016/j.wasman.2007.08.024
[6]. Agrawal, D., 2015, Impact Assessment of Bio-Medical Waste in Southern Rajasthan. 3(09), 1-4.
[7]. Dudi, M., Sharma, R. and Jain, M., 2015, Knowledge Regarding BMW Management Among Rhos (Resident House Officers) In A Tertiary Care Centre. Journal of Research in Medical and Dental Sciences, 3(3), pp. 185-187. 10.5455/jrmds.2015336
[8]. Ajmera V, Jayalkshmi LS. 2016, A Study to Assess the Knowledge Regarding Bio-Medical Waste Management among B. Sc Nursing Students of Selected Nursing Colleges of Udaipur (Raj). 5(4), 1734-1738.
[9]. Singh, H. and Choudhary, M. P., 2019, Factual Status of Bio-Medical Waste Management in Kota, Rajasthan, India. International Journal of Engineering and Advanced Technology, 8(6), pp. 2482-2489. http://dx.doi.org/10.35940/ijeat.F8741.088619
[10]. Windfeld, E. S. and Brooks, M. S. L., 2015, Medical waste management–A review. Journal of Environmental Management, 163, pp. 98-108.
[11]. Nataraj, G., Baveja, S., Kuyare, S., Poojary, A., Mehta, P., Kshirsagar, N. and Gogtay, N., 2008, Report: Medical students for monitoring biomedical waste segregation practices—why and how? Experience from a medical college. Waste Management & Research, 26(3), pp.288-290. https://doi.org/10.1177/0734242X07081481
[12]. Debrah, J. K. and Dinis, M. A. P., 2023, Chemical characteristics of bottom ash from biomedical waste incinerators in Ghana. Environmental Monitoring and Assessment, 195(5), p. 568. https://doi.org/10.1007/s10661-023-11132-w
[13]. Abolayo, T. T., Sawyerr, H. O., Yusuf, R. O., Ajai, T. S., and Towolawi, A. T., 2022, A Comparative Study of Dumpsites Metal Loads and Ecological Risk in Selected Communities in Kwara and Ekiti States, Nigeria. medRxiv, pp. 2022-12. https://doi.org/10.1101/2022.12.25.22283930
[14]. Ministryof Environment, Forest and Climate Change G of I. 2016, Biomedical Waste Management Rules, 2016, Gaz. India, Extraordinary, Part II, Sect. 3, Sub-section (i): 1.
[15]. Tsakalou, C., Papamarkou, S., Tsakiridis, P. E., Bartzas, G. and Tsakalakis, K., 2018, Characterization and leachability evaluation of medical wastes incineration fly and bottom ashes and their vitrification outgrowths. Journal of Environmental Chemical Engineering, 6(1), pp. 367-376. https://doi.org/10.1016/j.jece.2017.12.012
[16]. Zhao, L., Zhang, F. S., Wang, K. and Zhu, J., 2009, Chemical properties of heavy metals in typical hospital waste incinerator ashes in China. Waste Management, 29(3), pp. 1114-1121. https://doi.org/10.1016/j.wasman.2008.09.003
Viewed PDF 9 3 -
Availability of Human Resources as a Determinant of Health Service Quality in Multihazard Disasters in Palu City, IndonesiaAuthor: Setya HaksamaDOI: 10.21522/TIJPH.2013.12.04.Art084
Availability of Human Resources as a Determinant of Health Service Quality in Multihazard Disasters in Palu City, Indonesia
Abstract:
Health aspects in disaster management, including earthquakes, are very important to formulate because they include pre-disaster, emergency response and post-disaster aspects so that appropriate mitigation and preparedness can be carried out to reduce the impacts that occur. This study aimed to analyze the influence of health resource factors on the quality of health services in multihazard disasters. This study applied a cross-sectional design, involving 57 people selected using accidental sampling techniques. The independent variables were health service providers; human resources; health financing; materials; methods; institutional structures; health information system technology; drugs and health supplies; community conditions; environment; preparedness; and basic needs during disasters. While the dependent variable was the quality of health services in multihazard disasters. All variables were measured by filling out a questionnaire. The measurement data were analyzed using multiple linear regression tests. The results showed that the p-value was less than 0.05 only for the availability of human resources, which was 0.013; so this is a factor that significantly influences the quality of health services. Thus it could be concluded that the determinant of the quality of health services in multihazard disasters in Palu City, Indonesia was the availability of human resources.
Availability of Human Resources as a Determinant of Health Service Quality in Multihazard Disasters in Palu City, Indonesia
References:
[1] Qadriina, H. I., Herdiansyah, H., Aryo, B., 2024, Social capital of disaster-affected communities in post-disaster conditions: A case study of the Cianjur Earthquake, West Java, Indonesia, 2022, Disaster Advances, 17(5), 1-8.
[2] Ayuningtyas, D., Windiarti, S., Hadi, M. S., Fasrini, U. U., Barinda, S., 2021, Disaster preparedness and mitigation in Indonesia: A narrative review. Iran J Public Health, 50(8), 1536-1546.
[3] Kementerian PUPR, 2018, Kajian gempa Palu Provinsi Sulawesi Tengah (Palu, Indonesia: Badan Penelitian dan Pengembangan Kementerian Pekerjaan Umum dan Perumahan Rakyat).
[4] Wiratma, B., 2019, Rekap baru dirampungkan, ini jumlah terbaru korban terdampak bencana di Kota Palu. Date of access: 26/08/2020. https://www.tribunnews.com/regional/2019/03/01/rekap-baru-dirampungkan-ini-jumlah-terbaru-korban-terdampak-bencana-di-kota-palu
[5] Kato, A., Ben-Zion, Y, 2021, The generation of large earthquakes. Nat Rev Earth Environ, 2, 26-39. doi: 10.1038/s43017-020-00108-w
[6] Khatri, R. B., Endalamaw, A., Erku, D., et al., 2023, Preparedness, impacts, and responses of public health emergencies towards health security: qualitative synthesis of evidence. Arch Public Health, 81, 208. doi: 10.1186/s13690-023-01223-y
[7] Singh, G., 2023, Earthquake prediction using convolutional neural network. Disaster Advances, 16(6), 45-52.
[8] Mavrouli, M., Mavroulis, S., Lekkas, E., Tsakris, A., 2023, The impact of earthquakes on public health: A narrative review of infectious diseases in the post-disaster period aiming to disaster risk reduction. Microorganisms, 11(2), 419. doi: 10.3390/microorganisms11020419.
[9] Ellwanger, J. H., Veiga, A. B. G., Kaminski, V. L., Valverde-Villegas, J. M., Freitas, A. W. Q, Chies, J. A. B., 2021, Control and prevention of infectious diseases from a one health perspective. Genet Mol Biol., 44(1 Suppl 1), e20200256. doi 10.1590/1678-4685-GMB-2020-0256.
[10] Nuzzo, J. B., Meyer, D., Snyder, M., et al., 2019, What makes health systems resilient against infectious disease outbreaks and natural hazards? Results from a scoping review. BMC Public Health, 19, 1310. doi: 10.1186/s12889-019-7707-z.
[11] Haldane, V., De Foo, C., Abdalla, S. M., et al., 2021, Health systems resilience in managing the COVID-19 pandemic: lessons from 28 countries. Nat Med, 27, 964–980. doi: 10.1038/s41591-021-01381-y.
[12] Shami, E., Gholipour, K., Naghibi, D., Azami-Aghdash, S., 2023, The roles and challenges of the primary health care systems in epidemic management: a scoping review. Prim Health Care Res Dev., 24, e55. Doi: 10.1017/S1463423623000452.
[13] Khan, Y., O'Sullivan, T., Brown, A., Tracey, S., Gibson, J., Généreux, M., Henry, B., Schwartz, B., 2018, Public health emergency preparedness: A framework to promote resilience. BMC Public Health, 18(1), 1344. doi: 10.1186/s12889-018-6250-7.
[14] George, A. S., Campbell, J., Ghaffar, A., 2018, Advancing the science behind human resources for health: Highlights from the health policy and systems research reader on human resources for health. Hum Resour Health, 16(1), 35. doi: 10.1186/s12960-018-0302-z.
[15] Khatri, N., Gupta, V., Varma, A., 2017, The relationship between HR capabilities and quality of patient care: The mediating role of proactive work behaviors. Hum Resour Manage., 2017, 56(4), 673-691. doi: 10.1002/hrm.21794.
[16] Nwankwo, O. N. O., Auer, C., Oyo-Ita, A., et al., 2024, Human resources for health: A framework synthesis to put health workers at the centre of healthcare. BMJ Global Health, 9, e014556.
[17] Yu, J., Yuan, L., Han, G., Li, H., Li, P., 2022, A study of the impact of strategic human resource management on organizational resilience. Behav Sci (Basel), 12(12), 508. doi: 10.3390/bs12120508.
[18] Zhang, C., Zeng, Q., Chen, C., et al., 2023, The strategic resources and competitive performance of family-owned and non-family-owned firms in the retail business of Los Angeles. J Knowl Econ., 14, 327-355. doi: 10.1007/s13132-021-00860-4.
[19] Figueroa, C.A., Harrison, R., Chauhan, A., Meyer, L., 2019, Priorities and challenges for health leadership and workforce management globally: a rapid review. BMC Health Serv Res., 19(1), 239. doi: 10.1186/s12913-019-4080-7.
[20] Nafari, E., Rezaei, B., 2022, Relationship between human resources strategies and organizational performance based on the balanced scorecard in a public hospital in Iran: a cross-sectional study. BMC Health Serv Res., 22(1), 363. doi: 10.1186/s12913-022-07767-z.
[21] Qin, X., Wang, B. L., Zhao, J., Wu, P., Liu, T., 2023, Learn from the best hospitals: a comparison of the mission, vision and values. BMC Health Serv Res., 23(1), 792. doi: 10.1186/s12913-023-09699-8.
[22] Motunrayo, T. T., 2024, Health workers perception on precautionary knowledge and practices in secondary hospitals and isolation centres for COVID-19 preventive measures in Lagos State, Nigeria. Texila International Journal of Public Health, 12(1), 1-15.
[23] Motunrayo, T. T., 2024, Assessment of health workers’ awareness of infection prevention and control preparedness levels in isolation centers and secondary hospitals in Lagos State, Nigeria. Texila International Journal of Public Health, 12(1), 1-14.
[24] Sikazwe, C. M. S., 2024, An assessment of knowledge of health workers in hospitals of Southern Province of Zambia, towards marketing of breastmilk substitutes regulations. Texila International Journal of Public Health, 12(1), 1-16.
[25] Piwowar-Sulej, K., 2020, Human resources development as an element of sustainable HRM - with the focus on production engineers. J Clean Prod., 278, 124008. doi: 10.1016/j.jclepro.2020.124008.
Viewed PDF 3 0 -
Participatory Action Research to Realize Disaster Health Crisis Preparedness in the CommunityAuthor: SunartoDOI: 10.21522/TIJPH.2013.12.04.Art087
Participatory Action Research to Realize Disaster Health Crisis Preparedness in the Community
Abstract:
Many Disaster Resilient Villages in Indonesia still face obstacles in realizing preparedness for health crises due to disasters. This study aimed to facilitate the Disaster Resilient Village Forum in realizing an early warning system that is easily responded to by the community and mobilization of health resources in the disaster health crisis preparedness phase. This study was conducted using the Participatory Action Research approach involving 150 participants from 4 Disaster Resilient Villages. The research objects include: 1) preparation of a participatory health crisis contingency plan document; 2) facilitating the socialization of early warning systems to vulnerable groups; 3) facilitation of disaster health crisis emergency response simulation; and 4) measuring the level of village resilience. The approach was carried out in several cycles consisting of 4 steps, namely planning, acting, observing and reflecting. The results of the study showed that the forum and the community implemented the four research objectives well by the objectives in one cycle. It is further concluded that the Participatory Action Research approach can be used well to facilitate the Disaster Resilient Village Forum in realizing an early warning system that is easily responded to by the community and the mobilization of health resources in the disaster health crisis preparedness phase.
Participatory Action Research to Realize Disaster Health Crisis Preparedness in the Community
References:
[1]. Sunarto, S., Nugroho, H. S. W., Suparji, S, Santosa, B. J., 2024, Quadrant of difficulty and usefulness for prioritizing community-based disaster preparedness parameter elements. Rawal Medical Journal, 49(1), 172-175. doi: 10.5455/rmj.20230918043333.
[2]. Djalante, R., Garschagen, M., 2017, A review of disaster trend and disaster risk governance in Indonesia: 1900–2015, In: Djalante, R., Garschagen, M., Thomalla, F., Shaw, R. (eds) Disaster Risk Reduction in Indonesia. Disaster Risk Reduction. Springer, Cham. doi: 10.1007/978-3-319-54466-3_2.
[3]. Paripurno, E. T., Putra, W., Triadi, W. S., 2023, Disaster risk assessment Magetan Regency, East Java. AIP Conf. Proc., 2598(1), 070009. doi: 10.1063/5.0135163.
[4]. Ramadorai, A, Ravi, P, Narayanan,V., 2019, Rhinocerebral Mucormycosis: A prospective analysis of an effective treatment protocol, Ann. Maxillofac. Surg. 9 192–196. https://doi.org/10.4103/ams.ams_231_18.
[5]. Filip, R., Gheorghita, P. R., Anchidin-Norocel, L., Dimian, M., Savage, W. K., 2022, Global challenges to public health care systems during the COVID-19 pandemic: A review of pandemic measures and problems. J Pers Med,12(8),1295. doi:10.3390/jpm12081295.
[6]. Al-Worafi, Y. M., 2024, Healthcare facilities in developing countries: infrastructure. In: Al-Worafi, Y.M. (eds) handbook of medical and health sciences in developing countries. Springer, Cham.
[7]. Knifton, L., Inglis, G., 2020, Poverty and mental health: policy, practice and research implications. BJPsych Bull, 44(5),193-196. doi:10.1192/bjb.2020.78.
[8]. Grasser, L. R., 2022, Addressing mental health concerns in refugees and displaced populations: is enough being done. Risk Manag Healthc Policy, 6(15), 909-922.
[9]. Tyubee, B. T., 2020, Disaster preparedness: approaches and frameworks. In: Leal Filho, W., Azul, A., Brandli, L., Lange Salvia, A., Özuyar, P., Wall, T. (eds) No Poverty. Springer, Cham.
[10]. Fischer, R. J., Halibozek, E. P., Walters, D. C., 2019, Contingency planning emergency response and safety. Introduction to Security, 249–68.
[11]. Nugroho, H. S. W., Suparji, S., Sunarto, S., Handoyo, H., Yessimbekov, Z., Burhanuddin, N., Selasa, P., 2020, Quadrant of difficulty-usefulness (QoDU) as new method in preparing for improvement of e-learning in health college. Risk Manag Health Policy, 13, 1625-1632. doi: 10.2147/RMHP.S268814.
[12]. Brydon-Miller, M., Kral, M., Ortiz Aragón, A., 2020, Participatory action research: international perspectives and practices. International review of qualitative research, 13(2), 103-111.
[13]. Kemmis, S., Taggart, R.M., Nixon, R., 2014, The action research: doing critical participatory action research. Singapore: Springer Publishing Company.
[14]. White, G. W., Suchowierska, M., Campbell, M., 2004, Developing and systematically implementing participatory action research. Arch Phys Med Rehabil. 85(4 Suppl 2), S3-12. doi: 10.1016/j.apmr.2003.08.109.
[15]. Lassa, J. A., Boli, Y., Nakmofa, Y., Fanggidae, S., Ofong, A., Leonis, H., 2018, Twenty years of community-based disaster risk reduction experience from a dryland village in Indonesia. Jamba, 10(1), 502.
[16]. Arifin, S., Wicaksono, S. S., Sumarto, S., Martitah, M., Sulistianingsih, D., 2021, Disaster resilient village-based approach to disaster risk reduction policy in Indonesia: A regulatory analysis. Jamba, 13(1), 1021.
[17]. Khan, Y., O'Sullivan, T., Brown, A., Tracey, S., Gibson, J., Généreux, M., Henry, B., Schwartz, B., 2018, Public health emergency preparedness: a framework to promote resilience. BMC Public Health, 18(1), 1344.
[18]. Canlas, I. P., Karpudewan, M., 2020, Blending the principles of participatory action research approach and elements of grounded theory in a disaster risk reduction eucation case study. International Journal of Qualitative Methods, 19. doi:10.1177/1609406920958964.
[19]. Bullock, J. A., Haddow, G. D., Coppola, D. P., 2013, Mitigation, prevention, and preparedness. introduction to homeland security. Report, 435-494.
[20]. Choptiany, J. M. H., Graeub, B. E., Hatik, S., Conversa, D., & Ledermann, S. T., 2019, Participatory assessment and adaptation for resilience to climate change. Consilience, 21, 17–31.
[21]. Carmen, E., Fazey, I., Ross, H. et al., 2022, Building community resilience in a context of climate change: The role of social capital. Ambio, 1371–1387.
[22]. Sunarto, S., Nugroho, H. S. W., Surtinah, N., Diah, O. P. V., Hanifah, S. S., 2024, Collaboration with the disaster resilient village forum in disaster emergency response simulation in Ngelang Kartoharjo Village Magetan. Front Community Serv Empower, 3(2), 1–6.
[23]. Biermann, O., Eckhardt, M., Carlfjord, S., Falk, M., Forsberg, B. C., 2016, Collaboration between non-governmental organizations and public services in health–a qualitative case study from rural Ecuador. Global Health Action, 9(1).
[24]. Sajadi, H. S., Ghadirian, L., Rajabi, F., Sayarifard, A., Rostamigooran, N., Majdzadeh, R., 2022, Interventions to increase participation of NGOs in preventive care: A scoping review. Health Sci Rep, 5(5), e770.
[25]. Sufri, S., Dwirahmadi, F., Phung, D., 2020, Enhancing community engagement in disaster early warning system in Aceh, Indonesia: Opportunities and challenges. Nat Hazards, 2691–2709.
[26]. Chirenje, L. I., Giliba, R. A., Musamba, E. B., 2013, Local communities participation in decision-making processes through planning and budgeting in African countries. Chinese Journal of Population Resources and Environment, 11 (1), 10–16. doi:10.1080/10042857.2013.777198.
[27]. Siddique, R , Nivedhitha, M.S. , Jacob,B., 2019, Quantitative analysis for detection of toxic elements in various irrigants, their combination (precipitate), and para-chloroaniline: An inductively coupled plasma mass spectrometry study, J. Conserv. Dent. 22 344–350. https://doi.org/10.4103/JCD.JCD_95_19.
[28]. Syamsidik, Oktari, R. S., Nugroho, A., Fahmi, M., Suppasri, A., Munadi, K., 2021, Fifteen years of the 2004 Indian Ocean tsunami in Aceh-Indonesia: Mitigation, preparedness and challenges for a long-term disaster recovery process. Int J Disaster Risk Reduct, 54, 102052.
[29]. Laverack, G., Manandhar, D., 2019, Participatory action research for health promotion: a review of the literature. Health Promotion International, 34(2), 124-133.
[30]. Van Niekerk, D., Nemakonde, L. D., Kruger, L., Forbes-Genade, K., 2018, Community-based disaster risk management. In: Rodríguez, H., Donner, W., Trainor, J. (eds) Handbook of disaster research. Handbooks of sociology and social research. Springer, Cham. doi:10.1007/978-3-319-63254-4_20.
[31]. Morrow, B., Smith, E., 2020, The impact of participatory approaches on health crisis preparedness in rural communities: findings from a case study. International Journal of Health Services, 50(3),310-325.
[32]. Duran, A., Rojas, C., 2021, The impact of community participation in disaster risk management: A case study. Disaster Management Journal, 35(2),123-135.
[33]. Kieny, M.P., Bekedam, H., Dolea, C., et al., 2020, Strengthening health systems for crisis response: Lessons learned from recent health emergencies. Global Health Action, 13(1),1807340.
[34]. Gupta, A., Luthra, S., 2022, Building community resilience through participatory approaches: evidence from disaster management practices. International Journal of Disaster Risk Reduction, 62,102379.
[35]. Lillie, T., Hsu, A., Edwards, D., 2019, The role of community engagement in emergency preparedness: a systematic review. Disaster Medicine and Public Health Preparedness, 13(4), 687-696.
[36]. Donnelly, L., Allen, T., Khalid, H., 2020, Understanding the barriers to effective disaster response: a qualitative study. International Journal of Emergency Management, 16(1), 58-70.
[37]. Paton, D., Jackson, D., Chan, C., 2021, Collaborative learning for community resilience in emergency management: evidence from participatory research. Journal of Risk Research, 24(3), 301-315.
Viewed PDF 2 0 -
The Antimicrobial Resistance Trend Pattern in A Subset Population of West BengalAuthor: Shayeri DasDOI: 10.21522/TIJPH.2013.12.04.Art085
The Antimicrobial Resistance Trend Pattern in A Subset Population of West Bengal
Abstract:
A deadly pandemic has threatened the world and is witnessing severe climate change. Constant environmental changes are leading to various viral/bacterial infections, which have increased the consumption of antibiotics. The rise in usage of antibiotics has increased significantly during the COVID-19 pandemic and post-COVID era. Generally, the most prescribed antibiotics fall under the broad-spectrum range as these work on many gram-positive and gram-negative disease-causing bacteria. There has been an increase in the accessibility and affordability of antibiotics among the population. The primordial factor for this is the over-the-counter buying of antibiotics followed by frequent usage of antibiotics. Patients often only finish part of the course of antibiotics. Frequent consumption of antibiotics and not completing the whole course of the antibiotics pose a severe and potentially irreversible threat to the healthy microbiome of the human intestine and a resistance pattern against the antibiotics. The study specifically focuses on understanding the antibiotic resistance pattern in the post-COVID scenario on the gut microbiome of the West Bengal population, making it particularly relevant to the local healthcare community. It underscores the urgent need for responsible antibiotic use, public awareness of the use of antibiotics, and antimicrobial resistance.
The Antimicrobial Resistance Trend Pattern in A Subset Population of West Bengal
References:
[1] Das, S, Agarwal, S., Bose, A., Das, D., 2024, Intestinal microbiome and antimicrobial resistivity: A study in recent times. Texila Internation Journal of Academic Research. DOI: 10.21522/TIJAR.2014.11.02. Art011.
[2] Barron, M., 2022, The Gut Resistome and the Spread of Antimicrobial Resistance. American Society of Microbiology, June 2022. https://asm.org/Articles/2022/June/The-Gut-Resistome-and-the-Spread-of-Antimicrobial#. Accessed 24 Aug 2024.
[3] Singh, S., Verma, N., Taneja, N., 2019, The human gut resistome: Current concepts & prospects. Indian Journal of Medical Research, 150(4): 345–358. DOI: 10.4103/ijmr.IJMR_1979_17.
[4] Ezmed., Antibiotic Chart: Drug Names, Coverage and Mechanism of Action, Jan 2024, https://www.ezmedlearning.com/blog/antibiotic-classes-drug-names-coverage-mechanism-action.Accessed 24 Aug 2024.
[5] Powell, A., Sheikh, Z., 2024, Antibiotics: Everything you should know. https://www.webmd.com/a-to-z-guides/what-are-antibiotics. Accessed on 24 Aug 2024.
[6] React, SIDA, Uppsala University, 2024, How do antibiotics work? https://www.reactgroup.org/toolbox/understand/antibiotics/how-do-antibiotics-work/. Accessed 24 Aug 2024.
[7] Infusion Services 2024; Cochise Oncology Article. https://cochiseoncology.com/infusion-services/. Accessed 24 Aug 2024.
[8] Pascaul, C., Vergara, A., Vila, J., 2018, Intestinal microbiota and antibiotic resistance: Perspectives and solutions. Human Microbial Journal, vol. 9, 11-15. https://doi.org/10.1016/j.humic.2018.05.002.
[9] Yang, L., Bajinka, O., Jarju, P.O. et al. The varying effects of antibiotics on gut microbiota. AMB Expr 11, 116, 2021. https://doi.org/10.1186/s13568-021-01274-w
[10] Matzaras, R., Nikopoulou, A., Protonotariou, E., Christaki, E., Gut Microbiota Modulation and Prevention of Dysbiosis as an Alternative Approach to Antimicrobial Resistance: A Narrative Review. Yale J Biol Med. 2022 Dec 22;95(4):479-494. PMID: 36568836; PMCID: PMC9765331.
[11] Aliouche, H., 2022, The Effect of Antibiotics on Gut Microbiome. News Medical Life Sciences. https://www.news-medical.net/health/. Accessed 24 Aug 2024.
[12] WHO Report 2020 Antibiotic Resistance. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance. Accessed 24 Aug 2024.
[13] [Porter, Gerard & Kotwani, Anita & Bhullar, Lovleen & Joshi, Jyoti. 2021, Over-the-counter sales of antibiotics for human use in India: The challenges and opportunities for regulation. Medical Law International. 21. 147-173. DOI: 10.1177/09685332211020786.
[14] Kotwani, A., Joshi, J., Lamkang, A. S., Over-the-Counter Sale of Antibiotics in India: A Qualitative Study of Providers' Perspectives across Two States. Antibiotics (Basel). 2021 Sep 17, 10(9), 1123. doi: 10.3390/antibiotics10091123. PMID: 34572705; PMCID: PMC8472180.
[15] Ghafur, Abdul. 2010. An obituary - On the death of antibiotics. The Journal of the Association of Physicians of India. 58. 143-4.
[16] Salunkhe, S.D. & Pandit, Vijaya & Dawane, Jayshree & Sarda, Kushal & More, C.S. 2013, Study of over-the-counter sale of antimicrobials in pharmacy outlets in Pune, India: A cross-sectional study. International Journal of Pharma and Bio Sciences. 4. P616-P622.
[17] WHO Factsheet, 2023 on Antimicrobial Resistance. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance#. Accessed 24 Aug 2024.
Viewed PDF 1 0 -
A Randomized Controlled Trial on Investigating the Effectiveness of Earplugs on Physiological and Behavioral Responses and Weight Gain in Preterm NeonatesAuthor: Roja Rani. ChakravartulaDOI: 10.21522/TIJPH.2013.12.04.Art088
A Randomized Controlled Trial on Investigating the Effectiveness of Earplugs on Physiological and Behavioral Responses and Weight Gain in Preterm Neonates
Abstract:
A randomized controlled trial was conducted to assess the effectiveness of earplugs on selected physiological and behavioral responses among preterm neonates, and their association with weight gain, using block randomization with computer-generated random numbers and the sealed envelope technique to recruit 223 preterm neonates born between 30 to less than 37 weeks of gestation, with a birth weight between 1000 grams and less than 2500 grams. A pair of earplugs was applied to each preterm infant in the study group in the SNCU. Heart rate, oxygen saturation, sleep duration, and behavioural responses were measured four times a day for five consecutive days. The statistical significance of these parameters was determined by repeated measures ANOVA, and Regression models. The mean heart rate of preterm neonates in the study group was statistically not significant during the intervention period. However, the application of earplugs improved oxygen saturation levels, increased sleep duration, and enhanced behavioural responses. There was a statistically significant (p<0.05) increase in weight gain during the intervention and similar trends were noted during the 2nd and 4th-week follow-up. It was determined that earplugs were effective in maintaining higher oxygen saturation, increasing sleep duration, enhancing behavioural responses, and were associated with weight gain. Non-invasive, cost-effective noise control measures, such as earplugs, can be recommended to improve physiological parameters like oxygen saturation, sleep duration, behavioural patterns, and weight gain in preterm neonates.
A Randomized Controlled Trial on Investigating the Effectiveness of Earplugs on Physiological and Behavioral Responses and Weight Gain in Preterm Neonates
References:
[1]. Priyali Prakash, 2023, May 13, Explained India recorded maximum preterm births in 2020, findings of WHO report. https://www.thehindu.com/sci-tech/health/article66838513.ece
[2]. The wire staff, 2023, May 11, In 2020, 13 Million Babies Were Born Too Early. India Is Among Top Five Nations Where It Happened'. https://thewire.in/health/in-2020-13-million-babies- were-born-too-early-india-is-among-top-five-nations-where-it-happened
[3]. World Health Organization (WHO), 2018, PretermBirthatwho.int/newsroom/preterm birth.
[4]. Ramani, R. H, Tilakaratne, P, Sukumaran, W.M, Ramasubramanian, Krishnan R. P., 2022, Critical appraisal of different triggering pathways for the pathobiology of pemphigus vulgaris-A review. Oral Dis. 28: 1760–1769. doi:10.1111/odi.13937
[5]. Arti Maria, Swati Upadhyay, Nagaratna Vallomkonda, 2021, Nurturing Beyond The Womb – Early Intervention Practices In Newborn Care Unit. Indian Pediatrics, S-(53).
[6]. Randa El-Sayed Mohammed, Gehan Maher Khamis, Yomn Youssef Sabry. 2018, Effect of preterm neonates' developmental supportive care on nurses performance. IOSR Journal of Nursing and Health Sciences. 7, pp33-45.
[7]. Suzan Salah Al Henawy, Rahma Soliman Bahgat, Abd El Rahman Mohamed Elmashadand Nagafa HafezFarag. 2021, Effect of developmental supportive care training program on nurses’ practice regarding behavioral response of premature neonates. International Journal of Advance Research in Nursing, 216-225
[8]. Abdulraoof Almadhoob, Arne Ohlsson and Cochrane Neonatal Group. 2020, Sound reduction management in the neonatal intensive care unit for preterm or very low birth weight infants. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD010333. pub3.
[9]. Fathma Thahmi Shingeri. Ashvij R. Shriyan, Roshan Ann Maben, Santosh T. Soans, 2020, Randomized control trial evaluating the effectiveness of earplugs in hearing loss in NICU preterm babies. International Journal of Contemporary Pediatrics. 7(4). 914-917. DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20201154
[10]. Sujatha R. Kannappan, Tirikhumla Chang, Jeevitha Alva, 2023, Will Earmuffs Improve Neonate Behavior in The Neonatal Intensive Care Unit? Journal of Health and Allied Sciences. DOI https://doi.org/ 10.1055/s-0043-1771401. ISSN 2582-4287.
[11]. Nasrin Khalesi, Nastaran Khosravi, Azadeh Ranjbar, Zahra Godarzi, Alireza Karimi, 2017, International Journal of Pediatric Otorhinolaryngology. 98,43-47 https://doi.org/10.1016/j.ijporl.2017.04.028
[12]. Eman Moselhi Matar, 2018, Effect of earplugs on the physiological response of preterm infants during a nebulizer session. Egyptian Nursing Journal. 15(3). 324-330DOI:10.4103/ENJ.ENJ_23_18
[13]. Michael J.Balsan, Jeanne Burns, Fred Kimock, Emily Hirsch, Andrew Unger, Richard Telesco et. al. 2021, A pilot study to assess the safety, efficacy and ease of use of a novel hearing protection device for hospitalized neonates. Early Hum Dev. Pubmed.gov. Clinical trial; 156: doi:10.1016/j.earlhumdev.2021.105365.
[14]. Subramaniam, N, Muthukrishnan, A., 2019, Oral mucositis and microbial colonization in oral cancer patients undergoing radiotherapy and chemotherapy: A prospective analysis in a tertiary care dental hospital, J. Investig. Clin. Dent. 10 e12454. https://doi.org/10.1111/jicd.12454.82.https://doi.org/10.1016/j.sleep.2022.01.006
[15]. Abujarir, R.H. Salama, W. Greer, M.A Thani, F. Visda, 2012, The impact of earmuffs on vital signs in the neonatal intensive care unit, JNPM, 5(3)
[16]. Deswinda D., Dini Maulinda, Bayhakki, 2022, The Effect of Earmuff and Earplug Use on Preterm Infants Towards Oxygen Saturation and Pulse. Journal Keperawatan Padjadjaran (JKP)10(1), 8-14. http://dx. doi.org/ 10.24198/jkp.v10i1,E-ISSN: 2442-7276, P-ISSN: 2338-5324
[17]. Abdeyazdan, Z., Ghassemi,S., & Marofi,M. 2014, The effects of earmuff on physiologic and motor responses in premature infants admitted in neonatal intensive care unit. Iran J Nurs Midwifery Res.19(2), 107-12
[18]. Howayda Mohamood Ali, Nagat Farouk Abolwafa, Shadia Abd Elmoniem Syan, 2023, Effect of ear plugs and eye cover on physiological and behavioural responses among preterm neonates in NICU. International Egyptian Journal of Nursing Science & Research.3(2),363-381
[19]. Yojana Parmar, Rajashri Karale, Vaishali Mohite, Prakash Naregal. 2018, A Study to Assess the Impact of Earmuffs on Physiological Parameters in Neonates in Neonatal Intensive Care Unit. International Journal of Health Sciences and Research. 8(9), 115-121 ISSN: 2249-9571
[20]. Amanpreet Kaur, Sukhwinder Kaur, Sanjay Munjal, Sandhya Ghai, Sourabh Dutta. 2021, Effect of Earmuffs on Physiological Parameters of Preterm Neonates Nursed in Incubators: A Before-and-After Study. Indian pediatrics, (58), 943-946
Viewed PDF 3 0 -
A Clinico-Epidemiological Profile of Scrotal Swellings among Adults in a Tertiary Care HospitalAuthor: Samir AhmadDOI: 10.21522/TIJPH.2013.12.04.Art091
A Clinico-Epidemiological Profile of Scrotal Swellings among Adults in a Tertiary Care Hospital
Abstract:
Scrotal swellings are a common clinical presentation among adult males, and they arise from a variety of causes, like infections, trauma, or tumours. This study aimed to examine the clinico-epidemiological profile of adult patients presenting with scrotal swellings at a tertiary care hospital. A cross-sectional study was conducted over one year, involving 194 adult male patients admitted to the Department of General Surgery at Sree Balaji Medical College Hospital. Comprehensive clinical examinations, high-resolution ultrasonography, and, where applicable, surgical interventions were employed to diagnose and treat the cases. The study found that the majority of scrotal swellings were caused by hydrocele (29.4%), followed by orchitis (19.1%), varicocele (14.9%), and spermatocele (13.4%). Surgical intervention was necessary in 71% of the cases, with Jaboulay’s procedure being the most commonly performed. Conservative management was applied in 29% of cases. Postoperative complications were observed in 45.4% of the patients, with scrotal edema being the most frequent complication. Age distribution indicated that the majority of cases (31.4%) occurred in patients aged 39-48 years, with the incidence decreasing in both younger and older age groups. In conclusion, scrotal swellings in adult males present a diverse array of etiologies, with hydrocele being the most prevalent. High-resolution ultrasonography plays a pivotal role in early diagnosis and treatment, minimizing complications and improving patient outcomes. Surgical intervention, when indicated, was effective, though postoperative complications such as scrotal edema require careful management.
A Clinico-Epidemiological Profile of Scrotal Swellings among Adults in a Tertiary Care Hospital
References:
[1]. Kryger, J. V., and Jarosz, S. L., 2018, Acute and chronic scrotal swelling. Nelson Pediatric Symptom-Based Diagnosis, 2018, 330-8.
[2]. Basta, A. M., Courtier, J., Phelps, A., Copp, H. L., and MacKenzie, J.D., 2015, Scrotal swelling in the neonate. Journal of Ultrasound in Medicine, 34(3), 495-505.
[3]. Mahala, M. K., Malviya, S., Malviya, A., Sharma, G., and Bhargava, R., 2020, A clinicopathological study of scrotal swellings in adults. Int J Surg, 4(3), 151-3.
[4]. Kailashnath, B. S., Mohan, A., and Akshatha, A.P., 2022, Clinical study of the management of scrotal swelling in adult patients at a rural medical college and research hospital. International Surgery Journal, 9(9), 1536-9.
[5]. Sosnowska-Sienkiewicz, P., Januszkiewicz-Lewandowska, D. and Mańkowski, P., 2023, Testicular and scrotal abnormalities in pediatric and adult patients. Polish Journal of Surgery, 96(SUPLEMENT 1), 88-96.
[6]. Sieger, N., Di Quilio, F. and Stolzenburg, J. U., 2020, What is beyond testicular torsion and epididymitis? Rare differential diagnoses of acute scrotal pain in adults: A systematic review. Annals of medicine and surgery, 55:265-74.
[7]. Teelin, K. L., Babu, T. M., and Urban, M. A., 2019, Prostatitis, epididymitis, and orchitis: acute scrotal pain. Introduction to Clinical Infectious Diseases: A Problem-Based Approach, 2019, 191-8.
[8]. Greenstein, J., Babson, V., Frisolone, J., Janiszewski, B., Kyvik, S., Mason, B., Paduch, M., Igneri, T., Hahn, B. and D'Antoni, A. V., 2021, Frequency of Urinary Tract Infections, Gonorrhea, and Chlamydia in Emergency Department Patients With Acute Scrotal Pain. Cureus, 2021, Jul;13(7).
[9]. Jensen, C. F. S., Østergren, P., Dupree, J.M., Ohl, D. A., Sønksen, J. and Fode, M., 2017, Varicocele and male infertility. Nature Reviews Urology, 14(9), 523-33.
[10]. Sharp, V. J., Kieran, K. and Arlen, A. M., 2013, Testicular torsion: diagnosis, evaluation, and management. American family physician, 88(12), 835-40.
[11]. Mahmalji, W., Jain, S. and Stower, M., 2011, A rare cause of scrotal swelling: transitional cell carcinoma of the bladder presenting as a testicular metastasis. Advances in urology, 2011(1),284121.
[12]. Patil, V., Shetty, S.M.C. and Das, S., 2015, Common and uncommon presentation of fluid within the scrotal spaces. Ultrasound International Open, 1(02), E34-40.
[13]. Pawar, U. and Gubbi, S., 2021, Clinical evaluation and management of scrotal swelling. International Surgery Journal, 8(12), 3601-5.
[14]. Melkundi, S. S., Patil, S. and Chhabra, S., 2015, Evaluation of testicular lesions, scrotal swellings by high resolution ultrasonography and colour doppler and its correlation with surgical management. Journal of Evolution of Medical and Dental Sciences, 4(104), 16960-5.
[15]. Rathi, R. and Gujjar, R., 2016, Role of high resolution ultrasonography and Color Doppler in scrotal pathology. Indian Journal of Basic and Applied Medical Research, 5(3), 461-5.
[16]. Uribe-Arcila, J. F., Delgado-Montoya, A. and Gaviria-Gil, F., 2020, Etiology of testicular pain 2019, Classification into ten logical subgroups. Revista mexicana de urología, 80(4).
[17]. Baria, D. K., Modi, M. K. P., Chaudhary, J. and Mehta, S., 2023, Study of Ultrasound Evaluation of Scrotal Pain in a Tertiary Care Hospital in Middle Gujarat, India. European Journal of Cardiovascular Medicine, 13(2).
[18]. Bashir, J., Abbasi, M. A., Bhatti, S. G., Khatti, S., Soomro, A. and Ahsan, M. F., 2022, Pattern and diagnosis of solid testicular swellings and it’s management outcome. Pakistan Journal of Medical & Health Sciences, 16(10), 453-.
[19]. Onwuasoanya, U. E., 2022, The role of Inguinal Varicocelectomy in the Treatment of Varicoceles. Asian Journal of Research and Reports in Urology, 5(2), 1-5.
[20]. Sharma, B. B., Aziz, M. R. and Kapur, N., 2020, Epididymo-orchitis Masquerading as Torsion in Scrotal Swelling Case: Radiologist’s Dilemma for the Diagnosis. Clin Case Rep Open Access, 3(2), 149.
[21]. Schechter, M. Y., Van Laecke, E., Spinoi,t A. F., 2022, Scrotal Swelling and Cysts. Normal and Abnormal Scrotum. 2022, 375-88.
[22]. Mehdi, S., Ahmed, M. N., Farhat, D. and Mohsin, M., 2022, Clinicopathological Profile And Management Of Scrotal Swellings in Adults In A Tertiary Care Hospital. JK Practitioner, 1;27.
[23]. Kamble, P. M., Deshpande, A. A., Thapar, V. B. and Das, K., 2015, Large abdominoscrotal hydrocele: Uncommon surgical entity. International journal of surgery case reports, 15:140-2.
[24]. Rambau, P. F., Chandika, A., Chalya, P. L. and Jackson, K., 2011, Scrotal Swelling and Testicular Atrophy due to Schistosomiasis in a 9‐Year‐Old Boy: A Case Report. Case reports in infectious diseases, 2011(1), 787961.
Viewed PDF 2 0 -
Application of Artificial Intelligence (AI) as the Assisting Strategy in the Cardiology DepartmentAuthor: Manju BabyDOI: 10.21522/TIJPH.2013.12.04.Art092
Application of Artificial Intelligence (AI) as the Assisting Strategy in the Cardiology Department
Abstract:
This manuscript explores the application of artificial intelligence (AI) in the cardiology department, highlighting its transformative impact on diagnostics, treatment, and patient management. AI encompasses various methods, including machine learning and deep learning, which enable the analysis of extensive data sets for improved decision-making in clinical practice. The paper discusses how the development of AI technologies that enhance the identification and prediction of cardiovascular diseases, through innovative analytical solutions that offer superior accuracy and speed compared to traditional methods. A significant focus is placed on AI’s capability to swiftly interpret complex ECG patterns, facilitating early diagnosis of life-threatening arrhythmias. Furthermore, the manuscript emphasizes the importance of personalized medicine, wherein AI-driven insights contribute to tailored care plans for individual patients. The strategic integration of AI within cardiology not only enhances the quality of care but also streamlines clinical workflows. By addressing ethical considerations and potential biases, this paper aims to provide a comprehensive overview of the current state and future potential of AI in cardiology, ultimately advocating for its wider implementation to advance patient outcomes in cardiovascular health.
Application of Artificial Intelligence (AI) as the Assisting Strategy in the Cardiology Department
References:
[1]. Harmon, D. M., Mangold, K., Baez Suarez, A., Scott, C. G., Murphree, D. H., Malik, A., Attia, Z. I., Lopez-Jimenez, F., Friedman, P. A., Dispenzieri, A., & Grogan, M. 2023, Post development Performance and Validation of the Artificial Intelligence-Enhanced Electrocardiogram for Detection of Cardiac Amyloidosis. JACC: Advances, 2(8), 100612. https://doi.org/10.1016/j.jacadv.2023.100612
[2]. Williams, R., Anderson, S., Cresswell, K., Kannelønning, M. S., Mozaffar, H., & Yang, X. 2024, Domesticating AI in medical diagnosis. Technology in Society, 76, 102469. https://doi.org/10.1016/j.techsoc.2024.102469
[3]. Huang, K.-C., Huang, C.-S., Su, M.-Y., Hung, C.-L., Ethan Tu, Y.-C., Lin, L.-C., & Hwang, J.-J. 2021, Artificial Intelligence Aids Cardiac Image Quality Assessment for Improving Precision in Strain Measurements. JACC: Cardiovascular Imaging, 14(2), 335–345. https://doi.org/10.1016/j.jcmg.2020.08.034
[4]. Adedinsewo, D. A., Pollak, A. W., Phillips, S. D., Smith, T. L., Svatikova, A., Hayes, S. N., Mulvagh, S. L., Norris, C., Roger, V. L., Noseworthy, P. A., Yao, X., & Carter, R. E. 2022, Cardiovascular Disease Screening in Women: Leveraging Artificial Intelligence and Digital Tools. Circulation Research, 130(4), 673–690. https://doi.org/10.1161/CIRCRESAHA.121.319876
[5]. Alharbi, Y. 2024, Artificial intelligence in cardiology: Present state and prospective directions. Journal of Radiation Research and Applied Sciences, 17(3), 101012. https://doi.org/10.1016/j.jrras.2024.101012
[6]. Attia, Z. I., Harmon, D. M., Behr, E. R., & Friedman, P. A. 2021, Application of artificial intelligence to the electrocardiogram. European Heart Journal, 42(46), 4717–4730. https://doi.org/10.1093/eurheartj/ehab649
[7]. Balloch, J., Sridharan, S., Oldham, G., Wray, J., Gough, P., Robinson, R., Sebire, N. J., Khalil, S., Asgari, E., Tan, C., Taylor, A., & Pimenta, D. 2024, Use of an ambient artificial intelligence tool to improve the quality of clinical documentation. Future Healthcare Journal, 11(3), 100157. https://doi.org/10.1016/j.fhj.2024.100157
[8]. Bahado-Singh, R., Friedman, P., Talbot, C., Aydas, B., Southekal, S., Mishra, N. K., Guda, C., Yilmaz, A., Radhakrishna, U., & Vishweswaraiah, S. 2023, Cell-free DNA in maternal blood and artificial intelligence: Accurate prenatal detection of fetal congenital heart defects. American Journal of Obstetrics and Gynecology, 228(1), 76.e1-76.e10. https://doi.org/10.1016/j.ajog.2022.07.062
[9]. Brendel, J. M., Walterspiel, J., Hagen, F., Kübler, J., Paul, J.-F., Nikolaou, K., Gawaz, M., Greulich, S., Krumm, P., & Winkelmann, M. 2024, Coronary artery disease evaluation during transcatheter aortic valve replacement work-up using photon-counting CT and artificial intelligence. Diagnostic and Interventional Imaging, 105(7–8), 273–280. https://doi.org/10.1016/j.diii.2024.01.010
[10]. Chen, E., Jiang, J., Su, R., Gao, M., Zhu, S., Zhou, J., & Huo, Y. 2020, A new smart wristband equipped with an artificial intelligence algorithm to detect atrial fibrillation. Heart Rhythm, 17(5), 847–853. https://doi.org/10.1016/j.hrthm.2020.01.034
[11]. De Koning, E., Van der Haas, Y., Saguna, S., Stoop, E., Bosch, J., Beeres, S., Schalij, M., & Boogers, M. 2023, AI Algorithm to Predict Acute Coronary Syndrome in Prehospital Cardiac Care: Retrospective Cohort Study. JMIR Cardio, 7, e51375. https://doi.org/10.2196/51375
[12]. Dey, D., Slomka, P. J., Leeson, P., Comaniciu, D., Shrestha, S., Sengupta, P. P., & Marwick, T. H. 2019, Artificial Intelligence in Cardiovascular Imaging. Journal of the American College of Cardiology, 73(11), 1317–1335. https://doi.org/10.1016/j.jacc.2018.12.054
[13]. Echefu, G., Shah, R., Sanchez, Z., Rickards, J., & Brown, S.-A. 2024, Artificial intelligence: Applications in cardio-oncology and potential impact on racial disparities. American Heart Journal Plus: Cardiology Research and Practice, 48, 100479. https://doi.org/10.1016/j.ahjo.2024.100479
[14]. Firima, E., Gonzalez, L., Manthabiseng, M., Bane, M., Lukau, B., Leigh, B., Kaufmann, B. A., Weisser, M., Amstutz, A., Tromp, J., Labhardt, N. D., & Burkard, T. 2024, Implementing focused echocardiography and AI-supported analysis in a population-based survey in Lesotho: Implications for community-based cardiovascular disease care models. Hypertension Research, 47(3), 708–713. https://doi.org/10.1038/s41440-023-01559-6
[15]. Gearhart, A., Dwork, N., & Jone, P.-N. 2022, Artificial intelligence in echocardiography to diagnose congenital heart disease and fetal echocardiography. Intelligence-Based Medicine, 6, 100082. https://doi.org/10.1016/j.ibmed.2022.100082
[16]. Haleem, A., Javaid, M., Singh, R. P., & Suman, R. 2021, Applications of Artificial Intelligence (AI) for cardiology during the COVID-19 pandemic. Sustainable Operations and Computers, 2, 71–78. https://doi.org/10.1016/j.susoc.2021.04.003
[17]. In Kim, Y., Roh, J.-H., Kweon, J., Kwon, H., Chae, J., Park, K., Lee, J.-H., Jeong, J.-O., Kang, D.-Y., Lee, P. H., Ahn, J.-M., Kang, S.-J., Park, D.-W., Lee, S.-W., Lee, C. W. W., Park, S.-J., & Kim, Y.-H. 2024, Artificial intelligence-based quantitative coronary angiography of major vessels using deep-learning. International Journal of Cardiology, 405, 131945. https://doi.org/10.1016/j.ijcard.2024.131945
[18]. Johnson, K. W., Torres Soto, J., Glicksberg, B. S., Shameer, K., Miotto, R., Ali, M., Ashley, E., & Dudley, J. T. 2018, Artificial Intelligence in Cardiology. Journal of the American College of Cardiology, 71(23), 2668–2679. https://doi.org/10.1016/j.jacc.2018.03.521
[19]. Wang, Y.-R., Yang, K., Wen, Y., Wang, P., Hu, Y., Lai, Y., Wang, Y., Zhao, K., Tang, S., Zhang, A., Zhan, H., Lu, M., Chen, X., Yang, S., Dong, Z., Wang, Y., Liu, H., Zhao, L., Huang, L., … Zhao, S. 2024, Screening and diagnosis of cardiovascular disease using artificial intelligence-enabled cardiac magnetic resonance imaging. Nature Medicine, 30(5), 1471–1480. https://doi.org/10.1038/s41591-024-02971-2
[20]. Jones, L. K., Gidding, S. S., Santos, R. D., Libby, P., Watts, G. F., & Sarkies, M. N. 2024, Application of implementation science for improving the utilization of an international clinical practice guidance on familial hypercholesterolemia. Journal of Clinical Lipidology, 18(4), e525–e536. https://doi.org/10.1016/j.jacl.2024.03.010
[21]. Kassem, K., Sperti, M., Cavallo, A., Vergani, A. M., Fassino, D., Moz, M., Liscio, A., Banali, R., Dahlweid, M., Benetti, L., Bruno, F., Gallone, G., De Filippo, O., Iannaccone, M., D’Ascenzo, F., De Ferrari, G. M., Morbiducci, U., Della Valle, E., & Deriu, M. A. 2024, An innovative artificial intelligence-based method to compress complex models into explainable, model-agnostic and reduced decision support systems with application to healthcare (NEAR). Artificial Intelligence in Medicine, 151, 102841. https://doi.org/10.1016/j.artmed.2024.102841
[22]. Liu, C.-M., Shih, E. S. C., Chen, J.-Y., Huang, C.-H., Wu, I.-C., Chen, P.-F., Higa, S., Yagi, N., Hu, Y.-F., Hwang, M.-J., & Chen, S.-A. 2022, Artificial Intelligence-Enabled Electrocardiogram Improves the Diagnosis and Prediction of Mortality in Patients With Pulmonary Hypertension. JACC: Asia, 2(3), 258–270. https://doi.org/10.1016/j.jacasi.2022.02.008
[23]. Lin, F., Zhang, P., Chen, Y., Liu, Y., Li, D., Tan, L., Wang, Y., Wang, D. W., Yang, X., Ma, F., & Li, Q. 2024, Artificial-intelligence-based risk prediction and mechanism discovery for atrial fibrillation using heartbeat-to-beat intervals. Med, 5(5), 414-431.e5. https://doi.org/10.1016/j.medj.2024.02.006
[24]. Kirchner, J., Gerçek, M., Gesch, J., Omran, H., Friedrichs, K., Rudolph, F., Ivannikova, M., Rossnagel, T., Piran, M., Pfister, R., Blanke, P., Rudolph, V., & Rudolph, T. K. 2024, Artificial intelligence-analyzed computed tomography in patients undergoing transcatheter tricuspid valve repair. International Journal of Cardiology, 411, 132233. https://doi.org/10.1016/j.ijcard.2024.132233
[25]. Krishna, H., Desai, K., Slostad, B., Bhayani, S., Arnold, J. H., Ouwerkerk, W., Hummel, Y., Lam, C. S. P., Ezekowitz, J., Frost, M., Jiang, Z., Equilbec, C., Twing, A., Pellikka, P. A., Frazin, L., & Kansal, M. 2023, Fully Automated Artificial Intelligence Assessment of Aortic Stenosis by Echocardiography. Journal of the American Society of Echocardiography, 36(7), 769–777. https://doi.org/10.1016/j.echo.2023.03.008
[26]. Krittanawong, C., Johnson, K. W., Choi, E., Kaplin, S., Venner, E., Murugan, M., Wang, Z., Glicksberg, B. S., Amos, C. I., Schatz, M. C., & Tang, W. H. W. 2022, Artificial Intelligence and Cardiovascular Genetics. Life, 12(2), 279. https://doi.org/10.3390/life12020279
[27]. Krittanawong, C., Zhang, H., Wang, Z., Aydar, M., & Kitai, T. 2017, Artificial Intelligence in Precision Cardiovascular Medicine. Journal of the American College of Cardiology, 69(21), 2657–2664. https://doi.org/10.1016/j.jacc.2017.03.571
[28]. Ledziński, Ł., & Grześk, G. 2023, Artificial Intelligence Technologies in Cardiology. Journal of Cardiovascular Development and Disease, 10(5), 202. https://doi.org/10.3390/jcdd10050202
[29]. Vrudhula, A., Stern, L., Cheng, P. C., Ricchiuto, P., Daluwatte, C., Witteles, R., Patel, J., & Ouyang, D. 2024, Impact of Case and Control Selection on Training Artificial Intelligence Screening of Cardiac Amyloidosis. JACC: Advances, 3(9), 100998. https://doi.org/10.1016/j.jacadv.2024.100998
[30]. Wang, H., Zu, Q., Lu, M., Chen, R., Yang, Z., Gao, Y., & Ding, J. 2022, Application of Medical Knowledge Graphs in Cardiology and Cardiovascular Medicine: A Brief Literature Review. Advances in Therapy, 39(9), 4052–4060. https://doi.org/10.1007/s12325-022-02254-7
[31]. Li, F., Bi, Z., Xu, H., Shi, Y., Duan, N., & Li, Z. 2023, Design and implementation of a smart Internet of Things chest pain center based on deep learning. Mathematical Biosciences and Engineering, 20(10), 18987–19011. https://doi.org/10.3934/mbe.2023840
[32]. Matthiesen, S., Diederichsen, S. Z., Hansen, M. K. H., Villumsen, C., Lassen, M. C. H., Jacobsen, P. K., Risum, N., Winkel, B. G., Philbert, B. T., Svendsen, J. H., & Andersen, T. O. 2021, Clinician Reimplementation Perspectives of a Decision-Support Tool for the Prediction of Cardiac Arrhythmia Based on Machine Learning: Near-Live Feasibility and Qualitative Study. JMIR Human Factors, 8(4), e26964. https://doi.org/10.2196/26964
[33]. Lin, C., Chen, C.-C., Chau, T., Lin, C.-S., Tsai, S.-H., Lee, D.-J., Lee, C.-C., Shang, H.-S., & Lin, S.-H. 2022, Artificial intelligence-enabled electrocardiography identifies severe dyscalcemias and has prognostic value. Clinica Chimica Acta, 536, 126–134. https://doi.org/10.1016/j.cca.2022.09.021
[34]. Moualla, S. K., McCarthy, P. M., Thomas, J. D., Dobbles, M., Petrescu, O. M., Loper, T., Barnhart, G. R., & Brennan, J. M. 2022, The artificial intelligence-enabled predictive model of progression from moderate to severe aortic stenosis. Intelligence-Based Medicine, 6, 100062. https://doi.org/10.1016/j.ibmed.2022.100062
[35]. Van Tongeren, O. L. R. M., Vanmaele, A., Rastogi, V., Hoeks, S. E., Verhagen, H. J. M., & De Bruin, J. L. 2024, Volume Measurements for Surveillance after Endovascular Aneurysm Repair using Artificial Intelligence. European Journal of Vascular and Endovascular Surgery, S1078588424007883. https://doi.org/10.1016/j.ejvs.2024.08.045
[36]. Vandenberk, B., Chew, D. S., Prasana, D., Gupta, S., & Exner, D. V. 2023, Successes and challenges of artificial intelligence in cardiology. Frontiers in Digital Health, 5, 1201392. https://doi.org/10.3389/fdgth.2023.1201392
[37]. Oikonomou, E. K., & Khera, R. 2024, Designing medical artificial intelligence systems for global use: Focus on interoperability, scalability, and accessibility. Hellenic Journal of Cardiology, S1109966624001581. https://doi.org/10.1016/j.hjc.2024.07.003
[38]. Samant, S., Bakhos, J. J., Wu, W., Zhao, S., Kassab, G. S., Khan, B., Panagopoulos, A., Makadia, J., Oguz, U. M., Banga, A., Fayaz, M., Glass, W., Chiastra, C., Burzotta, F., LaDisa, J. F., Iaizzo, P., Murasato, Y., Dubini, G., Migliavacca, F., … Chatzizisis, Y. S. 2023, Artificial Intelligence, Computational Simulations, and Extended Reality in Cardiovascular Interventions. JACC: Cardiovascular Interventions, 16(20), 2479–2497 https://doi.org/10.1016/j.jcin.2023.07.022
[39]. Schepart, A., Burton, A., Durkin, L., Fuller, A., Charap, E., Bhambri, R., & Ahmad, F. S. 2023, Artificial intelligence-enabled tools in cardiovascular medicine: A survey of current use, perceptions, and challenges. Cardiovascular Digital Health Journal, 4(3), 101–110. https://doi.org/10.1016/j.cvdhj.2023.04.003
[40]. Toprak, B., Solleder, H., Di Carluccio, E., Greenslade, J. H., Parsonage, W. A., Schulz, K., Cullen, L., Apple, F. S., Ziegler, A., Blankenberg, S., Stephensen, L., Brownlee, E., McCormick, E., Fincher, G., Hall, E. J., Hancock, R., Gaikwad, N., Gangathimmaiah, V., Hamilton-Craig, C., … Then, M. 2024, Diagnostic accuracy of a machine learning algorithm using point-of-care high-sensitivity cardiac troponin I for rapid rule-out of myocardial infarction: A retrospective study. The Lancet Digital Health, 6(10), e729–e738. https://doi.org/10.1016/S2589-7500(24)00191-2
[41]. Otaki, Y., Singh, A., Kavanagh, P., Miller, R. J. H., Parekh, T., Tamarappoo, B. K., Sharir, T., Einstein, A. J., Fish, M. B., Ruddy, T. D., Kaufmann, P. A., Sinusas, A. J., Miller, E. J., Bateman, T. M., Dorbala, S., Di Carli, M., Cadet, S., Liang, J. X., Dey, D., … Slomka, P. J. 2022, Clinical Deployment of Explainable Artificial Intelligence of SPECT for Diagnosis of Coronary Artery Disease. JACC: Cardiovascular Imaging, 15(6), 1091–1102. https://doi.org/10.1016/j.jcmg.2021.04.030
[42]. Soh, C. H., Wright, L., Baumann, A., Seidel, B., Yu, C., Nolan, M., Mylius, T., & Marwick, T. H. 2024, Use of artificial intelligence‐guided echocardiography to detect cardiac dysfunction and heart valve disease in rural and remote areas: Rationale and design of the AGILE‐echo trial. American Heart Journal, 277, 11–19. https://doi.org/10.1016/j.ahj.2024.08.004
[43]. Spielvogel, C. P., Haberl, D., Mascherbauer, K., Ning, J., Kluge, K., Traub-Weidinger, T., Davies, R. H., Pierce, I., Patel, K., Nakuz, T., Göllner, A., Amereller, D., Starace, M., Monaci, A., Weber, M., Li, X., Haug, A. R., Calabretta, R., Ma, X., … Nitsche, C. 2024, Diagnosis and prognosis of abnormal cardiac scintigraphy uptake suggestive of cardiac amyloidosis using artificial intelligence: A retrospective, international, multicentre, cross-tracer development and validation study. The Lancet Digital Health, 6(4), e251–e260. https://doi.org/10.1016/S2589-7500(23)00265-0
[44]. Strom, J. B., Playford, D., Stewart, S., & Strange, G. 2024, An Artificial Intelligence Algorithm for Detection of Severe Aortic Stenosis. JACC: Advances, 3(9), 101176. https://doi.org/10.1016/j.jacadv.2024.101176
[45]. Palmieri, V., Montisci, A., Vietri, M. T., Colombo, P. C., Sala, S., Maiello, C., Coscioni, E., Donatelli, F., & Napoli, C. 2023, Artificial intelligence, big data, and heart transplantation: Actualities. International Journal of Medical Informatics, 176, 105110. https://doi.org/10.1016/j.ijmedinf.2023.105110
[46]. Schuuring, M. J., Išgum, I., Cosyns, B., Chamuleau, S. A. J., & Bouma, B. J. 2021, Routine Echocardiography and Artificial Intelligence Solutions. Frontiers in Cardiovascular Medicine, 8, 648877. https://doi.org/10.3389/fcvm.2021.648877
[47]. Shaffer, B. C., Brown, S., Chinapen, S., Mangold, K. E., Lahoud, O., Lopez-Jimenez, F., Schaffer, W., Liu, J., Giralt, S., Devlin, S., Shah, G., Scordo, M., Papadopoulos, E., Landau, H., Usmani, S., Perales, M.-A., Friedman, P. A., Gersh, B. J., Attia, I. Z., … Kosmidou, I. 2024, Artificial intelligence-enabled interpretation of ECG images to predict hematopoietic cell transplantation toxicity. Blood Advances, 8(21), 5603–5611. https://doi.org/10.1182/bloodadvances.2024013636
[48]. Rushlow, D. R., Croghan, I. T., Inselman, J. W., Thacher, T. D., Friedman, P. A., Yao, X., Pellikka, P. A., Lopez-Jimenez, F., Bernard, M. E., Barry, B. A., Attia, I. Z., Misra, A., Foss, R. M., Molling, P. E., Rosas, S. L., & Noseworthy, P. A. 2022, Clinician Adoption of an Artificial Intelligence Algorithm to Detect Left Ventricular Systolic Dysfunction in Primary Care. Mayo Clinic Proceedings, 97(11), 2076–2085. https://doi.org/10.1016/j.mayocp.2022.04.008
[49]. Salem, M., Gada, H., Ramlawi, B., Sotelo, M., Nona, P., Wagner, L., Rogers, C., Brigman, L., & Vora, A. N. 2024, Predictors of Disease Progression and Adverse Clinical Outcomes in Patients with Moderate Aortic Stenosis Using an Artificial Intelligence-Based Software Platform. The American Journal of Cardiology, 223, 92–99. https://doi.org/10.1016/j.amjcard.2024.04.051
[50]. Sveric, K. M., Ulbrich, S., Dindane, Z., Winkler, A., Botan, R., Mierke, J., Trausch, A., Heidrich, F., & Linke, A. 2024, Improved assessment of left ventricular ejection fraction using artificial intelligence in echocardiography: A comparative analysis with cardiac magnetic resonance imaging. International Journal of Cardiology, 394, 131383. https://doi.org/10.1016/j.ijcard.2023.131383
[51]. Brown, S.-A. 2022, Introduction to “Artificial intelligence and health informatics in learning health systems in cardio-oncology.” American Heart Journal Plus: Cardiology Research and Practice, 18, 100156. https://doi.org/10.1016/j.ahjo.2022.100156
[52]. Jasani, M. 2024, AI in Healthcare: A Complete List of the Latest Statistics. Retrieved from: https://www.excellentwebworld.com/ai-in-healthcare-statistics/
[53]. Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 2021, 372: n71. doi: 10.1136/bmj. n71.
Viewed PDF 3 0 -
Supportive Supervision of Routine Immunization Service Providers, A Means to Improve Vaccine Cold Chain Management Practices in Sokoto StateAuthor: Zubair Abdulkarim IsahDOI: 10.21522/TIJPH.2013.12.04.Art093
Supportive Supervision of Routine Immunization Service Providers, A Means to Improve Vaccine Cold Chain Management Practices in Sokoto State
Abstract:
Integral to the Expanded Program on Immunization, is the Vaccine cold chain system which is used for storing, transporting, and distributing vaccines and other biologicals in recommended temperatures until they reach beneficiaries, a chain that must not be broken for vaccine to retain their potency. The success of national immunization programmes depends largely on effective logistics management of the vaccine cold chain system. This study has investigated the dependence of supportive supervision and attendance of Vaccine management-related training on the vaccine cold chain management practices of RI Service providers in Sokoto state. A descriptive cross-sectional study design was employed 230 equipped health facilities were sampled, and results were analyzed which revealed a positive correlation between supportive supervision and better vaccine management practices amongst routine immunization service providers, with a recommendation to the State Ministry of Health to invest in capacity building and refresher training of Routine immunization service providers and take ownership of supportive supervision.
Supportive Supervision of Routine Immunization Service Providers, A Means to Improve Vaccine Cold Chain Management Practices in Sokoto State
References:
[1]. Shattock, A. J., Helen C. J., So, Y. S., Austin, C., Philipp, L., Raymond, C., Andrew, J., Hutubessy, K. M., Kamran, B., et al., 2024, Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization, The Lancet, Volume 403, Issue 10441, 2307 – 2316, May 25, 2024.
[2]. Feyisa, D., 2021, Cold chain maintenance and vaccine stock management practices at public health centers providing child immunization services in Jimma Zone, Oromia Regional State, Ethiopia: Multi-centered, mixed method approach. Pediatr Heal Med Ther. 2021, 12: 359–72.
[3]. UNICEF and WHO, 2016, Achieving immunization targets with the comprehensive effective vaccine management (EVM) framework. WHO/UNICEF joint statement, (2016).
[4]. World Health Organization, 2015, Immunization in practice; module 2. A practical guide for health staff 2015, update. Available at: https://apps.who.int/iris/bitstream/ handle/10665/193412/9789241549097_eng.pdf/
[5]. World Health Organization, 2022, History of vaccination/a brief history of vaccination. Available at: https://apps.who.int/immunization_standards/vaccine_quality/pqs_ catalogue/catdocumentation.aspx?id_cat=35/
[6]. Centers for Disease Control and Prevention, 2023, CDC 24/7: Saving lives protecting People. Healthcare providers/professionals/providers home/administration tools/Vaccine Storage & Handling. Vaccine Storage & Handling Toolkit. Available at: https://www.cdc.gov/vaccines/hcp/admin/storage/toolkit/index.html
[7]. Princeton. B, Santhakumar. P, Prathap, L., 2020, Awareness on preventive measures taken by health care professionals attending COVID-19 patients among dental students. Eur J Dent. 14: S105–S109. doi:10.1055/s-0040-1721296
[8]. Lloyd, J. and Cheyne, J., 2017, The origins of the vaccine cold chain and a glimpse of the future, Journal of Vaccine, 35, 2115–2120 http://dx.doi.org/10.1016/j.vaccine.2016.11.097 0264-410X/ 2017 Published by Elsevier Ltd.
[9]. Sharma, L., Gupta, G., Kapuria, B., Singh, S. K., Gupta, S. and Agarwal, M. K., 2022, Strengthening the Immunization supply chain through EVM assessment: Comparing India’s two successive national assessments. J Family Med Prim Care 2022; 11: 5298-304.
[10]. Oluwafunmilayo, O. I., Ayobami, O. A., Caroline, A. B., Tope, M. I., Demilade, O. I., et al. 2024, Effect of integrated supportive supervision on availability of resources for health care service delivery and uptake of services in Ekiti State, Southwest Nigeria, evidence from the Saving One Million Lives program for result supported facilities. Pan African Medical Journal. 2024; 47(45), 10.11604/pamj.2024.47.45.34291 Available online at: https://www.panafrican-med-journal.com//content/article/47/45/full
[11]. Kruk, M. E., Porignon, D., Rockers, P. C. and Van-Lerberghe, W., 2010, The contribution of primary care to health and health systems in low- and middle-income countries: a critical review of major primary care initiatives. Soc Sci Med. 2010, Mar;70(6), 904-11. PubMed | Google Scholar.
[12]. Friedberg, M. W., Hussey, P. S. and Schneider, E. C., 2010, Primary care: a critical review of the evidence on quality and costs of health care. Health Aff (Millwood). 2010, May;29(5), 766-72. PubMed | Google Scholar.
[13]. Bailey, C., Blake, C., Schriver, M., Cubaka, V. K., Thomas, T. and Martin H. A., 2016, A systematic review of supportive supervision as a strategy to improve primary healthcare services in sub-Saharan Africa. Int Journal of Gynaecol. Obstet. 2016, Jan;132(1), 117-25. PubMed | Google Scholar.
[14]. Flahault, D., Piot, M. and Franklin A., 1988, World Health Organization. The supervision of health personnel at district level. Geneva; WHO. Google Scholar.
[15]. Bradley, S., Kamwendo, F., Masanja, H., Pinho, H., Waxman, R., Boostrom, C., et al. 2013, District Health managers´ perceptions of supervision in Malawi and Tanzania. Hum Resour Health. 2013, Sep 5; 11:43. PubMed | Google Scholar.
[16]. Ifeoluwapo, O.K., 2018, Supportive Supervision: A Tool for Creating Healthy Work Environment for Nurses International journal of Sciences, Volume 7 – October 2018 (10), http://www.ijSciences.com
[17]. World Health Organization, 2015, Supportive supervision: meeting of the implementation task force on supportive supervision. Geneva. 2(1), 15-17.
[18]. Program for Appropriate Technology in Health, 2013, Guidelines for implementing supportive supervision: a step by-step guide with tools to support immunization. Seatle: PATH (2013).
[19]. WHO MLM, 2008, Training for Mid-level managers (MLM). Module 4: supportive supervision. Geneva: World Health Organization; 2008, republished 2020 under the licence: CC BY-NC-SA 3.0 IGO.
[20]. Coyle, C., Aine, T., Mary, C., Damen, H., and Frédérique, V. 2022, Supportive Supervision for Community Health Workers: A Systems-Thinking Approach', (Oxford, 2022; online edn, Oxford Academic, 17 Nov. 2022), https://doi.org/10.1093/oso/9780198799498.003.0004, accessed 29 Oct. 2024.
[21]. Ergetie, F. S., Kassaw, A. T., and Sendekie, A. K. 2023, Vaccine cold chain management practices in primary health centers providing an expanded immunization program in Northwest Ethiopia: self-reported and actual practice observational study. Front. Public Health 11:1194807. doi: 10.3389/fpubh.2023.1194807.
[22]. Anand, P. S, Jadhav, P, Kamath, K.P, Kumar, S. R, Vijayalaxmi, S, Anil S., 2022, A case-control study on the association between periodontitis and coronavirus disease (COVID-19). J Periodontol. ;93: 584–590. doi:10.1002/JPER.21-0272.
[23]. Steinhardt, L. C., Onikpo, F., Kouamé, J., Piercefield, E., Lama, M, Deming, M. S., et al., 2015, Predictors of health worker performance after integrated management of childhood illness training in Benin: A cohort study. BMC Health Serv Res. 2015; 15:276. https://doi.org/10.1186/s12913-015-0910-4
Viewed PDF 3 1 -
Vaccine Cold Chain Management Practices among Routine Immunization Service Providers in Sokoto StateAuthor: Zubair Abdulkarim IsahDOI: 10.21522/TIJPH.2013.12.04.Art089
Vaccine Cold Chain Management Practices among Routine Immunization Service Providers in Sokoto State
Abstract:
Immunization is a cornerstone of public health policy and is demonstrably highly cost-effective when used to protect child health. Vaccines have transformed today’s public health system. The potency and effectiveness of vaccines lie primarily in their handling and cold chain management systems. The success of national immunization programmes depends largely on effective logistics management of the vaccine cold chain system. The novelty of this study is to thoroughly explore the Vaccine Cold Chain management practices among Routine Immunization service providers in Sokoto State and find interrelationships between the determinants. A descriptive cross-sectional study design was employed and 230 equipped health facilities were sampled, where facility-based, mixed self-reported and actual practice evaluations were made; Analysis of the results by Chi-square test revealed the level of education, years of experience, Attendance of Vaccine Cold chain management related trainings, supportive supervision of RI Service provider determined their Vaccine cold chain management practices. According to the study, Routine Immunization Service providers need to be re-trained periodically in Vaccine cold chain management to keep them in tune with the most recent information for optimal service delivery, The health facility in charge provides the needed oversight on Routine Immunization service providers; and Supportive supervision to be prioritized and owned by the State.
Vaccine Cold Chain Management Practices among Routine Immunization Service Providers in Sokoto State
References:
[1]. World Health Organization, 2023, WHO Recommendations for Routine Immunization – Summary tables.https://www.who.int/immunization/policy/immunization_tables/en/
[2]. World Health Organization, 2020, WHO Director-General’s opening remarks at the media briefing on COVID-19-5 March 2020, https://www.who.int/dg/speeches/detail/ who-director-general-s-opening-remarks at-the-media-briefing-on-covid-19—5-march-2020.
[3]. Bekker, L. G., Tatoud, R., Dabis, F., Feinberg, M., Kaleebu, P. and Marovich, M., 2020, The complex challenges of HIV vaccine development require renewed and expanded global commitment. 2020, Lancet 395, 384–388 2020.
[4]. Matz, K. M., Marzi, A. and Feldmann, H. 2019, Ebola vaccine trials: Progress in vaccine safety and immunogenicity. Expert Rev. Vaccines 18, 1229–1242 2019.
[5]. Pawelec, G. 2018, Age and immunity: what is “immunosenescence”? Exp. Gerontol. 105, 4–9
[6]. World Health Organization, 1998, Strategic Plan 1998–2001. First edition. Global Programme for Vaccines and Immunization, editor. Geneva: WHO; 1998. https:// apps. who. int/ iris/ bitst ream/ handle/ 10665/ 65204/ WHO_GPV_98. 04. pdf; jsessionid= B151A A1E1B 5021A 2F8D4894DA 6CC0B B6? sequence=1
[7]. White, J.A., Estrada, M., Weldon, W.C., Chumakov, K., Kouiavskaia, D., Fournier-Caruana, J. 2018, Assessing the potency and immunogenicity of inactivated poliovirus vaccine after exposure to freezing temperatures. Biologicals. 2018, 53:30–8.
[8]. Siddique, R, Nivedhitha, M.S, Jacob, B., 2019, Quantitative analysis for detection of toxic elements in various irrigants, their combination (precipitate), and para-chloroaniline: An inductively coupled plasma mass spectrometry study. Jn. Conserv Dent. 22: 344–350. doi:10.4103/JCD.JCD_95_19ns/files/TS_vaccine_stabi lity_table.Pdf
[9]. United Nations Children’s Fund and World Health Organization, (UNICEF and WHO, 2016). Achieving immunization targets with the comprehensive effective vaccine management (EVM) framework. WHO/UNICEF joint statement, 2016.
[10]. World Health Organization, 2015, Immunization in practice; Module 2. A practical guide for health staff apps.who.int/iris/bitstream/handle/10665/193412/9789241549097_eng.pdf/.
[11]. World Health Organization, 2022, Supply chain. https://www.who.int/teams/maternal‑newborn‑child‑adolescent‑health‑and‑ageing/ maternal‑ Health/about/essential-programme-on‑immunization
[12]. Centers for Disease Control and Prevention, CDC, 2022, Saving lives protecting People. Healthcare providers/professionals/providers home/administration tools/Vaccine Storage and Handling Toolkit. https://www.cdc.gov/vaccines/hcp/admin/storage/toolkit/index
[13]. Aparna, J, Maiti, S, Jessy P., 2021, Polyether ether ketone - As an alternative biomaterial for Metal Richmond crown-3-dimensional finite element analysis. J Conserv Dent. 24: 553–557. doi:10.4103/jcd.jcd_638_20
[14]. Bamakan, S.M.H., Moghaddam, S.G. and Manshadi, S.D., 2021, Blockchain-enabled pharmaceutical cold chain: applications, key challenges, and future trends. Journal of Cleaner Production, Vol. 302, pp.127021
[15]. Zaffran, M., Vandelaer, J., Kristensen, D., Melgaard, B., Yadav, P. and Antwi-Agyei K.O., 2012, The imperative for stronger vaccine supply and logistics systems. Vaccine 2013;31(suppl 2). doi: http://dx.doi.org/10.1016/, Journal of Vaccine. 2012,11.036.
[16]. U.S Department of Health and Human Services, 2014, Vaccine Cold Chain. Vaccine Storage and Handling Kit; 2014: 11. Accessed 05/10/2023. Google Scholar.
[17]. Esohe, O., Vivian, O., Oisedebame, O. and Ofure, J., 2017, Cold chain management practices of health care workers in primary health care facilities in Southern Nigeria, Pan African Medical Journal. 2017;27:34. doi:10.11604/pamj.2017.27.34.11946.
[18]. Lin, Q., Zhao, Q., and Lev, B. 2020, Cold chain transportation decision in the vaccine supply chain. Eur J Oper Res. 2020, 283, 182–95.
[19]. Princeton, B, Santhakumar, P, Prathap, L., 2020, Awareness on preventive measures taken by health care professionals attending COVID-19 patients among dental students. Eur J Dent. 14: S105–S109.
[20]. Ergetie, F.S., Kassaw, A.T. and Sendekie, A.K., 2023, Vaccine cold chain management practices in primary health centres providing an expanded immunization program in Northwest Ethiopia: self-reported and actual practice observational study. Front. Public Health 11, 1194807. doi: 10.3389/fpubh.2023.1194807.
[21]. United States Agency for International Development, USAID, 2017, Bauchi and Sokoto CECA/Gender Analysis, USAID/Northern Education Initiative Plus Contracted Under AID-620-A-15-00002.
Nestory, B., Mackfallen, A., Jean, B. and Domina, A. 2022, Vaccine management practices among healthcare workers in Morogoro, Tanzania: a cross-sectional study, Journal of Pharmaceutical Policy and Practice (2022) 15:95 https://doi.org/10.1186/s40545-022
Viewed PDF 3 1 -
Comparative Study to Assess the Bisap Score vs Ranson Score in Predicting Mortality among Acute PancreatitisAuthor: Karpagam K.DOI: 10.21522/TIJPH.2013.12.04.Art090
Comparative Study to Assess the Bisap Score vs Ranson Score in Predicting Mortality among Acute Pancreatitis
Abstract:
The upper abdomen contains the pancreas. It performs endocrine and exocrine tasks. The exocrine system secretes chemicals into the environment; this includes hormones secreted from excretory ducts and pancreatic enzymes secreted into the gastrointestinal (GI) tract via the pancreatic duct. The hormonal processes internal secretion; and pancreatic duct hormone secretion, which involves the direct bloodstream release of somatostatin, glucagon, and insulin. Clinical, pathologic, biochemical, and bacteriologic data relate to four entities in acute pancreatitis: necrotizing pancreatitis, interstitial edematous pancreatitis, pancreatic pseudocyst, pancreatic abscess, pancreatic parenchymal necrosis, extrapancreatic retroperitoneal fatty tissue necrosis, biologically active substances in pancreatic ascites, and infection of necrosis. Severe complications account for over 80% of fatalities. The purpose of the study is to compare the predictive power of the BISAP score and the Ranson score for acute pancreatitis mortality. Objects are as follows to evaluate patients with acute pancreatitis based on their BISAP and Ranson scores. To contrast the BISAP rating and the RANSON score in individuals with acute pancreatitis. To correlate certain demographic characteristics with the BISAP and RANSON scores of patients with acute pancreatitis. For this study, a quantitative research methodology was applied. The present study employs an evaluative research approach. In this study, a descriptive research design was employed. The study was carried out at Saveetha Medical College and Hospital. Based on the inclusion criteria, a convenience sample methodology was used to recruit a total of 30 study participants. A self-structured questionnaire method was used to collect the demographic data, according to the study's findings, the RANSON score has a higher mortality prediction than the BISAP score.
Comparative Study to Assess the Bisap Score vs Ranson Score in Predicting Mortality among Acute Pancreatitis
References:
[1]. Bhupinder Singh Walia, et al., 2022, Evaluation of acute pancreatitis based on BISAP scoring system: A cohort study of 50 cases. Sciendo, Volume & Issue: Volume 22(3), https://sciendo.com/article/10.2478/acm-2022-0016
[2]. Gao W, Yang H-X, Ma C-E., 2015, The Value of BISAP Score for Predicting Mortality and Severity in Acute Pancreatitis: https://pubmed.ncbi.nlm.nih.gov/26091293/
[3]. Jingoniya NK, Yadav BL, Verma PK, Bansal S, Gupta S., 2022. Comparative evaluation of BISAP score and computed tomography severity index as a predictor for severity of acute pancreatitis. Intenational Surgery Journal Volume 9(2), 421-425: https://www.ijsurgery.com/index.php/isj/article/view/8086
[4]. Jitin Yadav, et al., 2016, Predicting morbidity and mortality in acute pancreatitis in an Indian population: a comparative study of the BISAP score, Ranson’s score and CT severity index. Gastroenterology Report, 4(3), 216–220. doi: 10.1093/gastro/gov009. Epub 2015 Mar 2: https://pubmed.ncbi.nlm.nih.gov/25733696/
[5]. Kantly, R., Medikeri, A., 2018, Study on severity assessment of acute pancreatitis using BISAP score in rural area of south India. IntSurgJ; 5:2777-81. DOI:10.18203/2349-2902.isj20182997.
[6]. Lifen Chen, Guomin Lu, Qunyan Zhou, Qiang Zhan, 2013, Evaluation of the BISAP Score in Predicting Severity and Prognoses of Acute Pancreatitis in Chinese Patients. IntSurg; 98:6–12. doi: 10.9738/0020-8868-98.1.6.
[7]. Lixin Yang, et al., 2016, Comparison of BISAP, Ranson, MCTSI, and APACHE II in Predicting Severity and Prognoses of Hyperlipidemic Acute Pancreatitis in Chinese Patients:2016, 1834256. doi:10.1155/2016/1834256.
[8]. Murat ÖzgürKılıc, et al., 2017, Correlation between Ranson score and red cell distribution width in acute pancreatitis. UlusTravmaAcilCerrahiDerg, Vol. 23(2), DOI: 10.5505/tjtes.2016.27895.
[9]. ShandanaTarique, ShahidSarwar and Farrukh Iqbal., 2003, Validity of Ranson's Score for Predicting Mortality and Morbidity in Acute Pancreatitis. ProceedingS.Z.P.G.M.l. vol: 17(2), pp. 67-70.
[10]. Singh, R. K., Shakya, P., Kumar A., 2020, A Comparative study between bedside index of severity in acute pancreatitis (BISAP) and Ranson’s score in predicting severity of acute pancreatitis in correlation with computerized tomography scan in Kumaun region. International Journal of Research and Review. 7(4), 256-264.
[11]. Singh V. K., Bollen T. L., Wu BU, Repas K., Maurer R., Yu S, et al. 2011, An assessment of the severity of interstitial pancreatitis. Clinical Gastroenterology and Hepatology: the Official Clinical Practice Journal of the American Gastroenterological Association. 9(12), 1098–103. doi: 10.1016/j.cgh.2011.08.026 PMID: 21893128.
[12]. Sudarshan N., NarasimhaSwamy., 2021, Assessment of severity of acute pancreatitis with bedside index for severity in acute pancreatitis (BISAP) score. IP J Surg Allied Sci; 3(1), 13-17.
[13]. Sumitra Hagjer, Nitesh Kumar, 2018, Evaluation of the BISAP scoring system in prognostication of acute pancreatitis – A prospective observational study. International Journal of Surgery, Volume 54, Part A, Pages 76-81.
[14]. Venkatapuram, M. R., Sateesh, S., Batchu, D., 2018, A prospective study of BISAP score in assessing severity of acute pancreatitis. Int SurgJ; 5:1785-91. DOI: http://dx.doi.org/10.18203/2349-2902.isj20181571
[15]. Wu BU, Johannes R. S., Sun X., Tabak Y., Conwell D. L., Banks PA., 2008, The early prediction of mortality in acute pancreatitis: a large population-based study. Gut. 57(12), 1698–703. doi: 10.1136/gut.2008.152702 PMID: 18519429.
[16]. Xu Yin, et al., 2022, The Value of RANSON Score Combined with BMI in Predicting the Mortality in Severe Acute Pancreatitis: A Retrospective Study. International Journal of General Medicine: 15, 5015–5025.
[17]. Papachristou, G. I., Muddana, V., Yadav, D., O’Connell, M., Sanders, M. K., Slivka, A., & Whitcomb, D. C. 2010, Comparison of BISAP, Ranson's, APACHE-II, and CTSI scores in predicting organ failure, complications, and mortality in acute pancreatitis. The American Journal of Gastroenterology, 105(2), 435-441.
[18]. Bollen, T. L., van Santvoort, H. C., Besselink, M. G., van Leeuwen, M. S., Horvath, K. D., Freeny, P. C., &Gooszen, H. G. 2012, Update on acute pancreatitis: ultrasound, computed tomography, and magnetic resonance imaging features. Seminars in Ultrasound, CT and MRI, 33(4), 375-384.
[19]. Mounzer, R., Langmead, C. J., Wu, B. U., Evans, A. C., Bishehsari, F., Muddana, V.,Whitcomb, D. C. 2012, Comparison of existing clinical scoring systems to predict persistent organ failure in patients with acute pancreatitis. Gastroenterology, 142(7), 1476-1482.
[20]. Garcea, G., Gouda, M., Hebbes, C., Ong, S. L., Neal, C. P., & Dennison, A. R. 2008, Predictors of severity and survival in acute pancreatitis: validation of the efficacy of early warning scores. Pancreatology, 8(2), 170-176.
Viewed PDF 3 0 -
Analysis of TGF-β Gene Expression in Carboplatin Treated Lung Cancer CellsAuthor: Durairaj SekarDOI: 10.21522/TIJPH.2013.12.04.Art094
Analysis of TGF-β Gene Expression in Carboplatin Treated Lung Cancer Cells
Abstract:
Cancer, characterized by uncontrolled cell growth, remains a formidable challenge in modern medicine. Among various treatment modalities, chemotherapy, a systemic approach using drugs to impede cancer cell proliferation, is a cornerstone of cancer therapy. This study aimed to analyze the trends in TGF-β gene expression in carboplatin-treated lung cancer cell line A549. The materials and methods included an MTT assay to assess cell survivability, RNA isolation using the TRIzol method, and further analysis by RT-PCR, with data statistically analyzed using SPSS software. Results showed that TGF-β gene expression was significantly lower in the A549 cell line treated with carboplatin compared to the untreated cell line. Specifically, the treated cells exhibited a 40% reduction in TGF-β expression, a statistically significant decrease (p < 0.05). Given that TGF-β is known to promote tumorigenesis, the observed reduction suggests that carboplatin may control tumor progression by downregulating TGF- β expression and the proliferation of cancer cells. In conclusion, our study demonstrates the effectiveness of carboplatin as a chemotherapy agent in inhibiting the proliferation of lung cancer cells (A549) in non-small cell lung cancer (NSCLC) by reducing TGF-β gene expression levels. These findings underscore the potential of carboplatin to modulate gene expression associated with tumor growth, offering a promising therapeutic strategy for NSCLC management. Future studies should explore the broader implications of TGF-β modulation in cancer treatment and investigate the potential of combining carboplatin with other therapeutic agents to enhance its efficacy.
Analysis of TGF-β Gene Expression in Carboplatin Treated Lung Cancer Cells
References:
[1]. Siegel, R. L., Giaquinto, A. N., & Jemal, A., (2024). Cancer statistics, 2024. CA: A Cancer Journal for Clinicians, 74(1), 12–49. https://doi.org/10.3322/caac.21820
[2]. World Health Organization., (2023, May). Lung Cancer. Https://Www.Who.Int/News-Room/Fact-Sheets/Detail/Lung-Cancer
[3]. Chaitanya Thandra, K., Barsouk, A., Saginala, K., Sukumar Aluru, J., & Barsouk, A., (2021). Epidemiology of lung cancer. Współczesna Onkologia, 25(1), 45–52. https://doi.org/10.5114/wo.2021.103829
[4]. Alexander, M., Kim, S. Y., & Cheng, H., (2020). Update 2020: Management of Non-Small Cell Lung Cancer. Lung, 198(6), 897–907. https://doi.org/10.1007/s00408-020-00407-5
[5]. Couraud, S., Zalcman, G., Milleron, B., Morin, F., & Souquet, P.-J., (2012). Lung cancer in never smokers – A review. European Journal of Cancer, 48(9), 1299–1311. https://doi.org/10.1016/j.ejca.2012.03.007
[6]. Zhang, C., Xu, C., Gao, X., & Yao, Q., (2022). Platinum-based drugs for cancer therapy and anti-tumor strategies. Theranostics, 12(5), 2115–2132. https://doi.org/10.7150/thno.69424
[7]. Sun, C.-C., Li, S.-J., & Li, D.-J. (2016). Hsa-miR-134 suppresses non-small cell lung cancer (NSCLC) development through down-regulation of CCND1. Oncotarget, 7(24), 35960–35978. https://doi.org/10.18632/oncotarget.8482
[8]. Liu, X., Han, Q., Rong, X., Yang, M., Han, Y., Yu, J., & Lin, X., (2020). ANKHD1 promotes the proliferation and invasion of non-small‑cell lung cancer cells via regulating YAP oncoprotein expression and inactivating the Hippo pathway. International Journal of Oncology. https://doi.org/10.3892/ijo.2020.4994
[9]. Kuppusamy, K. M., Selvaraj, S., Singaravelu, P., John, C. M., Racheal, K., Varghese, K., Kaliyamoorthy, D., Perumal, E., & Gunasekaran, K., (2023). Anti-microbial and anti-cancer efficacy of acetone extract of Rosa chinensis against resistant strain and lung cancer cell line. BMC Complementary Medicine and Therapies, 23(1), 406. https://doi.org/10.1186/s12906-023-04222-2
[10]. Ganesh, A., Ashikha Shirin Usman, P. P., K. P., A., Thomas, P., Ganapathy, D. M., & Sekar, D., (2024). Expression analysis of transforming growth factor beta (TGF-β) in oral squamous cell carcinoma. Oral Oncology Reports, 9, 100195. https://doi.org/10.1016/j.oor.2024.100195
[11]. Villar, V. H., Subotički, T., Đikić, D., Mitrović-Ajtić, O., Simon, F., & Santibanez, J. F. (2023). Transforming Growth Factor-β1 in Cancer Immunology: Opportunities for Immunotherapy (pp. 309–328). https://doi.org/10.1007/978-3-031-26163-3_17
[12]. Lamouille, S., Xu, J., & Derynck, R. (2014). Molecular mechanisms of epithelial-mesenchymal transition. Nature Reviews. Molecular Cell Biology, 15(3), 178–196. https://doi.org/10.1038/nrm3758
[13]. van den Bulk, J., de Miranda, N. F. C. C., & ten Dijke, P., (2021). Therapeutic targeting of TGF-β in cancer: hacking a master switch of immune suppression. Clinical Science, 135(1), 35–52. https://doi.org/10.1042/CS20201236
[14]. Dasari, S., & Tchounwou, P. B., (2014). Cisplatin in cancer therapy: molecular mechanisms of action. European Journal of Pharmacology, 740, 364–378. https://doi.org/10.1016/j.ejphar.2014.07.025
[15]. National Cancer Institute., (2007). Carboplatin. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/drugs/carboplatin
[16]. Stöhr, W., Paulides, M., Bielack, S., Jürgens, H., Koscielniak, E., Rossi, R., Langer, T., & Beck, J. D., (2007). Nephrotoxicity of cisplatin and carboplatin in sarcoma patients: A report from the late effects surveillance system. Pediatric Blood & Cancer, 48(2), 140–147. https://doi.org/10.1002/pbc.20812
[17]. Rajasegaran, T., How, C. W., Saud, A., Ali, A., & Lim, J. C. W., (2023). Targeting Inflammation in Non-Small Cell Lung Cancer through Drug Repurposing. Pharmaceuticals, 16(3), 451. https://doi.org/10.3390/ph16030451
[18]. Cocetta, V., Ragazzi, E., & Montopoli, M., (2019). Mitochondrial Involvement in Cisplatin Resistance. International Journal of Molecular Sciences, 20(14), 3384. https://doi.org/10.3390/ijms20143384
[19]. Galluzzi, L., Senovilla, L., Vitale, I., Michels, J., Martins, I., Kepp, O., Castedo, M., & Kroemer, G., (2012). Molecular mechanisms of cisplatin resistance. Oncogene, 31(15), 1869–1883. https://doi.org/10.1038/onc.2011.384
[20]. Kogure, Y., Iwasawa, S., Saka, H., Hamamoto, Y., Kada, A., Hashimoto, H., Atagi, S., Takiguchi, Y., Ebi, N., Inoue, A., Kurata, T., Okamoto, I., Yamaguchi, M., Harada, T., Seike, M., Ando, M., Saito, A. M., Kubota, K., Takenoyama, M., Gemma, A. (2021). Efficacy and safety of carboplatin with nab-paclitaxel versus docetaxel in older patients with squamous non-small-cell lung cancer (CAPITAL): A randomised, multicentre, open-label, phase 3 trial. The Lancet Healthy Longevity, 2(12), e791–e800. https://doi.org/10.1016/S2666-7568(21)00255-5
[21]. Shreya Reddy, C. S., Usman P. P, A. S., Ganapathy, D. M., K. P., A., & Sekar, D., (2024). MicroRNA-21 as a biomarker in terminal stage oral squamous cell carcinoma (OSCC) in the South Indian population. Oral Oncology Reports, 9, 100139. https://doi.org/10.1016/j.oor.2023.100139
[22]. Preca, B.-T., Bajdak, K., Mock, K., Lehmann, W., Sundararajan, V., Bronsert, P., Matzge-Ogi, A., Orian-Rousseau, V., Brabletz, S., Brabletz, T., Maurer, J., & Stemmler, M. P. (2017). A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer. Oncotarget, 8(7), 11530–11543. https://doi.org/10.18632/oncotarget.14563
[23]. Deng, R., Wang, S.-M., Yin, T., Ye, T.-H., Shen, G.-B., Li, L., Zhao, J.-Y., Sang, Y.-X., Duan, X.-G., & Wei, Y.-Q., (2012). Inhibition of Tumor Growth and Alteration of Associated Macrophage Cell Type by an HO-1 Inhibitor in Breast Carcinoma-Bearing Mice. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, 20(10), 473–482. https://doi.org/10.3727/096504013X13715991125684
Viewed PDF 3 0 -
Effect of Gender Preference for Healthcare Services Providers by Caregivers on Immunization Coverage in Zamfara State, Northern NigeriaAuthor: Abdulrazak Olajide OlatunjiDOI: 10.21522/TIJPH.2013.12.04.Art096
Effect of Gender Preference for Healthcare Services Providers by Caregivers on Immunization Coverage in Zamfara State, Northern Nigeria
Abstract:
The study examines the effect of gender preference for healthcare services providers by caregivers (parents and guardians) on immunization coverage in Zamfara state, Northern Nigeria. Primary data was collected from 200 caregivers from Kaura Namoda, Bakura and Gusau local government areas of the state using a semi-structured questionnaire administered by the interviewers. The data was analyzed using descriptive statistical tools and Binary Logistic regression models. The variables include preference for male healthcare providers, preference for female healthcare providers, and immunization coverage. The descriptive result shows that about 198 (99%) of the 200 caregivers preferred female healthcare providers, and only 2 (1%) are indifferent which means they have no particular gender preference. Results from Binary Logistic regression reveal a positive relationship between female healthcare providers and a potential increase of childhood immunization coverage and a negative relationship between male healthcare providers and a potential increase of childhood immunization coverage in those communities. In conclusion, to increase immunization coverage in Zamfara State, female healthcare providers should be prioritized over male healthcare providers.
Effect of Gender Preference for Healthcare Services Providers by Caregivers on Immunization Coverage in Zamfara State, Northern Nigeria
References:
[1]. Ejemai, Saye and Fiammelta, 2022, Gender Inequality and Childhood Immunization in Nigeria. Working paper: Link: Ejemai%2C+Saye+and+Fiammelta+%282022%29%2C&sca_esv=594946161&sxsrf=AM9HkKl3T5rwSHLM5&sclient=gws-wiz-serp
[2]. Cecilia Vidal Fuertes, Nicole E. Johns, Tracey S. Goodman, Shirin Heidari, Jean Munro, and Ahmad Reza Hossein poor, 2022, The Association between Childhood Immunization and Gender Inequality: A Multi-Country Ecological Analysis of Zero-Dose DTP Prevalence and DTP3 Immunization Coverage: Vaccines Basel. 2022 Jul; 10(7): 1032. Published online 2022 Jun 27. doi: 10.3390/vaccines10071032.
[3]. Orif., 2022 Office of International Religious Freedom, 2021 Report on International Religious Freedom: Nigeria: https://www.state.gov/reports/2021-report-on-international-religious-freedom/nigeria/
[4]. Vincent O. Nmehielle., 2004, “Sharia Law in the Northern States of Nigeria: To Implement or Not to Implement, the Constitutionality Is the Question’: Human Rights Quarterly Vol. 26, No. 3 Aug, 2004, pp. 730-759 (30 pages) Published By: The Johns Hopkins University Press.
[5]. Antai, D., 2009. Inequitable childhood immunization uptake in Nigeria: A multilevel analysis of individual and contextual determinants. BMC Infectious Diseases, 9, 181.doi.org/101186/1471-2334-9-181.
[6]. Gidado, S., Nguku, P., Biya, O., Waziri, N. E., Mohammed, A., Nsubuga, P., & Sabitu, K., 2014. Determinants of routine immunization coverage in Bungudu, Zamfara state, northern Nigeria. The Pan African Medical Journal, 18(1).
[7]. Galadima, A. N., Zulkefli, N. A. M., Said S. M., Ahmad, N., Factors influencing childhood immunisation uptake in Africa: a systematic review. BMC Public Health. 2021, 21:1475. doi: 10.1186/s12889-021-11466-5, PMID: [PMC free article] [PubMed] [CrossRef] [Google Scholar]
[8]. Dauda Milgwe Madubu., Sociodemographic Factors Associated with Childhood Vaccination Status in Sokoto State, Nigeria, 2021.
[9]. Elizabeth, B., Adedire, Ikeoluwapo Ajayi, Olufunmilayo. Fawole, Olufemi Ajumobi, Simon Kasasa, Peter Wasswa5* and Patrick Nguku., 2008, Immunisation coverage and its determinants among children aged 12-23 months in Atakumosa-west district, Osun State Nigeria: A cross-sectional study.
[10]. Abdulraheem, I., Onajole, A., Jimoh, A., Oladipo, A., 2011. Reasons for incomplete vaccination and factors for missed opportunities among rural Nigerian children. J. Public Health Epidemiol. 3, 194–203.
[11]. World Health Organisation, UNICEF. Progress and challenges with achieving universal immunization coverage, 2017.
[12]. WHO/UNICEF estimates of national immunization coverage Data as of July 2018. Geneva: World Health Organisation, 2018.
Viewed PDF 2 0 -
Molecular Docking Analysis of 9-Octadecene, 9,12,15-Octadecatrienoic acid, Methyl Ester, Phytol, 9,12-Octadecadienoic Acid and 9-Octadecenoic Acid with Anticancer Target Enzyme Caspase 3 (PDB: 1CP3)Author: P. AmudhaDOI: 10.21522/TIJPH.2013.12.04.Art097
Molecular Docking Analysis of 9-Octadecene, 9,12,15-Octadecatrienoic acid, Methyl Ester, Phytol, 9,12-Octadecadienoic Acid and 9-Octadecenoic Acid with Anticancer Target Enzyme Caspase 3 (PDB: 1CP3)
Abstract:
Computers and computing methods are commonly used in biological research today. In silico-molecular docking is a highly effective technology for identifying novel ligands for proteins with established structures and is crucial in the development of structure-based medicines. Caspase 3 plays a central role in apoptosis and splits many protein substrates in the cell when activated, which leads to cell death. Since it is known that many chemotherapies drugs trigger apoptosis in cancer cells, the promotion or activation of apoptosis through targeted control of apoptosis regulators has been proposed as a promising strategy for the discovery of cancer drugs. Therefore, in this present study in silico-molecular docking was carried out to determine the binding properties of 9-octadecene, 9, 12 and methyl ester, phytol, 15-octadecatrienoic acid, 9 and 12-octadecadien acids and 9-octadecenoic acid and target Protein 1CP3 (Caspase3). The study suggests that methyl ester, 9-octadecene, 9, 12-octadecadinenoic acid, phytol, 9,12,15-octadecatrienoic acid and phytol can inhibit caspase-3. Among the various phyto-compounds, 9,12,15-octadecatrienoic acid has more possible bond interactions than other compounds. Therefore, this study can serve as evidence of in vivo cancer activity that helps these molecules to come onto the market as over-the-counter medicines.
Molecular Docking Analysis of 9-Octadecene, 9,12,15-Octadecatrienoic acid, Methyl Ester, Phytol, 9,12-Octadecadienoic Acid and 9-Octadecenoic Acid with Anticancer Target Enzyme Caspase 3 (PDB: 1CP3)
References:
[1]. Krovat, E.M., Steindl, T., Langer, T., 2005, Recent advances in docking and scoring. Current computer-aided drug design. 1(1):93-102. https://doi.org/10.2174/1573409052952314
[2]. Venkatesan, S.K., Shukla, A.K., Dubey, V.K., 2010, Molecular docking studies of selected tricyclic and quinone derivatives on trypanothione reductase of Leishmania infantum. Journal of Computational Chemistry. 31(13):2463-75. https://doi.org/10.1002/jcc.21538
[3]. Tirumala, M.G., Anchi, P., Raja, S., Rachamalla, M., Godugu, C., 2021, Novel methods and approaches for safety evaluation of nanoparticle formulations: A focus towards in vitro models and adverse outcome pathways. Frontiers in pharmacology. 12:612659. https://doi.org/10.3389/fphar.2021.612659
[4]. Porter, A.G., Jänicke, R.U., 1999, Emerging roles of caspase-3 in apoptosis. Cell death & differentiation, 6(2), 99-104. https://doi.org/10.1038/sj.cdd.4400476
[5]. McIlwain, D.R., Berger, T., Mak, T.W., 2013, Caspase functions in cell death and disease. Cold Spring Harbor perspectives in biology. 5(4):a008656. DOI: 10.1101/cshperspect.a008656
[6]. Tuffery, P., Derreumaux, P., 2012, Flexibility and binding affinity in protein–ligand, protein–protein and multi-component protein interactions: limitations of current computational approaches. Journal of The Royal Society Interface. 9(66):20-33. https://doi.org/10.1098/rsif.2011.0584
[7]. Ghose, A.K., Crippen, G.M., 1987, Atomic physicochemical parameters for three dimensional-structure-directed quantitative structure activity relationships. Modelling dispersive and hydrophobic interactions. Journal of chemical information and computer sciences. 27, 21–35. https://doi.org/10.1021/ci00053a005
[8]. Binkowski, T.A., Naghibzadeg, S., Liang, J., 2003, CASTp computed atlas of surface topography of proteins. Nucleic acids research. 31, 3352– 3355. https://doi.org/10.1093/nar/gkg512
[9]. Vidya, S.M., Krishna, V., Manjunatha, B.K., Rajesh, K.P., Bharath, B.R., Manjunatha, H., 2012, Antibacterial and molecular docking studies of entagenic acid, a bioactive principle from seed kernel of Entada pursaetha. DC. Medicinal Chemistry Research. 21, 3195-3203. https://doi.org/10.1007/s00044-011-9614-4
[10]. Trott, O., Olson, A.J., 2010, AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of computational chemistry. 31, 455–461. https://doi.org/10.1002/jcc.21334
[11]. Van De Waterbeemd, H., Gifford, E., 2003, ADMET in silico modelling: towards prediction paradise? Nature reviews Drug discovery. 192–204. https://doi.org/10.1038/nrd1032
[12]. Stennicke, H.R., Ryan, C.A., Salvesen, G.S., 2002, Reprieval from execution: the molecular basis of caspase inhibition. Trends in biochemical sciences. 27(2), 94-101. https://doi.org/10.1016/S0968-0004(01)02045-X
[13]. Stennicke, H.R., Salvesen, G.S., 1999, Catalytic properties of the caspases. Cell Death & Differentiation. 6(11), 1054-9. https://doi.org/10.1038/sj.cdd.4400599
[14]. Web, S.J., Harrison, D.J., Willey, A.H., 1997, In Apoptosis: Pharmacological Implication sand Therapeutic Opportunities, S.H. Kaufmann (Ed.), San Diego, Academic Press.
[15]. Nuttall, M.E., Lee, D., McLaughlin, B., Erhardt, J.A., 2001, Selective inhibitors of apoptotic caspases: implications for novel therapeutic strategies. Drug Discovery Today, 6(2), 85-91. https://doi.org/10.1016/S1359-6446(00)01601-9
[16]. Persad, R., Liu, C., Wu, T.T., Houlihan, P.S., Hamilton, S.R., Diehl, A.M., Rashid, A., 2004, Overexpression of caspase-3 in hepatocellular carcinomas. Modern pathology. 17(7):861-7. https://doi.org/10.1038/modpathol.3800146
[17]. Chang, Y.J., Linh, N.H., Shih, Y.H., Yu, H.M., Li, M.S., Chen, Y.R., 2016, Alzheimer's amyloid-beta sequesters caspase-3 in vitro via its C-terminal tail. ACS Chemical Neuroscience. 7, 1097-1106. https://doi.org/10.1021/acschemneuro.6b00049
[18]. Flanagan. L., Meyer, M., Fay, J., Curry, S., Bacon, O., Duessmann, H., John, K., Boland, K.C., McNamara, D.A., Kay, E.W., Bantel, H., Schulze-Bergkamen, H., Prehn, J.H., 2016, Low levels of caspase-3 predict favourable response to 5FU-based chemotherapy in advanced colorectal cancer: caspase-3 inhibition as a therapeutic approach. Cell death & disease. 7, e2087. https://doi.org/10.1038/cddis.2016.7
[19]. Yadav, P., Yadav, R., Jain, S., Vaidya, A., 2021, Caspase‐3: A primary target for natural and synthetic compounds for cancer therapy. Chemical biology & drug design. 98(1):144-65. https://doi.org/10.1111/cbdd.13860
[20]. Srivastava, S., Singh, P., Jha, K.K., Mishra, G., Srivastava, S., Khosa, RL., 2012, Evaluation of anti-arthritic potential of the methanolic extract of the aerial parts of Costus speciosus. Journal of Ayurveda and integrative medicine. 3(4), 204-8. DOI: 10.4103/0975-9476.104443.
[21]. Tabassum, S., Zaki, M., Afzal, M., Arjmand, F., 2014, Synthesis and characterization of Cu (II)-based anticancer chemotherapeutic agent targeting topoisomerase Iα: in vitro DNA binding, pBR322 cleavage, molecular docking studies and cytotoxicity against human cancer cell lines. European journal of medicinal chemistry. 74, 509–523. https://doi.org/10.1016/j.ejmech.2013.12.046
[22]. Zhang, Y., Lee, P., Liang, S., Zhou, Z., Wu, X., Yang, F., Liang, H., 2015, Structural basis of non‐steroidal anti‐inflammatory drug diclofenac binding to human serum albumin. Chemical biology & drug design, 86(5), 1178-1184. https://doi.org/10.1111/cbdd.12583
Viewed PDF 1 0 -
Ghana Needs a Comprehensive Blueprint for Pandemic ManagementAuthor: Victor Collins WutorDOI: 10.21522/TIJPH.2013.12.04.Art095
Ghana Needs a Comprehensive Blueprint for Pandemic Management
Abstract:
This major study aimed to determine Ghanaian physicians, pharmacists, and nurses' knowledge, perception, and preparedness for a pandemic or another wave of COVID-19. The cross-sectional study, comprising 55 questions about COVID-19 knowledge, 29 about perception, and 21 about preparedness, was conducted between May and July 2023. The questionnaire was distributed through various social media platforms, ensuring a national reach. Participation from all 16 regions of Ghana was recorded for all three professionals. The inclusion criteria, a key aspect, are based on the healthcare professionals directly linked with hospitals and facilities who had direct contact with patients. Three thousand three hundred and twenty-three healthcare professionals responded to the survey, giving a 97% response rate. Seven hundred seventy-seven physicians, 1199 pharmacists, and 1347 nurses responded to the study, showcasing the extensive expertise of Ghanaian healthcare professionals. The findings reveal that Ghanaian physicians ranked high regarding their knowledge of COVID-19. Our study further shows that 98% of the pharmacist participants provided positive feedback about knowledge-related questions and an adequate understanding of attitudes toward coronavirus symptoms, transmission, disease severity, and preventive measures. The study also reveals that Ghanaian nurses were knowledgeable, had a good perception, and were prepared for a pandemic or another wave of COVID-19. However, the study also highlights a concerning trend where the level of preparedness for a pandemic or another wave of COVID-19 was low in all instances. In conclusion, this study underscores the critical role of knowledge in shaping the actions of Ghanaian healthcare professionals in response to the COVID-19 pandemic threats. It also emphasizes the urgent need for a comprehensive blueprint for pandemic management in Ghana to address this gap.
Ghana Needs a Comprehensive Blueprint for Pandemic Management
References:
[1]. Adokiya, M. N., & Awoonor-Williams, J. K., 2016, Ebola virus disease surveillance and response preparedness in northern Ghana. Global Health Action, 9(1), 29763.
[2]. Amponsah-Tabi, S., Djokoto, R., Opoku, S., Senu, E., Boakye, D. K., Azanu, W. K., Ankobea-Kokroe, F., Owusu-Asubonteng, G., Ansah, R. O., & Owusu, E., 2023, Knowledge, attitude, and acceptability of COVID-19 vaccine among residents in rural communities in Ghana: A multi-regional study. BMC Infectious Diseases, 23(1), 60.
[3]. Annan, A. A., Yar, D. D., Owusu, M., Biney, E. A., Forson, P. K., Okyere, P. B., Gyimah, A. A., & Owusu-Dabo, E., 2017, Healthcare workers indicate ill-preparedness for the Ebola Virus outbreak in the Ashanti region of Ghana. BMC Public Health, pp. 17, 1–7.
[4]. Antwi-Boasiako, J., & Asamoah-Gyadu, G., 2023, Government preparedness towards Ebola and COVID-19 health crises in Ghana. Public Organization Review, 23(2), 515-530.
[5]. Asante, D. O., Dai, A., Walker, A. N., Zhou, Z., Kpogo, S. A., Lu, R., Huang, K., & Zou, J., 2023, Assessing hypertension and diabetes knowledge, attitudes, and practices among residents in Akatsi South District, Ghana, using the KAP questionnaire. Frontiers in Public Health, p. 11, 1056999.
[6]. Bamgboye, E. L., Omiye, J. A., Afolaranmi, O. J., Davids, M. R., Tannor, E. K., Wadee, S., Niang, A., Were, A., & Naicker, S., 2021, COVID-19 pandemic: Is Africa different? Journal of the National Medical Association, 113(3), 324-335.
[7]. Chersich, M. F., Gray, G., Fairlie, L., Eichbaum, Q., Mayhew, S., Allwood, B., English, R., Scorgie, F., Luchters, S., & Simpson, G., 2020, COVID-19 in Africa: Care and protection for frontline healthcare workers. Globalization and Health, 16, 1-6.
[8]. Chiluba, B. C., & Dube, G., 2020, Descriptive review of epidemiological geographic mapping of coronavirus disease 2019 (COVID-19) online. Biomedical and Biotechnology Research Journal (BBRJ), 4(2), 83-89.
[9]. Craig, J., Kalanxhi, E., & Hauck, S., 2020, National estimates of critical care capacity in 54 African countries. (preprint).
[10]. Du, J., Dong, L., Wang, T., Yuan, C., Fu, R., Zhang, L., Liu, B., Zhang, M., Yin, Y., & Qin, J., 2020, Psychological symptoms among frontline healthcare workers during the COVID-19 outbreak in Wuhan. General Hospital Psychiatry, pp. 67, 144.
[11]. Ferretti, L., Ledda, A., Wymant, C., Zhao, L., Ledda, V., Abeler-Dörner, L., Kendall, M., Murray, A., Cheng, H.-Y., & Ng, T.-C., 2020, The timing of COVID-19 transmission. MedRxiv, 2020.2009. 2004.20188516.
[12]. Garchie, E. I., Mensah, B. T., & Ntiamoah, E. O., 2023, Occupational health and safety practices among frontline Medical laboratory staff in the COVID-19 testing centers in the Bono region of Ghana. Current Research in Vaccines Vaccination, 2(3), 63-72.
[13]. Guest, J. L., Del Rio, C., & Sanchez, T., 2020, The three steps needed to end the COVID-19 pandemic are bold public health leadership, rapid innovations, and courageous political will. In (Vol. 6, pp. e19043): JMIR Publications Toronto, Canada.
[14]. Heuschen, A.-K., Abdul-Mumin, A., Abubakari, A., Agbozo, F., Lu, G., Jahn, A., & Müller, O., 2023, Effects of the COVID-19 pandemic on Ghana's general health and malaria control: a qualitative study with mothers and health care professionals. Malaria Journal, 22(1), 78.
[15]. Kopacz, M. S., Ames, D., & Koenig, H. G., 2019, It is time to discuss physician burnout and moral injury: the Lancet Psychiatry, 6(11), e28.
[16]. Luo, M., Guo, L., Yu, M., Jiang, W., & Wang, H., 2020, The psychological and mental impact of coronavirus disease 2019 (COVID-19) on medical staff and the general public–A systematic review and meta-analysis. Psychiatry Research, 291, 113190.
[17]. Organization, W. H., 2021a, COVID-19-related mortality and morbidity among healthcare providers—based on information as of 14 February 2021.
[18]. Organization, W. H., 2021b, COVID-19 weekly epidemiological update, 11 May 2021.
[19]. Raina, S. K., Kumar, R., Galwankar, S., Garg, S., Bhatt, R., Dhariwal, A. C., Christopher, D., Parekh, B. J., Krishnan, S. V., & Aggarwal, P., 2020, Are we prepared? Lessons from COVID-19 and OMAG position paper on epidemic preparedness. Journal of Family Medicine and Primary Care, 9(5), 2161–2166.
[20]. Romero-Rodríguez, E., Pérula-de Torres, L. Á., Castro-Jiménez, R., González-Lama, J., Jiménez-García, C., González-Bernal, J. J., González-Santos, J., Vélez-Santamaría, R., Sánchez-González, E., & Santamaría-Peláez, M., 2022, Hospital admission and vaccination as predictive factors of long COVID-19 symptoms. Frontiers in Medicine, 9, 1016013.
[21]. Salehi, R., de Young, S., Asamoah, A., Aryee, S. E., Eli, R., Couper, B., Smith, B., Djokoto, C., Agyeman, Y. N., & Zakaria, A.-F. S., 2023, Evaluation of a continuing professional development strategy on COVID-19 for 10,000 health workers in Ghana: a two-pronged approach. Human Resources for Health, 21(1), 18.
[22]. Suleiman, A., Bsisu, I., Guzu, H., Santarisi, A., Alsatari, M., Abbad, A., Jaber, A., Harb, T. A., Abuhejleh, A., & Nadi, N., 2020, Preparedness of frontline doctors in Jordan healthcare facilities for the COVID-19 outbreak. International Journal of Environmental Research and Public Health, 17(9), 3181.
[23]. Victor C Wutor., 2021, The pharmacist is a member of the COVID-19 public health team. Ghana College of Pharmacists Journal. 1 (1) 49-52
[24]. Wutor, V., 2021, While waiting for COVID-19 vaccine rollout and treatment! International Journal of Community Medicine and Public Health Wutor V. Int J Community Med Public Health. 2021 Feb;8(2):845-848
Viewed PDF 3 0 -
Case Series of Comminuted Fractures of Proximal Tibia with Ligament Injuries Treated with Knee Spanning Ilizarov FixationAuthor: Suraj Sunderraj JosephDOI: 10.21522/TIJPH.2013.12.04.Art098
Case Series of Comminuted Fractures of Proximal Tibia with Ligament Injuries Treated with Knee Spanning Ilizarov Fixation
Abstract:
Comminuted fractures of the tibial plateau with intra-articular extension and ligament injuries are caused by high-energy trauma. The associated high rate of soft tissue injuries leads to complications like joint stiffness, compartment syndrome, malunion, skin loss, osteomyelitis, knee contractures, and potential amputation. The knee-spanning Ilizarov external fixator minimizes these complications by allowing early mobilization and weight-bearing, reducing soft tissue injury and blood loss, and providing stable fixation. Assessment using the Knee Society Score pre- and post-operatively showed improvement. This prospective study includes 15 patients with comminuted tibial intra-articular fractures and associated ligament injuries, treated with knee-spanning Ilizarov fixation. Clinical and radiological assessments post-procedure indicated positive outcomes. Out of 15 patients, 80% achieved good clinical and radiological outcomes, including early mobilization, normal gait, and successful fracture healing. Complications included pin tract infections (2 patients), knee stiffness (1 patient), and secondary procedures such as arthrodesis and TKR due to arthritis.
Case Series of Comminuted Fractures of Proximal Tibia with Ligament Injuries Treated with Knee Spanning Ilizarov Fixation
References:
[1]. Rockwood, C., Green, D., 2006, Fractures in Adults, 6th ed., Volume 2, Philadelphia: Lippincott Williams & Wilkins.
[2]. Joveniaux, P., Ohl, X., Harisboure, A., Berrichi, A., Labatut, L., Simon, P., Mainard, D., Vix, N., Dehoux, E., 2010, Distal tibia fractures: management and complications of 101 cases, International Orthopaedics, 34(4), pp. 583-588, https://doi.org/10.1007/s00264-009-0832-z
[3]. Dillin, L., Slabaugh, P., 1986, Delayed wound healing, infection, and non-union following open reduction and internal fixation of tibial plafond fractures, Journal of Trauma, 26(12), pp. 1116-1119.
[4]. McFerran, M. A., Smith, S. W., Boulas, H. J., Schwartz, H. S., 1992, Complications encountered in the treatment of pilon fractures, Journal of Orthopaedic Trauma, 6(2), pp. 195-200.
[5]. Teeny, S. M., Wiss, D. A., 1993, Open reduction and internal fixation of tibial plafond fractures: variables contributing to poor results and complications, Clinical Orthopaedics and Related Research, 292, pp. 108-117.
[6]. Tull, F., Borrelli, J., 2003, Soft-tissue injury associated with closed fractures: evaluation and management, Journal of the American Academy of Orthopaedic Surgeons, 11, pp. 431-438.
[7]. Sirkin, M., Sanders, R., DiPasquale, T., Herscovici, D., 2004, A staged protocol for soft tissue management in the treatment of complex pilon fractures, Journal of Orthopaedic Trauma, 18(Suppl 8), pp. S32-S38.
[8]. Dickson, K. F., Montgomery, S., Field, J., 2001, High energy plafond fractures treated by a spanning external fixator initially and followed by a second stage open reduction internal fixation of the articular surface—preliminary report, Injury, 32(Suppl 4), pp. 92-98.
[9]. Mauffrey, C., Vasario, G., Battiston, B., Lewis, C., Beazley, J., Seligson, D., 2011, Tibial pilon fractures: a review of incidence, diagnosis, treatment, and complications, Acta Orthopaedica Belgica, 77, pp. 432-440.
[10]. Zelle, B., Bhandari, M., Espiritu, M., Koval, K., Zlowodzki, M., 2006, Treatment of distal tibia fractures without articular involvement: a systematic review of 1125 fractures, Journal of Orthopaedic Trauma, 20(1), pp. 76-79.
[11]. Robinson, C. M., McLauchlan, G. J., McLean, I. P., Court-Brown, C. M., 1995, Distal metaphyseal fractures of the tibia with minimal involvement of the ankle: classification and treatment by locked intramedullary nailing, Journal of Bone and Joint Surgery British Volume, 77-B, pp. 781-787.
[12]. Casstevens, C., Le, T., Archdeacon, M. T., Wyrick, J. D., 2012, Management of extra-articular fractures of the distal tibia: intramedullary nailing versus plate fixation, Journal of the American Academy of Orthopaedic Surgeons, 20(11), pp. 675-683.
[13]. Newman, S. D., Mauffrey, C. P., Krikler, S., 2011, Distal metadiaphyseal tibial fractures, Injury, 42(10), pp. 975-984.
[14]. Tornetta, P. III, Weiner, L., Bergman, M., Watnik, N., Steuer, J., Kelly, M., Yang, E., 1993, Pilon fractures: treatment with combined internal and external fixation, Journal of Orthopaedic Trauma, 7(6), pp. 489-496.
[15]. Wrysch, B., McFerran, M. A., McAndrew, M., Limbird, T. J., Harper, M. C., Johnson, K. D., Schwartz, H. S., 1996, Operative treatment of fractures of the tibial plafond: a randomized, prospective study, Journal of Bone and Joint Surgery American Volume, 78(11), pp. 1646-1657.
[16]. Ristiniemi, J., Flinkkila, T., Hyvonen, P., Lakovaara, M., Pakarinen, H., Jalovaara, P., 2007, RhBMP-7 accelerates the healing in distal tibial fractures treated by external fixation, Journal of Bone and Joint Surgery British Volume, 89(2), pp. 265-272.
[17]. Barbieri, R., Schenk, R., Koval, K., Aurori, K., Aurori, B., 1996, Hybrid external fixation in the treatment of tibial plafond fractures, Clinical Orthopaedics and Related Research, 332, pp. 16-22.
[18]. McDonald, M. G., Burgess, R. C., Bolano, L. E., Nicholls, P. J., 1996, Ilizarov treatment of pilon fractures, Clinical Orthopaedics and Related Research, 325, pp. 232-238.
[19]. Lovisetti, G., Agus, M. A., Pace, F., Capitani, D., Sala, F., 2009, Management of distal tibial intra-articular fractures with circular external fixation, Strategies in Trauma and Limb Reconstruction, 4(1), pp. 1-6.
[20]. 20. Vasiliadis, E. S., Grivas, T. B., Psarakis, S. A., Evangelos, P., Kaspiris, A., Triantafyllopoulos, G., 2009, Advantages of the Ilizarov external fixation in the management of intra-articular fractures of the distal tibia, Journal of Orthopaedic Surgery and Research, 4, pp. 35, https://doi.org/10.1186/1749-799X-4-35
Viewed PDF 3 0